name,category,terms1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),INTERPRO[450001881$IPR002123:Phospholipid/glycerol acyltransferase, 450004045$IPR004552:1-acyl-sn-glycerol-3-phosphate acyltransferase]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism, 470038778$hsa00564:Glycerophospholipid metabolism, 470038779$hsa00565:Ether lipid metabolism]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),OMIM_DISEASE[520000551$Berardinelli-Seip congenital lipodystrophy, 520002904$Lipodystrophy, congenital generalized, type 1]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),PIR_SUPERFAMILY[630012579$PIRSF015813:1-acyl-sn-glycerol-3-phosphate acyltransferase]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),SMART[760000502$SM00563:PlsC]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790000362$congenital generalized lipodystrophy, 790000430$diabetes mellitus, 790000446$disease mutation, 790000919$membrane, 790001156$phospholipid biosynthesis, 790001162$phosphoprotein, 790001547$transferase, 790001555$transmembrane]
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta),UP_SEQ_FEATURE[850000732$chain:1-acyl-sn-glycerol-3-phosphate acyltransferase beta, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117491$short sequence motif:HXXXXD motif, 850118574$splice variant, 850118623$transmembrane region]
1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon),INTERPRO[450001881$IPR002123:Phospholipid/glycerol acyltransferase]
1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon),PIR_SUPERFAMILY[630005165$PIRSF005233:1-acyl-sn-glycerol-3-phosphate acyltransferase]
1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon),SMART[760000502$SM00563:PlsC]
1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000919$membrane, 790001156$phospholipid biosynthesis, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon),UP_SEQ_FEATURE[850000734$chain:1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon, 850117294$sequence conflict, 850117295$sequence variant, 850117491$short sequence motif:HXXXXD motif, 850118623$transmembrane region]
3-oxoacid CoA transferase 2,COG_ONTOLOGY[90000084$Lipid metabolism]
3-oxoacid CoA transferase 2,INTERPRO[450003673$IPR004163:Coenzyme A transferase binding site, 450003674$IPR004164:Coenzyme A transferase active site, 450003675$IPR004165:Coenzyme A transferase, 450011470$IPR012791:3-oxoacid CoA-transferase, subunit B, 450011471$IPR012792:3-oxoacid CoA-transferase, subunit A, 450012966$IPR014388:3-oxoacid CoA-transferase]
3-oxoacid CoA transferase 2,KEGG_PATHWAY[470038735$hsa00072:Synthesis and degradation of ketone bodies, 470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038790$hsa00650:Butanoate metabolism]
3-oxoacid CoA transferase 2,PIR_SUPERFAMILY[630000994$PIRSF000858:3-oxoacid CoA-transferase, 630000995$PIRSF000858:SCOT-t, 630010698$PIRSF012663:CoA-transferase, beta subunit]
3-oxoacid CoA transferase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001547$transferase, 790001550$transit peptide]
3-oxoacid CoA transferase 2,UP_SEQ_FEATURE[850062757$chain:Succinyl-CoA:3-ketoacid-coenzyme A transferase 2, mitochondrial, 850111264$region of interest:CoA-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
5'-3' exoribonuclease 1,COG_ONTOLOGY[90000059$DNA replication, recombination, and repair / Cell division and chromosome partitioning / Translation]
5'-3' exoribonuclease 1,INTERPRO[450004335$IPR004859:Putative 5-3 exonuclease, 450014815$IPR016494:5'-3' exoribonuclease 1]
5'-3' exoribonuclease 1,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
5'-3' exoribonuclease 1,PIR_SUPERFAMILY[630006695$PIRSF006743:5'-3' exonuclease, Xnr1 type, 630006696$PIRSF006743:Exonuclease_Xnr1]
5'-3' exoribonuclease 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001162$phosphoprotein, 790001163$phosphoric diester hydrolase, 790001212$polymorphism, 790001339$rna-binding, 790001580$tumor suppressor]
5'-3' exoribonuclease 1,UP_SEQ_FEATURE[850002132$chain:5'-3' exoribonuclease 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
5'-3' exoribonuclease 2,COG_ONTOLOGY[90000059$DNA replication, recombination, and repair / Cell division and chromosome partitioning / Translation]
5'-3' exoribonuclease 2,INTERPRO[450001661$IPR001878:Zinc finger, CCHC-type, 450004335$IPR004859:Putative 5-3 exonuclease, 450015471$IPR017151:5'-3' exoribonuclease 2]
5'-3' exoribonuclease 2,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
5'-3' exoribonuclease 2,PIR_SUPERFAMILY[630028770$PIRSF037239:5'-3' exonuclease, Xrn2 type, 630028771$PIRSF037239:Exonuclease_Xrn2]
5'-3' exoribonuclease 2,SMART[760000311$SM00343:ZnF_C2HC]
5'-3' exoribonuclease 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790000937$metal-binding, 790000988$mrna processing, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001544$transcription termination, 790001648$zinc, 790001651$zinc-finger]
5'-3' exoribonuclease 2,UP_SEQ_FEATURE[850002133$chain:5'-3' exoribonuclease 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118776$zinc finger region:CCHC-type]
5'-nucleotidase domain containing 2,INTERPRO[450007657$IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase, 450015015$IPR016695:Purine 5'-nucleotidase]
5'-nucleotidase domain containing 2,PIR_SUPERFAMILY[630014184$PIRSF017434:Purine_5'-nucleotidase]
5'-nucleotidase domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001212$polymorphism]
5'-nucleotidase domain containing 2,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850002150$chain:5'-nucleotidase domain-containing protein 2, 850106107$metal ion-binding site:Magnesium, 850106170$metal ion-binding site:Magnesium; via carbonyl oxygen, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
5-hydroxytryptamine (serotonin) receptor 1F,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000383$IPR000450:5-Hydroxytryptamine 1F receptor, 450001978$IPR002231:5-Hydroxytryptamine receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
5-hydroxytryptamine (serotonin) receptor 1F,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
5-hydroxytryptamine (serotonin) receptor 1F,PIR_SUPERFAMILY[630005396$PIRSF005474:5-hydroxytryptamine receptor 1, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
5-hydroxytryptamine (serotonin) receptor 1F,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001026$neurotransmitter receptor, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
5-hydroxytryptamine (serotonin) receptor 1F,UP_SEQ_FEATURE[850002196$chain:5-hydroxytryptamine receptor 1F, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3,INTERPRO[450001187$IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, 450002719$IPR003094:Fructose-2,6-bisphosphatase, 450011723$IPR013078:Phosphoglycerate mutase, 450011724$IPR013079:6-phosphofructo-2-kinase, 450014584$IPR016260:Bifunctional 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3,KEGG_PATHWAY[470038729$hsa00051:Fructose and mannose metabolism]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3,PIR_SUPERFAMILY[630000821$PIRSF000709:6PFK_2-Ptase, 630000822$PIRSF000709:bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000825$kinase, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001151$phosphohistidine, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001168$phosphotransferase, 790001189$placenta, 790001547$transferase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000158$active site:Tele-phosphohistidine intermediate, 850000362$binding site:Fructose-6-phosphate, 850002500$chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 3, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110612$region of interest:6-phosphofructo-2-kinase, 850111707$region of interest:Fructose-2,6-bisphosphatase, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
6-pyruvoyltetrahydropterin synthase,INTERPRO[450006489$IPR007115:6-pyruvoyl tetrahydropterin synthase-related, 450006490$IPR007116:6-pyruvoyl tetrahydropterin synthase]
6-pyruvoyltetrahydropterin synthase,KEGG_PATHWAY[470038800$hsa00790:Folate biosynthesis]
6-pyruvoyltetrahydropterin synthase,OMIM_DISEASE[520002461$Hyperphenylalaninemia due to PTS deficiency, 520002462$Hyperphenylalaninemia, BH4-deficient, A, 520003975$Phenylketonuria due to PTS deficiency]
6-pyruvoyltetrahydropterin synthase,PIR_SUPERFAMILY[630006041$PIRSF006113:6-pyruvoyl tetrahydropterin synthase]
6-pyruvoyltetrahydropterin synthase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000891$lyase, 790000937$metal-binding, 790001141$phenylketonuria, 790001162$phosphoprotein, 790001497$tetrahydrobiopterin biosynthesis, 790001648$zinc]
6-pyruvoyltetrahydropterin synthase,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000114$active site:Proton acceptor, 850002525$chain:6-pyruvoyl tetrahydrobiopterin synthase, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
A kinase (PRKA) anchor protein 10,INTERPRO[450000294$IPR000342:Regulator of G protein signalling]
A kinase (PRKA) anchor protein 10,OMIM_DISEASE[520000755$Cardiac conduction defect, susceptibility to, 520002951$Longevity, reduced]
A kinase (PRKA) anchor protein 10,SMART[760000285$SM00315:RGS]
A kinase (PRKA) anchor protein 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001550$transit peptide]
A kinase (PRKA) anchor protein 10,UP_SEQ_FEATURE[850002953$chain:A kinase anchor protein 10, mitochondrial, 850105179$domain:RGS 1, 850105180$domain:RGS 2, 850106258$modified residue, 850114056$region of interest:PKA-RII subunit binding, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
A kinase (PRKA) anchor protein 7,INTERPRO[450017747$IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain, 450017748$IPR019511:Protein kinase A anchor protein, RI-RII subunit-binding domain]
A kinase (PRKA) anchor protein 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001100$palmitate, 790001212$polymorphism]
A kinase (PRKA) anchor protein 7,UP_SEQ_FEATURE[850002970$chain:A-kinase anchor protein 7 isoform gamma, 850002971$chain:A-kinase anchor protein 7 isoforms alpha and beta, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850114237$region of interest:Required for apical membrane localization, 850114425$region of interest:Required for membrane localization, 850114538$region of interest:RII-binding, 850117295$sequence variant, 850118574$splice variant]
ABI family, member 3,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
ABI family, member 3,SMART[760000295$SM00326:SH3]
ABI family, member 3,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
ABI family, member 3,UP_SEQ_FEATURE[850003171$chain:ABI gene family member 3, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850117295$sequence variant]
ADAM metallopeptidase with thrombospondin type 1 motif, 13,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450001412$IPR001590:Peptidase M12B, ADAM/reprolysin, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450007420$IPR008085:Thrombospondin, type 1 repeat, subgroup, 450011909$IPR013273:Peptidase M12B, ADAM-TS, 450016643$IPR018358:Disintegrin, conserved site]
ADAM metallopeptidase with thrombospondin type 1 motif, 13,OMIM_DISEASE[520004059$Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes, 520004850$Thrombotic thrombocytopenic purpura, familial]
ADAM metallopeptidase with thrombospondin type 1 motif, 13,SMART[760000182$SM00209:TSP1]
ADAM metallopeptidase with thrombospondin type 1 motif, 13,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000192$blood coagulation, 790000211$calcium, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000666$hemostasis, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc, 790001652$zymogen]
ADAM metallopeptidase with thrombospondin type 1 motif, 13,UP_SEQ_FEATURE[850002935$chain:A disintegrin and metalloproteinase with thrombospondin motifs 13, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103526$domain:Disintegrin, 850104962$domain:Peptidase M12B, 850105555$domain:TSP type-1 1, 850105566$domain:TSP type-1 2, 850105575$domain:TSP type-1 3, 850105576$domain:TSP type-1 4, 850105577$domain:TSP type-1 5, 850105578$domain:TSP type-1 6, 850105579$domain:TSP type-1 7, 850105580$domain:TSP type-1 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850105909$metal ion-binding site:Calcium, 850106244$metal ion-binding site:Zinc; catalytic, 850106259$mutagenesis site, 850111381$region of interest:Cysteine-rich, 850114683$region of interest:Spacer, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118574$splice variant]
ADP-ribosylation factor 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets.]
ADP-ribosylation factor 1,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 1,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
ADP-ribosylation factor 1,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 1,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000639$gtp-binding, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 1,UP_SEQ_FEATURE[850004004$chain:ADP-ribosylation factor 1, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand, 850118624$turn]
ADP-ribosylation factor 3,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 3,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 3,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 3,SP_PIR_KEYWORDS[790000189$blocked amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 3,UP_SEQ_FEATURE[850004008$chain:ADP-ribosylation factor 3, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106296$nucleotide phosphate-binding region:GTP]
ADP-ribosylation factor 4,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 4,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 4,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000356$complete proteome, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790000983$monomer, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 4,UP_SEQ_FEATURE[850004009$chain:ADP-ribosylation factor 4, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
ADP-ribosylhydrolase like 2,INTERPRO[450004957$IPR005502:ADP-ribosylation/Crystallin J1]
ADP-ribosylhydrolase like 2,PIR_SUPERFAMILY[630005953$PIRSF006017:ADP-ribosylglycohydrolase]
ADP-ribosylhydrolase like 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism]
ADP-ribosylhydrolase like 2,UP_SEQ_FEATURE[850039760$chain:Poly(ADP-ribose) glycohydrolase ARH3, 850102565$compositionally biased region:Poly-Ala, 850105852$helix, 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
ASF1 anti-silencing function 1 homolog A (S. cerevisiae),INTERPRO[450006222$IPR006818:Histone chaperone,  ASF1-like]
ASF1 anti-silencing function 1 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000288$Chaperone, 790000311$chromatin regulator, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
ASF1 anti-silencing function 1 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850023883$chain:Histone chaperone ASF1A, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112404$region of interest:Interaction with histone H3, CHAF1B, and HIRA, 850114347$region of interest:Required for interaction with HIRA, 850117294$sequence conflict, 850117685$short sequence motif:Required for interaction with HIRA, 850118575$strand]
ASF1 anti-silencing function 1 homolog B (S. cerevisiae),INTERPRO[450006222$IPR006818:Histone chaperone,  ASF1-like]
ASF1 anti-silencing function 1 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000288$Chaperone, 790000311$chromatin regulator, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001065$nucleus, 790001162$phosphoprotein, 790001426$spermatogenesis, 790001539$Transcription, 790001543$transcription regulation]
ASF1 anti-silencing function 1 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850023884$chain:Histone chaperone ASF1B, 850106258$modified residue, 850112183$region of interest:Interaction with CHAF1B, 850112401$region of interest:Interaction with histone H3, 850117294$sequence conflict]
AT rich interactive domain 3C (BRIGHT-like),INTERPRO[450001424$IPR001606:AT-rich interaction region]
AT rich interactive domain 3C (BRIGHT-like),SMART[760000444$SM00501:BRIGHT]
AT rich interactive domain 3C (BRIGHT-like),SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
AT rich interactive domain 3C (BRIGHT-like),UP_SEQ_FEATURE[850006388$chain:AT-rich interactive domain-containing protein 3C, 850102507$compositionally biased region:Glu-rich, 850102586$compositionally biased region:Pro-rich, 850103060$domain:ARID, 850117295$sequence variant]
ATG5 autophagy related 5 homolog (S. cerevisiae),INTERPRO[450006608$IPR007239:Autophagy-related  protein 5]
ATG5 autophagy related 5 homolog (S. cerevisiae),KEGG_PATHWAY[470038839$hsa04140:Regulation of autophagy, 470038864$hsa04622:RIG-I-like receptor signaling pathway]
ATG5 autophagy related 5 homolog (S. cerevisiae),PIR_SUPERFAMILY[630008090$PIRSF008751:Saccharomyces APG5 protein]
ATG5 autophagy related 5 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000148$autophagy, 790000356$complete proteome, 790000407$cytoplasm, 790000811$isopeptide bond, 790001212$polymorphism, 790001592$ubl conjugation]
ATG5 autophagy related 5 homolog (S. cerevisiae),UP_SEQ_FEATURE[850006859$chain:Autophagy protein 5, 850102711$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATP citrate lyase,BIOCARTA[30000178$h_malatexPathway:Shuttle for transfer of acetyl groups from mitochondria to the cytosol]
ATP citrate lyase,COG_ONTOLOGY[90000064$Energy production and conversion]
ATP citrate lyase,INTERPRO[450003321$IPR003781:CoA-binding, 450005258$IPR005810:Succinyl-CoA ligase, alpha subunit, 450005259$IPR005811:ATP-citrate lyase/succinyl-CoA ligase, 450012420$IPR013816:ATP-grasp fold, subdomain 2, 450013130$IPR014608:ATP-citrate synthase, 450014426$IPR016040:NAD(P)-binding domain, 450014470$IPR016102:Succinyl-CoA synthetase-like, 450014499$IPR016143:Citrate synthase-like, small alpha subdomain, 450015768$IPR017440:ATP-citrate lyase/succinyl-CoA ligase, active site, 450016185$IPR017866:Succinyl-CoA synthetase, beta subunit, conserved site]
ATP citrate lyase,KEGG_PATHWAY[470038726$hsa00020:Citrate cycle (TCA cycle)]
ATP citrate lyase,PIR_SUPERFAMILY[630001722$PIRSF001553:SucCS_alpha, 630027971$PIRSF036511:ATP citrate synthase, fused large and small subunits, 630027972$PIRSF036511:ATP_citrt_syn]
ATP citrate lyase,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000874$lipid synthesis, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
ATP citrate lyase,UP_SEQ_FEATURE[850000158$active site:Tele-phosphohistidine intermediate, 850006580$chain:ATP-citrate synthase, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111264$region of interest:CoA-binding, 850117294$sequence conflict, 850117295$sequence variant]
ATP synthase mitochondrial F1 complex assembly factor 2,INTERPRO[450010286$IPR011419:ATP12, ATPase F1F0-assembly protein]
ATP synthase mitochondrial F1 complex assembly factor 2,OMIM_DISEASE[520001143$Complex V, mitochondrial respiratory chain, deficiency of]
ATP synthase mitochondrial F1 complex assembly factor 2,SP_PIR_KEYWORDS[790000288$Chaperone, 790000356$complete proteome, 790000446$disease mutation, 790000969$mitochondrion, 790001550$transit peptide]
ATP synthase mitochondrial F1 complex assembly factor 2,UP_SEQ_FEATURE[850006446$chain:ATP synthase mitochondrial F1 complex assembly factor 2, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
ATP-binding cassette, sub-family A (ABC1), member 5,COG_ONTOLOGY[90000055$Defense mechanisms]
ATP-binding cassette, sub-family A (ABC1), member 5,INTERPRO[450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site]
ATP-binding cassette, sub-family A (ABC1), member 5,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family A (ABC1), member 5,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family A (ABC1), member 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000501$endosome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000897$lysosome, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
ATP-binding cassette, sub-family A (ABC1), member 5,UP_SEQ_FEATURE[850006540$chain:ATP-binding cassette sub-family A member 5, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
ATP-binding cassette, sub-family A (ABC1), member 7,INTERPRO[450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site]
ATP-binding cassette, sub-family A (ABC1), member 7,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family A (ABC1), member 7,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family A (ABC1), member 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000501$endosome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001063$nucleotide-binding, 790001136$phagocytosis, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
ATP-binding cassette, sub-family A (ABC1), member 7,UP_SEQ_FEATURE[850006542$chain:ATP-binding cassette sub-family A member 7, 850102883$disulfide bond, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,COG_ONTOLOGY[90000055$Defense mechanisms]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,INTERPRO[450001001$IPR001140:ABC transporter, transmembrane region, 450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site, 450016252$IPR017940:ABC transporter integral membrane type 1]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,PIR_SUPERFAMILY[630002866$PIRSF002775:human multidrug resistance protein cMOAT2]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
ATP-binding cassette, sub-family C (CFTR/MRP), member 10,UP_SEQ_FEATURE[850032752$chain:Multidrug resistance-associated protein 7, 850102992$domain:ABC transmembrane type-1 1, 850102993$domain:ABC transmembrane type-1 2, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850106258$modified residue, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
ATP-binding cassette, sub-family C (CFTR/MRP), member 12,COG_ONTOLOGY[90000055$Defense mechanisms]
ATP-binding cassette, sub-family C (CFTR/MRP), member 12,INTERPRO[450001001$IPR001140:ABC transporter, transmembrane region, 450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site, 450016252$IPR017940:ABC transporter integral membrane type 1]
ATP-binding cassette, sub-family C (CFTR/MRP), member 12,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family C (CFTR/MRP), member 12,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family C (CFTR/MRP), member 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
ATP-binding cassette, sub-family C (CFTR/MRP), member 12,UP_SEQ_FEATURE[850032753$chain:Multidrug resistance-associated protein 9, 850102992$domain:ABC transmembrane type-1 1, 850102993$domain:ABC transmembrane type-1 2, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
ATP-binding cassette, sub-family C (CFTR/MRP), member 5,COG_ONTOLOGY[90000055$Defense mechanisms]
ATP-binding cassette, sub-family C (CFTR/MRP), member 5,INTERPRO[450001001$IPR001140:ABC transporter, transmembrane region, 450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site, 450016252$IPR017940:ABC transporter integral membrane type 1]
ATP-binding cassette, sub-family C (CFTR/MRP), member 5,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family C (CFTR/MRP), member 5,PIR_SUPERFAMILY[630002866$PIRSF002775:human multidrug resistance protein cMOAT2]
ATP-binding cassette, sub-family C (CFTR/MRP), member 5,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family C (CFTR/MRP), member 5,SP_PIR_KEYWORDS[790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
ATP-binding cassette, sub-family C (CFTR/MRP), member 5,UP_SEQ_FEATURE[850032750$chain:Multidrug resistance-associated protein 5, 850102992$domain:ABC transmembrane type-1 1, 850102993$domain:ABC transmembrane type-1 2, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850118623$transmembrane region]
ATP-binding cassette, sub-family C, member 6 pseudogene 2; ATP-binding cassette, sub-family C (CFTR/MRP), member 6,INTERPRO[450001001$IPR001140:ABC transporter, transmembrane region, 450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450004757$IPR005292:Multi drug resistance-associated protein (MRP), 450016190$IPR017871:ABC transporter, conserved site, 450016252$IPR017940:ABC transporter integral membrane type 1]
ATP-binding cassette, sub-family C, member 6 pseudogene 2; ATP-binding cassette, sub-family C (CFTR/MRP), member 6,KEGG_PATHWAY[470038812$hsa02010:ABC transporters]
ATP-binding cassette, sub-family C, member 6 pseudogene 2; ATP-binding cassette, sub-family C (CFTR/MRP), member 6,OMIM_DISEASE[520004165$Pseudoxanthoma elasticum, 520004166$Pseudoxanthoma elasticum, forme fruste]
ATP-binding cassette, sub-family C, member 6 pseudogene 2; ATP-binding cassette, sub-family C (CFTR/MRP), member 6,PIR_SUPERFAMILY[630002866$PIRSF002775:human multidrug resistance protein cMOAT2]
ATP-binding cassette, sub-family C, member 6 pseudogene 2; ATP-binding cassette, sub-family C (CFTR/MRP), member 6,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family C, member 6 pseudogene 2; ATP-binding cassette, sub-family C (CFTR/MRP), member 6,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001555$transmembrane, 790001558$transport, 790001622$vision]
ATP-binding cassette, sub-family C, member 6 pseudogene 2; ATP-binding cassette, sub-family C (CFTR/MRP), member 6,UP_SEQ_FEATURE[850032751$chain:Multidrug resistance-associated protein 6, 850102992$domain:ABC transmembrane type-1 1, 850102993$domain:ABC transmembrane type-1 2, 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ATP-binding cassette, sub-family F (GCN20), member 1,COG_ONTOLOGY[90000073$General function prediction only]
ATP-binding cassette, sub-family F (GCN20), member 1,INTERPRO[450003006$IPR003439:ABC transporter-like, 450003154$IPR003593:ATPase, AAA+ type, core, 450016190$IPR017871:ABC transporter, conserved site]
ATP-binding cassette, sub-family F (GCN20), member 1,SMART[760000335$SM00382:AAA]
ATP-binding cassette, sub-family F (GCN20), member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000811$isopeptide bond, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
ATP-binding cassette, sub-family F (GCN20), member 1,UP_SEQ_FEATURE[850006558$chain:ATP-binding cassette sub-family F member 1, 850102507$compositionally biased region:Glu-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102998$domain:ABC transporter 1, 850102999$domain:ABC transporter 2, 850106258$modified residue, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATP/GTP binding protein-like 4,COG_ONTOLOGY[90000007$Amino acid transport and metabolism]
ATP/GTP binding protein-like 4,INTERPRO[450000726$IPR000834:Peptidase M14, carboxypeptidase A]
ATP/GTP binding protein-like 4,SMART[760000546$SM00631:Zn_pept]
ATP/GTP binding protein-like 4,SP_PIR_KEYWORDS[790000242$carboxypeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001648$zinc]
ATP/GTP binding protein-like 4,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850014085$chain:Cytosolic carboxypeptidase 6, 850106218$metal ion-binding site:Zinc, 850117295$sequence variant]
ATPase family, AAA domain containing 2B,INTERPRO[450001324$IPR001487:Bromodomain, 450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450016644$IPR018359:Bromodomain, conserved site]
ATPase family, AAA domain containing 2B,SMART[760000267$SM00297:BROMO, 760000335$SM00382:AAA]
ATPase family, AAA domain containing 2B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000206$bromodomain, 790000344$coiled coil, 790000356$complete proteome, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
ATPase family, AAA domain containing 2B,UP_SEQ_FEATURE[850006783$chain:ATPase family AAA domain-containing protein 2B, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850103166$domain:Bromo, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
ATPase family, AAA domain containing 4,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450005381$IPR005937:26S proteasome subunit P45]
ATPase family, AAA domain containing 4,SMART[760000335$SM00382:AAA]
ATPase family, AAA domain containing 4,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding, 790001254$proteasome]
ATPase family, AAA domain containing 4,UP_SEQ_FEATURE[850044603$chain:Proline-rich protein 15-like protein]
ATPase type 13A3,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005967$IPR006544:ATPase, P-type, unknown pump specificity (type V), 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase type 13A3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane]
ATPase type 13A3,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850041313$chain:Probable cation-transporting ATPase 13A3, 850102584$compositionally biased region:Poly-Tyr, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATPase, Ca++ transporting, ubiquitous,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005235$IPR005782:ATPase, P-type, calcium-transporting, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, ubiquitous,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038891$hsa05010:Alzheimer's disease]
ATPase, Ca++ transporting, ubiquitous,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, ubiquitous,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001356$sarcoplasmic reticulum, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Ca++ transporting, ubiquitous,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850000242$binding site:ATP, 850058909$chain:Sarcoplasmic/endoplasmic reticulum calcium ATPase 3, 850105910$metal ion-binding site:Calcium 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATPase, Cu++ transporting, alpha polypeptide,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450001660$IPR001877:ATPase 1, copper-transporting, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005553$IPR006121:Heavy metal transport/detoxification protein, 450005554$IPR006122:Copper ion-binding, 450005825$IPR006403:ATPase, P type, cation/copper-transporter, 450005838$IPR006416:ATPase, P-type, heavy metal translocating, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016277$IPR017969:Heavy-metal-associated, conserved site, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Cu++ transporting, alpha polypeptide,OMIM_DISEASE[520001292$Cutis laxa, neonatal, 520003147$Menkes disease, 520003736$Occipital horn syndrome]
ATPase, Cu++ transporting, alpha polypeptide,PIR_SUPERFAMILY[630001447$PIRSF001299:copper-transporting ATPase]
ATPase, Cu++ transporting, alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000371$copper, 790000373$copper transport, 790000407$cytoplasm, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000929$Menkes syndrome, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Cu++ transporting, alpha polypeptide,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850012583$chain:Copper-transporting ATPase 1, 850102581$compositionally biased region:Poly-Ser, 850104137$domain:HMA 1, 850104138$domain:HMA 2, 850104139$domain:HMA 3, 850104141$domain:HMA 4, 850104142$domain:HMA 5, 850104143$domain:HMA 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,INTERPRO[450005225$IPR005772:ATPase, V1 complex, subunit F, eukaryotic, 450007526$IPR008218:ATPase, V1/A1 complex, subunit F]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,PIR_SUPERFAMILY[630012715$PIRSF015945:ATPase_V1_F_euk, 630012716$PIRSF015945:V-type ATPase, subunit F]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000798$ion transport, 790001212$polymorphism, 790001558$transport]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,UP_SEQ_FEATURE[850099812$chain:V-type proton ATPase subunit F, 850117294$sequence conflict, 850117295$sequence variant]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,INTERPRO[450000213$IPR000245:ATPase, V0 complex, proteolipid subunit C, 450002116$IPR002379:ATPase, F0/V0 complex, subunit C]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038840$hsa04142:Lysosome, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,PIR_SUPERFAMILY[630001438$PIRSF001292:vacuolar H(+)-transporting ATPase 16K chain]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport, 790001602$Vacuole]
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b,UP_SEQ_FEATURE[850099777$chain:V-type proton ATPase 21 kDa proteolipid subunit, 850117295$sequence variant, 850118208$site:Essential for proton translocation, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1,INTERPRO[450007666$IPR008389:ATPase, V0 complex, subunit E, 450015711$IPR017385:ATPase, V0 complex, subunit E, metazoa]
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1,PIR_SUPERFAMILY[630029683$PIRSF038097:V-ATP_synth_e1/e2, 630029684$PIRSF038097:V-type ATPase, subunits e1/e2]
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000743$hydrolase, 790000798$ion transport, 790000919$membrane, 790001555$transmembrane, 790001558$transport]
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1,UP_SEQ_FEATURE[850099807$chain:V-type proton ATPase subunit E 1, 850118623$transmembrane region]
ATPase, H+ transporting, lysosomal V0 subunit a1,INTERPRO[450002209$IPR002490:ATPase, V0/A0 complex, 116-kDa subunit]
ATPase, H+ transporting, lysosomal V0 subunit a1,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038840$hsa04142:Lysosome, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal V0 subunit a1,PIR_SUPERFAMILY[630001439$PIRSF001293:V-type ATPase subunit]
ATPase, H+ transporting, lysosomal V0 subunit a1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
ATPase, H+ transporting, lysosomal V0 subunit a1,UP_SEQ_FEATURE[850099766$chain:V-type proton ATPase 116 kDa subunit a isoform 1, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATPase, H+ transporting, lysosomal accessory protein 1,INTERPRO[450007665$IPR008388:ATPase, V1 complex, subunit S1]
ATPase, H+ transporting, lysosomal accessory protein 1,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038840$hsa04142:Lysosome, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal accessory protein 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000616$glycoprotein, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790001063$nucleotide-binding, 790001405$signal, 790001555$transmembrane, 790001558$transport, 790001602$Vacuole]
ATPase, H+ transporting, lysosomal accessory protein 1,UP_SEQ_FEATURE[850099822$chain:V-type proton ATPase subunit S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118623$transmembrane region]
ATPase, H+/K+ exchanging, alpha polypeptide,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005228$IPR005775:ATPase, P-type cation exchange, alpha subunit, eukaryotic, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005505$IPR006069:ATPase, P-type cation exchange, alpha subunit, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450013574$IPR015127:ATPase, P-type, gastric H+/K+-transporter, N-terminal, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, H+/K+ exchanging, alpha polypeptide,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation]
ATPase, H+/K+ exchanging, alpha polypeptide,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, H+/K+ exchanging, alpha polypeptide,SP_PIR_KEYWORDS[790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000616$glycoprotein, 790000739$Hydrogen ion transport, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001226$potassium, 790001229$potassium transport, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, H+/K+ exchanging, alpha polypeptide,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850040205$chain:Potassium-transporting ATPase alpha chain 1, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATPase, Na+/K+ transporting, beta 1 polypeptide,INTERPRO[450000345$IPR000402:ATPase, P-type cation exchange, beta subunit, 450014005$IPR015565:ATPase, P-type, sodium/potassium-dependent, beta-1 subunit]
ATPase, Na+/K+ transporting, beta 1 polypeptide,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction, 470038890$hsa04960:Aldosterone-regulated sodium reabsorption]
ATPase, Na+/K+ transporting, beta 1 polypeptide,OMIM_DISEASE[520000630$Blood pressure regulation QTL]
ATPase, Na+/K+ transporting, beta 1 polypeptide,PIR_SUPERFAMILY[630001446$PIRSF001298:Na(+)/K(+)-transporting ATPase beta chain]
ATPase, Na+/K+ transporting, beta 1 polypeptide,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001226$potassium, 790001229$potassium transport, 790001409$Signal-anchor, 790001418$Sodium, 790001421$Sodium transport, 790001422$sodium/potassium transport, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Na+/K+ transporting, beta 1 polypeptide,UP_SEQ_FEATURE[850061287$chain:Sodium/potassium-transporting ATPase subunit beta-1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ATPase, Na+/K+ transporting, beta 2 polypeptide,INTERPRO[450000345$IPR000402:ATPase, P-type cation exchange, beta subunit]
ATPase, Na+/K+ transporting, beta 2 polypeptide,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction, 470038890$hsa04960:Aldosterone-regulated sodium reabsorption]
ATPase, Na+/K+ transporting, beta 2 polypeptide,PIR_SUPERFAMILY[630005680$PIRSF005757:Na(+)/K(+)-exchanging ATPase beta-3 chain]
ATPase, Na+/K+ transporting, beta 2 polypeptide,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000798$ion transport, 790000919$membrane, 790000924$membrane protein, 790001212$polymorphism, 790001226$potassium, 790001229$potassium transport, 790001409$Signal-anchor, 790001418$Sodium, 790001421$Sodium transport, 790001422$sodium/potassium transport, 790001555$transmembrane, 790001558$transport]
ATPase, Na+/K+ transporting, beta 2 polypeptide,UP_SEQ_FEATURE[850061293$chain:Sodium/potassium-transporting ATPase subunit beta-2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ATX1 antioxidant protein 1 homolog (yeast),INTERPRO[450005553$IPR006121:Heavy metal transport/detoxification protein, 450016277$IPR017969:Heavy-metal-associated, conserved site]
ATX1 antioxidant protein 1 homolog (yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000288$Chaperone, 790000356$complete proteome, 790000371$copper, 790000373$copper transport, 790000798$ion transport, 790000937$metal-binding, 790001558$transport]
ATX1 antioxidant protein 1 homolog (yeast),UP_SEQ_FEATURE[850012566$chain:Copper transport protein ATOX1, 850104136$domain:HMA, 850105852$helix, 850105958$metal ion-binding site:Copper, 850118575$strand, 850118624$turn]
Alstrom syndrome 1 pseudogene,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
Alstrom syndrome 1 pseudogene,UP_SEQ_FEATURE[850049398$chain:Putative ALMS1-like protein, 850117295$sequence variant]
ArfGAP with dual PH domains 1,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
ArfGAP with dual PH domains 1,PIR_SUPERFAMILY[630029700$PIRSF038114:Centaurin-alpha 1/2]
ArfGAP with dual PH domains 1,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH]
ArfGAP with dual PH domains 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000191$blood, 790000199$brain, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
ArfGAP with dual PH domains 1,UP_SEQ_FEATURE[850006009$chain:Arf-GAP with dual PH domain-containing protein 1, 850103059$domain:Arf-GAP, 850104980$domain:PH 1, 850104981$domain:PH 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118575$strand, 850118624$turn, 850118762$zinc finger region:C4-type]
B-box and SPRY domain containing,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450005994$IPR006574:SPRY-associated]
B-box and SPRY domain containing,SMART[760000304$SM00336:BBOX, 760000524$SM00589:PRY]
B-box and SPRY domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000407$cytoplasm, 790000798$ion transport, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001558$transport, 790001648$zinc, 790001651$zinc-finger]
B-box and SPRY domain containing,UP_SEQ_FEATURE[850007030$chain:B box and SPRY domain-containing protein, 850103078$domain:B30.2/SPRY, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118638$zinc finger region:B box-type]
B-cell CLL/lymphoma 3,COG_ONTOLOGY[90000073$General function prediction only]
B-cell CLL/lymphoma 3,INTERPRO[450001870$IPR002110:Ankyrin]
B-cell CLL/lymphoma 3,OMIM_DISEASE[520002872$Leukemia/lymphoma, B-cell, 3]
B-cell CLL/lymphoma 3,SMART[760000220$SM00248:ANK]
B-cell CLL/lymphoma 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000086$ank repeat, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
B-cell CLL/lymphoma 3,UP_SEQ_FEATURE[850007053$chain:B-cell lymphoma 3 protein, 850102586$compositionally biased region:Pro-rich, 850102592$compositionally biased region:Pro/Ser-rich, 850105852$helix, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850118624$turn]
B-cell CLL/lymphoma 7A,INTERPRO[450006210$IPR006804:BCL7, N-terminal]
B-cell CLL/lymphoma 7A,OMIM_DISEASE[520000500$B-cell non-Hodgkin lymphoma, high-grade]
B-cell CLL/lymphoma 7A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
B-cell CLL/lymphoma 7A,UP_SEQ_FEATURE[850007046$chain:B-cell CLL/lymphoma 7 protein family member A, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
B-cell CLL/lymphoma 7B,INTERPRO[450006210$IPR006804:BCL7, N-terminal]
B-cell CLL/lymphoma 7B,OMIM_DISEASE[520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
B-cell CLL/lymphoma 7B,SP_PIR_KEYWORDS[790000044$allergen, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001640$williams-beuren syndrome]
B-cell CLL/lymphoma 7B,UP_SEQ_FEATURE[850007047$chain:B-cell CLL/lymphoma 7 protein family member B, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
BCL2-associated athanogene,INTERPRO[450000534$IPR000626:Ubiquitin, 450002727$IPR003103:Apoptosis regulator Bcl-2 protein, BAG, 450015414$IPR017093:Molecular chaperone regulator BAG-1, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
BCL2-associated athanogene,PIR_SUPERFAMILY[630028529$PIRSF037029:BAG_1, 630028530$PIRSF037029:molecular chaperone regulator BAG-1]
BCL2-associated athanogene,SMART[760000186$SM00213:UBQ, 760000236$SM00264:BAG]
BCL2-associated athanogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000053$alternative splicing, 790000109$Apoptosis, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001304$repeat, 790001592$ubl conjugation]
BCL2-associated athanogene,UP_SEQ_FEATURE[850007264$chain:BAG family molecular chaperone regulator 1, 850102404$compositionally biased region:Arg-rich, 850103084$domain:BAG, 850105602$domain:Ubiquitin-like, 850105852$helix, 850110668$region of interest:7 X 6 AA tandem repeat of E-E-X(4), 850112427$region of interest:Interaction with HSPA8, 850112702$region of interest:Interaction with PPP1R15A, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
BCL2/adenovirus E1B 19kDa interacting protein 3-like,INTERPRO[450009601$IPR010548:BNIP3]
BCL2/adenovirus E1B 19kDa interacting protein 3-like,PIR_SUPERFAMILY[630008969$PIRSF010075:human E1B 19K/Bcl-2-interacting protein Nip3]
BCL2/adenovirus E1B 19kDa interacting protein 3-like,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000733$host-virus interaction, 790000919$membrane, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001555$transmembrane]
BCL2/adenovirus E1B 19kDa interacting protein 3-like,UP_SEQ_FEATURE[850007433$chain:BCL2/adenovirus E1B 19 kDa protein- interacting protein 3-like, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
BCL6 co-repressor,INTERPRO[450001870$IPR002110:Ankyrin]
BCL6 co-repressor,OMIM_DISEASE[520003306$Microphthalmia, syndromic 2]
BCL6 co-repressor,SMART[760000220$SM00248:ANK]
BCL6 co-repressor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000311$chromatin regulator, 790000356$complete proteome, 790000446$disease mutation, 790000958$microphthalmia, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
BCL6 co-repressor,UP_SEQ_FEATURE[850007427$chain:BCL-6 corepressor, 850102568$compositionally biased region:Poly-Asp, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850106259$mutagenesis site, 850112123$region of interest:Interaction with BCL6, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
BEN domain containing 6,INTERPRO[450016660$IPR018379:BEN domain]
BEN domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome]
BEN domain containing 6,UP_SEQ_FEATURE[850007461$chain:BEN domain-containing protein 6, 850103098$domain:BEN, 850118574$splice variant]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),INTERPRO[450008710$IPR009617:Adipose-regulatory protein, Seipin]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),OMIM_DISEASE[520002905$Lipodystrophy, congenital generalized, type 2, 520003610$Neuropathy, distal hereditary motor, type V, 520004483$Silver spastic paraplegia syndrome, 520004539$Spastic paraplegia 17 (autosomal dominant), 520004540$spastic paraplegia 17 (Silver syndrome), 520004549$Spastic paraplegia with amyotrophy of hands and feet (Silver syndrome), 520004595$Spinal muscular atrophy, distal, type V]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000362$congenital generalized lipodystrophy, 790000430$diabetes mellitus, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000675$hereditary spastic paraplegia, 790000919$membrane, 790001015$neurodegeneration, 790001555$transmembrane]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),UP_SEQ_FEATURE[850059230$chain:Seipin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
C-type lectin domain family 4, member F,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
C-type lectin domain family 4, member F,INTERPRO[450002094$IPR002353:Type II antifreeze protein, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 4, member F,SP_PIR_KEYWORDS[790000356$complete proteome, 790000496$Endocytosis, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
C-type lectin domain family 4, member F,UP_SEQ_FEATURE[850008733$chain:C-type lectin domain family 4 member F, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
C-type lectin domain family 6, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450002094$IPR002353:Type II antifreeze protein, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 6, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 6, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790000848$Lectin, 790000919$membrane, 790001409$Signal-anchor, 790001555$transmembrane]
C-type lectin domain family 6, member A,UP_SEQ_FEATURE[850008738$chain:C-type lectin domain family 6 member A, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
C1GALT1-specific chaperone 1,KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
C1GALT1-specific chaperone 1,OMIM_DISEASE[520004880$Tn syndrome]
C1GALT1-specific chaperone 1,SP_PIR_KEYWORDS[790000288$Chaperone, 790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
C1GALT1-specific chaperone 1,UP_SEQ_FEATURE[850008786$chain:C1GALT1-specific chaperone 1, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
C1q and tumor necrosis factor related protein 1,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
C1q and tumor necrosis factor related protein 1,SMART[760000097$SM00110:C1Q]
C1q and tumor necrosis factor related protein 1,SP_PIR_KEYWORDS[790000345$collagen, 790000356$complete proteome, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
C1q and tumor necrosis factor related protein 1,UP_SEQ_FEATURE[850012307$chain:Complement C1q tumor necrosis factor- related protein 1, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide]
C1q and tumor necrosis factor related protein 2,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
C1q and tumor necrosis factor related protein 2,SMART[760000097$SM00110:C1Q]
C1q and tumor necrosis factor related protein 2,SP_PIR_KEYWORDS[790000345$collagen, 790000356$complete proteome, 790001363$Secreted, 790001405$signal]
C1q and tumor necrosis factor related protein 2,UP_SEQ_FEATURE[850012308$chain:Complement C1q tumor necrosis factor- related protein 2, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850117814$signal peptide]
CAP-GLY domain containing linker protein 3,INTERPRO[450000819$IPR000938:Cytoskeleton-associated protein, CAP-Gly, 450001870$IPR002110:Ankyrin]
CAP-GLY domain containing linker protein 3,SMART[760000220$SM00248:ANK]
CAP-GLY domain containing linker protein 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790000624$golgi apparatus, 790001212$polymorphism, 790001304$repeat]
CAP-GLY domain containing linker protein 3,UP_SEQ_FEATURE[850009295$chain:CAP-Gly domain-containing linker protein 3, 850102572$compositionally biased region:Poly-Glu, 850103283$domain:CAP-Gly 1, 850103284$domain:CAP-Gly 2, 850105852$helix, 850111797$region of interest:GoLD, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117295$sequence variant, 850118575$strand, 850118624$turn]
CASK interacting protein 2,COG_ONTOLOGY[90000073$General function prediction only]
CASK interacting protein 2,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450001470$IPR001660:Sterile alpha motif SAM, 450001870$IPR002110:Ankyrin, 450010373$IPR011511:Variant SH3, 450012380$IPR013761:Sterile alpha motif-type]
CASK interacting protein 2,SMART[760000220$SM00248:ANK, 760000295$SM00326:SH3, 760000399$SM00454:SAM]
CASK interacting protein 2,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain]
CASK interacting protein 2,UP_SEQ_FEATURE[850009798$chain:Caskin-2, 850102586$compositionally biased region:Pro-rich, 850105250$domain:SAM 1, 850105251$domain:SAM 2, 850105350$domain:SH3, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850117295$sequence variant]
CASP8 and FADD-like apoptosis regulator,BBID[10000060$36.Death_of_Key_Intracellular_Targets, 10000108$86.Apoptosis_Nematode&_Vert]
CASP8 and FADD-like apoptosis regulator,BIOCARTA[30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation]
CASP8 and FADD-like apoptosis regulator,INTERPRO[450001153$IPR001309:Peptidase C14, ICE, catalytic subunit p20, 450001658$IPR001875:Death effector, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450010009$IPR011029:DEATH-like, 450010431$IPR011600:Peptidase C14, caspase catalytic, 450014334$IPR015917:Peptidase C14, caspase precursor p45, core]
CASP8 and FADD-like apoptosis regulator,KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
CASP8 and FADD-like apoptosis regulator,PIR_SUPERFAMILY[630029212$PIRSF037643:Casp8 and Fadd-like apoptosis regulator/caspase, types 8/10, 630030829$PIRSF500657:Casp8 and Fadd-like apoptosis regulator]
CASP8 and FADD-like apoptosis regulator,SMART[760000023$SM00031:DED, 760000102$SM00115:CASc]
CASP8 and FADD-like apoptosis regulator,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000733$host-virus interaction, 790001212$polymorphism, 790001304$repeat]
CASP8 and FADD-like apoptosis regulator,UP_SEQ_FEATURE[850009799$chain:CASP8 and FADD-like apoptosis regulator subunit p12, 850009800$chain:CASP8 and FADD-like apoptosis regulator subunit p43, 850103512$domain:DED 1, 850103513$domain:DED 2, 850105852$helix, 850106259$mutagenesis site, 850111188$region of interest:Caspase, 850112147$region of interest:Interaction with caspase-3, 850112149$region of interest:Interaction with caspase-8, 850112150$region of interest:Interaction with caspase-8 propeptide, 850112151$region of interest:Interaction with caspase-8 subunits p18 and p10, 850112316$region of interest:Interaction with FADD, 850112968$region of interest:Interaction with TRAF1 and TRAF2, 850113791$region of interest:Not proteolytically processed and involved in apoptosis inhibition, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
CCAAT/enhancer binding protein (C/EBP), delta,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014789$IPR016468:CCAAT/enhancer-binding]
CCAAT/enhancer binding protein (C/EBP), delta,PIR_SUPERFAMILY[630005805$PIRSF005879:CCAAT/enhancer-binding, 630005806$PIRSF005879:CCAAT/enhancer-binding protein]
CCAAT/enhancer binding protein (C/EBP), delta,SMART[760000306$SM00338:BRLZ]
CCAAT/enhancer binding protein (C/EBP), delta,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000811$isopeptide bond, 790000852$leucine zipper, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
CCAAT/enhancer binding protein (C/EBP), delta,UP_SEQ_FEATURE[850010081$chain:CCAAT/enhancer-binding protein delta, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
CCAAT/enhancer binding protein (C/EBP), epsilon,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014789$IPR016468:CCAAT/enhancer-binding]
CCAAT/enhancer binding protein (C/EBP), epsilon,OMIM_DISEASE[520004573$Specific granule deficiency]
CCAAT/enhancer binding protein (C/EBP), epsilon,PIR_SUPERFAMILY[630005805$PIRSF005879:CCAAT/enhancer-binding, 630005806$PIRSF005879:CCAAT/enhancer-binding protein]
CCAAT/enhancer binding protein (C/EBP), epsilon,SMART[760000306$SM00338:BRLZ]
CCAAT/enhancer binding protein (C/EBP), epsilon,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
CCAAT/enhancer binding protein (C/EBP), epsilon,UP_SEQ_FEATURE[850010082$chain:CCAAT/enhancer-binding protein epsilon, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850117294$sequence conflict]
CCAAT/enhancer binding protein (C/EBP), gamma,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper]
CCAAT/enhancer binding protein (C/EBP), gamma,SMART[760000306$SM00338:BRLZ]
CCAAT/enhancer binding protein (C/EBP), gamma,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
CCAAT/enhancer binding protein (C/EBP), gamma,UP_SEQ_FEATURE[850010083$chain:CCAAT/enhancer-binding protein gamma, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper]
CCR4-NOT transcription complex, subunit 10,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450017972$IPR019734:Tetratricopeptide repeat]
CCR4-NOT transcription complex, subunit 10,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
CCR4-NOT transcription complex, subunit 10,SMART[760000020$SM00028:TPR]
CCR4-NOT transcription complex, subunit 10,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
CCR4-NOT transcription complex, subunit 10,UP_SEQ_FEATURE[850010108$chain:CCR4-NOT transcription complex subunit 10, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
CCR4-NOT transcription complex, subunit 4,COG_ONTOLOGY[90000115$Transcription]
CCR4-NOT transcription complex, subunit 4,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450001628$IPR001841:Zinc finger, RING-type, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
CCR4-NOT transcription complex, subunit 4,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
CCR4-NOT transcription complex, subunit 4,SMART[760000158$SM00184:RING, 760000328$SM00360:RRM]
CCR4-NOT transcription complex, subunit 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
CCR4-NOT transcription complex, subunit 4,UP_SEQ_FEATURE[850010114$chain:CCR4-NOT transcription complex subunit 4, 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn, 850118751$zinc finger region:C3H1-type, 850118920$zinc finger region:RING-type; degenerate]
CD164 molecule, sialomucin,INTERPRO[450007293$IPR007947:CD164 related protein]
CD164 molecule, sialomucin,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
CD164 molecule, sialomucin,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
CD164 molecule, sialomucin,PIR_SUPERFAMILY[630030215$PIRSF038740:mucin core protein 24]
CD164 molecule, sialomucin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000375$core protein, 790000501$endosome, 790000616$glycoprotein, 790000897$lysosome, 790000919$membrane, 790001001$myogenesis, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
CD164 molecule, sialomucin,UP_SEQ_FEATURE[850060706$chain:Sialomucin core protein 24, 850102605$compositionally biased region:Thr-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850114294$region of interest:Required for endosomal and lysosomal localization, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD2 molecule,BBID[10000037$150.caspase_and_NFKB_activation, 10000090$7.IL17_hematopoesis, 10000103$81.Structure_of_Caps_and_SMACs, 10000113$90.IB_and-cat-Arm_processing_of_Ci, 10000120$99.NF-kB_activation]
CD2 molecule,BIOCARTA[30000081$h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development, 30000151$h_il17Pathway:IL 17 Signaling Pathway, 30000205$h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents, 30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules]
CD2 molecule,INTERPRO[450007701$IPR008424:Immunoglobulin C2-set, 450011750$IPR013106:Immunoglobulin V-set, 450011921$IPR013285:T-cell surface antigen CD2, 450012396$IPR013783:Immunoglobulin-like fold, 450014068$IPR015631:Signalling lymphocyte activation molecule, 450014069$IPR015632:T-cell adhesion molecule CD2]
CD2 molecule,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038867$hsa04640:Hematopoietic cell lineage]
CD2 molecule,PIR_SUPERFAMILY[630002122$PIRSF001984:T-cell surface glycoprotein CD2]
CD2 molecule,SP_PIR_KEYWORDS[790000002$3d-structure, 790000256$cell adhesion, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001479$T-cell, 790001555$transmembrane, 790001556$transmembrane protein]
CD2 molecule,UP_SEQ_FEATURE[850063388$chain:T-cell surface antigen CD2, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850113261$region of interest:LFA-3 (CD58) binding region 1, 850113262$region of interest:LFA-3 (CD58) binding region 2, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
CD200 receptor 1,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
CD200 receptor 1,SMART[760000357$SM00409:IG]
CD200 receptor 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
CD200 receptor 1,UP_SEQ_FEATURE[850010495$chain:Cell surface glycoprotein CD200 receptor 1, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD200 receptor 1-like,INTERPRO[450006486$IPR007110:Immunoglobulin-like]
CD200 receptor 1-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
CD200 receptor 1-like,UP_SEQ_FEATURE[850010498$chain:Cell surface glycoprotein CD200 receptor 2, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD209 molecule,INTERPRO[450001149$IPR001304:C-type lectin, 450002094$IPR002353:Type II antifreeze protein, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
CD209 molecule,OMIM_DISEASE[520001447$Dengue fever, protection against, 520002347$HIV type 1, susceptibility to, 520003456$Mycobacterium tuberculosis, susceptibility to]
CD209 molecule,SMART[760000026$SM00034:CLECT]
CD209 molecule,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000496$Endocytosis, 790000616$glycoprotein, 790000733$host-virus interaction, 790000763$immune response, 790000848$Lectin, 790000907$mannose-binding, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001409$Signal-anchor, 790001555$transmembrane]
CD209 molecule,UP_SEQ_FEATURE[850010134$chain:CD209 antigen, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850106259$mutagenesis site, 850110682$region of interest:7 X approximate tandem repeats, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850117295$sequence variant, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
CD22 molecule,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
CD22 molecule,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038867$hsa04640:Hematopoietic cell lineage, 470038870$hsa04662:B cell receptor signaling pathway]
CD22 molecule,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
CD22 molecule,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000152$B-cell, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000436$dimer, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
CD22 molecule,UP_SEQ_FEATURE[850000550$binding site:Sialic acid, 850007061$chain:B-cell receptor CD22, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD248 molecule, endosialin,BBID[10000106$84.Ubiquitination_Pathways_Cell_Cycle]
CD248 molecule, endosialin,INTERPRO[450001149$IPR001304:C-type lectin, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450014523$IPR016186:C-type lectin-like, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016659$IPR018378:C-type lectin, conserved site]
CD248 molecule, endosialin,PIR_SUPERFAMILY[630029930$PIRSF038358:CD248 antigen/endosialin]
CD248 molecule, endosialin,SMART[760000026$SM00034:CLECT, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
CD248 molecule, endosialin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
CD248 molecule, endosialin,UP_SEQ_FEATURE[850017415$chain:Endosialin, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850103705$domain:EGF-like; calcium-binding, 850105415$domain:Sushi, 850105822$glycosylation site:O-linked (GalNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD302 molecule; lymphocyte antigen 75,INTERPRO[450000481$IPR000562:Type II fibronectin, collagen-binding, 450000667$IPR000772:Ricin B lectin, 450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
CD302 molecule; lymphocyte antigen 75,PIR_SUPERFAMILY[630002546$PIRSF002427:mannose receptor, 630030220$PIRSF038745:CD302 antigen]
CD302 molecule; lymphocyte antigen 75,SMART[760000026$SM00034:CLECT, 760000050$SM00059:FN2, 760000403$SM00458:RICIN]
CD302 molecule; lymphocyte antigen 75,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000496$Endocytosis, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
CD302 molecule; lymphocyte antigen 75,UP_SEQ_FEATURE[850010151$chain:CD302 antigen, 850029238$chain:Lymphocyte antigen 75, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850103185$domain:C-type lectin 1, 850103186$domain:C-type lectin 10, 850103187$domain:C-type lectin 2, 850103188$domain:C-type lectin 3, 850103189$domain:C-type lectin 4, 850103190$domain:C-type lectin 5, 850103191$domain:C-type lectin 6, 850103192$domain:C-type lectin 7, 850103193$domain:C-type lectin 8, 850103194$domain:C-type lectin 9, 850103794$domain:Fibronectin type-II, 850105188$domain:Ricin B-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CDC14 cell division cycle 14 homolog A (S. cerevisiae),INTERPRO[450000291$IPR000340:Dual specificity phosphatase, catalytic domain, 450000292$IPR000340:Protein-tyrosine phosphatase, dual specificity, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
CDC14 cell division cycle 14 homolog A (S. cerevisiae),KEGG_PATHWAY[470038834$hsa04110:Cell cycle]
CDC14 cell division cycle 14 homolog A (S. cerevisiae),PIR_SUPERFAMILY[630029241$PIRSF037669:dual specificity protein phosphatase CDC14]
CDC14 cell division cycle 14 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000743$hydrolase, 790001065$nucleus, 790001212$polymorphism, 790001261$protein phosphatase]
CDC14 cell division cycle 14 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850016445$chain:Dual specificity protein phosphatase CDC14A, 850106259$mutagenesis site, 850110788$region of interest:A, 850110979$region of interest:B, 850113278$region of interest:Linker, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
CKLF-like MARVEL transmembrane domain containing 7,INTERPRO[450007548$IPR008253:Marvel]
CKLF-like MARVEL transmembrane domain containing 7,SP_PIR_KEYWORDS[790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000919$membrane, 790001555$transmembrane]
CKLF-like MARVEL transmembrane domain containing 7,UP_SEQ_FEATURE[850011557$chain:CKLF-like MARVEL transmembrane domain- containing protein 7, 850104755$domain:MARVEL, 850118623$transmembrane region]
CMT1A duplicated region transcript 4,OMIM_DISEASE[520001932$Framingham Heart Study genome-wide association: results for pulmonary function measures]
CMT1A duplicated region transcript 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
CMT1A duplicated region transcript 4,UP_SEQ_FEATURE[850011728$chain:CMT1A duplicated region transcript 4 protein, 850117295$sequence variant]
COBW domain containing 5; similar to COBW domain containing 1; COBW domain containing 7; COBW domain containing 3,COG_ONTOLOGY[90000073$General function prediction only]
COBW domain containing 5; similar to COBW domain containing 1; COBW domain containing 7; COBW domain containing 3,INTERPRO[450003063$IPR003495:Cobalamin (vitamin B12) biosynthesis CobW-like, 450010457$IPR011629:Cobalamin (vitamin B12) biosynthesis CobW-like, C-terminal]
COBW domain containing 5; similar to COBW domain containing 1; COBW domain containing 7; COBW domain containing 3,PIR_SUPERFAMILY[630005661$PIRSF005738:conserved hypothetical protein YciC]
COBW domain containing 5; similar to COBW domain containing 1; COBW domain containing 7; COBW domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding]
COBW domain containing 5; similar to COBW domain containing 1; COBW domain containing 7; COBW domain containing 3,UP_SEQ_FEATURE[850011875$chain:COBW domain-containing protein 3, 850011876$chain:COBW domain-containing protein 5, 850050151$chain:Putative COBW domain-containing protein 7, 850103377$domain:CobW C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850118574$splice variant]
COMM domain containing 10,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
COMM domain containing 10,UP_SEQ_FEATURE[850012273$chain:COMM domain-containing protein 10, 850103407$domain:COMM, 850117295$sequence variant]
COMM domain containing 2,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
COMM domain containing 2,UP_SEQ_FEATURE[850012274$chain:COMM domain-containing protein 2, 850103407$domain:COMM, 850117294$sequence conflict, 850117295$sequence variant]
COMM domain containing 5,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
COMM domain containing 5,UP_SEQ_FEATURE[850012277$chain:COMM domain-containing protein 5, 850103407$domain:COMM, 850117294$sequence conflict, 850117295$sequence variant]
COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis),INTERPRO[450000616$IPR000717:Proteasome component region PCI, 450010816$IPR011991:Winged helix repressor DNA-binding]
COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis),SMART[760000076$SM00088:PINT]
COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001410$signalosome]
COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis),UP_SEQ_FEATURE[850012529$chain:COP9 signalosome complex subunit 4, 850104917$domain:PCI, 850106258$modified residue, 850117294$sequence conflict]
CREB regulated transcription coactivator 1,OMIM_DISEASE[520003374$Mucoepidermoid salivary gland carcinoma]
CREB regulated transcription coactivator 1,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
CREB regulated transcription coactivator 1,UP_SEQ_FEATURE[850012700$chain:CREB-regulated transcription coactivator 1, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal, 850117940$site:Breakpoint for translocation to form the MECT1-MAML2 and MAML2-MECT1 fusion proteins, 850118546$site:Required for ubiquitination and degradation, 850118574$splice variant]
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae),INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core]
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae),SMART[760000335$SM00382:AAA]
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000356$complete proteome, 790000460$dna replication, 790000466$dna-binding, 790000649$helicase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae),UP_SEQ_FEATURE[850011420$chain:Chromosome transmission fidelity protein 18 homolog, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant]
CUB domain containing protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
CUB domain containing protein 1,UP_SEQ_FEATURE[850012806$chain:CUB domain-containing protein 1, 850102883$disulfide bond, 850103432$domain:CUB, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118113$site:Cleavage; by ST14/MT-SP1, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CUG triplet repeat, RNA binding protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014322$IPR015903:Ribonucleoprotein, BRUNO-like]
CUG triplet repeat, RNA binding protein 1,SMART[760000328$SM00360:RRM]
CUG triplet repeat, RNA binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000988$mrna processing, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
CUG triplet repeat, RNA binding protein 1,UP_SEQ_FEATURE[850012820$chain:CUG-BP- and ETR-3-like factor 1, 850102597$compositionally biased region:Ser-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
ClpB caseinolytic peptidase B homolog (E. coli),INTERPRO[450001121$IPR001270:Chaperonin clpA/B, 450001870$IPR002110:Ankyrin, 450003154$IPR003593:ATPase, AAA+ type, core, 450011737$IPR013093:ATPase associated with various cellular activities, AAA-2, 450017726$IPR019489:Clp ATPase, C-terminal]
ClpB caseinolytic peptidase B homolog (E. coli),SMART[760000220$SM00248:ANK, 760000335$SM00382:AAA]
ClpB caseinolytic peptidase B homolog (E. coli),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat]
ClpB caseinolytic peptidase B homolog (E. coli),UP_SEQ_FEATURE[850009796$chain:Caseinolytic peptidase B protein homolog, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117295$sequence variant, 850118574$splice variant]
D-dopachrome tautomerase,INTERPRO[450001243$IPR001398:Macrophage migration inhibitory factor, 450012939$IPR014347:Tautomerase, 450018060$IPR019829:Macrophage migration inhibitory factor, conserved site]
D-dopachrome tautomerase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000891$lyase, 790000916$Melanin biosynthesis]
D-dopachrome tautomerase,UP_SEQ_FEATURE[850014205$chain:D-dopachrome decarboxylase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand]
D-dopachrome tautomerase-like,INTERPRO[450001243$IPR001398:Macrophage migration inhibitory factor, 450018060$IPR019829:Macrophage migration inhibitory factor, conserved site]
D-dopachrome tautomerase-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000891$lyase]
D-dopachrome tautomerase-like,UP_SEQ_FEATURE[850014208$chain:D-dopachrome decarboxylase-like protein, 850106258$modified residue]
DDRGK domain containing 1,INTERPRO[450017399$IPR019153:DDRGK domain]
DDRGK domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
DDRGK domain containing 1,UP_SEQ_FEATURE[850014351$chain:DDRGK domain-containing protein 1, 850104917$domain:PCI, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
DEAD (Asp-Glu-Ala-As) box polypeptide 19A,INTERPRO[450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-As) box polypeptide 19A,PIR_SUPERFAMILY[630001467$PIRSF001323:ATP-dependent RNA helicase DHH1]
DEAD (Asp-Glu-Ala-As) box polypeptide 19A,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-As) box polypeptide 19A,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000649$helicase, 790000743$hydrolase, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001063$nucleotide-binding, 790001065$nucleus, 790001266$protein transport, 790001339$rna-binding, 790001554$translocation, 790001558$transport]
DEAD (Asp-Glu-Ala-As) box polypeptide 19A,UP_SEQ_FEATURE[850006693$chain:ATP-dependent RNA helicase DDX19A, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DEAD (Asp-Glu-Ala-As) box polypeptide 19B,INTERPRO[450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-As) box polypeptide 19B,PIR_SUPERFAMILY[630001467$PIRSF001323:ATP-dependent RNA helicase DHH1]
DEAD (Asp-Glu-Ala-As) box polypeptide 19B,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-As) box polypeptide 19B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000649$helicase, 790000743$hydrolase, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001339$rna-binding, 790001554$translocation, 790001558$transport]
DEAD (Asp-Glu-Ala-As) box polypeptide 19B,UP_SEQ_FEATURE[850006694$chain:ATP-dependent RNA helicase DDX19B, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif, 850118574$splice variant, 850118575$strand]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31,UP_SEQ_FEATURE[850041108$chain:Probable ATP-dependent RNA helicase DDX31, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif, 850118574$splice variant]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450001661$IPR001878:Zinc finger, CCHC-type, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41,PIR_SUPERFAMILY[630001466$PIRSF001321:ATP-dependent RNA helicase]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41,SMART[760000311$SM00343:ZnF_C2HC, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790000937$metal-binding, 790000988$mrna processing, 790000989$mrna splicing, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding, 790001433$Spliceosome, 790001648$zinc, 790001651$zinc-finger]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41,UP_SEQ_FEATURE[850041110$chain:Probable ATP-dependent RNA helicase DDX41, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif, 850118575$strand, 850118776$zinc finger region:CCHC-type]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790000988$mrna processing, 790000989$mrna splicing, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46,UP_SEQ_FEATURE[850041112$chain:Probable ATP-dependent RNA helicase DDX46, 850102404$compositionally biased region:Arg-rich, 850102568$compositionally biased region:Poly-Asp, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,PIR_SUPERFAMILY[630026222$PIRSF034443:PIRSF034443]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49,UP_SEQ_FEATURE[850041114$chain:Probable ATP-dependent RNA helicase DDX49, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DEAH (Asp-Glu-Ala-His) box polypeptide 32,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
DEAH (Asp-Glu-Ala-His) box polypeptide 32,INTERPRO[450006856$IPR007502:Helicase-associated region, 450010537$IPR011709:Region of unknown function DUF1605, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAH (Asp-Glu-Ala-His) box polypeptide 32,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism]
DEAH (Asp-Glu-Ala-His) box polypeptide 32,UP_SEQ_FEATURE[850053800$chain:Putative pre-mRNA-splicing factor ATP- dependent RNA helicase DHX32, 850104106$domain:Helicase ATP-binding, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117387$short sequence motif:DEAH box, 850118574$splice variant]
DEK oncogene,INTERPRO[450002665$IPR003034:DNA-binding SAP, 450013325$IPR014876:DEK, C-terminal]
DEK oncogene,OMIM_DISEASE[520002844$Leukemia, acute nonlymphocytic]
DEK oncogene,SMART[760000456$SM00513:SAP]
DEK oncogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene]
DEK oncogene,UP_SEQ_FEATURE[850045563$chain:Protein DEK, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102468$compositionally biased region:Asp/Glu-rich (highly acidic), 850105257$domain:SAP, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand, 850118624$turn]
DEP domain containing 1B,INTERPRO[450000169$IPR000198:RhoGAP, 450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450010816$IPR011991:Winged helix repressor DNA-binding]
DEP domain containing 1B,SMART[760000041$SM00049:DEP, 760000293$SM00324:RhoGAP]
DEP domain containing 1B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
DEP domain containing 1B,UP_SEQ_FEATURE[850014891$chain:DEP domain-containing protein 1B, 850102577$compositionally biased region:Poly-Lys, 850103515$domain:DEP, 850105183$domain:Rho-GAP, 850117294$sequence conflict, 850117295$sequence variant]
DIRAS family, GTP-binding RAS-like 1,INTERPRO[450001599$IPR001806:Ras GTPase, 450003144$IPR003577:Ras small GTPase, Ras type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
DIRAS family, GTP-binding RAS-like 1,SMART[760000147$SM00173:RAS]
DIRAS family, GTP-binding RAS-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
DIRAS family, GTP-binding RAS-like 1,UP_SEQ_FEATURE[850022560$chain:GTP-binding protein Di-Ras1, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000084$h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N, 450013753$IPR015311:Apoptosis, DNA fragmentation factor 40 kDa]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SMART[760000238$SM00266:CAD]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),UP_SEQ_FEATURE[850015551$chain:DNA fragmentation factor subunit beta, 850103367$domain:CIDE-N, 850105852$helix, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
DNA fragmentation factor, 45kDa, alpha polypeptide,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000084$h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
DNA fragmentation factor, 45kDa, alpha polypeptide,INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N, 450013568$IPR015121:DNA fragmentation factor 45kDa, C-terminal, 450015622$IPR017299:DNA fragmentation factor, alpha subunit]
DNA fragmentation factor, 45kDa, alpha polypeptide,KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
DNA fragmentation factor, 45kDa, alpha polypeptide,PIR_SUPERFAMILY[630029432$PIRSF037865:DFF_alpha, 630029433$PIRSF037865:DNA fragmentation factor, alpha subunit]
DNA fragmentation factor, 45kDa, alpha polypeptide,SMART[760000238$SM00266:CAD]
DNA fragmentation factor, 45kDa, alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001162$phosphoprotein]
DNA fragmentation factor, 45kDa, alpha polypeptide,UP_SEQ_FEATURE[850015550$chain:DNA fragmentation factor subunit alpha, 850103367$domain:CIDE-N, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118020$site:Cleavage; by caspase-3, 850118574$splice variant, 850118575$strand, 850118624$turn]
DNA segment on chromosome 4 (unique) 234 expressed sequence,INTERPRO[450008535$IPR009431:D1 dopamine receptor-interacting, calcyon]
DNA segment on chromosome 4 (unique) 234 expressed sequence,PIR_SUPERFAMILY[630002500$PIRSF002383:Calcyon, 630002501$PIRSF002383:neuron specific protein/calcyon]
DNA segment on chromosome 4 (unique) 234 expressed sequence,SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001555$transmembrane]
DNA segment on chromosome 4 (unique) 234 expressed sequence,UP_SEQ_FEATURE[850034018$chain:Neuron-specific protein family member 1, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
Der1-like domain family, member 2,INTERPRO[450006950$IPR007599:Der1-like]
Der1-like domain family, member 2,SP_PIR_KEYWORDS[790000243$carcinogenesis, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001555$transmembrane, 790001595$unfolded protein response]
Der1-like domain family, member 2,UP_SEQ_FEATURE[850014905$chain:Derlin-2, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
Dmx-like 1,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
Dmx-like 1,SMART[760000289$SM00320:WD40]
Dmx-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
Dmx-like 1,UP_SEQ_FEATURE[850015490$chain:DmX-like protein 1, 850102568$compositionally biased region:Poly-Asp, 850106258$modified residue, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117174$repeat:WD 12, 850117176$repeat:WD 14, 850117177$repeat:WD 15, 850117178$repeat:WD 16, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117295$sequence variant]
DnaJ (Hsp40) homolog, subfamily C, member 1,INTERPRO[450000876$IPR001005:SANT, DNA-binding, 450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450013228$IPR014778:Myb, DNA-binding, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016201$IPR017884:SANT, eukarya, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 1,SMART[760000243$SM00271:DnaJ, 760000623$SM00717:SANT]
DnaJ (Hsp40) homolog, subfamily C, member 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000288$Chaperone, 790000356$complete proteome, 790000466$dna-binding, 790000499$endoplasmic reticulum, 790000919$membrane, 790000959$microsome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
DnaJ (Hsp40) homolog, subfamily C, member 1,UP_SEQ_FEATURE[850016159$chain:DnaJ homolog subfamily C member 1, 850104487$domain:J, 850105255$domain:SANT 1, 850105256$domain:SANT 2, 850105852$helix, 850106258$modified residue, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
DnaJ (Hsp40) homolog, subfamily C, member 28,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
DnaJ (Hsp40) homolog, subfamily C, member 28,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450016538$IPR018253:Heat shock protein DnaJ, conserved site, 450017231$IPR018961:DnaJ homologue, subfamily C, member 28]
DnaJ (Hsp40) homolog, subfamily C, member 28,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 28,SP_PIR_KEYWORDS[790000288$Chaperone, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
DnaJ (Hsp40) homolog, subfamily C, member 28,UP_SEQ_FEATURE[850016178$chain:DnaJ homolog subfamily C member 28, 850102572$compositionally biased region:Poly-Glu, 850104487$domain:J, 850106258$modified residue, 850117294$sequence conflict]
DnaJ (Hsp40) homolog, subfamily C, member 3,BIOCARTA[30000262$h_rnaPathway:Double Stranded RNA Induced Gene Expression]
DnaJ (Hsp40) homolog, subfamily C, member 3,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016538$IPR018253:Heat shock protein DnaJ, conserved site, 450017972$IPR019734:Tetratricopeptide repeat]
DnaJ (Hsp40) homolog, subfamily C, member 3,SMART[760000020$SM00028:TPR, 760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 3,SP_PIR_KEYWORDS[790000104$Antiviral defense, 790000288$Chaperone, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790001304$repeat, 790001405$signal, 790001537$tpr repeat, 790001595$unfolded protein response]
DnaJ (Hsp40) homolog, subfamily C, member 3,UP_SEQ_FEATURE[850016179$chain:DnaJ homolog subfamily C member 3, 850104487$domain:J, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850117814$signal peptide]
DnaJ (Hsp40) homolog, subfamily C, member 5 gamma,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 5 gamma,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 5 gamma,SP_PIR_KEYWORDS[790000288$Chaperone, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism]
DnaJ (Hsp40) homolog, subfamily C, member 5 gamma,UP_SEQ_FEATURE[850016184$chain:DnaJ homolog subfamily C member 5G, 850102480$compositionally biased region:Cys-rich, 850104487$domain:J, 850106258$modified residue, 850117295$sequence variant]
DnaJ (Hsp40) homolog, subfamily C, member 7,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016538$IPR018253:Heat shock protein DnaJ, conserved site, 450017972$IPR019734:Tetratricopeptide repeat]
DnaJ (Hsp40) homolog, subfamily C, member 7,SMART[760000020$SM00028:TPR, 760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 7,SP_PIR_KEYWORDS[790000012$acetylation, 790000288$Chaperone, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat]
DnaJ (Hsp40) homolog, subfamily C, member 7,UP_SEQ_FEATURE[850016185$chain:DnaJ homolog subfamily C member 7, 850104487$domain:J, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9]
DnaJ (Hsp40) related, subfamily B, member 13,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
DnaJ (Hsp40) related, subfamily B, member 13,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002592$IPR002939:Chaperone DnaJ, C-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) related, subfamily B, member 13,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) related, subfamily B, member 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000288$Chaperone, 790000356$complete proteome]
DnaJ (Hsp40) related, subfamily B, member 13,UP_SEQ_FEATURE[850016147$chain:DnaJ homolog subfamily B member 13, 850104487$domain:J, 850118574$splice variant]
E1A binding protein p300,BIOCARTA[30000046$h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor, 30000047$h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1, 30000121$h_g2Pathway:Cell Cycle: G2/M Checkpoint, 30000136$h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology, 30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System, 30000161$h_il7Pathway:IL-7 Signal Transduction, 30000183$h_mef2dPathway:Role of MEF2D in T-cell Apoptosis, 30000184$h_melanocytepathway:Melanocyte Development and Pigmentation Pathway, 30000210$h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae, 30000216$h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system, 30000224$h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity, 30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha), 30000236$h_ppargPathway:Role of PPAR-gamma Coactivators in Obesity and Thermogenesis, 30000259$h_RELAPathway:Acetylation and Deacetylation of RelA in The Nucleus, 30000293$h_tgfbPathway:TGF beta signaling pathway, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
E1A binding protein p300,INTERPRO[450000168$IPR000197:Zinc finger, TAZ-type, 450000371$IPR000433:Zinc finger, ZZ-type, 450001324$IPR001487:Bromodomain, 450002725$IPR003101:Coactivator CBP, KIX, 450008365$IPR009255:Transcriptional coactivation, 450009371$IPR010303:Protein of unknown function DUF902, CREBbp, 450013195$IPR014744:Nuclear receptor coactivator, CREB-bp-like, interlocking, 450016644$IPR018359:Bromodomain, conserved site]
E1A binding protein p300,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038846$hsa04310:Wnt signaling pathway, 470038848$hsa04330:Notch signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway, 470038856$hsa04520:Adherens junction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038885$hsa04916:Melanogenesis, 470038894$hsa05016:Huntington's disease, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma, 470038905$hsa05215:Prostate cancer]
E1A binding protein p300,OMIM_DISEASE[520001093$Colorectal cancer, 520004363$Rubinstein-Taybi syndrome]
E1A binding protein p300,PIR_SUPERFAMILY[630027768$PIRSF036333:transcription coactivator CREB-binding protein]
E1A binding protein p300,SMART[760000262$SM00291:ZnF_ZZ, 760000267$SM00297:BROMO, 760000491$SM00551:ZnF_TAZ]
E1A binding protein p300,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000206$bromodomain, 790000258$cell cycle, 790000316$chromosomal rearrangement, 790000326$citrullination, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000733$host-virus interaction, 790000937$metal-binding, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
E1A binding protein p300,UP_SEQ_FEATURE[850023871$chain:Histone acetyltransferase p300, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850103166$domain:Bromo, 850104544$domain:KIX, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111035$region of interest:Binding region for E1A adenovirus, 850112430$region of interest:Interaction with HTLV-1 Tax, 850112592$region of interest:Interaction with NCOA2, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117911$site:Breakpoint for translocation to form MYST3-EP300 and EP300-MYST3, 850118319$site:Interaction with NCOA2, 850118575$strand, 850118624$turn, 850118931$zinc finger region:TAZ-type 1, 850118932$zinc finger region:TAZ-type 2, 850118951$zinc finger region:ZZ-type]
E2F transcription factor 3,INTERPRO[450002893$IPR003316:Transcription factor E2F/dimerisation partner (TDP), 450010816$IPR011991:Winged helix repressor DNA-binding, 450014070$IPR015633:E2F Family]
E2F transcription factor 3,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038899$hsa05200:Pathways in cancer, 470038902$hsa05212:Pancreatic cancer, 470038904$hsa05214:Glioma, 470038905$hsa05215:Prostate cancer, 470038908$hsa05218:Melanoma, 470038909$hsa05219:Bladder cancer, 470038910$hsa05220:Chronic myeloid leukemia, 470038912$hsa05222:Small cell lung cancer, 470038913$hsa05223:Non-small cell lung cancer]
E2F transcription factor 3,PIR_SUPERFAMILY[630016185$PIRSF019596:transcription factor E2F, 630030679$PIRSF500460:transcription factor E2F6]
E2F transcription factor 3,SP_PIR_KEYWORDS[790000020$activator, 790000258$cell cycle, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
E2F transcription factor 3,UP_SEQ_FEATURE[850065150$chain:Transcription factor E2F3, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850104712$domain:Leucine-zipper, 850111373$region of interest:Cyclin A/CDK2 binding, 850111439$region of interest:Dimerization, 850114517$region of interest:Retinoblastoma protein binding, 850114897$region of interest:Transactivation, 850117295$sequence variant, 850117395$short sequence motif:DEF box]
ECSIT homolog (Drosophila),BIOCARTA[30000153$h_il1rPathway:Signal transduction through IL1R, 30000300$h_tollPathway:Toll-Like Receptor Pathway]
ECSIT homolog (Drosophila),INTERPRO[450009479$IPR010418:ECSIT]
ECSIT homolog (Drosophila),KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
ECSIT homolog (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000763$immune response, 790000777$innate immunity, 790000969$mitochondrion, 790001065$nucleus, 790001212$polymorphism, 790001550$transit peptide]
ECSIT homolog (Drosophila),UP_SEQ_FEATURE[850018161$chain:Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
EFR3 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
EFR3 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850045728$chain:Protein EFR3 homolog B, 850106258$modified residue, 850118574$splice variant]
EGF-containing fibulin-like extracellular matrix protein 2,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
EGF-containing fibulin-like extracellular matrix protein 2,OMIM_DISEASE[520001290$Cutis laxa, autosomal recessive, type I]
EGF-containing fibulin-like extracellular matrix protein 2,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
EGF-containing fibulin-like extracellular matrix protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
EGF-containing fibulin-like extracellular matrix protein 2,UP_SEQ_FEATURE[850016990$chain:EGF-containing fibulin-like extracellular matrix protein 2, 850102883$disulfide bond, 850103619$domain:EGF-like 1; atypical, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
EGF-like-domain, multiple 7,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450010351$IPR011489:EMI domain, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450011755$IPR013111:EGF, extracellular, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
EGF-like-domain, multiple 7,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
EGF-like-domain, multiple 7,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000211$calcium, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000481$egf-like domain, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
EGF-like-domain, multiple 7,UP_SEQ_FEATURE[850017651$chain:Epidermal growth factor-like protein 7, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103714$domain:EMI, 850117295$sequence variant, 850117814$signal peptide]
EH-domain containing 3,INTERPRO[450000226$IPR000261:EPS15 homology (EH), 450001246$IPR001401:Dynamin, GTPase region, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
EH-domain containing 3,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
EH-domain containing 3,SMART[760000019$SM00027:EH, 760000045$SM00053:DYNc]
EH-domain containing 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000211$calcium, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000501$endosome, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein]
EH-domain containing 3,UP_SEQ_FEATURE[850000242$binding site:ATP, 850017020$chain:EH domain-containing protein 3, 850103571$domain:EF-hand, 850103706$domain:EH, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict]
EH-domain containing 4,INTERPRO[450000226$IPR000261:EPS15 homology (EH), 450001246$IPR001401:Dynamin, GTPase region, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
EH-domain containing 4,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
EH-domain containing 4,SMART[760000019$SM00027:EH, 760000045$SM00053:DYNc]
EH-domain containing 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000211$calcium, 790000356$complete proteome, 790000501$endosome, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
EH-domain containing 4,UP_SEQ_FEATURE[850000242$binding site:ATP, 850017021$chain:EH domain-containing protein 4, 850103571$domain:EF-hand, 850103706$domain:EH, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),BIOCARTA[30000307$h_vegfPathway:VEGF, Hypoxia, and Angiogenesis]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450002084$IPR002343:Paraneoplastic encephalomyelitis antigen, 450005971$IPR006548:Splicing factor ELAV/HuD, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),SMART[760000328$SM00360:RRM]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000953$methylation, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R),UP_SEQ_FEATURE[850017033$chain:ELAV-like protein 1, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850106258$modified residue, 850117294$sequence conflict]
ELKS/RAB6-interacting/CAST family member 2,INTERPRO[450017561$IPR019323:CAZ complex, RIM-binding protein]
ELKS/RAB6-interacting/CAST family member 2,OMIM_DISEASE[520002056$Genome-wide association with bone mass and geometry in the Framingham Heart Study]
ELKS/RAB6-interacting/CAST family member 2,SP_PIR_KEYWORDS[790000263$cell junction, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism, 790001475$synapse, 790001477$Synaptosome]
ELKS/RAB6-interacting/CAST family member 2,UP_SEQ_FEATURE[850017773$chain:ERC protein 2, 850102573$compositionally biased region:Poly-Gly, 850102574$compositionally biased region:Poly-His, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117295$sequence variant]
ENTH domain containing 1,INTERPRO[450000899$IPR001026:Epsin, N-terminal, 450008166$IPR008942:ENTH/VHS, 450012415$IPR013809:Epsin-like, N-terminal]
ENTH domain containing 1,SMART[760000245$SM00273:ENTH]
ENTH domain containing 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
ENTH domain containing 1,UP_SEQ_FEATURE[850017541$chain:ENTH domain-containing protein 1, 850103717$domain:ENTH, 850117295$sequence variant]
EP300 interacting inhibitor of differentiation 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001001$myogenesis, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
EP300 interacting inhibitor of differentiation 2,UP_SEQ_FEATURE[850017598$chain:EP300-interacting inhibitor of differentiation 2, 850102378$compositionally biased region:Ala-rich, 850117295$sequence variant, 850118574$splice variant]
EPH receptor A10,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000955$IPR001090:Ephrin receptor, ligand binding, 450001096$IPR001245:Tyrosine protein kinase, 450001270$IPR001426:Receptor tyrosine kinase, class V, conserved site, 450001470$IPR001660:Sterile alpha motif SAM, 450003484$IPR003961:Fibronectin, type III, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008173$IPR008957:Fibronectin, type III-like fold, 450011699$IPR013032:EGF-like region, conserved site, 450012380$IPR013761:Sterile alpha motif-type, 450014581$IPR016257:Tyrosine-protein kinase, ephrin receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
EPH receptor A10,PIR_SUPERFAMILY[630000779$PIRSF000666:tyrosine-protein kinase, ephrin receptor type, 630000780$PIRSF000666:TyrPK_ephrin_receptor]
EPH receptor A10,SMART[760000051$SM00060:FN3, 760000192$SM00219:TyrKc, 760000399$SM00454:SAM, 760000544$SM00615:EPH_lbd]
EPH receptor A10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001586$tyrosine-protein kinase]
EPH receptor A10,UP_SEQ_FEATURE[850017609$chain:Ephrin type-A receptor 10, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850105086$domain:Protein kinase, 850105249$domain:SAM, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
F-box and WD repeat domain containing 10; similar to FBXW10 protein,INTERPRO[450001490$IPR001680:WD40 repeat, 450001603$IPR001810:Cyclin-like F-box, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
F-box and WD repeat domain containing 10; similar to FBXW10 protein,SMART[760000228$SM00256:FBOX, 760000289$SM00320:WD40]
F-box and WD repeat domain containing 10; similar to FBXW10 protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
F-box and WD repeat domain containing 10; similar to FBXW10 protein,UP_SEQ_FEATURE[850018845$chain:F-box/WD repeat-containing protein 10, 850103725$domain:F-box, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
F-box and WD repeat domain containing 5,INTERPRO[450001490$IPR001680:WD40 repeat, 450001603$IPR001810:Cyclin-like F-box, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
F-box and WD repeat domain containing 5,SMART[760000228$SM00256:FBOX, 760000289$SM00320:WD40]
F-box and WD repeat domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway, 790001638$wd repeat]
F-box and WD repeat domain containing 5,UP_SEQ_FEATURE[850018851$chain:F-box/WD repeat-containing protein 5, 850103725$domain:F-box, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
F-box and leucine-rich repeat protein 13,COG_ONTOLOGY[90000112$Signal transduction mechanisms / RNA processing and modification]
F-box and leucine-rich repeat protein 13,INTERPRO[450001603$IPR001810:Cyclin-like F-box, 450005976$IPR006553:Leucine-rich repeat, cysteine-containing subtype]
F-box and leucine-rich repeat protein 13,PIR_SUPERFAMILY[630028327$PIRSF036848:conserved protein with F-box/LRR-repeat, Skp2 type]
F-box and leucine-rich repeat protein 13,SMART[760000228$SM00256:FBOX, 760000331$SM00367:LRR_CC]
F-box and leucine-rich repeat protein 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 13,UP_SEQ_FEATURE[850018787$chain:F-box/LRR-repeat protein 13, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
F-box and leucine-rich repeat protein 16,SP_PIR_KEYWORDS[790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 16,UP_SEQ_FEATURE[850018790$chain:F-box/LRR-repeat protein 16, 850102586$compositionally biased region:Pro-rich, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850117295$sequence variant]
F-box and leucine-rich repeat protein 18,INTERPRO[450001603$IPR001810:Cyclin-like F-box]
F-box and leucine-rich repeat protein 18,SMART[760000228$SM00256:FBOX]
F-box and leucine-rich repeat protein 18,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001555$transmembrane, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 18,UP_SEQ_FEATURE[850018792$chain:F-box/LRR-repeat protein 18, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
F-box and leucine-rich repeat protein 6,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450001603$IPR001810:Cyclin-like F-box, 450011745$IPR013101:Leucine-rich repeat 2]
F-box and leucine-rich repeat protein 6,PIR_SUPERFAMILY[630028327$PIRSF036848:conserved protein with F-box/LRR-repeat, Skp2 type]
F-box and leucine-rich repeat protein 6,SMART[760000228$SM00256:FBOX]
F-box and leucine-rich repeat protein 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001304$repeat, 790001593$ubl conjugation pathway]
F-box and leucine-rich repeat protein 6,UP_SEQ_FEATURE[850018802$chain:F-box/LRR-repeat protein 6, 850103725$domain:F-box, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850118574$splice variant]
F-box protein 24,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
F-box protein 24,INTERPRO[450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450001603$IPR001810:Cyclin-like F-box, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II]
F-box protein 24,SMART[760000228$SM00256:FBOX]
F-box protein 24,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001593$ubl conjugation pathway]
F-box protein 24,UP_SEQ_FEATURE[850018480$chain:F-box only protein 24, 850103725$domain:F-box, 850116897$repeat:RCC1, 850117295$sequence variant, 850118574$splice variant]
F-box protein 9,INTERPRO[450001603$IPR001810:Cyclin-like F-box]
F-box protein 9,SMART[760000228$SM00256:FBOX]
F-box protein 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001537$tpr repeat, 790001593$ubl conjugation pathway]
F-box protein 9,UP_SEQ_FEATURE[850018511$chain:F-box only protein 9, 850103725$domain:F-box, 850117118$repeat:TPR, 850118574$splice variant]
F11 receptor,INTERPRO[450003157$IPR003596:Immunoglobulin V-set, subgroup, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
F11 receptor,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038857$hsa04530:Tight junction, 470038873$hsa04670:Leukocyte transendothelial migration, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
F11 receptor,SMART[760000354$SM00406:IGv, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
F11 receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001528$Tight junction, 790001555$transmembrane]
F11 receptor,UP_SEQ_FEATURE[850026980$chain:Junctional adhesion molecule A, 850102883$disulfide bond, 850104408$domain:Ig-like V-type 1, 850104409$domain:Ig-like V-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
FCH and double SH3 domains 1,INTERPRO[450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3]
FCH and double SH3 domains 1,SMART[760000047$SM00055:FCH, 760000295$SM00326:SH3]
FCH and double SH3 domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain]
FCH and double SH3 domains 1,UP_SEQ_FEATURE[850019121$chain:FCH and double SH3 domains protein 1, 850102586$compositionally biased region:Pro-rich, 850103755$domain:FCH, 850105351$domain:SH3 1, 850105353$domain:SH3 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
FK506 binding protein 2, 13kDa,INTERPRO[450001034$IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type]
FK506 binding protein 2, 13kDa,PIR_SUPERFAMILY[630001631$PIRSF001468:FK506-binding protein 1]
FK506 binding protein 2, 13kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000810$Isomerase, 790000919$membrane, 790001212$polymorphism, 790001343$Rotamase, 790001405$signal]
FK506 binding protein 2, 13kDa,UP_SEQ_FEATURE[850019525$chain:FK506-binding protein 2, 850105058$domain:PPIase FKBP-type, 850105852$helix, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118575$strand, 850118624$turn]
FLYWCH-type zinc finger 1,INTERPRO[450006939$IPR007588:Zinc finger, FLYWCH-type]
FLYWCH-type zinc finger 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
FLYWCH-type zinc finger 1,UP_SEQ_FEATURE[850019726$chain:FLYWCH-type zinc finger-containing protein 1, 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118811$zinc finger region:FLYWCH-type 1, 850118812$zinc finger region:FLYWCH-type 2, 850118813$zinc finger region:FLYWCH-type 3, 850118814$zinc finger region:FLYWCH-type 4, 850118815$zinc finger region:FLYWCH-type 5]
FXYD domain containing ion transport regulator 7,INTERPRO[450000237$IPR000272:Ion-transport regulator, FXYD region]
FXYD domain containing ion transport regulator 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
FXYD domain containing ion transport regulator 7,UP_SEQ_FEATURE[850020200$chain:FXYD domain-containing ion transport regulator 7, 850106258$modified residue, 850118623$transmembrane region]
FYN binding protein (FYB-120/130),INTERPRO[450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3, 450016415$IPR018115:Xylose isomerase, active site]
FYN binding protein (FYB-120/130),SMART[760000295$SM00326:SH3]
FYN binding protein (FYB-120/130),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
FYN binding protein (FYB-120/130),UP_SEQ_FEATURE[850020201$chain:FYN-binding protein, 850102580$compositionally biased region:Poly-Pro, 850105350$domain:SH3, 850105852$helix, 850106258$modified residue, 850112832$region of interest:Interaction with SKAP1, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117706$short sequence motif:SH2-binding, 850117709$short sequence motif:SH2-binding; to FYN, 850117710$short sequence motif:SH2-binding; to LCP2, 850118575$strand, 850118624$turn]
FYVE, RhoGEF and PH domain containing 3,INTERPRO[450000189$IPR000219:Dbl homology (DH) domain, 450000262$IPR000306:Zinc finger, FYVE-type, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type, 450015781$IPR017455:Zinc finger, FYVE-related]
FYVE, RhoGEF and PH domain containing 3,KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
FYVE, RhoGEF and PH domain containing 3,PIR_SUPERFAMILY[630028886$PIRSF037335:FYVE, RhoGEF and PH domain containing protein(1-4)]
FYVE, RhoGEF and PH domain containing 3,SMART[760000055$SM00064:FYVE, 760000205$SM00233:PH, 760000294$SM00325:RhoGEF]
FYVE, RhoGEF and PH domain containing 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000641$guanine-nucleotide releasing factor, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
FYVE, RhoGEF and PH domain containing 3,UP_SEQ_FEATURE[850020206$chain:FYVE, RhoGEF and PH domain-containing protein 3, 850103518$domain:DH, 850104980$domain:PH 1, 850104981$domain:PH 2, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118819$zinc finger region:FYVE-type]
Fanconi anemia, complementation group E,BIOCARTA[30000029$h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility, 30000031$h_bard1Pathway:BRCA1-dependent Ub-ligase activity]
Fanconi anemia, complementation group E,OMIM_DISEASE[520001869$Fanconi anemia, complementation group E]
Fanconi anemia, complementation group E,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000540$Fanconi anemia, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
Fanconi anemia, complementation group E,UP_SEQ_FEATURE[850018961$chain:Fanconi anemia group E protein, 850105852$helix, 850106258$modified residue, 850112318$region of interest:Interaction with FANCC, 850117295$sequence variant, 850118575$strand]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),BBID[10000076$56.Macrophage_regulation_of_CD4+T_cells]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038916$hsa05322:Systemic lupus erythematosus]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),OMIM_DISEASE[520002972$Lupus erythematosus, systemic, susceptibility, 520003622$Neutropenia, alloimmune neonatal, 520005034$Viral infections, recurrent]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),PIR_SUPERFAMILY[630002118$PIRSF001980:Fc gamma receptor III]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SMART[760000357$SM00409:IG]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000761$igg-binding protein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),UP_SEQ_FEATURE[850029060$chain:Low affinity immunoglobulin gamma Fc region receptor III-A, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Fc receptor-like 5,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc receptor-like 5,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
Fc receptor-like 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
Fc receptor-like 5,UP_SEQ_FEATURE[850019117$chain:Fc receptor-like protein 5, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850104404$domain:Ig-like C2-type 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
FtsJ homolog 3 (E. coli),INTERPRO[450002544$IPR002877:Ribosomal RNA methyltransferase RrmJ/FtsJ, 450011596$IPR012920:Spb1, C-terminal, 450013948$IPR015507:Ribosomal RNA methyltransferase J]
FtsJ homolog 3 (E. coli),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001345$rrna processing, 790001547$transferase]
FtsJ homolog 3 (E. coli),UP_SEQ_FEATURE[850054277$chain:Putative rRNA methyltransferase 3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
FtsJ methyltransferase domain containing 2,INTERPRO[450000396$IPR000467:D111/G-patch, 450001055$IPR001202:WW/Rsp5/WWP, 450002544$IPR002877:Ribosomal RNA methyltransferase RrmJ/FtsJ]
FtsJ methyltransferase domain containing 2,SMART[760000389$SM00443:G_patch, 760000401$SM00456:WW]
FtsJ methyltransferase domain containing 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
FtsJ methyltransferase domain containing 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000532$binding site:S-adenosyl-L-methionine, 850000541$binding site:S-adenosyl-L-methionine; via amide nitrogen, 850058723$chain:S-adenosyl-L-methionine-dependent methyltransferase FTSJD2, 850104022$domain:G-patch, 850105731$domain:WW, 850106258$modified residue, 850112689$region of interest:Interaction with POLR2A]
G protein-coupled estrogen receptor 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450014127$IPR015692:G-protein-coupled receptor 30, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled estrogen receptor 1,PIR_SUPERFAMILY[630030083$PIRSF038579:G protein-coupled estrogen receptor 1, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled estrogen receptor 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
G protein-coupled estrogen receptor 1,UP_SEQ_FEATURE[850020270$chain:G-protein coupled estrogen receptor 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 107,INTERPRO[450008730$IPR009637:Transmembrane receptor, eukaryota]
G protein-coupled receptor 107,PIR_SUPERFAMILY[630010160$PIRSF011955:Caenorhabditis elegans hypothetical protein C15H9.5]
G protein-coupled receptor 107,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
G protein-coupled receptor 107,UP_SEQ_FEATURE[850046310$chain:Protein GPR107, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118623$transmembrane region]
G protein-coupled receptor 141,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 141,PIR_SUPERFAMILY[630030103$PIRSF038599:probable G protein-coupled receptor 141, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 141,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 141,UP_SEQ_FEATURE[850042041$chain:Probable G-protein coupled receptor 141, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 143,INTERPRO[450001259$IPR001414:Ocular albinism protein, type 1]
G protein-coupled receptor 143,OMIM_DISEASE[520003739$Ocular albinism, Nettleship-Falls type]
G protein-coupled receptor 143,SP_PIR_KEYWORDS[790000035$Albinism, 790000356$complete proteome, 790000446$disease mutation, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 143,UP_SEQ_FEATURE[850020275$chain:G-protein coupled receptor 143, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 146,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 146,PIR_SUPERFAMILY[630030102$PIRSF038598:probable G protein-coupled receptor 146, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 146,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 146,UP_SEQ_FEATURE[850042044$chain:Probable G-protein coupled receptor 146, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 149,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 149,PIR_SUPERFAMILY[630030211$PIRSF038717:probable G protein-coupled receptor 149, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 149,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 149,UP_SEQ_FEATURE[850042046$chain:Probable G-protein coupled receptor 149, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 151,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 151,PIR_SUPERFAMILY[630030157$PIRSF038655:probable G protein-coupled receptor 151, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 151,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 151,UP_SEQ_FEATURE[850042048$chain:Probable G-protein coupled receptor 151, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 172B,INTERPRO[450008466$IPR009357:Protein of unknown function DUF1011]
G protein-coupled receptor 172B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
G protein-coupled receptor 172B,UP_SEQ_FEATURE[850039982$chain:Porcine endogenous retrovirus A receptor 2, 850102572$compositionally biased region:Poly-Glu, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
G protein-coupled receptor 19,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 19,PIR_SUPERFAMILY[630030101$PIRSF038597:probable G protein-coupled receptor 19, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 19,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
G protein-coupled receptor 19,UP_SEQ_FEATURE[850042062$chain:Probable G-protein coupled receptor 19, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 20,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 20,PIR_SUPERFAMILY[630030151$PIRSF038649:probable G protein-coupled receptor 20, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 20,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 20,UP_SEQ_FEATURE[850020282$chain:G-protein coupled receptor 20, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 22,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 22,PIR_SUPERFAMILY[630030158$PIRSF038656:probable G protein-coupled receptor 22, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 22,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 22,UP_SEQ_FEATURE[850042064$chain:Probable G-protein coupled receptor 22, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 32,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000718$IPR000826:Formyl/methionyl peptide receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 32,PIR_SUPERFAMILY[630030067$PIRSF038563:probable G protein-coupled receptor 32, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 32,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 32,UP_SEQ_FEATURE[850042068$chain:Probable G-protein coupled receptor 32, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 64,INTERPRO[450000174$IPR000203:GPS, 450000724$IPR000832:GPCR, family 2, secretin-like, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site]
G protein-coupled receptor 64,PIR_SUPERFAMILY[630030178$PIRSF038676:G protein-coupled receptor 64, 630031208$PIRSF800007:secretin receptor-like G protein-coupled receptors]
G protein-coupled receptor 64,SMART[760000273$SM00303:GPS]
G protein-coupled receptor 64,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 64,UP_SEQ_FEATURE[850020292$chain:G-protein coupled receptor 64, 850102576$compositionally biased region:Poly-Leu, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 77,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450001124$IPR001274:C5A-anaphylatoxin receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 77,PIR_SUPERFAMILY[630030070$PIRSF038566:C5a anaphylatoxin chemotactic receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 77,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 77,UP_SEQ_FEATURE[850008821$chain:C5a anaphylatoxin chemotactic receptor C5L2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor associated sorting protein 2,INTERPRO[450006311$IPR006911:Protein of unknown function DUF634]
G protein-coupled receptor associated sorting protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001301$receptor]
G protein-coupled receptor associated sorting protein 2,UP_SEQ_FEATURE[850020314$chain:G-protein coupled receptor-associated sorting protein 2, 850117295$sequence variant]
G protein-coupled receptor kinase 4,BIOCARTA[30000007$h_agpcrPathway:Attenuation of GPCR Signaling]
G protein-coupled receptor kinase 4,INTERPRO[450000207$IPR000239:GPCR kinase, 450000294$IPR000342:Regulator of G protein signalling, 450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
G protein-coupled receptor kinase 4,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038841$hsa04144:Endocytosis]
G protein-coupled receptor kinase 4,SMART[760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000285$SM00315:RGS]
G protein-coupled receptor kinase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000881$lipoprotein, 790001063$nucleotide-binding, 790001100$palmitate, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
G protein-coupled receptor kinase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850020253$chain:G protein-coupled receptor kinase 4, 850103028$domain:AGC-kinase C-terminal, 850105086$domain:Protein kinase, 850105178$domain:RGS, 850106263$nucleotide phosphate-binding region:ATP, 850113517$region of interest:N-terminal, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
G1 to S phase transition 1,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
G1 to S phase transition 1,INTERPRO[450000689$IPR000795:Protein synthesis factor, GTP-binding, 450003670$IPR004160:Translation elongation factor EFTu/EF1A, C-terminal, 450003671$IPR004161:Translation elongation factor EFTu/EF1A, domain 2, 450008904$IPR009818:Ataxin-2, C-terminal]
G1 to S phase transition 1,PIR_SUPERFAMILY[630003099$PIRSF003011:suppressor 2 protein]
G1 to S phase transition 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001255$protein biosynthesis]
G1 to S phase transition 1,UP_SEQ_FEATURE[850018069$chain:Eukaryotic peptide chain release factor GTP-binding subunit ERF3A, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand, 850118624$turn]
GATA binding protein 1 (globin transcription factor 1),BIOCARTA[30000009$h_ahspPathway:Hemoglobin's Chaperone]
GATA binding protein 1 (globin transcription factor 1),INTERPRO[450000580$IPR000679:Zinc finger, GATA-type, 450011732$IPR013088:Zinc finger, NHR/GATA-type, 450014695$IPR016374:Transcription factor, GATA-1/2/3]
GATA binding protein 1 (globin transcription factor 1),OMIM_DISEASE[520000316$Anemia, X-linked, without thrombocytopenia, 520001582$Dyserythropoietic anemia with thrombocytopenia, 520002860$Leukemia, megakaryoblastic, of Down syndrome, 520002861$Leukemia, megakaryoblastic, with or without Down syndrome, 520003004$Macrothrombocytopenia, 520004824$Thrombocytopenia with beta-thalassemia, X-linked]
GATA binding protein 1 (globin transcription factor 1),PIR_SUPERFAMILY[630003115$PIRSF003027:TF_GATA-1/2/3]
GATA binding protein 1 (globin transcription factor 1),SMART[760000352$SM00401:ZnF_GATA]
GATA binding protein 1 (globin transcription factor 1),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
GATA binding protein 1 (globin transcription factor 1),UP_SEQ_FEATURE[850017809$chain:Erythroid transcription factor, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850106259$mutagenesis site, 850114400$region of interest:Required for interaction with ZFPM1, 850117295$sequence variant, 850118574$splice variant, 850118823$zinc finger region:GATA-type 1, 850118824$zinc finger region:GATA-type 2]
GATA binding protein 4,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes, 30000140$h_hopPathway:Hop Pathway in Cardiac Development, 30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart)]
GATA binding protein 4,INTERPRO[450000580$IPR000679:Zinc finger, GATA-type, 450007350$IPR008013:GATA-type transcription activator, N-terminal, 450011732$IPR013088:Zinc finger, NHR/GATA-type, 450014696$IPR016375:Transcription factor GATA-4/5/6]
GATA binding protein 4,OMIM_DISEASE[520000453$Atrial septal defect-2]
GATA binding protein 4,PIR_SUPERFAMILY[630003117$PIRSF003028:TF_GATA_4/5/6, 630003118$PIRSF003028:transcription factor GATA-4/5/6 types]
GATA binding protein 4,SMART[760000352$SM00401:ZnF_GATA]
GATA binding protein 4,SP_PIR_KEYWORDS[790000020$activator, 790000141$atrial septal defect, 790000245$Cardiomyopathy, 790000356$complete proteome, 790000446$disease mutation, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
GATA binding protein 4,UP_SEQ_FEATURE[850065172$chain:Transcription factor GATA-4, 850102565$compositionally biased region:Poly-Ala, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118823$zinc finger region:GATA-type 1, 850118824$zinc finger region:GATA-type 2]
GATA like protein-1,INTERPRO[450000580$IPR000679:Zinc finger, GATA-type, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
GATA like protein-1,SMART[760000352$SM00401:ZnF_GATA]
GATA like protein-1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
GATA like protein-1,UP_SEQ_FEATURE[850020716$chain:GATA-like protein 1, 850118822$zinc finger region:GATA-type]
GATA zinc finger domain containing 2A,INTERPRO[450000580$IPR000679:Zinc finger, GATA-type]
GATA zinc finger domain containing 2A,SMART[760000352$SM00401:ZnF_GATA]
GATA zinc finger domain containing 2A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
GATA zinc finger domain containing 2A,UP_SEQ_FEATURE[850065702$chain:Transcriptional repressor p66-alpha, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118822$zinc finger region:GATA-type]
GATS, stromal antigen 3 opposite strand,COG_ONTOLOGY[90000070$Function unknown]
GATS, stromal antigen 3 opposite strand,SP_PIR_KEYWORDS[790000356$complete proteome]
GATS, stromal antigen 3 opposite strand,UP_SEQ_FEATURE[850053875$chain:Putative protein GATS, 850117294$sequence conflict]
GDP dissociation inhibitor 1,INTERPRO[450000699$IPR000806:Rab GDI protein, 450001776$IPR002005:Rab GTPase activator, 450016490$IPR018203:GDP dissociation inhibitor]
GDP dissociation inhibitor 1,OMIM_DISEASE[520003198$Mental retardation, X-linked nonspecific]
GDP dissociation inhibitor 1,PIR_SUPERFAMILY[630016226$PIRSF019647:GDP dissociation inhibitor XAP-4]
GDP dissociation inhibitor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000640$GTPase activation, 790000930$mental retardation, 790001162$phosphoprotein]
GDP dissociation inhibitor 1,UP_SEQ_FEATURE[850056508$chain:Rab GDP dissociation inhibitor alpha, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
GDP-mannose pyrophosphorylase A,INTERPRO[450001293$IPR001451:Bacterial transferase hexapeptide repeat, 450005282$IPR005835:Nucleotidyl transferase, 450016642$IPR018357:Hexapeptide transferase, conserved site]
GDP-mannose pyrophosphorylase A,KEGG_PATHWAY[470038729$hsa00051:Fructose and mannose metabolism, 470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
GDP-mannose pyrophosphorylase A,PIR_SUPERFAMILY[630000942$PIRSF000815:glucose-1-phosphate adenylyltransferase]
GDP-mannose pyrophosphorylase A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001064$nucleotidyltransferase, 790001212$polymorphism, 790001547$transferase]
GDP-mannose pyrophosphorylase A,UP_SEQ_FEATURE[850030432$chain:Mannose-1-phosphate guanyltransferase alpha, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GDP-mannose pyrophosphorylase B,INTERPRO[450001293$IPR001451:Bacterial transferase hexapeptide repeat, 450005282$IPR005835:Nucleotidyl transferase, 450016642$IPR018357:Hexapeptide transferase, conserved site]
GDP-mannose pyrophosphorylase B,KEGG_PATHWAY[470038729$hsa00051:Fructose and mannose metabolism, 470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
GDP-mannose pyrophosphorylase B,PIR_SUPERFAMILY[630005756$PIRSF005831:mannose-1-phosphate guanylyltransferase]
GDP-mannose pyrophosphorylase B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001064$nucleotidyltransferase, 790001212$polymorphism, 790001547$transferase]
GDP-mannose pyrophosphorylase B,UP_SEQ_FEATURE[850030435$chain:Mannose-1-phosphate guanyltransferase beta, 850117295$sequence variant, 850118574$splice variant]
GEM interacting protein,INTERPRO[450000169$IPR000198:RhoGAP, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding]
GEM interacting protein,SMART[760000096$SM00109:C1, 760000293$SM00324:RhoGAP]
GEM interacting protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
GEM interacting protein,UP_SEQ_FEATURE[850020868$chain:GEM-interacting protein, 850102566$compositionally biased region:Poly-Arg, 850102586$compositionally biased region:Pro-rich, 850105183$domain:Rho-GAP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
GIPC PDZ domain containing family, member 3,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450015705$IPR017379:Uncharacterised conserved protein UCP038083, PDZ]
GIPC PDZ domain containing family, member 3,PIR_SUPERFAMILY[630029665$PIRSF038083:UCP038083_GIPC, 630029666$PIRSF038083:uncharacterized protein with PDZ domain, GIPC type]
GIPC PDZ domain containing family, member 3,SMART[760000200$SM00228:PDZ]
GIPC PDZ domain containing family, member 3,SP_PIR_KEYWORDS[790000356$complete proteome]
GIPC PDZ domain containing family, member 3,UP_SEQ_FEATURE[850036996$chain:PDZ domain-containing protein GIPC3, 850104918$domain:PDZ]
GIY-YIG domain containing 2; GIY-YIG domain containing 1,INTERPRO[450000261$IPR000305:Excinuclease ABC, C subunit, N-terminal]
GIY-YIG domain containing 2; GIY-YIG domain containing 1,SMART[760000410$SM00465:GIYc]
GIY-YIG domain containing 2; GIY-YIG domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000498$Endonuclease, 790000743$hydrolase, 790000937$metal-binding, 790001049$nuclease, 790001065$nucleus, 790001648$zinc, 790001651$zinc-finger]
GIY-YIG domain containing 2; GIY-YIG domain containing 1,UP_SEQ_FEATURE[850062638$chain:Structure-specific endonuclease subunit slx1, 850104050$domain:GIY-YIG, 850106259$mutagenesis site, 850118574$splice variant, 850118926$zinc finger region:SLX1-type]
GLE1 RNA export mediator homolog (yeast),INTERPRO[450011156$IPR012476:GLE1-like]
GLE1 RNA export mediator homolog (yeast),OMIM_DISEASE[520000391$Arthrogryposis, lethal, with anterior horn cell disease, 520002827$Lethal congenital contracture syndrome, 520002828$Lethal congenital contracture syndrome 1]
GLE1 RNA export mediator homolog (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001554$translocation, 790001558$transport]
GLE1 RNA export mediator homolog (yeast),UP_SEQ_FEATURE[850035214$chain:Nucleoporin GLE1, 850106258$modified residue, 850112634$region of interest:Interaction with NUP155, 850112637$region of interest:Interaction with NUPL2, 850113412$region of interest:Mediates the shuttling between the nucleus and the cytoplasm, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GRAM domain containing 3,INTERPRO[450003692$IPR004182:GRAM]
GRAM domain containing 3,SMART[760000505$SM00568:GRAM]
GRAM domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
GRAM domain containing 3,UP_SEQ_FEATURE[850022344$chain:GRAM domain-containing protein 3, 850104079$domain:GRAM, 850106258$modified residue, 850117294$sequence conflict]
GRB10 interacting GYF protein 2,INTERPRO[450002786$IPR003169:GYF]
GRB10 interacting GYF protein 2,OMIM_DISEASE[520003923$Parkinson disease 11]
GRB10 interacting GYF protein 2,SMART[760000390$SM00444:GYF]
GRB10 interacting GYF protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790001106$parkinson disease, 790001162$phosphoprotein, 790001212$polymorphism]
GRB10 interacting GYF protein 2,UP_SEQ_FEATURE[850038010$chain:PERQ amino acid-rich with GYF domain- containing protein 2, 850102404$compositionally biased region:Arg-rich, 850102485$compositionally biased region:Gln-rich, 850102507$compositionally biased region:Glu-rich, 850102573$compositionally biased region:Poly-Gly, 850102586$compositionally biased region:Pro-rich, 850104094$domain:GYF, 850106258$modified residue, 850114306$region of interest:Required for GRB10-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GRB2-associated binding protein 1,BIOCARTA[30000186$h_metPathway:Signaling of Hepatocyte Growth Factor Receptor]
GRB2-associated binding protein 1,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
GRB2-associated binding protein 1,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038877$hsa04722:Neurotrophin signaling pathway, 470038901$hsa05211:Renal cell carcinoma]
GRB2-associated binding protein 1,SMART[760000205$SM00233:PH]
GRB2-associated binding protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001407$signal transduction]
GRB2-associated binding protein 1,UP_SEQ_FEATURE[850022389$chain:GRB2-associated-binding protein 1, 850102586$compositionally biased region:Pro-rich, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GRB2-associated binding protein 3,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
GRB2-associated binding protein 3,SMART[760000205$SM00233:PH]
GRB2-associated binding protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
GRB2-associated binding protein 3,UP_SEQ_FEATURE[850022391$chain:GRB2-associated-binding protein 3, 850104979$domain:PH, 850117295$sequence variant]
GRB2-related adaptor protein 2,INTERPRO[450000852$IPR000980:SH2 motif, 450001294$IPR001452:Src homology-3 domain]
GRB2-related adaptor protein 2,KEGG_PATHWAY[470038869$hsa04660:T cell receptor signaling pathway]
GRB2-related adaptor protein 2,SMART[760000224$SM00252:SH2, 760000295$SM00326:SH3]
GRB2-related adaptor protein 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001397$SH2 domain, 790001398$sh3 domain]
GRB2-related adaptor protein 2,UP_SEQ_FEATURE[850022394$chain:GRB2-related adapter protein 2, 850105346$domain:SH2, 850105351$domain:SH3 1, 850105353$domain:SH3 2, 850106258$modified residue, 850117295$sequence variant]
GTF2I repeat domain containing 1,INTERPRO[450003720$IPR004212:GTF2I-like repeat, 450014980$IPR016659:Transcription factor II-I]
GTF2I repeat domain containing 1,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
GTF2I repeat domain containing 1,OMIM_DISEASE[520005093$Williams-Beuren syndrome]
GTF2I repeat domain containing 1,PIR_SUPERFAMILY[630013214$PIRSF016441:general transcription factor II-I, 630013215$PIRSF016441:TF_II-I]
GTF2I repeat domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001640$williams-beuren syndrome]
GTF2I repeat domain containing 1,UP_SEQ_FEATURE[850021043$chain:General transcription factor II-I repeat domain-containing protein 1, 850102597$compositionally biased region:Ser-rich, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850116107$repeat:GTF2I-like 1, 850116108$repeat:GTF2I-like 2, 850116109$repeat:GTF2I-like 3, 850116110$repeat:GTF2I-like 4, 850116111$repeat:GTF2I-like 5, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
GTP binding protein 1,COG_ONTOLOGY[90000073$General function prediction only]
GTP binding protein 1,INTERPRO[450000689$IPR000795:Protein synthesis factor, GTP-binding, 450003670$IPR004160:Translation elongation factor EFTu/EF1A, C-terminal, 450003671$IPR004161:Translation elongation factor EFTu/EF1A, domain 2]
GTP binding protein 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
GTP binding protein 1,UP_SEQ_FEATURE[850022547$chain:GTP-binding protein 1, 850102565$compositionally biased region:Poly-Ala, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant]
GTP binding protein 3 (mitochondrial),INTERPRO[450002575$IPR002917:GTP-binding protein, HSR1-related, 450004013$IPR004520:tRNA modification GTPase TrmE, 450004692$IPR005225:Small GTP-binding protein, 450017219$IPR018948:GTP-binding protein TrmE, N-terminal]
GTP binding protein 3 (mitochondrial),PIR_SUPERFAMILY[630005894$PIRSF005958:thiophen / furan oxidation protein]
GTP binding protein 3 (mitochondrial),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000639$gtp-binding, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism, 790001550$transit peptide, 790001572$trna processing]
GTP binding protein 3 (mitochondrial),UP_SEQ_FEATURE[850066767$chain:tRNA modification GTPase GTPBP3, mitochondrial, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
GTP binding protein 4,COG_ONTOLOGY[90000073$General function prediction only]
GTP binding protein 4,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450005508$IPR006073:GTP1/OBG, 450009719$IPR010674:Nucleolar GTP-binding 1, 450011649$IPR012973:NOG, C-terminal]
GTP binding protein 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001331$ribosome biogenesis]
GTP binding protein 4,UP_SEQ_FEATURE[850035174$chain:Nucleolar GTP-binding protein 1, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict]
GTP-binding protein 8 (putative),INTERPRO[450002575$IPR002917:GTP-binding protein, HSR1-related, 450018216$IPR019987:GTP-binding protein, ribosome biogenesis,  YsxC]
GTP-binding protein 8 (putative),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
GTP-binding protein 8 (putative),UP_SEQ_FEATURE[850022553$chain:GTP-binding protein 8, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GTPase activating Rap/RanGAP domain-like 1,INTERPRO[450000284$IPR000331:Rap/ran-GAP]
GTPase activating Rap/RanGAP domain-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
GTPase activating Rap/RanGAP domain-like 1,UP_SEQ_FEATURE[850056599$chain:Ral GTPase-activating protein alpha subunit 1, 850102581$compositionally biased region:Poly-Ser, 850105144$domain:Rap-GAP, 850106258$modified residue, 850106259$mutagenesis site, 850113451$region of interest:Minimal domain that binds to TCF3/E12, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GTPase activating protein and VPS9 domains 1,INTERPRO[450001714$IPR001936:Ras GTPase-activating protein, 450002747$IPR003123:Vacuolar sorting protein 9, 450012589$IPR013995:Vacuolar sorting protein 9, subgroup]
GTPase activating protein and VPS9 domains 1,PIR_SUPERFAMILY[630029845$PIRSF038237:Rab31 guanine nucleotide exchange factor Gapex-5]
GTPase activating protein and VPS9 domains 1,SMART[760000146$SM00167:VPS9, 760000292$SM00323:RasGAP]
GTPase activating protein and VPS9 domains 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000496$Endocytosis, 790000501$endosome, 790000640$GTPase activation, 790000641$guanine-nucleotide releasing factor, 790000919$membrane, 790001162$phosphoprotein]
GTPase activating protein and VPS9 domains 1,UP_SEQ_FEATURE[850022655$chain:GTPase-activating protein and VPS9 domain-containing protein 1, 850105148$domain:Ras-GAP, 850105626$domain:VPS9, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
H19, imprinted maternally expressed transcript (non-protein coding),OMIM_DISEASE[520000548$Beckwith-Wiedemann syndrome, 520004484$Silver-Russell syndrome]
H2A histone family, member X,INTERPRO[450001877$IPR002119:Histone H2A, 450006498$IPR007125:Histone core]
H2A histone family, member X,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
H2A histone family, member X,PIR_SUPERFAMILY[630002183$PIRSF002048:histone H2A]
H2A histone family, member X,SMART[760000361$SM00414:H2A]
H2A histone family, member X,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000258$cell cycle, 790000315$chromosomal protein, 790000356$complete proteome, 790000449$DNA binding, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000466$dna-binding, 790000811$isopeptide bond, 790000915$meiosis, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
H2A histone family, member X,UP_SEQ_FEATURE[850024000$chain:Histone H2A.x, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117811$short sequence motif:[ST]-Q motif]
H2B histone family, member M,INTERPRO[450000478$IPR000558:Histone H2B, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
H2B histone family, member M,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
H2B histone family, member M,SMART[760000373$SM00427:H2B]
H2B histone family, member M,SP_PIR_KEYWORDS[790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790001058$nucleosome core, 790001065$nucleus, 790001212$polymorphism]
H2B histone family, member M,UP_SEQ_FEATURE[850024038$chain:Histone H2B type F-M, 850117295$sequence variant]
H2B histone family, member W, testis-specific,INTERPRO[450000478$IPR000558:Histone H2B, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
H2B histone family, member W, testis-specific,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
H2B histone family, member W, testis-specific,SMART[760000373$SM00427:H2B]
H2B histone family, member W, testis-specific,SP_PIR_KEYWORDS[790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790000919$membrane, 790001058$nucleosome core, 790001065$nucleus, 790001212$polymorphism]
H2B histone family, member W, testis-specific,UP_SEQ_FEATURE[850024040$chain:Histone H2B type W-T, 850117295$sequence variant]
HES/HEY-like transcription factor,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450003196$IPR003650:Orange]
HES/HEY-like transcription factor,SMART[760000321$SM00353:HLH]
HES/HEY-like transcription factor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
HES/HEY-like transcription factor,UP_SEQ_FEATURE[850022910$chain:Hairy and enhancer of split-related protein HELT, 850102586$compositionally biased region:Pro-rich, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104869$domain:Orange, 850117295$sequence variant, 850118574$splice variant]
HIG1 hypoxia inducible domain family, member 1B,INTERPRO[450007024$IPR007667:Hypoxia induced protein conserved region]
HIG1 hypoxia inducible domain family, member 1B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
HIG1 hypoxia inducible domain family, member 1B,UP_SEQ_FEATURE[850023663$chain:HIG1 domain family member 1B, 850104125$domain:HIG1, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
HIG1 hypoxia inducible domain family, member 2A,INTERPRO[450007024$IPR007667:Hypoxia induced protein conserved region]
HIG1 hypoxia inducible domain family, member 2A,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
HIG1 hypoxia inducible domain family, member 2A,UP_SEQ_FEATURE[850023665$chain:HIG1 domain family member 2A, 850104125$domain:HIG1, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
HIR histone cell cycle regulation defective homolog A (S. cerevisiae),INTERPRO[450001490$IPR001680:WD40 repeat, 450010356$IPR011494:TUP1-like enhancer of split, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450017285$IPR019015:HIRA B motif, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
HIR histone cell cycle regulation defective homolog A (S. cerevisiae),SMART[760000289$SM00320:WD40]
HIR histone cell cycle regulation defective homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001638$wd repeat]
HIR histone cell cycle regulation defective homolog A (S. cerevisiae),UP_SEQ_FEATURE[850046410$chain:Protein HIRA, 850102570$compositionally biased region:Poly-Gln, 850102577$compositionally biased region:Poly-Lys, 850102585$compositionally biased region:Poly-Val, 850106258$modified residue, 850106259$mutagenesis site, 850112098$region of interest:Interaction with ASF1A, 850112154$region of interest:Interaction with CCNA1, 850112400$region of interest:Interaction with histone H2B, 850112406$region of interest:Interaction with histone H4, 850112659$region of interest:Interaction with PAX3, 850114465$region of interest:Required for repression of histone gene transcription, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
HLA complex P5,OMIM_DISEASE[520002032$Genome-wide association study targeting hIV1 viral setpoint., 520002068$Genomewide Association Study of an AIDS-Nonprogression Cohort Emphasizes the Role Played by HLA Genes (ANRS Genomewide Association Study 02).]
HLA complex P5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
HLA complex P5,UP_SEQ_FEATURE[850024214$chain:HLA class I histocompatibility antigen protein P5, 850117294$sequence conflict, 850117295$sequence variant]
HLA-B associated transcript 2,INTERPRO[450008829$IPR009738:BAT2, N-terminal]
HLA-B associated transcript 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
HLA-B associated transcript 2,UP_SEQ_FEATURE[850027970$chain:Large proline-rich protein BAT2, 850102566$compositionally biased region:Poly-Arg, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850106258$modified residue, 850110091$region of interest:2 X type B repeats, 850110245$region of interest:3 X 50 AA type C repeats, 850110403$region of interest:4 X 57 AA type A repeats, 850115075$repeat:1-1, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115274$repeat:2-1, 850115291$repeat:2-2, 850115418$repeat:3-1, 850115430$repeat:3-2, 850115435$repeat:3-3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
HLA-B associated transcript 4,INTERPRO[450000396$IPR000467:D111/G-patch, 450001870$IPR002110:Ankyrin]
HLA-B associated transcript 4,SMART[760000220$SM00248:ANK, 760000389$SM00443:G_patch]
HLA-B associated transcript 4,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
HLA-B associated transcript 4,UP_SEQ_FEATURE[850045166$chain:Protein BAT4, 850104022$domain:G-patch, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117295$sequence variant]
HMG box domain containing 3,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
HMG box domain containing 3,SMART[760000349$SM00398:HMG]
HMG box domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus]
HMG box domain containing 3,UP_SEQ_FEATURE[850024316$chain:HMG domain-containing protein 3, 850102404$compositionally biased region:Arg-rich, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850102920$DNA-binding region:HMG box, 850117294$sequence conflict]
HOP homeobox,BIOCARTA[30000140$h_hopPathway:Hop Pathway in Cardiac Development]
HOP homeobox,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
HOP homeobox,SMART[760000341$SM00389:HOX]
HOP homeobox,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000699$Homeobox, 790001065$nucleus, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
HOP homeobox,UP_SEQ_FEATURE[850024782$chain:Homeodomain-only protein, 850102933$DNA-binding region:Homeobox; atypical, 850117294$sequence conflict, 850118574$splice variant]
HUS1 checkpoint homolog b (S. pombe),INTERPRO[450006523$IPR007150:Hus1-like protein, 450014902$IPR016580:Cell cycle checkpoint, HUS1]
HUS1 checkpoint homolog b (S. pombe),PIR_SUPERFAMILY[630009697$PIRSF011312:Cell_cycle_HUS1]
HUS1 checkpoint homolog b (S. pombe),SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
HUS1 checkpoint homolog b (S. pombe),UP_SEQ_FEATURE[850010899$chain:Checkpoint protein HUS1B, 850117295$sequence variant]
HemK methyltransferase family member 1,INTERPRO[450001818$IPR002052:N-6 adenine-specific DNA methylase, conserved site, 450002040$IPR002295:N6 adenine-specific DNA methyltransferase, D21 class, 450004049$IPR004556:Modification methylase HemK, 450007196$IPR007848:Methyltransferase small]
HemK methyltransferase family member 1,KEGG_PATHWAY[470038740$hsa00150:Androgen and estrogen metabolism, 470038753$hsa00340:Histidine metabolism, 470038754$hsa00350:Tyrosine metabolism, 470038760$hsa00450:Selenoamino acid metabolism]
HemK methyltransferase family member 1,PIR_SUPERFAMILY[630028513$PIRSF037013:(N5)-glutamine methyltransferase, Hemk type]
HemK methyltransferase family member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000954$methyltransferase, 790001212$polymorphism, 790001547$transferase]
HemK methyltransferase family member 1,UP_SEQ_FEATURE[850023316$chain:HemK methyltransferase family member 1, 850117295$sequence variant]
Hermansky-Pudlak syndrome 1,OMIM_DISEASE[520002302$Hermansky-Pudlak syndrome 1]
Hermansky-Pudlak syndrome 1,PIR_SUPERFAMILY[630028443$PIRSF036954:HPS1]
Hermansky-Pudlak syndrome 1,SP_PIR_KEYWORDS[790000035$Albinism, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000676$Hermansky-Pudlak syndrome, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001622$vision]
Hermansky-Pudlak syndrome 1,UP_SEQ_FEATURE[850023530$chain:Hermansky-Pudlak syndrome 1 protein, 850102572$compositionally biased region:Poly-Glu, 850117290$repeat:[DE]-X(4)-L-L 1, 850117291$repeat:[DE]-X(4)-L-L 2, 850117292$repeat:[DE]-X(4)-L-L 3, 850117293$repeat:[DE]-X(4)-L-L 4, 850117294$sequence conflict, 850117295$sequence variant, 850117575$short sequence motif:Melanosome targeting signal, 850118574$splice variant]
Hermansky-Pudlak syndrome 3,INTERPRO[450015537$IPR017216:BLOC-2 complex, Hps3 subunit]
Hermansky-Pudlak syndrome 3,OMIM_DISEASE[520002304$Hermansky-Pudlak syndrome 3]
Hermansky-Pudlak syndrome 3,PIR_SUPERFAMILY[630029048$PIRSF037473:BLOC-2 complex, Hps3 subunit, 630029049$PIRSF037473:BLOC-2_complex_Hps3]
Hermansky-Pudlak syndrome 3,SP_PIR_KEYWORDS[790000035$Albinism, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000676$Hermansky-Pudlak syndrome, 790001162$phosphoprotein, 790001212$polymorphism]
Hermansky-Pudlak syndrome 3,UP_SEQ_FEATURE[850023532$chain:Hermansky-Pudlak syndrome 3 protein, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117344$short sequence motif:Clathrin-binding, 850118574$splice variant]
Holliday junction recognition protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000276$centromere, 790000288$Chaperone, 790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
Holliday junction recognition protein,UP_SEQ_FEATURE[850024343$chain:Holliday junction recognition protein, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
IKAROS family zinc finger 1 (Ikaros),COG_ONTOLOGY[90000073$General function prediction only]
IKAROS family zinc finger 1 (Ikaros),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
IKAROS family zinc finger 1 (Ikaros),OMIM_DISEASE[520002832$Leukemia, acute lymphoblastic]
IKAROS family zinc finger 1 (Ikaros),SMART[760000323$SM00355:ZnF_C2H2]
IKAROS family zinc finger 1 (Ikaros),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
IKAROS family zinc finger 1 (Ikaros),UP_SEQ_FEATURE[850015926$chain:DNA-binding protein Ikaros, 850102576$compositionally biased region:Poly-Leu, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850114251$region of interest:Required for binding PP1CC, 850114261$region of interest:Required for both high-affinity DNA binding and pericentromeric heterochromatin localization, 850117294$sequence conflict, 850118520$site:Required for both pericentromeric heterochromatin localization and complete DNA binding, 850118521$site:Required for both pericentromeric heterochromatin localization and DNA binding, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
IQ motif containing D,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region]
IQ motif containing D,SMART[760000009$SM00015:IQ]
IQ motif containing D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
IQ motif containing D,UP_SEQ_FEATURE[850026738$chain:IQ domain-containing protein D, 850104439$domain:IQ, 850117295$sequence variant, 850118574$splice variant]
IQ motif containing GTPase activating protein 2,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450000506$IPR000593:RasGAP protein, C-terminal, 450001055$IPR001202:WW/Rsp5/WWP, 450001520$IPR001715:Calponin-like actin-binding, 450001714$IPR001936:Ras GTPase-activating protein]
IQ motif containing GTPase activating protein 2,KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
IQ motif containing GTPase activating protein 2,SMART[760000009$SM00015:IQ, 760000025$SM00033:CH, 760000292$SM00323:RasGAP, 760000401$SM00456:WW]
IQ motif containing GTPase activating protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000218$calmodulin-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
IQ motif containing GTPase activating protein 2,UP_SEQ_FEATURE[850056695$chain:Ras GTPase-activating-like protein IQGAP2, 850102577$compositionally biased region:Poly-Lys, 850103317$domain:CH, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850105148$domain:Ras-GAP, 850105731$domain:WW, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
IQ motif containing H,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region]
IQ motif containing H,SMART[760000009$SM00015:IQ]
IQ motif containing H,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
IQ motif containing H,UP_SEQ_FEATURE[850026745$chain:IQ domain-containing protein H, 850104439$domain:IQ, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
IQ motif containing K,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
IQ motif containing K,UP_SEQ_FEATURE[850026747$chain:IQ domain-containing protein K, 850117295$sequence variant, 850118574$splice variant]
K(lysine) acetyltransferase 2A,COG_ONTOLOGY[90000045$Chromatin structure and dynamics / Transcription]
K(lysine) acetyltransferase 2A,INTERPRO[450000154$IPR000182:GCN5-related N-acetyltransferase, 450001324$IPR001487:Bromodomain, 450008567$IPR009464:PCAF, N-terminal, 450014522$IPR016181:Acyl-CoA N-acyltransferase, 450014697$IPR016376:Histone acetylase PCAF, 450016644$IPR018359:Bromodomain, conserved site]
K(lysine) acetyltransferase 2A,KEGG_PATHWAY[470038848$hsa04330:Notch signaling pathway]
K(lysine) acetyltransferase 2A,PIR_SUPERFAMILY[630003138$PIRSF003048:histone acetylase PCAF, 630003139$PIRSF003048:Histone_acetylase_PCAF]
K(lysine) acetyltransferase 2A,SMART[760000267$SM00297:BROMO]
K(lysine) acetyltransferase 2A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000206$bromodomain, 790000356$complete proteome, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
K(lysine) acetyltransferase 2A,UP_SEQ_FEATURE[850023863$chain:Histone acetyltransferase KAT2A, 850103166$domain:Bromo, 850104817$domain:N-acetyltransferase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1,INTERPRO[450000112$IPR000133:ER lumen protein retaining receptor]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1,PIR_SUPERFAMILY[630002528$PIRSF002409:ER lumen protein retaining receptor]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000919$membrane, 790001266$protein transport, 790001301$receptor, 790001555$transmembrane, 790001558$transport]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1,UP_SEQ_FEATURE[850017750$chain:ER lumen protein retaining receptor 1, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
KH-type splicing regulatory protein,INTERPRO[450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450013543$IPR015096:Region of unknown function DUF1897, 450016411$IPR018111:K Homology, type 1, subgroup]
KH-type splicing regulatory protein,SMART[760000291$SM00322:KH]
KH-type splicing regulatory protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000988$mrna processing, 790000989$mrna splicing, 790000990$mRNA transport, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation, 790001558$transport]
KH-type splicing regulatory protein,UP_SEQ_FEATURE[850018974$chain:Far upstream element-binding protein 2, 850102392$compositionally biased region:Ala/Gly/Pro-rich, 850102517$compositionally biased region:Gly-rich, 850102529$compositionally biased region:Gly/Pro-rich, 850104521$domain:KH 1, 850104527$domain:KH 2, 850104528$domain:KH 3, 850104529$domain:KH 4, 850105852$helix, 850106258$modified residue, 850110350$region of interest:4 X 12 AA imperfect repeats, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
KIAA0020,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
KIAA0020,INTERPRO[450001156$IPR001313:Pumilio RNA-binding region, 450010814$IPR011989:Armadillo-like helical, 450011635$IPR012959:CPL]
KIAA0020,SMART[760000017$SM00025:Pumilio]
KIAA0020,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
KIAA0020,UP_SEQ_FEATURE[850048933$chain:Pumilio domain-containing protein KIAA0020, 850105124$domain:PUM-HD, 850111832$region of interest:HA-8, 850116868$repeat:Pumilio 1, 850116869$repeat:Pumilio 2, 850116870$repeat:Pumilio 3, 850116871$repeat:Pumilio 4, 850116872$repeat:Pumilio 5, 850116873$repeat:Pumilio 6, 850117294$sequence conflict, 850117295$sequence variant]
KIAA0240,INTERPRO[450014107$IPR015671:Glioma tumour suppressor candidate region gene 1]
KIAA0240,SP_PIR_KEYWORDS[790000356$complete proteome]
KIAA0240,UP_SEQ_FEATURE[850075497$chain:Uncharacterized protein KIAA0240, 850117294$sequence conflict]
KIAA0323,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA0323,UP_SEQ_FEATURE[850046547$chain:Protein KIAA0323, 850106258$modified residue, 850117295$sequence variant]
KIAA0427,INTERPRO[450003415$IPR003890:MIF4G-like, type 3, 450014420$IPR016021:MIF4-like, type 1/2/3]
KIAA0427,SMART[760000483$SM00543:MIF4G]
KIAA0427,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001043$nonsense-mediated mrna decay, 790001162$phosphoprotein, 790001212$polymorphism, 790001551$translation regulation]
KIAA0427,UP_SEQ_FEATURE[850010071$chain:CBP80/20-dependent translation initiation factor, 850104778$domain:MIF4G, 850106258$modified residue, 850112588$region of interest:Interaction with NCBP1/CBP80, 850117295$sequence variant, 850118574$splice variant]
KIAA0556,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA0556,UP_SEQ_FEATURE[850075512$chain:Uncharacterized protein KIAA0556, 850102566$compositionally biased region:Poly-Arg, 850106258$modified residue, 850117295$sequence variant]
KIAA0774,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790001212$polymorphism]
KIAA0774,UP_SEQ_FEATURE[850031716$chain:Microtubule-associated tumor suppressor candidate 2, 850113298$region of interest:Localization to the growing distal tip of microtubules, 850113372$region of interest:Mediates interaction with MAPRE1, 850114774$region of interest:Sufficient for interaction with KIF2C, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KIAA0892,INTERPRO[450010815$IPR011990:Tetratricopeptide-like helical, 450017678$IPR019440:Cohesin loading factor]
KIAA0892,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000317$Chromosome partition, 790000356$complete proteome, 790000973$mitosis, 790001065$nucleus, 790001304$repeat, 790001537$tpr repeat]
KIAA0892,UP_SEQ_FEATURE[850011910$chain:Cohesin loading complex subunit SCC4 homolog, 850102378$compositionally biased region:Ala-rich, 850114782$region of interest:Sufficient for interaction with NIPBL, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850118574$splice variant]
KIAA1211,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1211,UP_SEQ_FEATURE[850075534$chain:Uncharacterized protein KIAA1211, 850102507$compositionally biased region:Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
KIAA1267,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1267,UP_SEQ_FEATURE[850032214$chain:MLL1/MLL complex subunit KIAA1267, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KIAA1430,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1430,UP_SEQ_FEATURE[850097496$chain:UPF0501 protein KIAA1430, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KIAA1644,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
KIAA1644,UP_SEQ_FEATURE[850075557$chain:Uncharacterized protein KIAA1644, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
KIAA1683,COG_ONTOLOGY[90000053$Cytoskeleton]
KIAA1683,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region]
KIAA1683,SMART[760000009$SM00015:IQ]
KIAA1683,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
KIAA1683,UP_SEQ_FEATURE[850075562$chain:Uncharacterized protein KIAA1683, 850102605$compositionally biased region:Thr-rich, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850104473$domain:IQ 4, 850104477$domain:IQ 5, 850104478$domain:IQ 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KIAA1688 protein,COG_ONTOLOGY[90000102$RNA processing and modification]
KIAA1688 protein,INTERPRO[450000169$IPR000198:RhoGAP, 450000748$IPR000857:Unconventional myosin/plant kinesin-like protein/non-motor protein conserved region MyTH4, 450001055$IPR001202:WW/Rsp5/WWP]
KIAA1688 protein,SMART[760000121$SM00139:MyTH4, 760000293$SM00324:RhoGAP, 760000401$SM00456:WW]
KIAA1688 protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
KIAA1688 protein,UP_SEQ_FEATURE[850075563$chain:Uncharacterized protein KIAA1688, 850102586$compositionally biased region:Pro-rich, 850104813$domain:MyTH4, 850105183$domain:Rho-GAP, 850105732$domain:WW 1, 850105733$domain:WW 2, 850106258$modified residue]
KIAA1881,COG_ONTOLOGY[90000070$Function unknown]
KIAA1881,INTERPRO[450003788$IPR004279:Perilipin]
KIAA1881,PIR_SUPERFAMILY[630028361$PIRSF036881:PAT, 630028364$PIRSF036884:lipid droplet-associating protein S3-12]
KIAA1881,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000871$lipid droplet, 790000919$membrane, 790001212$polymorphism, 790001304$repeat]
KIAA1881,UP_SEQ_FEATURE[850037725$chain:Perilipin-4, 850110161$region of interest:27 X 33 AA approximate tandem repeat, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KIAA1919,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
KIAA1919,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001457$sugar transport, 790001473$Symport, 790001555$transmembrane, 790001558$transport]
KIAA1919,UP_SEQ_FEATURE[850061218$chain:Sodium-dependent glucose transporter 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
KIAA1958,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
KIAA1958,UP_SEQ_FEATURE[850075581$chain:Uncharacterized protein KIAA1958, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
KIAA1967,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000940$metalloenzyme inhibitor, 790001162$phosphoprotein]
KIAA1967,UP_SEQ_FEATURE[850046556$chain:Protein KIAA1967, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
KISS1 receptor,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450007438$IPR008103:KiSS-1 peptide receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
KISS1 receptor,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
KISS1 receptor,OMIM_DISEASE[520002517$Hypogonadotropic hypogonadism, 520004080$Precocious puberty, central]
KISS1 receptor,PIR_SUPERFAMILY[630030075$PIRSF038571:KiSS-1 receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
KISS1 receptor,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000751$hypogonadotropic hypogonadism, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
KISS1 receptor,UP_SEQ_FEATURE[850027568$chain:KiSS-1 receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
KN motif and ankyrin repeat domains 2,INTERPRO[450001870$IPR002110:Ankyrin]
KN motif and ankyrin repeat domains 2,SMART[760000220$SM00248:ANK]
KN motif and ankyrin repeat domains 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
KN motif and ankyrin repeat domains 2,UP_SEQ_FEATURE[850027580$chain:KN motif and ankyrin repeat domain- containing protein 2, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KN motif and ankyrin repeat domains 3,INTERPRO[450001870$IPR002110:Ankyrin]
KN motif and ankyrin repeat domains 3,SMART[760000220$SM00248:ANK]
KN motif and ankyrin repeat domains 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
KN motif and ankyrin repeat domains 3,UP_SEQ_FEATURE[850027581$chain:KN motif and ankyrin repeat domain- containing protein 3, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117295$sequence variant, 850118574$splice variant]
Kruppel-like factor 1 (erythroid),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
Kruppel-like factor 1 (erythroid),OMIM_DISEASE[520000627$Blood group--Lutheran inhibitor]
Kruppel-like factor 1 (erythroid),SMART[760000323$SM00355:ZnF_C2H2]
Kruppel-like factor 1 (erythroid),SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
Kruppel-like factor 1 (erythroid),UP_SEQ_FEATURE[850027598$chain:Krueppel-like factor 1, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102586$compositionally biased region:Pro-rich, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
Kruppel-like factor 3 (basic),COG_ONTOLOGY[90000073$General function prediction only]
Kruppel-like factor 3 (basic),SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
Kruppel-like factor 3 (basic),UP_SEQ_FEATURE[850027608$chain:Krueppel-like factor 3, 850102586$compositionally biased region:Pro-rich, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850114223$region of interest:Repressor domain, 850117294$sequence conflict, 850117295$sequence variant, 850117353$short sequence motif:CTBP-binding motif, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
Kv channel interacting protein 2,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Kv channel interacting protein 2,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
Kv channel interacting protein 2,SMART[760000046$SM00054:EFh]
Kv channel interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001304$repeat, 790001558$transport, 790001631$voltage-gated channel]
Kv channel interacting protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850027659$chain:Kv channel-interacting protein 2, 850103582$domain:EF-hand 1; degenerate, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112463$region of interest:Interaction with KCND2, 850117294$sequence conflict, 850118574$splice variant]
LIM and senescent cell antigen-like domains 2,INTERPRO[450001575$IPR001781:Zinc finger, LIM-type, 450015675$IPR017351:PINCH]
LIM and senescent cell antigen-like domains 2,PIR_SUPERFAMILY[630029578$PIRSF038003:PINCH, 630029579$PIRSF038003:PINCH protein]
LIM and senescent cell antigen-like domains 2,SMART[760000114$SM00132:LIM]
LIM and senescent cell antigen-like domains 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000864$LIM domain, 790000919$membrane, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001648$zinc]
LIM and senescent cell antigen-like domains 2,UP_SEQ_FEATURE[850028641$chain:LIM and senescent cell antigen-like- containing domain protein 2, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850104719$domain:LIM zinc-binding 3, 850104721$domain:LIM zinc-binding 4, 850104722$domain:LIM zinc-binding 5, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
LIM and senescent cell antigen-like domains 3; LIMS3-LOC440895 read-through,INTERPRO[450001575$IPR001781:Zinc finger, LIM-type]
LIM and senescent cell antigen-like domains 3; LIMS3-LOC440895 read-through,SMART[760000114$SM00132:LIM]
LIM and senescent cell antigen-like domains 3; LIMS3-LOC440895 read-through,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000864$LIM domain, 790000937$metal-binding, 790001648$zinc]
LIM and senescent cell antigen-like domains 3; LIMS3-LOC440895 read-through,UP_SEQ_FEATURE[850028642$chain:LIM and senescent cell antigen-like- containing domain protein 3, 850104716$domain:LIM zinc-binding]
LIM domain binding 1,BIOCARTA[30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2]
LIM domain binding 1,INTERPRO[450002388$IPR002691:LIM binding protein]
LIM domain binding 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
LIM domain binding 1,UP_SEQ_FEATURE[850028659$chain:LIM domain-binding protein 1, 850106258$modified residue, 850106259$mutagenesis site, 850113276$region of interest:LIM-binding domain (LID), 850117295$sequence variant, 850118574$splice variant]
LIM domain kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001316$IPR001478:PDZ/DHR/GLGF, 450001575$IPR001781:Zinc finger, LIM-type, 450007363$IPR008025:PKC-activated phosphatase-1 inhibitor, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
LIM domain kinase 2,KEGG_PATHWAY[470038851$hsa04360:Axon guidance, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton]
LIM domain kinase 2,PIR_SUPERFAMILY[630000707$PIRSF000600:LIM protein kinase]
LIM domain kinase 2,SMART[760000114$SM00132:LIM, 760000200$SM00228:PDZ]
LIM domain kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000864$LIM domain, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001648$zinc]
LIM domain kinase 2,UP_SEQ_FEATURE[850000242$binding site:ATP, 850028651$chain:LIM domain kinase 2, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850104918$domain:PDZ, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
LIM homeobox 2,INTERPRO[450001200$IPR001356:Homeobox, 450001575$IPR001781:Zinc finger, LIM-type, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
LIM homeobox 2,SMART[760000114$SM00132:LIM, 760000341$SM00389:HOX]
LIM homeobox 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790000864$LIM domain, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc]
LIM homeobox 2,UP_SEQ_FEATURE[850028672$chain:LIM/homeobox protein Lhx2, 850102565$compositionally biased region:Poly-Ala, 850102927$DNA-binding region:Homeobox, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal]
LON peptidase N-terminal domain and ring finger 2,COG_ONTOLOGY[90000046$Coenzyme metabolism, 90000095$Posttranslational modification, protein turnover, chaperones]
LON peptidase N-terminal domain and ring finger 2,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450002735$IPR003111:Peptidase S16, lon N-terminal, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type, 450017972$IPR019734:Tetratricopeptide repeat]
LON peptidase N-terminal domain and ring finger 2,SMART[760000020$SM00028:TPR, 760000158$SM00184:RING, 760000409$SM00464:LON]
LON peptidase N-terminal domain and ring finger 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001648$zinc, 790001651$zinc-finger]
LON peptidase N-terminal domain and ring finger 2,UP_SEQ_FEATURE[850028989$chain:LON peptidase N-terminal domain and RING finger protein 2, 850102580$compositionally biased region:Poly-Pro, 850104735$domain:Lon, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118911$zinc finger region:RING-type]
LRRN4 C-terminal like,INTERPRO[450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
LRRN4 C-terminal like,SMART[760000051$SM00060:FN3]
LRRN4 C-terminal like,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
LRRN4 C-terminal like,UP_SEQ_FEATURE[850029162$chain:LRRN4 C-terminal-like protein, 850102572$compositionally biased region:Poly-Glu, 850103799$domain:Fibronectin type-III, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
LUC7-like (S. cerevisiae),INTERPRO[450004355$IPR004882:LUC7 related]
LUC7-like (S. cerevisiae),PIR_SUPERFAMILY[630021697$PIRSF028830:Luc7/Luc7-like protein, 630030647$PIRSF500423:Luc7-like protein]
LUC7-like (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001648$zinc, 790001651$zinc-finger]
LUC7-like (S. cerevisiae),UP_SEQ_FEATURE[850054263$chain:Putative RNA-binding protein Luc7-like 1, 850102442$compositionally biased region:Arg/Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118740$zinc finger region:C2H2-type; atypical]
LY6/PLAUR domain containing 3,INTERPRO[450001358$IPR001526:CD59 antigen, 450014439$IPR016054:Ly-6 antigen / uPA receptor -like, 450016648$IPR018363:CD59 antigen, conserved site]
LY6/PLAUR domain containing 3,SMART[760000116$SM00134:LU]
LY6/PLAUR domain containing 3,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001304$repeat, 790001405$signal]
LY6/PLAUR domain containing 3,UP_SEQ_FEATURE[850029210$chain:Ly6/PLAUR domain-containing protein 3, 850105610$domain:UPAR/Ly6 1, 850105611$domain:UPAR/Ly6 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105859$lipid moiety-binding region:GPI-anchor amidated cysteine, 850109701$propeptide:Removed in mature form, 850117814$signal peptide]
LY6/PLAUR domain containing 5,INTERPRO[450001358$IPR001526:CD59 antigen, 450016648$IPR018363:CD59 antigen, conserved site]
LY6/PLAUR domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal]
LY6/PLAUR domain containing 5,UP_SEQ_FEATURE[850029212$chain:Ly6/PLAUR domain-containing protein 5, 850105609$domain:UPAR/Ly6, 850105770$glycosylation site:N-linked (GlcNAc...), 850105855$lipid moiety-binding region:GPI-anchor amidated alanine, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
LanC lantibiotic synthetase component C-like 2 (bacterial),INTERPRO[450007171$IPR007822:Lanthionine synthetase C-like]
LanC lantibiotic synthetase component C-like 2 (bacterial),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
LanC lantibiotic synthetase component C-like 2 (bacterial),UP_SEQ_FEATURE[850027952$chain:LanC-like protein 2, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850112443$region of interest:Interaction with inositol phospholipids, 850117295$sequence variant]
Ly6/neurotoxin 1,INTERPRO[450001358$IPR001526:CD59 antigen, 450014439$IPR016054:Ly-6 antigen / uPA receptor -like, 450016648$IPR018363:CD59 antigen, conserved site]
Ly6/neurotoxin 1,PIR_SUPERFAMILY[630002157$PIRSF002021:Ly-6-like protein]
Ly6/neurotoxin 1,SMART[760000116$SM00134:LU]
Ly6/neurotoxin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal]
Ly6/neurotoxin 1,UP_SEQ_FEATURE[850029207$chain:Ly-6/neurotoxin-like protein 1, 850059126$chain:Secreted Ly-6/uPAR-related protein 2, 850102883$disulfide bond, 850105609$domain:UPAR/Ly6, 850105852$helix, 850105860$lipid moiety-binding region:GPI-anchor amidated glycine, 850109701$propeptide:Removed in mature form, 850117814$signal peptide, 850118575$strand, 850118624$turn]
MAF1 homolog (S. cerevisiae),INTERPRO[450013702$IPR015257:Maf1 regulator, 450015472$IPR017152:RNA polymerase III transcriptional repressor, MAF1]
MAF1 homolog (S. cerevisiae),PIR_SUPERFAMILY[630028772$PIRSF037240:repressor of RNA polymerase III transcription MAF1, 630028773$PIRSF037240:RNA_polIII_Trep_MAF1]
MAF1 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
MAF1 homolog (S. cerevisiae),UP_SEQ_FEATURE[850057245$chain:Repressor of RNA polymerase III transcription MAF1 homolog, 850106258$modified residue, 850117295$sequence variant]
MAP kinase interacting serine/threonine kinase 1,BBID[10000010$107.mRNA_translation-protein_synthesis]
MAP kinase interacting serine/threonine kinase 1,BIOCARTA[30000095$h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase, 30000105$h_erkPathway:Erk1/Erk2 Mapk Signaling pathway, 30000180$h_mapkPathway:MAPKinase Signaling Pathway, 30000195$h_mTORPathway:mTOR Signaling Pathway, 30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway ]
MAP kinase interacting serine/threonine kinase 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014166$IPR015731:MAP Kinase Interacting Kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
MAP kinase interacting serine/threonine kinase 1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038882$hsa04910:Insulin signaling pathway]
MAP kinase interacting serine/threonine kinase 1,SMART[760000193$SM00220:S_TKc]
MAP kinase interacting serine/threonine kinase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001551$translation regulation]
MAP kinase interacting serine/threonine kinase 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850030497$chain:MAP kinase-interacting serine/threonine- protein kinase 1, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
MAP kinase interacting serine/threonine kinase 2,BIOCARTA[30000105$h_erkPathway:Erk1/Erk2 Mapk Signaling pathway, 30000180$h_mapkPathway:MAPKinase Signaling Pathway]
MAP kinase interacting serine/threonine kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014166$IPR015731:MAP Kinase Interacting Kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
MAP kinase interacting serine/threonine kinase 2,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038882$hsa04910:Insulin signaling pathway]
MAP kinase interacting serine/threonine kinase 2,SMART[760000193$SM00220:S_TKc]
MAP kinase interacting serine/threonine kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000574$G protein-coupled receptor, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001551$translation regulation, 790001648$zinc]
MAP kinase interacting serine/threonine kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850030498$chain:MAP kinase-interacting serine/threonine- protein kinase 2, 850105086$domain:Protein kinase, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
MAP7 domain containing 2,INTERPRO[450007865$IPR008604:E-MAP-115]
MAP7 domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
MAP7 domain containing 2,UP_SEQ_FEATURE[850030509$chain:MAP7 domain-containing protein 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MAP7 domain containing 3,INTERPRO[450007865$IPR008604:E-MAP-115]
MAP7 domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
MAP7 domain containing 3,UP_SEQ_FEATURE[850030510$chain:MAP7 domain-containing protein 3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MARCKS-like 1,INTERPRO[450001861$IPR002101:Myristoylated alanine-rich C-kinase substrate MARCKS]
MARCKS-like 1,KEGG_PATHWAY[470038872$hsa04666:Fc gamma R-mediated phagocytosis]
MARCKS-like 1,SP_PIR_KEYWORDS[790000218$calmodulin-binding, 790000356$complete proteome, 790000881$lipoprotein, 790001004$myristate, 790001162$phosphoprotein]
MARCKS-like 1,UP_SEQ_FEATURE[850030516$chain:MARCKS-related protein, 850102577$compositionally biased region:Poly-Lys, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850111167$region of interest:Calmodulin-binding (PSD), 850117294$sequence conflict]
MAS-related GPR, member F,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
MAS-related GPR, member F,PIR_SUPERFAMILY[630001858$PIRSF001712:mas-related G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
MAS-related GPR, member F,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
MAS-related GPR, member F,UP_SEQ_FEATURE[850030541$chain:Mas-related G-protein coupled receptor member F, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
MAS1 oncogene-like,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
MAS1 oncogene-like,PIR_SUPERFAMILY[630001858$PIRSF001712:mas-related G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
MAS1 oncogene-like,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
MAS1 oncogene-like,UP_SEQ_FEATURE[850030548$chain:Mas-related G-protein coupled receptor MRG, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
MAX dimerization protein 3,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
MAX dimerization protein 3,PIR_SUPERFAMILY[630012606$PIRSF015841:MAX interacting protein]
MAX dimerization protein 3,SMART[760000321$SM00353:HLH]
MAX dimerization protein 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
MAX dimerization protein 3,UP_SEQ_FEATURE[850030703$chain:Max dimerization protein 3, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850112827$region of interest:Interaction with SIN3A and SIN3B, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MAX-like protein X,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
MAX-like protein X,SMART[760000321$SM00353:HLH]
MAX-like protein X,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
MAX-like protein X,UP_SEQ_FEATURE[850030708$chain:Max-like protein X, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MHC class I polypeptide-related sequence B,INTERPRO[450000912$IPR001039:MHC class I, alpha chain, alpha1 and alpha2, 450003158$IPR003597:Immunoglobulin C1-set, 450006486$IPR007110:Immunoglobulin-like, 450010088$IPR011161:MHC class I-like antigen recognition, 450012396$IPR013783:Immunoglobulin-like fold]
MHC class I polypeptide-related sequence B,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
MHC class I polypeptide-related sequence B,OMIM_DISEASE[520002068$Genomewide Association Study of an AIDS-Nonprogression Cohort Emphasizes the Role Played by HLA Genes (ANRS Genomewide Association Study 02).]
MHC class I polypeptide-related sequence B,SMART[760000355$SM00407:IGc1]
MHC class I polypeptide-related sequence B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000406$cytolysis, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
MHC class I polypeptide-related sequence B,UP_SEQ_FEATURE[850031608$chain:MHC class I polypeptide-related sequence B, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
MIF4G domain containing,INTERPRO[450003415$IPR003890:MIF4G-like, type 3, 450014420$IPR016021:MIF4-like, type 1/2/3]
MIF4G domain containing,SMART[760000483$SM00543:MIF4G]
MIF4G domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001551$translation regulation]
MIF4G domain containing,UP_SEQ_FEATURE[850031734$chain:MIF4G domain-containing protein, 850104778$domain:MIF4G, 850118574$splice variant]
MIT, microtubule interacting and transport, domain containing 1,INTERPRO[450006694$IPR007330:MIT]
MIT, microtubule interacting and transport, domain containing 1,SMART[760000651$SM00745:MIT]
MIT, microtubule interacting and transport, domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000501$endosome, 790000919$membrane, 790001266$protein transport, 790001558$transport]
MIT, microtubule interacting and transport, domain containing 1,UP_SEQ_FEATURE[850031808$chain:MIT domain-containing protein 1, 850104790$domain:MIT, 850117294$sequence conflict]
MKI67 (FHA domain) interacting nucleolar phosphoprotein,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
MKI67 (FHA domain) interacting nucleolar phosphoprotein,SMART[760000328$SM00360:RRM]
MKI67 (FHA domain) interacting nucleolar phosphoprotein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
MKI67 (FHA domain) interacting nucleolar phosphoprotein,UP_SEQ_FEATURE[850032200$chain:MKI67 FHA domain-interacting nucleolar phosphoprotein, 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112545$region of interest:Interaction with MKI67, 850117295$sequence variant, 850118575$strand]
MLX interacting protein-like,BIOCARTA[30000063$h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP]
MLX interacting protein-like,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
MLX interacting protein-like,OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520002062$Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
MLX interacting protein-like,SMART[760000321$SM00353:HLH]
MLX interacting protein-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001640$williams-beuren syndrome]
MLX interacting protein-like,UP_SEQ_FEATURE[850100885$chain:Williams-Beuren syndrome chromosomal region 14 protein, 850102580$compositionally biased region:Poly-Pro, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MORC family CW-type zinc finger 2,INTERPRO[450003155$IPR003594:ATP-binding region, ATPase-like, 450010064$IPR011124:Zinc finger, CW-type]
MORC family CW-type zinc finger 2,SMART[760000339$SM00387:HATPase_c]
MORC family CW-type zinc finger 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001648$zinc, 790001651$zinc-finger]
MORC family CW-type zinc finger 2,UP_SEQ_FEATURE[850032482$chain:MORC family CW-type zinc finger protein 2, 850106258$modified residue, 850118795$zinc finger region:CW-type]
MPN domain containing,INTERPRO[450000475$IPR000555:Mov34/MPN/PAD-1]
MPN domain containing,SMART[760000204$SM00232:JAB_MPN]
MPN domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001162$phosphoprotein, 790001252$Protease]
MPN domain containing,UP_SEQ_FEATURE[850032533$chain:MPN domain-containing protein, 850102517$compositionally biased region:Gly-rich, 850102572$compositionally biased region:Poly-Glu, 850104794$domain:MPN, 850106258$modified residue, 850117294$sequence conflict, 850117527$short sequence motif:JAMM motif, 850118574$splice variant]
MTERF domain containing 1,INTERPRO[450003235$IPR003690:Mitochodrial transcription termination factor-related]
MTERF domain containing 1,SMART[760000639$SM00733:Mterf]
MTERF domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
MTERF domain containing 1,UP_SEQ_FEATURE[850032601$chain:mTERF domain-containing protein 1, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
MYST histone acetyltransferase 1,COG_ONTOLOGY[90000042$Chromatin structure and dynamics]
MYST histone acetyltransferase 1,INTERPRO[450000831$IPR000953:Chromo domain, 450002410$IPR002717:MOZ/SAS-like protein, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014522$IPR016181:Acyl-CoA N-acyltransferase]
MYST histone acetyltransferase 1,PIR_SUPERFAMILY[630013101$PIRSF016324:PIRSF016324]
MYST histone acetyltransferase 1,SMART[760000268$SM00298:CHROMO]
MYST histone acetyltransferase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000025$Acyltransferase, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
MYST histone acetyltransferase 1,UP_SEQ_FEATURE[850042309$chain:Probable histone acetyltransferase MYST1, 850103361$domain:Chromo, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118743$zinc finger region:C2HC-type]
Meckel syndrome, type 1,INTERPRO[450009829$IPR010796:B9]
Meckel syndrome, type 1,OMIM_DISEASE[520000511$Bardet-Biedl syndrome 13, 520003104$Meckel syndrome, type 1]
Meckel syndrome, type 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000168$Bardet-Biedl syndrome, 790000356$complete proteome, 790000446$disease mutation, 790000914$meckel syndrome, 790001212$polymorphism]
Meckel syndrome, type 1,UP_SEQ_FEATURE[850030728$chain:Meckel syndrome type 1 protein, 850103082$domain:B9, 850117295$sequence variant, 850118574$splice variant]
N-acetylgalactosaminidase, alpha-,INTERPRO[450000093$IPR000111:Glycoside hydrolase, clan GH-D, 450001987$IPR002241:Glycoside hydrolase, family 27, 450012394$IPR013780:Glycosyl hydrolase, family 13, all-beta, 450012397$IPR013785:Aldolase-type TIM barrel]
N-acetylgalactosaminidase, alpha-,KEGG_PATHWAY[470038785$hsa00603:Glycosphingolipid biosynthesis, 470038840$hsa04142:Lysosome]
N-acetylgalactosaminidase, alpha-,OMIM_DISEASE[520002714$Kanzaki disease, 520004391$Schindler disease, type I, 520004392$Schindler disease, type III]
N-acetylgalactosaminidase, alpha-,PIR_SUPERFAMILY[630001228$PIRSF001080:glycosyl hydrolase, Mel1p type]
N-acetylgalactosaminidase, alpha-,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000509$epilepsy, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790000897$lysosome, 790001162$phosphoprotein, 790001405$signal]
N-acetylgalactosaminidase, alpha-,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850000555$binding site:Substrate, 850004850$chain:Alpha-N-acetylgalactosaminidase, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
N-acetyltransferase 5 (GCN5-related, putative),COG_ONTOLOGY[90000073$General function prediction only]
N-acetyltransferase 5 (GCN5-related, putative),INTERPRO[450000154$IPR000182:GCN5-related N-acetyltransferase, 450014522$IPR016181:Acyl-CoA N-acyltransferase]
N-acetyltransferase 5 (GCN5-related, putative),KEGG_PATHWAY[470038754$hsa00350:Tyrosine metabolism, 470038755$hsa00360:Phenylalanine metabolism, 470038778$hsa00564:Glycerophospholipid metabolism, 470038804$hsa00903:Limonene and pinene degradation]
N-acetyltransferase 5 (GCN5-related, putative),PIR_SUPERFAMILY[630001881$PIRSF001742:N-acetyltransferase complex, catalytic subunit]
N-acetyltransferase 5 (GCN5-related, putative),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001547$transferase]
N-acetyltransferase 5 (GCN5-related, putative),UP_SEQ_FEATURE[850033290$chain:N-terminal acetyltransferase B complex catalytic subunit NAT5, 850104817$domain:N-acetyltransferase, 850117294$sequence conflict]
N-acylethanolamine acid amidase,INTERPRO[450002816$IPR003199:Choloylglycine hydrolase, 450015019$IPR016699:Acid ceramidase-like]
N-acylethanolamine acid amidase,PIR_SUPERFAMILY[630014326$PIRSF017632:acid ceramidase, 630014327$PIRSF017632:Acid_ceramidase-like]
N-acylethanolamine acid amidase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790001212$polymorphism, 790001405$signal]
N-acylethanolamine acid amidase,UP_SEQ_FEATURE[850033249$chain:N-acylethanolamine-hydrolyzing acid amidase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,INTERPRO[450000753$IPR000863:Sulfotransferase]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,KEGG_PATHWAY[470038774$hsa00534:Heparan sulfate biosynthesis]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,PIR_SUPERFAMILY[630012567$PIRSF015800:Caenorhabditis elegans hypothetical protein F08B4.6]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000743$hydrolase, 790000775$inflammatory response, 790000919$membrane, 790000993$multifunctional enzyme, 790001409$Signal-anchor, 790001464$sulfotransferase, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,UP_SEQ_FEATURE[850000082$active site:For sulfotransferase activity, 850000476$binding site:PAPS, 850007994$chain:Bifunctional heparan sulfate N- deacetylase/N-sulfotransferase 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850106312$nucleotide phosphate-binding region:PAPS, 850111853$region of interest:Heparan sulfate N-deacetylase 1, 850111858$region of interest:Heparan sulfate N-sulfotransferase 1, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,INTERPRO[450000753$IPR000863:Sulfotransferase]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,KEGG_PATHWAY[470038774$hsa00534:Heparan sulfate biosynthesis]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,PIR_SUPERFAMILY[630012567$PIRSF015800:Caenorhabditis elegans hypothetical protein F08B4.6]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000743$hydrolase, 790000919$membrane, 790000993$multifunctional enzyme, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3,UP_SEQ_FEATURE[850000082$active site:For sulfotransferase activity, 850000476$binding site:PAPS, 850007996$chain:Bifunctional heparan sulfate N- deacetylase/N-sulfotransferase 3, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106312$nucleotide phosphate-binding region:PAPS, 850111855$region of interest:Heparan sulfate N-deacetylase 3, 850111860$region of interest:Heparan sulfate N-sulfotransferase 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
N-ethylmaleimide-sensitive factor attachment protein, gamma,INTERPRO[450000639$IPR000744:NSF attachment protein, 450010815$IPR011990:Tetratricopeptide-like helical]
N-ethylmaleimide-sensitive factor attachment protein, gamma,SP_PIR_KEYWORDS[790000356$complete proteome, 790000510$er-golgi transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
N-ethylmaleimide-sensitive factor attachment protein, gamma,UP_SEQ_FEATURE[850020584$chain:Gamma-soluble NSF attachment protein, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
N-terminal asparagine amidase,PIR_SUPERFAMILY[630019060$PIRSF023959:N-terminal asparagine amidohydrolase]
N-terminal asparagine amidase,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001212$polymorphism]
N-terminal asparagine amidase,UP_SEQ_FEATURE[850046976$chain:Protein N-terminal asparagine amidohydrolase, 850117295$sequence variant]
NAD kinase,INTERPRO[450002223$IPR002504:ATP-NAD/AcoX kinase, 450015765$IPR017437:ATP-NAD kinase, PpnK-type, all-beta, 450015766$IPR017438:ATP-NAD kinase, PpnK-type, alpha/beta]
NAD kinase,KEGG_PATHWAY[470038796$hsa00760:Nicotinate and nicotinamide metabolism]
NAD kinase,PIR_SUPERFAMILY[630004861$PIRSF004914:ATP-NAD(H) kinase, 630030337$PIRSF500062:ATP-NAD(H) kinase, eukaryotic type]
NAD kinase,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000937$metal-binding, 790001006$nad, 790001008$nadp, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
NAD kinase,UP_SEQ_FEATURE[850033402$chain:NAD kinase, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,INTERPRO[450007348$IPR008011:Complex 1 LYR protein, 450014809$IPR016488:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 6]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,PIR_SUPERFAMILY[630006604$PIRSF006643:NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 6, 630006605$PIRSF006643:NDUA6]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa,UP_SEQ_FEATURE[850033526$chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3,INTERPRO[450006877$IPR007523:Protein of unknown function DUF498]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001065$nucleus]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3,UP_SEQ_FEATURE[850033514$chain:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3, 850117295$sequence variant]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa,INTERPRO[450007348$IPR008011:Complex 1 LYR protein]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa,PIR_SUPERFAMILY[630019063$PIRSF023964:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001309$respiratory chain, 790001558$transport, 790001589$ubiquinone]
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa,UP_SEQ_FEATURE[850033540$chain:NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9, 850106258$modified residue, 850117295$sequence variant]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,INTERPRO[450002839$IPR003231:Acyl carrier protein (ACP), 450005594$IPR006162:Phosphopantetheine attachment site, 450005595$IPR006163:Phosphopantetheine-binding, 450008211$IPR009081:Acyl carrier protein-like]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,PIR_SUPERFAMILY[630002827$PIRSF002734:acyl/peptidyl carrier protein]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000249$carrier protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000489$electron transport, 790000542$Fatty acid biosynthesis, 790000874$lipid synthesis, 790000969$mitochondrion, 790001006$nad, 790001092$oxidoreductase, 790001161$Phosphopantetheine, 790001162$phosphoprotein, 790001309$respiratory chain, 790001550$transit peptide, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa,UP_SEQ_FEATURE[850003704$chain:Acyl carrier protein, mitochondrial, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118617$transit peptide:Mitochondrion, 850118624$turn]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,INTERPRO[450008527$IPR009423:NADH:ubiquinone oxidoreductase, subunit b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,PIR_SUPERFAMILY[630014491$PIRSF017834:NADH dehydrogenase [ubiquinone] (complex I), subunit C2, 630014492$PIRSF017834:NADH-UbQ_OxRdtase_b14.5b]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001555$transmembrane, 790001558$transport]
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa,UP_SEQ_FEATURE[850033542$chain:NADH dehydrogenase [ubiquinone] 1 subunit C2, 850106258$modified residue, 850117295$sequence variant, 850118623$transmembrane region]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,INTERPRO[450001725$IPR001949:NADH:ubiquinone oxidoreductase, 51 kDa subunit, conserved site, 450010398$IPR011537:NADH ubiquinone oxidoreductase, F subunit, 450010399$IPR011538:NADH:ubiquinone oxidoreductase, 51 kDa subunit, 450017791$IPR019554:Soluble ligand binding domain, 450017812$IPR019575:NADH ubiquinone oxidoreductase, F subunit, iron sulphur binding]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,OMIM_DISEASE[520000214$Alexander disease, 520002806$Leigh syndrome, 520003336$Mitochondrial complex I deficiency]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,PIR_SUPERFAMILY[630000261$PIRSF000217:NADH-ubiquinone oxidoreductase, 51 kDa subunit]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,SP_PIR_KEYWORDS[790000005$4fe-4s, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000489$electron transport, 790000559$Flavoprotein, 790000562$fmn, 790000802$iron, 790000806$iron-sulfur, 790000807$iron-sulfur protein, 790000849$leigh syndrome, 790000919$membrane, 790000926$membrane-associated complex, 790000937$metal-binding, 790000943$metalloprotein, 790000966$mitochondrial inner membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001091$oxidative phosphorylation, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001550$transit peptide, 790001558$transport, 790001589$ubiquinone]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa,UP_SEQ_FEATURE[850033543$chain:NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, 850106068$metal ion-binding site:Iron-sulfur (4Fe-4S), 850106258$modified residue, 850106292$nucleotide phosphate-binding region:FMN, 850106304$nucleotide phosphate-binding region:NAD(H), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa,INTERPRO[450001794$IPR002023:NADH:ubiquinone oxidoreductase, 24 kDa subunit, 450011036$IPR012335:Thioredoxin fold]
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa,OMIM_DISEASE[520003935$Parkinson disease, susceptibility to]
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa,PIR_SUPERFAMILY[630000259$PIRSF000216:NADH dehydrogenase [ubiquinone] (complex I), flavoprotein 2/NADH:quinone oxidoreductase (complex I), NuoE subunit, 630000260$PIRSF000216:NADH_DH_24kDa]
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa,SP_PIR_KEYWORDS[790000001$2Fe-2S, 790000356$complete proteome, 790000489$electron transport, 790000802$iron, 790000806$iron-sulfur, 790000807$iron-sulfur protein, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000966$mitochondrial inner membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001006$nad, 790001091$oxidative phosphorylation, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001550$transit peptide, 790001558$transport, 790001589$ubiquinone]
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa,UP_SEQ_FEATURE[850033544$chain:NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial, 850106062$metal ion-binding site:Iron-sulfur (2Fe-2S), 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
NCK interacting protein with SH3 domain,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450016828$IPR018556:Protein of unknown function DUF2013]
NCK interacting protein with SH3 domain,SMART[760000295$SM00326:SH3]
NCK interacting protein with SH3 domain,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001398$sh3 domain, 790001399$sh3-binding]
NCK interacting protein with SH3 domain,UP_SEQ_FEATURE[850033781$chain:NCK-interacting protein with SH3 domain, 850102552$compositionally biased region:Leu-rich, 850102586$compositionally biased region:Pro-rich, 850102600$compositionally biased region:Ser/Thr-rich, 850105350$domain:SH3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117892$site:Breakpoint for translocation to form MLL- AF3P21 oncogene, 850118574$splice variant]
NDRG family member 4,INTERPRO[450003654$IPR004142:Ndr]
NDRG family member 4,PIR_SUPERFAMILY[630019009$PIRSF023830:Caenorhabditis elegans hypothetical protein ZK1073.1]
NDRG family member 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein]
NDRG family member 4,UP_SEQ_FEATURE[850047002$chain:Protein NDRG4, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850118574$splice variant]
NEDD4 binding protein 2,INTERPRO[450002329$IPR002625:Smr protein/MutS2 C-terminal, 450003417$IPR003892:Ubiquitin system component Cue, 450012495$IPR013899:Region of unknown function DUF1771]
NEDD4 binding protein 2,SMART[760000408$SM00463:SMR, 760000486$SM00546:CUE]
NEDD4 binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
NEDD4 binding protein 2,UP_SEQ_FEATURE[850033797$chain:NEDD4-binding protein 2, 850102586$compositionally biased region:Pro-rich, 850103460$domain:CUE, 850105374$domain:Smr, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
NFKB activating protein,INTERPRO[450008379$IPR009269:Protein of unknown function DUF926]
NFKB activating protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
NFKB activating protein,UP_SEQ_FEATURE[850034189$chain:NF-kappa-B-activating protein, 850102554$compositionally biased region:Lys-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NFKB inhibitor interacting Ras-like 2,INTERPRO[450001599$IPR001806:Ras GTPase, 450004692$IPR005225:Small GTP-binding protein, 450012305$IPR013684:Miro-like]
NFKB inhibitor interacting Ras-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000639$gtp-binding, 790001063$nucleotide-binding]
NFKB inhibitor interacting Ras-like 2,UP_SEQ_FEATURE[850034186$chain:NF-kappa-B inhibitor-interacting Ras-like protein 2, 850106296$nucleotide phosphate-binding region:GTP, 850114670$region of interest:Small GTPase-like, 850117441$short sequence motif:Effector region, 850118574$splice variant]
NHS-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
NHS-like 1,UP_SEQ_FEATURE[850034207$chain:NHS-like protein 1, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NIMA (never in mitosis gene a)-related kinase 4,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
NIMA (never in mitosis gene a)-related kinase 4,SMART[760000193$SM00220:S_TKc]
NIMA (never in mitosis gene a)-related kinase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
NIMA (never in mitosis gene a)-related kinase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059871$chain:Serine/threonine-protein kinase Nek4, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
NIMA (never in mitosis gene a)-related kinase 6,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
NIMA (never in mitosis gene a)-related kinase 6,SMART[760000192$SM00219:TyrKc, 760000193$SM00220:S_TKc]
NIMA (never in mitosis gene a)-related kinase 6,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000317$Chromosome partition, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001388$serine/threonine-protein kinase, 790001547$transferase]
NIMA (never in mitosis gene a)-related kinase 6,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059873$chain:Serine/threonine-protein kinase Nek6, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,COG_ONTOLOGY[90000073$General function prediction only]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,INTERPRO[450006016$IPR006596:Nucleotide binding protein, PINc, 450013330$IPR014881:Nin one binding (NOB1) Zn-ribbon like, 450015437$IPR017117:D-site 20S pre-rRNA nuclease]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,PIR_SUPERFAMILY[630028638$PIRSF037125:D-site_20S_pre-rRNA_nuclease]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,SMART[760000582$SM00670:PINc]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,UP_SEQ_FEATURE[850058526$chain:RNA-binding protein NOB1, 850102572$compositionally biased region:Poly-Glu, 850104997$domain:PINc, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NK2 homeobox 4,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
NK2 homeobox 4,SMART[760000341$SM00389:HOX]
NK2 homeobox 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus]
NK2 homeobox 4,UP_SEQ_FEATURE[850024625$chain:Homeobox protein Nkx-2.4, 850102565$compositionally biased region:Poly-Ala, 850102580$compositionally biased region:Poly-Pro, 850102927$DNA-binding region:Homeobox, 850117294$sequence conflict]
NK6 homeobox 1,INTERPRO[450000039$IPR000047:Helix-turn-helix motif, lambda-like repressor, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
NK6 homeobox 1,KEGG_PATHWAY[470038889$hsa04950:Maturity onset diabetes of the young]
NK6 homeobox 1,SMART[760000341$SM00389:HOX]
NK6 homeobox 1,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
NK6 homeobox 1,UP_SEQ_FEATURE[850024631$chain:Homeobox protein Nkx-6.1, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102927$DNA-binding region:Homeobox, 850113166$region of interest:Involved in DNA-binding, 850114223$region of interest:Repressor domain, 850117294$sequence conflict]
NLR family, CARD domain containing 5,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450006487$IPR007111:NACHT nucleoside triphosphatase]
NLR family, CARD domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000853$leucine-rich repeat, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat]
NLR family, CARD domain containing 5,UP_SEQ_FEATURE[850047050$chain:Protein NLRC5, 850104825$domain:NACHT, 850106263$nucleotide phosphate-binding region:ATP, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116317$repeat:LRR 18, 850116318$repeat:LRR 19, 850116319$repeat:LRR 2, 850116320$repeat:LRR 20, 850116321$repeat:LRR 21, 850116322$repeat:LRR 22, 850116323$repeat:LRR 23, 850116324$repeat:LRR 24, 850116325$repeat:LRR 25, 850116326$repeat:LRR 26, 850116327$repeat:LRR 27, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
NLR family, pyrin domain containing 1,INTERPRO[450001158$IPR001315:Caspase Recruitment, 450001429$IPR001611:Leucine-rich repeat, 450003539$IPR004020:Pyrin, 450006487$IPR007111:NACHT nucleoside triphosphatase, 450010009$IPR011029:DEATH-like]
NLR family, pyrin domain containing 1,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
NLR family, pyrin domain containing 1,OMIM_DISEASE[520004783$Systemic lupus erythematosus, vitiligo-related, susceptibility to, 1, 520005042$Vitiligo-associated multiple autoimmune disease susceptibility 1]
NLR family, pyrin domain containing 1,PIR_SUPERFAMILY[630029074$PIRSF037494:NALP protein]
NLR family, pyrin domain containing 1,SMART[760000101$SM00114:CARD]
NLR family, pyrin domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000853$leucine-rich repeat, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat]
NLR family, pyrin domain containing 1,UP_SEQ_FEATURE[850033380$chain:NACHT, LRR and PYD domains-containing protein 1, 850103287$domain:CARD, 850103482$domain:DAPIN, 850104825$domain:NACHT, 850105852$helix, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
NLR family, pyrin domain containing 12,INTERPRO[450003539$IPR004020:Pyrin, 450006487$IPR007111:NACHT nucleoside triphosphatase, 450010009$IPR011029:DEATH-like]
NLR family, pyrin domain containing 12,OMIM_DISEASE[520001860$Familial cold autoinflammatory syndrome 2]
NLR family, pyrin domain containing 12,PIR_SUPERFAMILY[630029074$PIRSF037494:NALP protein]
NLR family, pyrin domain containing 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000853$leucine-rich repeat, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat]
NLR family, pyrin domain containing 12,UP_SEQ_FEATURE[850033383$chain:NACHT, LRR and PYD domains-containing protein 12, 850103482$domain:DAPIN, 850104825$domain:NACHT, 850106263$nucleotide phosphate-binding region:ATP, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
NODAL modulator 3; NODAL modulator 1; NODAL modulator 2,COG_ONTOLOGY[90000032$Cell envelope biogenesis, outer membrane]
NODAL modulator 3; NODAL modulator 1; NODAL modulator 2,INTERPRO[450007730$IPR008454:Collagen-binding surface protein Cna-like, B region]
NODAL modulator 3; NODAL modulator 1; NODAL modulator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
NODAL modulator 3; NODAL modulator 1; NODAL modulator 2,UP_SEQ_FEATURE[850034482$chain:Nodal modulator 1, 850034483$chain:Nodal modulator 2, 850034484$chain:Nodal modulator 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
NOL1/NOP2/Sun domain family, member 5C,INTERPRO[450001488$IPR001678:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p]
NOL1/NOP2/Sun domain family, member 5C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000954$methyltransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
NOL1/NOP2/Sun domain family, member 5C,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000532$binding site:S-adenosyl-L-methionine, 850052701$chain:Putative methyltransferase NSUN5C, 850106258$modified residue, 850114570$region of interest:S-adenosyl-L-methionine binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
NOP14 nucleolar protein homolog (yeast),INTERPRO[450006643$IPR007276:Nop14-like protein]
NOP14 nucleolar protein homolog (yeast),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001331$ribosome biogenesis, 790001345$rrna processing]
NOP14 nucleolar protein homolog (yeast),UP_SEQ_FEATURE[850035185$chain:Nucleolar protein 14, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
NSFL1 (p97) cofactor (p47),INTERPRO[450000885$IPR001012:UBX, 450011665$IPR012989:SEP]
NSFL1 (p97) cofactor (p47),SMART[760000145$SM00166:UBX, 760000493$SM00553:SEP]
NSFL1 (p97) cofactor (p47),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000624$golgi apparatus, 790000876$lipid-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
NSFL1 (p97) cofactor (p47),UP_SEQ_FEATURE[850034772$chain:NSFL1 cofactor p47, 850102572$compositionally biased region:Poly-Glu, 850105338$domain:SEP, 850105605$domain:UBX, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
NTPase, KAP family P-loop domain containing 1,INTERPRO[450010474$IPR011646:KAP P-loop]
NTPase, KAP family P-loop domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
NTPase, KAP family P-loop domain containing 1,UP_SEQ_FEATURE[850034798$chain:NTPase KAP family P-loop domain- containing protein 1, 850102570$compositionally biased region:Poly-Gln, 850104498$domain:KAP NTPase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
Nedd4 family interacting protein 1,INTERPRO[450017563$IPR019325:Protein of unknown function DUF2370]
Nedd4 family interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001304$repeat, 790001555$transmembrane, 790001592$ubl conjugation]
Nedd4 family interacting protein 1,UP_SEQ_FEATURE[850033793$chain:NEDD4 family-interacting protein 1, 850117294$sequence conflict, 850117769$short sequence motif:WW-binding 1, 850117770$short sequence motif:WW-binding 2, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Notch homolog 4 (Drosophila),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450000694$IPR000800:Notch region, 450001280$IPR001438:EGF-like, type 2, 450001663$IPR001881:EGF-like calcium-binding, 450001870$IPR002110:Ankyrin, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450007582$IPR008297:Notch, 450010484$IPR011656:Notch, NODP region, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
Notch homolog 4 (Drosophila),KEGG_PATHWAY[470038847$hsa04320:Dorso-ventral axis formation, 470038848$hsa04330:Notch signaling pathway]
Notch homolog 4 (Drosophila),PIR_SUPERFAMILY[630002402$PIRSF002279:Notch, 630002403$PIRSF002279:notch protein]
Notch homolog 4 (Drosophila),SMART[760000003$SM00004:NL, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000220$SM00248:ANK]
Notch homolog 4 (Drosophila),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000086$ank repeat, 790000264$cell membrane, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001045$notch signaling pathway, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001539$Transcription, 790001543$transcription regulation, 790001555$transmembrane, 790001569$triplet repeat expansion]
Notch homolog 4 (Drosophila),UP_SEQ_FEATURE[850033981$chain:Neurogenic locus notch homolog protein 4, 850034736$chain:Notch 4 extracellular truncation, 850034737$chain:Notch 4 intracellular domain, 850102566$compositionally biased region:Poly-Arg, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103598$domain:EGF-like 10, 850103602$domain:EGF-like 11; calcium-binding, 850103604$domain:EGF-like 12; calcium-binding, 850103606$domain:EGF-like 13; calcium-binding, 850103608$domain:EGF-like 14; calcium-binding, 850103610$domain:EGF-like 15; calcium-binding, 850103611$domain:EGF-like 16, 850103613$domain:EGF-like 17, 850103615$domain:EGF-like 18, 850103617$domain:EGF-like 19, 850103623$domain:EGF-like 2, 850103624$domain:EGF-like 20, 850103626$domain:EGF-like 21, 850103628$domain:EGF-like 22, 850103630$domain:EGF-like 23, 850103632$domain:EGF-like 24, 850103634$domain:EGF-like 25, 850103636$domain:EGF-like 26, 850103638$domain:EGF-like 27, 850103640$domain:EGF-like 28, 850103642$domain:EGF-like 29, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103693$domain:EGF-like 5; calcium-binding, 850103695$domain:EGF-like 6, 850103699$domain:EGF-like 7; calcium-binding, 850103701$domain:EGF-like 8; calcium-binding, 850103703$domain:EGF-like 9; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850116304$repeat:LNR 1, 850116305$repeat:LNR 2, 850116306$repeat:LNR 3, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ORAI calcium release-activated calcium modulator 1,INTERPRO[450011126$IPR012446:Protein of unknown function DUF1650]
ORAI calcium release-activated calcium modulator 1,OMIM_DISEASE[520002607$Immune dysfunction with T-cell inactivation due to calcium entry defect 1, 520004454$Severe combined immunodeficiency, autosomal recessive, with CRAC channel dysfunction]
ORAI calcium release-activated calcium modulator 1,PIR_SUPERFAMILY[630011239$PIRSF013454:Caenorhabditis elegans hypothetical protein C09F5.2]
ORAI calcium release-activated calcium modulator 1,SP_PIR_KEYWORDS[790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000763$immune response, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001360$scid, 790001555$transmembrane, 790001558$transport]
ORAI calcium release-activated calcium modulator 1,UP_SEQ_FEATURE[850008935$chain:Calcium release-activated calcium channel protein 1, 850102586$compositionally biased region:Pro-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ORAI calcium release-activated calcium modulator 2,INTERPRO[450011126$IPR012446:Protein of unknown function DUF1650]
ORAI calcium release-activated calcium modulator 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
ORAI calcium release-activated calcium modulator 2,UP_SEQ_FEATURE[850047103$chain:Protein orai-2, 850053885$chain:Putative protein ORAI2-2, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
OTU domain containing 6A,INTERPRO[450002899$IPR003323:Ovarian tumour, otubain]
OTU domain containing 6A,SP_PIR_KEYWORDS[790000356$complete proteome]
OTU domain containing 6A,UP_SEQ_FEATURE[850036303$chain:OTU domain-containing protein 6A, 850104870$domain:OTU]
OTU domain, ubiquitin aldehyde binding 1,INTERPRO[450002899$IPR003323:Ovarian tumour, otubain, 450014937$IPR016615:Ubiquitin thioesterase Otubain, 450017638$IPR019400:Peptidase C65, otubain]
OTU domain, ubiquitin aldehyde binding 1,PIR_SUPERFAMILY[630011258$PIRSF013503:ubiquitin thioesterase Otubain, 630011259$PIRSF013503:Ubiquitin_thioesterase_Otubain]
OTU domain, ubiquitin aldehyde binding 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000763$immune response, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
OTU domain, ubiquitin aldehyde binding 1,UP_SEQ_FEATURE[850068041$chain:Ubiquitin thioesterase OTUB1, 850104870$domain:OTU, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118536$site:Required for proximal ubiquitin-binding, 850118574$splice variant, 850118575$strand, 850118624$turn]
PAK1 interacting protein 1,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
PAK1 interacting protein 1,SMART[760000289$SM00320:WD40]
PAK1 interacting protein 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001408$Signal transduction inhibitor, 790001638$wd repeat]
PAK1 interacting protein 1,UP_SEQ_FEATURE[850036605$chain:p21-activated protein kinase-interacting protein 1, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict]
PARK2 co-regulated-like,INTERPRO[450017637$IPR019399:Parkin co-regulated protein]
PARK2 co-regulated-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
PARK2 co-regulated-like,UP_SEQ_FEATURE[850036705$chain:PACRG-like protein, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
PC4 and SFRS1 interacting protein 1,INTERPRO[450000267$IPR000313:PWWP]
PC4 and SFRS1 interacting protein 1,SMART[760000264$SM00293:PWWP]
PC4 and SFRS1 interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000533$eye lens, 790000616$glycoprotein, 790000632$growth factor, 790000635$growth regulation, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
PC4 and SFRS1 interacting protein 1,UP_SEQ_FEATURE[850036959$chain:PC4 and SFRS1-interacting protein, 850105126$domain:PWWP, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae),INTERPRO[450000307$IPR000357:HEAT]
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000853$leucine-rich repeat, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae),UP_SEQ_FEATURE[850060891$chain:Sister chromatid cohesion protein PDS5 homolog A, 850106258$modified residue, 850116139$repeat:HEAT, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850117294$sequence conflict, 850118574$splice variant]
PDX1 C-terminal inhibiting factor 1,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP]
PDX1 C-terminal inhibiting factor 1,SMART[760000401$SM00456:WW]
PDX1 C-terminal inhibiting factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein]
PDX1 C-terminal inhibiting factor 1,UP_SEQ_FEATURE[850038949$chain:Phosphorylated CTD-interacting factor 1, 850102581$compositionally biased region:Poly-Ser, 850105731$domain:WW, 850105852$helix, 850106258$modified residue, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand, 850118624$turn]
PDZ and LIM domain 2 (mystique),INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450001575$IPR001781:Zinc finger, LIM-type]
PDZ and LIM domain 2 (mystique),PIR_SUPERFAMILY[630014741$PIRSF018094:PDZ and LIM domain protein]
PDZ and LIM domain 2 (mystique),SMART[760000114$SM00132:LIM, 760000200$SM00228:PDZ]
PDZ and LIM domain 2 (mystique),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000864$LIM domain, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001648$zinc]
PDZ and LIM domain 2 (mystique),UP_SEQ_FEATURE[850036978$chain:PDZ and LIM domain protein 2, 850102597$compositionally biased region:Ser-rich, 850104716$domain:LIM zinc-binding, 850104918$domain:PDZ, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
PDZ domain containing 2,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
PDZ domain containing 2,SMART[760000200$SM00228:PDZ]
PDZ domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted]
PDZ domain containing 2,UP_SEQ_FEATURE[850036984$chain:PDZ domain-containing protein 2, 850044442$chain:Processed PDZ domain-containing protein 2, 850102597$compositionally biased region:Ser-rich, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850104928$domain:PDZ 6, 850117294$sequence conflict, 850117295$sequence variant, 850118033$site:Cleavage; by caspases, 850118574$splice variant]
PHD finger protein 1,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002638$IPR002999:Tudor domain, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
PHD finger protein 1,SMART[760000221$SM00249:PHD, 760000302$SM00333:TUDOR]
PHD finger protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
PHD finger protein 1,UP_SEQ_FEATURE[850038131$chain:PHD finger protein 1, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
PHD finger protein 14,COG_ONTOLOGY[90000073$General function prediction only]
PHD finger protein 14,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
PHD finger protein 14,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD]
PHD finger protein 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
PHD finger protein 14,UP_SEQ_FEATURE[850038137$chain:PHD finger protein 14, 850102511$compositionally biased region:Glu/Lys-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
PHD finger protein 20-like 1,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002638$IPR002999:Tudor domain, 450012596$IPR014002:Tudor-like, plant, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
PHD finger protein 20-like 1,SMART[760000221$SM00249:PHD, 760000302$SM00333:TUDOR, 760000649$SM00743:Agenet]
PHD finger protein 20-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
PHD finger protein 20-like 1,UP_SEQ_FEATURE[850038141$chain:PHD finger protein 20-like protein 1, 850067164$chain:Tudor domain-containing protein PHF20L1, 850105584$domain:Tudor 1, 850105585$domain:Tudor 2, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118877$zinc finger region:PHD-type]
PHD finger protein 23,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
PHD finger protein 23,SMART[760000221$SM00249:PHD]
PHD finger protein 23,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001648$zinc, 790001651$zinc-finger]
PHD finger protein 23,UP_SEQ_FEATURE[850038144$chain:PHD finger protein 23, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict, 850117920$site:Breakpoint for translocation to form NUP98-PHF23 oncogene, 850118574$splice variant, 850118877$zinc finger region:PHD-type]
PIH1 domain containing 1,INTERPRO[450011657$IPR012981:Nop17p]
PIH1 domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
PIH1 domain containing 1,UP_SEQ_FEATURE[850039165$chain:PIH1 domain-containing protein 1, 850117294$sequence conflict, 850117295$sequence variant]
PML-RARA regulated adaptor molecule 1,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3]
PML-RARA regulated adaptor molecule 1,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
PML-RARA regulated adaptor molecule 1,SMART[760000295$SM00326:SH3]
PML-RARA regulated adaptor molecule 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000876$lipid-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain]
PML-RARA regulated adaptor molecule 1,UP_SEQ_FEATURE[850039620$chain:PML-RARA-regulated adapter molecule 1, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850106258$modified residue, 850110690$region of interest:8 X 12 AA repeats of K-P-P-[PQ]-P-[EQ]- [VAF]-T-D-L-P-K, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
POM121 membrane glycoprotein (rat),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001554$translocation, 790001555$transmembrane, 790001558$transport]
POM121 membrane glycoprotein (rat),UP_SEQ_FEATURE[850034836$chain:Nuclear envelope pore membrane protein POM 121, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850102605$compositionally biased region:Thr-rich, 850106258$modified residue, 850111255$region of interest:Cisternal side, 850114079$region of interest:Pore side, 850114484$region of interest:Required for targeting to the nucleus and nuclear pore complex, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
POU class 2 homeobox 1,INTERPRO[450000280$IPR000327:POU-specific, 450000844$IPR000972:Octamer-binding transcription factor, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450012446$IPR013847:POU, 450016278$IPR017970:Homeobox, conserved site]
POU class 2 homeobox 1,OMIM_DISEASE[520004059$Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes]
POU class 2 homeobox 1,PIR_SUPERFAMILY[630002733$PIRSF002625:transcription factor Oct-1]
POU class 2 homeobox 1,SMART[760000320$SM00352:POU, 760000341$SM00389:HOX]
POU class 2 homeobox 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
POU class 2 homeobox 1,UP_SEQ_FEATURE[850040236$chain:POU domain, class 2, transcription factor 1, 850102927$DNA-binding region:Homeobox, 850105054$domain:POU-specific, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
POU class 2 homeobox 2,BBID[10000100$79.B_cell_Activation]
POU class 2 homeobox 2,INTERPRO[450000280$IPR000327:POU-specific, 450000844$IPR000972:Octamer-binding transcription factor, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450012446$IPR013847:POU, 450016278$IPR017970:Homeobox, conserved site]
POU class 2 homeobox 2,PIR_SUPERFAMILY[630002735$PIRSF002627:transcription factor Oct-2]
POU class 2 homeobox 2,SMART[760000320$SM00352:POU, 760000341$SM00389:HOX]
POU class 2 homeobox 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000152$B-cell, 790000356$complete proteome, 790000407$cytoplasm, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
POU class 2 homeobox 2,UP_SEQ_FEATURE[850040237$chain:POU domain, class 2, transcription factor 2, 850102517$compositionally biased region:Gly-rich, 850102927$DNA-binding region:Homeobox, 850104712$domain:Leucine-zipper, 850105054$domain:POU-specific, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850118574$splice variant, 850118624$turn]
POU class 5 homeobox 1,INTERPRO[450000280$IPR000327:POU-specific, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450012446$IPR013847:POU, 450014024$IPR015585:POU domain class 5, 450016278$IPR017970:Homeobox, conserved site]
POU class 5 homeobox 1,PIR_SUPERFAMILY[630002736$PIRSF002628:transcription factor Oct-3]
POU class 5 homeobox 1,SMART[760000320$SM00352:POU, 760000341$SM00389:HOX]
POU class 5 homeobox 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790000811$isopeptide bond, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
POU class 5 homeobox 1,UP_SEQ_FEATURE[850040254$chain:POU domain, class 5, transcription factor 1, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850102927$DNA-binding region:Homeobox, 850105054$domain:POU-specific, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
POZ (BTB) and AT hook containing zinc finger 1,COG_ONTOLOGY[90000118$Transcription / Cell division and chromosome partitioning]
POZ (BTB) and AT hook containing zinc finger 1,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450000544$IPR000637:HMG-I and HMG-Y, DNA-binding, conserved site, 450006475$IPR007087:Zinc finger, C2H2-type, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like, 450016267$IPR017956:AT hook, DNA-binding, conserved site]
POZ (BTB) and AT hook containing zinc finger 1,SMART[760000197$SM00225:BTB, 760000323$SM00355:ZnF_C2H2, 760000336$SM00384:AT_hook]
POZ (BTB) and AT hook containing zinc finger 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
POZ (BTB) and AT hook containing zinc finger 1,UP_SEQ_FEATURE[850040262$chain:POZ-, AT hook-, and zinc finger- containing protein 1, 850102884$DNA-binding region:A.T hook, 850103177$domain:BTB, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7]
PPPDE peptidase domain containing 1,INTERPRO[450007845$IPR008580:Protein of unknown function DUF862, eukaryotic]
PPPDE peptidase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
PPPDE peptidase domain containing 1,UP_SEQ_FEATURE[850040276$chain:PPPDE peptidase domain-containing protein 1, 850105067$domain:PPPDE peptidase, 850117294$sequence conflict, 850118574$splice variant]
PQ loop repeat containing 2,INTERPRO[450006023$IPR006603:Cystinosin/ERS1p repeat]
PQ loop repeat containing 2,SMART[760000590$SM00679:CTNS]
PQ loop repeat containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
PQ loop repeat containing 2,UP_SEQ_FEATURE[850040281$chain:PQ-loop repeat-containing protein 2, 850105069$domain:PQ-loop 1, 850105070$domain:PQ-loop 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
PR domain containing 14,COG_ONTOLOGY[90000073$General function prediction only]
PR domain containing 14,INTERPRO[450001068$IPR001214:SET, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
PR domain containing 14,SMART[760000286$SM00317:SET, 760000323$SM00355:ZnF_C2H2]
PR domain containing 14,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
PR domain containing 14,UP_SEQ_FEATURE[850040289$chain:PR domain zinc finger protein 14, 850105340$domain:SET, 850117295$sequence variant, 850118685$zinc finger region:C2H2-type 1; atypical, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
PWWP domain containing 2A,INTERPRO[450000267$IPR000313:PWWP]
PWWP domain containing 2A,SMART[760000264$SM00293:PWWP]
PWWP domain containing 2A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
PWWP domain containing 2A,UP_SEQ_FEATURE[850056273$chain:PWWP domain-containing protein 2A, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850105126$domain:PWWP, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
PX domain containing serine/threonine kinase,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001492$IPR001683:Phox-like, 450002748$IPR003124:Actin-binding WH2]
PX domain containing serine/threonine kinase,OMIM_DISEASE[520002007$Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci]
PX domain containing serine/threonine kinase,SMART[760000218$SM00246:WH2, 760000282$SM00312:PX]
PX domain containing serine/threonine kinase,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001212$polymorphism]
PX domain containing serine/threonine kinase,UP_SEQ_FEATURE[850056283$chain:PX domain-containing protein kinase-like protein, 850105086$domain:Protein kinase, 850105129$domain:PX, 850105698$domain:WH2, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
PYD and CARD domain containing,INTERPRO[450001158$IPR001315:Caspase Recruitment, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450003539$IPR004020:Pyrin, 450010009$IPR011029:DEATH-like]
PYD and CARD domain containing,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway, 470038865$hsa04623:Cytosolic DNA-sensing pathway]
PYD and CARD domain containing,SMART[760000101$SM00114:CARD]
PYD and CARD domain containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001580$tumor suppressor]
PYD and CARD domain containing,UP_SEQ_FEATURE[850005859$chain:Apoptosis-associated speck-like protein containing a CARD, 850103287$domain:CARD, 850103482$domain:DAPIN, 850105852$helix, 850118574$splice variant, 850118575$strand, 850118624$turn]
Parkinson disease (autosomal recessive, juvenile) 2, parkin,BIOCARTA[30000219$h_parkinPathway:Role of Parkin in the Ubiquitin-Proteasomal Pathway, 30000220$h_ParkinsonsPathway:Alpha-synuclein and Parkin-mediated proteolysis in Parkinson's disease]
Parkinson disease (autosomal recessive, juvenile) 2, parkin,INTERPRO[450000534$IPR000626:Ubiquitin, 450002535$IPR002867:Zinc finger, C6HC-type, 450003500$IPR003977:Parkin, 450014411$IPR016010:Parkin, C-terminal, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
Parkinson disease (autosomal recessive, juvenile) 2, parkin,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038892$hsa05012:Parkinson's disease]
Parkinson disease (autosomal recessive, juvenile) 2, parkin,OMIM_DISEASE[520000125$Adenocarcinoma of lung, somatic, 520000126$Adenocarcinoma, ovarian, somatic, 520001989$Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum, 520002819$Leprosy, susceptibility to, 520003932$Parkinson disease, juvenile, type 2]
Parkinson disease (autosomal recessive, juvenile) 2, parkin,PIR_SUPERFAMILY[630029447$PIRSF037880:Parkin]
Parkinson disease (autosomal recessive, juvenile) 2, parkin,SMART[760000186$SM00213:UBQ, 760000562$SM00647:IBR]
Parkinson disease (autosomal recessive, juvenile) 2, parkin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000859$ligase, 790000937$metal-binding, 790001065$nucleus, 790001106$parkinson disease, 790001108$Parkinsonism, 790001212$polymorphism, 790001304$repeat, 790001351$s-nitrosylation, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
Parkinson disease (autosomal recessive, juvenile) 2, parkin,UP_SEQ_FEATURE[850016689$chain:E3 ubiquitin-protein ligase parkin, 850105602$domain:Ubiquitin-like, 850105852$helix, 850106259$mutagenesis site, 850114840$region of interest:SYT11 binding 1, 850114841$region of interest:SYT11 binding 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118829$zinc finger region:IBR-type, 850118913$zinc finger region:RING-type 1; atypical, 850118915$zinc finger region:RING-type 2]
Purkinje cell protein 2,INTERPRO[450002733$IPR003109:GoLoco motif]
Purkinje cell protein 2,SMART[760000342$SM00390:GoLoco]
Purkinje cell protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001304$repeat]
Purkinje cell protein 2,UP_SEQ_FEATURE[850048972$chain:Purkinje cell protein 2 homolog, 850104071$domain:GoLoco 1, 850104072$domain:GoLoco 2]
RAB GTPase activating protein 1,INTERPRO[450000166$IPR000195:RabGAP/TBC, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
RAB GTPase activating protein 1,PIR_SUPERFAMILY[630029978$PIRSF038444:Rab1-like GAP]
RAB GTPase activating protein 1,SMART[760000143$SM00164:TBC, 760000407$SM00462:PTB]
RAB GTPase activating protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000640$GTPase activation, 790001162$phosphoprotein]
RAB GTPase activating protein 1,UP_SEQ_FEATURE[850056511$chain:Rab GTPase-activating protein 1, 850104993$domain:PID, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850118574$splice variant]
RAB interacting factor,INTERPRO[450006869$IPR007515:Mss4, 450010223$IPR011323:Mss4/translationally controlled tumour-associated TCTP]
RAB interacting factor,PIR_SUPERFAMILY[630014986$PIRSF018365:guanine nucleotide exchange factor MSS4]
RAB interacting factor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790000937$metal-binding, 790001266$protein transport, 790001558$transport, 790001648$zinc]
RAB interacting factor,UP_SEQ_FEATURE[850022689$chain:Guanine nucleotide exchange factor MSS4, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
RAB11 family interacting protein 5 (class I),INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450016334$IPR018029:C2 membrane targeting protein, 450016658$IPR018376:Enoyl-CoA hydratase/isomerase, conserved site, 450017288$IPR019018:Rab11-binding domain , FIP domain, C-terminal]
RAB11 family interacting protein 5 (class I),KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
RAB11 family interacting protein 5 (class I),SMART[760000211$SM00239:C2]
RAB11 family interacting protein 5 (class I),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000501$endosome, 790000919$membrane, 790000969$mitochondrion, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
RAB11 family interacting protein 5 (class I),UP_SEQ_FEATURE[850056531$chain:Rab11 family-interacting protein 5, 850103199$domain:C2, 850105153$domain:RBD-FIP, 850106258$modified residue, 850117294$sequence conflict]
RAB11A, member RAS oncogene family,BIOCARTA[30000245$h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery]
RAB11A, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450014034$IPR015595:Rab11-related]
RAB11A, member RAS oncogene family,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
RAB11A, member RAS oncogene family,PIR_SUPERFAMILY[630001856$PIRSF001710:Ras-related protein Rab, 630030791$PIRSF500595:Ras-related protein, Rab11/Rab25 types]
RAB11A, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB11A, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000258$cell cycle, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000501$endosome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB11A, member RAS oncogene family,UP_SEQ_FEATURE[850056754$chain:Ras-related protein Rab-11A, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
RAB11B, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450001841$IPR002078:RNA polymerase sigma factor 54, interaction, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450014034$IPR015595:Rab11-related]
RAB11B, member RAS oncogene family,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
RAB11B, member RAS oncogene family,PIR_SUPERFAMILY[630001856$PIRSF001710:Ras-related protein Rab, 630030791$PIRSF500595:Ras-related protein, Rab11/Rab25 types]
RAB11B, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB11B, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000258$cell cycle, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB11B, member RAS oncogene family,UP_SEQ_FEATURE[850056755$chain:Ras-related protein Rab-11B, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
RAB15, member RAS onocogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAB15, member RAS onocogene family,SMART[760000149$SM00175:RAB]
RAB15, member RAS onocogene family,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB15, member RAS onocogene family,UP_SEQ_FEATURE[850056759$chain:Ras-related protein Rab-15, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850118574$splice variant]
RAB26, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450001841$IPR002078:RNA polymerase sigma factor 54, interaction, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAB26, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB26, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB26, member RAS oncogene family,UP_SEQ_FEATURE[850056776$chain:Ras-related protein Rab-26, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
RAB2A, member RAS oncogene family,BIOCARTA[30000245$h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery]
RAB2A, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAB2A, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB2A, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000925$membrane trafficking, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001235$prenylated cysteine, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB2A, member RAS oncogene family,UP_SEQ_FEATURE[850056780$chain:Ras-related protein Rab-2A, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850114377$region of interest:Required for interaction with PRKCI, 850117294$sequence conflict, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
RAB33B, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAB33B, member RAS oncogene family,PIR_SUPERFAMILY[630001856$PIRSF001710:Ras-related protein Rab]
RAB33B, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB33B, member RAS oncogene family,SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB33B, member RAS oncogene family,UP_SEQ_FEATURE[850056788$chain:Ras-related protein Rab-33B, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP]
RAB40C, member RAS oncogene family,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
RAB40C, member RAS oncogene family,OMIM_DISEASE[520002597$Identification of ten loci associated with height highlights new biological pathways in human growth]
RAB40C, member RAS oncogene family,PIR_SUPERFAMILY[630029084$PIRSF037502:Ras-related protein Rab-40]
RAB40C, member RAS oncogene family,SMART[760000149$SM00175:RAB, 760000225$SM00253:SOCS]
RAB40C, member RAS oncogene family,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001100$palmitate, 790001236$prenylation, 790001593$ubl conjugation pathway]
RAB40C, member RAS oncogene family,UP_SEQ_FEATURE[850056803$chain:Ras-related protein Rab-40C, 850105375$domain:SOCS box, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP]
RAB5A, member RAS oncogene family,BIOCARTA[30000089$h_eea1Pathway:The role of FYVE-finger proteins in vesicle transport, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets., 30000245$h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery]
RAB5A, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450014038$IPR015599:Rab5-related]
RAB5A, member RAS oncogene family,KEGG_PATHWAY[470038841$hsa04144:Endocytosis, 470038893$hsa05014:Amyotrophic lateral sclerosis (ALS)]
RAB5A, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB5A, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000264$cell membrane, 790000356$complete proteome, 790000501$endosome, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000925$membrane trafficking, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001235$prenylated cysteine, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB5A, member RAS oncogene family,UP_SEQ_FEATURE[850056809$chain:Ras-related protein Rab-5A, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
RAB5C, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450014038$IPR015599:Rab5-related]
RAB5C, member RAS oncogene family,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
RAB5C, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB5C, member RAS oncogene family,SP_PIR_KEYWORDS[790000012$acetylation, 790000264$cell membrane, 790000356$complete proteome, 790000501$endosome, 790000637$GTP binding, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001212$polymorphism, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB5C, member RAS oncogene family,UP_SEQ_FEATURE[850056811$chain:Ras-related protein Rab-5C, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant, 850117441$short sequence motif:Effector region]
RAD23 homolog A (S. cerevisiae),INTERPRO[450000382$IPR000449:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, 450000534$IPR000626:Ubiquitin, 450004292$IPR004806:UV excision repair protein Rad23, 450006054$IPR006636:Heat shock chaperonin-binding, 450013211$IPR014761:UV excision repair protein Rad23, C-terminal, 450013801$IPR015360:XPC-binding domain, 450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
RAD23 homolog A (S. cerevisiae),KEGG_PATHWAY[470038823$hsa03420:Nucleotide excision repair]
RAD23 homolog A (S. cerevisiae),SMART[760000144$SM00165:UBA, 760000186$SM00213:UBQ, 760000633$SM00727:STI1]
RAD23 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000733$host-virus interaction, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
RAD23 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850099707$chain:UV excision repair protein RAD23 homolog A, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105598$domain:UBA 1, 850105599$domain:UBA 2, 850105602$domain:Ubiquitin-like, 850105852$helix, 850106258$modified residue, 850111901$region of interest:HIV-1 Vpr binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
RAD50 homolog (S. cerevisiae),BIOCARTA[30000028$h_atmPathway:ATM Signaling Pathway, 30000029$h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility]
RAD50 homolog (S. cerevisiae),INTERPRO[450002966$IPR003395:RecF/RecN/SMC protein, N-terminal, 450004076$IPR004584:Recombination/repair protein Rad50, 450006871$IPR007517:Rad50 zinc hook, 450011774$IPR013134:Zinc hook, Rad50]
RAD50 homolog (S. cerevisiae),KEGG_PATHWAY[470038825$hsa03440:Homologous recombination, 470038826$hsa03450:Non-homologous end-joining]
RAD50 homolog (S. cerevisiae),OMIM_DISEASE[520002063$Genome-Wide Scan on Total Serum IgE Levels Identifies FCER1A as Novel Susceptibility Locus]
RAD50 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000315$chromosomal protein, 790000344$coiled coil, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000743$hydrolase, 790000915$meiosis, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001494$telomere, 790001648$zinc]
RAD50 homolog (S. cerevisiae),UP_SEQ_FEATURE[850015752$chain:DNA repair protein RAD50, 850102383$compositionally biased region:Ala/Asp-rich (DA-box), 850105750$domain:Zinc-hook, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
RAD9 homolog A (S. pombe),BIOCARTA[30000029$h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility]
RAD9 homolog A (S. pombe),INTERPRO[450006636$IPR007268:Rad9, 450014874$IPR016552:Cell cycle checkpoint, RAD9]
RAD9 homolog A (S. pombe),PIR_SUPERFAMILY[630008452$PIRSF009303:Cell_cycle_RAD9]
RAD9 homolog A (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000452$DNA damage, 790000459$dna repair, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
RAD9 homolog A (S. pombe),UP_SEQ_FEATURE[850010253$chain:Cell cycle checkpoint control protein RAD9A, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114090$region of interest:Possesses 3'-5' exonuclease activity, 850114743$region of interest:Sufficient for interaction with ABL1, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
RAN binding protein 6,COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
RAN binding protein 6,INTERPRO[450000307$IPR000357:HEAT, 450010814$IPR011989:Armadillo-like helical]
RAN binding protein 6,PIR_SUPERFAMILY[630013958$PIRSF017194:importin, subunit beta-3]
RAN binding protein 6,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001266$protein transport, 790001304$repeat, 790001558$transport]
RAN binding protein 6,UP_SEQ_FEATURE[850056623$chain:Ran-binding protein 6, 850102565$compositionally biased region:Poly-Ala, 850106258$modified residue, 850114174$region of interest:Ran-GTP binding, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850117294$sequence conflict]
RAN guanine nucleotide release factor,INTERPRO[450007038$IPR007681:Ran-interacting Mog1 protein, 450014485$IPR016123:Mog1/PsbP, alpha/beta/alpha sandwich]
RAN guanine nucleotide release factor,PIR_SUPERFAMILY[630021695$PIRSF028828:nuclear import protein MOG1]
RAN guanine nucleotide release factor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000641$guanine-nucleotide releasing factor, 790001065$nucleus, 790001266$protein transport, 790001558$transport]
RAN guanine nucleotide release factor,UP_SEQ_FEATURE[850056614$chain:Ran guanine nucleotide release factor, 850117294$sequence conflict, 850118574$splice variant]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,COG_ONTOLOGY[90000016$Carbohydrate transport and metabolism]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,INTERPRO[450000132$IPR000156:Ran Binding Protein 1, 450000205$IPR000237:GRIP, 450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450010818$IPR011993:Pleckstrin homology-type, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,SMART[760000020$SM00028:TPR, 760000141$SM00160:RanBD, 760000661$SM00755:Grip]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat]
RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,UP_SEQ_FEATURE[850056643$chain:RANBP2-like and GRIP domain-containing protein 4, 850056644$chain:RANBP2-like and GRIP domain-containing protein 5, 850056645$chain:RANBP2-like and GRIP domain-containing protein 6, 850056646$chain:RANBP2-like and GRIP domain-containing protein 7, 850102581$compositionally biased region:Poly-Ser, 850104082$domain:GRIP, 850105139$domain:RanBD1 1, 850105140$domain:RanBD1 2, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117294$sequence conflict, 850118574$splice variant]
RAS protein activator like 3,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
RAS protein activator like 3,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001635$IPR001849:Pleckstrin homology, 450001714$IPR001936:Ras GTPase-activating protein]
RAS protein activator like 3,SMART[760000205$SM00233:PH, 760000211$SM00239:C2, 760000292$SM00323:RasGAP]
RAS protein activator like 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism]
RAS protein activator like 3,UP_SEQ_FEATURE[850056706$chain:RAS protein activator like-3, 850102404$compositionally biased region:Arg-rich, 850102573$compositionally biased region:Poly-Gly, 850102586$compositionally biased region:Pro-rich, 850103199$domain:C2, 850104979$domain:PH, 850105148$domain:Ras-GAP, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
RCAN family member 3,INTERPRO[450006329$IPR006931:Calcipressin]
RCAN family member 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
RCAN family member 3,UP_SEQ_FEATURE[850008914$chain:Calcipressin-3, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
RCD1 required for cell differentiation1 homolog (S. pombe),INTERPRO[450006586$IPR007216:Cell differentiation, Rcd1-like]
RCD1 required for cell differentiation1 homolog (S. pombe),KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
RCD1 required for cell differentiation1 homolog (S. pombe),PIR_SUPERFAMILY[630019492$PIRSF025013:PIRSF025013]
RCD1 required for cell differentiation1 homolog (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
RCD1 required for cell differentiation1 homolog (S. pombe),UP_SEQ_FEATURE[850010300$chain:Cell differentiation protein RCD1 homolog, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118624$turn]
RCE1 homolog, prenyl protein peptidase (S. cerevisiae),INTERPRO[450003220$IPR003675:Abortive infection protein]
RCE1 homolog, prenyl protein peptidase (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
RCE1 homolog, prenyl protein peptidase (S. cerevisiae),UP_SEQ_FEATURE[850008831$chain:CAAX prenyl protease 2, 850117295$sequence variant, 850118623$transmembrane region]
RGM domain family, member A,INTERPRO[450008597$IPR009496:Repulsive guidance molecule, C-terminal, 450009589$IPR010536:Repulsive guidance molecule, N-terminal]
RGM domain family, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal]
RGM domain family, member A,UP_SEQ_FEATURE[850057254$chain:Repulsive guidance molecule A, 850105770$glycosylation site:N-linked (GlcNAc...), 850105855$lipid moiety-binding region:GPI-anchor amidated alanine, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
RGP1 retrograde golgi transport homolog (S. cerevisiae),INTERPRO[450013297$IPR014848:Rgp1]
RGP1 retrograde golgi transport homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome]
RGP1 retrograde golgi transport homolog (S. cerevisiae),UP_SEQ_FEATURE[850057447$chain:Retrograde Golgi transport protein RGP1 homolog]
RIMS binding protein 3B; RIMS binding protein 3C; RIMS binding protein 3,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450003484$IPR003961:Fibronectin, type III, 450010373$IPR011511:Variant SH3]
RIMS binding protein 3B; RIMS binding protein 3C; RIMS binding protein 3,SMART[760000051$SM00060:FN3, 760000295$SM00326:SH3]
RIMS binding protein 3B; RIMS binding protein 3C; RIMS binding protein 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
RIMS binding protein 3B; RIMS binding protein 3C; RIMS binding protein 3,UP_SEQ_FEATURE[850058158$chain:RIMS-binding protein 3A, 850102586$compositionally biased region:Pro-rich, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850105351$domain:SH3 1, 850105353$domain:SH3 2, 850105354$domain:SH3 3, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
RNA (guanine-7-) methyltransferase,INTERPRO[450004440$IPR004971:mRNA capping enzyme, large subunit, 450015219$IPR016899:mRNA (guanine-N(7))-methyltransferase]
RNA (guanine-7-) methyltransferase,PIR_SUPERFAMILY[630021631$PIRSF028762:ABD1, 630021632$PIRSF028762:mRNA (guanine-N(7))-methyltransferase]
RNA (guanine-7-) methyltransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000954$methyltransferase, 790000987$mrna capping, 790000988$mrna processing, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
RNA (guanine-7-) methyltransferase,UP_SEQ_FEATURE[850000448$binding site:mRNA cap, 850000532$binding site:S-adenosyl-L-methionine, 850000543$binding site:S-adenosyl-L-methionine; via carbonyl oxygen, 850032556$chain:mRNA cap guanine-N7 methyltransferase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850113482$region of interest:mRNA cap binding, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
RNA (guanine-9-) methyltransferase domain containing 3,INTERPRO[450006719$IPR007356:tRNA (guanine-N1-)-methyltransferase, eukaryotic, 450014410$IPR016009:tRNA (guanine-N1-)-methyltransferase]
RNA (guanine-9-) methyltransferase domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000954$methyltransferase, 790001212$polymorphism, 790001547$transferase]
RNA (guanine-9-) methyltransferase domain containing 3,UP_SEQ_FEATURE[850058328$chain:RNA (guanine-9-)-methyltransferase domain-containing protein 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
RNA binding motif protein 5,INTERPRO[450000396$IPR000467:D111/G-patch, 450000430$IPR000504:RNA recognition motif, RNP-1, 450001659$IPR001876:Zinc finger, RanBP2-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014303$IPR015880:Zinc finger, C2H2-like]
RNA binding motif protein 5,SMART[760000323$SM00355:ZnF_C2H2, 760000328$SM00360:RRM, 760000389$SM00443:G_patch, 760000487$SM00547:ZnF_RBZ]
RNA binding motif protein 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000937$metal-binding, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001433$Spliceosome, 790001648$zinc, 790001651$zinc-finger]
RNA binding motif protein 5,UP_SEQ_FEATURE[850058500$chain:RNA-binding protein 5, 850104022$domain:G-patch, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850106258$modified residue, 850114397$region of interest:Required for interaction with U2AF2, 850114744$region of interest:Sufficient for interaction with ACIN1, PRPF8, SFRS3, SNRPB, SNRPN, SNRNP70 and SNRNP200, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118740$zinc finger region:C2H2-type; atypical, 850118900$zinc finger region:RanBP2-type]
RNA methyltransferase like 1,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
RNA methyltransferase like 1,INTERPRO[450001366$IPR001537:tRNA/rRNA methyltransferase, SpoU, 450011766$IPR013123:RNA 2-O ribose methyltransferase, substrate binding]
RNA methyltransferase like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000954$methyltransferase, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
RNA methyltransferase like 1,UP_SEQ_FEATURE[850000541$binding site:S-adenosyl-L-methionine; via amide nitrogen, 850000542$binding site:S-adenosyl-L-methionine; via amide nitrogen and carbonyl oxygen, 850000543$binding site:S-adenosyl-L-methionine; via carbonyl oxygen, 850058347$chain:RNA methyltransferase-like protein 1, 850117294$sequence conflict, 850117295$sequence variant]
RNA pseudouridylate synthase domain containing 2,INTERPRO[450005577$IPR006145:Pseudouridine synthase, 450005578$IPR006145:Pseudouridine synthase, RsuA and RluB/C/D/E/F, 450005650$IPR006224:Pseudouridine synthase, conserved site, 450005651$IPR006224:Pseudouridine synthase, RluC/RluD, conserved site, 450005652$IPR006225:Pseudouridine synthase, RluC/RluD, 450005653$IPR006225:Pseudouridine synthase, RluD]
RNA pseudouridylate synthase domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
RNA pseudouridylate synthase domain containing 2,UP_SEQ_FEATURE[850058440$chain:RNA pseudouridylate synthase domain- containing protein 2, 850102565$compositionally biased region:Poly-Ala, 850106258$modified residue, 850117294$sequence conflict]
RNA pseudouridylate synthase domain containing 3,INTERPRO[450005577$IPR006145:Pseudouridine synthase, 450005578$IPR006145:Pseudouridine synthase, RsuA and RluB/C/D/E/F, 450005650$IPR006224:Pseudouridine synthase, conserved site, 450005651$IPR006224:Pseudouridine synthase, RluC/RluD, conserved site]
RNA pseudouridylate synthase domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
RNA pseudouridylate synthase domain containing 3,UP_SEQ_FEATURE[850058441$chain:RNA pseudouridylate synthase domain- containing protein 3, 850117295$sequence variant, 850118574$splice variant]
RNA terminal phosphate cyclase-like 1,INTERPRO[450000197$IPR000228:RNA 3'-terminal phosphate cyclase- like, 450012405$IPR013796:RNA 3'-terminal phosphate cyclase, insert region, 450014765$IPR016443:RNA 3'-terminal phosphate cyclase-like, eukaryotic]
RNA terminal phosphate cyclase-like 1,PIR_SUPERFAMILY[630005303$PIRSF005378:RNA 3'-terminal phosphate cyclase, 630005304$PIRSF005378:RNA3'_term_phos_cycl_euk]
RNA terminal phosphate cyclase-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001331$ribosome biogenesis]
RNA terminal phosphate cyclase-like 1,UP_SEQ_FEATURE[850058331$chain:RNA 3'-terminal phosphate cyclase-like protein, 850117294$sequence conflict]
RPA interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
RPA interacting protein,UP_SEQ_FEATURE[850058610$chain:RPA-interacting protein, 850102716$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); in isoform 2, 850106258$modified residue, 850106259$mutagenesis site, 850113402$region of interest:Mediates nuclear export, 850117295$sequence variant, 850118574$splice variant, 850118921$zinc finger region:RIP-type]
RUN and FYVE domain containing 3,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
RUN and FYVE domain containing 3,INTERPRO[450003532$IPR004012:RUN]
RUN and FYVE domain containing 3,SMART[760000527$SM00593:RUN]
RUN and FYVE domain containing 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001016$neurogenesis, 790001162$phosphoprotein]
RUN and FYVE domain containing 3,UP_SEQ_FEATURE[850047544$chain:Protein RUFY3, 850105223$domain:RUN, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
RUN and SH3 domain containing 2,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450003532$IPR004012:RUN, 450010373$IPR011511:Variant SH3]
RUN and SH3 domain containing 2,SMART[760000295$SM00326:SH3, 760000527$SM00593:RUN]
RUN and SH3 domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
RUN and SH3 domain containing 2,UP_SEQ_FEATURE[850026732$chain:Iporin, 850102572$compositionally biased region:Poly-Glu, 850105223$domain:RUN, 850105350$domain:SH3, 850106258$modified residue, 850117295$sequence variant]
Rap guanine nucleotide exchange factor (GEF) 6,INTERPRO[450000135$IPR000159:Ras-association, 450000508$IPR000595:Cyclic nucleotide-binding, 450000558$IPR000651:Guanine nucleotide exchange factor for Ras-like GTPases, N-terminal, 450001316$IPR001478:PDZ/DHR/GLGF, 450001677$IPR001895:Guanine-nucleotide dissociation stimulator CDC25, 450008163$IPR008937:Ras guanine nucleotide exchange factor, 450013163$IPR014710:RmlC-like jelly roll fold]
Rap guanine nucleotide exchange factor (GEF) 6,SMART[760000088$SM00100:cNMP, 760000129$SM00147:RasGEF, 760000200$SM00228:PDZ, 760000201$SM00229:RasGEFN, 760000284$SM00314:RA]
Rap guanine nucleotide exchange factor (GEF) 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000641$guanine-nucleotide releasing factor, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
Rap guanine nucleotide exchange factor (GEF) 6,UP_SEQ_FEATURE[850056656$chain:Rap guanine nucleotide exchange factor 6, 850102597$compositionally biased region:Ser-rich, 850104821$domain:N-terminal Ras-GEF, 850104918$domain:PDZ, 850105145$domain:Ras-associating, 850105149$domain:Ras-GEF, 850105852$helix, 850106258$modified residue, 850106279$nucleotide phosphate-binding region:cNMP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
Ras association and DIL domains,INTERPRO[450000135$IPR000159:Ras-association, 450000219$IPR000253:Forkhead-associated, 450001316$IPR001478:PDZ/DHR/GLGF, 450002403$IPR002710:Dilute, 450016719$IPR018444:Dil domain]
Ras association and DIL domains,SMART[760000200$SM00228:PDZ, 760000212$SM00240:FHA, 760000284$SM00314:RA]
Ras association and DIL domains,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein, 790001212$polymorphism]
Ras association and DIL domains,UP_SEQ_FEATURE[850056710$chain:Ras-associating and dilute domain- containing protein, 850102586$compositionally biased region:Pro-rich, 850103525$domain:Dilute, 850103775$domain:FHA, 850104918$domain:PDZ, 850105145$domain:Ras-associating, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
Ras homolog enriched in brain like 1,INTERPRO[450001599$IPR001806:Ras GTPase, 450003144$IPR003577:Ras small GTPase, Ras type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450014041$IPR015602:Ras small GTPase, Rheb-related]
Ras homolog enriched in brain like 1,SMART[760000147$SM00173:RAS]
Ras homolog enriched in brain like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
Ras homolog enriched in brain like 1,UP_SEQ_FEATURE[850022652$chain:GTPase RhebL1, 850105890$lipid moiety-binding region:S-farnesyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117441$short sequence motif:Effector region, 850118574$splice variant]
Ras-related associated with diabetes,INTERPRO[450001599$IPR001806:Ras GTPase, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450015682$IPR017358:GTP-binding, GEM/REM/Rad]
Ras-related associated with diabetes,PIR_SUPERFAMILY[630029597$PIRSF038017:GTP-binding protein, GEM type, 630029598$PIRSF038017:GTP-binding_GEM]
Ras-related associated with diabetes,SP_PIR_KEYWORDS[790000002$3d-structure, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism]
Ras-related associated with diabetes,UP_SEQ_FEATURE[850022578$chain:GTP-binding protein RAD, 850105852$helix, 850106296$nucleotide phosphate-binding region:GTP, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
Rho guanine nucleotide exchange factor (GEF) 5-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
Rho guanine nucleotide exchange factor (GEF) 5-like,UP_SEQ_FEATURE[850057576$chain:Rho guanine nucleotide exchange factor 5- like protein, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850117294$sequence conflict]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,INTERPRO[450000189$IPR000219:Dbl homology (DH) domain, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type, 450014156$IPR015721:Rho GTP exchange factor]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,SMART[760000205$SM00233:PH, 760000294$SM00325:RhoGEF]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism]
Rho/Rac guanine nucleotide exchange factor (GEF) 18,UP_SEQ_FEATURE[850057570$chain:Rho guanine nucleotide exchange factor 18, 850102586$compositionally biased region:Pro-rich, 850103518$domain:DH, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
S100 calcium binding protein A1,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A1,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A1,SP_PIR_KEYWORDS[790000199$brain, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000407$cytoplasm, 790000480$EF hand, 790000679$heterodimer, 790000701$homodimer, 790000937$metal-binding, 790001304$repeat, 790001648$zinc]
S100 calcium binding protein A1,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047552$chain:Protein S100-A1, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2]
S100 calcium binding protein A10,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain]
S100 calcium binding protein A10,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A10,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000480$EF hand, 790000686$heterotetramer, 790001162$phosphoprotein]
S100 calcium binding protein A10,UP_SEQ_FEATURE[850047553$chain:Protein S100-A10, 850105852$helix, 850106258$modified residue, 850110929$region of interest:Ancestral calcium site, 850118575$strand]
S100 calcium binding protein A4,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A4,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000480$EF hand, 790001304$repeat]
S100 calcium binding protein A4,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047562$chain:Protein S100-A4, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
S100 calcium binding protein A9,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A9,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000100$Antimicrobial, 790000189$blocked amino end, 790000211$calcium, 790000212$calcium binding, 790000264$cell membrane, 790000291$chemotaxis, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000480$EF hand, 790000679$heterodimer, 790000774$inflammation, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted]
S100 calcium binding protein A9,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047569$chain:Protein S100-A9, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
S100 calcium binding protein Z,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein Z,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein Z,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790001212$polymorphism, 790001304$repeat]
S100 calcium binding protein Z,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047574$chain:Protein S100-Z, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117295$sequence variant]
SAM pointed domain containing ets transcription factor,INTERPRO[450000358$IPR000418:Ets, 450002742$IPR003118:Sterile alpha motif/pointed, 450010816$IPR011991:Winged helix repressor DNA-binding]
SAM pointed domain containing ets transcription factor,PIR_SUPERFAMILY[630029528$PIRSF037958:SAM pointed domain-containing Ets transcription factor]
SAM pointed domain containing ets transcription factor,SMART[760000223$SM00251:SAM_PNT, 760000360$SM00413:ETS]
SAM pointed domain containing ets transcription factor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
SAM pointed domain containing ets transcription factor,UP_SEQ_FEATURE[850058876$chain:SAM pointed domain-containing Ets transcription factor, 850102913$DNA-binding region:ETS, 850105048$domain:PNT, 850105852$helix, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SAP30 binding protein,INTERPRO[450011159$IPR012479:HCNGP-like]
SAP30 binding protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
SAP30 binding protein,UP_SEQ_FEATURE[850058883$chain:SAP30-binding protein, 850102605$compositionally biased region:Thr-rich, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
SAR1 homolog B (S. cerevisiae),INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006097$IPR006687:GTP-binding protein SAR1, 450006099$IPR006689:ARF/SAR superfamily]
SAR1 homolog B (S. cerevisiae),OMIM_DISEASE[520000301$Anderson disease, 520001034$Chylomicron retention disease]
SAR1 homolog B (S. cerevisiae),PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
SAR1 homolog B (S. cerevisiae),SMART[760000152$SM00178:SAR]
SAR1 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000639$gtp-binding, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001266$protein transport, 790001558$transport]
SAR1 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850022599$chain:GTP-binding protein SAR1b, 850106107$metal ion-binding site:Magnesium, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant]
SCO cytochrome oxidase deficient homolog 1 (yeast),INTERPRO[450003322$IPR003782:Copper chaperone SCO1/SenC, 450011036$IPR012335:Thioredoxin fold, 450015599$IPR017276:Synthesis of cytochrome c oxidase, Sco1/Sco2]
SCO cytochrome oxidase deficient homolog 1 (yeast),OMIM_DISEASE[520002283$Hepatic failure, early onset, and neurologic disorder]
SCO cytochrome oxidase deficient homolog 1 (yeast),PIR_SUPERFAMILY[630029311$PIRSF037736:SCO1, 630029312$PIRSF037736:SCO1 protein]
SCO cytochrome oxidase deficient homolog 1 (yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000288$Chaperone, 790000356$complete proteome, 790000371$copper, 790000446$disease mutation, 790000937$metal-binding, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
SCO cytochrome oxidase deficient homolog 1 (yeast),UP_SEQ_FEATURE[850047614$chain:Protein SCO1 homolog, mitochondrial, 850105852$helix, 850105958$metal ion-binding site:Copper, 850111982$region of interest:Important for dimerization, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
SDA1 domain containing 1,INTERPRO[450007295$IPR007949:SDA1, 450011653$IPR012977:Region of unknown function, nucleolar NUC130/133, N-terminal]
SDA1 domain containing 1,PIR_SUPERFAMILY[630014782$PIRSF018142:uncharacterized conserved protein]
SDA1 domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001331$ribosome biogenesis, 790001558$transport]
SDA1 domain containing 1,UP_SEQ_FEATURE[850047623$chain:Protein SDA1 homolog, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SEC14-like 2 (S. cerevisiae),INTERPRO[450000939$IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport, 450001103$IPR001251:Cellular retinaldehyde-binding/triple function, C-terminal, 450007565$IPR008273:Cellular retinaldehyde-binding/triple function, N-terminal, 450008192$IPR009038:GOLD]
SEC14-like 2 (S. cerevisiae),SMART[760000458$SM00516:SEC14]
SEC14-like 2 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000876$lipid-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001558$transport]
SEC14-like 2 (S. cerevisiae),UP_SEQ_FEATURE[850059082$chain:SEC14-like protein 2, 850103410$domain:CRAL-TRIO, 850104069$domain:GOLD, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SEC14-like 3 (S. cerevisiae),INTERPRO[450000939$IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport, 450001103$IPR001251:Cellular retinaldehyde-binding/triple function, C-terminal, 450007565$IPR008273:Cellular retinaldehyde-binding/triple function, N-terminal, 450008192$IPR009038:GOLD]
SEC14-like 3 (S. cerevisiae),SMART[760000458$SM00516:SEC14]
SEC14-like 3 (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000876$lipid-binding, 790001212$polymorphism, 790001558$transport]
SEC14-like 3 (S. cerevisiae),UP_SEQ_FEATURE[850059083$chain:SEC14-like protein 3, 850103410$domain:CRAL-TRIO, 850104069$domain:GOLD, 850117295$sequence variant]
SEC24 family, member A (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
SEC24 family, member A (S. cerevisiae),INTERPRO[450006295$IPR006895:Zinc finger, Sec23/Sec24-type, 450006296$IPR006896:Sec23/Sec24 trunk region, 450006300$IPR006900:Sec23/Sec24 helical region, 450006497$IPR007123:Gelsolin region, 450011666$IPR012990:Sec23/Sec24 beta-sandwich]
SEC24 family, member A (S. cerevisiae),PIR_SUPERFAMILY[630013991$PIRSF017225:vesicle coat complex COPII, subunit SEC24]
SEC24 family, member A (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
SEC24 family, member A (S. cerevisiae),UP_SEQ_FEATURE[850048115$chain:Protein transport protein Sec24A, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850115067$region of interest:Zinc finger-like, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
SEC31 homolog B (S. cerevisiae),INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
SEC31 homolog B (S. cerevisiae),SMART[760000289$SM00320:WD40]
SEC31 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001558$transport, 790001638$wd repeat]
SEC31 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850048121$chain:Protein transport protein Sec31B, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SEC63 homolog (S. cerevisiae),INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450003689$IPR004179:Sec63 domain, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016426$IPR018127:Sec63 domain, subgroup, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
SEC63 homolog (S. cerevisiae),OMIM_DISEASE[520004039$Polycystic liver disease]
SEC63 homolog (S. cerevisiae),SMART[760000243$SM00271:DnaJ, 760000540$SM00611:SEC63]
SEC63 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000288$Chaperone, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
SEC63 homolog (S. cerevisiae),UP_SEQ_FEATURE[850065879$chain:Translocation protein SEC63 homolog, 850102468$compositionally biased region:Asp/Glu-rich (highly acidic), 850104487$domain:J, 850105333$domain:SEC63 1, 850105334$domain:SEC63 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
SET domain containing 4,INTERPRO[450001068$IPR001214:SET, 450013794$IPR015353:Rubisco LSMT substrate-binding, 450015172$IPR016852:Lysine methylase, YDR198C, predicted]
SET domain containing 4,PIR_SUPERFAMILY[630020728$PIRSF027158:lysine methylase, YDR198C type, 630020729$PIRSF027158:Lys_MTase_YDR198C_prd]
SET domain containing 4,SMART[760000286$SM00317:SET]
SET domain containing 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
SET domain containing 4,UP_SEQ_FEATURE[850060452$chain:SET domain-containing protein 4, 850105340$domain:SET, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SET domain containing 5,INTERPRO[450001068$IPR001214:SET]
SET domain containing 5,SMART[760000286$SM00317:SET]
SET domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
SET domain containing 5,UP_SEQ_FEATURE[850060453$chain:SET domain-containing protein 5, 850102597$compositionally biased region:Ser-rich, 850105340$domain:SET, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SET domain containing 6,INTERPRO[450001068$IPR001214:SET, 450010254$IPR011383:RuBisCO-cytochrome methylase, RMS1]
SET domain containing 6,PIR_SUPERFAMILY[630010050$PIRSF011771:RMS1_SET, 630010051$PIRSF011771:RuBisCO-cytochrome methylase, RMS1 type]
SET domain containing 6,SMART[760000286$SM00317:SET]
SET domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
SET domain containing 6,UP_SEQ_FEATURE[850060454$chain:SET domain-containing protein 6, 850105340$domain:SET, 850117294$sequence conflict, 850118574$splice variant]
SH2 domain containing 5,INTERPRO[450000852$IPR000980:SH2 motif, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
SH2 domain containing 5,SMART[760000224$SM00252:SH2, 760000407$SM00462:PTB]
SH2 domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001397$SH2 domain]
SH2 domain containing 5,UP_SEQ_FEATURE[850060516$chain:SH2 domain-containing protein 5, 850105346$domain:SH2, 850106258$modified residue]
SH2 domain protein 2A,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain protein 2A,KEGG_PATHWAY[470038852$hsa04370:VEGF signaling pathway]
SH2 domain protein 2A,SMART[760000224$SM00252:SH2]
SH2 domain protein 2A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000081$angiogenesis, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain, 790001399$sh3-binding]
SH2 domain protein 2A,UP_SEQ_FEATURE[850060511$chain:SH2 domain-containing protein 2A, 850102586$compositionally biased region:Pro-rich, 850105346$domain:SH2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant]
SH3-binding domain protein 5-like,INTERPRO[450007286$IPR007940:SH3-binding 5]
SH3-binding domain protein 5-like,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
SH3-binding domain protein 5-like,UP_SEQ_FEATURE[850060546$chain:SH3 domain-binding protein 5-like, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue]
SH3KBP1 binding protein 1,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450001490$IPR001680:WD40 repeat, 450002755$IPR003131:Potassium channel, voltage dependent, Kv,  tetramerisation, 450010229$IPR011333:BTB/POZ fold, 450014355$IPR015943:WD40/YVTN repeat-like, 450018010$IPR019775:WD40 repeat, conserved site]
SH3KBP1 binding protein 1,PIR_SUPERFAMILY[630020980$PIRSF027709:PIRSF027709]
SH3KBP1 binding protein 1,SMART[760000197$SM00225:BTB, 760000289$SM00320:WD40]
SH3KBP1 binding protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
SH3KBP1 binding protein 1,UP_SEQ_FEATURE[850060557$chain:SH3KBP1-binding protein 1, 850103177$domain:BTB, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae),INTERPRO[450010814$IPR011989:Armadillo-like helical]
SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae),OMIM_DISEASE[520003079$Marinesco-Sjogren syndrome]
SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001212$polymorphism, 790001266$protein transport, 790001405$signal, 790001554$translocation, 790001558$transport]
SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae),UP_SEQ_FEATURE[850035331$chain:Nucleotide exchange factor SIL1, 850105770$glycosylation site:N-linked (GlcNAc...), 850112426$region of interest:Interaction with HSPA5 and localization to the endoplasmic reticulum, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
SIX homeobox 1,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
SIX homeobox 1,OMIM_DISEASE[520000656$Brachiootic syndrome 3, 520001326$Deafness, autosomal dominant 23]
SIX homeobox 1,SMART[760000341$SM00389:HOX]
SIX homeobox 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000415$deafness, 790000428$developmental protein, 790000446$disease mutation, 790000466$dna-binding, 790000699$Homeobox, 790001041$non-syndromic deafness, 790001065$nucleus]
SIX homeobox 1,UP_SEQ_FEATURE[850024663$chain:Homeobox protein SIX1, 850102927$DNA-binding region:Homeobox, 850117294$sequence conflict, 850117295$sequence variant]
SLAIN motif family, member 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
SLAIN motif family, member 2,UP_SEQ_FEATURE[850060946$chain:SLAIN motif-containing protein 2, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict]
SMAD family member 2,BIOCARTA[30000293$h_tgfbPathway:TGF beta signaling pathway]
SMAD family member 2,INTERPRO[450000993$IPR001132:SMAD domain, Dwarfin-type, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450011686$IPR013019:MAD homology, MH1, 450012402$IPR013790:Dwarfin, 450016174$IPR017855:SMAD domain-like]
SMAD family member 2,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038846$hsa04310:Wnt signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway, 470038856$hsa04520:Adherens junction, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038902$hsa05212:Pancreatic cancer]
SMAD family member 2,SMART[760000463$SM00523:DWA, 760000464$SM00524:DWB]
SMAD family member 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
SMAD family member 2,UP_SEQ_FEATURE[850032504$chain:Mothers against decapentaplegic homolog 2, 850104765$domain:MH1, 850104766$domain:MH2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117675$short sequence motif:PY-motif, 850118574$splice variant, 850118575$strand]
SMAD family member 3,BIOCARTA[30000119$h_g1Pathway:Cell Cycle: G1/S Check Point , 30000210$h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae, 30000293$h_tgfbPathway:TGF beta signaling pathway, 30000299$h_tob1Pathway:Role of Tob in T-cell activation]
SMAD family member 3,INTERPRO[450000993$IPR001132:SMAD domain, Dwarfin-type, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450011686$IPR013019:MAD homology, MH1, 450012402$IPR013790:Dwarfin, 450016174$IPR017855:SMAD domain-like]
SMAD family member 3,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038846$hsa04310:Wnt signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway, 470038856$hsa04520:Adherens junction, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038902$hsa05212:Pancreatic cancer, 470038910$hsa05220:Chronic myeloid leukemia]
SMAD family member 3,OMIM_DISEASE[520002065$Genomewide association analysis of coronary artery disease]
SMAD family member 3,PIR_SUPERFAMILY[630019054$PIRSF023942:PIRSF023942]
SMAD family member 3,SMART[760000463$SM00523:DWA, 760000464$SM00524:DWB]
SMAD family member 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
SMAD family member 3,UP_SEQ_FEATURE[850032505$chain:Mothers against decapentaplegic homolog 3, 850104765$domain:MH1, 850104766$domain:MH2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114799$region of interest:Sufficient for interaction with XPO4, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
SMAD family member 5,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes, 30000074$h_ctcfPathway:CTCF: First Multivalent Nuclear Factor]
SMAD family member 5,INTERPRO[450000993$IPR001132:SMAD domain, Dwarfin-type, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450011686$IPR013019:MAD homology, MH1, 450012402$IPR013790:Dwarfin, 450016174$IPR017855:SMAD domain-like]
SMAD family member 5,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
SMAD family member 5,PIR_SUPERFAMILY[630028833$PIRSF037286:Smad protein, 630030713$PIRSF500500:receptor-regulated Smad protein, Smad 1/Smad 5/Smad 8 types]
SMAD family member 5,SMART[760000463$SM00523:DWA, 760000464$SM00524:DWB]
SMAD family member 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
SMAD family member 5,UP_SEQ_FEATURE[850032507$chain:Mothers against decapentaplegic homolog 5, 850102577$compositionally biased region:Poly-Lys, 850104765$domain:MH1, 850104766$domain:MH2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict]
SMAD family member 6,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes]
SMAD family member 6,INTERPRO[450000993$IPR001132:SMAD domain, Dwarfin-type, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450011686$IPR013019:MAD homology, MH1, 450012402$IPR013790:Dwarfin, 450016174$IPR017855:SMAD domain-like]
SMAD family member 6,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
SMAD family member 6,PIR_SUPERFAMILY[630028833$PIRSF037286:Smad protein, 630030640$PIRSF500412:inhibitory Smad protein, Smad 6/Smad 7 types]
SMAD family member 6,SMART[760000463$SM00523:DWA, 760000464$SM00524:DWB]
SMAD family member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
SMAD family member 6,UP_SEQ_FEATURE[850032508$chain:Mothers against decapentaplegic homolog 6, 850102565$compositionally biased region:Poly-Ala, 850102566$compositionally biased region:Poly-Arg, 850102573$compositionally biased region:Poly-Gly, 850102576$compositionally biased region:Poly-Leu, 850102580$compositionally biased region:Poly-Pro, 850104765$domain:MH1, 850104766$domain:MH2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
SMAD specific E3 ubiquitin protein ligase 2,COG_ONTOLOGY[90000102$RNA processing and modification]
SMAD specific E3 ubiquitin protein ligase 2,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000485$IPR000569:HECT, 450001055$IPR001202:WW/Rsp5/WWP, 450016334$IPR018029:C2 membrane targeting protein]
SMAD specific E3 ubiquitin protein ligase 2,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038841$hsa04144:Endocytosis, 470038850$hsa04350:TGF-beta signaling pathway]
SMAD specific E3 ubiquitin protein ligase 2,PIR_SUPERFAMILY[630001740$PIRSF001569:E3 ubiquitin-protein ligase, Nedd4/Rsp5p types, 630030673$PIRSF500454:smad ubiquitination regulatory factor]
SMAD specific E3 ubiquitin protein ligase 2,SMART[760000104$SM00119:HECTc, 760000211$SM00239:C2, 760000401$SM00456:WW]
SMAD specific E3 ubiquitin protein ligase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790000919$membrane, 790001065$nucleus, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
SMAD specific E3 ubiquitin protein ligase 2,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850016754$chain:E3 ubiquitin-protein ligase SMURF2, 850103199$domain:C2, 850104105$domain:HECT, 850105732$domain:WW 1, 850105733$domain:WW 2, 850105734$domain:WW 3, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) pseudogene; SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae); SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae),BIOCARTA[30000282$h_sumoPathway:Basic Mechanisms of SUMOylation]
SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) pseudogene; SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae); SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae),INTERPRO[450000534$IPR000626:Ubiquitin, 450018185$IPR019955:Ubiquitin supergroup]
SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) pseudogene; SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae); SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae),PIR_SUPERFAMILY[630005285$PIRSF005358:small ubiquitin-related modifier 1]
SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) pseudogene; SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae); SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae),SMART[760000186$SM00213:UBQ]
SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) pseudogene; SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae); SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000811$isopeptide bond, 790001065$nucleus, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) pseudogene; SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae); SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae),UP_SEQ_FEATURE[850061072$chain:Small ubiquitin-related modifier 2, 850061075$chain:Small ubiquitin-related modifier 3, 850102710$cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850105602$domain:Ubiquitin-like, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae),INTERPRO[450000534$IPR000626:Ubiquitin, 450018185$IPR019955:Ubiquitin supergroup]
SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae),OMIM_DISEASE[520001486$Diabetes mellitus, insulin-dependent, 5]
SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae),PIR_SUPERFAMILY[630005285$PIRSF005358:small ubiquitin-related modifier 1]
SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae),SMART[760000186$SM00213:UBQ]
SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000811$isopeptide bond, 790001212$polymorphism, 790001593$ubl conjugation pathway]
SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae),UP_SEQ_FEATURE[850061077$chain:Small ubiquitin-related modifier 4, 850102710$cross-link:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), 850105602$domain:Ubiquitin-like, 850117295$sequence variant]
SMYD family member 5,INTERPRO[450001068$IPR001214:SET, 450002557$IPR002893:Zinc finger, MYND-type]
SMYD family member 5,SMART[760000286$SM00317:SET]
SMYD family member 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
SMYD family member 5,UP_SEQ_FEATURE[850060448$chain:SET and MYND domain-containing protein 5, 850102507$compositionally biased region:Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850105340$domain:SET, 850117294$sequence conflict, 850118853$zinc finger region:MYND-type]
SPARC related modular calcium binding 2,INTERPRO[450000615$IPR000716:Thyroglobulin type-1, 450001814$IPR002048:Calcium-binding EF-hand, 450002091$IPR002350:Proteinase inhibitor I1, Kazal, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2, 450017814$IPR019577:SPARC/Testican, calcium-binding domain]
SPARC related modular calcium binding 2,SMART[760000046$SM00054:EFh, 760000184$SM00211:TY, 760000251$SM00280:KAZAL]
SPARC related modular calcium binding 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000171$basement membrane, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790001304$repeat, 790001363$Secreted, 790001405$signal]
SPARC related modular calcium binding 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850061581$chain:SPARC-related modular calcium-binding protein 2, 850102883$disulfide bond, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850104500$domain:Kazal-like, 850105486$domain:Thyroglobulin type-1 1, 850105489$domain:Thyroglobulin type-1 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae),INTERPRO[450011891$IPR013256:Chromatin SPT2]
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae),SMART[760000687$SM00784:SPT2]
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae),UP_SEQ_FEATURE[850047816$chain:Protein SPT2 homolog, 850102568$compositionally biased region:Poly-Asp, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SR-related CTD-associated factor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
SR-related CTD-associated factor 1,UP_SEQ_FEATURE[850062073$chain:Splicing factor, arginine/serine-rich 19, 850102404$compositionally biased region:Arg-rich, 850102507$compositionally biased region:Glu-rich, 850102554$compositionally biased region:Lys-rich, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850113652$region of interest:Necessary for interaction with the CTD domain of POLR2A, 850117294$sequence conflict, 850117295$sequence variant]
SRR1 domain containing,INTERPRO[450011618$IPR012942:SRR1]
SRR1 domain containing,PIR_SUPERFAMILY[630006273$PIRSF006338:hepatocellular carcinoma complicating hemochromatosis protein]
SRR1 domain containing,SP_PIR_KEYWORDS[790000182$biological rhythms, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
SRR1 domain containing,UP_SEQ_FEATURE[850062301$chain:SRR1-like protein, 850102565$compositionally biased region:Poly-Ala, 850102576$compositionally biased region:Poly-Leu, 850110266$region of interest:3 X 7 AA tandem repeats of R-E-A-A-P-R-G, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117294$sequence conflict, 850117295$sequence variant]
SRY (sex determining region Y)-box 12,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2, 450015712$IPR017386:SOX-12/11/4a]
SRY (sex determining region Y)-box 12,PIR_SUPERFAMILY[630029685$PIRSF038098:SOX-12/11/4a, 630029686$PIRSF038098:SOX-12/11/4a protein]
SRY (sex determining region Y)-box 12,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 12,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 12,UP_SEQ_FEATURE[850065308$chain:Transcription factor SOX-12, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102920$DNA-binding region:HMG box]
SRY (sex determining region Y)-box 18,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 18,OMIM_DISEASE[520002573$Hypotrichosis-lymphedema-telangiectasia syndrome]
SRY (sex determining region Y)-box 18,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 18,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000446$disease mutation, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 18,UP_SEQ_FEATURE[850065317$chain:Transcription factor SOX-18, 850102920$DNA-binding region:HMG box, 850117295$sequence variant]
SRY (sex determining region Y)-box 30,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 30,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 30,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 30,UP_SEQ_FEATURE[850065331$chain:Transcription factor SOX-30, 850102586$compositionally biased region:Pro-rich, 850102920$DNA-binding region:HMG box, 850117295$sequence variant, 850118574$splice variant]
SRY (sex determining region Y)-box 9,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 9,OMIM_DISEASE[520000092$Acampomelic campomelic dysplasia, 520000736$Campomelic dysplasia, 520000737$Campomelic dysplasia with autosomal sex reversal]
SRY (sex determining region Y)-box 9,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 9,UP_SEQ_FEATURE[850065337$chain:Transcription factor SOX-9, 850102501$compositionally biased region:Gln/Pro-rich, 850102580$compositionally biased region:Poly-Pro, 850102920$DNA-binding region:HMG box, 850105852$helix, 850117295$sequence variant, 850118575$strand]
ST3 beta-galactoside alpha-2,3-sialyltransferase 5,INTERPRO[450001485$IPR001675:Glycosyl transferase, family 29, 450010937$IPR012163:Sialyltransferase]
ST3 beta-galactoside alpha-2,3-sialyltransferase 5,KEGG_PATHWAY[470038786$hsa00604:Glycosphingolipid biosynthesis]
ST3 beta-galactoside alpha-2,3-sialyltransferase 5,OMIM_DISEASE[520000265$Amish infantile epilepsy syndrome]
ST3 beta-galactoside alpha-2,3-sialyltransferase 5,PIR_SUPERFAMILY[630005480$PIRSF005557:sialyltransferase, 630005481$PIRSF005557:Sialyl_trans]
ST3 beta-galactoside alpha-2,3-sialyltransferase 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000509$epilepsy, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
ST3 beta-galactoside alpha-2,3-sialyltransferase 5,UP_SEQ_FEATURE[850027893$chain:Lactosylceramide alpha-2,3- sialyltransferase, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,INTERPRO[450001485$IPR001675:Glycosyl transferase, family 29, 450010937$IPR012163:Sialyltransferase]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,PIR_SUPERFAMILY[630005480$PIRSF005557:sialyltransferase, 630005481$PIRSF005557:Sialyl_trans]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
ST3 beta-galactoside alpha-2,3-sialyltransferase 6,UP_SEQ_FEATURE[850067358$chain:Type 2 lactosamine alpha-2,3- sialyltransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2,INTERPRO[450001485$IPR001675:Glycosyl transferase, family 29]
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2,UP_SEQ_FEATURE[850007725$chain:Beta-galactoside alpha-2,6- sialyltransferase 2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4,BIOCARTA[30000017$h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides]
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4,INTERPRO[450001485$IPR001675:Glycosyl transferase, family 29, 450010937$IPR012163:Sialyltransferase]
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4,PIR_SUPERFAMILY[630005480$PIRSF005557:sialyltransferase, 630005481$PIRSF005557:Sialyl_trans]
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4,UP_SEQ_FEATURE[850011714$chain:CMP-N-acetylneuraminate-poly-alpha-2,8- sialyltransferase, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
STE20-related kinase adaptor beta,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
STE20-related kinase adaptor beta,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism]
STE20-related kinase adaptor beta,UP_SEQ_FEATURE[850000242$binding site:ATP, 850062408$chain:STE20-related kinase adapter protein beta, 850105086$domain:Protein kinase, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant]
SUMO1/sentrin/SMT3 specific peptidase 3,INTERPRO[450003199$IPR003653:Peptidase C48, SUMO/Sentrin/Ubl1]
SUMO1/sentrin/SMT3 specific peptidase 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
SUMO1/sentrin/SMT3 specific peptidase 3,UP_SEQ_FEATURE[850059423$chain:Sentrin-specific protease 3, 850102507$compositionally biased region:Glu-rich, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850106259$mutagenesis site, 850114140$region of interest:Protease, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,BIOCARTA[30000142$h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,INTERPRO[450000283$IPR000330:SNF2-related, 450001324$IPR001487:Bromodomain, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450005982$IPR006562:HSA, 450005996$IPR006576:BRK domain, 450012593$IPR013999:HAS subgroup, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012606$IPR014012:Helicase/SANT-associated, DNA binding, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450013427$IPR014978:Glutamine-Leucine-Glutamine, QLQ, 450016644$IPR018359:Bromodomain, conserved site]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,PIR_SUPERFAMILY[630027745$PIRSF036309:SNF2-family ATP-dependent chromatin remodeling factor, 630031063$PIRSF500926:SWI/SNF related, matrix associated, actin dependent regulator of chromatin]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,SMART[760000267$SM00297:BROMO, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc, 760000510$SM00573:HSA, 760000526$SM00592:BRK]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000138$atp-binding, 790000206$bromodomain, 790000311$chromatin regulator, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,UP_SEQ_FEATURE[850064930$chain:Transcription activator BRG1, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850103166$domain:Bromo, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850104152$domain:HSA, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850113649$region of interest:Necessary for interaction with SS18L1/CREST, 850117294$sequence conflict, 850117295$sequence variant, 850117399$short sequence motif:DEGH box, 850118516$site:Required for binding to 'Lys-15'- acetylated histone 3, 850118575$strand, 850118624$turn]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,INTERPRO[450000283$IPR000330:SNF2-related, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450009088$IPR010003:HepA-related, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,OMIM_DISEASE[520004390$Schimke immunoosseous dysplasia]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1,UP_SEQ_FEATURE[850063123$chain:SWI/SNF-related matrix-associated actin- dependent regulator of chromatin subfamily A-like protein 1, 850104100$domain:HARP 1, 850104101$domain:HARP 2, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117405$short sequence motif:DESH box]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1,BIOCARTA[30000142$h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1,COG_ONTOLOGY[90000045$Chromatin structure and dynamics / Transcription, 90000073$General function prediction only]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1,INTERPRO[450000831$IPR000953:Chromo domain, 450000876$IPR001005:SANT, DNA-binding, 450006880$IPR007526:SWIRM, 450013228$IPR014778:Myb, DNA-binding, 450016201$IPR017884:SANT, eukarya]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1,SMART[760000268$SM00298:CHROMO, 760000623$SM00717:SANT]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790001016$neurogenesis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1,UP_SEQ_FEATURE[850063111$chain:SWI/SNF complex subunit SMARCC1, 850102507$compositionally biased region:Glu-rich, 850102565$compositionally biased region:Poly-Ala, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105254$domain:SANT, 850105453$domain:SWIRM, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
Scm-like with four mbt domains 1,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450003607$IPR004092:Mbt repeat, 450012380$IPR013761:Sterile alpha motif-type]
Scm-like with four mbt domains 1,SMART[760000399$SM00454:SAM, 760000500$SM00561:MBT]
Scm-like with four mbt domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat]
Scm-like with four mbt domains 1,UP_SEQ_FEATURE[850058998$chain:Scm-like with four MBT domains protein 1, 850105249$domain:SAM, 850106258$modified residue, 850110936$region of interest:Antigenic epitope, 850116372$repeat:MBT 1, 850116373$repeat:MBT 2, 850116374$repeat:MBT 3, 850116375$repeat:MBT 4, 850117294$sequence conflict, 850118574$splice variant]
Shwachman-Bodian-Diamond syndrome pseudogene; Shwachman-Bodian-Diamond syndrome,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
Shwachman-Bodian-Diamond syndrome pseudogene; Shwachman-Bodian-Diamond syndrome,INTERPRO[450001897$IPR002140:Ribosome maturation protein SBDS, 450016328$IPR018023:Ribosome maturation protein SBDS, conserved site, 450017248$IPR018978:Ribosome maturation protein SBDS, C-terminal, 450018018$IPR019783:Ribosome maturation protein SBDS, N-terminal]
Shwachman-Bodian-Diamond syndrome pseudogene; Shwachman-Bodian-Diamond syndrome,OMIM_DISEASE[520004474$Shwachman-Bodian-Diamond syndrome]
Shwachman-Bodian-Diamond syndrome pseudogene; Shwachman-Bodian-Diamond syndrome,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790001162$phosphoprotein, 790001331$ribosome biogenesis]
Shwachman-Bodian-Diamond syndrome pseudogene; Shwachman-Bodian-Diamond syndrome,UP_SEQ_FEATURE[850058020$chain:Ribosome maturation protein SBDS, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
Smith-Magenis syndrome chromosome region, candidate 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
Smith-Magenis syndrome chromosome region, candidate 7,UP_SEQ_FEATURE[850061114$chain:Smith-Magenis syndrome chromosome region candidate gene 7 protein, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
T-box 10,INTERPRO[450001505$IPR001699:Transcription factor, T-box, 450016474$IPR018186:Transcription factor, T-box, conserved site]
T-box 10,SMART[760000371$SM00425:TBOX]
T-box 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
T-box 10,UP_SEQ_FEATURE[850063328$chain:T-box transcription factor TBX10, 850102955$DNA-binding region:T-box, 850117294$sequence conflict, 850117295$sequence variant]
T-cell activation RhoGTPase activating protein,INTERPRO[450000169$IPR000198:RhoGAP]
T-cell activation RhoGTPase activating protein,OMIM_DISEASE[520003637$Newly identified genetic risk variants for celiac disease related to the immune response]
T-cell activation RhoGTPase activating protein,SMART[760000293$SM00324:RhoGAP]
T-cell activation RhoGTPase activating protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001212$polymorphism]
T-cell activation RhoGTPase activating protein,UP_SEQ_FEATURE[850063346$chain:T-cell activation Rho GTPase-activating protein, 850105183$domain:Rho-GAP, 850117295$sequence variant, 850118574$splice variant]
T-cell leukemia translocation altered gene,INTERPRO[450014882$IPR016560:T-cell leukaemia translocation-associated protein]
T-cell leukemia translocation altered gene,PIR_SUPERFAMILY[630008892$PIRSF009935:T-cell leukemia translocation-associated protein, 630008893$PIRSF009935:TCTA]
T-cell leukemia translocation altered gene,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000356$complete proteome, 790001271$Proto-oncogene]
T-cell leukemia translocation altered gene,UP_SEQ_FEATURE[850063364$chain:T-cell leukemia translocation-altered gene protein, 850117294$sequence conflict]
TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa,PIR_SUPERFAMILY[630029908$PIRSF038329:TATA box-binding protein-associated factor RNA polymerase I subunit B]
TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa,UP_SEQ_FEATURE[850063596$chain:TATA box-binding protein-associated factor RNA polymerase I subunit B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TATA element modulatory factor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000624$golgi apparatus, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
TATA element modulatory factor 1,UP_SEQ_FEATURE[850063602$chain:TATA element modulatory factor, 850106258$modified residue, 850106259$mutagenesis site, 850112295$region of interest:Interaction with Elongin BC complex, 850117295$sequence variant, 850118574$splice variant]
TBC1 domain family, member 10C,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 10C,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 10C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation]
TBC1 domain family, member 10C,UP_SEQ_FEATURE[850009371$chain:Carabin, 850105135$domain:Rab-GAP TBC, 850106259$mutagenesis site, 850112140$region of interest:Interaction with calcineurin]
TBC1 domain family, member 20,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 20,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 20,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000640$GTPase activation, 790000733$host-virus interaction, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
TBC1 domain family, member 20,UP_SEQ_FEATURE[850063660$chain:TBC1 domain family member 20, 850105135$domain:Rab-GAP TBC, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
TBC1 domain family, member 25,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 25,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 25,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism]
TBC1 domain family, member 25,UP_SEQ_FEATURE[850063666$chain:TBC1 domain family member 25, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102581$compositionally biased region:Poly-Ser, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TBC1 domain family, member 28,SP_PIR_KEYWORDS[790000356$complete proteome]
TBC1 domain family, member 28,UP_SEQ_FEATURE[850063668$chain:TBC1 domain family member 28, 850105135$domain:Rab-GAP TBC, 850117294$sequence conflict]
TBC1 domain family, member 9B (with GRAM domain),INTERPRO[450000166$IPR000195:RabGAP/TBC, 450003692$IPR004182:GRAM, 450010817$IPR011992:EF-Hand type, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
TBC1 domain family, member 9B (with GRAM domain),SMART[760000143$SM00164:TBC, 760000505$SM00568:GRAM]
TBC1 domain family, member 9B (with GRAM domain),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000640$GTPase activation, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
TBC1 domain family, member 9B (with GRAM domain),UP_SEQ_FEATURE[850063683$chain:TBC1 domain family member 9B, 850103571$domain:EF-hand, 850104080$domain:GRAM 1, 850104081$domain:GRAM 2, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
TBP-like 1,COG_ONTOLOGY[90000115$Transcription]
TBP-like 1,INTERPRO[450000707$IPR000814:TATA-box binding, 450011004$IPR012295:Beta2-adaptin/TATA-box binding, C-terminal, 450013887$IPR015445:TATA-Box binding protein-like]
TBP-like 1,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors, 470038894$hsa05016:Huntington's disease]
TBP-like 1,PIR_SUPERFAMILY[630003135$PIRSF003046:TATA-box binding protein]
TBP-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790001065$nucleus]
TBP-like 1,UP_SEQ_FEATURE[850063600$chain:TATA box-binding protein-like protein 1, 850117294$sequence conflict]
TCR gamma alternate reading frame protein; T cell receptor gamma variable 9; T cell receptor gamma constant 1,INTERPRO[450003157$IPR003596:Immunoglobulin V-set, subgroup, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
TCR gamma alternate reading frame protein; T cell receptor gamma variable 9; T cell receptor gamma constant 1,SMART[760000354$SM00406:IGv]
TEA domain family member 3,INTERPRO[450000711$IPR000818:TEA/ATTS, 450014683$IPR016361:Transcriptional enhancer factor]
TEA domain family member 3,PIR_SUPERFAMILY[630002716$PIRSF002603:TEF, 630002717$PIRSF002603:transcriptional enhancer factor, 630030880$PIRSF500720:transcriptional enhancer factor TEF-5 (TEAD3)]
TEA domain family member 3,SMART[760000372$SM00426:TEA]
TEA domain family member 3,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
TEA domain family member 3,UP_SEQ_FEATURE[850065565$chain:Transcriptional enhancer factor TEF-5, 850102586$compositionally biased region:Pro-rich, 850102958$DNA-binding region:TEA, 850114917$region of interest:Transcriptional activation, 850117295$sequence variant]
TEA domain family member 4,INTERPRO[450000711$IPR000818:TEA/ATTS, 450014683$IPR016361:Transcriptional enhancer factor]
TEA domain family member 4,PIR_SUPERFAMILY[630002716$PIRSF002603:TEF, 630002717$PIRSF002603:transcriptional enhancer factor, 630030882$PIRSF500722:transcriptional enhancer factor TEF-3 (TEAD4)]
TEA domain family member 4,SMART[760000372$SM00426:TEA]
TEA domain family member 4,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
TEA domain family member 4,UP_SEQ_FEATURE[850065563$chain:Transcriptional enhancer factor TEF-3, 850102958$DNA-binding region:TEA, 850117294$sequence conflict, 850117295$sequence variant]
TEL2, telomere maintenance 2, homolog (S. cerevisiae),INTERPRO[450017575$IPR019337:Telomere length regulation protein]
TEL2, telomere maintenance 2, homolog (S. cerevisiae),PIR_SUPERFAMILY[630007737$PIRSF008133:human hypothetical protein DKFZp434A073.1]
TEL2, telomere maintenance 2, homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000315$chromosomal protein, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001494$telomere]
TEL2, telomere maintenance 2, homolog (S. cerevisiae),UP_SEQ_FEATURE[850063788$chain:Telomere length regulation protein TEL2 homolog, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
TGFB-induced factor homeobox 1,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
TGFB-induced factor homeobox 1,OMIM_DISEASE[520002361$Holoprosencephaly-4, 520002565$Hypotrichosis simplex, contiguous gene syndrome with]
TGFB-induced factor homeobox 1,SMART[760000341$SM00389:HOX]
TGFB-induced factor homeobox 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790000698$holoprosencephaly, 790000699$Homeobox, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
TGFB-induced factor homeobox 1,UP_SEQ_FEATURE[850024670$chain:Homeobox protein TGIF1, 850102566$compositionally biased region:Poly-Arg, 850102935$DNA-binding region:Homeobox; TALE-type, 850117294$sequence conflict, 850117295$sequence variant, 850117353$short sequence motif:CTBP-binding motif, 850118574$splice variant]
TGFB-induced factor homeobox 2,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
TGFB-induced factor homeobox 2,SMART[760000341$SM00389:HOX]
TGFB-induced factor homeobox 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
TGFB-induced factor homeobox 2,UP_SEQ_FEATURE[850024671$chain:Homeobox protein TGIF2, 850102935$DNA-binding region:Homeobox; TALE-type, 850106258$modified residue, 850106259$mutagenesis site, 850114222$region of interest:Repressive function]
THAP domain containing 10,INTERPRO[450006032$IPR006612:Zinc finger, C2CH-type]
THAP domain containing 10,SMART[760000600$SM00692:DM3]
THAP domain containing 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
THAP domain containing 10,UP_SEQ_FEATURE[850064068$chain:THAP domain-containing protein 10, 850118935$zinc finger region:THAP-type]
THAP domain containing 5,INTERPRO[450006032$IPR006612:Zinc finger, C2CH-type]
THAP domain containing 5,SMART[760000600$SM00692:DM3]
THAP domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001648$zinc, 790001651$zinc-finger]
THAP domain containing 5,UP_SEQ_FEATURE[850064073$chain:THAP domain-containing protein 5, 850118574$splice variant, 850118935$zinc finger region:THAP-type]
TNFAIP3 interacting protein 1,PIR_SUPERFAMILY[630029928$PIRSF038355:Nef-associated factor 1]
TNFAIP3 interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
TNFAIP3 interacting protein 1,UP_SEQ_FEATURE[850064558$chain:TNFAIP3-interacting protein 1, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850113099$region of interest:Interacts with Nef, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,BIOCARTA[30000283$h_tall1Pathway:TACI and BCMA stimulation of B cell immune responses.]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,INTERPRO[450005489$IPR006052:Tumor Necrosis Factor, 450008180$IPR008983:Tumour necrosis factor-like]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038874$hsa04672:Intestinal immune network for IgA production]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,PIR_SUPERFAMILY[630030266$PIRSF038812:tumor necrosis factor ligand superfamily member 13]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,SMART[760000180$SM00207:TNF]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000081$angiogenesis, 790000109$Apoptosis, 790000264$cell membrane, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000402$cytokine, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001409$Signal-anchor, 790001555$transmembrane]
TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13,UP_SEQ_FEATURE[850067174$chain:Tumor necrosis factor ligand superfamily member 12, membrane form, 850067175$chain:Tumor necrosis factor ligand superfamily member 12, secreted form, 850067176$chain:Tumor necrosis factor ligand superfamily member 13, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850117969$site:Cleavage, 850118052$site:Cleavage; by furin, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
TP53 target 1 (non-protein coding),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
TP53 target 1 (non-protein coding),UP_SEQ_FEATURE[850064801$chain:TP53-target gene 1 protein, 850117294$sequence conflict, 850118574$splice variant]
TRAF3 interacting protein 2,INTERPRO[450012192$IPR013568:SEFIR]
TRAF3 interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
TRAF3 interacting protein 2,UP_SEQ_FEATURE[850003830$chain:Adapter protein CIKS, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae),COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae),INTERPRO[450007196$IPR007848:Methyltransferase small]
TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae),PIR_SUPERFAMILY[630006077$PIRSF006150:RNA methyltransferase, RumA/RumB/RumT types, 630030632$PIRSF500403:HpaII tiny fragments locus 9c protein]
TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000954$methyltransferase, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001547$transferase, 790001572$trna processing]
TRM2 tRNA methyltransferase 2 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000532$binding site:S-adenosyl-L-methionine, 850066738$chain:tRNA (uracil-5-)-methyltransferase homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TSC22 domain family, member 3; GRAM domain containing 4,INTERPRO[450000493$IPR000580:TSC-22 / Dip / Bun, 450003692$IPR004182:GRAM]
TSC22 domain family, member 3; GRAM domain containing 4,PIR_SUPERFAMILY[630008527$PIRSF009379:mouse TSC-22 protein]
TSC22 domain family, member 3; GRAM domain containing 4,SMART[760000505$SM00568:GRAM]
TSC22 domain family, member 3; GRAM domain containing 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
TSC22 domain family, member 3; GRAM domain containing 4,UP_SEQ_FEATURE[850022345$chain:GRAM domain-containing protein 4, 850067046$chain:TSC22 domain family protein 3, 850104079$domain:GRAM, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850110939$region of interest:AP1-binding, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
TSPY-like 2,INTERPRO[450001919$IPR002164:Nucleosome assembly protein (NAP)]
TSPY-like 2,SP_PIR_KEYWORDS[790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
TSPY-like 2,UP_SEQ_FEATURE[850063916$chain:Testis-specific Y-encoded-like protein 2, 850102404$compositionally biased region:Arg-rich, 850102448$compositionally biased region:Asn-rich, 850102458$compositionally biased region:Asp-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict]
TSR1, 20S rRNA accumulation, homolog (S. cerevisiae),COG_ONTOLOGY[90000070$Function unknown]
TSR1, 20S rRNA accumulation, homolog (S. cerevisiae),INTERPRO[450006428$IPR007034:Protein of unknown function DUF663, 450011624$IPR012948:AARP2CN]
TSR1, 20S rRNA accumulation, homolog (S. cerevisiae),PIR_SUPERFAMILY[630014060$PIRSF017298:PIRSF017298]
TSR1, 20S rRNA accumulation, homolog (S. cerevisiae),SMART[760000688$SM00785:AARP2CN]
TSR1, 20S rRNA accumulation, homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001331$ribosome biogenesis]
TSR1, 20S rRNA accumulation, homolog (S. cerevisiae),UP_SEQ_FEATURE[850040476$chain:Pre-rRNA-processing protein TSR1 homolog, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
TatD DNase domain containing 1,INTERPRO[450000991$IPR001130:Deoxyribonuclease, TatD-related, 450010991$IPR012278:Deoxyribonuclease, TatD Mg-dependent, 450014394$IPR015992:Deoxyribonuclease, TatD, 450016513$IPR018228:Deoxyribonuclease, TatD-related, conserved site]
TatD DNase domain containing 1,PIR_SUPERFAMILY[630005834$PIRSF005902:DNase_TatD, 630005835$PIRSF005902:Mg-dependent DNase, TatD type]
TatD DNase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus]
TatD DNase domain containing 1,UP_SEQ_FEATURE[850050480$chain:Putative deoxyribonuclease TATDN1, 850117294$sequence conflict, 850118574$splice variant]
TatD DNase domain containing 2,INTERPRO[450000991$IPR001130:Deoxyribonuclease, TatD-related, 450014394$IPR015992:Deoxyribonuclease, TatD, 450016513$IPR018228:Deoxyribonuclease, TatD-related, conserved site]
TatD DNase domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
TatD DNase domain containing 2,UP_SEQ_FEATURE[850050482$chain:Putative deoxyribonuclease TATDN2, 850106258$modified residue, 850117295$sequence variant]
Treacher Collins-Franceschetti syndrome 1,INTERPRO[450003516$IPR003993:Treacher Collins syndrome, treacle, 450006014$IPR006594:LisH dimerisation motif, 450016178$IPR017859:Treacher Collins Syndrome, treacle-like]
Treacher Collins-Franceschetti syndrome 1,OMIM_DISEASE[520004907$Treacher Collins mandibulofacial dysostosis]
Treacher Collins-Franceschetti syndrome 1,SMART[760000580$SM00667:LisH]
Treacher Collins-Franceschetti syndrome 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001558$transport]
Treacher Collins-Franceschetti syndrome 1,UP_SEQ_FEATURE[850066512$chain:Treacle protein, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850104733$domain:LisH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Tu translation elongation factor, mitochondrial,INTERPRO[450000689$IPR000795:Protein synthesis factor, GTP-binding, 450003670$IPR004160:Translation elongation factor EFTu/EF1A, C-terminal, 450003671$IPR004161:Translation elongation factor EFTu/EF1A, domain 2, 450004034$IPR004541:Translation elongation factor EFTu/EF1A, bacterial and organelle]
Tu translation elongation factor, mitochondrial,OMIM_DISEASE[520001119$Combined oxidative phosphorylation deficiency 4]
Tu translation elongation factor, mitochondrial,PIR_SUPERFAMILY[630003095$PIRSF003007:translation elongation factor Tu]
Tu translation elongation factor, mitochondrial,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000491$elongation factor, 790000637$GTP binding, 790000639$gtp-binding, 790000969$mitochondrion, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001255$protein biosynthesis, 790001550$transit peptide]
Tu translation elongation factor, mitochondrial,UP_SEQ_FEATURE[850017130$chain:Elongation factor Tu, mitochondrial, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
UBX domain protein 1,INTERPRO[450000382$IPR000449:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, 450000885$IPR001012:UBX, 450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote]
UBX domain protein 1,PIR_SUPERFAMILY[630014177$PIRSF017426:Caenorhabditis elegans hypothetical protein F23C8.4]
UBX domain protein 1,SMART[760000144$SM00165:UBA, 760000145$SM00166:UBX]
UBX domain protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
UBX domain protein 1,UP_SEQ_FEATURE[850068164$chain:UBX domain-containing protein 1, 850105597$domain:UBA, 850105605$domain:UBX, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
UBX domain protein 2A,INTERPRO[450000885$IPR001012:UBX, 450011665$IPR012989:SEP]
UBX domain protein 2A,SMART[760000145$SM00166:UBX, 760000493$SM00553:SEP]
UBX domain protein 2A,SP_PIR_KEYWORDS[790000356$complete proteome]
UBX domain protein 2A,UP_SEQ_FEATURE[850068170$chain:UBX domain-containing protein 2A, 850105338$domain:SEP, 850105605$domain:UBX]
UDP glucuronosyltransferase 1 family, polypeptide A3; UDP glucuronosyltransferase 1 family, polypeptide A5; UDP glucuronosyltransferase 1 family, polypeptide A4; UDP glucuronosyltransferase 1 family, polypeptide A7; UDP glucuronosyltransferase 1 family, polypeptide A6; UDP glucuronosyltransferase 1 family, polypeptide A10; UDP glucuronosyltransferase 1 family, polypeptide A9; UDP glucuronosyltransferase 1 family, polypeptide A8; UDP glucuronosyltransferase 1 family, polypeptide A1,INTERPRO[450001963$IPR002213:UDP-glucuronosyl/UDP-glucosyltransferase]
UDP glucuronosyltransferase 1 family, polypeptide A3; UDP glucuronosyltransferase 1 family, polypeptide A5; UDP glucuronosyltransferase 1 family, polypeptide A4; UDP glucuronosyltransferase 1 family, polypeptide A7; UDP glucuronosyltransferase 1 family, polypeptide A6; UDP glucuronosyltransferase 1 family, polypeptide A10; UDP glucuronosyltransferase 1 family, polypeptide A9; UDP glucuronosyltransferase 1 family, polypeptide A8; UDP glucuronosyltransferase 1 family, polypeptide A1,KEGG_PATHWAY[470038728$hsa00040:Pentose and glucuronate interconversions, 470038731$hsa00053:Ascorbate and aldarate metabolism, 470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism, 470038765$hsa00500:Starch and sucrose metabolism, 470038801$hsa00830:Retinol metabolism, 470038802$hsa00860:Porphyrin and chlorophyll metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038810$hsa00983:Drug metabolism]
UDP glucuronosyltransferase 1 family, polypeptide A3; UDP glucuronosyltransferase 1 family, polypeptide A5; UDP glucuronosyltransferase 1 family, polypeptide A4; UDP glucuronosyltransferase 1 family, polypeptide A7; UDP glucuronosyltransferase 1 family, polypeptide A6; UDP glucuronosyltransferase 1 family, polypeptide A10; UDP glucuronosyltransferase 1 family, polypeptide A9; UDP glucuronosyltransferase 1 family, polypeptide A8; UDP glucuronosyltransferase 1 family, polypeptide A1,OMIM_DISEASE[520001274$Crigler-Najjar syndrome, type I, 520001275$Crigler-Najjar syndrome, type II, 520002081$Gilbert syndrome, 520002408$Hyperbilirubinemia, familial transcient neonatal]
UDP glucuronosyltransferase 1 family, polypeptide A3; UDP glucuronosyltransferase 1 family, polypeptide A5; UDP glucuronosyltransferase 1 family, polypeptide A4; UDP glucuronosyltransferase 1 family, polypeptide A7; UDP glucuronosyltransferase 1 family, polypeptide A6; UDP glucuronosyltransferase 1 family, polypeptide A10; UDP glucuronosyltransferase 1 family, polypeptide A9; UDP glucuronosyltransferase 1 family, polypeptide A8; UDP glucuronosyltransferase 1 family, polypeptide A1,PIR_SUPERFAMILY[630005607$PIRSF005678:glucuronosyltransferase]
UDP glucuronosyltransferase 1 family, polypeptide A3; UDP glucuronosyltransferase 1 family, polypeptide A5; UDP glucuronosyltransferase 1 family, polypeptide A4; UDP glucuronosyltransferase 1 family, polypeptide A7; UDP glucuronosyltransferase 1 family, polypeptide A6; UDP glucuronosyltransferase 1 family, polypeptide A10; UDP glucuronosyltransferase 1 family, polypeptide A9; UDP glucuronosyltransferase 1 family, polypeptide A8; UDP glucuronosyltransferase 1 family, polypeptide A1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000691$hexosyltransferase, 790000919$membrane, 790000959$microsome, 790001212$polymorphism, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
UDP glucuronosyltransferase 1 family, polypeptide A3; UDP glucuronosyltransferase 1 family, polypeptide A5; UDP glucuronosyltransferase 1 family, polypeptide A4; UDP glucuronosyltransferase 1 family, polypeptide A7; UDP glucuronosyltransferase 1 family, polypeptide A6; UDP glucuronosyltransferase 1 family, polypeptide A10; UDP glucuronosyltransferase 1 family, polypeptide A9; UDP glucuronosyltransferase 1 family, polypeptide A8; UDP glucuronosyltransferase 1 family, polypeptide A1,UP_SEQ_FEATURE[850068229$chain:UDP-glucuronosyltransferase 1-1, 850068230$chain:UDP-glucuronosyltransferase 1-10, 850068232$chain:UDP-glucuronosyltransferase 1-3, 850068233$chain:UDP-glucuronosyltransferase 1-4, 850068234$chain:UDP-glucuronosyltransferase 1-5, 850068235$chain:UDP-glucuronosyltransferase 1-6, 850068236$chain:UDP-glucuronosyltransferase 1-7, 850068238$chain:UDP-glucuronosyltransferase 1-8, 850068239$chain:UDP-glucuronosyltransferase 1-9, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5,INTERPRO[450003390$IPR003859:Metazoa galactosyltransferase]
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5,KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5,PIR_SUPERFAMILY[630013377$PIRSF016591:beta-1,4-galactosyltransferase, B4GalT1-6 types, 630031039$PIRSF500893:beta-1,4-galactosyltransferase 5]
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000906$manganese, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5,UP_SEQ_FEATURE[850007553$chain:Beta-1,4-galactosyltransferase 5, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106173$metal ion-binding site:Manganese, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2,INTERPRO[450002359$IPR002659:Glycosyl transferase, family 31]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2,KEGG_PATHWAY[470038773$hsa00533:Keratan sulfate biosynthesis, 470038784$hsa00601:Glycosphingolipid biosynthesis]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2,UP_SEQ_FEATURE[850033198$chain:N-acetyllactosaminide beta-1,3-N- acetylglucosaminyltransferase, 850068196$chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7,INTERPRO[450002359$IPR002659:Glycosyl transferase, family 31]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7,KEGG_PATHWAY[470038773$hsa00533:Keratan sulfate biosynthesis]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7,UP_SEQ_FEATURE[850068203$chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11),INTERPRO[450000667$IPR000772:Ricin B lectin, 450001029$IPR001173:Glycosyl transferase, family 2]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11),KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11),SMART[760000403$SM00458:RICIN]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000848$Lectin, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11),UP_SEQ_FEATURE[850039921$chain:Polypeptide N- acetylgalactosaminyltransferase 11, 850102883$disulfide bond, 850105188$domain:Ricin B-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850111204$region of interest:Catalytic subdomain A, 850111205$region of interest:Catalytic subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1,INTERPRO[450002323$IPR002618:UTP--glucose-1-phosphate uridylyltransferase]
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001064$nucleotidyltransferase, 790001212$polymorphism, 790001547$transferase]
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850068288$chain:UDP-N-acetylhexosamine pyrophosphorylase- like protein 1, 850117295$sequence variant, 850117731$short sequence motif:Substrate binding, 850118574$splice variant]
UHRF1 binding protein 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
UHRF1 binding protein 1,UP_SEQ_FEATURE[850068315$chain:UHRF1-binding protein 1, 850106258$modified residue, 850117295$sequence variant]
UL16 binding protein 2,INTERPRO[450000912$IPR001039:MHC class I, alpha chain, alpha1 and alpha2, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450010088$IPR011161:MHC class I-like antigen recognition]
UL16 binding protein 2,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
UL16 binding protein 2,PIR_SUPERFAMILY[630029379$PIRSF037807:retinoic acid early inducible protein 1]
UL16 binding protein 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal]
UL16 binding protein 2,UP_SEQ_FEATURE[850034460$chain:NKG2D ligand 2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105861$lipid moiety-binding region:GPI-anchor amidated serine, 850106259$mutagenesis site, 850109701$propeptide:Removed in mature form, 850113443$region of interest:MHC class I alpha-1 like, 850113444$region of interest:MHC class I alpha-2 like, 850117814$signal peptide]
UTP6, small subunit (SSU) processome component, homolog (yeast),COG_ONTOLOGY[90000073$General function prediction only]
UTP6, small subunit (SSU) processome component, homolog (yeast),INTERPRO[450002731$IPR003107:RNA-processing protein, HAT helix, 450012543$IPR013949:U3 small nucleolar RNA-associated protein 6]
UTP6, small subunit (SSU) processome component, homolog (yeast),SMART[760000338$SM00386:HAT]
UTP6, small subunit (SSU) processome component, homolog (yeast),SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001345$rrna processing]
UTP6, small subunit (SSU) processome component, homolog (yeast),UP_SEQ_FEATURE[850067846$chain:U3 small nucleolar RNA-associated protein 6 homolog, 850116114$repeat:HAT 1, 850116123$repeat:HAT 2, 850116124$repeat:HAT 3, 850116125$repeat:HAT 4, 850116126$repeat:HAT 5, 850117295$sequence variant]
UV radiation resistance associated gene,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting]
UV radiation resistance associated gene,SMART[760000211$SM00239:C2]
UV radiation resistance associated gene,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
UV radiation resistance associated gene,UP_SEQ_FEATURE[850099710$chain:UV radiation resistance-associated gene protein, 850103199$domain:C2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
Usher syndrome 1C binding protein 1,INTERPRO[450017773$IPR019536:Usher syndrome type-1C protein-binding protein 1, PDZ domain]
Usher syndrome 1C binding protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
Usher syndrome 1C binding protein 1,UP_SEQ_FEATURE[850099688$chain:Usher syndrome type-1C protein-binding protein 1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
V-set and immunoglobulin domain containing 4,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
V-set and immunoglobulin domain containing 4,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
V-set and immunoglobulin domain containing 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000352$complement alternate pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000763$immune response, 790000768$Immunoglobulin domain, 790000777$innate immunity, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
V-set and immunoglobulin domain containing 4,UP_SEQ_FEATURE[850099733$chain:V-set and immunoglobulin domain- containing protein 4, 850102883$disulfide bond, 850104200$domain:Ig-like 1, 850104264$domain:Ig-like 2, 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
V-set and transmembrane domain containing 2B,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
V-set and transmembrane domain containing 2B,SMART[760000357$SM00409:IG]
V-set and transmembrane domain containing 2B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000768$Immunoglobulin domain, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
V-set and transmembrane domain containing 2B,UP_SEQ_FEATURE[850099738$chain:V-set and transmembrane domain-containing protein 2B, 850102883$disulfide bond, 850104407$domain:Ig-like V-type, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,INTERPRO[450000458$IPR000535:Major sperm protein, 450008175$IPR008962:PapD-like, 450015083$IPR016763:Vesicle-associated membrane protein]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,KEGG_PATHWAY[470038857$hsa04530:Tight junction]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,PIR_SUPERFAMILY[630016271$PIRSF019693:VAMP-associated]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,UP_SEQ_FEATURE[850100248$chain:Vesicle-associated membrane protein- associated protein A, 850104795$domain:MSP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
Vpr (HIV-1) binding protein,INTERPRO[450006014$IPR006594:LisH dimerisation motif, 450012341$IPR013720:LisH dimerisation motif, subgroup]
Vpr (HIV-1) binding protein,SMART[760000580$SM00667:LisH]
Vpr (HIV-1) binding protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000811$isopeptide bond, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
Vpr (HIV-1) binding protein,UP_SEQ_FEATURE[850048385$chain:Protein VPRBP, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850104733$domain:LisH, 850106258$modified residue, 850115056$region of interest:WD repeat-like region, 850117295$sequence variant, 850118574$splice variant]
WAP four-disulfide core domain 11,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
WAP four-disulfide core domain 11,UP_SEQ_FEATURE[850048398$chain:Protein WFDC11, 850117814$signal peptide]
WD repeat domain 18,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 18,SMART[760000289$SM00320:WD40]
WD repeat domain 18,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 18,UP_SEQ_FEATURE[850100727$chain:WD repeat-containing protein 18, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117294$sequence conflict, 850117295$sequence variant]
WD repeat domain 25,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 25,SMART[760000289$SM00320:WD40]
WD repeat domain 25,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 25,UP_SEQ_FEATURE[850100731$chain:WD repeat-containing protein 25, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
WD repeat domain 31,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 31,SMART[760000289$SM00320:WD40]
WD repeat domain 31,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 31,UP_SEQ_FEATURE[850100736$chain:WD repeat-containing protein 31, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117295$sequence variant, 850118574$splice variant]
WD repeat domain 33,INTERPRO[450001490$IPR001680:WD40 repeat, 450007490$IPR008160:Collagen triple helix repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 33,SMART[760000289$SM00320:WD40]
WD repeat domain 33,SP_PIR_KEYWORDS[790000012$acetylation, 790000345$collagen, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 33,UP_SEQ_FEATURE[850100737$chain:WD repeat-containing protein 33, 850103389$domain:Collagen-like, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850117295$sequence variant]
WD repeat domain 40A,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 40A,SMART[760000289$SM00320:WD40]
WD repeat domain 40A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway, 790001638$wd repeat]
WD repeat domain 40A,UP_SEQ_FEATURE[850014333$chain:DDB1- and CUL4-associated factor 12, 850106259$mutagenesis site, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117294$sequence conflict, 850117295$sequence variant]
WD repeat domain 43,INTERPRO[450001490$IPR001680:WD40 repeat, 450011655$IPR012979:Protein of unknown function NUC189, C-terminal, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 43,SMART[760000289$SM00320:WD40]
WD repeat domain 43,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 43,UP_SEQ_FEATURE[850100744$chain:WD repeat-containing protein 43, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6]
WD repeat domain 51B,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 51B,SMART[760000289$SM00320:WD40]
WD repeat domain 51B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 51B,UP_SEQ_FEATURE[850100753$chain:WD repeat-containing protein 51B, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7]
WD repeat domain 6,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 6,SMART[760000289$SM00320:WD40]
WD repeat domain 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000924$membrane protein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 6,UP_SEQ_FEATURE[850100762$chain:WD repeat-containing protein 6, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9]
WD repeat domain 74,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup]
WD repeat domain 74,SMART[760000289$SM00320:WD40]
WD repeat domain 74,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 74,UP_SEQ_FEATURE[850100776$chain:WD repeat-containing protein 74, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117294$sequence conflict, 850118574$splice variant]
WD repeat domain 77,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 77,SMART[760000289$SM00320:WD40]
WD repeat domain 77,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 77,UP_SEQ_FEATURE[850031543$chain:Methylosome protein 50, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant]
WD repeat domain 81,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 81,SMART[760000289$SM00320:WD40]
WD repeat domain 81,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 81,UP_SEQ_FEATURE[850100781$chain:WD repeat-containing protein 81, 850102507$compositionally biased region:Glu-rich, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
WD repeat domain 86,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450016671$IPR018391:Pyrrolo-quinoline quinone beta-propeller repeat, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 86,SMART[760000289$SM00320:WD40, 760000503$SM00564:PQQ]
WD repeat domain 86,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 86,UP_SEQ_FEATURE[850100786$chain:WD repeat-containing protein 86, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117295$sequence variant, 850118574$splice variant]
WD repeat domain, phosphoinositide interacting 2,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450018010$IPR019775:WD40 repeat, conserved site]
WD repeat domain, phosphoinositide interacting 2,SMART[760000289$SM00320:WD40]
WD repeat domain, phosphoinositide interacting 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain, phosphoinositide interacting 2,UP_SEQ_FEATURE[850100717$chain:WD repeat domain phosphoinositide- interacting protein 2, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117294$sequence conflict, 850118574$splice variant]
WDYHV motif containing 1,INTERPRO[450017407$IPR019161:Protein of unknown function WDYHV]
WDYHV motif containing 1,PIR_SUPERFAMILY[630011380$PIRSF013964:Caenorhabditis elegans hypothetical protein R06C7.6]
WDYHV motif containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001212$polymorphism]
WDYHV motif containing 1,UP_SEQ_FEATURE[850046977$chain:Protein N-terminal glutamine amidohydrolase, 850105852$helix, 850117295$sequence variant, 850118575$strand]
WNK lysine deficient protein kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
WNK lysine deficient protein kinase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
WNK lysine deficient protein kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850060063$chain:Serine/threonine-protein kinase WNK2, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant]
WNT1 inducible signaling pathway protein 1,INTERPRO[450000756$IPR000867:Insulin-like growth factor-binding protein, IGFBP, 450000771$IPR000884:Thrombospondin, type 1 repeat, 450000878$IPR001007:von Willebrand factor, type C, 450005633$IPR006207:Cystine knot, C-terminal, 450005634$IPR006208:Cystine knot, 450011083$IPR012395:IGFBP-related, CNN, 450016206$IPR017891:Insulin-like growth factor binding protein, N-terminal]
WNT1 inducible signaling pathway protein 1,PIR_SUPERFAMILY[630027950$PIRSF036495:IGFBP-related protein, CNN type, 630027951$PIRSF036495:IGFBP_rP_CNN]
WNT1 inducible signaling pathway protein 1,SMART[760000033$SM00041:CT, 760000106$SM00121:IB, 760000182$SM00209:TSP1, 760000187$SM00214:VWC]
WNT1 inducible signaling pathway protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001363$Secreted, 790001405$signal, 790001642$wnt signaling pathway]
WNT1 inducible signaling pathway protein 1,UP_SEQ_FEATURE[850100909$chain:WNT1-inducible-signaling pathway protein 1, 850102883$disulfide bond, 850103430$domain:CTCK, 850104416$domain:IGFBP N-terminal, 850105554$domain:TSP type-1, 850105643$domain:VWFC, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
WW domain containing E3 ubiquitin protein ligase 2,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000485$IPR000569:HECT, 450001055$IPR001202:WW/Rsp5/WWP]
WW domain containing E3 ubiquitin protein ligase 2,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
WW domain containing E3 ubiquitin protein ligase 2,SMART[760000104$SM00119:HECTc, 760000211$SM00239:C2, 760000401$SM00456:WW]
WW domain containing E3 ubiquitin protein ligase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000733$host-virus interaction, 790000859$ligase, 790001162$phosphoprotein, 790001304$repeat, 790001593$ubl conjugation pathway]
WW domain containing E3 ubiquitin protein ligase 2,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850033802$chain:NEDD4-like E3 ubiquitin-protein ligase WWP2, 850103199$domain:C2, 850104105$domain:HECT, 850105732$domain:WW 1, 850105733$domain:WW 2, 850105734$domain:WW 3, 850105735$domain:WW 4, 850106258$modified residue, 850117294$sequence conflict]
Williams Beuren syndrome chromosome region 27,INTERPRO[450011853$IPR013216:Methyltransferase type 11]
Williams Beuren syndrome chromosome region 27,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001640$williams-beuren syndrome]
Williams Beuren syndrome chromosome region 27,UP_SEQ_FEATURE[850100889$chain:Williams-Beuren syndrome chromosomal region 27 protein, 850117295$sequence variant]
Wolf-Hirschhorn syndrome candidate 1,INTERPRO[450000267$IPR000313:PWWP, 450000793$IPR000910:High mobility group, HMG1/HMG2, 450001068$IPR001214:SET, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450003176$IPR003616:Post-SET zinc-binding region, 450005980$IPR006560:AWS, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
Wolf-Hirschhorn syndrome candidate 1,KEGG_PATHWAY[470038751$hsa00310:Lysine degradation]
Wolf-Hirschhorn syndrome candidate 1,OMIM_DISEASE[520005107$Wolf-Hirschhorn syndrome]
Wolf-Hirschhorn syndrome candidate 1,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000264$SM00293:PWWP, 760000286$SM00317:SET, 760000349$SM00398:HMG, 760000451$SM00508:PostSET, 760000507$SM00570:AWS]
Wolf-Hirschhorn syndrome candidate 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000937$metal-binding, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
Wolf-Hirschhorn syndrome candidate 1,UP_SEQ_FEATURE[850042344$chain:Probable histone-lysine N- methyltransferase NSD2, 850102920$DNA-binding region:HMG box, 850103074$domain:AWS, 850105053$domain:Post-SET, 850105127$domain:PWWP 1, 850105128$domain:PWWP 2, 850105340$domain:SET, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2, 850118883$zinc finger region:PHD-type 3, 850118885$zinc finger region:PHD-type 4; atypical]
Wolf-Hirschhorn syndrome candidate 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
Wolf-Hirschhorn syndrome candidate 2,UP_SEQ_FEATURE[850033821$chain:Negative elongation factor A, 850104104$domain:HDAg-like, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
X-ray repair complementing defective repair in Chinese hamster cells 1,INTERPRO[450001201$IPR001357:BRCT, 450002401$IPR002706:DNA-repair protein Xrcc1, N-terminal]
X-ray repair complementing defective repair in Chinese hamster cells 1,KEGG_PATHWAY[470038822$hsa03410:Base excision repair]
X-ray repair complementing defective repair in Chinese hamster cells 1,PIR_SUPERFAMILY[630016186$PIRSF019598:DNA-repair protein XRCC1]
X-ray repair complementing defective repair in Chinese hamster cells 1,SMART[760000263$SM00292:BRCT]
X-ray repair complementing defective repair in Chinese hamster cells 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
X-ray repair complementing defective repair in Chinese hamster cells 1,UP_SEQ_FEATURE[850015788$chain:DNA repair protein XRCC1, 850103154$domain:BRCT 1, 850103155$domain:BRCT 2, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
X-ray repair complementing defective repair in Chinese hamster cells 2,INTERPRO[450001379$IPR001553:RecA bacterial DNA recombination]
X-ray repair complementing defective repair in Chinese hamster cells 2,KEGG_PATHWAY[470038825$hsa03440:Homologous recombination]
X-ray repair complementing defective repair in Chinese hamster cells 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
X-ray repair complementing defective repair in Chinese hamster cells 2,UP_SEQ_FEATURE[850015789$chain:DNA repair protein XRCC2, 850106258$modified residue, 850117295$sequence variant]
XK, Kell blood group complex subunit-related, X-linked,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
XK, Kell blood group complex subunit-related, X-linked,UP_SEQ_FEATURE[850101015$chain:XK-related protein 2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
XPA binding protein 2,INTERPRO[450002731$IPR003107:RNA-processing protein, HAT helix, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
XPA binding protein 2,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
XPA binding protein 2,SMART[760000020$SM00028:TPR, 760000338$SM00386:HAT]
XPA binding protein 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001433$Spliceosome, 790001539$Transcription]
XPA binding protein 2,UP_SEQ_FEATURE[850040454$chain:Pre-mRNA-splicing factor syf1, 850106258$modified residue, 850116114$repeat:HAT 1, 850116115$repeat:HAT 10, 850116116$repeat:HAT 11, 850116117$repeat:HAT 12, 850116118$repeat:HAT 13, 850116119$repeat:HAT 14, 850116123$repeat:HAT 2, 850116124$repeat:HAT 3, 850116125$repeat:HAT 4, 850116126$repeat:HAT 5, 850116127$repeat:HAT 6, 850116128$repeat:HAT 7, 850116129$repeat:HAT 8, 850116130$repeat:HAT 9, 850117294$sequence conflict, 850117295$sequence variant]
abhydrolase domain containing 14B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus]
abhydrolase domain containing 14B,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850003156$chain:Abhydrolase domain-containing protein 14B, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand]
abl-interactor 1,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000626$IPR000727:Target SNARE coiled-coil region, 450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
abl-interactor 1,SMART[760000295$SM00326:SH3, 760000348$SM00397:t_SNARE]
abl-interactor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000263$cell junction, 790000267$cell projection, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001475$synapse, 790001477$Synaptosome]
abl-interactor 1,UP_SEQ_FEATURE[850003175$chain:Abl interactor 1, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850114260$region of interest:Required for binding to WASF1, 850117294$sequence conflict, 850117295$sequence variant, 850117890$site:Breakpoint for translocation to form MLL- ABI1, 850118574$splice variant]
acetylserotonin O-methyltransferase-like,INTERPRO[450000943$IPR001077:O-methyltransferase, family 2, 450003241$IPR003697:Maf-like protein]
acetylserotonin O-methyltransferase-like,PIR_SUPERFAMILY[630006240$PIRSF006305:Maf]
acetylserotonin O-methyltransferase-like,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
acetylserotonin O-methyltransferase-like,UP_SEQ_FEATURE[850033226$chain:N-acetylserotonin O-methyltransferase- like protein, 850105852$helix, 850106258$modified residue, 850110953$region of interest:ASMT-like, 850113317$region of interest:MAF-like, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
acid phosphatase, prostate,INTERPRO[450000480$IPR000560:Histidine acid phosphatase]
acid phosphatase, prostate,KEGG_PATHWAY[470038794$hsa00740:Riboflavin metabolism]
acid phosphatase, prostate,PIR_SUPERFAMILY[630001035$PIRSF000896:acid phosphatase]
acid phosphatase, prostate,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790000919$membrane, 790001151$phosphohistidine, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
acid phosphatase, prostate,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850044742$chain:Prostatic acid phosphatase, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
acid phosphatase, testicular,INTERPRO[450000480$IPR000560:Histidine acid phosphatase]
acid phosphatase, testicular,KEGG_PATHWAY[470038794$hsa00740:Riboflavin metabolism]
acid phosphatase, testicular,PIR_SUPERFAMILY[630001035$PIRSF000896:acid phosphatase]
acid phosphatase, testicular,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
acid phosphatase, testicular,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850063862$chain:Testicular acid phosphatase, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
actin-like 9,INTERPRO[450003522$IPR004000:Actin/actin-like]
actin-like 9,SMART[760000240$SM00268:ACTIN]
actin-like 9,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
actin-like 9,UP_SEQ_FEATURE[850003610$chain:Actin-like protein 9, 850117294$sequence conflict, 850117295$sequence variant]
activin A receptor, type IIB,INTERPRO[450000286$IPR000333:Activin type II receptor, 450000401$IPR000472:TGF-beta receptor/activin receptor, type I/II, 450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014202$IPR015768:Activin type II receptor, C-terminal, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
activin A receptor, type IIB,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038850$hsa04350:TGF-beta signaling pathway]
activin A receptor, type IIB,OMIM_DISEASE[520002317$Heterotaxy, visceral, 4, autosomal, 520002803$Left-right axis malformations]
activin A receptor, type IIB,PIR_SUPERFAMILY[630000737$PIRSF000627:type II serine/threonine-protein kinase receptor, Activin/BMP types, 630030675$PIRSF500456:Activin receptor, type IIB]
activin A receptor, type IIB,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000685$heterotaxy, 790000825$kinase, 790000899$magnesium, 790000906$manganese, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001212$polymorphism, 790001301$receptor, 790001388$serine/threonine-protein kinase, 790001405$signal, 790001547$transferase, 790001555$transmembrane]
activin A receptor, type IIB,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850003684$chain:Activin receptor type-2B, 850102883$disulfide bond, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
activity-regulated cytoskeleton-associated protein,PIR_SUPERFAMILY[630010124$PIRSF011879:rat growth factor Arg3.1]
activity-regulated cytoskeleton-associated protein,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000410$cytoskeleton, 790000428$developmental protein, 790000496$Endocytosis, 790000501$endosome, 790000919$membrane, 790001223$postsynaptic cell membrane, 790001475$synapse]
activity-regulated cytoskeleton-associated protein,UP_SEQ_FEATURE[850003686$chain:Activity-regulated cytoskeleton- associated protein, 850111082$region of interest:Binds SH3GL1 or SH3GL3, 850114249$region of interest:Required for binding DNM2]
acyl-CoA synthetase family member 3,COG_ONTOLOGY[90000086$Lipid metabolism / Secondary metabolites biosynthesis, transport, and catabolism]
acyl-CoA synthetase family member 3,INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase]
acyl-CoA synthetase family member 3,PIR_SUPERFAMILY[630001720$PIRSF001552:4-coumarate-CoA ligase]
acyl-CoA synthetase family member 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000543$fatty acid metabolism, 790000859$ligase, 790000873$lipid metabolism, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism, 790001550$transit peptide]
acyl-CoA synthetase family member 3,UP_SEQ_FEATURE[850000242$binding site:ATP, 850003718$chain:Acyl-CoA synthetase family member 3, mitochondrial, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
acyl-CoA synthetase medium-chain family member 3,COG_ONTOLOGY[90000084$Lipid metabolism]
acyl-CoA synthetase medium-chain family member 3,INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase]
acyl-CoA synthetase medium-chain family member 3,KEGG_PATHWAY[470038790$hsa00650:Butanoate metabolism]
acyl-CoA synthetase medium-chain family member 3,OMIM_DISEASE[520000029$?Hypertension, essential]
acyl-CoA synthetase medium-chain family member 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000543$fatty acid metabolism, 790000859$ligase, 790000873$lipid metabolism, 790000899$magnesium, 790000937$metal-binding, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide]
acyl-CoA synthetase medium-chain family member 3,UP_SEQ_FEATURE[850000242$binding site:ATP, 850003761$chain:Acyl-coenzyme A synthetase ACSM3, mitochondrial, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
acyl-CoA synthetase medium-chain family member 4,COG_ONTOLOGY[90000084$Lipid metabolism]
acyl-CoA synthetase medium-chain family member 4,INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase]
acyl-CoA synthetase medium-chain family member 4,KEGG_PATHWAY[470038790$hsa00650:Butanoate metabolism]
acyl-CoA synthetase medium-chain family member 4,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000543$fatty acid metabolism, 790000859$ligase, 790000873$lipid metabolism, 790000899$magnesium, 790000937$metal-binding, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide]
acyl-CoA synthetase medium-chain family member 4,UP_SEQ_FEATURE[850000242$binding site:ATP, 850003762$chain:Acyl-coenzyme A synthetase ACSM4, mitochondrial, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
acyl-CoA synthetase short-chain family member 1,INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase, 450010730$IPR011904:Acetate--CoA ligase]
acyl-CoA synthetase short-chain family member 1,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038787$hsa00620:Pyruvate metabolism, 470038789$hsa00640:Propanoate metabolism]
acyl-CoA synthetase short-chain family member 1,PIR_SUPERFAMILY[630001720$PIRSF001552:4-coumarate-CoA ligase]
acyl-CoA synthetase short-chain family member 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000859$ligase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism, 790001550$transit peptide]
acyl-CoA synthetase short-chain family member 1,UP_SEQ_FEATURE[850003329$chain:Acetyl-coenzyme A synthetase 2-like, mitochondrial, 850102565$compositionally biased region:Poly-Ala, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
acyl-CoA synthetase short-chain family member 2,BIOCARTA[30000069$h_cptPathway:Mitochondrial Carnitine Palmitoyltransferase (CPT) System]
acyl-CoA synthetase short-chain family member 2,INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase, 450010730$IPR011904:Acetate--CoA ligase]
acyl-CoA synthetase short-chain family member 2,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038787$hsa00620:Pyruvate metabolism, 470038789$hsa00640:Propanoate metabolism]
acyl-CoA synthetase short-chain family member 2,PIR_SUPERFAMILY[630001720$PIRSF001552:4-coumarate-CoA ligase]
acyl-CoA synthetase short-chain family member 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790001063$nucleotide-binding, 790001162$phosphoprotein]
acyl-CoA synthetase short-chain family member 2,UP_SEQ_FEATURE[850003330$chain:Acetyl-coenzyme A synthetase, cytoplasmic, 850106258$modified residue, 850117294$sequence conflict]
acyl-CoA thioesterase 4; similar to peroxisomal long-chain acyl-coA thioesterase,INTERPRO[450006263$IPR006862:Acyl-CoA thioester hydrolase/bile acid-CoA amino acid N-acetyltransferase, 450013389$IPR014940:BAAT/Acyl-CoA thioester hydrolase C-terminal, 450014983$IPR016662:Acyl-CoA thioesterase, long chain]
acyl-CoA thioesterase 4; similar to peroxisomal long-chain acyl-coA thioesterase,KEGG_PATHWAY[470038811$hsa01040:Biosynthesis of unsaturated fatty acids]
acyl-CoA thioesterase 4; similar to peroxisomal long-chain acyl-coA thioesterase,PIR_SUPERFAMILY[630013298$PIRSF016521:acyl-CoA thioesterase (hydrolase), 630013299$PIRSF016521:Acyl-CoA_hydro]
acyl-CoA thioesterase 4; similar to peroxisomal long-chain acyl-coA thioesterase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000743$hydrolase, 790001128$peroxisome, 790001212$polymorphism, 790001382$serine esterase]
acyl-CoA thioesterase 4; similar to peroxisomal long-chain acyl-coA thioesterase,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850003772$chain:Acyl-coenzyme A thioesterase 4, 850117294$sequence conflict, 850117295$sequence variant, 850117578$short sequence motif:Microbody targeting signal]
acyl-CoA wax alcohol acyltransferase 1,INTERPRO[450006503$IPR007130:Diacylglycerol acyltransferase]
acyl-CoA wax alcohol acyltransferase 1,PIR_SUPERFAMILY[630012776$PIRSF016000:2-acylglycerol O-acyltransferase 1]
acyl-CoA wax alcohol acyltransferase 1,SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000873$lipid metabolism, 790000874$lipid synthesis, 790000919$membrane, 790001547$transferase, 790001555$transmembrane]
acyl-CoA wax alcohol acyltransferase 1,UP_SEQ_FEATURE[850003726$chain:Acyl-CoA wax alcohol acyltransferase 1, 850118623$transmembrane region]
acyl-Coenzyme A oxidase 1, palmitoyl,BIOCARTA[30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)]
acyl-Coenzyme A oxidase 1, palmitoyl,INTERPRO[450001257$IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site, 450002355$IPR002655:Acyl-CoA oxidase, C-terminal, 450005525$IPR006091:Acyl-CoA oxidase/dehydrogenase, central region, 450010980$IPR012258:Acyl-CoA oxidase, 450012383$IPR013764:Acyl-CoA oxidase/dehydrogenase, type1/2, C-terminal, 450012398$IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal]
acyl-Coenzyme A oxidase 1, palmitoyl,KEGG_PATHWAY[470038734$hsa00071:Fatty acid metabolism, 470038782$hsa00592:alpha-Linolenic acid metabolism, 470038811$hsa01040:Biosynthesis of unsaturated fatty acids, 470038821$hsa03320:PPAR signaling pathway]
acyl-Coenzyme A oxidase 1, palmitoyl,OMIM_DISEASE[520003961$Peroxisomal acyl-CoA oxidase deficiency]
acyl-Coenzyme A oxidase 1, palmitoyl,PIR_SUPERFAMILY[630000202$PIRSF000168:acyl-CoA oxidase, 630000203$PIRSF000168:Acyl-CoA_oxidase]
acyl-Coenzyme A oxidase 1, palmitoyl,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000541$fatty acid beta-oxidation, 790000543$fatty acid metabolism, 790000559$Flavoprotein, 790000873$lipid metabolism, 790001092$oxidoreductase, 790001128$peroxisome, 790001162$phosphoprotein, 790001212$polymorphism]
acyl-Coenzyme A oxidase 1, palmitoyl,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000341$binding site:FAD, 850000343$binding site:FAD; via amide nitrogen, 850037915$chain:Peroxisomal acyl-coenzyme A oxidase 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117578$short sequence motif:Microbody targeting signal, 850118574$splice variant]
acyloxyacyl hydrolase (neutrophil),INTERPRO[450000952$IPR001087:Lipase, GDSL, 450007472$IPR008138:Saposin-like type B, 2, 450007473$IPR008139:Saposin B, 450007558$IPR008265:Lipase, GDSL, active site, 450010000$IPR011001:Saposin-like]
acyloxyacyl hydrolase (neutrophil),PIR_SUPERFAMILY[630001014$PIRSF000878:acyloxyacyl hydrolase]
acyloxyacyl hydrolase (neutrophil),SMART[760000647$SM00741:SapB]
acyloxyacyl hydrolase (neutrophil),SP_PIR_KEYWORDS[790000241$carboxylic ester hydrolase, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000855$leukocyte, 790001212$polymorphism, 790001405$signal, 790001652$zymogen]
acyloxyacyl hydrolase (neutrophil),UP_SEQ_FEATURE[850003799$chain:Acyloxyacyl hydrolase large subunit, 850003800$chain:Acyloxyacyl hydrolase small subunit, 850102883$disulfide bond, 850105263$domain:Saposin B-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
acylphosphatase 2, muscle type,INTERPRO[450001585$IPR001792:Acylphosphatase, 450001586$IPR001792:Acylphosphatase-like, 450016276$IPR017968:Acylphosphatase, conserved site]
acylphosphatase 2, muscle type,KEGG_PATHWAY[470038787$hsa00620:Pyruvate metabolism]
acylphosphatase 2, muscle type,PIR_SUPERFAMILY[630001412$PIRSF001266:acylphosphatase]
acylphosphatase 2, muscle type,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase]
acylphosphatase 2, muscle type,UP_SEQ_FEATURE[850003804$chain:Acylphosphatase-2, 850103019$domain:Acylphosphatase-like, 850106258$modified residue]
adaptor-related protein complex 1, gamma 1 subunit,INTERPRO[450002270$IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal, 450007483$IPR008152:Clathrin adaptor, alpha/beta/gamma-adaptin, appendage, Ig-like subdomain, 450007484$IPR008153:Clathrin adaptor, gamma-adaptin, appendage, 450010814$IPR011989:Armadillo-like helical, 450015427$IPR017107:Adaptor protein complex AP-1, gamma subunit]
adaptor-related protein complex 1, gamma 1 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 1, gamma 1 subunit,PIR_SUPERFAMILY[630028597$PIRSF037094:adaptor protein complex AP-1, gamma subunit, 630028598$PIRSF037094:AP1_complex_gamma]
adaptor-related protein complex 1, gamma 1 subunit,SMART[760000711$SM00809:Alpha_adaptinC2]
adaptor-related protein complex 1, gamma 1 subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000496$Endocytosis, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 1, gamma 1 subunit,UP_SEQ_FEATURE[850005699$chain:AP-1 complex subunit gamma-1, 850104033$domain:GAE, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
adaptor-related protein complex 1, mu 1 subunit,INTERPRO[450001237$IPR001392:Clathrin adaptor, mu subunit, 450008176$IPR008968:Clathrin adaptor, mu subunit, C-terminal, 450016525$IPR018240:Clathrin adaptor, mu subunit, conserved site]
adaptor-related protein complex 1, mu 1 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 1, mu 1 subunit,PIR_SUPERFAMILY[630005930$PIRSF005992:adaptor protein complex, mu subunit, 630005931$PIRSF005992:Clathrin_mu]
adaptor-related protein complex 1, mu 1 subunit,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 1, mu 1 subunit,UP_SEQ_FEATURE[850005702$chain:AP-1 complex subunit mu-1, 850104767$domain:MHD, 850106258$modified residue, 850117295$sequence variant]
adaptor-related protein complex 2, sigma 1 subunit,INTERPRO[450000697$IPR000804:Clathrin adaptor, sigma subunit/coatomer, zeta subunit, 450014956$IPR016635:Adaptor protein complex, sigma subunit]
adaptor-related protein complex 2, sigma 1 subunit,KEGG_PATHWAY[470038841$hsa04144:Endocytosis, 470038894$hsa05016:Huntington's disease]
adaptor-related protein complex 2, sigma 1 subunit,PIR_SUPERFAMILY[630012338$PIRSF015588:adaptor protein complex, sigma subunit, 630012339$PIRSF015588:AP_complex_sigma]
adaptor-related protein complex 2, sigma 1 subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000334$coated pit, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 2, sigma 1 subunit,UP_SEQ_FEATURE[850005726$chain:AP-2 complex subunit sigma, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
adaptor-related protein complex 3, mu 2 subunit,INTERPRO[450000697$IPR000804:Clathrin adaptor, sigma subunit/coatomer, zeta subunit, 450001237$IPR001392:Clathrin adaptor, mu subunit, 450008176$IPR008968:Clathrin adaptor, mu subunit, C-terminal, 450016525$IPR018240:Clathrin adaptor, mu subunit, conserved site]
adaptor-related protein complex 3, mu 2 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 3, mu 2 subunit,PIR_SUPERFAMILY[630005930$PIRSF005992:adaptor protein complex, mu subunit, 630005931$PIRSF005992:Clathrin_mu]
adaptor-related protein complex 3, mu 2 subunit,SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 3, mu 2 subunit,UP_SEQ_FEATURE[850005734$chain:AP-3 complex subunit mu-2, 850104767$domain:MHD]
adaptor-related protein complex 4, beta 1 subunit,INTERPRO[450002270$IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal, 450010814$IPR011989:Armadillo-like helical, 450013598$IPR015151:Clathrin adaptor, beta-adaptin, appendage, C-terminal subdomain, 450014665$IPR016342:Adaptor protein complex, beta subunit]
adaptor-related protein complex 4, beta 1 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 4, beta 1 subunit,PIR_SUPERFAMILY[630002416$PIRSF002291:adaptor protein complex, beta subunit, 630002417$PIRSF002291:AP_complex_beta]
adaptor-related protein complex 4, beta 1 subunit,SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 4, beta 1 subunit,UP_SEQ_FEATURE[850005738$chain:AP-4 complex subunit beta-1, 850117294$sequence conflict, 850117295$sequence variant]
adenomatosis polyposis coli 2,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
adenomatosis polyposis coli 2,INTERPRO[450000194$IPR000225:Armadillo, 450008333$IPR009223:APC cysteine-rich, 450008334$IPR009224:SAMP, 450008343$IPR009234:APC basic, 450010814$IPR011989:Armadillo-like helical]
adenomatosis polyposis coli 2,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038903$hsa05213:Endometrial cancer, 470038907$hsa05217:Basal cell carcinoma]
adenomatosis polyposis coli 2,SMART[760000159$SM00185:ARM]
adenomatosis polyposis coli 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000624$golgi apparatus, 790000919$membrane, 790000960$microtubule, 790001212$polymorphism, 790001304$repeat, 790001642$wnt signaling pathway]
adenomatosis polyposis coli 2,UP_SEQ_FEATURE[850003855$chain:Adenomatous polyposis coli protein 2, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850110472$region of interest:5 X 20 AA approximate repeat of F-X-V-E- X-T-P-X-C-F-S-R-X-S-S-L-S-S-L-S, 850112232$region of interest:Interaction with CTNNB1, 850112515$region of interest:Interaction with MAPRE1 and MAPRE3, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115674$repeat:ARM 1, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4, 850115687$repeat:ARM 5, 850115688$repeat:ARM 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),INTERPRO[450001016$IPR001159:Double-stranded RNA binding, 450002186$IPR002466:Adenosine deaminase/editase, 450013172$IPR014720:Double-stranded RNA-binding-like]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),OMIM_DISEASE[520001932$Framingham Heart Study genome-wide association: results for pulmonary function measures]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),PIR_SUPERFAMILY[630001393$PIRSF001248:double-stranded RNA-specific adenosine deaminase]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),SMART[760000326$SM00358:DSRM, 760000492$SM00552:ADEAMc]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000988$mrna processing, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding, 790001648$zinc]
adenosine deaminase, RNA-specific, B1 (RED1 homolog rat),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000433$binding site:Inositol hexakisphosphate, 850016332$chain:Double-stranded RNA-specific editase 1, 850102990$domain:A to I editase, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
adenosine deaminase-like,INTERPRO[450001209$IPR001365:Adenosine/AMP deaminase, 450006065$IPR006650:Adenosine/AMP deaminase active site]
adenosine deaminase-like,PIR_SUPERFAMILY[630001394$PIRSF001249:adenosine deaminase]
adenosine deaminase-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001062$nucleotide metabolism]
adenosine deaminase-like,UP_SEQ_FEATURE[850003867$chain:Adenosine deaminase-like protein, 850117294$sequence conflict, 850118574$splice variant]
adenosine kinase,INTERPRO[450001598$IPR001805:Adenosine kinase, 450001928$IPR002173:Carbohydrate/puine kinase, PfkB, conserved site, 450010441$IPR011611:Carbohydrate/purine kinase]
adenosine kinase,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenosine kinase,PIR_SUPERFAMILY[630005929$PIRSF005991:adenosine kinase]
adenosine kinase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001280$purine salvage, 790001547$transferase]
adenosine kinase,UP_SEQ_FEATURE[850003869$chain:Adenosine kinase, 850105852$helix, 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
adenosine monophosphate deaminase 2 (isoform L),INTERPRO[450001209$IPR001365:Adenosine/AMP deaminase, 450005754$IPR006329:AMP deaminase, 450006065$IPR006650:Adenosine/AMP deaminase active site, 450014621$IPR016297:AMP deaminase, metazoa]
adenosine monophosphate deaminase 2 (isoform L),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenosine monophosphate deaminase 2 (isoform L),PIR_SUPERFAMILY[630001396$PIRSF001251:AMP deaminase, 630001397$PIRSF001251:AMP_deaminase_met]
adenosine monophosphate deaminase 2 (isoform L),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001062$nucleotide metabolism, 790001162$phosphoprotein]
adenosine monophosphate deaminase 2 (isoform L),UP_SEQ_FEATURE[850005142$chain:AMP deaminase 2, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
adenosylhomocysteinase,INTERPRO[450000035$IPR000043:S-adenosyl-L-homocysteine hydrolase, 450014301$IPR015878:S-adenosyl-L-homocysteine hydrolase, NAD binding, 450014426$IPR016040:NAD(P)-binding domain]
adenosylhomocysteinase,KEGG_PATHWAY[470038747$hsa00270:Cysteine and methionine metabolism, 470038760$hsa00450:Selenoamino acid metabolism]
adenosylhomocysteinase,OMIM_DISEASE[520002447$Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase]
adenosylhomocysteinase,PIR_SUPERFAMILY[630001256$PIRSF001109:adenosylhomocysteine hydrolase, SAHH type, 630001257$PIRSF001109:Ad_hcy_hydrolase]
adenosylhomocysteinase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000706$homotetramer, 790000743$hydrolase, 790001006$nad, 790001075$one-carbon metabolism, 790001212$polymorphism, 790001508$thioether hydrolase]
adenosylhomocysteinase,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850003881$chain:Adenosylhomocysteinase, 850105852$helix, 850106258$modified residue, 850113539$region of interest:NAD binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
adenylate cyclase 2 (brain),INTERPRO[450000923$IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase, 450008505$IPR009398:Adenylate cyclase-like, 450016581$IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site]
adenylate cyclase 2 (brain),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038829$hsa04020:Calcium signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038845$hsa04270:Vascular smooth muscle contraction, 470038858$hsa04540:Gap junction, 470038883$hsa04912:GnRH signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation, 470038885$hsa04916:Melanogenesis, 470038922$hsa05414:Dilated cardiomyopathy]
adenylate cyclase 2 (brain),PIR_SUPERFAMILY[630001609$PIRSF001445:adenylate cyclase]
adenylate cyclase 2 (brain),SMART[760000036$SM00044:CYCc]
adenylate cyclase 2 (brain),SP_PIR_KEYWORDS[790000138$atp-binding, 790000222$camp biosynthesis, 790000356$complete proteome, 790000616$glycoprotein, 790000891$lyase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001167$phosphorus-oxygen lyase, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
adenylate cyclase 2 (brain),UP_SEQ_FEATURE[850003893$chain:Adenylate cyclase type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106139$metal ion-binding site:Magnesium 2; via carbonyl oxygen, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
adenylate cyclase 5,INTERPRO[450000923$IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase, 450008505$IPR009398:Adenylate cyclase-like, 450016581$IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site]
adenylate cyclase 5,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038831$hsa04062:Chemokine signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038845$hsa04270:Vascular smooth muscle contraction, 470038858$hsa04540:Gap junction, 470038883$hsa04912:GnRH signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation, 470038885$hsa04916:Melanogenesis, 470038922$hsa05414:Dilated cardiomyopathy]
adenylate cyclase 5,PIR_SUPERFAMILY[630001609$PIRSF001445:adenylate cyclase]
adenylate cyclase 5,SMART[760000036$SM00044:CYCc]
adenylate cyclase 5,SP_PIR_KEYWORDS[790000138$atp-binding, 790000222$camp biosynthesis, 790000356$complete proteome, 790000616$glycoprotein, 790000891$lyase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane]
adenylate cyclase 5,UP_SEQ_FEATURE[850003896$chain:Adenylate cyclase type 5, 850104091$domain:Guanylate cyclase 1, 850104092$domain:Guanylate cyclase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106139$metal ion-binding site:Magnesium 2; via carbonyl oxygen, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
adenylate kinase 3,INTERPRO[450000742$IPR000850:Adenylate kinase, 450005685$IPR006259:Adenylate kinase, subfamily, 450007210$IPR007862:Adenylate kinase, zinc-finger lid region]
adenylate kinase 3,KEGG_PATHWAY[470038744$hsa00240:Pyrimidine metabolism]
adenylate kinase 3,PIR_SUPERFAMILY[630000849$PIRSF000734:adenylate kinase]
adenylate kinase 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000639$gtp-binding, 790000825$kinase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001547$transferase]
adenylate kinase 3,UP_SEQ_FEATURE[850000229$binding site:AMP, 850022628$chain:GTP:AMP phosphotransferase mitochondrial, 850105852$helix, 850106258$modified residue, 850106262$nucleotide phosphate-binding region:AMP, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
adrenergic, beta, receptor kinase 2,INTERPRO[450000207$IPR000239:GPCR kinase, 450000294$IPR000342:Regulator of G protein signalling, 450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450001635$IPR001849:Pleckstrin homology, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450010818$IPR011993:Pleckstrin homology-type, 450014178$IPR015743:Beta-adrenergic receptor kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
adrenergic, beta, receptor kinase 2,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038841$hsa04144:Endocytosis, 470038879$hsa04740:Olfactory transduction]
adrenergic, beta, receptor kinase 2,PIR_SUPERFAMILY[630000692$PIRSF000585:beta-adrenergic-receptor kinase]
adrenergic, beta, receptor kinase 2,SMART[760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000205$SM00233:PH, 760000285$SM00315:RGS]
adrenergic, beta, receptor kinase 2,SP_PIR_KEYWORDS[790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790001063$nucleotide-binding, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
adrenergic, beta, receptor kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850007575$chain:Beta-adrenergic receptor kinase 2, 850103028$domain:AGC-kinase C-terminal, 850104979$domain:PH, 850105086$domain:Protein kinase, 850105178$domain:RGS, 850106263$nucleotide phosphate-binding region:ATP, 850113517$region of interest:N-terminal, 850117294$sequence conflict, 850117295$sequence variant]
akirin 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000763$immune response, 790000777$innate immunity, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
akirin 2,UP_SEQ_FEATURE[850004209$chain:Akirin-2, 850102378$compositionally biased region:Ala-rich, 850106258$modified residue, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal]
aldehyde dehydrogenase 1 family, member A3,INTERPRO[450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal, 450014511$IPR016163:Aldehyde dehydrogenase, C-terminal]
aldehyde dehydrogenase 1 family, member A3,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038753$hsa00340:Histidine metabolism, 470038754$hsa00350:Tyrosine metabolism, 470038755$hsa00360:Phenylalanine metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
aldehyde dehydrogenase 1 family, member A3,PIR_SUPERFAMILY[630000172$PIRSF000147:NAD-dependent aldehyde dehydrogenase]
aldehyde dehydrogenase 1 family, member A3,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
aldehyde dehydrogenase 1 family, member A3,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000114$active site:Proton acceptor, 850004327$chain:Aldehyde dehydrogenase family 1 member A3, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant, 850118573$site:Transition state stabilizer]
aldehyde dehydrogenase 3 family, member B2,INTERPRO[450011082$IPR012394:Aldehyde dehydrogenase NAD(P)-dependent, 450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal, 450014511$IPR016163:Aldehyde dehydrogenase, C-terminal]
aldehyde dehydrogenase 3 family, member B2,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038753$hsa00340:Histidine metabolism, 470038754$hsa00350:Tyrosine metabolism, 470038755$hsa00360:Phenylalanine metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
aldehyde dehydrogenase 3 family, member B2,PIR_SUPERFAMILY[630027949$PIRSF036492:ALDH]
aldehyde dehydrogenase 3 family, member B2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
aldehyde dehydrogenase 3 family, member B2,UP_SEQ_FEATURE[850004333$chain:Aldehyde dehydrogenase family 3 member B2, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant]
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II),INTERPRO[450001240$IPR001395:Aldo/keto reductase, 450016460$IPR018170:Aldo/keto reductase, conserved site]
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II),KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038780$hsa00590:Arachidonic acid metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450]
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001006$nad, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism]
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000555$binding site:Substrate, 850004368$chain:Aldo-keto reductase family 1 member C3, 850105852$helix, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118285$site:Important for substrate specificity, 850118376$site:Involved in ligand recognition and product release, 850118396$site:Lowers pKa of active site Tyr, 850118575$strand, 850118624$turn]
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase),INTERPRO[450001240$IPR001395:Aldo/keto reductase]
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase),PIR_SUPERFAMILY[630000111$PIRSF000097:aldo-keto reductase]
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001006$nad, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism]
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000461$binding site:NADP, 850000555$binding site:Substrate, 850004120$chain:Aflatoxin B1 aldehyde reductase member 3, 850105852$helix, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118396$site:Lowers pKa of active site Tyr, 850118575$strand, 850118624$turn]
alkB, alkylation repair homolog 7 (E. coli),SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001405$signal]
alkB, alkylation repair homolog 7 (E. coli),UP_SEQ_FEATURE[850004453$chain:Alkylated DNA repair protein alkB homolog 7, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
alkaline ceramidase 3,INTERPRO[450008142$IPR008901:Alkaline phytoceramidase]
alkaline ceramidase 3,KEGG_PATHWAY[470038783$hsa00600:Sphingolipid metabolism]
alkaline ceramidase 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000624$golgi apparatus, 790000743$hydrolase, 790000919$membrane, 790001555$transmembrane]
alkaline ceramidase 3,UP_SEQ_FEATURE[850004398$chain:Alkaline ceramidase 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850118623$transmembrane region]
alkaline phosphatase, placental (Regan isozyme),INTERPRO[450001728$IPR001952:Alkaline phosphatase, 450016171$IPR017849:Alkaline phosphatase-like, alpha/beta/alpha, 450016583$IPR018299:Alkaline phosphatase, active site]
alkaline phosphatase, placental (Regan isozyme),KEGG_PATHWAY[470038800$hsa00790:Folate biosynthesis]
alkaline phosphatase, placental (Regan isozyme),PIR_SUPERFAMILY[630001030$PIRSF000891:alkaline phosphatase]
alkaline phosphatase, placental (Regan isozyme),SMART[760000086$SM00098:alkPPc]
alkaline phosphatase, placental (Regan isozyme),SP_PIR_KEYWORDS[790000002$3d-structure, 790000190$blocked carboxyl end, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000701$homodimer, 790000743$hydrolase, 790000881$lipoprotein, 790000899$magnesium, 790000919$membrane, 790000924$membrane protein, 790000937$metal-binding, 790000943$metalloprotein, 790001149$phosphatidylinositol linkage, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001189$placenta, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane, 790001648$zinc]
alkaline phosphatase, placental (Regan isozyme),UP_SEQ_FEATURE[850000109$active site:Phosphoserine intermediate, 850004415$chain:Alkaline phosphatase, placental type, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105858$lipid moiety-binding region:GPI-anchor amidated aspartate, 850106107$metal ion-binding site:Magnesium, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118623$transmembrane region, 850118624$turn]
allograft inflammatory factor 1,INTERPRO[450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
allograft inflammatory factor 1,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity]
allograft inflammatory factor 1,PIR_SUPERFAMILY[630027759$PIRSF036323:allograft inflammatory factor-1]
allograft inflammatory factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000019$actin-binding, 790000211$calcium, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000480$EF hand, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
allograft inflammatory factor 1,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850004554$chain:Allograft inflammatory factor 1, 850103572$domain:EF-hand 1, 850103584$domain:EF-hand 2; degenerate, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
alpha-kinase 2,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450003676$IPR004166:MHCK/EF2 kinase, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
alpha-kinase 2,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG, 760000713$SM00811:Alpha_kinase]
alpha-kinase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000768$Immunoglobulin domain, 790000825$kinase, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
alpha-kinase 2,UP_SEQ_FEATURE[850004885$chain:Alpha-protein kinase 2, 850102581$compositionally biased region:Poly-Ser, 850102883$disulfide bond, 850103039$domain:Alpha-type protein kinase, 850104199$domain:Ig-like, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
amiloride-sensitive cation channel 4, pituitary,INTERPRO[450001656$IPR001873:Na+ channel, amiloride-sensitive]
amiloride-sensitive cation channel 4, pituitary,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001418$Sodium, 790001419$sodium channel, 790001421$Sodium transport, 790001555$transmembrane, 790001558$transport]
amiloride-sensitive cation channel 4, pituitary,UP_SEQ_FEATURE[850004981$chain:Amiloride-sensitive cation channel 4, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
amino-terminal enhancer of split,INTERPRO[450005066$IPR005617:Groucho/TLE, N-terminal Q-rich region]
amino-terminal enhancer of split,PIR_SUPERFAMILY[630029914$PIRSF038339:amino-terminal enhancer of split]
amino-terminal enhancer of split,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001642$wnt signaling pathway]
amino-terminal enhancer of split,UP_SEQ_FEATURE[850005013$chain:Amino-terminal enhancer of split, 850102488$compositionally biased region:Gln-rich (Q domain), 850102530$compositionally biased region:Gly/Pro-rich (GP domain), 850111216$region of interest:CCN domain, 850117294$sequence conflict, 850117295$sequence variant]
amyloid beta (A4) precursor protein-binding, family B, member 2,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
amyloid beta (A4) precursor protein-binding, family B, member 2,OMIM_DISEASE[520000242$Alzheimer disease, late-onset]
amyloid beta (A4) precursor protein-binding, family B, member 2,SMART[760000401$SM00456:WW, 760000407$SM00462:PTB]
amyloid beta (A4) precursor protein-binding, family B, member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat]
amyloid beta (A4) precursor protein-binding, family B, member 2,UP_SEQ_FEATURE[850005172$chain:Amyloid beta A4 precursor protein-binding family B member 2, 850104994$domain:PID 1, 850104995$domain:PID 2, 850105731$domain:WW, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
amyloid beta precursor protein (cytoplasmic tail) binding protein 2,INTERPRO[450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
amyloid beta precursor protein (cytoplasmic tail) binding protein 2,SMART[760000020$SM00028:TPR]
amyloid beta precursor protein (cytoplasmic tail) binding protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000919$membrane, 790000960$microtubule, 790001065$nucleus, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001537$tpr repeat, 790001558$transport]
amyloid beta precursor protein (cytoplasmic tail) binding protein 2,UP_SEQ_FEATURE[850005177$chain:Amyloid protein-binding protein 2, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117294$sequence conflict, 850117295$sequence variant]
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11,UP_SEQ_FEATURE[850005182$chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein, 850117295$sequence variant, 850118574$splice variant]
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12,UP_SEQ_FEATURE[850005183$chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein, 850106258$modified residue, 850117295$sequence variant]
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4,UP_SEQ_FEATURE[850005186$chain:Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
ankylosis, progressive homolog (mouse),INTERPRO[450008973$IPR009887:Progressive ankylosis]
ankylosis, progressive homolog (mouse),OMIM_DISEASE[520000997$Chondrocalcinosis 2, 520001262$Craniometaphyseal dysplasia]
ankylosis, progressive homolog (mouse),SP_PIR_KEYWORDS[790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000919$membrane, 790001148$phosphate transport, 790001555$transmembrane, 790001558$transport]
ankylosis, progressive homolog (mouse),UP_SEQ_FEATURE[850044506$chain:Progressive ankylosis protein homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ankyrin 2, neuronal,INTERPRO[450000415$IPR000488:Death, 450000789$IPR000906:ZU5, 450001870$IPR002110:Ankyrin, 450010009$IPR011029:DEATH-like]
ankyrin 2, neuronal,OMIM_DISEASE[520000754$Cardiac arrhythmia, ankyrin-B-related, 520002944$Long QT syndrome-4]
ankyrin 2, neuronal,PIR_SUPERFAMILY[630002424$PIRSF002298:ankyrin]
ankyrin 2, neuronal,SMART[760000004$SM00005:DEATH, 760000191$SM00218:ZU5, 760000220$SM00248:ANK]
ankyrin 2, neuronal,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000446$disease mutation, 790000886$long qt syndrome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin 2, neuronal,UP_SEQ_FEATURE[850005443$chain:Ankyrin-2, 850103507$domain:Death, 850105753$domain:ZU5, 850106258$modified residue, 850106259$mutagenesis site, 850112861$region of interest:Interaction with SPTBN1, 850114211$region of interest:Repeat-rich region, 850115632$repeat:ANK 1, 850115633$repeat:ANK 10, 850115634$repeat:ANK 11, 850115635$repeat:ANK 12, 850115636$repeat:ANK 13, 850115637$repeat:ANK 14, 850115638$repeat:ANK 15, 850115639$repeat:ANK 16, 850115640$repeat:ANK 17, 850115641$repeat:ANK 18, 850115642$repeat:ANK 19, 850115644$repeat:ANK 2, 850115645$repeat:ANK 20, 850115646$repeat:ANK 21, 850115647$repeat:ANK 22, 850115648$repeat:ANK 23, 850115649$repeat:ANK 24, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850116925$repeat:Repeat A, 850116926$repeat:Repeat A; approximate, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat and BTB (POZ) domain containing 2,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450001870$IPR002110:Ankyrin, 450008207$IPR009072:Histone-fold, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related]
ankyrin repeat and BTB (POZ) domain containing 2,PIR_SUPERFAMILY[630029983$PIRSF038450:ankyrin repeat and BTB/POZ domain protein, ABTB2 type]
ankyrin repeat and BTB (POZ) domain containing 2,SMART[760000197$SM00225:BTB, 760000220$SM00248:ANK]
ankyrin repeat and BTB (POZ) domain containing 2,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat and BTB (POZ) domain containing 2,UP_SEQ_FEATURE[850005318$chain:Ankyrin repeat and BTB/POZ domain- containing protein 2, 850103177$domain:BTB, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117295$sequence variant]
ankyrin repeat and SOCS box-containing 1,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001870$IPR002110:Ankyrin]
ankyrin repeat and SOCS box-containing 1,SMART[760000220$SM00248:ANK, 760000225$SM00253:SOCS]
ankyrin repeat and SOCS box-containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000086$ank repeat, 790000356$complete proteome, 790000428$developmental protein, 790001304$repeat, 790001593$ubl conjugation pathway]
ankyrin repeat and SOCS box-containing 1,UP_SEQ_FEATURE[850005339$chain:Ankyrin repeat and SOCS box protein 1, 850105375$domain:SOCS box, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6]
ankyrin repeat domain 11; hypothetical protein LOC100128265,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 11; hypothetical protein LOC100128265,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 11; hypothetical protein LOC100128265,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
ankyrin repeat domain 11; hypothetical protein LOC100128265,UP_SEQ_FEATURE[850005361$chain:Ankyrin repeat domain-containing protein 11, 850055381$chain:Putative uncharacterized protein FLJ34945, 850102554$compositionally biased region:Lys-rich, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117294$sequence conflict]
ankyrin repeat domain 13A,INTERPRO[450001870$IPR002110:Ankyrin, 450003428$IPR003903:Ubiquitin interacting motif]
ankyrin repeat domain 13A,SMART[760000220$SM00248:ANK, 760000632$SM00726:UIM]
ankyrin repeat domain 13A,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 13A,UP_SEQ_FEATURE[850005363$chain:Ankyrin repeat domain-containing protein 13A, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117162$repeat:UIM 1, 850117163$repeat:UIM 2, 850117164$repeat:UIM 3, 850117294$sequence conflict, 850117295$sequence variant]
ankyrin repeat domain 28,COG_ONTOLOGY[90000073$General function prediction only]
ankyrin repeat domain 28,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 28,PIR_SUPERFAMILY[630002426$PIRSF002300:syphilis spirochete probable ankyrin]
ankyrin repeat domain 28,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 28,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
ankyrin repeat domain 28,UP_SEQ_FEATURE[850060140$chain:Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, 850106258$modified residue, 850106259$mutagenesis site, 850115632$repeat:ANK 1, 850115633$repeat:ANK 10, 850115634$repeat:ANK 11, 850115635$repeat:ANK 12, 850115636$repeat:ANK 13, 850115637$repeat:ANK 14, 850115638$repeat:ANK 15, 850115639$repeat:ANK 16, 850115640$repeat:ANK 17, 850115641$repeat:ANK 18, 850115642$repeat:ANK 19, 850115644$repeat:ANK 2, 850115645$repeat:ANK 20, 850115646$repeat:ANK 21, 850115647$repeat:ANK 22, 850115648$repeat:ANK 23, 850115649$repeat:ANK 24, 850115650$repeat:ANK 25, 850115651$repeat:ANK 26, 850115652$repeat:ANK 27, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117294$sequence conflict, 850118574$splice variant]
ankyrin repeat domain 6,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 6,PIR_SUPERFAMILY[630002425$PIRSF002299:hypothetical protein DKFZp434E1335.1]
ankyrin repeat domain 6,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790000811$isopeptide bond, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
ankyrin repeat domain 6,UP_SEQ_FEATURE[850005413$chain:Ankyrin repeat domain-containing protein 6, 850102580$compositionally biased region:Poly-Pro, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
annexin A1,BIOCARTA[30000124$h_gcrPathway:Corticosteroids and cardioprotection]
annexin A1,INTERPRO[450001304$IPR001464:Annexin, 450002122$IPR002388:Annexin, type I, 450016537$IPR018252:Annexin repeat, conserved site, 450016775$IPR018502:Annexin repeat]
annexin A1,PIR_SUPERFAMILY[630002477$PIRSF002359:annexin I]
annexin A1,SMART[760000303$SM00335:ANX]
annexin A1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000088$annexin, 790000211$calcium, 790000212$calcium binding, 790000216$calcium/phospholipid-binding, 790000264$cell membrane, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000473$duplication, 790000497$endonexin fold, 790000616$glycoprotein, 790000774$inflammation, 790000811$isopeptide bond, 790000919$membrane, 790001065$nucleus, 790001152$phospholipase a2 inhibitor, 790001155$phospholipid binding, 790001162$phosphoprotein, 790001304$repeat]
annexin A1,UP_SEQ_FEATURE[850005447$chain:Annexin A1, 850102736$cross-link:Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), 850105852$helix, 850106258$modified residue, 850115661$repeat:Annexin 1, 850115662$repeat:Annexin 2, 850115663$repeat:Annexin 3, 850115664$repeat:Annexin 4, 850118575$strand]
annexin A6,INTERPRO[450001304$IPR001464:Annexin, 450002126$IPR002393:Annexin, type VI, 450016537$IPR018252:Annexin repeat, conserved site, 450016775$IPR018502:Annexin repeat]
annexin A6,PIR_SUPERFAMILY[630002477$PIRSF002359:annexin I, 630002479$PIRSF002361:annexin VI]
annexin A6,SMART[760000303$SM00335:ANX]
annexin A6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000088$annexin, 790000211$calcium, 790000212$calcium binding, 790000216$calcium/phospholipid-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000473$duplication, 790000497$endonexin fold, 790001155$phospholipid binding, 790001162$phosphoprotein, 790001304$repeat]
annexin A6,UP_SEQ_FEATURE[850005459$chain:Annexin A6, 850105852$helix, 850106258$modified residue, 850115661$repeat:Annexin 1, 850115662$repeat:Annexin 2, 850115663$repeat:Annexin 3, 850115664$repeat:Annexin 4, 850115665$repeat:Annexin 5, 850115666$repeat:Annexin 6, 850115667$repeat:Annexin 7, 850115668$repeat:Annexin 8, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
anoctamin 8,INTERPRO[450006989$IPR007632:Protein of unknown function DUF590]
anoctamin 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001555$transmembrane, 790001558$transport]
anoctamin 8,UP_SEQ_FEATURE[850005488$chain:Anoctamin-8, 850102507$compositionally biased region:Glu-rich, 850102517$compositionally biased region:Gly-rich, 850102552$compositionally biased region:Leu-rich, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
anoctamin 9,INTERPRO[450006989$IPR007632:Protein of unknown function DUF590]
anoctamin 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
anoctamin 9,UP_SEQ_FEATURE[850005489$chain:Anoctamin-9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
anthrax toxin receptor 2,INTERPRO[450001802$IPR002035:von Willebrand factor, type A, 450007676$IPR008399:Anthrax toxin receptor, C-terminal, 450007677$IPR008400:Anthrax toxin receptor, extracellular, 450015684$IPR017360:Anthrax toxin receptor 2]
anthrax toxin receptor 2,OMIM_DISEASE[520001905$Fibromatosis, juvenile hyaline, 520002392$Hyalinosis, infantile systemic]
anthrax toxin receptor 2,PIR_SUPERFAMILY[630029605$PIRSF038023:anthrax toxin receptor, 630029606$PIRSF038023:Anthrax_toxin_receptor_2]
anthrax toxin receptor 2,SMART[760000296$SM00327:VWA]
anthrax toxin receptor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
anthrax toxin receptor 2,UP_SEQ_FEATURE[850005535$chain:Anthrax toxin receptor 2, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102883$disulfide bond, 850105627$domain:VWFA, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105986$metal ion-binding site:Divalent metal cation, 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A,INTERPRO[450007252$IPR007904:APOBEC-like, C-terminal, 450011795$IPR013158:APOBEC-like, N-terminal, 450014525$IPR016192:APOBEC/CMP deaminase, zinc-binding]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850041736$chain:Probable DNA dC->dU-editing enzyme APOBEC-3A, 850106244$metal ion-binding site:Zinc; catalytic, 850117295$sequence variant]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B,INTERPRO[450007252$IPR007904:APOBEC-like, C-terminal, 450011795$IPR013158:APOBEC-like, N-terminal, 450014525$IPR016192:APOBEC/CMP deaminase, zinc-binding]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790001212$polymorphism, 790001339$rna-binding, 790001648$zinc]
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850041737$chain:Probable DNA dC->dU-editing enzyme APOBEC-3B, 850106218$metal ion-binding site:Zinc, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
apolipoprotein M,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000643$hdl, 790000875$lipid transport, 790000881$lipoprotein, 790001363$Secreted, 790001405$signal, 790001558$transport]
apolipoprotein M,UP_SEQ_FEATURE[850005829$chain:Apolipoprotein M, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand]
arginine decarboxylase,COG_ONTOLOGY[90000007$Amino acid transport and metabolism]
arginine decarboxylase,INTERPRO[450000155$IPR000183:Orn/DAP/Arg decarboxylase 2, 450002158$IPR002433:Ornithine decarboxylase]
arginine decarboxylase,KEGG_PATHWAY[470038752$hsa00330:Arginine and proline metabolism]
arginine decarboxylase,PIR_SUPERFAMILY[630001481$PIRSF001335:ornithine decarboxylase, 630030393$PIRSF500127:ornithine decarboxylase, fungal/metazoan type]
arginine decarboxylase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000417$decarboxylase, 790000891$lyase, 790001210$polyamine biosynthesis, 790001212$polymorphism, 790001283$pyridoxal phosphate]
arginine decarboxylase,UP_SEQ_FEATURE[850006051$chain:Arginine decarboxylase, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
armadillo repeat containing 5,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450000194$IPR000225:Armadillo, 450010814$IPR011989:Armadillo-like helical]
armadillo repeat containing 5,SMART[760000159$SM00185:ARM, 760000197$SM00225:BTB]
armadillo repeat containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
armadillo repeat containing 5,UP_SEQ_FEATURE[850006121$chain:Armadillo repeat-containing protein 5, 850103177$domain:BTB, 850115674$repeat:ARM 1, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4, 850115687$repeat:ARM 5, 850115688$repeat:ARM 6, 850115689$repeat:ARM 7, 850117295$sequence variant, 850118574$splice variant]
armadillo repeat containing 6,INTERPRO[450000194$IPR000225:Armadillo, 450010814$IPR011989:Armadillo-like helical]
armadillo repeat containing 6,SMART[760000159$SM00185:ARM]
armadillo repeat containing 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat]
armadillo repeat containing 6,UP_SEQ_FEATURE[850006122$chain:Armadillo repeat-containing protein 6, 850106258$modified residue, 850115674$repeat:ARM 1, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4]
armadillo repeat containing 9,INTERPRO[450006014$IPR006594:LisH dimerisation motif, 450010814$IPR011989:Armadillo-like helical]
armadillo repeat containing 9,SMART[760000580$SM00667:LisH]
armadillo repeat containing 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
armadillo repeat containing 9,UP_SEQ_FEATURE[850028895$chain:LisH domain-containing protein ARMC9, 850102581$compositionally biased region:Poly-Ser, 850104733$domain:LisH, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
aryl hydrocarbon receptor interacting protein,BIOCARTA[30000005$h_acrPathway:Ahr Signal Transduction Pathway]
aryl hydrocarbon receptor interacting protein,INTERPRO[450001034$IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450017972$IPR019734:Tetratricopeptide repeat]
aryl hydrocarbon receptor interacting protein,OMIM_DISEASE[520002076$GH-secreting pituitary adenoma, 520004006$Pituitary adenoma, ACTH-secreting, 520004007$Pituitary adenoma, growth hormone-secreting, 520004009$Pituitary adenoma, prolactin-secreting]
aryl hydrocarbon receptor interacting protein,SMART[760000020$SM00028:TPR]
aryl hydrocarbon receptor interacting protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
aryl hydrocarbon receptor interacting protein,UP_SEQ_FEATURE[850004196$chain:AH receptor-interacting protein, 850105058$domain:PPIase FKBP-type, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117295$sequence variant]
arylacetamide deacetylase-like 4,INTERPRO[450001923$IPR002168:Lipase, GDXG, active site, 450011738$IPR013094:Alpha/beta hydrolase fold-3, 450015477$IPR017157:Arylacetamide deacetylase]
arylacetamide deacetylase-like 4,PIR_SUPERFAMILY[630028788$PIRSF037251:arylacetamide deacetylase, 630028789$PIRSF037251:Arylacetamide_deacetylase]
arylacetamide deacetylase-like 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001409$Signal-anchor, 790001555$transmembrane]
arylacetamide deacetylase-like 4,UP_SEQ_FEATURE[850006202$chain:Arylacetamide deacetylase-like 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
arylformamidase,COG_ONTOLOGY[90000084$Lipid metabolism]
arylformamidase,KEGG_PATHWAY[470038756$hsa00380:Tryptophan metabolism, 470038788$hsa00630:Glyoxylate and dicarboxylate metabolism]
arylformamidase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001576$tryptophan catabolism]
arylformamidase,UP_SEQ_FEATURE[850041050$chain:Probable arylformamidase, 850117294$sequence conflict, 850118574$splice variant]
arylsulfatase D,COG_ONTOLOGY[90000075$Inorganic ion transport and metabolism]
arylsulfatase D,INTERPRO[450000800$IPR000917:Sulfatase, 450016171$IPR017849:Alkaline phosphatase-like, alpha/beta/alpha]
arylsulfatase D,PIR_SUPERFAMILY[630001123$PIRSF000971:animal sulfatase]
arylsulfatase D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790000937$metal-binding, 790001212$polymorphism, 790001405$signal, 790001465$sulfuric ester hydrolase]
arylsulfatase D,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850006223$chain:Arylsulfatase D, 850105770$glycosylation site:N-linked (GlcNAc...), 850105909$metal ion-binding site:Calcium, 850105944$metal ion-binding site:Calcium; via 3-oxoalanine, 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
asialoglycoprotein receptor 1,INTERPRO[450001149$IPR001304:C-type lectin, 450002094$IPR002353:Type II antifreeze protein, 450005088$IPR005640:Hepatic lectin, N-terminal, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
asialoglycoprotein receptor 1,PIR_SUPERFAMILY[630002543$PIRSF002424:hepatic lectin]
asialoglycoprotein receptor 1,SMART[760000026$SM00034:CLECT]
asialoglycoprotein receptor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000344$coiled coil, 790000356$complete proteome, 790000447$disulfide bond, 790000496$Endocytosis, 790000616$glycoprotein, 790000848$Lectin, 790000881$lipoprotein, 790000919$membrane, 790000937$metal-binding, 790001100$palmitate, 790001162$phosphoprotein, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane, 790001556$transmembrane protein]
asialoglycoprotein receptor 1,UP_SEQ_FEATURE[850000265$binding site:Carbohydrate, 850006244$chain:Asialoglycoprotein receptor 1, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850105910$metal ion-binding site:Calcium 1, 850105915$metal ion-binding site:Calcium 1; via carbonyl oxygen, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105925$metal ion-binding site:Calcium 3, 850117444$short sequence motif:Endocytosis signal, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
asialoglycoprotein receptor 2,INTERPRO[450001149$IPR001304:C-type lectin, 450002094$IPR002353:Type II antifreeze protein, 450005088$IPR005640:Hepatic lectin, N-terminal, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
asialoglycoprotein receptor 2,PIR_SUPERFAMILY[630002543$PIRSF002424:hepatic lectin]
asialoglycoprotein receptor 2,SMART[760000026$SM00034:CLECT]
asialoglycoprotein receptor 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000496$Endocytosis, 790000616$glycoprotein, 790000848$Lectin, 790000881$lipoprotein, 790000885$liver, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane, 790001556$transmembrane protein]
asialoglycoprotein receptor 2,UP_SEQ_FEATURE[850006245$chain:Asialoglycoprotein receptor 2, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850117294$sequence conflict, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
asparaginase like 1,INTERPRO[450000214$IPR000246:Peptidase T2, asparaginase 2]
asparaginase like 1,PIR_SUPERFAMILY[630006231$PIRSF006297:YbiK protein]
asparaginase like 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase]
asparaginase like 1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850027707$chain:L-asparaginase, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae),INTERPRO[450001141$IPR001296:Glycosyl transferase, group 1]
asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae),KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae),OMIM_DISEASE[520001182$Congenital disorder of glycosylation, type Ik]
asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae),PIR_SUPERFAMILY[630013735$PIRSF016957:chitobiosyldiphosphodolichol beta-mannosyltransferase]
asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000359$congenital disorder of glycosylation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000619$glycosyltransferase, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae),UP_SEQ_FEATURE[850011050$chain:Chitobiosyldiphosphodolichol beta- mannosyltransferase, 850106258$modified residue, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
asparaginyl-tRNA synthetase 2, mitochondrial (putative),INTERPRO[450002056$IPR002312:Aspartyl-tRNA synthetase, class IIb, 450003870$IPR004364:Aminoacyl-tRNA synthetase, class II (D, K and N), 450003871$IPR004365:Nucleic acid binding, OB-fold, tRNA/helicase-type, 450004015$IPR004522:Asparaginyl-tRNA synthetase, class IIb, 450005622$IPR006195:Aminoacyl-tRNA synthetase, class II, conserved region, 450011038$IPR012340:Nucleic acid-binding, OB-fold, 450016442$IPR018150:Aminoacyl-tRNA synthetase, class II (D, K and N)-like]
asparaginyl-tRNA synthetase 2, mitochondrial (putative),KEGG_PATHWAY[470038807$hsa00970:Aminoacyl-tRNA biosynthesis]
asparaginyl-tRNA synthetase 2, mitochondrial (putative),PIR_SUPERFAMILY[630001693$PIRSF001525:lysine-tRNA ligase]
asparaginyl-tRNA synthetase 2, mitochondrial (putative),SP_PIR_KEYWORDS[790000012$acetylation, 790000066$Aminoacyl-tRNA synthetase, 790000138$atp-binding, 790000356$complete proteome, 790000859$ligase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism, 790001255$protein biosynthesis, 790001550$transit peptide]
asparaginyl-tRNA synthetase 2, mitochondrial (putative),UP_SEQ_FEATURE[850041053$chain:Probable asparaginyl-tRNA synthetase, mitochondrial, 850106258$modified residue, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
aspartate beta-hydroxylase domain containing 1,INTERPRO[450007154$IPR007803:Aspartyl/Asparaginyl beta-hydroxylase]
aspartate beta-hydroxylase domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000437$dioxygenase, 790000919$membrane, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001409$Signal-anchor, 790001555$transmembrane]
aspartate beta-hydroxylase domain containing 1,UP_SEQ_FEATURE[850006285$chain:Aspartate beta-hydroxylase domain- containing protein 1, 850102517$compositionally biased region:Gly-rich, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
aspartic peptidase, retroviral-like 1,INTERPRO[450001744$IPR001969:Peptidase aspartic, active site, 450001766$IPR001995:Peptidase A2A, retrovirus, catalytic]
aspartic peptidase, retroviral-like 1,SP_PIR_KEYWORDS[790000130$Aspartyl protease, 790000144$autocatalytic cleavage, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001252$Protease, 790001555$transmembrane]
aspartic peptidase, retroviral-like 1,UP_SEQ_FEATURE[850057460$chain:Retroviral-like aspartic protease 1, 850104941$domain:Peptidase A2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ataxin 2-like,INTERPRO[450008698$IPR009604:LsmAD domain, 450008904$IPR009818:Ataxin-2, C-terminal]
ataxin 2-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790000953$methylation, 790001162$phosphoprotein]
ataxin 2-like,UP_SEQ_FEATURE[850006400$chain:Ataxin-2-like protein, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850112554$region of interest:Interaction with MPL, 850117294$sequence conflict, 850118574$splice variant]
atlastin GTPase 1,INTERPRO[450014315$IPR015894:Guanylate-binding protein, N-terminal]
atlastin GTPase 1,OMIM_DISEASE[520004565$Spastic paraplegia-3A]
atlastin GTPase 1,SP_PIR_KEYWORDS[790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000639$gtp-binding, 790000675$hereditary spastic paraplegia, 790000743$hydrolase, 790000919$membrane, 790001015$neurodegeneration, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane]
atlastin GTPase 1,UP_SEQ_FEATURE[850006413$chain:Atlastin-1, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850114800$region of interest:Sufficient for membrane association, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
atonal homolog 7 (Drosophila),INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
atonal homolog 7 (Drosophila),SMART[760000321$SM00353:HLH]
atonal homolog 7 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000466$dna-binding, 790001016$neurogenesis, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
atonal homolog 7 (Drosophila),UP_SEQ_FEATURE[850045129$chain:Protein atonal homolog 7, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif]
atonal homolog 8 (Drosophila),INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
atonal homolog 8 (Drosophila),SMART[760000321$SM00353:HLH]
atonal homolog 8 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000466$dna-binding, 790001016$neurogenesis, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
atonal homolog 8 (Drosophila),UP_SEQ_FEATURE[850045132$chain:Protein atonal homolog 8, 850102586$compositionally biased region:Pro-rich, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850117295$sequence variant, 850118574$splice variant]
atrophin 1,INTERPRO[450002600$IPR002951:Atrophin-like, 450016301$IPR017993:Atrophin-1]
atrophin 1,OMIM_DISEASE[520001452$Dentatorubro-pallidoluysian atrophy]
atrophin 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000509$epilepsy, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001569$triplet repeat expansion]
atrophin 1,UP_SEQ_FEATURE[850006808$chain:Atrophin-1, 850102379$compositionally biased region:Ala/Arg-rich, 850102416$compositionally biased region:Arg/Glu-rich (mixed charge), 850102516$compositionally biased region:Glu/Ser-rich, 850102570$compositionally biased region:Poly-Gln, 850102574$compositionally biased region:Poly-His, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
aurora kinase B,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
aurora kinase B,SMART[760000193$SM00220:S_TKc]
aurora kinase B,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000276$centromere, 790000315$chromosomal protein, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
aurora kinase B,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059727$chain:Serine/threonine-protein kinase 12, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
beaded filament structural protein 1, filensin,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
beaded filament structural protein 1, filensin,INTERPRO[450016344$IPR018039:Intermediate filament protein, conserved site]
beaded filament structural protein 1, filensin,OMIM_DISEASE[520000847$Cataract, cortical, juvenile-onset]
beaded filament structural protein 1, filensin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000252$cataract, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000534$eye lens protein, 790000788$Intermediate filament, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
beaded filament structural protein 1, filensin,UP_SEQ_FEATURE[850019490$chain:Filensin, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
bestrophin 2,INTERPRO[450000526$IPR000615:Bestrophin]
bestrophin 2,SP_PIR_KEYWORDS[790000211$calcium, 790000264$cell membrane, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001555$transmembrane, 790001558$transport]
bestrophin 2,UP_SEQ_FEATURE[850007492$chain:Bestrophin-2, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118587$topological domain:In membrane, 850118623$transmembrane region]
bicaudal D homolog 1 (Drosophila),INTERPRO[450016751$IPR018477:Bicaudal-D protein, microtubule-associated]
bicaudal D homolog 1 (Drosophila),OMIM_DISEASE[520001996$Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis]
bicaudal D homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790001162$phosphoprotein]
bicaudal D homolog 1 (Drosophila),UP_SEQ_FEATURE[850045210$chain:Protein bicaudal D homolog 1, 850113113$region of interest:Interacts with RAB6A, 850117294$sequence conflict, 850118574$splice variant]
biliverdin reductase B (flavin reductase (NADPH)),INTERPRO[450001342$IPR001509:NAD-dependent epimerase/dehydratase, 450014426$IPR016040:NAD(P)-binding domain]
biliverdin reductase B (flavin reductase (NADPH)),KEGG_PATHWAY[470038802$hsa00860:Porphyrin and chlorophyll metabolism]
biliverdin reductase B (flavin reductase (NADPH)),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000993$multifunctional enzyme, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism]
biliverdin reductase B (flavin reductase (NADPH)),UP_SEQ_FEATURE[850019658$chain:Flavin reductase, 850105852$helix, 850106303$nucleotide phosphate-binding region:NAD or NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
biogenesis of lysosomal organelles complex-1, subunit 2,INTERPRO[450017509$IPR019269:Biogenesis of lysosome-related organelles complex-1, subunit 2]
biogenesis of lysosomal organelles complex-1, subunit 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
biogenesis of lysosomal organelles complex-1, subunit 2,UP_SEQ_FEATURE[850008108$chain:Biogenesis of lysosome-related organelles complex 1 subunit 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
biogenesis of lysosomal organelles complex-1, subunit 3,INTERPRO[450015566$IPR017245:BLOC-1 complex, subunit 3]
biogenesis of lysosomal organelles complex-1, subunit 3,OMIM_DISEASE[520002309$Hermansky-Pudlak syndrome 8]
biogenesis of lysosomal organelles complex-1, subunit 3,PIR_SUPERFAMILY[630029197$PIRSF037630:BLOC-1_complex_subunit_3]
biogenesis of lysosomal organelles complex-1, subunit 3,SP_PIR_KEYWORDS[790000035$Albinism, 790000356$complete proteome, 790000407$cytoplasm, 790000676$Hermansky-Pudlak syndrome, 790001162$phosphoprotein]
biogenesis of lysosomal organelles complex-1, subunit 3,UP_SEQ_FEATURE[850008109$chain:Biogenesis of lysosome-related organelles complex 1 subunit 3, 850106258$modified residue]
biphenyl hydrolase-like (serine hydrolase),INTERPRO[450000062$IPR000073:Alpha/beta hydrolase fold-1]
biphenyl hydrolase-like (serine hydrolase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000241$carboxylic ester hydrolase, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790001405$signal]
biphenyl hydrolase-like (serine hydrolase),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000090$active site:Nucleophile, 850100017$chain:Valacyclovir hydrolase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117814$signal peptide, 850117835$site:Binding of alpha-amino group of substrate, 850118574$splice variant, 850118575$strand, 850118624$turn]
blocked early in transport 1 homolog (S. cerevisiae)-like,INTERPRO[450000626$IPR000727:Target SNARE coiled-coil region]
blocked early in transport 1 homolog (S. cerevisiae)-like,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
blocked early in transport 1 homolog (S. cerevisiae)-like,SMART[760000348$SM00397:t_SNARE]
blocked early in transport 1 homolog (S. cerevisiae)-like,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001266$protein transport, 790001555$transmembrane, 790001558$transport]
blocked early in transport 1 homolog (S. cerevisiae)-like,UP_SEQ_FEATURE[850007497$chain:BET1-like protein, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
bol, boule-like (Drosophila),INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
bol, boule-like (Drosophila),OMIM_DISEASE[520004728$Susceptibility loci for intracranial aneurysm in European and Japanese populations]
bol, boule-like (Drosophila),SMART[760000328$SM00360:RRM]
bol, boule-like (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790001339$rna-binding, 790001426$spermatogenesis, 790001551$translation regulation]
bol, boule-like (Drosophila),UP_SEQ_FEATURE[850045234$chain:Protein boule-like, 850103483$domain:DAZ-like, 850105211$domain:RRM, 850117294$sequence conflict, 850118574$splice variant]
branched chain aminotransferase 2, mitochondrial,INTERPRO[450001372$IPR001544:Aminotransferase, class IV, 450005239$IPR005786:Branched-chain amino acid aminotransferase II, 450016584$IPR018300:Aminotransferase, class IV, conserved site]
branched chain aminotransferase 2, mitochondrial,KEGG_PATHWAY[470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038749$hsa00290:Valine, leucine and isoleucine biosynthesis, 470038797$hsa00770:Pantothenate and CoA biosynthesis]
branched chain aminotransferase 2, mitochondrial,PIR_SUPERFAMILY[630006407$PIRSF006468:BCAT1]
branched chain aminotransferase 2, mitochondrial,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000064$amino-acid biosynthesis, 790000070$Aminotransferase, 790000200$branched-chain amino acid biosynthesis, 790000356$complete proteome, 790000407$cytoplasm, 790000969$mitochondrion, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase, 790001550$transit peptide]
branched chain aminotransferase 2, mitochondrial,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850008334$chain:Branched-chain-amino-acid aminotransferase, mitochondrial, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
breakpoint cluster region,BBID[10000037$150.caspase_and_NFKB_activation, 10000041$158.14-3-3_signal_transduction, 10000103$81.Structure_of_Caps_and_SMACs]
breakpoint cluster region,BIOCARTA[30000127$h_gleevecpathway:Inhibition of Cellular Proliferation by Gleevec, 30000164$h_integrinPathway:Integrin Signaling Pathway]
breakpoint cluster region,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000169$IPR000198:RhoGAP, 450000189$IPR000219:Dbl homology (DH) domain, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001635$IPR001849:Pleckstrin homology, 450013570$IPR015123:Bcr-Abl oncoprotein oligomerisation, 450016334$IPR018029:C2 membrane targeting protein]
breakpoint cluster region,KEGG_PATHWAY[470038899$hsa05200:Pathways in cancer, 470038910$hsa05220:Chronic myeloid leukemia]
breakpoint cluster region,OMIM_DISEASE[520002834$Leukemia, acute lymphocytic, 520002857$Leukemia, chronic myeloid, 520003072$Many sequence variants affecting diversity of adult human height]
breakpoint cluster region,SMART[760000205$SM00233:PH, 760000211$SM00239:C2, 760000293$SM00324:RhoGAP, 760000294$SM00325:RhoGEF]
breakpoint cluster region,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000203$breakpoint cluster region, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000573$fusion protein, 790000640$GTPase activation, 790000641$guanine-nucleotide releasing factor, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001271$Proto-oncogene, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001549$transforming protein]
breakpoint cluster region,UP_SEQ_FEATURE[850008352$chain:Breakpoint cluster region protein, 850102576$compositionally biased region:Poly-Leu, 850103199$domain:C2, 850103518$domain:DH, 850104979$domain:PH, 850105183$domain:Rho-GAP, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111038$region of interest:Binding to ABL SH2-domain, 850113238$region of interest:Kinase, 850117294$sequence conflict, 850117295$sequence variant, 850117861$site:Breakpoint for translocation to form BCR- ABL oncogene, 850118574$splice variant]
brix domain containing 2,INTERPRO[450006485$IPR007109:Brix domain]
brix domain containing 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001065$nucleus, 790001331$ribosome biogenesis]
brix domain containing 2,UP_SEQ_FEATURE[850008403$chain:Brix domain-containing protein 2, 850103163$domain:Brix, 850106258$modified residue, 850117294$sequence conflict]
bromodomain and PHD finger containing, 1,COG_ONTOLOGY[90000073$General function prediction only, 90000118$Transcription / Cell division and chromosome partitioning]
bromodomain and PHD finger containing, 1,INTERPRO[450000267$IPR000313:PWWP, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like, 450016644$IPR018359:Bromodomain, conserved site, 450017779$IPR019542:Enhancer of polycomb-like, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
bromodomain and PHD finger containing, 1,SMART[760000221$SM00249:PHD, 760000264$SM00293:PWWP, 760000267$SM00297:BROMO, 760000323$SM00355:ZnF_C2H2]
bromodomain and PHD finger containing, 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000206$bromodomain, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
bromodomain and PHD finger containing, 1,UP_SEQ_FEATURE[850037707$chain:Peregrin, 850103166$domain:Bromo, 850105126$domain:PWWP, 850105852$helix, 850106258$modified residue, 850112529$region of interest:Interaction with MEAF6 and ING5, 850112581$region of interest:Interaction with MYST3 and MYST4, 850114470$region of interest:Required for RUNX1 and RUNX2 transcriptional activation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118655$zinc finger region:C2H2-type, 850118762$zinc finger region:C4-type, 850118877$zinc finger region:PHD-type]
bromodomain containing 8,INTERPRO[450001324$IPR001487:Bromodomain, 450016644$IPR018359:Bromodomain, conserved site]
bromodomain containing 8,SMART[760000267$SM00297:BROMO]
bromodomain containing 8,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000206$bromodomain, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000635$growth regulation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001415$skeletal muscle, 790001539$Transcription, 790001543$transcription regulation]
bromodomain containing 8,UP_SEQ_FEATURE[850008430$chain:Bromodomain-containing protein 8, 850103167$domain:Bromo 1, 850103168$domain:Bromo 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
butyrophilin, subfamily 2, member A3,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450003157$IPR003596:Immunoglobulin V-set, subgroup, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450005994$IPR006574:SPRY-associated, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
butyrophilin, subfamily 2, member A3,PIR_SUPERFAMILY[630030241$PIRSF038779:butyrophilin]
butyrophilin, subfamily 2, member A3,SMART[760000354$SM00406:IGv, 760000394$SM00449:SPRY, 760000524$SM00589:PRY]
butyrophilin, subfamily 2, member A3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
butyrophilin, subfamily 2, member A3,UP_SEQ_FEATURE[850008555$chain:Butyrophilin subfamily 2 member A3, 850102883$disulfide bond, 850103078$domain:B30.2/SPRY, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
butyrophilin-like 2 (MHC class II associated),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
butyrophilin-like 2 (MHC class II associated),OMIM_DISEASE[520004377$Sarcoidosis, susceptibility to, 520004378$Sarcoidosis, susceptibility to, 2, 520004442$Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility]
butyrophilin-like 2 (MHC class II associated),SMART[760000357$SM00409:IG]
butyrophilin-like 2 (MHC class II associated),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001409$Signal-anchor, 790001555$transmembrane]
butyrophilin-like 2 (MHC class II associated),UP_SEQ_FEATURE[850008560$chain:Butyrophilin-like protein 2, 850102883$disulfide bond, 850104408$domain:Ig-like V-type 1, 850104409$domain:Ig-like V-type 2, 850104410$domain:Ig-like V-type 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
butyrophilin-like 8,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450003160$IPR003599:Immunoglobulin subtype, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450005994$IPR006574:SPRY-associated, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
butyrophilin-like 8,SMART[760000357$SM00409:IG, 760000394$SM00449:SPRY, 760000524$SM00589:PRY]
butyrophilin-like 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
butyrophilin-like 8,UP_SEQ_FEATURE[850008562$chain:Butyrophilin-like protein 8, 850102883$disulfide bond, 850103078$domain:B30.2/SPRY, 850104408$domain:Ig-like V-type 1, 850104409$domain:Ig-like V-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cAMP responsive element binding protein 3,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
cAMP responsive element binding protein 3,KEGG_PATHWAY[470038885$hsa04916:Melanogenesis, 470038894$hsa05016:Huntington's disease, 470038905$hsa05215:Prostate cancer]
cAMP responsive element binding protein 3,SMART[760000306$SM00338:BRLZ]
cAMP responsive element binding protein 3,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000291$chemotaxis, 790000356$complete proteome, 790000466$dna-binding, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000733$host-virus interaction, 790000919$membrane, 790001065$nucleus, 790001304$repeat, 790001409$Signal-anchor, 790001539$Transcription, 790001543$transcription regulation, 790001555$transmembrane]
cAMP responsive element binding protein 3,UP_SEQ_FEATURE[850012988$chain:Cyclic AMP-responsive element-binding protein 3, 850044422$chain:Processed cyclic AMP-responsive element- binding protein 3, 850102586$compositionally biased region:Pro-rich, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850105770$glycosylation site:N-linked (GlcNAc...), 850114908$region of interest:Transcription activation (acidic), 850117294$sequence conflict, 850117480$short sequence motif:HCFC1-binding-motif (HBM), 850117559$short sequence motif:LXXLL motif 1, 850117562$short sequence motif:LXXLL motif 2, 850118104$site:Cleavage; by PS1, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
cAMP responsive element modulator,BIOCARTA[30000071$h_cremPathway:Regulation of Spermatogenesis by CREM, 30000085$h_dreampathway:Repression of Pain Sensation by the Transcriptional Regulator DREAM]
cAMP responsive element modulator,INTERPRO[450001443$IPR001630:cAMP response element binding (CREB) protein, 450002726$IPR003102:Coactivator CBP, pKID, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
cAMP responsive element modulator,PIR_SUPERFAMILY[630029843$PIRSF038235:cAMP response element-binding protein (CREB)]
cAMP responsive element modulator,SMART[760000306$SM00338:BRLZ]
cAMP responsive element modulator,SP_PIR_KEYWORDS[790000020$activator, 790000052$alternative promoter usage, 790000053$alternative splicing, 790000221$cAMP binding, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790000679$heterodimer, 790000852$leucine zipper, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001426$spermatogenesis, 790001521$thymus, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
cAMP responsive element modulator,UP_SEQ_FEATURE[850009248$chain:cAMP-responsive element modulator, 850102900$DNA-binding region:Basic motif, 850104538$domain:KID, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cadherin 15, type 1, M-cadherin (myotubule),INTERPRO[450000201$IPR000233:Cadherin cytoplasmic region, 450001884$IPR002126:Cadherin]
cadherin 15, type 1, M-cadherin (myotubule),KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs)]
cadherin 15, type 1, M-cadherin (myotubule),OMIM_DISEASE[520003161$Mental retardation, autosomal dominant 3]
cadherin 15, type 1, M-cadherin (myotubule),PIR_SUPERFAMILY[630002623$PIRSF002504:cadherin]
cadherin 15, type 1, M-cadherin (myotubule),SMART[760000099$SM00112:CA]
cadherin 15, type 1, M-cadherin (myotubule),SP_PIR_KEYWORDS[790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000316$chromosomal rearrangement, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000919$membrane, 790000930$mental retardation, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
cadherin 15, type 1, M-cadherin (myotubule),UP_SEQ_FEATURE[850008841$chain:Cadherin-15, 850103211$domain:Cadherin 1, 850103222$domain:Cadherin 2, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cadherin 3, type 1, P-cadherin (placental),INTERPRO[450000201$IPR000233:Cadherin cytoplasmic region, 450001884$IPR002126:Cadherin]
cadherin 3, type 1, P-cadherin (placental),KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs)]
cadherin 3, type 1, P-cadherin (placental),OMIM_DISEASE[520001636$Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 520002566$Hypotrichosis, congenital, with juvenile macular dystrophy, 520002567$Hypotrichosis, congential, with juvenile macular dystrophy]
cadherin 3, type 1, P-cadherin (placental),PIR_SUPERFAMILY[630002623$PIRSF002504:cadherin]
cadherin 3, type 1, P-cadherin (placental),SMART[760000099$SM00112:CA]
cadherin 3, type 1, P-cadherin (placental),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000212$calcium binding, 790000256$cell adhesion, 790000264$cell membrane, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000446$disease mutation, 790000473$duplication, 790000479$ectodermal dysplasia, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001622$vision]
cadherin 3, type 1, P-cadherin (placental),UP_SEQ_FEATURE[850008851$chain:Cadherin-3, 850102597$compositionally biased region:Ser-rich, 850103211$domain:Cadherin 1, 850103222$domain:Cadherin 2, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
calbindin 2,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calbindin 2,PIR_SUPERFAMILY[630012240$PIRSF015393:calretinin]
calbindin 2,SMART[760000046$SM00054:EFh]
calbindin 2,SP_PIR_KEYWORDS[790000199$brain, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000473$duplication, 790000480$EF hand, 790001304$repeat]
calbindin 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000625$calcium-binding region:2; possibly ancestral, 850000626$calcium-binding region:3, 850000630$calcium-binding region:4, 850000631$calcium-binding region:5, 850000633$calcium-binding region:6; possibly ancestral, 850009204$chain:Calretinin, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850103588$domain:EF-hand 5, 850103589$domain:EF-hand 6, 850117294$sequence conflict]
calcium binding protein 39,INTERPRO[450012475$IPR013878:Mo25-like]
calcium binding protein 39,KEGG_PATHWAY[470038842$hsa04150:mTOR signaling pathway]
calcium binding protein 39,PIR_SUPERFAMILY[630008467$PIRSF009316:hypothetical protein, Saccharomyces cerevisiae YKL189w type]
calcium binding protein 39,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm]
calcium binding protein 39,UP_SEQ_FEATURE[850008973$chain:Calcium-binding protein 39, 850105852$helix, 850106258$modified residue, 850118624$turn]
calcium binding protein 5,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450014189$IPR015754:Calcium binding protein, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calcium binding protein 5,SMART[760000046$SM00054:EFh]
calcium binding protein 5,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001304$repeat]
calcium binding protein 5,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850008972$chain:Calcium-binding protein 3, 850008976$chain:Calcium-binding protein 5, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850117295$sequence variant]
calcium channel, voltage-dependent, L type, alpha 1F subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004905$IPR005446:Voltage-dependent calcium channel, L-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain]
calcium channel, voltage-dependent, L type, alpha 1F subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038845$hsa04270:Vascular smooth muscle contraction, 470038883$hsa04912:GnRH signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, L type, alpha 1F subunit,OMIM_DISEASE[520000189$Aland Island eye disease, 520001161$Cone-rod dystrophy, X-linked, 3, 520003657$Night blindness, congenital stationary, X-linked, type 2, 520003658$Night blindness, congenital stationary, X-linked, type 2A, 520003738$Ocular albinism, Forsius-Eriksson type]
calcium channel, voltage-dependent, L type, alpha 1F subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, L type, alpha 1F subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000357$Cone-rod dystrophy, 790000366$Congenital stationary night blindness, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001555$transmembrane, 790001558$transport, 790001622$vision, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, L type, alpha 1F subunit,UP_SEQ_FEATURE[850100534$chain:Voltage-dependent L-type calcium channel subunit alpha-1F, 850102572$compositionally biased region:Poly-Glu, 850102575$compositionally biased region:Poly-Ile, 850102576$compositionally biased region:Poly-Leu, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111061$region of interest:Binding to the beta subunit, 850111436$region of interest:Dihydropyridine binding, 850114003$region of interest:Phenylalkylamine binding, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117294$sequence conflict, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004906$IPR005447:Voltage-dependent calcium channel, N-type, alpha-1 subunit, 450004907$IPR005448:Voltage-dependent calcium channel, P/Q-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038878$hsa04730:Long-term depression, 470038880$hsa04742:Taste transduction, 470038887$hsa04930:Type II diabetes mellitus]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,OMIM_DISEASE[520000894$Cerebellar ataxia, pure, 520001785$Episodic ataxia, type 2, 520002248$Hemiplegic migraine, familial, 520004638$Spinocerebellar ataxia-6]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001431$spinocerebellar ataxia, 790001555$transmembrane, 790001558$transport, 790001569$triplet repeat expansion, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit,UP_SEQ_FEATURE[850100541$chain:Voltage-dependent P/Q-type calcium channel subunit alpha-1A, 850102566$compositionally biased region:Poly-Arg, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102574$compositionally biased region:Poly-His, 850102580$compositionally biased region:Poly-Pro, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850111061$region of interest:Binding to the beta subunit, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117294$sequence conflict, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
calcium channel, voltage-dependent, T type, alpha 1G subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004904$IPR005445:Voltage-dependent calcium channel, T-type, alpha-1 subunit, 450005268$IPR005821:Ion transport]
calcium channel, voltage-dependent, T type, alpha 1G subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038887$hsa04930:Type II diabetes mellitus]
calcium channel, voltage-dependent, T type, alpha 1G subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, T type, alpha 1G subunit,UP_SEQ_FEATURE[850100543$chain:Voltage-dependent T-type calcium channel subunit alpha-1G, 850102573$compositionally biased region:Poly-Gly, 850102574$compositionally biased region:Poly-His, 850105770$glycosylation site:N-linked (GlcNAc...), 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117294$sequence conflict, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
calcium channel, voltage-dependent, beta 1 subunit,INTERPRO[450000497$IPR000584:Voltage-dependent calcium channel, L-type, beta subunit, 450001294$IPR001452:Src homology-3 domain, 450004902$IPR005443:Voltage-dependent calcium channel, L-type, beta-1 subunit, 450007478$IPR008145:Guanylate kinase/L-type calcium channel region]
calcium channel, voltage-dependent, beta 1 subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, beta 1 subunit,PIR_SUPERFAMILY[630012355$PIRSF015600:human voltage-dependent calcium channel beta chain]
calcium channel, voltage-dependent, beta 1 subunit,SMART[760000063$SM00072:GuKc, 760000295$SM00326:SH3]
calcium channel, voltage-dependent, beta 1 subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, beta 1 subunit,UP_SEQ_FEATURE[850100536$chain:Voltage-dependent L-type calcium channel subunit beta-1, 850105350$domain:SH3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium channel, voltage-dependent, beta 3 subunit,INTERPRO[450000497$IPR000584:Voltage-dependent calcium channel, L-type, beta subunit, 450001294$IPR001452:Src homology-3 domain, 450007416$IPR008079:Voltage-dependent calcium channel, L-type, beta-3 subunit, 450007478$IPR008145:Guanylate kinase/L-type calcium channel region]
calcium channel, voltage-dependent, beta 3 subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, beta 3 subunit,PIR_SUPERFAMILY[630012355$PIRSF015600:human voltage-dependent calcium channel beta chain]
calcium channel, voltage-dependent, beta 3 subunit,SMART[760000063$SM00072:GuKc, 760000295$SM00326:SH3]
calcium channel, voltage-dependent, beta 3 subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, beta 3 subunit,UP_SEQ_FEATURE[850100538$chain:Voltage-dependent L-type calcium channel subunit beta-3, 850105350$domain:SH3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium channel, voltage-dependent, gamma subunit 1,INTERPRO[450003550$IPR004031:PMP-22/EMP/MP20/Claudin, 450004879$IPR005421:Voltage-dependent calcium channel, gamma-1 subunit, 450007646$IPR008368:Voltage-dependent calcium channel, gamma subunit]
calcium channel, voltage-dependent, gamma subunit 1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, gamma subunit 1,PIR_SUPERFAMILY[630015063$PIRSF018449:voltage-dependent calcium channel gamma-1 subunit]
calcium channel, voltage-dependent, gamma subunit 1,SP_PIR_KEYWORDS[790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, gamma subunit 1,UP_SEQ_FEATURE[850100509$chain:Voltage-dependent calcium channel gamma-1 subunit, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118623$transmembrane region]
calcium homeostasis modulator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
calcium homeostasis modulator 2,UP_SEQ_FEATURE[850008932$chain:Calcium homeostasis modulator protein 2, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
calcium/calmodulin-dependent protein kinase II gamma,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000043$h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation, 30000070$h_crebPathway:Transcription factor CREB and its extracellular signals, 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
calcium/calmodulin-dependent protein kinase II gamma,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012167$IPR013543:Calcium/calmodulin dependent protein kinase II, association-domain, 450014177$IPR015742:Calcium/calmodulin-dependent protein kinase II isoform, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase II gamma,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038846$hsa04310:Wnt signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038879$hsa04740:Olfactory transduction, 470038883$hsa04912:GnRH signaling pathway, 470038885$hsa04916:Melanogenesis, 470038904$hsa05214:Glioma]
calcium/calmodulin-dependent protein kinase II gamma,PIR_SUPERFAMILY[630000701$PIRSF000594:calcium/calmodulin-dependent protein kinase II]
calcium/calmodulin-dependent protein kinase II gamma,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase II gamma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase II gamma,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009093$chain:Calcium/calmodulin-dependent protein kinase type II subunit gamma, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,KEGG_PATHWAY[470038886$hsa04920:Adipocytokine signaling pathway]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009078$chain:Calcium/calmodulin-dependent protein kinase kinase 1, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110972$region of interest:Autoinhibitory domain, 850111164$region of interest:Calmodulin-binding, 850114558$region of interest:RP domain, 850117295$sequence variant, 850118574$splice variant]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038832$hsa04070:Phosphatidylinositol signaling system, 470038835$hsa04114:Oocyte meiosis, 470038845$hsa04270:Vascular smooth muscle contraction, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038879$hsa04740:Olfactory transduction, 470038882$hsa04910:Insulin signaling pathway, 470038883$hsa04912:GnRH signaling pathway, 470038885$hsa04916:Melanogenesis, 470038891$hsa05010:Alzheimer's disease, 470038904$hsa05214:Glioma]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),PIR_SUPERFAMILY[630002469$PIRSF002350:calmodulin]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),SMART[760000046$SM00054:EFh]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000473$duplication, 790000480$EF hand, 790000811$isopeptide bond, 790000825$kinase, 790000950$methylated amino acid, 790000953$methylation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta),UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850000630$calcium-binding region:4, 850009122$chain:Calmodulin, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
calmodulin binding transcription activator 1,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450001870$IPR002110:Ankyrin, 450002569$IPR002909:Cell surface receptor IPT/TIG, 450005011$IPR005559:CG-1]
calmodulin binding transcription activator 1,SMART[760000009$SM00015:IQ, 760000220$SM00248:ANK, 760000375$SM00429:IPT]
calmodulin binding transcription activator 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
calmodulin binding transcription activator 1,UP_SEQ_FEATURE[850009135$chain:Calmodulin-binding transcription activator 1, 850102573$compositionally biased region:Poly-Gly, 850102585$compositionally biased region:Poly-Val, 850102903$DNA-binding region:CG-1, 850104420$domain:IPT/TIG, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
calpain, small subunit 1,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
calpain, small subunit 1,SMART[760000046$SM00054:EFh]
calpain, small subunit 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000264$cell membrane, 790000356$complete proteome, 790000397$cysteine proteinase, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000473$duplication, 790000480$EF hand, 790000679$heterodimer, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001304$repeat]
calpain, small subunit 1,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850009167$chain:Calpain small subunit 1, 850102521$compositionally biased region:Gly-rich (hydrophobic), 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850103581$domain:EF-hand 1; atypical, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850103588$domain:EF-hand 5, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
calreticulin,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart)]
calreticulin,INTERPRO[450000773$IPR000886:Endoplasmic reticulum, targeting sequence, 450001404$IPR001580:Calreticulin/calnexin, 450008191$IPR009033:Calreticulin/calnexin, P, 450008288$IPR009169:Calreticulin, 450011956$IPR013320:Concanavalin A-like lectin/glucanase, subgroup, 450016423$IPR018124:Calreticulin/calnexin, conserved site]
calreticulin,KEGG_PATHWAY[470038860$hsa04612:Antigen processing and presentation]
calreticulin,PIR_SUPERFAMILY[630002474$PIRSF002356:Calreticulin]
calreticulin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000530$extracellular matrix, 790000616$glycoprotein, 790000784$integrin binding, 790000848$Lectin, 790000937$metal-binding, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc]
calreticulin,UP_SEQ_FEATURE[850009200$chain:Calreticulin, 850102471$compositionally biased region:Asp/Glu/Lys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850110284$region of interest:3 X approximate repeats, 850110424$region of interest:4 X approximate repeats, 850111124$region of interest:C-domain, 850113514$region of interest:N-domain, 850113854$region of interest:P-domain, 850115075$repeat:1-1, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115274$repeat:2-1, 850115291$repeat:2-2, 850115306$repeat:2-3, 850117294$sequence conflict, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide]
calumenin,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calumenin,PIR_SUPERFAMILY[630027762$PIRSF036326:reticulocalbin]
calumenin,SMART[760000046$SM00054:EFh]
calumenin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001356$sarcoplasmic reticulum, 790001363$Secreted, 790001405$signal]
calumenin,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000628$calcium-binding region:3; possibly ancestral, 850000630$calcium-binding region:4, 850000631$calcium-binding region:5, 850000632$calcium-binding region:6, 850009221$chain:Calumenin, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850103588$domain:EF-hand 5, 850103589$domain:EF-hand 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118574$splice variant]
canopy 3 homolog (zebrafish),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000763$immune response, 790000777$innate immunity, 790001212$polymorphism, 790001405$signal]
canopy 3 homolog (zebrafish),UP_SEQ_FEATURE[850045312$chain:Protein canopy homolog 3, 850102883$disulfide bond, 850105263$domain:Saposin B-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,INTERPRO[450004794$IPR005331:Carbohydrate sulfotransferase, 8-13, 450016317$IPR018011:Carbohydrate sulfotransferase-related]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,SP_PIR_KEYWORDS[790000232$carbohydrate metabolism, 790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8,UP_SEQ_FEATURE[850009417$chain:Carbohydrate sulfotransferase 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106312$nucleotide phosphate-binding region:PAPS, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,INTERPRO[450000753$IPR000863:Sulfotransferase]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,UP_SEQ_FEATURE[850009410$chain:Carbohydrate sulfotransferase 15, 850105770$glycosylation site:N-linked (GlcNAc...), 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
carboxypeptidase D,INTERPRO[450000726$IPR000834:Peptidase M14, carboxypeptidase A, 450013216$IPR014766:Carboxypeptidase, regulatory region, 450014007$IPR015567:Peptidase M14B, caboxypeptidase D unit2]
carboxypeptidase D,SMART[760000546$SM00631:Zn_pept]
carboxypeptidase D,SP_PIR_KEYWORDS[790000242$carboxypeptidase, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000881$lipoprotein, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001648$zinc]
carboxypeptidase D,UP_SEQ_FEATURE[850000091$active site:Nucleophile 1, 850000092$active site:Nucleophile 2, 850009661$chain:Carboxypeptidase D, 850105770$glycosylation site:N-linked (GlcNAc...), 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850111180$region of interest:Carboxypeptidase-like 1, 850111181$region of interest:Carboxypeptidase-like 2, 850111182$region of interest:Carboxypeptidase-like 3, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein),INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein),SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein),UP_SEQ_FEATURE[850009681$chain:Carcinoembryonic antigen-related cell adhesion molecule 1, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
carcinoembryonic antigen-related cell adhesion molecule 7,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
carcinoembryonic antigen-related cell adhesion molecule 7,PIR_SUPERFAMILY[630002149$PIRSF002013:biliary glycoprotein]
carcinoembryonic antigen-related cell adhesion molecule 7,SMART[760000357$SM00409:IG]
carcinoembryonic antigen-related cell adhesion molecule 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000768$Immunoglobulin domain, 790000881$lipoprotein, 790000919$membrane, 790001149$phosphatidylinositol linkage, 790001212$polymorphism, 790001304$repeat, 790001405$signal]
carcinoembryonic antigen-related cell adhesion molecule 7,UP_SEQ_FEATURE[850009693$chain:Carcinoembryonic antigen-related cell adhesion molecule 7, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105861$lipid moiety-binding region:GPI-anchor amidated serine, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
carcinoembryonic antigen-related cell adhesion molecule 8,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
carcinoembryonic antigen-related cell adhesion molecule 8,SMART[760000357$SM00409:IG]
carcinoembryonic antigen-related cell adhesion molecule 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000768$Immunoglobulin domain, 790000881$lipoprotein, 790000919$membrane, 790001149$phosphatidylinositol linkage, 790001212$polymorphism, 790001304$repeat, 790001405$signal]
carcinoembryonic antigen-related cell adhesion molecule 8,UP_SEQ_FEATURE[850009694$chain:Carcinoembryonic antigen-related cell adhesion molecule 8, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105858$lipid moiety-binding region:GPI-anchor amidated aspartate, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
cardiolipin synthase 1,INTERPRO[450000392$IPR000462:CDP-alcohol phosphatidyltransferase]
cardiolipin synthase 1,KEGG_PATHWAY[470038778$hsa00564:Glycerophospholipid metabolism]
cardiolipin synthase 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001156$phospholipid biosynthesis, 790001547$transferase, 790001555$transmembrane]
cardiolipin synthase 1,UP_SEQ_FEATURE[850009702$chain:Cardiolipin synthase, 850118623$transmembrane region]
cartilage associated protein,OMIM_DISEASE[520003809$Osteogenesis imperfecta, type IIB, 520003811$Osteogenesis imperfecta, type VII]
cartilage associated protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
cartilage associated protein,UP_SEQ_FEATURE[850009762$chain:Cartilage-associated protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
casein kinase 1, alpha 1,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart), 30000214$h_p35alzheimersPathway:Deregulation of CDK5 in Alzheimers Disease, 30000216$h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system, 30000313$h_wntPathway:WNT Signaling Pathway]
casein kinase 1, alpha 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, alpha 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway]
casein kinase 1, alpha 1,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, alpha 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000825$kinase, 790000827$kinetochore, 790000973$mitosis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, alpha 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009774$chain:Casein kinase I isoform alpha, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
casein kinase 2, alpha 1 polypeptide pseudogene; casein kinase 2, alpha 1 polypeptide,BIOCARTA[30000091$h_egfPathway:EGF Signaling Pathway, 30000100$h_epoPathway:EPO Signaling Pathway, 30000147$h_igf1Pathway:IGF-1 Signaling Pathway, 30000155$h_il2Pathway:IL 2 signaling pathway, 30000160$h_il6Pathway:IL 6 signaling pathway, 30000163$h_insulinPathway:Insulin Signaling Pathway, 30000173$h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development, 30000201$h_ngfPathway:Nerve growth factor pathway (NGF), 30000222$h_pdgfPathway:PDGF Signaling Pathway, 30000301$h_TPOPathway:TPO Signaling Pathway, 30000313$h_wntPathway:WNT Signaling Pathway]
casein kinase 2, alpha 1 polypeptide pseudogene; casein kinase 2, alpha 1 polypeptide,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 2, alpha 1 polypeptide pseudogene; casein kinase 2, alpha 1 polypeptide,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038856$hsa04520:Adherens junction, 470038857$hsa04530:Tight junction]
casein kinase 2, alpha 1 polypeptide pseudogene; casein kinase 2, alpha 1 polypeptide,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein]
casein kinase 2, alpha 1 polypeptide pseudogene; casein kinase 2, alpha 1 polypeptide,SMART[760000193$SM00220:S_TKc]
casein kinase 2, alpha 1 polypeptide pseudogene; casein kinase 2, alpha 1 polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000686$heterotetramer, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 2, alpha 1 polypeptide pseudogene; casein kinase 2, alpha 1 polypeptide,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009786$chain:Casein kinase II subunit alpha, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
caspase 8 associated protein 2,SP_PIR_KEYWORDS[790000020$activator, 790000109$Apoptosis, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
caspase 8 associated protein 2,UP_SEQ_FEATURE[850009801$chain:CASP8-associated protein 2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850113555$region of interest:NCOA2-binding, 850117294$sequence conflict, 850117295$sequence variant]
caspase 8, apoptosis-related cysteine peptidase,BBID[10000037$150.caspase_and_NFKB_activation, 10000063$39.Deg_of_Chromosomal_DNA, 10000065$40.Deg_of_Chrom_DNA_TNF-ind_apoptosis, 10000067$44.Sig_Trans_TNFR1-DR3-DR4_DR5, 10000068$46.P13K_PTEN, 10000093$72.IAP_interaction_with_cell_death_pathways, 10000108$86.Apoptosis_Nematode&_Vert]
caspase 8, apoptosis-related cysteine peptidase,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000060$h_ceramidePathway:Ceramide Signaling Pathway, 30000079$h_d4gdiPathway:D4-GDI Signaling Pathway, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000274$h_soddPathway:SODD/TNFR1 Signaling Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
caspase 8, apoptosis-related cysteine peptidase,INTERPRO[450001153$IPR001309:Peptidase C14, ICE, catalytic subunit p20, 450001658$IPR001875:Death effector, 450001895$IPR002138:Peptidase C14, caspase non-catalytic subunit p10, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450010009$IPR011029:DEATH-like, 450010431$IPR011600:Peptidase C14, caspase catalytic, 450014334$IPR015917:Peptidase C14, caspase precursor p45, core, 450014488$IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site]
caspase 8, apoptosis-related cysteine peptidase,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway, 470038843$hsa04210:Apoptosis, 470038862$hsa04620:Toll-like receptor signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway, 470038864$hsa04622:RIG-I-like receptor signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038894$hsa05016:Huntington's disease, 470038899$hsa05200:Pathways in cancer, 470038923$hsa05416:Viral myocarditis]
caspase 8, apoptosis-related cysteine peptidase,OMIM_DISEASE[520000487$Autoimmune lymphoproliferative syndrome, type IIB, 520000688$Breast cancer, protection against, 520002293$Hepatocellular carcinoma, somatic, 520002967$Lung cancer, protection against]
caspase 8, apoptosis-related cysteine peptidase,PIR_SUPERFAMILY[630029212$PIRSF037643:Casp8 and Fadd-like apoptosis regulator/caspase, types 8/10, 630030828$PIRSF500656:caspase-8]
caspase 8, apoptosis-related cysteine peptidase,SMART[760000023$SM00031:DED, 760000102$SM00115:CASc]
caspase 8, apoptosis-related cysteine peptidase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001509$thiol protease, 790001652$zymogen]
caspase 8, apoptosis-related cysteine peptidase,UP_SEQ_FEATURE[850009845$chain:Caspase-8 subunit p10, 850009847$chain:Caspase-8 subunit p18, 850103512$domain:DED 1, 850103513$domain:DED 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
caspase recruitment domain family, member 9,INTERPRO[450001158$IPR001315:Caspase Recruitment]
caspase recruitment domain family, member 9,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
caspase recruitment domain family, member 9,PIR_SUPERFAMILY[630029924$PIRSF038351:caspase recruitment domain-containing protein 9]
caspase recruitment domain family, member 9,SMART[760000101$SM00114:CARD]
caspase recruitment domain family, member 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
caspase recruitment domain family, member 9,UP_SEQ_FEATURE[850009812$chain:Caspase recruitment domain-containing protein 9, 850103287$domain:CARD, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
catenin (cadherin-associated protein), alpha 1, 102kDa,BIOCARTA[30000058$h_cell2cellPathway:Cell to Cell Adhesion Signaling]
catenin (cadherin-associated protein), alpha 1, 102kDa,INTERPRO[450000541$IPR000633:Vinculin, conserved site, 450000906$IPR001033:Alpha-catenin, 450005513$IPR006077:Vinculin/alpha-catenin]
catenin (cadherin-associated protein), alpha 1, 102kDa,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038857$hsa04530:Tight junction, 470038873$hsa04670:Leukocyte transendothelial migration, 470038899$hsa05200:Pathways in cancer, 470038903$hsa05213:Endometrial cancer, 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC)]
catenin (cadherin-associated protein), alpha 1, 102kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
catenin (cadherin-associated protein), alpha 1, 102kDa,UP_SEQ_FEATURE[850009894$chain:Catenin alpha-1, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cell death-inducing DFFA-like effector b,INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N]
cell death-inducing DFFA-like effector b,SMART[760000238$SM00266:CAD]
cell death-inducing DFFA-like effector b,SP_PIR_KEYWORDS[790000002$3d-structure, 790000109$Apoptosis, 790000356$complete proteome, 790001162$phosphoprotein]
cell death-inducing DFFA-like effector b,UP_SEQ_FEATURE[850010287$chain:Cell death activator CIDE-B, 850103367$domain:CIDE-N, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
cell death-inducing DFFA-like effector c,INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N]
cell death-inducing DFFA-like effector c,SMART[760000238$SM00266:CAD]
cell death-inducing DFFA-like effector c,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm]
cell death-inducing DFFA-like effector c,UP_SEQ_FEATURE[850010285$chain:Cell death activator CIDE-3, 850103367$domain:CIDE-N, 850118574$splice variant]
cell division cycle 25 homolog B (S. pombe),INTERPRO[450000646$IPR000751:M-phase inducer phosphatase, 450001562$IPR001763:Rhodanese-like]
cell division cycle 25 homolog B (S. pombe),KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038834$hsa04110:Cell cycle, 470038884$hsa04914:Progesterone-mediated oocyte maturation]
cell division cycle 25 homolog B (S. pombe),PIR_SUPERFAMILY[630001061$PIRSF000918:protein-tyrosine-phosphatase Cdc25A]
cell division cycle 25 homolog B (S. pombe),SMART[760000395$SM00450:RHOD]
cell division cycle 25 homolog B (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000259$cell cycle control, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000743$hydrolase, 790000973$mitosis, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001587$tyrosine-specific phosphatase]
cell division cycle 25 homolog B (S. pombe),UP_SEQ_FEATURE[850029445$chain:M-phase inducer phosphatase 2, 850105184$domain:Rhodanese, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cell division cycle 25 homolog C (S. pombe),BIOCARTA[30000191$h_mPRPathway:How Progesterone Initiates the Oocyte Maturation, 30000233$h_plk3Pathway:Regulation of cell cycle progression by Plk3]
cell division cycle 25 homolog C (S. pombe),INTERPRO[450000646$IPR000751:M-phase inducer phosphatase, 450001562$IPR001763:Rhodanese-like]
cell division cycle 25 homolog C (S. pombe),KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038835$hsa04114:Oocyte meiosis, 470038884$hsa04914:Progesterone-mediated oocyte maturation]
cell division cycle 25 homolog C (S. pombe),PIR_SUPERFAMILY[630001060$PIRSF000917:protein-tyrosine-phosphatase Cdc25C]
cell division cycle 25 homolog C (S. pombe),SMART[760000395$SM00450:RHOD]
cell division cycle 25 homolog C (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000259$cell cycle control, 790000260$cell division, 790000356$complete proteome, 790000733$host-virus interaction, 790000743$hydrolase, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001587$tyrosine-specific phosphatase]
cell division cycle 25 homolog C (S. pombe),UP_SEQ_FEATURE[850029446$chain:M-phase inducer phosphatase 3, 850105184$domain:Rhodanese, 850106258$modified residue, 850106259$mutagenesis site, 850111902$region of interest:HIV-1 Vpr binding site, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
cell division cycle 26 homolog (S. cerevisiae); cell division cycle 26 homolog (S. cerevisiae) pseudogene,INTERPRO[450017132$IPR018860:Anaphase-promoting complex, subunit CDC26]
cell division cycle 26 homolog (S. cerevisiae); cell division cycle 26 homolog (S. cerevisiae) pseudogene,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038835$hsa04114:Oocyte meiosis, 470038837$hsa04120:Ubiquitin mediated proteolysis, 470038884$hsa04914:Progesterone-mediated oocyte maturation]
cell division cycle 26 homolog (S. cerevisiae); cell division cycle 26 homolog (S. cerevisiae) pseudogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001593$ubl conjugation pathway]
cell division cycle 26 homolog (S. cerevisiae); cell division cycle 26 homolog (S. cerevisiae) pseudogene,UP_SEQ_FEATURE[850005244$chain:Anaphase-promoting complex subunit CDC26, 850105852$helix, 850106258$modified residue]
cell division cycle 34 homolog (S. cerevisiae),BBID[10000106$84.Ubiquitination_Pathways_Cell_Cycle]
cell division cycle 34 homolog (S. cerevisiae),BIOCARTA[30000111$h_fbw7Pathway:Cyclin E Destruction Pathway, 30000121$h_g2Pathway:Cell Cycle: G2/M Checkpoint, 30000270$h_skp2e2fPathway:E2F1 Destruction Pathway]
cell division cycle 34 homolog (S. cerevisiae),INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
cell division cycle 34 homolog (S. cerevisiae),KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
cell division cycle 34 homolog (S. cerevisiae),SMART[760000185$SM00212:UBCc]
cell division cycle 34 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000356$complete proteome, 790000859$ligase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001593$ubl conjugation pathway]
cell division cycle 34 homolog (S. cerevisiae),UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068099$chain:Ubiquitin-conjugating enzyme E2 R1, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118575$strand, 850118624$turn]
cell division cycle 37 homolog (S. cerevisiae),INTERPRO[450004388$IPR004918:Cdc37, 450012453$IPR013855:Cdc37, N-terminal, 450012470$IPR013873:Cdc37, C-terminal, 450012471$IPR013874:Cdc37, Hsp90 binding]
cell division cycle 37 homolog (S. cerevisiae),PIR_SUPERFAMILY[630014172$PIRSF017420:Hsp90 co-chaperone Cdc37]
cell division cycle 37 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
cell division cycle 37 homolog (S. cerevisiae),UP_SEQ_FEATURE[850024889$chain:Hsp90 co-chaperone Cdc37, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand]
centromere protein H,INTERPRO[450007703$IPR008426:Centromere protein Cenp-H]
centromere protein H,SP_PIR_KEYWORDS[790000012$acetylation, 790000315$chromosomal protein, 790000344$coiled coil, 790000356$complete proteome, 790000827$kinetochore, 790001065$nucleus, 790001212$polymorphism]
centromere protein H,UP_SEQ_FEATURE[850010659$chain:Centromere protein H, 850106258$modified residue, 850117295$sequence variant]
centromere protein K,SP_PIR_KEYWORDS[790000276$centromere, 790000315$chromosomal protein, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000827$kinetochore, 790001065$nucleus]
centromere protein K,UP_SEQ_FEATURE[850010662$chain:Centromere protein K, 850117294$sequence conflict, 850117896$site:Breakpoint for translocation to form MLL- CENPK oncogene]
centrosomal protein 76kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein]
centrosomal protein 76kDa,UP_SEQ_FEATURE[850010705$chain:Centrosomal protein of 76 kDa, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
cereblon,INTERPRO[450002735$IPR003111:Peptidase S16, lon N-terminal]
cereblon,OMIM_DISEASE[520003165$Mental retardation, autosomal recessive 2A]
cereblon,SMART[760000409$SM00464:LON]
cereblon,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790000930$mental retardation]
cereblon,UP_SEQ_FEATURE[850045364$chain:Protein cereblon, 850104735$domain:Lon, 850117294$sequence conflict, 850118574$splice variant]
cerebral dopamine neurotrophic factor,INTERPRO[450017583$IPR019345:Armet protein]
cerebral dopamine neurotrophic factor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000632$growth factor, 790001363$Secreted, 790001405$signal]
cerebral dopamine neurotrophic factor,UP_SEQ_FEATURE[850010744$chain:Cerebral dopamine neurotrophic factor, 850102883$disulfide bond, 850105852$helix, 850117814$signal peptide, 850118574$splice variant, 850118624$turn]
cerebral endothelial cell adhesion molecule,INTERPRO[450000773$IPR000886:Endoplasmic reticulum, targeting sequence, 450002354$IPR002654:Glycosyl transferase, family 25]
cerebral endothelial cell adhesion molecule,PIR_SUPERFAMILY[630016398$PIRSF019839:glycosyltransferase]
cerebral endothelial cell adhesion molecule,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001405$signal]
cerebral endothelial cell adhesion molecule,UP_SEQ_FEATURE[850022148$chain:Glycosyltransferase 25 family member 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118574$splice variant]
ceroid-lipofuscinosis, neuronal 5,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
ceroid-lipofuscinosis, neuronal 5,OMIM_DISEASE[520000926$Ceroid-lipofuscinosis, neuronal-5, variant late infantile]
ceroid-lipofuscinosis, neuronal 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000509$epilepsy, 790000616$glycoprotein, 790000897$lysosome, 790001015$neurodegeneration, 790001019$neuronal ceroid lipofuscinosis, 790001212$polymorphism, 790001405$signal]
ceroid-lipofuscinosis, neuronal 5,UP_SEQ_FEATURE[850010746$chain:Ceroid-lipofuscinosis neuronal protein 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
chemokine (C-C motif) ligand 13,BBID[10000012$109.Chemokine_families]
chemokine (C-C motif) ligand 13,INTERPRO[450000719$IPR000827:Small chemokine, C-C group, conserved site, 450001604$IPR001811:Small chemokine, interleukin-8-like]
chemokine (C-C motif) ligand 13,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway]
chemokine (C-C motif) ligand 13,PIR_SUPERFAMILY[630002087$PIRSF001950:small inducible chemokine, C/CC types, 630030769$PIRSF500572:small inducible cytokine, A2 type]
chemokine (C-C motif) ligand 13,SMART[760000172$SM00199:SCY]
chemokine (C-C motif) ligand 13,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000775$inflammatory response, 790001212$polymorphism, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal]
chemokine (C-C motif) ligand 13,UP_SEQ_FEATURE[850008601$chain:C-C motif chemokine 13, long chain, 850008602$chain:C-C motif chemokine 13, medium chain, 850008603$chain:C-C motif chemokine 13, short chain, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
chemokine (C-C motif) ligand 27,INTERPRO[450000719$IPR000827:Small chemokine, C-C group, conserved site]
chemokine (C-C motif) ligand 27,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway, 470038874$hsa04672:Intestinal immune network for IgA production]
chemokine (C-C motif) ligand 27,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790001212$polymorphism, 790001405$signal]
chemokine (C-C motif) ligand 27,UP_SEQ_FEATURE[850008620$chain:C-C motif chemokine 27, 850102883$disulfide bond, 850117295$sequence variant, 850117814$signal peptide]
chemokine (C-C motif) receptor-like 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000305$IPR000355:Chemokine receptor, 450004841$IPR005383:C-C chemokine receptor, type 11, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
chemokine (C-C motif) receptor-like 1,PIR_SUPERFAMILY[630030051$PIRSF038545:chemokine receptor, 630031154$PIRSF501028:chemokine receptor-like  protein CCRL1, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
chemokine (C-C motif) receptor-like 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
chemokine (C-C motif) receptor-like 1,UP_SEQ_FEATURE[850008588$chain:C-C chemokine receptor type 11, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chemokine (C-X-C motif) ligand 16,INTERPRO[450016352$IPR018048:Small chemokine, C-X-C, conserved site]
chemokine (C-X-C motif) ligand 16,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C-X-C motif) ligand 16,SP_PIR_KEYWORDS[790000264$cell membrane, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
chemokine (C-X-C motif) ligand 16,UP_SEQ_FEATURE[850008777$chain:C-X-C motif chemokine 16, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850111243$region of interest:Chemokine, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chemokine (C-X-C motif) receptor 3,BBID[10000030$14.chemokine_receptor-ligand, 10000036$15.T-cell_polarization-chemokine_receptors, 10000043$16.Chemokines-rec-T-cells]
chemokine (C-X-C motif) receptor 3,BIOCARTA[30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000181$h_mCalpainPathway:mCalpain and friends in Cell motility, 30000203$h_nktPathway:Selective expression of chemokine receptors during T-cell polarization, 30000205$h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells]
chemokine (C-X-C motif) receptor 3,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000305$IPR000355:Chemokine receptor, 450003586$IPR004070:C-X-C chemokine receptor, type 3, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
chemokine (C-X-C motif) receptor 3,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C-X-C motif) receptor 3,PIR_SUPERFAMILY[630030051$PIRSF038545:chemokine receptor, 630031149$PIRSF501023:chemokine receptor CXCR3, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
chemokine (C-X-C motif) receptor 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
chemokine (C-X-C motif) receptor 3,UP_SEQ_FEATURE[850008765$chain:C-X-C chemokine receptor type 3, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chimerin (chimaerin) 1,BIOCARTA[30000246$h_rac1Pathway:Rac 1 cell motility signaling pathway]
chimerin (chimaerin) 1,INTERPRO[450000169$IPR000198:RhoGAP, 450000852$IPR000980:SH2 motif, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450015680$IPR017356:N-chimaerin]
chimerin (chimaerin) 1,OMIM_DISEASE[520001570$Duane retraction syndrome 2]
chimerin (chimaerin) 1,PIR_SUPERFAMILY[630029593$PIRSF038015:chimaerin, 630029594$PIRSF038015:N-chimaerin]
chimerin (chimaerin) 1,SMART[760000096$SM00109:C1, 760000224$SM00252:SH2, 760000293$SM00324:RhoGAP]
chimerin (chimaerin) 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000640$GTPase activation, 790000937$metal-binding, 790001397$SH2 domain, 790001648$zinc, 790001651$zinc-finger]
chimerin (chimaerin) 1,UP_SEQ_FEATURE[850033259$chain:N-chimaerin, 850105183$domain:Rho-GAP, 850105346$domain:SH2, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118624$turn, 850118892$zinc finger region:Phorbol-ester/DAG-type]
chloride channel 7,INTERPRO[450000551$IPR000644:Cystathionine beta-synthase, core, 450001600$IPR001807:Chloride channel, voltage gated, 450001995$IPR002249:Chloride channel CLC-7, 450005736$IPR006311:Twin-arginine translocation pathway signal, 450013194$IPR014743:Chloride channel, core]
chloride channel 7,OMIM_DISEASE[520003819$Osteopetrosis, autosomal dominant 2, 520003820$Osteopetrosis, autosomal dominant, type II, 520003824$Osteopetrosis, autosomal recessive 4, 520003828$Osteopetrosis, recessive]
chloride channel 7,PIR_SUPERFAMILY[630012791$PIRSF016017:PIRSF016017]
chloride channel 7,SMART[760000103$SM00116:CBS]
chloride channel 7,SP_PIR_KEYWORDS[790000102$antiport, 790000138$atp-binding, 790000255$CBS domain, 790000295$chloride, 790000356$complete proteome, 790000446$disease mutation, 790000798$ion transport, 790000897$lysosome, 790000919$membrane, 790001063$nucleotide-binding, 790001084$osteopetrosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
chloride channel 7,UP_SEQ_FEATURE[850000281$binding site:Chloride, 850000287$binding site:Chloride; via amide nitrogen, 850022835$chain:H(+)/Cl(-) exchange transporter 7, 850103311$domain:CBS 1, 850103312$domain:CBS 2, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850112009$region of interest:In-membrane helix, 850112010$region of interest:In-membrane loop between two helices, 850117294$sequence conflict, 850117295$sequence variant, 850117701$short sequence motif:Selectivity filter part_1, 850117702$short sequence motif:Selectivity filter part_2, 850117703$short sequence motif:Selectivity filter part_3, 850118429$site:Mediates proton transfer from the outer aqueous phase to the interior of the protein; involved in linking H(+) and Cl(-) transport, 850118430$site:Mediates proton transfer from the protein to the inner aqueous phase, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
chloride channel Ka,INTERPRO[450000551$IPR000644:Cystathionine beta-synthase, core, 450001600$IPR001807:Chloride channel, voltage gated, 450001996$IPR002250:Chloride channel CLC-K, 450013194$IPR014743:Chloride channel, core]
chloride channel Ka,OMIM_DISEASE[520000534$Bartter syndrome, type 4, digenic]
chloride channel Ka,PIR_SUPERFAMILY[630012657$PIRSF015889:chloride channel, Ka/Kb types]
chloride channel Ka,SMART[760000103$SM00116:CBS]
chloride channel Ka,SP_PIR_KEYWORDS[790000002$3d-structure, 790000255$CBS domain, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
chloride channel Ka,UP_SEQ_FEATURE[850011081$chain:Chloride channel protein ClC-Ka, 850103311$domain:CBS 1, 850103312$domain:CBS 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118623$transmembrane region, 850118624$turn]
chloride intracellular channel 3,INTERPRO[450002597$IPR002946:Intracellular chloride channel, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
chloride intracellular channel 3,PIR_SUPERFAMILY[630029378$PIRSF037806:chloride intracellular channel protein]
chloride intracellular channel 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000407$cytoplasm, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
chloride intracellular channel 3,UP_SEQ_FEATURE[850011087$chain:Chloride intracellular channel protein 3, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850114321$region of interest:Required for insertion into the membrane, 850117295$sequence variant, 850118575$strand, 850118623$transmembrane region]
cholecystokinin B receptor,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000268$IPR000314:Gastrin receptor, 450008246$IPR009126:Cholecystokinin receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
cholecystokinin B receptor,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction]
cholecystokinin B receptor,PIR_SUPERFAMILY[630030085$PIRSF038581:cholecystokinin receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
cholecystokinin B receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000709$hormone receptor, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
cholecystokinin B receptor,UP_SEQ_FEATURE[850020664$chain:Gastrin/cholecystokinin type B receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cholesteryl ester transfer protein, plasma,INTERPRO[450000985$IPR001124:Lipid-binding serum glycoprotein, C-terminal, 450015450$IPR017130:Cholesteryl ester transfer, 450016254$IPR017942:Lipid-binding serum glycoprotein, N-terminal, 450016265$IPR017954:Lipid-binding serum glycoprotein, conserved site]
cholesteryl ester transfer protein, plasma,OMIM_DISEASE[520000930$CETP deficiency, 520001123$Common genetic variation near MC4R is associated with waist circumference and insulin resistance, 520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, 520002325$High density lipoprotein cholesterol level QTL 10, 520002404$Hyperalphalipoproteinemia, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520002950$Longevity, exceptional, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
cholesteryl ester transfer protein, plasma,PIR_SUPERFAMILY[630028701$PIRSF037185:cholesteryl ester transfer protein, 630028702$PIRSF037185:Cholesteryl_ester_transf]
cholesteryl ester transfer protein, plasma,SMART[760000297$SM00328:BPI1, 760000298$SM00329:BPI2]
cholesteryl ester transfer protein, plasma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000133$atherosclerosis, 790000305$cholesterol metabolism, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000616$glycoprotein, 790000873$lipid metabolism, 790000875$lipid transport, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001442$steroid metabolism, 790001558$transport]
cholesteryl ester transfer protein, plasma,UP_SEQ_FEATURE[850011196$chain:Cholesteryl ester transfer protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
cholinergic receptor, nicotinic, alpha 2 (neuronal),INTERPRO[450002127$IPR002394:Nicotinic acetylcholine receptor, N-terminal, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
cholinergic receptor, nicotinic, alpha 2 (neuronal),OMIM_DISEASE[520001761$Epilepsy, nocturnal frontal lobe, type 4]
cholinergic receptor, nicotinic, alpha 2 (neuronal),PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
cholinergic receptor, nicotinic, alpha 2 (neuronal),SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000509$epilepsy, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001558$transport]
cholinergic receptor, nicotinic, alpha 2 (neuronal),UP_SEQ_FEATURE[850034022$chain:Neuronal acetylcholine receptor subunit alpha-2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cholinergic receptor, nicotinic, alpha 6,INTERPRO[450002127$IPR002394:Nicotinic acetylcholine receptor, N-terminal, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
cholinergic receptor, nicotinic, alpha 6,PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
cholinergic receptor, nicotinic, alpha 6,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001301$receptor, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001558$transport]
cholinergic receptor, nicotinic, alpha 6,UP_SEQ_FEATURE[850034026$chain:Neuronal acetylcholine receptor subunit alpha-6, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cholinergic receptor, nicotinic, beta 1 (muscle),BIOCARTA[30000004$h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis]
cholinergic receptor, nicotinic, beta 1 (muscle),INTERPRO[450002127$IPR002394:Nicotinic acetylcholine receptor, N-terminal, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
cholinergic receptor, nicotinic, beta 1 (muscle),OMIM_DISEASE[520003448$Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency, 520003452$Myasthenic syndrome, slow-channel congenital]
cholinergic receptor, nicotinic, beta 1 (muscle),PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
cholinergic receptor, nicotinic, beta 1 (muscle),SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000365$congenital myasthenic syndrome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000797$ion channel, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001026$neurotransmitter receptor, 790001162$phosphoprotein, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001224$postsynaptic membrane, 790001301$receptor, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
cholinergic receptor, nicotinic, beta 1 (muscle),UP_SEQ_FEATURE[850003348$chain:Acetylcholine receptor subunit beta, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cholinergic receptor, nicotinic, beta 3,INTERPRO[450002127$IPR002394:Nicotinic acetylcholine receptor, N-terminal, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
cholinergic receptor, nicotinic, beta 3,PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
cholinergic receptor, nicotinic, beta 3,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001026$neurotransmitter receptor, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001558$transport]
cholinergic receptor, nicotinic, beta 3,UP_SEQ_FEATURE[850034032$chain:Neuronal acetylcholine receptor subunit beta-3, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cholinergic receptor, nicotinic, gamma,BIOCARTA[30000004$h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis]
cholinergic receptor, nicotinic, gamma,INTERPRO[450002127$IPR002394:Nicotinic acetylcholine receptor, N-terminal, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
cholinergic receptor, nicotinic, gamma,OMIM_DISEASE[520001807$Escobar syndrome, 520003408$Multiple pterygium syndrome, lethal type, 520003444$Myasthenia gravis, neonatal transient]
cholinergic receptor, nicotinic, gamma,PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
cholinergic receptor, nicotinic, gamma,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000797$ion channel, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001026$neurotransmitter receptor, 790001162$phosphoprotein, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001224$postsynaptic membrane, 790001301$receptor, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
cholinergic receptor, nicotinic, gamma,UP_SEQ_FEATURE[850003357$chain:Acetylcholine receptor subunit gamma, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chondroitin polymerizing factor,INTERPRO[450007705$IPR008428:Chondroitin N-acetylgalactosaminyltransferase]
chondroitin polymerizing factor,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
chondroitin polymerizing factor,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
chondroitin polymerizing factor,UP_SEQ_FEATURE[850011247$chain:Chondroitin sulfate synthase 2, 850102378$compositionally biased region:Ala-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850105986$metal ion-binding site:Divalent metal cation, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromobox homolog 2 (Pc class homolog, Drosophila),INTERPRO[450000831$IPR000953:Chromo domain, 450016267$IPR017956:AT hook, DNA-binding, conserved site]
chromobox homolog 2 (Pc class homolog, Drosophila),PIR_SUPERFAMILY[630008491$PIRSF009342:mouse modifier protein 3]
chromobox homolog 2 (Pc class homolog, Drosophila),SMART[760000268$SM00298:CHROMO, 760000336$SM00384:AT_hook]
chromobox homolog 2 (Pc class homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
chromobox homolog 2 (Pc class homolog, Drosophila),UP_SEQ_FEATURE[850011370$chain:Chromobox protein homolog 2, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850102884$DNA-binding region:A.T hook, 850103361$domain:Chromo, 850105852$helix, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
chromobox homolog 6,INTERPRO[450000831$IPR000953:Chromo domain, 450016292$IPR017984:Chromo domain subgroup]
chromobox homolog 6,SMART[760000268$SM00298:CHROMO]
chromobox homolog 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000311$chromatin regulator, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
chromobox homolog 6,UP_SEQ_FEATURE[850011373$chain:Chromobox protein homolog 6, 850103361$domain:Chromo, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand]
chromobox homolog 8 (Pc class homolog, Drosophila),INTERPRO[450000831$IPR000953:Chromo domain]
chromobox homolog 8 (Pc class homolog, Drosophila),SMART[760000268$SM00298:CHROMO]
chromobox homolog 8 (Pc class homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000311$chromatin regulator, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
chromobox homolog 8 (Pc class homolog, Drosophila),UP_SEQ_FEATURE[850011375$chain:Chromobox protein homolog 8, 850103361$domain:Chromo, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand]
chromodomain helicase DNA binding protein 3,INTERPRO[450000283$IPR000330:SNF2-related, 450000831$IPR000953:Chromo domain, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450008565$IPR009462:Protein of unknown function DUF1086, 450008566$IPR009463:Protein of unknown function DUF1087, 450011633$IPR012957:CHD, C-terminal 2, 450011634$IPR012958:CHD, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450018020$IPR019787:Zinc finger, PHD-finger]
chromodomain helicase DNA binding protein 3,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000268$SM00298:CHROMO, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
chromodomain helicase DNA binding protein 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000311$chromatin regulator, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
chromodomain helicase DNA binding protein 3,UP_SEQ_FEATURE[850011383$chain:Chromodomain-helicase-DNA-binding protein 3, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850103362$domain:Chromo 1, 850103363$domain:Chromo 2, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117387$short sequence motif:DEAH box, 850118574$splice variant, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
chromogranin A (parathyroid secretory protein 1),INTERPRO[450001612$IPR001819:Chromogranin A/B, 450001762$IPR001990:Chromogranin/secretogranin, 450016358$IPR018054:Chromogranin, conserved site]
chromogranin A (parathyroid secretory protein 1),PIR_SUPERFAMILY[630001948$PIRSF001811:chromogranin A]
chromogranin A (parathyroid secretory protein 1),SP_PIR_KEYWORDS[790000002$3d-structure, 790000059$amidated carboxyl end, 790000060$amidation, 790000211$calcium, 790000212$calcium binding, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001461$sulfation]
chromogranin A (parathyroid secretory protein 1),UP_SEQ_FEATURE[850011392$chain:Chromogranin-A, 850102883$disulfide bond, 850105822$glycosylation site:O-linked (GalNAc...), 850106258$modified residue, 850106365$peptide:AL-11, 850107497$peptide:EA-92, 850107546$peptide:ER-37, 850107549$peptide:ES-43, 850107761$peptide:GR-44, 850107796$peptide:GV-19, 850108099$peptide:LF-19, 850108631$peptide:Pancreastatin, 850109205$peptide:SS-18, 850109550$peptide:Vasostatin-1, 850109551$peptide:Vasostatin-2, 850109583$peptide:WA-8, 850109589$peptide:WE-14, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
chromosome 1 open reading frame 114,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 114,UP_SEQ_FEATURE[850073582$chain:Uncharacterized protein C1orf114, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 144,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 1 open reading frame 144,UP_SEQ_FEATURE[850097363$chain:UPF0485 protein C1orf144, 850106258$modified residue, 850118574$splice variant]
chromosome 1 open reading frame 145,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 1 open reading frame 145,UP_SEQ_FEATURE[850073601$chain:Uncharacterized protein C1orf145, 850118574$splice variant]
chromosome 1 open reading frame 200,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 1 open reading frame 200,UP_SEQ_FEATURE[850055260$chain:Putative uncharacterized protein C1orf200, 850117294$sequence conflict]
chromosome 1 open reading frame 216,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 1 open reading frame 216,UP_SEQ_FEATURE[850097494$chain:UPF0500 protein C1orf216, 850117294$sequence conflict]
chromosome 1 open reading frame 26,INTERPRO[450006016$IPR006596:Nucleotide binding protein, PINc, 450018056$IPR019825:Legume lectin, beta chain,  Mn/Ca-binding site]
chromosome 1 open reading frame 26,SMART[760000582$SM00670:PINc]
chromosome 1 open reading frame 26,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 26,UP_SEQ_FEATURE[850073650$chain:Uncharacterized protein C1orf26, 850102581$compositionally biased region:Poly-Ser, 850104997$domain:PINc, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 1 open reading frame 50,INTERPRO[450017771$IPR019534:Protein of unknown function DUF2452]
chromosome 1 open reading frame 50,PIR_SUPERFAMILY[630011236$PIRSF013449:Caenorhabditis elegans hypothetical protein C08B11.9]
chromosome 1 open reading frame 50,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 50,UP_SEQ_FEATURE[850073657$chain:Uncharacterized protein C1orf50, 850117295$sequence variant]
chromosome 1 open reading frame 52,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 1 open reading frame 52,UP_SEQ_FEATURE[850098211$chain:UPF0690 protein C1orf52, 850106258$modified residue, 850118574$splice variant]
chromosome 1 open reading frame 70,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 1 open reading frame 70,UP_SEQ_FEATURE[850066271$chain:Transmembrane protein C1orf70, 850118623$transmembrane region]
chromosome 1 open reading frame 83,INTERPRO[450003178$IPR003618:Transcription elongation factor S-II, central region, 450009997$IPR010990:Transcription elongation factor, TFIIS/elongin A/CRSP70, N-terminal, 450013215$IPR014765:Transcription elongation factor, TFIIS/CRSP70, N-terminal, 450016237$IPR017923:TFIIS N-terminal]
chromosome 1 open reading frame 83,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 1 open reading frame 83,UP_SEQ_FEATURE[850073670$chain:Uncharacterized protein C1orf83, 850105476$domain:TFIIS central, 850105477$domain:TFIIS N-terminal, 850117294$sequence conflict, 850118574$splice variant]
chromosome 1 open reading frame 86,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 86,UP_SEQ_FEATURE[850073673$chain:Uncharacterized protein C1orf86, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 10 open reading frame 136,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 10 open reading frame 136,UP_SEQ_FEATURE[850055189$chain:Putative uncharacterized protein C10orf136]
chromosome 10 open reading frame 18,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 10 open reading frame 18,UP_SEQ_FEATURE[850072898$chain:Uncharacterized protein C10orf18, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 11 open reading frame 73,INTERPRO[450007766$IPR008493:Protein of unknown function DUF775]
chromosome 11 open reading frame 73,PIR_SUPERFAMILY[630020624$PIRSF027026:PIRSF027026]
chromosome 11 open reading frame 73,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790001212$polymorphism]
chromosome 11 open reading frame 73,UP_SEQ_FEATURE[850072989$chain:Uncharacterized protein C11orf73, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 12 open reading frame 40; chromosome 12 open reading frame 4,INTERPRO[450017549$IPR019311:Protein of unknown function DUF2362]
chromosome 12 open reading frame 40; chromosome 12 open reading frame 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 12 open reading frame 40; chromosome 12 open reading frame 4,UP_SEQ_FEATURE[850073044$chain:Uncharacterized protein C12orf4, 850073046$chain:Uncharacterized protein C12orf40, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 12 open reading frame 56,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 12 open reading frame 56,UP_SEQ_FEATURE[850073064$chain:Uncharacterized protein C12orf56, 850118574$splice variant]
chromosome 12 open reading frame 65,INTERPRO[450000302$IPR000352:Class I peptide chain release factor]
chromosome 12 open reading frame 65,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 12 open reading frame 65,UP_SEQ_FEATURE[850073074$chain:Uncharacterized protein C12orf65, 850117295$sequence variant, 850118574$splice variant]
chromosome 12 open reading frame 68,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 12 open reading frame 68,UP_SEQ_FEATURE[850073076$chain:Uncharacterized protein C12orf68, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 14 open reading frame 129,INTERPRO[450007310$IPR007967:Protein of unknown function DUF727]
chromosome 14 open reading frame 129,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm]
chromosome 14 open reading frame 129,UP_SEQ_FEATURE[850022508$chain:GSK3-beta interaction protein, 850105852$helix, 850106259$mutagenesis site, 850112379$region of interest:Interaction with GSK3B, 850117294$sequence conflict, 850118575$strand]
chromosome 14 open reading frame 156,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
chromosome 14 open reading frame 156,SMART[760000328$SM00360:RRM]
chromosome 14 open reading frame 156,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation, 790001550$transit peptide]
chromosome 14 open reading frame 156,UP_SEQ_FEATURE[850062291$chain:SRA stem-loop-interacting RNA-binding protein, mitochondrial, 850105211$domain:RRM, 850106258$modified residue, 850106259$mutagenesis site, 850118617$transit peptide:Mitochondrion]
chromosome 14 open reading frame 177,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 14 open reading frame 177,UP_SEQ_FEATURE[850055216$chain:Putative uncharacterized protein C14orf177, 850117295$sequence variant]
chromosome 14 open reading frame 180,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 14 open reading frame 180,UP_SEQ_FEATURE[850066257$chain:Transmembrane protein C14orf180, 850118623$transmembrane region]
chromosome 14 open reading frame 50,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 14 open reading frame 50,UP_SEQ_FEATURE[850073191$chain:Uncharacterized protein C14orf50, 850106258$modified residue, 850117295$sequence variant]
chromosome 14 open reading frame 53,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
chromosome 14 open reading frame 53,UP_SEQ_FEATURE[850073193$chain:Uncharacterized protein C14orf53]
chromosome 15 open reading frame 26,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 15 open reading frame 26,UP_SEQ_FEATURE[850073217$chain:Uncharacterized protein C15orf26, 850117295$sequence variant, 850118574$splice variant]
chromosome 15 open reading frame 32,OMIM_DISEASE[520001932$Framingham Heart Study genome-wide association: results for pulmonary function measures]
chromosome 15 open reading frame 32,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 15 open reading frame 32,UP_SEQ_FEATURE[850073221$chain:Uncharacterized protein C15orf32, 850117295$sequence variant, 850118574$splice variant]
chromosome 16 open reading frame 13,INTERPRO[450009407$IPR010342:Protein of unknown function DUF938]
chromosome 16 open reading frame 13,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein]
chromosome 16 open reading frame 13,UP_SEQ_FEATURE[850097795$chain:UPF0585 protein C16orf13, 850106258$modified residue, 850118574$splice variant]
chromosome 16 open reading frame 5,INTERPRO[450006048$IPR006629:LPS-induced tumor necrosis factor alpha factor, 450017821$IPR019584:Zinc finger region, LITAF-like]
chromosome 16 open reading frame 5,SMART[760000621$SM00714:LITAF]
chromosome 16 open reading frame 5,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 16 open reading frame 5,UP_SEQ_FEATURE[850028907$chain:LITAF-like protein, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict]
chromosome 16 open reading frame 52,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 16 open reading frame 52,UP_SEQ_FEATURE[850073299$chain:Uncharacterized protein C16orf52, 850118574$splice variant]
chromosome 16 open reading frame 55,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 16 open reading frame 55,UP_SEQ_FEATURE[850073303$chain:Uncharacterized protein C16orf55, 850117295$sequence variant]
chromosome 16 open reading frame 62,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
chromosome 16 open reading frame 62,UP_SEQ_FEATURE[850097628$chain:UPF0505 protein C16orf62, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 16 open reading frame 65,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
chromosome 16 open reading frame 65,SMART[760000200$SM00228:PDZ]
chromosome 16 open reading frame 65,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 16 open reading frame 65,UP_SEQ_FEATURE[850036990$chain:PDZ domain-containing protein C16orf65, 850104918$domain:PDZ, 850118574$splice variant]
chromosome 16 open reading frame 73,INTERPRO[450011038$IPR012340:Nucleic acid-binding, OB-fold]
chromosome 16 open reading frame 73,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 16 open reading frame 73,UP_SEQ_FEATURE[850073316$chain:Uncharacterized protein C16orf73, 850117295$sequence variant]
chromosome 16 open reading frame 75,OMIM_DISEASE[520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci]
chromosome 16 open reading frame 75,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000460$dna replication, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 16 open reading frame 75,UP_SEQ_FEATURE[850056973$chain:RecQ-mediated genome instability protein 2, 850102947$DNA-binding region:OB, 850106259$mutagenesis site, 850118574$splice variant]
chromosome 17 open reading frame 103,INTERPRO[450014522$IPR016181:Acyl-CoA N-acyltransferase]
chromosome 17 open reading frame 103,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 17 open reading frame 103,UP_SEQ_FEATURE[850046327$chain:Protein GTLF3B, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 17 open reading frame 39,INTERPRO[450016890$IPR018618:Vacuolar import and degradation protein Vid24]
chromosome 17 open reading frame 39,PIR_SUPERFAMILY[630028865$PIRSF037319:vacuole import and degradation protein Vid24]
chromosome 17 open reading frame 39,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 17 open reading frame 39,UP_SEQ_FEATURE[850073369$chain:Uncharacterized protein C17orf39, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict]
chromosome 17 open reading frame 45,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 17 open reading frame 45,UP_SEQ_FEATURE[850055486$chain:Putative uncharacterized protein NCRNA00188, mitochondrial, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
chromosome 17 open reading frame 46,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 17 open reading frame 46,UP_SEQ_FEATURE[850073371$chain:Uncharacterized protein C17orf46, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 17 open reading frame 55,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 17 open reading frame 55,UP_SEQ_FEATURE[850073379$chain:Uncharacterized protein C17orf55, 850117295$sequence variant]
chromosome 17 open reading frame 68,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 17 open reading frame 68,UP_SEQ_FEATURE[850073395$chain:Uncharacterized protein C17orf68, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 17 open reading frame 81,INTERPRO[450017756$IPR019519:Histone acetylation protein 2]
chromosome 17 open reading frame 81,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
chromosome 17 open reading frame 81,UP_SEQ_FEATURE[850014909$chain:Dermal papilla-derived protein 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 17 open reading frame 96,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
chromosome 17 open reading frame 96,UP_SEQ_FEATURE[850073412$chain:Uncharacterized protein C17orf96, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue]
chromosome 18 open reading frame 1,INTERPRO[450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich]
chromosome 18 open reading frame 1,PIR_SUPERFAMILY[630029678$PIRSF038094:transmembrane prostate androgen-induced protein]
chromosome 18 open reading frame 1,SMART[760000166$SM00192:LDLa]
chromosome 18 open reading frame 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000919$membrane, 790001555$transmembrane]
chromosome 18 open reading frame 1,UP_SEQ_FEATURE[850073451$chain:Uncharacterized protein C18orf1, 850102883$disulfide bond, 850104664$domain:LDL-receptor class A, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 18 open reading frame 45,COG_ONTOLOGY[90000022$Carbohydrate transport and metabolism / Posttranslational modification, protein turnover, chaperones / Intracellular trafficking and secretion]
chromosome 18 open reading frame 45,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
chromosome 18 open reading frame 45,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 18 open reading frame 45,UP_SEQ_FEATURE[850066266$chain:Transmembrane protein C18orf45, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 19 open reading frame 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 19 open reading frame 12,UP_SEQ_FEATURE[850073499$chain:Uncharacterized protein C19orf12, 850118574$splice variant, 850118623$transmembrane region]
chromosome 19 open reading frame 25,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 19 open reading frame 25,UP_SEQ_FEATURE[850097072$chain:UPF0449 protein C19orf25, 850106258$modified residue, 850118574$splice variant]
chromosome 19 open reading frame 30,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 19 open reading frame 30,UP_SEQ_FEATURE[850039205$chain:Pituitary gland-specific factor 1, 850117295$sequence variant, 850118574$splice variant]
chromosome 19 open reading frame 38,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
chromosome 19 open reading frame 38,UP_SEQ_FEATURE[850046404$chain:Protein HIDE1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 19 open reading frame 55,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 19 open reading frame 55,UP_SEQ_FEATURE[850073524$chain:Uncharacterized protein C19orf55, 850102597$compositionally biased region:Ser-rich, 850117295$sequence variant, 850118574$splice variant]
chromosome 19 open reading frame 56,INTERPRO[450004811$IPR005351:Uncharacterised protein family UPF0139]
chromosome 19 open reading frame 56,PIR_SUPERFAMILY[630007702$PIRSF008065:uncharacterized conserved protein]
chromosome 19 open reading frame 56,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 19 open reading frame 56,UP_SEQ_FEATURE[850086889$chain:UPF0139 membrane protein C19orf56, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 19 open reading frame 6,INTERPRO[450017390$IPR019144:Membralin]
chromosome 19 open reading frame 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
chromosome 19 open reading frame 6,UP_SEQ_FEATURE[850031066$chain:Membralin, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850105770$glycosylation site:N-linked (GlcNAc...), 850118574$splice variant, 850118623$transmembrane region]
chromosome 19 open reading frame 62,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 19 open reading frame 62,UP_SEQ_FEATURE[850008345$chain:BRCA1-A complex subunit MERIT40, 850106258$modified residue, 850115054$region of interest:VWFA-like, 850117294$sequence conflict, 850118574$splice variant]
chromosome 19 open reading frame 70,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 19 open reading frame 70,UP_SEQ_FEATURE[850047429$chain:Protein QIL1, 850117294$sequence conflict]
chromosome 2 open reading frame 27B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 2 open reading frame 27B,UP_SEQ_FEATURE[850073934$chain:Uncharacterized protein C2orf27, 850102580$compositionally biased region:Poly-Pro, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 2 open reading frame 34,INTERPRO[450017648$IPR019410:Methyltransferase-16, putative]
chromosome 2 open reading frame 34,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 2 open reading frame 34,UP_SEQ_FEATURE[850073935$chain:Uncharacterized protein C2orf34, 850117294$sequence conflict, 850118574$splice variant]
chromosome 2 open reading frame 56,COG_ONTOLOGY[90000070$Function unknown]
chromosome 2 open reading frame 56,INTERPRO[450003328$IPR003788:Protein of unknown function DUF185]
chromosome 2 open reading frame 56,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 2 open reading frame 56,UP_SEQ_FEATURE[850046879$chain:Protein midA homolog, mitochondrial, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
chromosome 2 open reading frame 65,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 2 open reading frame 65,UP_SEQ_FEATURE[850073960$chain:Uncharacterized protein C2orf65, 850117295$sequence variant, 850118574$splice variant]
chromosome 2 open reading frame 7,INTERPRO[450002761$IPR003137:Protease-associated PA]
chromosome 2 open reading frame 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
chromosome 2 open reading frame 7,UP_SEQ_FEATURE[850044801$chain:Protease-associated domain-containing protein of 21 kDa, 850104878$domain:PA, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117814$signal peptide, 850118450$site:Not glycosylated]
chromosome 2 open reading frame 79,INTERPRO[450002507$IPR002833:Peptidyl-tRNA hydrolase, PTH2, 450016186$IPR017867:Protein-tyrosine phosphatase, low molecular weight]
chromosome 2 open reading frame 79,SMART[760000198$SM00226:LMWPc]
chromosome 2 open reading frame 79,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 2 open reading frame 79,UP_SEQ_FEATURE[850073975$chain:Uncharacterized protein C2orf79]
chromosome 20 open reading frame 186,INTERPRO[450000985$IPR001124:Lipid-binding serum glycoprotein, C-terminal, 450016254$IPR017942:Lipid-binding serum glycoprotein, N-terminal, 450016265$IPR017954:Lipid-binding serum glycoprotein, conserved site]
chromosome 20 open reading frame 186,SMART[760000297$SM00328:BPI1, 760000298$SM00329:BPI2]
chromosome 20 open reading frame 186,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chromosome 20 open reading frame 186,UP_SEQ_FEATURE[850029012$chain:Long palate, lung and nasal epithelium carcinoma-associated protein 4, 850102517$compositionally biased region:Gly-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
chromosome 20 open reading frame 194,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type]
chromosome 20 open reading frame 194,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 20 open reading frame 194,UP_SEQ_FEATURE[850073715$chain:Uncharacterized protein C20orf194, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 20 open reading frame 200,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 20 open reading frame 200,UP_SEQ_FEATURE[850055271$chain:Putative uncharacterized protein C20orf200, 850106258$modified residue, 850117295$sequence variant]
chromosome 20 open reading frame 4,INTERPRO[450007292$IPR007946:AAR2]
chromosome 20 open reading frame 4,PIR_SUPERFAMILY[630014361$PIRSF017682:U5 snRNP recycling factor Aar2]
chromosome 20 open reading frame 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001212$polymorphism]
chromosome 20 open reading frame 4,UP_SEQ_FEATURE[850073730$chain:Uncharacterized protein C20orf4, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 20 open reading frame 46,OMIM_DISEASE[520001996$Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis]
chromosome 20 open reading frame 46,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 20 open reading frame 46,UP_SEQ_FEATURE[850066276$chain:Transmembrane protein C20orf46, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 20 open reading frame 71,INTERPRO[450016254$IPR017942:Lipid-binding serum glycoprotein, N-terminal]
chromosome 20 open reading frame 71,SMART[760000297$SM00328:BPI1]
chromosome 20 open reading frame 71,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790001212$polymorphism, 790001405$signal]
chromosome 20 open reading frame 71,UP_SEQ_FEATURE[850060646$chain:Short palate, lung and nasal epithelium carcinoma-associated protein 3, 850102570$compositionally biased region:Poly-Gln, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
chromosome 21 open reading frame 45,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000276$centromere, 790000356$complete proteome, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 21 open reading frame 45,UP_SEQ_FEATURE[850046885$chain:Protein Mis18-alpha, 850106258$modified residue, 850106259$mutagenesis site]
chromosome 21 open reading frame 66,INTERPRO[450011568$IPR012890:GC-rich sequence DNA-binding factor-like]
chromosome 21 open reading frame 66,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
chromosome 21 open reading frame 66,UP_SEQ_FEATURE[850020723$chain:GC-rich sequence DNA-binding factor homolog, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
chromosome 21 open reading frame 70; hypothetical LOC729774; hypothetical LOC729535,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 21 open reading frame 70; hypothetical LOC729774; hypothetical LOC729535,UP_SEQ_FEATURE[850073780$chain:Uncharacterized protein C21orf70, 850102566$compositionally biased region:Poly-Arg, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
chromosome 22 open reading frame 29,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 22 open reading frame 29,UP_SEQ_FEATURE[850073817$chain:Uncharacterized protein C22orf29, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 22 open reading frame 30,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 22 open reading frame 30,UP_SEQ_FEATURE[850073819$chain:Uncharacterized protein C22orf30, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 22 open reading frame 32,INTERPRO[450017054$IPR018782:Uncharacterised protein family UPF0466]
chromosome 22 open reading frame 32,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide, 790001555$transmembrane]
chromosome 22 open reading frame 32,UP_SEQ_FEATURE[850097126$chain:UPF0466 protein C22orf32, mitochondrial, 850102462$compositionally biased region:Asp/Glu-rich, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
chromosome 22 open reading frame 43,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 22 open reading frame 43,UP_SEQ_FEATURE[850055287$chain:Putative uncharacterized protein C22orf43, 850102458$compositionally biased region:Asp-rich, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 3 open reading frame 20,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
chromosome 3 open reading frame 20,UP_SEQ_FEATURE[850074069$chain:Uncharacterized protein C3orf20, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 3 open reading frame 35,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 3 open reading frame 35,UP_SEQ_FEATURE[850005768$chain:AP20 region protein 1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 3 open reading frame 39,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790001405$signal, 790001547$transferase]
chromosome 3 open reading frame 39,UP_SEQ_FEATURE[850069447$chain:Uncharacterized glycosyltransferase AGO61, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide]
chromosome 3 open reading frame 63,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 3 open reading frame 63,UP_SEQ_FEATURE[850074100$chain:Uncharacterized protein C3orf63, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 3 open reading frame 71,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 3 open reading frame 71,UP_SEQ_FEATURE[850074104$chain:Uncharacterized protein C3orf71, 850102566$compositionally biased region:Poly-Arg, 850118623$transmembrane region]
chromosome 3 open reading frame 75,INTERPRO[450016899$IPR018627:Protein of unknown function DUF2348]
chromosome 3 open reading frame 75,PIR_SUPERFAMILY[630018304$PIRSF022251:uncharacterized conserved protein, TMEM103 type]
chromosome 3 open reading frame 75,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 3 open reading frame 75,UP_SEQ_FEATURE[850096570$chain:UPF0405 protein C3orf75, 850118574$splice variant]
chromosome 4 open reading frame 23,INTERPRO[450010499$IPR011671:AdoMet-dependent methyltransferase, predicted]
chromosome 4 open reading frame 23,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000954$methyltransferase, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001547$transferase, 790001572$trna processing]
chromosome 4 open reading frame 23,UP_SEQ_FEATURE[850044106$chain:Probable tRNA (uracil-O(2)-)- methyltransferase, 850117295$sequence variant, 850118574$splice variant]
chromosome 4 open reading frame 26,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chromosome 4 open reading frame 26,UP_SEQ_FEATURE[850074179$chain:Uncharacterized protein C4orf26, 850117295$sequence variant, 850117814$signal peptide]
chromosome 4 open reading frame 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 4 open reading frame 3,UP_SEQ_FEATURE[850074182$chain:Uncharacterized protein C4orf3, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 4 open reading frame 32,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
chromosome 4 open reading frame 32,UP_SEQ_FEATURE[850074184$chain:Uncharacterized protein C4orf32, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 4 open reading frame 36,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 4 open reading frame 36,UP_SEQ_FEATURE[850074188$chain:Uncharacterized protein C4orf36, 850117295$sequence variant]
chromosome 4 open reading frame 42,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 4 open reading frame 42,UP_SEQ_FEATURE[850074194$chain:Uncharacterized protein C4orf42, 850117295$sequence variant]
chromosome 4 open reading frame 44,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 4 open reading frame 44,UP_SEQ_FEATURE[850074195$chain:Uncharacterized protein C4orf44, 850117294$sequence conflict]
chromosome 5 open reading frame 13,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 5 open reading frame 13,UP_SEQ_FEATURE[850034051$chain:Neuronal protein 3.1, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant]
chromosome 5 open reading frame 25,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 5 open reading frame 25,UP_SEQ_FEATURE[850074255$chain:Uncharacterized protein C5orf25, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 5 open reading frame 34,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 5 open reading frame 34,UP_SEQ_FEATURE[850074256$chain:Uncharacterized protein C5orf34, 850117295$sequence variant]
chromosome 5 open reading frame 42,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 5 open reading frame 42,UP_SEQ_FEATURE[850074265$chain:Uncharacterized protein C5orf42, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 5 open reading frame 44,INTERPRO[450009439$IPR010378:Protein of unknown function DUF974]
chromosome 5 open reading frame 44,PIR_SUPERFAMILY[630007692$PIRSF008023:uncharacterized conserved protein]
chromosome 5 open reading frame 44,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 5 open reading frame 44,UP_SEQ_FEATURE[850097690$chain:UPF0533 protein C5orf44, 850117294$sequence conflict, 850118574$splice variant]
chromosome 5 open reading frame 45,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 5 open reading frame 45,UP_SEQ_FEATURE[850097712$chain:UPF0544 protein C5orf45, 850117295$sequence variant, 850118574$splice variant]
chromosome 5 open reading frame 47,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 5 open reading frame 47,UP_SEQ_FEATURE[850074268$chain:Uncharacterized protein C5orf47, 850102577$compositionally biased region:Poly-Lys]
chromosome 5 open reading frame 56,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 5 open reading frame 56,UP_SEQ_FEATURE[850074278$chain:Uncharacterized protein C5orf56, 850117294$sequence conflict, 850118574$splice variant]
chromosome 6 open reading frame 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chromosome 6 open reading frame 1,UP_SEQ_FEATURE[850074321$chain:Uncharacterized protein C6orf1, 850117295$sequence variant, 850117814$signal peptide]
chromosome 6 open reading frame 10,OMIM_DISEASE[520003402$Multiple Genetic Loci for Bone Mineral Density and Fractures]
chromosome 6 open reading frame 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
chromosome 6 open reading frame 10,UP_SEQ_FEATURE[850074323$chain:Uncharacterized protein C6orf10, 850102554$compositionally biased region:Lys-rich, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 6 open reading frame 130,INTERPRO[450002300$IPR002589:Appr-1-p processing]
chromosome 6 open reading frame 130,PIR_SUPERFAMILY[630016401$PIRSF019842:Melanoplus sanguinipes entomopoxvirus hypothetical protein 225]
chromosome 6 open reading frame 130,SMART[760000449$SM00506:A1pp]
chromosome 6 open reading frame 130,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome]
chromosome 6 open reading frame 130,UP_SEQ_FEATURE[850074336$chain:Uncharacterized protein C6orf130, 850104739$domain:Macro, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
chromosome 6 open reading frame 146,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 6 open reading frame 146,UP_SEQ_FEATURE[850074345$chain:Uncharacterized protein C6orf146, 850117295$sequence variant]
chromosome 6 open reading frame 150,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 6 open reading frame 150,UP_SEQ_FEATURE[850074349$chain:Uncharacterized protein C6orf150, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
chromosome 6 open reading frame 154,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 6 open reading frame 154,UP_SEQ_FEATURE[850074350$chain:Uncharacterized protein C6orf154, 850102572$compositionally biased region:Poly-Glu]
chromosome 6 open reading frame 167,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 6 open reading frame 167,UP_SEQ_FEATURE[850074355$chain:Uncharacterized protein C6orf167, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 6 open reading frame 168,INTERPRO[450017801$IPR019564:Outer mitochondrial membrane transport complex protein, Tom37/Metaxin]
chromosome 6 open reading frame 168,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 6 open reading frame 168,UP_SEQ_FEATURE[850074357$chain:Uncharacterized protein C6orf168, 850102565$compositionally biased region:Poly-Ala]
chromosome 6 open reading frame 204,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 6 open reading frame 204,UP_SEQ_FEATURE[850012085$chain:Coiled-coil domain-containing protein C6orf204, 850117295$sequence variant, 850118574$splice variant]
chromosome 6 open reading frame 226,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 6 open reading frame 226,UP_SEQ_FEATURE[850074372$chain:Uncharacterized protein C6orf226]
chromosome 6 open reading frame 227,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 6 open reading frame 227,UP_SEQ_FEATURE[850055315$chain:Putative uncharacterized protein C6orf227, 850117295$sequence variant]
chromosome 6 open reading frame 27,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chromosome 6 open reading frame 27,UP_SEQ_FEATURE[850046243$chain:Protein G7c, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
chromosome 6 open reading frame 48; small nucleolar RNA, C/D box 52,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 6 open reading frame 48; small nucleolar RNA, C/D box 52,UP_SEQ_FEATURE[850046245$chain:Protein G8, 850118574$splice variant]
chromosome 7 open reading frame 28A; similar to Chromosome 7 open reading frame 28B; chromosome 7 open reading frame 28B,INTERPRO[450017404$IPR019158:Protein of unknown function DUF2049]
chromosome 7 open reading frame 28A; similar to Chromosome 7 open reading frame 28B; chromosome 7 open reading frame 28B,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000897$lysosome, 790001162$phosphoprotein]
chromosome 7 open reading frame 28A; similar to Chromosome 7 open reading frame 28B; chromosome 7 open reading frame 28B,UP_SEQ_FEATURE[850097726$chain:UPF0550 protein C7orf28, 850106258$modified residue, 850117294$sequence conflict]
chromosome 7 open reading frame 31,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 7 open reading frame 31,UP_SEQ_FEATURE[850074415$chain:Uncharacterized protein C7orf31, 850117295$sequence variant]
chromosome 7 open reading frame 36,INTERPRO[450017437$IPR019191:Essential protein Yae1, N-terminal]
chromosome 7 open reading frame 36,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 7 open reading frame 36,UP_SEQ_FEATURE[850074420$chain:Uncharacterized protein C7orf36, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 7 open reading frame 38,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 7 open reading frame 38,UP_SEQ_FEATURE[850074421$chain:Uncharacterized protein C7orf38, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 7 open reading frame 41,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 7 open reading frame 41,UP_SEQ_FEATURE[850097078$chain:UPF0452 protein C7orf41, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850118574$splice variant]
chromosome 7 open reading frame 44,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 7 open reading frame 44,UP_SEQ_FEATURE[850074424$chain:Uncharacterized protein C7orf44, 850117294$sequence conflict, 850118623$transmembrane region]
chromosome 7 open reading frame 47,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
chromosome 7 open reading frame 47,UP_SEQ_FEATURE[850098201$chain:UPF0683 protein C7orf47, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue]
chromosome 7 open reading frame 50,INTERPRO[450017565$IPR019327:Protein of unknown function DUF2373]
chromosome 7 open reading frame 50,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
chromosome 7 open reading frame 50,UP_SEQ_FEATURE[850074428$chain:Uncharacterized protein C7orf50, 850106258$modified residue]
chromosome 7 open reading frame 51,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 7 open reading frame 51,UP_SEQ_FEATURE[850074430$chain:Uncharacterized protein C7orf51, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850118574$splice variant]
chromosome 7 open reading frame 61,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 7 open reading frame 61,UP_SEQ_FEATURE[850074435$chain:Uncharacterized protein C7orf61]
chromosome 8 open reading frame 44,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 8 open reading frame 44,UP_SEQ_FEATURE[850055323$chain:Putative uncharacterized protein C8orf44, 850117295$sequence variant]
chromosome 8 open reading frame 45,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
chromosome 8 open reading frame 45,INTERPRO[450001062$IPR001208:DNA-dependent ATPase MCM]
chromosome 8 open reading frame 45,SMART[760000318$SM00350:MCM]
chromosome 8 open reading frame 45,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 8 open reading frame 45,UP_SEQ_FEATURE[850074477$chain:Uncharacterized protein C8orf45, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 8 open reading frame 47,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 8 open reading frame 47,UP_SEQ_FEATURE[850074481$chain:Uncharacterized protein C8orf47, 850102507$compositionally biased region:Glu-rich, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 8 open reading frame 73,INTERPRO[450010814$IPR011989:Armadillo-like helical]
chromosome 8 open reading frame 73,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 8 open reading frame 73,UP_SEQ_FEATURE[850055331$chain:Putative uncharacterized protein C8orf73, 850102552$compositionally biased region:Leu-rich, 850117295$sequence variant]
chromosome 8 open reading frame 82,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 8 open reading frame 82,UP_SEQ_FEATURE[850097916$chain:UPF0598 protein C8orf82, 850117294$sequence conflict, 850118574$splice variant]
chromosome 9 open reading frame 106,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 9 open reading frame 106,UP_SEQ_FEATURE[850055334$chain:Putative uncharacterized protein C9orf106]
chromosome 9 open reading frame 128,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 9 open reading frame 128,UP_SEQ_FEATURE[850074521$chain:Uncharacterized protein C9orf128, 850117295$sequence variant, 850118574$splice variant]
chromosome 9 open reading frame 135,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
chromosome 9 open reading frame 135,UP_SEQ_FEATURE[850074527$chain:Uncharacterized protein C9orf135, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 9 open reading frame 142,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 9 open reading frame 142,UP_SEQ_FEATURE[850074530$chain:Uncharacterized protein C9orf142, 850106258$modified residue, 850118574$splice variant]
chromosome 9 open reading frame 167,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450009510$IPR010448:Torsin]
chromosome 9 open reading frame 167,SMART[760000335$SM00382:AAA]
chromosome 9 open reading frame 167,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane]
chromosome 9 open reading frame 167,UP_SEQ_FEATURE[850064605$chain:Torsin family protein C9orf167, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118623$transmembrane region]
chromosome 9 open reading frame 171,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 9 open reading frame 171,UP_SEQ_FEATURE[850074538$chain:Uncharacterized protein C9orf171, 850117295$sequence variant, 850118574$splice variant]
chromosome 9 open reading frame 25,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 9 open reading frame 25,UP_SEQ_FEATURE[850074541$chain:Uncharacterized protein C9orf25, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
chromosome 9 open reading frame 3,INTERPRO[450001709$IPR001930:Peptidase M1, membrane alanine aminopeptidase, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450013233$IPR014782:Peptidase M1, membrane alanine aminopeptidase, N-terminal, 450013656$IPR015211:Peptidase M1, leukotriene A4 hydrolase, aminopeptidase C-terminal]
chromosome 9 open reading frame 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000069$Aminopeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001648$zinc]
chromosome 9 open reading frame 3,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850005050$chain:Aminopeptidase O, 850106244$metal ion-binding site:Zinc; catalytic, 850117295$sequence variant, 850118574$splice variant]
chromosome 9 open reading frame 43,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 9 open reading frame 43,UP_SEQ_FEATURE[850074548$chain:Uncharacterized protein C9orf43, 850102485$compositionally biased region:Gln-rich, 850106258$modified residue, 850117295$sequence variant]
chromosome 9 open reading frame 50,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 9 open reading frame 50,UP_SEQ_FEATURE[850074550$chain:Uncharacterized protein C9orf50, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 9 open reading frame 72,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 9 open reading frame 72,UP_SEQ_FEATURE[850074556$chain:Uncharacterized protein C9orf72, 850117295$sequence variant, 850118574$splice variant]
chromosome 9 open reading frame 78,INTERPRO[450009792$IPR010756:Hepatocellular carcinoma-associated antigen 59]
chromosome 9 open reading frame 78,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 9 open reading frame 78,UP_SEQ_FEATURE[850074560$chain:Uncharacterized protein C9orf78, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 9 open reading frame 97,INTERPRO[450001562$IPR001763:Rhodanese-like]
chromosome 9 open reading frame 97,SMART[760000395$SM00450:RHOD]
chromosome 9 open reading frame 97,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 9 open reading frame 97,UP_SEQ_FEATURE[850000018$active site:Cysteine persulfide intermediate, 850064306$chain:Thiosulfate sulfurtransferase/rhodanese- like domain-containing protein 2, 850105184$domain:Rhodanese, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 9 open reading frame 98,INTERPRO[450000742$IPR000850:Adenylate kinase]
chromosome 9 open reading frame 98,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001547$transferase]
chromosome 9 open reading frame 98,UP_SEQ_FEATURE[850049318$chain:Putative adenylate kinase-like protein C9orf98, 850106263$nucleotide phosphate-binding region:ATP, 850110876$region of interest:Adenylate kinase, 850117295$sequence variant, 850118574$splice variant]
chromosome X open reading frame 15,INTERPRO[450017378$IPR019132:Taxilin]
chromosome X open reading frame 15,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome X open reading frame 15,UP_SEQ_FEATURE[850020586$chain:Gamma-taxilin, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chromosome X open reading frame 23,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001162$phosphoprotein]
chromosome X open reading frame 23,UP_SEQ_FEATURE[850074704$chain:Uncharacterized protein CXorf23, 850106258$modified residue, 850118574$splice variant]
cirrhosis, autosomal recessive 1A (cirhin),INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup]
cirrhosis, autosomal recessive 1A (cirhin),OMIM_DISEASE[520001051$Cirrhosis, North American Indian childhood type]
cirrhosis, autosomal recessive 1A (cirhin),SMART[760000289$SM00320:WD40]
cirrhosis, autosomal recessive 1A (cirhin),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
cirrhosis, autosomal recessive 1A (cirhin),UP_SEQ_FEATURE[850011514$chain:Cirhin, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cisplatin resistance-associated overexpressed protein,INTERPRO[450004355$IPR004882:LUC7 related]
cisplatin resistance-associated overexpressed protein,PIR_SUPERFAMILY[630021697$PIRSF028830:Luc7/Luc7-like protein, 630030648$PIRSF500424:PIRSF500424]
cisplatin resistance-associated overexpressed protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein]
cisplatin resistance-associated overexpressed protein,UP_SEQ_FEATURE[850029170$chain:Luc7-like protein 3, 850102442$compositionally biased region:Arg/Ser-rich, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
clarin 1,OMIM_DISEASE[520004999$Usher syndrome, type 3]
clarin 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000616$glycoprotein, 790000645$Hearing, 790000919$membrane, 790001212$polymorphism, 790001316$retinitis pigmentosa, 790001377$sensory transduction, 790001555$transmembrane, 790001600$usher syndrome, 790001622$vision]
clarin 1,UP_SEQ_FEATURE[850011559$chain:Clarin-1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
clathrin, light chain (Lcb),INTERPRO[450000867$IPR000996:Clathrin light chain]
clathrin, light chain (Lcb),KEGG_PATHWAY[470038840$hsa04142:Lysosome, 470038841$hsa04144:Endocytosis, 470038894$hsa05016:Huntington's disease]
clathrin, light chain (Lcb),PIR_SUPERFAMILY[630002413$PIRSF002289:clathrin light chain]
clathrin, light chain (Lcb),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000334$coated pit, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000447$disulfide bond, 790000919$membrane, 790001162$phosphoprotein]
clathrin, light chain (Lcb),UP_SEQ_FEATURE[850011634$chain:Clathrin light chain B, 850102883$disulfide bond, 850106258$modified residue, 850113150$region of interest:Involved in binding clathrin heavy chain, 850117294$sequence conflict, 850118574$splice variant]
claudin 3,INTERPRO[450003116$IPR003549:Claudin-3, 450003550$IPR004031:PMP-22/EMP/MP20/Claudin, 450005618$IPR006187:Claudin, 450016282$IPR017974:Claudin, conserved site]
claudin 3,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038857$hsa04530:Tight junction, 470038873$hsa04670:Leukocyte transendothelial migration]
claudin 3,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001528$Tight junction, 790001555$transmembrane, 790001640$williams-beuren syndrome]
claudin 3,UP_SEQ_FEATURE[850011653$chain:Claudin-3, 850106258$modified residue, 850113080$region of interest:Interactions with TJP1, TJP2 and TJP3, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
claudin 4,INTERPRO[450003117$IPR003550:Claudin-4, 450003550$IPR004031:PMP-22/EMP/MP20/Claudin, 450005618$IPR006187:Claudin, 450016282$IPR017974:Claudin, conserved site]
claudin 4,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038857$hsa04530:Tight junction, 470038873$hsa04670:Leukocyte transendothelial migration]
claudin 4,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001528$Tight junction, 790001555$transmembrane, 790001640$williams-beuren syndrome]
claudin 4,UP_SEQ_FEATURE[850011654$chain:Claudin-4, 850113080$region of interest:Interactions with TJP1, TJP2 and TJP3, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
claudin 7,INTERPRO[450003119$IPR003552:Claudin-7, 450003550$IPR004031:PMP-22/EMP/MP20/Claudin, 450005618$IPR006187:Claudin, 450016282$IPR017974:Claudin, conserved site]
claudin 7,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038857$hsa04530:Tight junction, 470038873$hsa04670:Leukocyte transendothelial migration]
claudin 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001528$Tight junction, 790001555$transmembrane]
claudin 7,UP_SEQ_FEATURE[850011657$chain:Claudin-7, 850113080$region of interest:Interactions with TJP1, TJP2 and TJP3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cleft lip and palate associated transmembrane protein 1,INTERPRO[450007706$IPR008429:Cleft lip and palate transmembrane 1]
cleft lip and palate associated transmembrane protein 1,OMIM_DISEASE[520002966$Lung cancer susceptibility locus at 5p15.33]
cleft lip and palate associated transmembrane protein 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
cleft lip and palate associated transmembrane protein 1,UP_SEQ_FEATURE[850011684$chain:Cleft lip and palate transmembrane protein 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
clusterin associated protein 1,INTERPRO[450017604$IPR019366:Clusterin-associated protein-1]
clusterin associated protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
clusterin associated protein 1,UP_SEQ_FEATURE[850011702$chain:Clusterin-associated protein 1, 850102458$compositionally biased region:Asp-rich, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
coactivator-associated arginine methyltransferase 1,BIOCARTA[30000046$h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor, 30000047$h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1, 30000136$h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
coactivator-associated arginine methyltransferase 1,COG_ONTOLOGY[90000106$Secondary metabolites biosynthesis, transport, and catabolism / General function prediction only]
coactivator-associated arginine methyltransferase 1,INTERPRO[450009518$IPR010456:Ribosomal L11 methyltransferase]
coactivator-associated arginine methyltransferase 1,PIR_SUPERFAMILY[630028639$PIRSF037127:type 1 arginine N-methyltransferase, 630030626$PIRSF500397:coactivator-associated arginine methyltransferase 1]
coactivator-associated arginine methyltransferase 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000954$methyltransferase, 790001065$nucleus, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
coactivator-associated arginine methyltransferase 1,UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850000543$binding site:S-adenosyl-L-methionine; via carbonyl oxygen, 850024112$chain:Histone-arginine methyltransferase CARM1, 850106258$modified residue, 850114898$region of interest:Transactivation domain, 850117294$sequence conflict, 850118574$splice variant]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,PIR_SUPERFAMILY[630016142$PIRSF019545:factor VIII intron 22 protein]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,UP_SEQ_FEATURE[850018906$chain:Factor VIII intron 22 protein, 850106258$modified residue, 850117294$sequence conflict]
coagulation factor XII (Hageman factor),BIOCARTA[30000165$h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway]
coagulation factor XII (Hageman factor),INTERPRO[450000001$IPR000001:Kringle, 450000069$IPR000083:Fibronectin, type I, 450000481$IPR000562:Type II fibronectin, collagen-binding, 450000637$IPR000742:EGF-like, type 3, 450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450012970$IPR014394:Coagulation factor XII/hepatocyte growth factor activator, 450016359$IPR018056:Kringle, conserved site, 450016361$IPR018059:Kringle, subgroup, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
coagulation factor XII (Hageman factor),KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
coagulation factor XII (Hageman factor),OMIM_DISEASE[520000325$Angioedema, hereditary, type III, 520000328$Angioneurotic edema, hereditary, with normal C1-inhibitor concentration and function, 520000329$Angioneurotic edema, hereditary, X-linked, 520001854$Factor XII deficiency]
coagulation factor XII (Hageman factor),PIR_SUPERFAMILY[630001295$PIRSF001146:coagulation factor XII/hepatocyte growth factor activator, 630001296$PIRSF001146:Factor_XII_HGFA]
coagulation factor XII (Hageman factor),SMART[760000013$SM00020:Tryp_SPc, 760000049$SM00058:FN1, 760000050$SM00059:FN2, 760000112$SM00130:KR, 760000155$SM00181:EGF]
coagulation factor XII (Hageman factor),SP_PIR_KEYWORDS[790000192$blood coagulation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000549$fibrinolysis, 790000616$glycoprotein, 790000743$hydrolase, 790000830$kringle, 790001191$plasma, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001652$zymogen]
coagulation factor XII (Hageman factor),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850007682$chain:Beta-factor XIIa part 1, 850007683$chain:Beta-factor XIIa part 2, 850011757$chain:Coagulation factor XIIa heavy chain, 850011758$chain:Coagulation factor XIIa light chain, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103781$domain:Fibronectin type-I, 850103794$domain:Fibronectin type-II, 850104556$domain:Kringle, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105814$glycosylation site:O-linked (Fuc), 850105822$glycosylation site:O-linked (GalNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
coagulation factor XIII, A1 polypeptide,BIOCARTA[30000113$h_fibrinolysisPathway:Fibrinolysis Pathway]
coagulation factor XIII, A1 polypeptide,INTERPRO[450000965$IPR001102:Transglutaminase, N-terminal, 450002585$IPR002931:Transglutaminase-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450008174$IPR008958:Transglutaminase, C-terminal, 450012396$IPR013783:Immunoglobulin-like fold, 450012414$IPR013808:Transglutaminase, conserved site]
coagulation factor XIII, A1 polypeptide,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
coagulation factor XIII, A1 polypeptide,OMIM_DISEASE[520001855$Factor XIIIA deficiency]
coagulation factor XIII, A1 polypeptide,SMART[760000405$SM00460:TGc]
coagulation factor XIII, A1 polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000025$Acyltransferase, 790000067$aminoacyltransferase, 790000192$blood coagulation, 790000211$calcium, 790000332$coagulation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000616$glycoprotein, 790000686$heterotetramer, 790000701$homodimer, 790000937$metal-binding, 790001191$plasma, 790001212$polymorphism, 790001363$Secreted, 790001547$transferase, 790001652$zymogen]
coagulation factor XIII, A1 polypeptide,UP_SEQ_FEATURE[850011759$chain:Coagulation factor XIII A chain, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850106258$modified residue, 850109636$propeptide:Activation peptide, 850117294$sequence conflict, 850117295$sequence variant, 850118126$site:Cleavage; by thrombin; to produce active factor XIII-A, 850118575$strand, 850118624$turn]
coatomer protein complex, subunit epsilon,INTERPRO[450006226$IPR006822:Coatomer, epsilon subunit, 450010815$IPR011990:Tetratricopeptide-like helical]
coatomer protein complex, subunit epsilon,PIR_SUPERFAMILY[630013249$PIRSF016478:Coatomer_esu, 630013250$PIRSF016478:oatomer, epsilon subunit]
coatomer protein complex, subunit epsilon,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
coatomer protein complex, subunit epsilon,UP_SEQ_FEATURE[850011799$chain:Coatomer subunit epsilon, 850106258$modified residue, 850117295$sequence variant]
coatomer protein complex, subunit zeta 1,INTERPRO[450000697$IPR000804:Clathrin adaptor, sigma subunit/coatomer, zeta subunit]
coatomer protein complex, subunit zeta 1,PIR_SUPERFAMILY[630012713$PIRSF015943:vesicle coat complex COPI, zeta subunit]
coatomer protein complex, subunit zeta 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
coatomer protein complex, subunit zeta 1,UP_SEQ_FEATURE[850011806$chain:Coatomer subunit zeta-1, 850105852$helix, 850106258$modified residue, 850118575$strand]
coenzyme Q4 homolog (S. cerevisiae),INTERPRO[450007070$IPR007715:Coenzyme Q biosynthesis Coq4]
coenzyme Q4 homolog (S. cerevisiae),PIR_SUPERFAMILY[630026722$PIRSF035049:ubiquinone biosynthesis protein COQ4]
coenzyme Q4 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001550$transit peptide, 790001590$ubiquinone biosynthesis]
coenzyme Q4 homolog (S. cerevisiae),UP_SEQ_FEATURE[850067936$chain:Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
coiled-coil domain containing 113,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 113,UP_SEQ_FEATURE[850011937$chain:Coiled-coil domain-containing protein 113, 850117294$sequence conflict, 850117295$sequence variant]
coiled-coil domain containing 121,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
coiled-coil domain containing 121,UP_SEQ_FEATURE[850011944$chain:Coiled-coil domain-containing protein 121]
coiled-coil domain containing 127,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 127,UP_SEQ_FEATURE[850011953$chain:Coiled-coil domain-containing protein 127, 850117295$sequence variant]
coiled-coil domain containing 141,INTERPRO[450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
coiled-coil domain containing 141,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000768$Immunoglobulin domain, 790001212$polymorphism]
coiled-coil domain containing 141,UP_SEQ_FEATURE[850011966$chain:Coiled-coil domain-containing protein 141, 850104199$domain:Ig-like, 850117295$sequence variant, 850118574$splice variant]
coiled-coil domain containing 144B; coiled-coil domain containing 144A; coiled-coil domain containing 144C,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
coiled-coil domain containing 144B; coiled-coil domain containing 144A; coiled-coil domain containing 144C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000811$isopeptide bond, 790001592$ubl conjugation]
coiled-coil domain containing 144B; coiled-coil domain containing 144A; coiled-coil domain containing 144C,UP_SEQ_FEATURE[850011968$chain:Coiled-coil domain-containing protein 144A, 850011969$chain:Coiled-coil domain-containing protein 144B, 850102581$compositionally biased region:Poly-Ser, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850117294$sequence conflict, 850118574$splice variant]
coiled-coil domain containing 146,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 146,UP_SEQ_FEATURE[850011970$chain:Coiled-coil domain-containing protein 146, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
coiled-coil domain containing 155,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
coiled-coil domain containing 155,INTERPRO[450000291$IPR000340:Dual specificity phosphatase, catalytic domain, 450000292$IPR000340:Protein-tyrosine phosphatase, dual specificity, 450001562$IPR001763:Rhodanese-like]
coiled-coil domain containing 155,SMART[760000395$SM00450:RHOD]
coiled-coil domain containing 155,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
coiled-coil domain containing 155,UP_SEQ_FEATURE[850011982$chain:Coiled-coil domain-containing protein 155, 850102572$compositionally biased region:Poly-Glu, 850102576$compositionally biased region:Poly-Leu, 850117295$sequence variant, 850118623$transmembrane region]
coiled-coil domain containing 24,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome]
coiled-coil domain containing 24,UP_SEQ_FEATURE[850011994$chain:Coiled-coil domain-containing protein 24, 850117294$sequence conflict, 850118574$splice variant]
coiled-coil domain containing 40,INTERPRO[450012550$IPR013956:E3 ubiquitin ligase, BRE1]
coiled-coil domain containing 40,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 40,UP_SEQ_FEATURE[850012009$chain:Coiled-coil domain-containing protein 40, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
coiled-coil domain containing 70,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
coiled-coil domain containing 70,UP_SEQ_FEATURE[850012045$chain:Coiled-coil domain-containing protein 70, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
coiled-coil domain containing 8,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 8,UP_SEQ_FEATURE[850012056$chain:Coiled-coil domain-containing protein 8, 850102566$compositionally biased region:Poly-Arg, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
coiled-coil domain containing 97,INTERPRO[450016885$IPR018613:Protein of unknown function DUF2052, coiled-coil]
coiled-coil domain containing 97,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
coiled-coil domain containing 97,UP_SEQ_FEATURE[850012079$chain:Coiled-coil domain-containing protein 97, 850106258$modified residue]
coiled-coil-helix-coiled-coil-helix domain containing 2; similar to coiled-coil-helix-coiled-coil-helix domain containing 2,INTERPRO[450009675$IPR010625:CHCH]
coiled-coil-helix-coiled-coil-helix domain containing 2; similar to coiled-coil-helix-coiled-coil-helix domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide]
coiled-coil-helix-coiled-coil-helix domain containing 2; similar to coiled-coil-helix-coiled-coil-helix domain containing 2,UP_SEQ_FEATURE[850012100$chain:Coiled-coil-helix-coiled-coil-helix domain-containing protein 2, mitochondrial, 850103322$domain:CHCH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
cold inducible RNA binding protein,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
cold inducible RNA binding protein,SMART[760000328$SM00360:RRM]
cold inducible RNA binding protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001307$repressor, 790001339$rna-binding, 790001450$stress response]
cold inducible RNA binding protein,UP_SEQ_FEATURE[850012147$chain:Cold-inducible RNA-binding protein, 850102517$compositionally biased region:Gly-rich, 850105211$domain:RRM, 850105852$helix, 850118575$strand]
collagen and calcium binding EGF domains 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450007490$IPR008160:Collagen triple helix repeat, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
collagen and calcium binding EGF domains 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
collagen and calcium binding EGF domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000081$angiogenesis, 790000211$calcium, 790000345$collagen, 790000356$complete proteome, 790000428$developmental protein, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
collagen and calcium binding EGF domains 1,UP_SEQ_FEATURE[850012220$chain:Collagen and calcium-binding EGF domain- containing protein 1, 850102883$disulfide bond, 850103390$domain:Collagen-like 1, 850103399$domain:Collagen-like 2, 850103705$domain:EGF-like; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
collagen triple helix repeat containing 1,INTERPRO[450007490$IPR008160:Collagen triple helix repeat]
collagen triple helix repeat containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000345$collagen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000530$extracellular matrix, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
collagen triple helix repeat containing 1,UP_SEQ_FEATURE[850012221$chain:Collagen triple helix repeat-containing protein 1, 850103389$domain:Collagen-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
collagen, type IV, alpha 3 (Goodpasture antigen),INTERPRO[450001284$IPR001442:Type 4 procollagen, C-terminal repeat, 450007490$IPR008160:Collagen triple helix repeat]
collagen, type IV, alpha 3 (Goodpasture antigen),OMIM_DISEASE[520000235$Alport syndrome, autosomal recessive, 520002245$Hematuria, benign familial]
collagen, type IV, alpha 3 (Goodpasture antigen),PIR_SUPERFAMILY[630002387$PIRSF002258:collagen alpha 1(IV) chain]
collagen, type IV, alpha 3 (Goodpasture antigen),SMART[760000098$SM00111:C4]
collagen, type IV, alpha 3 (Goodpasture antigen),SP_PIR_KEYWORDS[790000049$Alport syndrome, 790000053$alternative splicing, 790000171$basement membrane, 790000256$cell adhesion, 790000257$cell binding, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000811$isopeptide bond, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001565$trimer, 790001568$triple helix, 790001592$ubl conjugation]
collagen, type IV, alpha 3 (Goodpasture antigen),UP_SEQ_FEATURE[850012210$chain:Collagen alpha-3(IV) chain, 850067264$chain:Tumstatin, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102766$cross-link:S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1533), 850102773$cross-link:S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1651), 850102883$disulfide bond, 850103388$domain:Collagen IV NC1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850110686$region of interest:7S domain, 850111602$region of interest:Epitope recognized by Goodpasture antibodies, 850114488$region of interest:Required for the anti-angiogenic activity of tumstatin, 850114489$region of interest:Required for the anti-tumor cell activity of tumstatin, 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118038$site:Cleavage; by collagenase, 850118574$splice variant]
collagen, type VI, alpha 2,INTERPRO[450001802$IPR002035:von Willebrand factor, type A, 450007490$IPR008160:Collagen triple helix repeat]
collagen, type VI, alpha 2,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
collagen, type VI, alpha 2,OMIM_DISEASE[520000561$Bethlem myopathy, 520003529$Myosclerosis, congenital, 520004976$Ullrich congenital muscular dystrophy]
collagen, type VI, alpha 2,PIR_SUPERFAMILY[630002388$PIRSF002259:collagen VI]
collagen, type VI, alpha 2,SMART[760000296$SM00327:VWA]
collagen, type VI, alpha 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000189$blocked amino end, 790000256$cell adhesion, 790000257$cell binding, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001289$pyroglutamic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001565$trimer, 790001568$triple helix]
collagen, type VI, alpha 2,UP_SEQ_FEATURE[850012207$chain:Collagen alpha-2(VI) chain, 850105628$domain:VWFA 1, 850105633$domain:VWFA 2, 850105634$domain:VWFA 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850113761$region of interest:Nonhelical region, 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118574$splice variant]
collagen, type VIII, alpha 2,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
collagen, type VIII, alpha 2,OMIM_DISEASE[520001218$Corneal dystrophy, polymorphous posterior, 2, 520001944$Fuchs endothelial corneal dystrophy]
collagen, type VIII, alpha 2,PIR_SUPERFAMILY[630002389$PIRSF002261:collagen alpha 1(VIII) chain]
collagen, type VIII, alpha 2,SMART[760000097$SM00110:C1Q]
collagen, type VIII, alpha 2,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000171$basement membrane, 790000256$cell adhesion, 790000345$collagen, 790000356$complete proteome, 790000446$disease mutation, 790000530$extracellular matrix, 790000745$hydroxylation, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
collagen, type VIII, alpha 2,UP_SEQ_FEATURE[850012208$chain:Collagen alpha-2(VIII) chain, 850103196$domain:C1q, 850113765$region of interest:Nonhelical region (NC1), 850113768$region of interest:Nonhelical region (NC2), 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
collagen, type XV, alpha 1,INTERPRO[450001584$IPR001791:Laminin G, 450002753$IPR003129:Laminin G, thrombospondin-type, N-terminal, 450007490$IPR008160:Collagen triple helix repeat, 450009569$IPR010515:Collagenase NC10 and endostatin, 450011359$IPR012680:Laminin G, subdomain 2, 450014523$IPR016186:C-type lectin-like]
collagen, type XV, alpha 1,SMART[760000183$SM00210:TSPN, 760000253$SM00282:LamG]
collagen, type XV, alpha 1,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000256$cell adhesion, 790000345$collagen, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
collagen, type XV, alpha 1,UP_SEQ_FEATURE[850012190$chain:Collagen alpha-1(XV) chain, 850017421$chain:Endostatin, 850105553$domain:TSP N-terminal, 850105770$glycosylation site:N-linked (GlcNAc...), 850110431$region of interest:4 X tandem repeats, 850113771$region of interest:Nonhelical region 1 (NC1), 850113772$region of interest:Nonhelical region 10 (NC10), 850113774$region of interest:Nonhelical region 2 (NC2), 850113775$region of interest:Nonhelical region 3 (NC3), 850113776$region of interest:Nonhelical region 4 (NC4), 850113777$region of interest:Nonhelical region 5 (NC5), 850113778$region of interest:Nonhelical region 6 (NC6), 850113779$region of interest:Nonhelical region 7 (NC7), 850113780$region of interest:Nonhelical region 8 (NC8), 850113781$region of interest:Nonhelical region 9 (NC9), 850114944$region of interest:Triple-helical region 1 (COL1), 850114949$region of interest:Triple-helical region 2 (COL2), 850114951$region of interest:Triple-helical region 3 (COL3), 850114952$region of interest:Triple-helical region 4 (COL4), 850114954$region of interest:Triple-helical region 5 (COL5), 850114956$region of interest:Triple-helical region 6 (COL6), 850114958$region of interest:Triple-helical region 7 (COL7), 850114960$region of interest:Triple-helical region 8 (COL8), 850114962$region of interest:Triple-helical region 9 (COL9), 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
collagen, type XVIII, alpha 1,INTERPRO[450007490$IPR008160:Collagen triple helix repeat, 450009424$IPR010363:Protein of unknown function DUF959, collagen XVIII, N-terminal, 450009569$IPR010515:Collagenase NC10 and endostatin, 450014523$IPR016186:C-type lectin-like]
collagen, type XVIII, alpha 1,OMIM_DISEASE[520002748$Knobloch syndrome, 520002749$Knobloch syndrome, type 1]
collagen, type XVIII, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000052$alternative promoter usage, 790000053$alternative splicing, 790000256$cell adhesion, 790000345$collagen, 790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc]
collagen, type XVIII, alpha 1,UP_SEQ_FEATURE[850012193$chain:Collagen alpha-1(XVIII) chain, 850017421$chain:Endostatin, 850102883$disulfide bond, 850104018$domain:FZ, 850105553$domain:TSP N-terminal, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850105852$helix, 850106218$metal ion-binding site:Zinc, 850113771$region of interest:Nonhelical region 1 (NC1), 850113772$region of interest:Nonhelical region 10 (NC10), 850113773$region of interest:Nonhelical region 11 (NC11), 850113774$region of interest:Nonhelical region 2 (NC2), 850113775$region of interest:Nonhelical region 3 (NC3), 850113776$region of interest:Nonhelical region 4 (NC4), 850113777$region of interest:Nonhelical region 5 (NC5), 850113778$region of interest:Nonhelical region 6 (NC6), 850113779$region of interest:Nonhelical region 7 (NC7), 850113780$region of interest:Nonhelical region 8 (NC8), 850113781$region of interest:Nonhelical region 9 (NC9), 850114944$region of interest:Triple-helical region 1 (COL1), 850114947$region of interest:Triple-helical region 10 (COL10), 850114949$region of interest:Triple-helical region 2 (COL2), 850114951$region of interest:Triple-helical region 3 (COL3), 850114952$region of interest:Triple-helical region 4 (COL4), 850114954$region of interest:Triple-helical region 5 (COL5), 850114956$region of interest:Triple-helical region 6 (COL6), 850114958$region of interest:Triple-helical region 7 (COL7), 850114960$region of interest:Triple-helical region 8 (COL8), 850114962$region of interest:Triple-helical region 9 (COL9), 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118574$splice variant, 850118575$strand]
collagen, type XX, alpha 1,INTERPRO[450001802$IPR002035:von Willebrand factor, type A, 450002753$IPR003129:Laminin G, thrombospondin-type, N-terminal, 450003484$IPR003961:Fibronectin, type III, 450007490$IPR008160:Collagen triple helix repeat, 450008173$IPR008957:Fibronectin, type III-like fold]
collagen, type XX, alpha 1,SMART[760000051$SM00060:FN3, 760000183$SM00210:TSPN, 760000296$SM00327:VWA]
collagen, type XX, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000345$collagen, 790000356$complete proteome, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
collagen, type XX, alpha 1,UP_SEQ_FEATURE[850012194$chain:Collagen alpha-1(XX) chain, 850103389$domain:Collagen-like, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850103871$domain:Fibronectin type-III 4, 850103882$domain:Fibronectin type-III 5, 850103893$domain:Fibronectin type-III 6, 850105553$domain:TSP N-terminal, 850105627$domain:VWFA, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),INTERPRO[450003099$IPR003532:Short hematopoietin receptor, family 2, conserved site, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),OMIM_DISEASE[520001195$Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia, 520002838$Leukemia, acute myeloid, M2 type, 520004183$Pulmonary alveolar proteinosis]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),SMART[760000051$SM00060:FN3]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000634$growth factor receptor, 790000919$membrane, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),UP_SEQ_FEATURE[850022370$chain:Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
complement component 1, q subcomponent, B chain,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
complement component 1, q subcomponent, B chain,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038895$hsa05020:Prion diseases, 470038916$hsa05322:Systemic lupus erythematosus]
complement component 1, q subcomponent, B chain,OMIM_DISEASE[520000717$C1q deficiency, type B]
complement component 1, q subcomponent, B chain,PIR_SUPERFAMILY[630002593$PIRSF002477:complement subcomponent C1q chain A]
complement component 1, q subcomponent, B chain,SMART[760000097$SM00110:C1Q]
complement component 1, q subcomponent, B chain,SP_PIR_KEYWORDS[790000002$3d-structure, 790000345$collagen, 790000355$complement pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000679$heterodimer, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000763$immune response, 790000777$innate immunity, 790001191$plasma, 790001212$polymorphism, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001568$triple helix]
complement component 1, q subcomponent, B chain,UP_SEQ_FEATURE[850012305$chain:Complement C1q subcomponent subunit B, 850102883$disulfide bond, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850105818$glycosylation site:O-linked (Gal...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
complement component 9,BIOCARTA[30000016$h_alternativePathway:Alternative Complement Pathway, 30000066$h_classicPathway:Classical Complement Pathway, 30000067$h_compPathway:Complement Pathway, 30000171$h_lectinPathway:Lectin Induced Complement Pathway]
complement component 9,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450001647$IPR001862:Membrane attack complex component/perforin/complement C9, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450011699$IPR013032:EGF-like region, conserved site]
complement component 9,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038895$hsa05020:Prion diseases, 470038916$hsa05322:Systemic lupus erythematosus]
complement component 9,OMIM_DISEASE[520000730$C9 deficiency, 520000731$C9 deficiency with dermatomyositis]
complement component 9,PIR_SUPERFAMILY[630002597$PIRSF002481:complement C9]
complement component 9,SMART[760000166$SM00192:LDLa, 760000182$SM00209:TSP1, 760000402$SM00457:MACPF]
complement component 9,SP_PIR_KEYWORDS[790000264$cell membrane, 790000352$complement alternate pathway, 790000355$complement pathway, 790000356$complete proteome, 790000406$cytolysis, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000763$immune response, 790000774$inflammation, 790000777$innate immunity, 790000919$membrane, 790000921$membrane attack complex, 790000994$multimer, 790001162$phosphoprotein, 790001191$plasma, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
complement component 9,UP_SEQ_FEATURE[850012364$chain:complement component 9, 850012373$chain:Complement component C9, 850012374$chain:Complement component C9a, 850012375$chain:Complement component C9b, 850102883$disulfide bond, 850103596$domain:EGF-like, 850104664$domain:LDL-receptor class A, 850104738$domain:MACPF, 850105554$domain:TSP type-1, 850105756$glycosylation site:C-linked (Man), 850105759$glycosylation site:C-linked (Man); partial, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118124$site:Cleavage; by thrombin, 850118623$transmembrane region]
complement factor H,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450014444$IPR016060:Complement control module]
complement factor H,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
complement factor H,OMIM_DISEASE[520000540$Basal laminar drusen, 520001139$Complement factor H deficiency, 520001140$Complement factor H polymorphism in age-related macular degeneration, 520001846$Factor H and factor H-like 1, 520002270$Hemolytic-uremic syndrome, 520003013$Macular degeneration, age-related, 4, 520003138$Membranoproliferative glomerulonephritis with CFH deficiency, 520003478$Myocardial infarction, susceptibility to]
complement factor H,PIR_SUPERFAMILY[630002598$PIRSF002482:complement factor H]
complement factor H,SMART[760000024$SM00032:CCP]
complement factor H,SP_PIR_KEYWORDS[790000002$3d-structure, 790000032$age-related macular degeneration, 790000053$alternative splicing, 790000352$complement alternate pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790000777$innate immunity, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001471$sushi]
complement factor H,UP_SEQ_FEATURE[850012386$chain:Complement factor H, 850102883$disulfide bond, 850105416$domain:Sushi 1, 850105417$domain:Sushi 10, 850105418$domain:Sushi 11, 850105419$domain:Sushi 12, 850105420$domain:Sushi 13, 850105421$domain:Sushi 14, 850105422$domain:Sushi 15, 850105423$domain:Sushi 16, 850105424$domain:Sushi 17, 850105425$domain:Sushi 18, 850105426$domain:Sushi 19, 850105429$domain:Sushi 2, 850105430$domain:Sushi 20, 850105440$domain:Sushi 3, 850105446$domain:Sushi 4, 850105447$domain:Sushi 5, 850105448$domain:Sushi 6, 850105449$domain:Sushi 7, 850105450$domain:Sushi 8, 850105451$domain:Sushi 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118450$site:Not glycosylated, 850118574$splice variant, 850118575$strand, 850118624$turn]
complexin 1,INTERPRO[450008093$IPR008849:Synaphin]
complexin 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000522$exocytosis, 790001027$neurotransmitter transport, 790001558$transport]
complexin 1,UP_SEQ_FEATURE[850012405$chain:Complexin-1, 850112942$region of interest:Interaction with the SNARE complex]
coronin, actin binding protein, 1A,INTERPRO[450001490$IPR001680:WD40 repeat, 450013497$IPR015048:Region of unknown function DUF1899, 450013498$IPR015049:Region of unknown function DUF1900, 450013946$IPR015505:Coronin, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
coronin, actin binding protein, 1A,SMART[760000289$SM00320:WD40]
coronin, actin binding protein, 1A,SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
coronin, actin binding protein, 1A,UP_SEQ_FEATURE[850012625$chain:Coronin-1A, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant]
coronin, actin binding protein, 2A,INTERPRO[450001490$IPR001680:WD40 repeat, 450007480$IPR008147:Glutamine synthetase, beta-Grasp, 450013497$IPR015048:Region of unknown function DUF1899, 450013498$IPR015049:Region of unknown function DUF1900, 450013946$IPR015505:Coronin, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
coronin, actin binding protein, 2A,SMART[760000289$SM00320:WD40]
coronin, actin binding protein, 2A,SP_PIR_KEYWORDS[790000019$actin-binding, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
coronin, actin binding protein, 2A,UP_SEQ_FEATURE[850012628$chain:Coronin-2A, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant]
coronin, actin binding protein, 2B,INTERPRO[450001490$IPR001680:WD40 repeat, 450013497$IPR015048:Region of unknown function DUF1899, 450013498$IPR015049:Region of unknown function DUF1900, 450013946$IPR015505:Coronin, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
coronin, actin binding protein, 2B,SMART[760000289$SM00320:WD40]
coronin, actin binding protein, 2B,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
coronin, actin binding protein, 2B,UP_SEQ_FEATURE[850012629$chain:Coronin-2B, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cortexin 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
cortexin 1,UP_SEQ_FEATURE[850012636$chain:Cortexin-1, 850118623$transmembrane region]
cortistatin; apoptosis-inducing, TAF9-like domain 1,INTERPRO[450016435$IPR018142:Somatostatin/Cortistatin, C-terminal]
cortistatin; apoptosis-inducing, TAF9-like domain 1,PIR_SUPERFAMILY[630001951$PIRSF001814:somatostatin]
cortistatin; apoptosis-inducing, TAF9-like domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000276$centromere, 790000315$chromosomal protein, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000708$hormone, 790001065$nucleus, 790001363$Secreted, 790001405$signal]
cortistatin; apoptosis-inducing, TAF9-like domain 1,UP_SEQ_FEATURE[850010673$chain:Centromere protein S, 850102883$disulfide bond, 850107247$peptide:Cortistatin-17, 850107248$peptide:Cortistatin-29, 850117814$signal peptide, 850118574$splice variant]
creatine kinase, mitochondrial 2 (sarcomeric),INTERPRO[450000644$IPR000749:ATP:guanido phosphotransferase, 450013197$IPR014746:Glutamine synthetase/guanido kinase, catalytic region]
creatine kinase, mitochondrial 2 (sarcomeric),KEGG_PATHWAY[470038752$hsa00330:Arginine and proline metabolism]
creatine kinase, mitochondrial 2 (sarcomeric),SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000825$kinase, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001063$nucleotide-binding, 790001547$transferase, 790001550$transit peptide]
creatine kinase, mitochondrial 2 (sarcomeric),UP_SEQ_FEATURE[850000242$binding site:ATP, 850012694$chain:Creatine kinase S-type, mitochondrial, 850105852$helix, 850106263$nucleotide phosphate-binding region:ATP, 850111184$region of interest:Cardiolipin-binding, 850117294$sequence conflict, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
crumbs homolog 3 (Drosophila),KEGG_PATHWAY[470038857$hsa04530:Tight junction]
crumbs homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001528$Tight junction, 790001555$transmembrane]
crumbs homolog 3 (Drosophila),UP_SEQ_FEATURE[850012741$chain:Crumbs protein homolog 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117634$short sequence motif:PDZ-binding, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
crystallin, gamma B,INTERPRO[450000933$IPR001064:Beta and gamma crystallin]
crystallin, gamma B,PIR_SUPERFAMILY[630002405$PIRSF002281:beta/gamma crystallins, 630030672$PIRSF500453:gamma crystallin]
crystallin, gamma B,SMART[760000219$SM00247:XTALbg]
crystallin, gamma B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000473$duplication, 790000533$eye lens, 790000534$eye lens protein, 790001089$oxidation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
crystallin, gamma B,UP_SEQ_FEATURE[850020514$chain:Gamma-crystallin B, 850103104$domain:Beta/gamma crystallin 'Greek key' 1, 850103108$domain:Beta/gamma crystallin 'Greek key' 2, 850103109$domain:Beta/gamma crystallin 'Greek key' 3, 850103110$domain:Beta/gamma crystallin 'Greek key' 4, 850105852$helix, 850106258$modified residue, 850111296$region of interest:Connecting peptide, 850117295$sequence variant, 850118568$site:Susceptible to oxidation, 850118575$strand, 850118624$turn]
crystallin, zeta (quinone reductase)-like 1,COG_ONTOLOGY[90000066$Energy production and conversion / General function prediction only]
crystallin, zeta (quinone reductase)-like 1,INTERPRO[450001848$IPR002085:Alcohol dehydrogenase superfamily, zinc-containing, 450002103$IPR002364:Quinone oxidoreductase/zeta-crystallin, conserved site, 450011786$IPR013149:Alcohol dehydrogenase, zinc-binding, 450011791$IPR013154:Alcohol dehydrogenase GroES-like, 450014426$IPR016040:NAD(P)-binding domain]
crystallin, zeta (quinone reductase)-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism]
crystallin, zeta (quinone reductase)-like 1,UP_SEQ_FEATURE[850056474$chain:Quinone oxidoreductase-like protein 1, 850117294$sequence conflict, 850117295$sequence variant]
cullin 4B,INTERPRO[450001217$IPR001373:Cullin, N-terminal, 450001218$IPR001373:Cullin, N-terminal region, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014507$IPR016157:Cullin, conserved site, 450014508$IPR016158:Cullin homology, 450017796$IPR019559:Cullin protein, neddylation domain]
cullin 4B,KEGG_PATHWAY[470038823$hsa03420:Nucleotide excision repair, 470038837$hsa04120:Ubiquitin mediated proteolysis]
cullin 4B,OMIM_DISEASE[520003156$Mental retardation syndrome, X-linked, Cabezas type, 520003241$Mental retardation-hypotonic facies syndrome, X-linked, 2]
cullin 4B,PIR_SUPERFAMILY[630014534$PIRSF017874:cullin, 630030699$PIRSF500485:cullin 4]
cullin 4B,SMART[760000156$SM00182:CULLIN]
cullin 4B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000811$isopeptide bond, 790000930$mental retardation, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
cullin 4B,UP_SEQ_FEATURE[850012838$chain:Cullin-4B, 850102597$compositionally biased region:Ser-rich, 850102713$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
cyclic nucleotide gated channel alpha 3,INTERPRO[450000508$IPR000595:Cyclic nucleotide-binding, 450005268$IPR005821:Ion transport, 450013163$IPR014710:RmlC-like jelly roll fold, 450016762$IPR018488:Cyclic nucleotide-binding, conserved site]
cyclic nucleotide gated channel alpha 3,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
cyclic nucleotide gated channel alpha 3,OMIM_DISEASE[520000104$Achromatopsia-2]
cyclic nucleotide gated channel alpha 3,PIR_SUPERFAMILY[630002523$PIRSF002403:cyclic nucleotide-gated channel, alpha subunit]
cyclic nucleotide gated channel alpha 3,SMART[760000088$SM00100:cNMP]
cyclic nucleotide gated channel alpha 3,SP_PIR_KEYWORDS[790000283$cGMP, 790000286$cGMP-binding, 790000356$complete proteome, 790000446$disease mutation, 790000797$ion channel, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790000924$membrane protein, 790001063$nucleotide-binding, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001555$transmembrane, 790001558$transport, 790001622$vision]
cyclic nucleotide gated channel alpha 3,UP_SEQ_FEATURE[850000279$binding site:cGMP, 850013003$chain:Cyclic nucleotide-gated cation channel alpha-3, 850106275$nucleotide phosphate-binding region:cGMP, 850117295$sequence variant, 850118623$transmembrane region]
cyclin B1,BIOCARTA[30000012$h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics, 30000059$h_cellcyclePathway:Cyclins and Cell Cycle Regulation, 30000121$h_g2Pathway:Cell Cycle: G2/M Checkpoint, 30000191$h_mPRPathway:How Progesterone Initiates the Oocyte Maturation, 30000241$h_ptc1Pathway:Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle, 30000277$h_srcRPTPPathway:Activation of Src by Protein-tyrosine phosphatase alpha, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
cyclin B1,INTERPRO[450003872$IPR004367:Cyclin, C-terminal, 450006082$IPR006670:Cyclin, 450006083$IPR006671:Cyclin, N-terminal, 450012382$IPR013763:Cyclin-related, 450012974$IPR014400:Cyclin, A/B/D/E, 450013896$IPR015454:G2/mitotic-specific cyclin B]
cyclin B1,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038835$hsa04114:Oocyte meiosis, 470038836$hsa04115:p53 signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation]
cyclin B1,PIR_SUPERFAMILY[630001911$PIRSF001771:cyclin, A/B/D/E types, 630001912$PIRSF001771:Cyclin_A_B_D_E]
cyclin B1,SMART[760000337$SM00385:CYCLIN]
cyclin B1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000258$cell cycle, 790000259$cell cycle control, 790000260$cell division, 790000356$complete proteome, 790000389$cyclin, 790000407$cytoplasm, 790000410$cytoskeleton, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
cyclin B1,UP_SEQ_FEATURE[850020357$chain:G2/mitotic-specific cyclin-B1, 850102554$compositionally biased region:Lys-rich, 850105852$helix, 850106258$modified residue, 850112167$region of interest:Interaction with CDK2, 850118575$strand, 850118624$turn]
cyclin B3,INTERPRO[450003872$IPR004367:Cyclin, C-terminal, 450006082$IPR006670:Cyclin, 450006083$IPR006671:Cyclin, N-terminal, 450012382$IPR013763:Cyclin-related, 450013894$IPR015452:G2/mitotic-specific cyclin B3]
cyclin B3,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038836$hsa04115:p53 signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation]
cyclin B3,SMART[760000337$SM00385:CYCLIN]
cyclin B3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000389$cyclin, 790000915$meiosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
cyclin B3,UP_SEQ_FEATURE[850020359$chain:G2/mitotic-specific cyclin-B3, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117370$short sequence motif:D-box, 850118574$splice variant]
cyclin E2,INTERPRO[450003872$IPR004367:Cyclin, C-terminal, 450006082$IPR006670:Cyclin, 450006083$IPR006671:Cyclin, N-terminal, 450012382$IPR013763:Cyclin-related, 450012974$IPR014400:Cyclin, A/B/D/E]
cyclin E2,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038835$hsa04114:Oocyte meiosis, 470038836$hsa04115:p53 signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038905$hsa05215:Prostate cancer, 470038912$hsa05222:Small cell lung cancer]
cyclin E2,PIR_SUPERFAMILY[630001911$PIRSF001771:cyclin, A/B/D/E types, 630001912$PIRSF001771:Cyclin_A_B_D_E]
cyclin E2,SMART[760000337$SM00385:CYCLIN]
cyclin E2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000389$cyclin, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
cyclin E2,UP_SEQ_FEATURE[850020338$chain:G1/S-specific cyclin-E2, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant]
cyclin G associated kinase,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012613$IPR014019:Phosphatase tensin type, 450012614$IPR014020:Tensin phosphatase, C2 domain, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
cyclin G associated kinase,OMIM_DISEASE[520002067$Genomewide association study for susceptibility genes contributing to familial Parkinson disease]
cyclin G associated kinase,PIR_SUPERFAMILY[630029776$PIRSF038164:auxilin/cyclin G-associated kinase, 630030904$PIRSF500744:cyclin G-associated kinase, vertebrate type]
cyclin G associated kinase,SMART[760000243$SM00271:DnaJ]
cyclin G associated kinase,SP_PIR_KEYWORDS[790000138$atp-binding, 790000258$cell cycle, 790000263$cell junction, 790000356$complete proteome, 790000389$cyclin, 790000407$cytoplasm, 790000624$golgi apparatus, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
cyclin G associated kinase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850013018$chain:Cyclin G-associated kinase, 850102580$compositionally biased region:Poly-Pro, 850103206$domain:C2 tensin-type, 850104487$domain:J, 850104989$domain:Phosphatase tensin-type, 850105086$domain:Protein kinase, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
cyclin L2; chemokine (C-C motif) receptor 6,BBID[10000030$14.chemokine_receptor-ligand]
cyclin L2; chemokine (C-C motif) receptor 6,COG_ONTOLOGY[90000030$Cell division and chromosome partitioning / Transcription / DNA replication, recombination, and repair]
cyclin L2; chemokine (C-C motif) receptor 6,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000305$IPR000355:Chemokine receptor, 450003583$IPR004067:C-C chemokine receptor, type 6, 450006082$IPR006670:Cyclin, 450006083$IPR006671:Cyclin, N-terminal, 450012382$IPR013763:Cyclin-related, 450013871$IPR015429:Transcription regulator cyclin, 450015380$IPR017060:Cyclin L, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
cyclin L2; chemokine (C-C motif) receptor 6,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
cyclin L2; chemokine (C-C motif) receptor 6,OMIM_DISEASE[520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease]
cyclin L2; chemokine (C-C motif) receptor 6,PIR_SUPERFAMILY[630028057$PIRSF036580:cyclin, L type, 630028058$PIRSF036580:Cyclin_L, 630030051$PIRSF038545:chemokine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
cyclin L2; chemokine (C-C motif) receptor 6,SMART[760000337$SM00385:CYCLIN]
cyclin L2; chemokine (C-C motif) receptor 6,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000389$cyclin, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
cyclin L2; chemokine (C-C motif) receptor 6,UP_SEQ_FEATURE[850008593$chain:C-C chemokine receptor type 6, 850013136$chain:Cyclin-L2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111374$region of interest:Cyclin-like 1, 850111375$region of interest:Cyclin-like 2, 850114560$region of interest:RS, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cyclin-dependent kinase 6,BBID[10000052$26.cyclin-CDK_complexes, 10000064$4.cyclins_&_p27_cell_cycle, 10000092$71.Id_proteins_G0-to-S_cell_cycle, 10000105$83.Growth_factors_Survival_factors_Mitogens, 10000115$94.E2F_transcriptional_activity_cell_cycle]
cyclin-dependent kinase 6,BIOCARTA[30000059$h_cellcyclePathway:Cyclins and Cell Cycle Regulation, 30000090$h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth, 30000119$h_g1Pathway:Cell Cycle: G1/S Check Point , 30000248$h_RacCycDPathway:Influence of Ras and Rho proteins on G1 to S Transition]
cyclin-dependent kinase 6,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
cyclin-dependent kinase 6,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038836$hsa04115:p53 signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038902$hsa05212:Pancreatic cancer, 470038904$hsa05214:Glioma, 470038908$hsa05218:Melanoma, 470038910$hsa05220:Chronic myeloid leukemia, 470038912$hsa05222:Small cell lung cancer, 470038913$hsa05223:Non-small cell lung cancer]
cyclin-dependent kinase 6,OMIM_DISEASE[520001130$Common variants at CD40 and other loci confer risk of rheumatoid arthritis, 520001993$Genome-wide association analysis identifies 20 loci that influence adult height, 520002597$Identification of ten loci associated with height highlights new biological pathways in human growth, 520003072$Many sequence variants affecting diversity of adult human height, 520004678$Stature QTL 11]
cyclin-dependent kinase 6,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein]
cyclin-dependent kinase 6,SMART[760000193$SM00220:S_TKc]
cyclin-dependent kinase 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000258$cell cycle, 790000259$cell cycle control, 790000260$cell division, 790000356$complete proteome, 790000389$cyclin, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
cyclin-dependent kinase 6,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010447$chain:Cell division protein kinase 6, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
cyclin-dependent kinase 9,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
cyclin-dependent kinase 9,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein]
cyclin-dependent kinase 9,SMART[760000193$SM00220:S_TKc]
cyclin-dependent kinase 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
cyclin-dependent kinase 9,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010450$chain:Cell division protein kinase 9, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),BBID[10000052$26.cyclin-CDK_complexes]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),BIOCARTA[30000059$h_cellcyclePathway:Cyclins and Cell Cycle Regulation, 30000119$h_g1Pathway:Cell Cycle: G1/S Check Point ]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),INTERPRO[450001870$IPR002110:Ankyrin]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038850$hsa04350:TGF-beta signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038912$hsa05222:Small cell lung cancer]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),OMIM_DISEASE[520000046$A common variant on chromosome 9p21 affects the risk of myocardial infarction, 520000069$A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, 520000139$Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome wide association data, 520001994$Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520003247$Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes, 520004248$Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes, 520004728$Susceptibility loci for intracranial aneurysm in European and Japanese populations]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),PIR_SUPERFAMILY[630027780$PIRSF036346:cyclin-dependent kinase inhibitor p19]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),SMART[760000220$SM00248:ANK]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),SP_PIR_KEYWORDS[790000086$ank repeat, 790000258$cell cycle, 790000259$cell cycle control, 790000356$complete proteome, 790000389$cyclin, 790000446$disease mutation, 790000825$kinase, 790001260$protein kinase inhibitor, 790001304$repeat, 790001580$tumor suppressor]
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),UP_SEQ_FEATURE[850013070$chain:Cyclin-dependent kinase 4 inhibitor B, 850115643$repeat:ANK 1; truncated, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117294$sequence conflict, 850117295$sequence variant]
cyclin-dependent kinase-like 3,BIOCARTA[30000012$h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics, 30000013$h_akapCentrosomePathway:Protein Kinase A at the Centrosome, 30000014$h_aktPathway:AKT Signaling Pathway, 30000063$h_chrebpPathway:ChREBP regulation by carbohydrates and cAMP, 30000065$h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors, 30000074$h_ctcfPathway:CTCF: First Multivalent Nuclear Factor, 30000105$h_erkPathway:Erk1/Erk2 Mapk Signaling pathway, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000146$h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway, 30000168$h_keratinocytePathway:Keratinocyte Differentiation, 30000195$h_mTORPathway:mTOR Signaling Pathway, 30000214$h_p35alzheimersPathway:Deregulation of CDK5 in Alzheimers Disease, 30000289$h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality, 30000313$h_wntPathway:WNT Signaling Pathway]
cyclin-dependent kinase-like 3,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
cyclin-dependent kinase-like 3,SMART[760000193$SM00220:S_TKc]
cyclin-dependent kinase-like 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
cyclin-dependent kinase-like 3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850013115$chain:Cyclin-dependent kinase-like 3, 850105086$domain:Protein kinase, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117810$short sequence motif:[NKR]KIAxRE, 850118574$splice variant]
cystatin B (stefin B),INTERPRO[450000008$IPR000010:Proteinase inhibitor I25, cystatin, 450001518$IPR001713:Proteinase inhibitor I25A, stefin A, 450016374$IPR018073:Proteinase inhibitor I25, cystatin, conserved site]
cystatin B (stefin B),OMIM_DISEASE[520001764$Epilepsy, progressive myoclonic 1]
cystatin B (stefin B),PIR_SUPERFAMILY[630001805$PIRSF001638:cystatin]
cystatin B (stefin B),SMART[760000035$SM00043:CY]
cystatin B (stefin B),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000189$blocked amino end, 790000356$complete proteome, 790000398$cysteine proteinase inhibitor, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000509$epilepsy, 790001065$nucleus, 790001162$phosphoprotein, 790001253$protease inhibitor, 790001510$thiol protease inhibitor]
cystatin B (stefin B),UP_SEQ_FEATURE[850013224$chain:Cystatin-B, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117699$short sequence motif:Secondary area of contact, 850118513$site:Reactive site, 850118575$strand]
cysteine-rich with EGF-like domains 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450005638$IPR006212:Furin-like repeat, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
cysteine-rich with EGF-like domains 1,OMIM_DISEASE[520000460$Atrioventricular septal defect, partial, with heterotaxy syndrome, 520000461$Atrioventricular septal defect, susceptibility to, 2]
cysteine-rich with EGF-like domains 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000233$SM00261:FU]
cysteine-rich with EGF-like domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
cysteine-rich with EGF-like domains 1,UP_SEQ_FEATURE[850013392$chain:Cysteine-rich with EGF-like domain protein 1, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850116009$repeat:FU 1, 850116015$repeat:FU 2, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cysteine-serine-rich nuclear protein 1,SP_PIR_KEYWORDS[790000020$activator, 790000109$Apoptosis, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
cysteine-serine-rich nuclear protein 1,UP_SEQ_FEATURE[850013397$chain:Cysteine/serine-rich nuclear protein 1, 850102480$compositionally biased region:Cys-rich, 850102597$compositionally biased region:Ser-rich, 850117295$sequence variant]
cysteine/histidine-rich 1,INTERPRO[450001138$IPR001293:Zinc finger, TRAF-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
cysteine/histidine-rich 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
cysteine/histidine-rich 1,UP_SEQ_FEATURE[850013241$chain:Cysteine and histidine-rich protein 1, 850118574$splice variant, 850118920$zinc finger region:RING-type; degenerate, 850118936$zinc finger region:TRAF-type]
cysteinyl-tRNA synthetase,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
cysteinyl-tRNA synthetase,INTERPRO[450001257$IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site, 450002053$IPR002308:Cysteinyl-tRNA synthetase, class Ia, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold, 450014235$IPR015803:Cysteinyl-tRNA synthetase, class Ia, N-terminal, 450014236$IPR015804:Cysteinyl-tRNA synthetase, class Ia, C-terminal]
cysteinyl-tRNA synthetase,KEGG_PATHWAY[470038807$hsa00970:Aminoacyl-tRNA biosynthesis]
cysteinyl-tRNA synthetase,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000066$Aminoacyl-tRNA synthetase, 790000138$atp-binding, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001271$Proto-oncogene, 790001648$zinc]
cysteinyl-tRNA synthetase,UP_SEQ_FEATURE[850000242$binding site:ATP, 850013405$chain:Cysteinyl-tRNA synthetase, cytoplasmic, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117296$short sequence motif:"HIGH" region, 850117297$short sequence motif:"KMSKS" region, 850118574$splice variant]
cytochrome P450, family 1, subfamily A, polypeptide 2,BIOCARTA[30000003$h_AcetaminophenPathway:Mechanism of Acetaminophen Activity and Toxicity, 30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity]
cytochrome P450, family 1, subfamily A, polypeptide 2,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 1, subfamily A, polypeptide 2,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450007403$IPR008066:Cytochrome P450, E-class, group I, CYP1, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 1, subfamily A, polypeptide 2,KEGG_PATHWAY[470038743$hsa00232:Caffeine metabolism, 470038756$hsa00380:Tryptophan metabolism, 470038781$hsa00591:Linoleic acid metabolism, 470038801$hsa00830:Retinol metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
cytochrome P450, family 1, subfamily A, polypeptide 2,PIR_SUPERFAMILY[630000058$PIRSF000045:cytochrome P450 CYP2D6]
cytochrome P450, family 1, subfamily A, polypeptide 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000314$chromoprotein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001556$transmembrane protein]
cytochrome P450, family 1, subfamily A, polypeptide 2,UP_SEQ_FEATURE[850013667$chain:Cytochrome P450 1A2, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450007406$IPR008069:Cytochrome P450, E-class, group I, CYP2D-like, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 1,PIR_SUPERFAMILY[630000058$PIRSF000045:cytochrome P450 CYP2D6]
cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 1,SP_PIR_KEYWORDS[790000652$heme, 790000802$iron, 790000937$metal-binding, 790000984$Monooxygenase, 790001092$oxidoreductase]
cytochrome P450, family 2, subfamily U, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 2, subfamily U, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450007406$IPR008069:Cytochrome P450, E-class, group I, CYP2D-like, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 2, subfamily U, polypeptide 1,KEGG_PATHWAY[470038780$hsa00590:Arachidonic acid metabolism]
cytochrome P450, family 2, subfamily U, polypeptide 1,PIR_SUPERFAMILY[630000058$PIRSF000045:cytochrome P450 CYP2D6]
cytochrome P450, family 2, subfamily U, polypeptide 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001555$transmembrane]
cytochrome P450, family 2, subfamily U, polypeptide 1,UP_SEQ_FEATURE[850013754$chain:Cytochrome P450 2U1, 850106026$metal ion-binding site:Iron (heme axial ligand), 850118574$splice variant, 850118623$transmembrane region]
cytochrome P450, family 27, subfamily A, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 27, subfamily A, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 27, subfamily A, polypeptide 1,KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038821$hsa03320:PPAR signaling pathway]
cytochrome P450, family 27, subfamily A, polypeptide 1,OMIM_DISEASE[520000916$Cerebrotendinous xanthomatosis]
cytochrome P450, family 27, subfamily A, polypeptide 1,PIR_SUPERFAMILY[630000059$PIRSF000046:cytochrome P450 CYP11B1]
cytochrome P450, family 27, subfamily A, polypeptide 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000252$cataract, 790000314$chromoprotein, 790000356$complete proteome, 790000446$disease mutation, 790000488$electron transfer, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000969$mitochondrion, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001550$transit peptide, 790001556$transmembrane protein]
cytochrome P450, family 27, subfamily A, polypeptide 1,UP_SEQ_FEATURE[850062471$chain:Sterol 26-hydroxylase, mitochondrial, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850114701$region of interest:Sterol-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
cytochrome P450, family 3, subfamily A, polypeptide 5,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 3, subfamily A, polypeptide 5,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450002135$IPR002402:Cytochrome P450, E-class, group II, 450002136$IPR002403:Cytochrome P450, E-class, group IV, 450007409$IPR008072:Cytochrome P450, E-class, CYP3A, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 3, subfamily A, polypeptide 5,KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038781$hsa00591:Linoleic acid metabolism, 470038801$hsa00830:Retinol metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038810$hsa00983:Drug metabolism]
cytochrome P450, family 3, subfamily A, polypeptide 5,OMIM_DISEASE[520002484$Hypertension, salt-sensitive essential, susceptibility to]
cytochrome P450, family 3, subfamily A, polypeptide 5,PIR_SUPERFAMILY[630000064$PIRSF000051:cytochrome P450 CYP3A5]
cytochrome P450, family 3, subfamily A, polypeptide 5,SP_PIR_KEYWORDS[790000314$chromoprotein, 790000356$complete proteome, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001556$transmembrane protein]
cytochrome P450, family 3, subfamily A, polypeptide 5,UP_SEQ_FEATURE[850013779$chain:Cytochrome P450 3A5, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117294$sequence conflict, 850117295$sequence variant]
cytochrome P450, family 3, subfamily A, polypeptide 7,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 3, subfamily A, polypeptide 7,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002135$IPR002402:Cytochrome P450, E-class, group II, 450007409$IPR008072:Cytochrome P450, E-class, CYP3A, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 3, subfamily A, polypeptide 7,KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038781$hsa00591:Linoleic acid metabolism, 470038801$hsa00830:Retinol metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038810$hsa00983:Drug metabolism]
cytochrome P450, family 3, subfamily A, polypeptide 7,PIR_SUPERFAMILY[630000064$PIRSF000051:cytochrome P450 CYP3A5, 630000065$PIRSF000052:trichodiene oxygenase]
cytochrome P450, family 3, subfamily A, polypeptide 7,SP_PIR_KEYWORDS[790000314$chromoprotein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001556$transmembrane protein]
cytochrome P450, family 3, subfamily A, polypeptide 7,UP_SEQ_FEATURE[850013780$chain:Cytochrome P450 3A7, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant]
cytochrome c-1,COG_ONTOLOGY[90000064$Energy production and conversion]
cytochrome c-1,INTERPRO[450002070$IPR002326:Cytochrome c1, 450008201$IPR009056:Cytochrome c, monohaem]
cytochrome c-1,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038844$hsa04260:Cardiac muscle contraction, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
cytochrome c-1,PIR_SUPERFAMILY[630000014$PIRSF000010:cytochrome c1, heme protein, 630030831$PIRSF500663:cytochrome c1, eukaryote type]
cytochrome c-1,SP_PIR_KEYWORDS[790000314$chromoprotein, 790000356$complete proteome, 790000488$electron transfer, 790000489$electron transport, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001091$oxidative phosphorylation, 790001092$oxidoreductase, 790001212$polymorphism, 790001309$respiratory chain, 790001550$transit peptide, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
cytochrome c-1,UP_SEQ_FEATURE[850000391$binding site:Heme (covalent), 850013618$chain:Cytochrome c1, heme protein, mitochondrial, 850103474$domain:Cytochrome c, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
cytokine inducible SH2-containing protein,INTERPRO[450000852$IPR000980:SH2 motif, 450001330$IPR001496:SOCS protein, C-terminal]
cytokine inducible SH2-containing protein,KEGG_PATHWAY[470038866$hsa04630:Jak-STAT signaling pathway]
cytokine inducible SH2-containing protein,PIR_SUPERFAMILY[630006289$PIRSF006354:suppressor of cytokine signaling (SOCS) 1-3]
cytokine inducible SH2-containing protein,SMART[760000224$SM00252:SH2, 760000225$SM00253:SOCS]
cytokine inducible SH2-containing protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000191$blood, 790000356$complete proteome, 790000402$cytokine, 790000635$growth regulation, 790001029$neutrophil, 790001397$SH2 domain, 790001408$Signal transduction inhibitor, 790001592$ubl conjugation, 790001593$ubl conjugation pathway]
cytokine inducible SH2-containing protein,UP_SEQ_FEATURE[850013999$chain:Cytokine-inducible SH2-containing protein, 850105346$domain:SH2, 850105375$domain:SOCS box, 850118574$splice variant]
cytokine receptor-like factor 1,INTERPRO[450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold, 450013599$IPR015152:Erythropoietin receptor, ligand binding]
cytokine receptor-like factor 1,OMIM_DISEASE[520001075$Cold-induced sweating syndrome, 520001276$Crisponi syndrome]
cytokine receptor-like factor 1,SMART[760000051$SM00060:FN3]
cytokine receptor-like factor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal]
cytokine receptor-like factor 1,UP_SEQ_FEATURE[850013994$chain:Cytokine receptor-like factor 1, 850102883$disulfide bond, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide]
cytokine-dependent hematopoietic cell linker,INTERPRO[450000852$IPR000980:SH2 motif]
cytokine-dependent hematopoietic cell linker,SMART[760000224$SM00252:SH2]
cytokine-dependent hematopoietic cell linker,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain]
cytokine-dependent hematopoietic cell linker,UP_SEQ_FEATURE[850013998$chain:Cytokine-dependent hematopoietic cell linker, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850105346$domain:SH2, 850106258$modified residue, 850113368$region of interest:Mediates interaction with LAT and GRB2, 850113377$region of interest:Mediates interaction with PLCG1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cytoplasmic FMR1 interacting protein 2,INTERPRO[450007418$IPR008081:Cytoplasmic FMR1-interacting, 450014858$IPR016536:Cytoplasmic FMR1-interacting, subgroup]
cytoplasmic FMR1 interacting protein 2,KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
cytoplasmic FMR1 interacting protein 2,PIR_SUPERFAMILY[630007746$PIRSF008153:cytoplasmic FMR1-interacting protein, 630007747$PIRSF008153:FMR1_interacting]
cytoplasmic FMR1 interacting protein 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000256$cell adhesion, 790000263$cell junction, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001335$rna editing, 790001475$synapse, 790001477$Synaptosome]
cytoplasmic FMR1 interacting protein 2,UP_SEQ_FEATURE[850014043$chain:Cytoplasmic FMR1-interacting protein 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cytoplasmic linker associated protein 1,INTERPRO[450000307$IPR000357:HEAT, 450010814$IPR011989:Armadillo-like helical]
cytoplasmic linker associated protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000827$kinetochore, 790000960$microtubule, 790000973$mitosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
cytoplasmic linker associated protein 1,UP_SEQ_FEATURE[850011688$chain:CLIP-associating protein 1, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850112201$region of interest:Interaction with CLIP2, 850112542$region of interest:Interaction with microtubules, MAPRE1 and MAPRE3, 850112671$region of interest:Interaction with PHLDB2 and RSN, 850113294$region of interest:Localization to kinetochores, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cytospin B,INTERPRO[450001520$IPR001715:Calponin-like actin-binding]
cytospin B,SMART[760000025$SM00033:CH]
cytospin B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene]
cytospin B,UP_SEQ_FEATURE[850014118$chain:Cytospin-B, 850102597$compositionally biased region:Ser-rich, 850103317$domain:CH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dachsous 2 (Drosophila),INTERPRO[450001884$IPR002126:Cadherin]
dachsous 2 (Drosophila),SMART[760000099$SM00112:CA]
dachsous 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
dachsous 2 (Drosophila),UP_SEQ_FEATURE[850048758$chain:Protocadherin-23, 850103211$domain:Cadherin 1, 850103212$domain:Cadherin 10, 850103213$domain:Cadherin 11, 850103214$domain:Cadherin 12, 850103215$domain:Cadherin 13, 850103216$domain:Cadherin 14, 850103217$domain:Cadherin 15, 850103218$domain:Cadherin 16, 850103219$domain:Cadherin 17, 850103220$domain:Cadherin 18, 850103221$domain:Cadherin 19, 850103222$domain:Cadherin 2, 850103223$domain:Cadherin 20, 850103224$domain:Cadherin 21, 850103225$domain:Cadherin 22, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
decorin,COG_ONTOLOGY[90000070$Function unknown]
decorin,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450014674$IPR016352:Small leucine-rich proteoglycan, class I, decorin/asporin/byglycan]
decorin,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
decorin,OMIM_DISEASE[520001209$Corneal dystrophy, congenital stromal]
decorin,PIR_SUPERFAMILY[630002608$PIRSF002490:class I small leucine-rich proteoglycan, decorin/asporin/byglycan types, 630002609$PIRSF002490:SLRP_I]
decorin,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
decorin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000308$chondroitin sulfate proteoglycan, 790000346$collagen binding, 790000356$complete proteome, 790000424$dermatan sulfate, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat]
decorin,UP_SEQ_FEATURE[850014440$chain:Decorin, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
dehydrodolichyl diphosphate synthase,INTERPRO[450001283$IPR001441:Di-trans-poly-cis-decaprenylcistransferase-like, 450016792$IPR018520:Di-trans-poly-cis-decaprenylcistransferase-like, conserved site]
dehydrodolichyl diphosphate synthase,KEGG_PATHWAY[470038803$hsa00900:Terpenoid backbone biosynthesis]
dehydrodolichyl diphosphate synthase,PIR_SUPERFAMILY[630005562$PIRSF005638:cis-prenyltransferase, 630030528$PIRSF500283:dehydrodolichyl diphosphate synthase, Fungi/Metazoa type]
dehydrodolichyl diphosphate synthase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001547$transferase]
dehydrodolichyl diphosphate synthase,UP_SEQ_FEATURE[850014707$chain:Dehydrodolichyl diphosphate synthase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dehydrogenase/reductase (SDR family) member 9,COG_ONTOLOGY[90000073$General function prediction only]
dehydrogenase/reductase (SDR family) member 9,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
dehydrogenase/reductase (SDR family) member 9,KEGG_PATHWAY[470038801$hsa00830:Retinol metabolism]
dehydrogenase/reductase (SDR family) member 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790000959$microsome, 790001006$nad, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001405$signal]
dehydrogenase/reductase (SDR family) member 9,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850000555$binding site:Substrate, 850014729$chain:Dehydrogenase/reductase SDR family member 9, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
delta-like 2 homolog (Drosophila),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001280$IPR001438:EGF-like, type 2, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
delta-like 2 homolog (Drosophila),SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
delta-like 2 homolog (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
delta-like 2 homolog (Drosophila),UP_SEQ_FEATURE[850045565$chain:Protein delta homolog 2, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
delta-like 3 (Drosophila),BIOCARTA[30000137$h_hesPathway:Segmentation Clock]
delta-like 3 (Drosophila),INTERPRO[450000637$IPR000742:EGF-like, type 3, 450001280$IPR001438:EGF-like, type 2, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010479$IPR011651:Notch ligand, N-terminal, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular]
delta-like 3 (Drosophila),KEGG_PATHWAY[470038848$hsa04330:Notch signaling pathway]
delta-like 3 (Drosophila),OMIM_DISEASE[520004655$Spondylocostal dysostosis, autosomal recessive, 1]
delta-like 3 (Drosophila),SMART[760000155$SM00181:EGF]
delta-like 3 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000919$membrane, 790001045$notch signaling pathway, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001592$ubl conjugation]
delta-like 3 (Drosophila),UP_SEQ_FEATURE[850014798$chain:Delta-like protein 3, 850102883$disulfide bond, 850103551$domain:DSL, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
deltex homolog 1 (Drosophila),INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450003680$IPR004170:WWE domain, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450016422$IPR018123:WWE domain, subgroup, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
deltex homolog 1 (Drosophila),KEGG_PATHWAY[470038848$hsa04330:Notch signaling pathway]
deltex homolog 1 (Drosophila),SMART[760000158$SM00184:RING, 760000589$SM00678:WWE]
deltex homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001045$notch signaling pathway, 790001065$nucleus, 790001304$repeat, 790001399$sh3-binding, 790001648$zinc, 790001651$zinc-finger]
deltex homolog 1 (Drosophila),UP_SEQ_FEATURE[850045567$chain:Protein deltex-1, 850102586$compositionally biased region:Pro-rich, 850105737$domain:WWE 1, 850105738$domain:WWE 2, 850117294$sequence conflict, 850117711$short sequence motif:SH3-binding, 850118911$zinc finger region:RING-type]
deoxyhypusine synthase,INTERPRO[450002461$IPR002773:Deoxyhypusine synthase]
deoxyhypusine synthase,PIR_SUPERFAMILY[630006596$PIRSF006637:deoxyhypusine synthase]
deoxyhypusine synthase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000755$hypusine biosynthesis, 790001006$nad, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
deoxyhypusine synthase,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000454$binding site:NAD, 850000458$binding site:NAD; via amide nitrogen, 850000551$binding site:Spermidine, 850014861$chain:Deoxyhypusine synthase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106301$nucleotide phosphate-binding region:NAD, 850114688$region of interest:Spermidine binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
deoxyribonuclease I-like 1,INTERPRO[450004603$IPR005135:Endonuclease/exonuclease/phosphatase, 450007506$IPR008185:Deoxyribonuclease I, eukaryotic, 450014526$IPR016202:Deoxyribonuclease I-like, 450016360$IPR018057:Deoxyribonuclease I, active site]
deoxyribonuclease I-like 1,PIR_SUPERFAMILY[630001140$PIRSF000988:deoxyribonuclease I, 630001141$PIRSF000988:DNase_I_euk]
deoxyribonuclease I-like 1,SMART[760000421$SM00476:DNaseIc]
deoxyribonuclease I-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000498$Endonuclease, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001405$signal]
deoxyribonuclease I-like 1,UP_SEQ_FEATURE[850014875$chain:Deoxyribonuclease-1-like 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
dermokine,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
dermokine,UP_SEQ_FEATURE[850014922$chain:Dermokine, 850102517$compositionally biased region:Gly-rich, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
diacylglycerol O-acyltransferase homolog 1 (mouse),INTERPRO[450003810$IPR004299:Membrane bound O-acyl transferase, MBOAT]
diacylglycerol O-acyltransferase homolog 1 (mouse),KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism, 470038801$hsa00830:Retinol metabolism]
diacylglycerol O-acyltransferase homolog 1 (mouse),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001162$phosphoprotein, 790001547$transferase, 790001555$transmembrane]
diacylglycerol O-acyltransferase homolog 1 (mouse),UP_SEQ_FEATURE[850015003$chain:Diacylglycerol O-acyltransferase 1, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
diacylglycerol kinase, theta 110kDa,COG_ONTOLOGY[90000085$Lipid metabolism / General function prediction only]
diacylglycerol kinase, theta 110kDa,INTERPRO[450000135$IPR000159:Ras-association, 450000651$IPR000756:Diacylglycerol kinase accessory region, 450001060$IPR001206:Diacylglycerol kinase, catalytic region, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450010290$IPR011424:C1-like]
diacylglycerol kinase, theta 110kDa,KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism, 470038778$hsa00564:Glycerophospholipid metabolism, 470038832$hsa04070:Phosphatidylinositol signaling system]
diacylglycerol kinase, theta 110kDa,OMIM_DISEASE[520002067$Genomewide association study for susceptibility genes contributing to familial Parkinson disease]
diacylglycerol kinase, theta 110kDa,SMART[760000037$SM00045:DAGKa, 760000038$SM00046:DAGKc, 760000096$SM00109:C1, 760000284$SM00314:RA]
diacylglycerol kinase, theta 110kDa,SP_PIR_KEYWORDS[790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000825$kinase, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
diacylglycerol kinase, theta 110kDa,UP_SEQ_FEATURE[850015001$chain:Diacylglycerol kinase theta, 850103479$domain:DAGKc, 850105145$domain:Ras-associating, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117559$short sequence motif:LXXLL motif 1, 850117562$short sequence motif:LXXLL motif 2, 850118893$zinc finger region:Phorbol-ester/DAG-type 1, 850118894$zinc finger region:Phorbol-ester/DAG-type 2, 850118895$zinc finger region:Phorbol-ester/DAG-type 3]
diacylglycerol lipase, beta,INTERPRO[450002577$IPR002921:Lipase, class 3]
diacylglycerol lipase, beta,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000743$hydrolase, 790000869$lipid degradation, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
diacylglycerol lipase, beta,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850061135$chain:Sn1-specific diacylglycerol lipase beta, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
diaphanous homolog 1 (Drosophila),BIOCARTA[30000087$h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia, 30000179$h_malPathway:Role of MAL in Rho-Mediated Activation of SRF, 30000261$h_rhoPathway:Rho cell motility signaling pathway]
diaphanous homolog 1 (Drosophila),INTERPRO[450002728$IPR003104:Actin-binding FH2 and DRF autoregulatory, 450008514$IPR009408:Formin Homology 1, 450009525$IPR010465:DRF autoregulatory, 450009531$IPR010472:Diaphanous FH3, 450009532$IPR010473:Diaphanous GTPase-binding, 450013217$IPR014767:Diaphanous autoregulatory, 450013218$IPR014768:GTPase-binding/formin homology 3, 450013867$IPR015425:Actin-binding FH2]
diaphanous homolog 1 (Drosophila),KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038881$hsa04810:Regulation of actin cytoskeleton]
diaphanous homolog 1 (Drosophila),OMIM_DISEASE[520001313$Deafness, autosomal dominant 1]
diaphanous homolog 1 (Drosophila),SMART[760000441$SM00498:FH2]
diaphanous homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000264$cell membrane, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000415$deafness, 790000445$direct protein sequencing, 790000645$Hearing, 790000811$isopeptide bond, 790000919$membrane, 790001041$non-syndromic deafness, 790001162$phosphoprotein, 790001304$repeat, 790001592$ubl conjugation]
diaphanous homolog 1 (Drosophila),UP_SEQ_FEATURE[850045582$chain:Protein diaphanous homolog 1, 850102434$compositionally biased region:Arg/Lys-rich (basic), 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103478$domain:DAD, 850103773$domain:FH1, 850103774$domain:FH2, 850104044$domain:GBD/FH3, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
dihydropyrimidinase-like 5,INTERPRO[450006091$IPR006680:Amidohydrolase 1, 450010604$IPR011778:D-hydantoinase]
dihydropyrimidinase-like 5,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
dihydropyrimidinase-like 5,PIR_SUPERFAMILY[630001385$PIRSF001238:cyclic amidohydrolases (dihydroorotase, allantoinase)]
dihydropyrimidinase-like 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001162$phosphoprotein]
dihydropyrimidinase-like 5,UP_SEQ_FEATURE[850015147$chain:Dihydropyrimidinase-related protein 5, 850106258$modified residue, 850117294$sequence conflict]
dihydroxyacetone kinase 2 homolog (S. cerevisiae),INTERPRO[450003527$IPR004006:Dak kinase, 450003528$IPR004007:Dak phosphatase, 450011412$IPR012734:Dihydroxyacetone kinase]
dihydroxyacetone kinase 2 homolog (S. cerevisiae),KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism, 470038864$hsa04622:RIG-I-like receptor signaling pathway]
dihydroxyacetone kinase 2 homolog (S. cerevisiae),PIR_SUPERFAMILY[630012417$PIRSF015659:glycerone kinase DAK1]
dihydroxyacetone kinase 2 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000138$atp-binding, 790000338$cobalt, 790000356$complete proteome, 790000537$FAD, 790000825$kinase, 790000891$lyase, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001212$polymorphism, 790001547$transferase]
dihydroxyacetone kinase 2 homolog (S. cerevisiae),UP_SEQ_FEATURE[850000157$active site:Tele-hemiaminal-histidine intermediate, 850000242$binding site:ATP, 850000323$binding site:Dihydroxyacetone, 850007964$chain:Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing), 850103480$domain:DAK1, 850103481$domain:DAK2, 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
dipeptidyl-peptidase 7,INTERPRO[450008009$IPR008758:Peptidase S28]
dipeptidyl-peptidase 7,PIR_SUPERFAMILY[630013319$PIRSF016539:Lysosomal Pro-X carboxypeptidase / Dipeptidyl-peptidase 2]
dipeptidyl-peptidase 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000069$Aminopeptidase, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000440$dipeptidylpeptide hydrolase, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790001212$polymorphism, 790001252$Protease, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001652$zymogen]
dipeptidyl-peptidase 7,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850015223$chain:Dipeptidyl-peptidase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
discoidin, CUB and LCCL domain containing 2,INTERPRO[450000360$IPR000421:Coagulation factor 5/8 type, C-terminal, 450000750$IPR000859:CUB, 450003560$IPR004043:LCCL]
discoidin, CUB and LCCL domain containing 2,SMART[760000034$SM00042:CUB, 760000203$SM00231:FA58C, 760000533$SM00603:LCCL]
discoidin, CUB and LCCL domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
discoidin, CUB and LCCL domain containing 2,UP_SEQ_FEATURE[850015264$chain:Discoidin, CUB and LCCL domain-containing protein 2, 850102580$compositionally biased region:Poly-Pro, 850102883$disulfide bond, 850103432$domain:CUB, 850103733$domain:F5/8 type C, 850104661$domain:LCCL, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
discs, large (Drosophila) homolog-associated protein 3,INTERPRO[450004495$IPR005026:Guanylate-kinase-associated protein]
discs, large (Drosophila) homolog-associated protein 3,PIR_SUPERFAMILY[630014622$PIRSF017965:disks large-associated protein 1]
discs, large (Drosophila) homolog-associated protein 3,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse]
discs, large (Drosophila) homolog-associated protein 3,UP_SEQ_FEATURE[850015435$chain:Disks large-associated protein 3, 850102574$compositionally biased region:Poly-His, 850106258$modified residue]
dishevelled, dsh homolog 2 (Drosophila),INTERPRO[450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450001015$IPR001158:DIX, 450001316$IPR001478:PDZ/DHR/GLGF, 450002925$IPR003351:Dishevelled protein, 450007617$IPR008339:Dishevelled region, 450007619$IPR008341:Dishevelled-2 region, 450010816$IPR011991:Winged helix repressor DNA-binding, 450013947$IPR015506:Dishevelled related protein]
dishevelled, dsh homolog 2 (Drosophila),KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038848$hsa04330:Notch signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038907$hsa05217:Basal cell carcinoma]
dishevelled, dsh homolog 2 (Drosophila),SMART[760000014$SM00021:DAX, 760000041$SM00049:DEP, 760000200$SM00228:PDZ]
dishevelled, dsh homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790001162$phosphoprotein, 790001642$wnt signaling pathway]
dishevelled, dsh homolog 2 (Drosophila),UP_SEQ_FEATURE[850059219$chain:Segment polarity protein dishevelled homolog DVL-2, 850102566$compositionally biased region:Poly-Arg, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850103515$domain:DEP, 850103527$domain:DIX, 850104918$domain:PDZ, 850105852$helix, 850106258$modified residue, 850118575$strand]
docking protein 3,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450002137$IPR002404:Insulin receptor substrate-1, PTB, 450010818$IPR011993:Pleckstrin homology-type]
docking protein 3,SMART[760000205$SM00233:PH, 760000280$SM00310:PTBI]
docking protein 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
docking protein 3,UP_SEQ_FEATURE[850016215$chain:Docking protein 3, 850102586$compositionally biased region:Pro-rich, 850104482$domain:IRS-type PTB, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dolichyl pyrophosphate phosphatase 1,INTERPRO[450000279$IPR000326:Phosphatidic acid phosphatase type 2/haloperoxidase]
dolichyl pyrophosphate phosphatase 1,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
dolichyl pyrophosphate phosphatase 1,SMART[760000008$SM00014:acidPPc]
dolichyl pyrophosphate phosphatase 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790001555$transmembrane]
dolichyl pyrophosphate phosphatase 1,UP_SEQ_FEATURE[850016292$chain:Dolichyldiphosphatase 1, 850118623$transmembrane region]
drebrin-like,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450001868$IPR002108:Actin-binding, cofilin/tropomyosin type]
drebrin-like,SMART[760000090$SM00102:ADF, 760000295$SM00326:SH3]
drebrin-like,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000496$Endocytosis, 790000763$immune response, 790001162$phosphoprotein, 790001398$sh3 domain]
drebrin-like,UP_SEQ_FEATURE[850016368$chain:Drebrin-like protein, 850103020$domain:ADF-H, 850105350$domain:SH3, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118020$site:Cleavage; by caspase-3, 850118574$splice variant, 850118575$strand, 850118624$turn]
dual oxidase 2,INTERPRO[450000986$IPR001125:Recoverin, 450001778$IPR002007:Haem peroxidase, animal, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450011756$IPR013112:FAD-binding 8, 450011764$IPR013121:Ferric reductase, NAD binding, 450011771$IPR013130:Ferric reductase-like transmembrane component, N-terminal, 450016241$IPR017927:Ferredoxin reductase-type FAD-binding domain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2, 450018023$IPR019791:Haem peroxidase, animal, subgroup]
dual oxidase 2,OMIM_DISEASE[520002558$Hypothyroidism, congenital, due to DUOX2 deficiency]
dual oxidase 2,SMART[760000046$SM00054:EFh]
dual oxidase 2,SP_PIR_KEYWORDS[790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000363$congenital hypothyroidism, 790000446$disease mutation, 790000537$FAD, 790000616$glycoprotein, 790000741$hydrogen peroxide, 790000919$membrane, 790001008$nadp, 790001092$oxidoreductase, 790001127$peroxidase, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001527$Thyroid hormones biosynthesis, 790001555$transmembrane]
dual oxidase 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850016392$chain:Dual oxidase 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103737$domain:FAD-binding FR-type, 850103763$domain:Ferric oxidoreductase, 850105770$glycosylation site:N-linked (GlcNAc...), 850112984$region of interest:Interaction with TXNDC11, 850113994$region of interest:Peroxidase-like; mediates peroxidase activity, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,BIOCARTA[30000269$h_shhPathway:Sonic Hedgehog (Shh) Pathway]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,SMART[760000193$SM00220:S_TKc]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001586$tyrosine-protein kinase]
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850016452$chain:Dual specificity tyrosine- phosphorylation-regulated kinase 1A, 850102574$compositionally biased region:Poly-His, 850102581$compositionally biased region:Poly-Ser, 850102600$compositionally biased region:Ser/Thr-rich, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117325$short sequence motif:Bipartite nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
dullard homolog (Xenopus laevis),INTERPRO[450003783$IPR004274:NLI interacting factor, 450010773$IPR011948:Dullard-like phosphatase domain]
dullard homolog (Xenopus laevis),SMART[760000514$SM00577:CPDc]
dullard homolog (Xenopus laevis),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001261$protein phosphatase, 790001555$transmembrane]
dullard homolog (Xenopus laevis),UP_SEQ_FEATURE[850060161$chain:Serine/threonine-protein phosphatase dullard, 850103756$domain:FCP1 homology, 850106259$mutagenesis site, 850117295$sequence variant, 850118623$transmembrane region]
dynactin 1 (p150, glued homolog, Drosophila),BIOCARTA[30000173$h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development]
dynactin 1 (p150, glued homolog, Drosophila),INTERPRO[450000819$IPR000938:Cytoskeleton-associated protein, CAP-Gly]
dynactin 1 (p150, glued homolog, Drosophila),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 1 (p150, glued homolog, Drosophila),OMIM_DISEASE[520000291$Amyotrophic lateral sclerosis, susceptibility to, 520003611$Neuropathy, distal hereditary motor, type VIIB, 520003965$Perry syndrome]
dynactin 1 (p150, glued homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000475$dynein, 790000960$microtubule, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
dynactin 1 (p150, glued homolog, Drosophila),UP_SEQ_FEATURE[850016476$chain:Dynactin subunit 1, 850102597$compositionally biased region:Ser-rich, 850103282$domain:CAP-Gly, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
dynactin 5 (p25),INTERPRO[450001293$IPR001451:Bacterial transferase hexapeptide repeat]
dynactin 5 (p25),OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
dynactin 5 (p25),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
dynactin 5 (p25),UP_SEQ_FEATURE[850016482$chain:Dynactin subunit 5]
dynein, cytoplasmic 1, light intermediate chain 1,INTERPRO[450007741$IPR008467:Dynein light intermediate chain]
dynein, cytoplasmic 1, light intermediate chain 1,PIR_SUPERFAMILY[630015160$PIRSF018553:PIRSF018553]
dynein, cytoplasmic 1, light intermediate chain 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000475$dynein, 790000960$microtubule, 790000986$motor protein, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
dynein, cytoplasmic 1, light intermediate chain 1,UP_SEQ_FEATURE[850014034$chain:Cytoplasmic dynein 1 light intermediate chain 1, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
dystroglycan 1 (dystrophin-associated glycoprotein 1),BBID[10000002$10.Dysdap, 10000084$63.LAT_couples_T-cell_receptor, 10000104$82.TCR_and_Cap_or_SMAC]
dystroglycan 1 (dystrophin-associated glycoprotein 1),BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation]
dystroglycan 1 (dystrophin-associated glycoprotein 1),INTERPRO[450006062$IPR006644:Dystroglycan-type cadherin-like, 450007739$IPR008465:Dystroglycan, 450012396$IPR013783:Immunoglobulin-like fold]
dystroglycan 1 (dystrophin-associated glycoprotein 1),KEGG_PATHWAY[470038854$hsa04512:ECM-receptor interaction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy, 470038923$hsa05416:Viral myocarditis]
dystroglycan 1 (dystrophin-associated glycoprotein 1),SMART[760000642$SM00736:CADG]
dystroglycan 1 (dystrophin-associated glycoprotein 1),SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
dystroglycan 1 (dystrophin-associated glycoprotein 1),UP_SEQ_FEATURE[850004758$chain:Alpha-dystroglycan, 850007674$chain:Beta-dystroglycan, 850102883$disulfide bond, 850104974$domain:Peptidase S72, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
dystrophia myotonica, WD repeat containing,COG_ONTOLOGY[90000073$General function prediction only]
dystrophia myotonica, WD repeat containing,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
dystrophia myotonica, WD repeat containing,SMART[760000289$SM00320:WD40]
dystrophia myotonica, WD repeat containing,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
dystrophia myotonica, WD repeat containing,UP_SEQ_FEATURE[850016563$chain:Dystrophia myotonica WD repeat-containing protein, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict]
early B-cell factor 4,INTERPRO[450002569$IPR002909:Cell surface receptor IPT/TIG, 450003091$IPR003523:Transcription factor COE, 450012396$IPR013783:Immunoglobulin-like fold, 450016635$IPR018350:Transcription factor COE, conserved site]
early B-cell factor 4,PIR_SUPERFAMILY[630014937$PIRSF018314:transcription factor, collier type]
early B-cell factor 4,SMART[760000375$SM00429:IPT]
early B-cell factor 4,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
early B-cell factor 4,UP_SEQ_FEATURE[850065131$chain:Transcription factor COE4, 850104420$domain:IPT/TIG, 850117294$sequence conflict, 850118574$splice variant, 850118773$zinc finger region:C5-type]
echinoderm microtubule associated protein like 2,INTERPRO[450001490$IPR001680:WD40 repeat, 450004577$IPR005108:HELP, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
echinoderm microtubule associated protein like 2,SMART[760000289$SM00320:WD40]
echinoderm microtubule associated protein like 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000960$microtubule, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
echinoderm microtubule associated protein like 2,UP_SEQ_FEATURE[850016885$chain:Echinoderm microtubule-associated protein-like 2, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant]
echinoderm microtubule associated protein like 4,COG_ONTOLOGY[90000073$General function prediction only]
echinoderm microtubule associated protein like 4,INTERPRO[450000480$IPR000560:Histidine acid phosphatase, 450001490$IPR001680:WD40 repeat, 450004577$IPR005108:HELP, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site, 450016532$IPR018247:EF-HAND 1, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
echinoderm microtubule associated protein like 4,SMART[760000289$SM00320:WD40]
echinoderm microtubule associated protein like 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000960$microtubule, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
echinoderm microtubule associated protein like 4,UP_SEQ_FEATURE[850016887$chain:Echinoderm microtubule-associated protein-like 4, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant]
ecotropic viral integration site 1,INTERPRO[450001068$IPR001214:SET, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
ecotropic viral integration site 1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038910$hsa05220:Chronic myeloid leukemia]
ecotropic viral integration site 1,OMIM_DISEASE[520000015$3q21q26 syndrome]
ecotropic viral integration site 1,PIR_SUPERFAMILY[630028617$PIRSF037110:transcription factor with zinc finger motifs, PRDM3/PRDM16 types, 630030578$PIRSF500343:transcription factor EVI1]
ecotropic viral integration site 1,SMART[760000286$SM00317:SET, 760000323$SM00355:ZnF_C2H2]
ecotropic viral integration site 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000052$alternative promoter usage, 790000053$alternative splicing, 790000109$Apoptosis, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
ecotropic viral integration site 1,UP_SEQ_FEATURE[850030721$chain:MDS1 and EVI1 complex locus protein EVI1, 850030722$chain:MDS1 and EVI1 complex locus protein MDS1, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850106258$modified residue, 850106259$mutagenesis site, 850112514$region of interest:Interaction with MAPK9, SMAD3 and probably SUV39H1, 850117294$sequence conflict, 850117295$sequence variant, 850117354$short sequence motif:CTBP-binding motif 1, 850117355$short sequence motif:CTBP-binding motif 2, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
ecotropic viral integration site 2B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001405$signal, 790001555$transmembrane]
ecotropic viral integration site 2B,UP_SEQ_FEATURE[850045782$chain:Protein EVI2B, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ectonucleotide pyrophosphatase/phosphodiesterase 6,INTERPRO[450002301$IPR002591:Type I phosphodiesterase/nucleotide pyrophosphatase/phosphate transferase, 450016171$IPR017849:Alkaline phosphatase-like, alpha/beta/alpha]
ectonucleotide pyrophosphatase/phosphodiesterase 6,KEGG_PATHWAY[470038779$hsa00565:Ether lipid metabolism]
ectonucleotide pyrophosphatase/phosphodiesterase 6,PIR_SUPERFAMILY[630001501$PIRSF001353:phosphodiesterase I / nucleotide pyrophosphatase 4]
ectonucleotide pyrophosphatase/phosphodiesterase 6,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000869$lipid degradation, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
ectonucleotide pyrophosphatase/phosphodiesterase 6,UP_SEQ_FEATURE[850016937$chain:Ectonucleotide pyrophosphatase/phosphodiesterase family member 6, 850016938$chain:Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 soluble form, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
egf-like module containing, mucin-like, hormone receptor-like 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000174$IPR000203:GPS, 450000637$IPR000742:EGF-like, type 3, 450000724$IPR000832:GPCR, family 2, secretin-like, 450001543$IPR001740:GPCR, family 2, EMR1 hormone receptor, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
egf-like module containing, mucin-like, hormone receptor-like 1,PIR_SUPERFAMILY[630030187$PIRSF038685:EGF-like module-containing mucin-like hormone receptor-like 1, 630031208$PIRSF800007:secretin receptor-like G protein-coupled receptors]
egf-like module containing, mucin-like, hormone receptor-like 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000273$SM00303:GPS]
egf-like module containing, mucin-like, hormone receptor-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
egf-like module containing, mucin-like, hormone receptor-like 1,UP_SEQ_FEATURE[850016995$chain:EGF-like module-containing mucin-like hormone receptor-like 1, 850102600$compositionally biased region:Ser/Thr-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
egf-like module containing, mucin-like, hormone receptor-like 2,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000174$IPR000203:GPS, 450000637$IPR000742:EGF-like, type 3, 450000724$IPR000832:GPCR, family 2, secretin-like, 450001543$IPR001740:GPCR, family 2, EMR1 hormone receptor, 450001663$IPR001881:EGF-like calcium-binding, 450002683$IPR003056:GPCR, family 2, CD97 antigen, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016289$IPR017981:GPCR, family 2-like, 450016291$IPR017983:GPCR, family 2, secretin-like, conserved site, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
egf-like module containing, mucin-like, hormone receptor-like 2,PIR_SUPERFAMILY[630031208$PIRSF800007:secretin receptor-like G protein-coupled receptors]
egf-like module containing, mucin-like, hormone receptor-like 2,SMART[760000153$SM00179:EGF_CA, 760000273$SM00303:GPS]
egf-like module containing, mucin-like, hormone receptor-like 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000481$egf-like domain, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
egf-like module containing, mucin-like, hormone receptor-like 2,UP_SEQ_FEATURE[850016996$chain:EGF-like module-containing mucin-like hormone receptor-like 2, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103693$domain:EGF-like 5; calcium-binding, 850104076$domain:GPS, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850117969$site:Cleavage, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
egl nine homolog 2 (C. elegans),INTERPRO[450004592$IPR005123:Oxoglutarate and iron-dependent oxygenase, 450006039$IPR006620:Prolyl 4-hydroxylase, alpha subunit]
egl nine homolog 2 (C. elegans),KEGG_PATHWAY[470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma]
egl nine homolog 2 (C. elegans),SMART[760000609$SM00702:P4Hc]
egl nine homolog 2 (C. elegans),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001626$vitamin c]
egl nine homolog 2 (C. elegans),UP_SEQ_FEATURE[850000176$binding site:2-oxoglutarate, 850017011$chain:Egl nine homolog 2, 850103759$domain:Fe2OG dioxygenase, 850106003$metal ion-binding site:Iron, 850106259$mutagenesis site, 850117294$sequence conflict]
elastase, neutrophil expressed,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
elastase, neutrophil expressed,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
elastase, neutrophil expressed,OMIM_DISEASE[520002244$Hematopoiesis, cyclic, 520003623$Neutropenia, congenital]
elastase, neutrophil expressed,SMART[760000013$SM00020:Tryp_SPc]
elastase, neutrophil expressed,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
elastase, neutrophil expressed,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850034168$chain:Neutrophil elastase, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
elastin microfibril interfacer 2,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
elastin microfibril interfacer 2,INTERPRO[450000941$IPR001073:Complement C1q protein, 450008180$IPR008983:Tumour necrosis factor-like, 450010351$IPR011489:EMI domain]
elastin microfibril interfacer 2,SMART[760000097$SM00110:C1Q]
elastin microfibril interfacer 2,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
elastin microfibril interfacer 2,UP_SEQ_FEATURE[850017185$chain:EMILIN-2, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850103714$domain:EMI, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide]
elongation factor Tu GTP binding domain containing 2,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
elongation factor Tu GTP binding domain containing 2,INTERPRO[450000547$IPR000640:Translation elongation factor EFG/EF2, C-terminal, 450000689$IPR000795:Protein synthesis factor, GTP-binding, 450003671$IPR004161:Translation elongation factor EFTu/EF1A, domain 2, 450004692$IPR005225:Small GTP-binding protein, 450004970$IPR005517:Translation elongation factor EFG/EF2, domain IV, 450013173$IPR014721:Ribosomal protein S5 domain 2-type fold]
elongation factor Tu GTP binding domain containing 2,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
elongation factor Tu GTP binding domain containing 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000639$gtp-binding, 790000988$mrna processing, 790000989$mrna splicing, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001433$Spliceosome, 790001613$viral nucleoprotein]
elongation factor Tu GTP binding domain containing 2,UP_SEQ_FEATURE[850000826$chain:116 kDa U5 small nuclear ribonucleoprotein component, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant]
endoplasmic reticulum to nucleus signaling 2,COG_ONTOLOGY[90000070$Function unknown]
endoplasmic reticulum to nucleus signaling 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002110$IPR002372:Pyrrolo-quinoline quinone repeat, 450005987$IPR006567:PUG domain, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450009567$IPR010513:Ribonuclease L, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016671$IPR018391:Pyrrolo-quinoline quinone beta-propeller repeat]
endoplasmic reticulum to nucleus signaling 2,SMART[760000503$SM00564:PQQ, 760000516$SM00580:PUG]
endoplasmic reticulum to nucleus signaling 2,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000138$atp-binding, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000825$kinase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001405$signal, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001555$transmembrane]
endoplasmic reticulum to nucleus signaling 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850060082$chain:Serine/threonine-protein kinase/endoribonuclease IRE2, 850104519$domain:KEN, 850105086$domain:Protein kinase, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
enolase 1, (alpha),BIOCARTA[30000128$h_glycolysisPathway:Glycolysis Pathway]
enolase 1, (alpha),INTERPRO[450000822$IPR000941:Enolase, 450001198$IPR001354:Mandelate racemase/muconate lactonizing enzyme]
enolase 1, (alpha),KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038814$hsa03018:RNA degradation]
enolase 1, (alpha),OMIM_DISEASE[520001698$Enolase deficiency]
enolase 1, (alpha),PIR_SUPERFAMILY[630001557$PIRSF001400:Enolase]
enolase 1, (alpha),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000050$alternative initiation, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000615$glycolysis, 790000891$lyase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001200$Plasminogen activation, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
enolase 1, (alpha),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000131$active site:Proton donor, 850000555$binding site:Substrate, 850004765$chain:Alpha-enolase, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106259$mutagenesis site, 850111600$region of interest:Epitope recognized by CAR and healthy patient antibodies, 850111601$region of interest:Epitope recognized by CAR antibodies, 850114375$region of interest:Required for interaction with PLG, 850114464$region of interest:Required for repression of c-myc promoter activity, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
enolase 3 (beta, muscle),INTERPRO[450000822$IPR000941:Enolase]
enolase 3 (beta, muscle),KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038814$hsa03018:RNA degradation]
enolase 3 (beta, muscle),OMIM_DISEASE[520001699$Enolase-beta deficiency]
enolase 3 (beta, muscle),PIR_SUPERFAMILY[630001557$PIRSF001400:Enolase]
enolase 3 (beta, muscle),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000611$glycogen storage disease, 790000615$glycolysis, 790000891$lyase, 790000899$magnesium, 790000937$metal-binding, 790001212$polymorphism]
enolase 3 (beta, muscle),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000131$active site:Proton donor, 850000555$binding site:Substrate, 850007680$chain:Beta-enolase, 850106107$metal ion-binding site:Magnesium, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118574$splice variant]
enoyl Coenzyme A hydratase 1, peroxisomal,COG_ONTOLOGY[90000084$Lipid metabolism]
enoyl Coenzyme A hydratase 1, peroxisomal,INTERPRO[450001553$IPR001753:Crotonase, core, 450016658$IPR018376:Enoyl-CoA hydratase/isomerase, conserved site]
enoyl Coenzyme A hydratase 1, peroxisomal,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000543$fatty acid metabolism, 790000810$Isomerase, 790000873$lipid metabolism, 790000969$mitochondrion, 790001128$peroxisome, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide]
enoyl Coenzyme A hydratase 1, peroxisomal,UP_SEQ_FEATURE[850000574$binding site:Substrate; via amide nitrogen, 850014768$chain:Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117578$short sequence motif:Microbody targeting signal, 850118252$site:Important for catalytic activity, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
epidermal growth factor receptor pathway substrate 15-like 1,INTERPRO[450000226$IPR000261:EPS15 homology (EH), 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
epidermal growth factor receptor pathway substrate 15-like 1,SMART[760000019$SM00027:EH, 760000046$SM00054:EFh]
epidermal growth factor receptor pathway substrate 15-like 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000211$calcium, 790000264$cell membrane, 790000334$coated pit, 790000344$coiled coil, 790000356$complete proteome, 790000496$Endocytosis, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
epidermal growth factor receptor pathway substrate 15-like 1,UP_SEQ_FEATURE[850017648$chain:Epidermal growth factor receptor substrate 15-like 1, 850102586$compositionally biased region:Pro-rich, 850103571$domain:EF-hand, 850103707$domain:EH 1, 850103708$domain:EH 2, 850103709$domain:EH 3, 850106258$modified residue, 850109883$region of interest:15 X 3 AA repeats of D-P-F, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9]
epithelial splicing regulatory protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
epithelial splicing regulatory protein 1,SMART[760000328$SM00360:RRM]
epithelial splicing regulatory protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
epithelial splicing regulatory protein 1,UP_SEQ_FEATURE[850017707$chain:Epithelial splicing regulatory protein 1, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
epsin 3,INTERPRO[450000899$IPR001026:Epsin, N-terminal, 450003428$IPR003903:Ubiquitin interacting motif, 450008166$IPR008942:ENTH/VHS, 450012415$IPR013809:Epsin-like, N-terminal]
epsin 3,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
epsin 3,SMART[760000245$SM00273:ENTH, 760000632$SM00726:UIM]
epsin 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000876$lipid-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
epsin 3,UP_SEQ_FEATURE[850000483$binding site:Phosphatidylinositol lipid headgroup, 850017728$chain:Epsin-3, 850103717$domain:ENTH, 850106258$modified residue, 850110214$region of interest:3 X 3 AA repeats of N-P-F, 850110481$region of interest:5 X 3 AA repeats of [DE]-P-W, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850117162$repeat:UIM 1, 850117163$repeat:UIM 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
erythropoietin,BIOCARTA[30000099$h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB, 30000100$h_epoPathway:EPO Signaling Pathway, 30000106$h_erythPathway:Erythrocyte Differentiation Pathway, 30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System, 30000280$h_stemPathway:Regulation of hematopoiesis by cytokines]
erythropoietin,INTERPRO[450001166$IPR001323:Erythropoietin/thrombopoeitin, 450002647$IPR003013:Erythropoietin, 450018002$IPR019767:Erythropoietin/thrombopoeitin, conserved site]
erythropoietin,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038867$hsa04640:Hematopoietic cell lineage]
erythropoietin,OMIM_DISEASE[520003315$Microvascular complications of diabetes 2]
erythropoietin,PIR_SUPERFAMILY[630002088$PIRSF001951:EPO]
erythropoietin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000513$erythrocyte maturation, 790000616$glycoprotein, 790000708$hormone, 790001137$pharmaceutical, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
erythropoietin,UP_SEQ_FEATURE[850017811$chain:Erythropoietin, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850105852$helix, 850109705$propeptide:Removed in mature form (Partial), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
essential meiotic endonuclease 1 homolog 1 (S. pombe),INTERPRO[450005598$IPR006166:DNA repair nuclease, XPF-type/Helicase]
essential meiotic endonuclease 1 homolog 1 (S. pombe),KEGG_PATHWAY[470038825$hsa03440:Homologous recombination]
essential meiotic endonuclease 1 homolog 1 (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000498$Endonuclease, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
essential meiotic endonuclease 1 homolog 1 (S. pombe),UP_SEQ_FEATURE[850012709$chain:Crossover junction endonuclease EME1, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
essential meiotic endonuclease 1 homolog 2 (S. pombe),INTERPRO[450005598$IPR006166:DNA repair nuclease, XPF-type/Helicase]
essential meiotic endonuclease 1 homolog 2 (S. pombe),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000458$dna recombination, 790000459$dna repair, 790000498$Endonuclease, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus]
essential meiotic endonuclease 1 homolog 2 (S. pombe),UP_SEQ_FEATURE[850041466$chain:Probable crossover junction endonuclease EME2, 850118574$splice variant]
ethylmalonic encephalopathy 1,INTERPRO[450001128$IPR001279:Beta-lactamase-like]
ethylmalonic encephalopathy 1,OMIM_DISEASE[520001815$Ethylmalonic encephalopathy]
ethylmalonic encephalopathy 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000743$hydrolase, 790000937$metal-binding, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001550$transit peptide, 790001648$zinc]
ethylmalonic encephalopathy 1,UP_SEQ_FEATURE[850045777$chain:Protein ETHE1, mitochondrial, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
ets variant 3,BIOCARTA[30000108$h_etsPathway:METS affect on Macrophage Differentiation]
ets variant 3,INTERPRO[450000358$IPR000418:Ets, 450010816$IPR011991:Winged helix repressor DNA-binding]
ets variant 3,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
ets variant 3,SMART[760000360$SM00413:ETS]
ets variant 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
ets variant 3,UP_SEQ_FEATURE[850018043$chain:ETS translocation variant 3, 850102913$DNA-binding region:ETS, 850106258$modified residue, 850118574$splice variant]
ets variant 7,INTERPRO[450000358$IPR000418:Ets, 450002742$IPR003118:Sterile alpha motif/pointed, 450010816$IPR011991:Winged helix repressor DNA-binding, 450012380$IPR013761:Sterile alpha motif-type]
ets variant 7,KEGG_PATHWAY[470038847$hsa04320:Dorso-ventral axis formation]
ets variant 7,SMART[760000223$SM00251:SAM_PNT, 760000360$SM00413:ETS]
ets variant 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
ets variant 7,UP_SEQ_FEATURE[850065164$chain:Transcription factor ETV7, 850102913$DNA-binding region:ETS, 850105048$domain:PNT, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
eukaryotic elongation factor-2 kinase,BIOCARTA[30000096$h_eifPathway:Eukaryotic protein translation]
eukaryotic elongation factor-2 kinase,COG_ONTOLOGY[90000073$General function prediction only]
eukaryotic elongation factor-2 kinase,INTERPRO[450003676$IPR004166:MHCK/EF2 kinase, 450006017$IPR006597:Sel1-like, 450010815$IPR011990:Tetratricopeptide-like helical, 450015726$IPR017400:Elongation factor 2 kinase]
eukaryotic elongation factor-2 kinase,PIR_SUPERFAMILY[630029738$PIRSF038139:Elongation_factor_2_kinase]
eukaryotic elongation factor-2 kinase,SMART[760000583$SM00671:SEL1, 760000713$SM00811:Alpha_kinase]
eukaryotic elongation factor-2 kinase,SP_PIR_KEYWORDS[790000138$atp-binding, 790000211$calcium, 790000218$calmodulin-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
eukaryotic elongation factor-2 kinase,UP_SEQ_FEATURE[850018056$chain:Eukaroytic elongation factor 2 kinase, 850103039$domain:Alpha-type protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111164$region of interest:Calmodulin-binding, 850114151$region of interest:Pseudosubstrate/autoinhibitory domain, 850117295$sequence variant]
eukaryotic translation elongation factor 1 alpha 2,INTERPRO[450000689$IPR000795:Protein synthesis factor, GTP-binding, 450003670$IPR004160:Translation elongation factor EFTu/EF1A, C-terminal, 450003671$IPR004161:Translation elongation factor EFTu/EF1A, domain 2, 450004032$IPR004539:Translation elongation factor EF1A, eukaryotic and archaeal]
eukaryotic translation elongation factor 1 alpha 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000491$elongation factor, 790000639$gtp-binding, 790000953$methylation, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001255$protein biosynthesis]
eukaryotic translation elongation factor 1 alpha 2,UP_SEQ_FEATURE[850000381$binding site:Glycerylphosphorylethanolamine (covalent), 850017082$chain:Elongation factor 1-alpha 2, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict]
eukaryotic translation initiation factor 1B,INTERPRO[450001726$IPR001950:Translation initiation factor SUI1, 450005318$IPR005874:Eukaryotic translation initiation factor SUI1]
eukaryotic translation initiation factor 1B,PIR_SUPERFAMILY[630004475$PIRSF004499:SUI1_euk, 630004476$PIRSF004499:translation initiation factor 1, eukaryotic type]
eukaryotic translation initiation factor 1B,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000776$Initiation factor, 790001255$protein biosynthesis]
eukaryotic translation initiation factor 1B,UP_SEQ_FEATURE[850018080$chain:Eukaryotic translation initiation factor 1b, 850106258$modified residue, 850117294$sequence conflict]
eukaryotic translation initiation factor 2-alpha kinase 2,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000250$h_ranklPathway:Bone Remodelling, 30000262$h_rnaPathway:Double Stranded RNA Induced Gene Expression, 30000300$h_tollPathway:Toll-Like Receptor Pathway]
eukaryotic translation initiation factor 2-alpha kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001016$IPR001159:Double-stranded RNA binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450013172$IPR014720:Double-stranded RNA-binding-like, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
eukaryotic translation initiation factor 2-alpha kinase 2,SMART[760000326$SM00358:DSRM]
eukaryotic translation initiation factor 2-alpha kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000104$Antiviral defense, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001388$serine/threonine-protein kinase, 790001547$transferase]
eukaryotic translation initiation factor 2-alpha kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850026469$chain:Interferon-induced, double-stranded RNA- activated protein kinase, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850109967$region of interest:2 X 13 AA approximate repeats, 850115074$repeat:1, 850115273$repeat:2, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa,INTERPRO[450000556$IPR000649:Initiation factor 2B related]
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa,OMIM_DISEASE[520002886$Leukoencephaly with vanishing white matter, 520003871$Ovarioleukodystrophy]
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa,PIR_SUPERFAMILY[630003412$PIRSF003327:translation regulator GCD2]
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000776$Initiation factor, 790000856$leukodystrophy, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis]
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa,UP_SEQ_FEATURE[850065828$chain:Translation initiation factor eIF-2B subunit delta, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
eukaryotic translation initiation factor 2C, 3,BIOCARTA[30000083$h_dicerPathway:Dicer Pathway]
eukaryotic translation initiation factor 2C, 3,INTERPRO[450002724$IPR003100:Argonaute and Dicer protein, PAZ, 450002783$IPR003165:Stem cell self-renewal protein Piwi, 450013261$IPR014811:Region of unknown function DUF1785]
eukaryotic translation initiation factor 2C, 3,PIR_SUPERFAMILY[630008433$PIRSF009286:argonaute family proteins, 630031060$PIRSF500923:eukaryotic translation initiation factor 2C (eIF2C )]
eukaryotic translation initiation factor 2C, 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000776$Initiation factor, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001342$rna-mediated gene silencing, 790001551$translation regulation]
eukaryotic translation initiation factor 2C, 3,UP_SEQ_FEATURE[850045099$chain:Protein argonaute-3, 850104911$domain:PAZ, 850105001$domain:Piwi, 850117294$sequence conflict]
eukaryotic translation initiation factor 3, subunit A,BIOCARTA[30000096$h_eifPathway:Eukaryotic protein translation, 30000167$h_iresPathway:Internal Ribosome entry pathway, 30000195$h_mTORPathway:mTOR Signaling Pathway]
eukaryotic translation initiation factor 3, subunit A,INTERPRO[450000616$IPR000717:Proteasome component region PCI]
eukaryotic translation initiation factor 3, subunit A,SMART[760000076$SM00088:PINT]
eukaryotic translation initiation factor 3, subunit A,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000776$Initiation factor, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis, 790001304$repeat]
eukaryotic translation initiation factor 3, subunit A,UP_SEQ_FEATURE[850018095$chain:Eukaryotic translation initiation factor 3 subunit A, 850102458$compositionally biased region:Asp-rich, 850102507$compositionally biased region:Glu-rich, 850104917$domain:PCI, 850106258$modified residue, 850110141$region of interest:25 X 10 AA approximate tandem repeats of [DE]-[DE]-[DE]-R-[SEVGFPILV]-[HPSN]- [RSW]-[RL]-[DRGTIHN]-[EPMANLGDT], 850112290$region of interest:Interaction with EIF3B, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115379$repeat:23; truncated, 850115380$repeat:24, 850115403$repeat:25; approximate, 850115416$repeat:2; truncated, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117295$sequence variant]
eukaryotic translation initiation factor 4 gamma, 3,INTERPRO[450002885$IPR003307:eIF4-gamma/eIF5/eIF2-epsilon, 450003415$IPR003890:MIF4G-like, type 3, 450003416$IPR003891:Initiation factor eIF-4 gamma, MA3, 450014420$IPR016021:MIF4-like, type 1/2/3]
eukaryotic translation initiation factor 4 gamma, 3,KEGG_PATHWAY[470038923$hsa05416:Viral myocarditis]
eukaryotic translation initiation factor 4 gamma, 3,SMART[760000457$SM00515:eIF5C, 760000483$SM00543:MIF4G, 760000484$SM00544:MA3]
eukaryotic translation initiation factor 4 gamma, 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000733$host-virus interaction, 790000776$Initiation factor, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis, 790001304$repeat, 790001339$rna-binding, 790001551$translation regulation]
eukaryotic translation initiation factor 4 gamma, 3,UP_SEQ_FEATURE[850018127$chain:Eukaryotic translation initiation factor 4 gamma 3, 850104771$domain:MI, 850104778$domain:MIF4G, 850105686$domain:W2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111569$region of interest:eIF3/EIF4A-binding, 850111570$region of interest:EIF4A-binding, 850111571$region of interest:EIF4E-binding, 850113565$region of interest:Necessary but not sufficient for MKNK1- binding, 850113864$region of interest:PABPC1-binding, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850117294$sequence conflict, 850117295$sequence variant, 850118044$site:Cleavage; by enterovirus/rhinovirus protease 2A, 850118051$site:Cleavage; by foot-and-mouth disease virus leader protease, 850118574$splice variant, 850118624$turn]
eukaryotic translation initiation factor 4E nuclear import factor 1,INTERPRO[450017134$IPR018862:Eukayotic translation initiation factor 4E transporter]
eukaryotic translation initiation factor 4E nuclear import factor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000776$Initiation factor, 790001065$nucleus, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
eukaryotic translation initiation factor 4E nuclear import factor 1,UP_SEQ_FEATURE[850018131$chain:Eukaryotic translation initiation factor 4E transporter, 850102404$compositionally biased region:Arg-rich, 850106258$modified residue, 850106259$mutagenesis site, 850111571$region of interest:EIF4E-binding, 850117294$sequence conflict, 850117605$short sequence motif:Nuclear export signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
eukaryotic translation initiation factor 4E; similar to hCG1777996; similar to eukaryotic translation initiation factor 4E,BBID[10000010$107.mRNA_translation-protein_synthesis, 10000082$61.Myc_network, 10000105$83.Growth_factors_Survival_factors_Mitogens]
eukaryotic translation initiation factor 4E; similar to hCG1777996; similar to eukaryotic translation initiation factor 4E,BIOCARTA[30000095$h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase, 30000096$h_eifPathway:Eukaryotic protein translation, 30000146$h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway, 30000167$h_iresPathway:Internal Ribosome entry pathway, 30000195$h_mTORPathway:mTOR Signaling Pathway, 30000267$h_SARSpathway:SARS Coronavirus Protease]
eukaryotic translation initiation factor 4E; similar to hCG1777996; similar to eukaryotic translation initiation factor 4E,INTERPRO[450000913$IPR001040:Eukaryotic translation initiation factor 4E (eIF-4E), 450018005$IPR019770:Eukaryotic translation initiation factor 4E (eIF-4E), conserved site]
eukaryotic translation initiation factor 4E; similar to hCG1777996; similar to eukaryotic translation initiation factor 4E,KEGG_PATHWAY[470038842$hsa04150:mTOR signaling pathway, 470038882$hsa04910:Insulin signaling pathway]
eukaryotic translation initiation factor 4E; similar to hCG1777996; similar to eukaryotic translation initiation factor 4E,PIR_SUPERFAMILY[630003112$PIRSF003024:translation initiation factor eIF-4E]
eukaryotic translation initiation factor 4E; similar to hCG1777996; similar to eukaryotic translation initiation factor 4E,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000776$Initiation factor, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001339$rna-binding, 790001551$translation regulation]
eukaryotic translation initiation factor 4E; similar to hCG1777996; similar to eukaryotic translation initiation factor 4E,UP_SEQ_FEATURE[850018129$chain:Eukaryotic translation initiation factor 4E, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
eukaryotic translation initiation factor 5B,INTERPRO[450000151$IPR000178:Initiation factor 2, 450000689$IPR000795:Protein synthesis factor, GTP-binding, 450003671$IPR004161:Translation elongation factor EFTu/EF1A, domain 2, 450004692$IPR005225:Small GTP-binding protein, 450014194$IPR015760:Translation initiation factor 2 related]
eukaryotic translation initiation factor 5B,PIR_SUPERFAMILY[630003100$PIRSF003012:translation initiation factor IF-2]
eukaryotic translation initiation factor 5B,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000639$gtp-binding, 790000776$Initiation factor, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis]
eukaryotic translation initiation factor 5B,UP_SEQ_FEATURE[850018157$chain:Eukaryotic translation initiation factor 5B, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102568$compositionally biased region:Poly-Asp, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant]
eukaryotic translation termination factor 1,INTERPRO[450003904$IPR004403:Peptide chain release factor eRF/aRF subunit 1, 450004607$IPR005140:eRF1 domain 1, 450004608$IPR005141:eRF1 domain 2, 450004609$IPR005142:eRF1 domain 3]
eukaryotic translation termination factor 1,PIR_SUPERFAMILY[630003146$PIRSF003055:peptide chain release factor, subunit 1]
eukaryotic translation termination factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001255$protein biosynthesis]
eukaryotic translation termination factor 1,UP_SEQ_FEATURE[850018071$chain:Eukaryotic peptide chain release factor subunit 1, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
excision repair cross-complementing rodent repair deficiency, complementation group 8,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
excision repair cross-complementing rodent repair deficiency, complementation group 8,KEGG_PATHWAY[470038823$hsa03420:Nucleotide excision repair, 470038837$hsa04120:Ubiquitin mediated proteolysis]
excision repair cross-complementing rodent repair deficiency, complementation group 8,OMIM_DISEASE[520001067$Cockayne syndrome, type A]
excision repair cross-complementing rodent repair deficiency, complementation group 8,SMART[760000289$SM00320:WD40]
excision repair cross-complementing rodent repair deficiency, complementation group 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000340$Cockayne syndrome, 790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000474$dwarfism, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001638$wd repeat]
excision repair cross-complementing rodent repair deficiency, complementation group 8,UP_SEQ_FEATURE[850015548$chain:DNA excision repair protein ERCC-8, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117295$sequence variant, 850118574$splice variant]
exocyst complex component 3-like 2,INTERPRO[450009392$IPR010326:Exocyst complex component Sec6]
exocyst complex component 3-like 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
exocyst complex component 3-like 2,UP_SEQ_FEATURE[850018191$chain:Exocyst complex component 3-like protein 2, 850117294$sequence conflict, 850117295$sequence variant]
exonuclease 3'-5' domain containing 3,INTERPRO[450002278$IPR002562:3'-5' exonuclease, 450002469$IPR002782:Protein of unknown function DUF82]
exonuclease 3'-5' domain containing 3,SMART[760000419$SM00474:35EXOc]
exonuclease 3'-5' domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism]
exonuclease 3'-5' domain containing 3,UP_SEQ_FEATURE[850041937$chain:Probable exonuclease mut-7 homolog, 850041938$chain:Probable exonuclease mut-7 homolog, isoform 5, 850102586$compositionally biased region:Pro-rich, 850102974$domain:3'-5' exonuclease, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 100, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 100, member A,UP_SEQ_FEATURE[850045807$chain:Protein FAM100A, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
family with sequence similarity 101, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 101, member A,UP_SEQ_FEATURE[850045811$chain:Protein FAM101A, 850117294$sequence conflict, 850118574$splice variant]
family with sequence similarity 103, member A1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
family with sequence similarity 103, member A1,UP_SEQ_FEATURE[850045815$chain:Protein FAM103A1, 850102506$compositionally biased region:Gln/Tyr-rich, 850106258$modified residue]
family with sequence similarity 105, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 105, member A,UP_SEQ_FEATURE[850045818$chain:Protein FAM105A, 850117294$sequence conflict, 850117295$sequence variant]
family with sequence similarity 105, member B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 105, member B,UP_SEQ_FEATURE[850045819$chain:Protein FAM105B, 850117294$sequence conflict, 850117295$sequence variant]
family with sequence similarity 109, member B,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
family with sequence similarity 109, member B,SMART[760000205$SM00233:PH]
family with sequence similarity 109, member B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 109, member B,UP_SEQ_FEATURE[850045824$chain:Protein FAM109B, 850104979$domain:PH, 850117295$sequence variant]
family with sequence similarity 117, member A,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
family with sequence similarity 117, member A,UP_SEQ_FEATURE[850045840$chain:Protein FAM117A, 850102586$compositionally biased region:Pro-rich]
family with sequence similarity 127, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 127, member A,UP_SEQ_FEATURE[850045856$chain:Protein FAM127A, 850117295$sequence variant]
family with sequence similarity 129, member C,INTERPRO[450001635$IPR001849:Pleckstrin homology]
family with sequence similarity 129, member C,SMART[760000205$SM00233:PH]
family with sequence similarity 129, member C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 129, member C,UP_SEQ_FEATURE[850034230$chain:Niban-like protein 2, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 13, member B,INTERPRO[450000169$IPR000198:RhoGAP]
family with sequence similarity 13, member B,SMART[760000293$SM00324:RhoGAP]
family with sequence similarity 13, member B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
family with sequence similarity 13, member B,UP_SEQ_FEATURE[850045879$chain:Protein FAM13B, 850102507$compositionally biased region:Glu-rich, 850105183$domain:Rho-GAP, 850117294$sequence conflict, 850117295$sequence variant]
family with sequence similarity 134, member C,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
family with sequence similarity 134, member C,UP_SEQ_FEATURE[850045872$chain:Protein FAM134C, 850106258$modified residue, 850118623$transmembrane region]
family with sequence similarity 150, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
family with sequence similarity 150, member A,UP_SEQ_FEATURE[850045883$chain:Protein FAM150A, 850117814$signal peptide]
family with sequence similarity 150, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001363$Secreted, 790001405$signal]
family with sequence similarity 150, member B,UP_SEQ_FEATURE[850045884$chain:Protein FAM150B, 850117814$signal peptide, 850118574$splice variant]
family with sequence similarity 153, member C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 153, member C,UP_SEQ_FEATURE[850045889$chain:Protein FAM153C, 850118574$splice variant]
family with sequence similarity 164, member C,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
family with sequence similarity 164, member C,UP_SEQ_FEATURE[850096628$chain:UPF0418 protein FAM164C, 850117294$sequence conflict]
family with sequence similarity 166, member A,INTERPRO[450017174$IPR018902:Uncharacterised protein family UPF0573/UPF0605]
family with sequence similarity 166, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 166, member A,UP_SEQ_FEATURE[850097932$chain:UPF0605 protein FAM166A, 850118574$splice variant]
family with sequence similarity 173, member B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 173, member B,UP_SEQ_FEATURE[850045903$chain:Protein FAM173B, 850117295$sequence variant, 850118623$transmembrane region]
family with sequence similarity 184, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 184, member A,UP_SEQ_FEATURE[850045919$chain:Protein FAM184A, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4,UP_SEQ_FEATURE[850045945$chain:Protein FAM19A4, 850117814$signal peptide]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001363$Secreted, 790001555$transmembrane]
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5,UP_SEQ_FEATURE[850045946$chain:Protein FAM19A5, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 20, member C,INTERPRO[450008675$IPR009581:Protein of unknown function DUF1193]
family with sequence similarity 20, member C,OMIM_DISEASE[520004211$Raine syndrome]
family with sequence similarity 20, member C,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
family with sequence similarity 20, member C,UP_SEQ_FEATURE[850014843$chain:Dentin matrix protein 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
family with sequence similarity 22, member G,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 22, member G,UP_SEQ_FEATURE[850045954$chain:Protein FAM22G, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
family with sequence similarity 45, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 45, member A,UP_SEQ_FEATURE[850045987$chain:Protein FAM45A, 850117294$sequence conflict, 850118574$splice variant]
family with sequence similarity 53, member C,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
family with sequence similarity 53, member C,UP_SEQ_FEATURE[850046006$chain:Protein FAM53C, 850106258$modified residue, 850117295$sequence variant]
family with sequence similarity 54, member B,INTERPRO[450007315$IPR007972:Protein of unknown function DUF729]
family with sequence similarity 54, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
family with sequence similarity 54, member B,UP_SEQ_FEATURE[850046008$chain:Protein FAM54B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 57, member A,INTERPRO[450006052$IPR006634:TRAM, LAG1 and CLN8 homology]
family with sequence similarity 57, member A,SMART[760000630$SM00724:TLC]
family with sequence similarity 57, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
family with sequence similarity 57, member A,UP_SEQ_FEATURE[850046015$chain:Protein FAM57A, 850105531$domain:TLC, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 71, member F2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 71, member F2,UP_SEQ_FEATURE[850046040$chain:Protein FAM71F2, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,INTERPRO[450017648$IPR019410:Methyltransferase-16, putative]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,UP_SEQ_FEATURE[850046075$chain:Protein FAM86A, 850046076$chain:Protein FAM86B1, 850046077$chain:Protein FAM86B2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
farnesyl-diphosphate farnesyltransferase 1,INTERPRO[450001825$IPR002060:Squalene/phytoene synthase, 450005871$IPR006449:Farnesyl-diphosphate farnesyltransferase, 450008170$IPR008949:Terpenoid synthase, 450018075$IPR019845:Squalene/phytoene synthase, conserved site]
farnesyl-diphosphate farnesyltransferase 1,KEGG_PATHWAY[470038736$hsa00100:Steroid biosynthesis]
farnesyl-diphosphate farnesyltransferase 1,PIR_SUPERFAMILY[630000602$PIRSF000506:farnesyl-diphosphate farnesyltransferase]
farnesyl-diphosphate farnesyltransferase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000304$Cholesterol biosynthesis, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000812$Isoprene biosynthesis, 790000874$lipid synthesis, 790000885$liver, 790000899$magnesium, 790000919$membrane, 790000993$multifunctional enzyme, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001440$Steroid biosynthesis, 790001445$sterol biosynthesis, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
farnesyl-diphosphate farnesyltransferase 1,UP_SEQ_FEATURE[850062267$chain:Squalene synthetase, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region, 850118624$turn]
farnesyltransferase, CAAX box, alpha,INTERPRO[450001850$IPR002088:Protein prenyltransferase, alpha subunit, 450008165$IPR008940:Protein prenyltransferase]
farnesyltransferase, CAAX box, alpha,PIR_SUPERFAMILY[630012876$PIRSF016105:PIRSF016105]
farnesyltransferase, CAAX box, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000679$heterodimer, 790001162$phosphoprotein, 790001237$prenyltransferase, 790001304$repeat, 790001547$transferase]
farnesyltransferase, CAAX box, alpha,UP_SEQ_FEATURE[850046112$chain:Protein farnesyltransferase/ geranylgeranyltransferase type-1 subunit alpha, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850116701$repeat:PFTA 1, 850116702$repeat:PFTA 2, 850116703$repeat:PFTA 3, 850116704$repeat:PFTA 4, 850116705$repeat:PFTA 5, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
fatty acid desaturase domain family, member 6,INTERPRO[450005254$IPR005804:Fatty acid desaturase, type 1]
fatty acid desaturase domain family, member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000542$Fatty acid biosynthesis, 790000874$lipid synthesis, 790000919$membrane, 790001092$oxidoreductase, 790001304$repeat, 790001555$transmembrane]
fatty acid desaturase domain family, member 6,UP_SEQ_FEATURE[850019047$chain:Fatty acid desaturase 6, 850110255$region of interest:3 X 6 AA tandem repeat of M-E-P-T-E-P, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117294$sequence conflict, 850117484$short sequence motif:Histidine box-1, 850117485$short sequence motif:Histidine box-2, 850117486$short sequence motif:Histidine box-3, 850118574$splice variant, 850118623$transmembrane region]
feline leukemia virus subgroup C cellular receptor family, member 2,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
feline leukemia virus subgroup C cellular receptor family, member 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
feline leukemia virus subgroup C cellular receptor family, member 2,UP_SEQ_FEATURE[850019160$chain:Feline leukemia virus subgroup C receptor-related protein 2, 850102572$compositionally biased region:Poly-Glu, 850110728$region of interest:8 X 6 AA tandem repeats of P-S-[VS]-S- [VIAG]-[HNP], 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115551$repeat:6; approximate, 850115567$repeat:7; approximate, 850115571$repeat:8, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
fermitin family homolog 3 (Drosophila),INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
fermitin family homolog 3 (Drosophila),OMIM_DISEASE[520002876$Leukocyte adhesion deficiency, type III]
fermitin family homolog 3 (Drosophila),PIR_SUPERFAMILY[630014369$PIRSF017692:Uncoordinated protein 112]
fermitin family homolog 3 (Drosophila),SMART[760000205$SM00233:PH, 760000266$SM00295:B41]
fermitin family homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000267$cell projection, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein]
fermitin family homolog 3 (Drosophila),UP_SEQ_FEATURE[850019189$chain:Fermitin family homolog 3, 850102577$compositionally biased region:Poly-Lys, 850103760$domain:FERM, 850104979$domain:PH, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
fibrillin 3,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450001962$IPR002212:Matrix fibril-associated, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010267$IPR011398:Fibrillin, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016196$IPR017878:TGF-beta binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
fibrillin 3,PIR_SUPERFAMILY[630027748$PIRSF036312:Fibrillin]
fibrillin 3,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
fibrillin 3,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000530$extracellular matrix, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
fibrillin 3,UP_SEQ_FEATURE[850019362$chain:Fibrillin-3, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103600$domain:EGF-like 10; calcium-binding, 850103602$domain:EGF-like 11; calcium-binding, 850103604$domain:EGF-like 12; calcium-binding, 850103606$domain:EGF-like 13; calcium-binding, 850103608$domain:EGF-like 14; calcium-binding, 850103610$domain:EGF-like 15; calcium-binding, 850103612$domain:EGF-like 16; calcium-binding, 850103613$domain:EGF-like 17, 850103616$domain:EGF-like 18; calcium-binding, 850103618$domain:EGF-like 19; calcium-binding, 850103625$domain:EGF-like 20; calcium-binding, 850103627$domain:EGF-like 21; calcium-binding, 850103629$domain:EGF-like 22; calcium-binding, 850103631$domain:EGF-like 23; calcium-binding, 850103633$domain:EGF-like 24; calcium-binding, 850103635$domain:EGF-like 25; calcium-binding, 850103637$domain:EGF-like 26; calcium-binding, 850103639$domain:EGF-like 27; calcium-binding, 850103640$domain:EGF-like 28, 850103643$domain:EGF-like 29; calcium-binding, 850103644$domain:EGF-like 2; calcium-binding, 850103646$domain:EGF-like 3, 850103648$domain:EGF-like 30; calcium-binding, 850103650$domain:EGF-like 31; calcium-binding, 850103652$domain:EGF-like 32; calcium-binding, 850103654$domain:EGF-like 33; calcium-binding, 850103656$domain:EGF-like 34; calcium-binding, 850103658$domain:EGF-like 35; calcium-binding, 850103660$domain:EGF-like 36; calcium-binding, 850103662$domain:EGF-like 37; calcium-binding, 850103664$domain:EGF-like 38; calcium-binding, 850103666$domain:EGF-like 39; calcium-binding, 850103670$domain:EGF-like 40; calcium-binding, 850103672$domain:EGF-like 41; calcium-binding, 850103674$domain:EGF-like 42; calcium-binding, 850103676$domain:EGF-like 43; calcium-binding, 850103678$domain:EGF-like 44; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850103699$domain:EGF-like 7; calcium-binding, 850103701$domain:EGF-like 8; calcium-binding, 850103703$domain:EGF-like 9; calcium-binding, 850105465$domain:TB 1, 850105466$domain:TB 2, 850105467$domain:TB 3, 850105468$domain:TB 4, 850105469$domain:TB 5, 850105470$domain:TB 6, 850105471$domain:TB 7, 850105472$domain:TB 8, 850105473$domain:TB 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
fibrinogen-like 2,COG_ONTOLOGY[90000070$Function unknown]
fibrinogen-like 2,INTERPRO[450001934$IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, 450013168$IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1]
fibrinogen-like 2,PIR_SUPERFAMILY[630002496$PIRSF002378:fibrinogen gamma chain]
fibrinogen-like 2,SMART[760000160$SM00186:FBG]
fibrinogen-like 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
fibrinogen-like 2,UP_SEQ_FEATURE[850019430$chain:Fibroleukin, 850102883$disulfide bond, 850103780$domain:Fibrinogen C-terminal, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
fibroblast growth factor (acidic) intracellular binding protein,INTERPRO[450007874$IPR008614:Acidic fibroblast growth factor binding]
fibroblast growth factor (acidic) intracellular binding protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
fibroblast growth factor (acidic) intracellular binding protein,UP_SEQ_FEATURE[850003451$chain:Acidic fibroblast growth factor intracellular-binding protein, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
fibroblast growth factor 6,INTERPRO[450001959$IPR002209:Heparin-binding growth factor/Fibroblast growth factor, 450002089$IPR002348:Interleukin 1/heparin-binding growth factor]
fibroblast growth factor 6,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038899$hsa05200:Pathways in cancer, 470038908$hsa05218:Melanoma]
fibroblast growth factor 6,PIR_SUPERFAMILY[630001926$PIRSF001783:fibroblast growth factor]
fibroblast growth factor 6,SMART[760000388$SM00442:FGF]
fibroblast growth factor 6,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000632$growth factor, 790000972$mitogen, 790001212$polymorphism, 790001271$Proto-oncogene, 790001363$Secreted, 790001405$signal]
fibroblast growth factor 6,UP_SEQ_FEATURE[850019405$chain:Fibroblast growth factor 6, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
fibroblast growth factor binding protein 1,INTERPRO[450009564$IPR010510:FGF binding 1]
fibroblast growth factor binding protein 1,PIR_SUPERFAMILY[630019049$PIRSF023927:fibroblast growth factor-binding protein]
fibroblast growth factor binding protein 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000633$Growth factor binding, 790000668$heparin binding, 790000919$membrane, 790001363$Secreted, 790001405$signal]
fibroblast growth factor binding protein 1,UP_SEQ_FEATURE[850019421$chain:Fibroblast growth factor-binding protein 1, 850102883$disulfide bond, 850105822$glycosylation site:O-linked (GalNAc...), 850106259$mutagenesis site, 850114766$region of interest:Sufficient for interaction with FGF2 and FGF2-induced effects, 850117814$signal peptide]
fibroblast growth factor receptor 4,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450003159$IPR003598:Immunoglobulin subtype 2, 450006486$IPR007110:Immunoglobulin-like, 450007559$IPR008266:Tyrosine protein kinase, active site, 450011699$IPR013032:EGF-like region, conserved site, 450011742$IPR013098:Immunoglobulin I-set, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold, 450014572$IPR016248:Fibroblast growth factor receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
fibroblast growth factor receptor 4,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038841$hsa04144:Endocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton]
fibroblast growth factor receptor 4,OMIM_DISEASE[520000741$Cancer progression/metastasis]
fibroblast growth factor receptor 4,PIR_SUPERFAMILY[630000738$PIRSF000628:FGFR, 630000739$PIRSF000628:fibroblast growth factor receptor]
fibroblast growth factor receptor 4,SMART[760000192$SM00219:TyrKc, 760000356$SM00408:IGc2]
fibroblast growth factor receptor 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000149$autophosphorylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000634$growth factor receptor, 790000768$Immunoglobulin domain, 790000825$kinase, 790000899$magnesium, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein, 790001586$tyrosine-protein kinase, 790001588$tyrosine-specific protein kinase]
fibroblast growth factor receptor 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850019413$chain:Fibroblast growth factor receptor 4, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
fibronectin leucine rich transmembrane protein 1,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003484$IPR003961:Fibronectin, type III]
fibronectin leucine rich transmembrane protein 1,SMART[760000007$SM00013:LRRNT, 760000051$SM00060:FN3]
fibronectin leucine rich transmembrane protein 1,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000356$complete proteome, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790000919$membrane, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
fibronectin leucine rich transmembrane protein 1,UP_SEQ_FEATURE[850028355$chain:Leucine-rich repeat transmembrane protein FLRT1, 850103799$domain:Fibronectin type-III, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
fibronectin type III and SPRY domain containing 1,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450003195$IPR003649:B-box, C-terminal, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold, 450016218$IPR017903:COS domain]
fibronectin type III and SPRY domain containing 1,SMART[760000051$SM00060:FN3, 760000445$SM00502:BBC]
fibronectin type III and SPRY domain containing 1,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
fibronectin type III and SPRY domain containing 1,UP_SEQ_FEATURE[850019435$chain:Fibronectin type III and SPRY domain- containing protein 1, 850103078$domain:B30.2/SPRY, 850103408$domain:COS, 850103799$domain:Fibronectin type-III, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
fibronectin type III and SPRY domain containing 2,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450003406$IPR003879:Butyrophylin-like, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
fibronectin type III and SPRY domain containing 2,SMART[760000051$SM00060:FN3]
fibronectin type III and SPRY domain containing 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
fibronectin type III and SPRY domain containing 2,UP_SEQ_FEATURE[850019436$chain:Fibronectin type III and SPRY domain- containing protein 2, 850103078$domain:B30.2/SPRY, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850117295$sequence variant]
fibronectin type III domain containing 5,INTERPRO[450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
fibronectin type III domain containing 5,SMART[760000051$SM00060:FN3]
fibronectin type III domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001128$peroxisome, 790001405$signal, 790001555$transmembrane]
fibronectin type III domain containing 5,UP_SEQ_FEATURE[850019441$chain:Fibronectin type III domain-containing protein 5, 850103799$domain:Fibronectin type-III, 850105770$glycosylation site:N-linked (GlcNAc...), 850117578$short sequence motif:Microbody targeting signal, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
fibrosin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
fibrosin,UP_SEQ_FEATURE[850041970$chain:Probable fibrosin-1 long transcript protein, 850102378$compositionally biased region:Ala-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
fidgetin-like 1,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450013857$IPR015415:Vps4 oligomerisation, C-terminal]
fidgetin-like 1,SMART[760000335$SM00382:AAA]
fidgetin-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
fidgetin-like 1,UP_SEQ_FEATURE[850019468$chain:Fidgetin-like protein 1, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
filamin A interacting protein 1-like,INTERPRO[450017377$IPR019131:Cortactin-binding protein-2, N-terminal]
filamin A interacting protein 1-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
filamin A interacting protein 1-like,UP_SEQ_FEATURE[850019483$chain:Filamin A-interacting protein 1-like, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
filamin A, alpha (actin binding protein 280),INTERPRO[450001143$IPR001298:Filamin/ABP280 repeat, 450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001520$IPR001715:Calponin-like actin-binding, 450012396$IPR013783:Immunoglobulin-like fold, 450016187$IPR017868:Filamin/ABP280 repeat-like]
filamin A, alpha (actin binding protein 280),KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038853$hsa04510:Focal adhesion]
filamin A, alpha (actin binding protein 280),OMIM_DISEASE[520001937$Frontometaphyseal dysplasia, 520002319$Heterotopia, periventricular, 520002320$Heterotopia, periventricular nodular, with frontometaphyseal dysplasia, 520002321$Heterotopia, periventricular, ED variant, 520003136$Melnick-Needles syndrome, 520003844$Otopalatodigital syndrome, type I, 520003845$Otopalatodigital syndrome, type II]
filamin A, alpha (actin binding protein 280),SMART[760000025$SM00033:CH, 760000496$SM00557:IG_FLMN]
filamin A, alpha (actin binding protein 280),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000017$actin binding, 790000019$actin-binding, 790000053$alternative splicing, 790000189$blocked amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000446$disease mutation, 790000473$duplication, 790000701$homodimer, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001484$tandem repeat]
filamin A, alpha (actin binding protein 280),UP_SEQ_FEATURE[850019484$chain:Filamin-A, 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850105852$helix, 850106258$modified residue, 850111881$region of interest:Hinge 1, 850111882$region of interest:Hinge 2, 850112342$region of interest:Interaction with furin, 850114627$region of interest:Self-association site, tail, 850115955$repeat:Filamin 1, 850115956$repeat:Filamin 10, 850115957$repeat:Filamin 11, 850115958$repeat:Filamin 12, 850115959$repeat:Filamin 13, 850115960$repeat:Filamin 14, 850115961$repeat:Filamin 15, 850115962$repeat:Filamin 16, 850115963$repeat:Filamin 17, 850115964$repeat:Filamin 18, 850115965$repeat:Filamin 19, 850115966$repeat:Filamin 2, 850115967$repeat:Filamin 20, 850115968$repeat:Filamin 21, 850115969$repeat:Filamin 22, 850115970$repeat:Filamin 23, 850115971$repeat:Filamin 24, 850115972$repeat:Filamin 3, 850115973$repeat:Filamin 4, 850115974$repeat:Filamin 5, 850115975$repeat:Filamin 6, 850115976$repeat:Filamin 7, 850115977$repeat:Filamin 8, 850115978$repeat:Filamin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118015$site:Cleavage; by calpain, 850118574$splice variant, 850118575$strand]
filamin B, beta (actin binding protein 278),INTERPRO[450001143$IPR001298:Filamin/ABP280 repeat, 450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001520$IPR001715:Calponin-like actin-binding, 450012396$IPR013783:Immunoglobulin-like fold, 450016187$IPR017868:Filamin/ABP280 repeat-like]
filamin B, beta (actin binding protein 278),KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038853$hsa04510:Focal adhesion]
filamin B, beta (actin binding protein 278),OMIM_DISEASE[520000426$Atelosteogenesis, type III, 520000427$Atelostogenesis, type I, 520000651$Boomerang dysplasia, 520002765$Larsen syndrome, 520002766$Larsen syndrome, autosomal dominant, 520002767$Larson syndrome, 520004651$Spondylocarpotarsal synostosis syndrome]
filamin B, beta (actin binding protein 278),SMART[760000025$SM00033:CH, 760000496$SM00557:IG_FLMN]
filamin B, beta (actin binding protein 278),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000474$dwarfism, 790001001$myogenesis, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
filamin B, beta (actin binding protein 278),UP_SEQ_FEATURE[850019486$chain:Filamin-B, 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850105852$helix, 850106258$modified residue, 850111881$region of interest:Hinge 1, 850111882$region of interest:Hinge 2, 850112323$region of interest:Interaction with FBLP1, 850112332$region of interest:Interaction with FLNA 1, 850112333$region of interest:Interaction with FLNA 2, 850112444$region of interest:Interaction with INPPL1, 850112924$region of interest:Interaction with the cytoplasmic tail of GP1BA, 850114627$region of interest:Self-association site, tail, 850115955$repeat:Filamin 1, 850115956$repeat:Filamin 10, 850115957$repeat:Filamin 11, 850115958$repeat:Filamin 12, 850115959$repeat:Filamin 13, 850115960$repeat:Filamin 14, 850115961$repeat:Filamin 15, 850115962$repeat:Filamin 16, 850115963$repeat:Filamin 17, 850115964$repeat:Filamin 18, 850115965$repeat:Filamin 19, 850115966$repeat:Filamin 2, 850115967$repeat:Filamin 20, 850115968$repeat:Filamin 21, 850115969$repeat:Filamin 22, 850115970$repeat:Filamin 23, 850115971$repeat:Filamin 24, 850115972$repeat:Filamin 3, 850115973$repeat:Filamin 4, 850115974$repeat:Filamin 5, 850115975$repeat:Filamin 6, 850115976$repeat:Filamin 7, 850115977$repeat:Filamin 8, 850115978$repeat:Filamin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
filamin C, gamma (actin binding protein 280),INTERPRO[450001143$IPR001298:Filamin/ABP280 repeat, 450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001520$IPR001715:Calponin-like actin-binding, 450012396$IPR013783:Immunoglobulin-like fold, 450016187$IPR017868:Filamin/ABP280 repeat-like]
filamin C, gamma (actin binding protein 280),KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038853$hsa04510:Focal adhesion]
filamin C, gamma (actin binding protein 280),OMIM_DISEASE[520003504$Myopathy, myofibrillar, filamin C-related]
filamin C, gamma (actin binding protein 280),SMART[760000025$SM00033:CH, 760000496$SM00557:IG_FLMN]
filamin C, gamma (actin binding protein 280),SP_PIR_KEYWORDS[790000002$3d-structure, 790000017$actin binding, 790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
filamin C, gamma (actin binding protein 280),UP_SEQ_FEATURE[850019488$chain:Filamin-C, 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111881$region of interest:Hinge 1, 850111882$region of interest:Hinge 2, 850112444$region of interest:Interaction with INPPL1, 850113138$region of interest:Intradomain insert, 850114627$region of interest:Self-association site, tail, 850115955$repeat:Filamin 1, 850115956$repeat:Filamin 10, 850115957$repeat:Filamin 11, 850115958$repeat:Filamin 12, 850115959$repeat:Filamin 13, 850115960$repeat:Filamin 14, 850115961$repeat:Filamin 15, 850115962$repeat:Filamin 16, 850115963$repeat:Filamin 17, 850115964$repeat:Filamin 18, 850115965$repeat:Filamin 19, 850115966$repeat:Filamin 2, 850115967$repeat:Filamin 20, 850115968$repeat:Filamin 21, 850115969$repeat:Filamin 22, 850115970$repeat:Filamin 23, 850115971$repeat:Filamin 24, 850115972$repeat:Filamin 3, 850115973$repeat:Filamin 4, 850115974$repeat:Filamin 5, 850115975$repeat:Filamin 6, 850115976$repeat:Filamin 7, 850115977$repeat:Filamin 8, 850115978$repeat:Filamin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
flightless I homolog (Drosophila),COG_ONTOLOGY[90000070$Function unknown]
flightless I homolog (Drosophila),INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450006496$IPR007122:Gelsolin, 450006497$IPR007123:Gelsolin region]
flightless I homolog (Drosophila),SMART[760000234$SM00262:GEL, 760000333$SM00369:LRR_TYP]
flightless I homolog (Drosophila),SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000445$direct protein sequencing, 790000853$leucine-rich repeat, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
flightless I homolog (Drosophila),UP_SEQ_FEATURE[850046148$chain:Protein flightless-1 homolog, 850102507$compositionally biased region:Glu-rich, 850102565$compositionally biased region:Poly-Ala, 850106258$modified residue, 850106259$mutagenesis site, 850112061$region of interest:Interaction with ACTL6A, 850112494$region of interest:Interaction with LRRFIP1 and LRRFIP2, 850116060$repeat:Gelsolin-like 1, 850116061$repeat:Gelsolin-like 2, 850116062$repeat:Gelsolin-like 3, 850116063$repeat:Gelsolin-like 4, 850116064$repeat:Gelsolin-like 5, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117295$sequence variant]
fms-related tyrosine kinase 3 ligand,INTERPRO[450003721$IPR004213:Flt3 ligand, 450011046$IPR012351:Four-helical cytokine, core]
fms-related tyrosine kinase 3 ligand,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
fms-related tyrosine kinase 3 ligand,PIR_SUPERFAMILY[630012510$PIRSF015744:Fms-related tyrosine kinase 3 ligand/SL cytokine]
fms-related tyrosine kinase 3 ligand,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
fms-related tyrosine kinase 3 ligand,UP_SEQ_FEATURE[850060940$chain:SL cytokine, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
folliculin interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
folliculin interacting protein 1,UP_SEQ_FEATURE[850019802$chain:Folliculin-interacting protein 1, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
follistatin-like 3 (secreted glycoprotein),INTERPRO[450002091$IPR002350:Proteinase inhibitor I1, Kazal, 450003191$IPR003645:Follistatin-like, N-terminal, 450010359$IPR011497:Protease inhibitor, Kazal-type, 450011589$IPR012913:Glucosidase II beta subunit-like, 450013810$IPR015369:Follistatin/Osteonectin-like EGF domain, 450016196$IPR017878:TGF-beta binding]
follistatin-like 3 (secreted glycoprotein),SMART[760000246$SM00274:FOLN, 760000251$SM00280:KAZAL]
follistatin-like 3 (secreted glycoprotein),SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001065$nucleus, 790001083$osteogenesis, 790001271$Proto-oncogene, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001539$Transcription, 790001543$transcription regulation]
follistatin-like 3 (secreted glycoprotein),UP_SEQ_FEATURE[850019807$chain:Follistatin-related protein 3, 850102883$disulfide bond, 850104011$domain:Follistatin-like 2, 850104501$domain:Kazal-like 1, 850104509$domain:Kazal-like 2, 850105464$domain:TB, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117814$signal peptide, 850118574$splice variant, 850118575$strand]
forkhead box K1,INTERPRO[450000219$IPR000253:Forkhead-associated, 450001565$IPR001766:Transcription factor, fork head, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box K1,SMART[760000212$SM00240:FHA, 760000307$SM00339:FH]
forkhead box K1,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000466$dna-binding, 790001001$myogenesis, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
forkhead box K1,UP_SEQ_FEATURE[850019879$chain:Forkhead box protein K1, 850102378$compositionally biased region:Ala-rich, 850102586$compositionally biased region:Pro-rich, 850102914$DNA-binding region:Fork-head, 850103775$domain:FHA, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
forkhead box P3,INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450006475$IPR007087:Zinc finger, C2H2-type, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box P3,OMIM_DISEASE[520001516$Diabetes mellitus, type I, susceptibility to, 520002620$Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked]
forkhead box P3,SMART[760000307$SM00339:FH, 760000323$SM00355:ZnF_C2H2]
forkhead box P3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000430$diabetes mellitus, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
forkhead box P3,UP_SEQ_FEATURE[850019897$chain:Forkhead box protein P3, 850102914$DNA-binding region:Fork-head, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118655$zinc finger region:C2H2-type]
formin-like 1,INTERPRO[450002728$IPR003104:Actin-binding FH2 and DRF autoregulatory, 450009531$IPR010472:Diaphanous FH3, 450009532$IPR010473:Diaphanous GTPase-binding, 450013217$IPR014767:Diaphanous autoregulatory, 450013218$IPR014768:GTPase-binding/formin homology 3, 450013867$IPR015425:Actin-binding FH2]
formin-like 1,SMART[760000441$SM00498:FH2]
formin-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
formin-like 1,UP_SEQ_FEATURE[850019959$chain:Formin-like protein 1, 850102586$compositionally biased region:Pro-rich, 850103478$domain:DAD, 850103774$domain:FH2, 850104044$domain:GBD/FH3, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
formyl peptide receptor 3,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000718$IPR000826:Formyl/methionyl peptide receptor, 450014126$IPR015691:fMet-Leu-Phe receptor I, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
formyl peptide receptor 3,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
formyl peptide receptor 3,PIR_SUPERFAMILY[630030065$PIRSF038561:N-formyl peptide receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
formyl peptide receptor 3,SP_PIR_KEYWORDS[790000264$cell membrane, 790000291$chemotaxis, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
formyl peptide receptor 3,UP_SEQ_FEATURE[850033263$chain:N-formyl peptide receptor 3, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
frequently rearranged in advanced T-cell lymphomas,BIOCARTA[30000313$h_wntPathway:WNT Signaling Pathway]
frequently rearranged in advanced T-cell lymphomas,INTERPRO[450007351$IPR008014:Glycogen synthase kinase-3 binding protein]
frequently rearranged in advanced T-cell lymphomas,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
frequently rearranged in advanced T-cell lymphomas,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001642$wnt signaling pathway]
frequently rearranged in advanced T-cell lymphomas,UP_SEQ_FEATURE[850048669$chain:Proto-oncogene FRAT1, 850102509$compositionally biased region:Glu-rich (highly acidic), 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850113172$region of interest:Involved in GSK-3 binding, 850117294$sequence conflict]
frizzled homolog 2 (Drosophila),INTERPRO[450000019$IPR000024:Frizzled cysteine-rich domain, 450000462$IPR000539:Frizzled protein, 450013966$IPR015526:Frizzled related, 450016289$IPR017981:GPCR, family 2-like]
frizzled homolog 2 (Drosophila),KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038907$hsa05217:Basal cell carcinoma]
frizzled homolog 2 (Drosophila),PIR_SUPERFAMILY[630006655$PIRSF006696:G protein-coupled receptor frizzled, 630031175$PIRSF501049:G protein-coupled receptor frizzled 1/2/7]
frizzled homolog 2 (Drosophila),SMART[760000054$SM00063:FRI]
frizzled homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane, 790001642$wnt signaling pathway]
frizzled homolog 2 (Drosophila),UP_SEQ_FEATURE[850020048$chain:Frizzled-2, 850102573$compositionally biased region:Poly-Gly, 850102883$disulfide bond, 850104018$domain:FZ, 850105770$glycosylation site:N-linked (GlcNAc...), 850117571$short sequence motif:Lys-Thr-X-X-X-Trp motif, 850117634$short sequence motif:PDZ-binding, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
frizzled homolog 6 (Drosophila),INTERPRO[450000019$IPR000024:Frizzled cysteine-rich domain, 450000462$IPR000539:Frizzled protein, 450013966$IPR015526:Frizzled related, 450016289$IPR017981:GPCR, family 2-like]
frizzled homolog 6 (Drosophila),KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038907$hsa05217:Basal cell carcinoma]
frizzled homolog 6 (Drosophila),SMART[760000054$SM00063:FRI]
frizzled homolog 6 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane, 790001642$wnt signaling pathway]
frizzled homolog 6 (Drosophila),UP_SEQ_FEATURE[850020052$chain:Frizzled-6, 850102883$disulfide bond, 850104018$domain:FZ, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117571$short sequence motif:Lys-Thr-X-X-X-Trp motif, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
fructosamine 3 kinase,INTERPRO[450014798$IPR016477:Fructosamine/Ketosamine-3-kinase]
fructosamine 3 kinase,PIR_SUPERFAMILY[630006149$PIRSF006221:Ketosamine-3-kinase]
fructosamine 3 kinase,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000825$kinase, 790001162$phosphoprotein, 790001547$transferase]
fructosamine 3 kinase,UP_SEQ_FEATURE[850020067$chain:Fructosamine-3-kinase, 850106258$modified residue]
fructosamine 3 kinase related protein,INTERPRO[450014798$IPR016477:Fructosamine/Ketosamine-3-kinase]
fructosamine 3 kinase related protein,PIR_SUPERFAMILY[630006149$PIRSF006221:Ketosamine-3-kinase]
fructosamine 3 kinase related protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790000825$kinase, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
fructosamine 3 kinase related protein,UP_SEQ_FEATURE[850027348$chain:Ketosamine-3-kinase, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
fructose-1,6-bisphosphatase 1,INTERPRO[450000121$IPR000146:Fructose-1,6-bisphosphatase, 450016266$IPR017955:Inositol monophosphatase/Fructose-1,6-bisphosphatase]
fructose-1,6-bisphosphatase 1,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038727$hsa00030:Pentose phosphate pathway, 470038729$hsa00051:Fructose and mannose metabolism, 470038882$hsa04910:Insulin signaling pathway]
fructose-1,6-bisphosphatase 1,OMIM_DISEASE[520001941$Fructose-1,6-bidphosphatase deficiency, 520001942$Fructose-bisphosphatase deficiency]
fructose-1,6-bisphosphatase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000045$allosteric enzyme, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000595$gluconeogenesis, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism]
fructose-1,6-bisphosphatase 1,UP_SEQ_FEATURE[850000229$binding site:AMP, 850000555$binding site:Substrate, 850020075$chain:Fructose-1,6-bisphosphatase 1, 850105852$helix, 850106134$metal ion-binding site:Magnesium 1, 850106137$metal ion-binding site:Magnesium 2, 850106139$metal ion-binding site:Magnesium 2; via carbonyl oxygen, 850106140$metal ion-binding site:Magnesium 3, 850106258$modified residue, 850106259$mutagenesis site, 850106262$nucleotide phosphate-binding region:AMP, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
fucosidase, alpha-L- 2, plasma,INTERPRO[450000815$IPR000933:Glycoside hydrolase, family 29, 450012395$IPR013781:Glycoside hydrolase, subgroup, catalytic core, 450014610$IPR016286:Glycoside hydrolase, family 29, subgroup, 450016798$IPR018526:Glycoside hydrolase, family 29, conserved site]
fucosidase, alpha-L- 2, plasma,KEGG_PATHWAY[470038767$hsa00511:Other glycan degradation]
fucosidase, alpha-L- 2, plasma,PIR_SUPERFAMILY[630001240$PIRSF001092:Alpha-L-fucosidase]
fucosidase, alpha-L- 2, plasma,SMART[760000714$SM00812:Alpha_L_fucos]
fucosidase, alpha-L- 2, plasma,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
fucosidase, alpha-L- 2, plasma,UP_SEQ_FEATURE[850039425$chain:Plasma alpha-L-fucosidase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118407$site:May be important for catalysis]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),INTERPRO[450002236$IPR002516:Glycosyl transferase, family 11]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis, 470038785$hsa00603:Glycosphingolipid biosynthesis]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),OMIM_DISEASE[520000641$Bombay phenotype]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),SP_PIR_KEYWORDS[790000194$blood group antigen, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group),UP_SEQ_FEATURE[850020414$chain:Galactoside 2-alpha-L-fucosyltransferase 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
fucosyltransferase 10 (alpha (1,3) fucosyltransferase),INTERPRO[450001336$IPR001503:Glycosyl transferase, family 10, 450015496$IPR017176:Alpha-(1, 3)-fucosyltransferase, metazoan]
fucosyltransferase 10 (alpha (1,3) fucosyltransferase),PIR_SUPERFAMILY[630028882$PIRSF037332:Alpha1_3FUT_met]
fucosyltransferase 10 (alpha (1,3) fucosyltransferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
fucosyltransferase 10 (alpha (1,3) fucosyltransferase),UP_SEQ_FEATURE[850004582$chain:Alpha-(1,3)-fucosyltransferase 10, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
fucosyltransferase 11 (alpha (1,3) fucosyltransferase),INTERPRO[450001336$IPR001503:Glycosyl transferase, family 10, 450015496$IPR017176:Alpha-(1, 3)-fucosyltransferase, metazoan]
fucosyltransferase 11 (alpha (1,3) fucosyltransferase),PIR_SUPERFAMILY[630028882$PIRSF037332:Alpha1_3FUT_met]
fucosyltransferase 11 (alpha (1,3) fucosyltransferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
fucosyltransferase 11 (alpha (1,3) fucosyltransferase),UP_SEQ_FEATURE[850004583$chain:Alpha-(1,3)-fucosyltransferase 11, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),INTERPRO[450001336$IPR001503:Glycosyl transferase, family 10]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),OMIM_DISEASE[520001946$Fucosyltransferase-6 deficiency]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),PIR_SUPERFAMILY[630005650$PIRSF005726:fucosyltransferase]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),UP_SEQ_FEATURE[850004581$chain:Alpha-(1,3)-fucosyltransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
fumarylacetoacetate hydrolase domain containing 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
fumarylacetoacetate hydrolase domain containing 1,INTERPRO[450002248$IPR002529:Fumarylacetoacetase, C-terminal-like, 450010142$IPR011234:Fumarylacetoacetase, C-terminal-related]
fumarylacetoacetate hydrolase domain containing 1,PIR_SUPERFAMILY[630005915$PIRSF005976:2-hydroxyhepta-2,4-diene-1,7-dioate isomerase]
fumarylacetoacetate hydrolase domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001212$polymorphism]
fumarylacetoacetate hydrolase domain containing 1,UP_SEQ_FEATURE[850020173$chain:Fumarylacetoacetate hydrolase domain- containing protein 1, 850105852$helix, 850105986$metal ion-binding site:Divalent metal cation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
furin (paired basic amino acid cleaving enzyme),BIOCARTA[30000207$h_notchpathway:Proteolysis and Signaling Pathway of Notch ]
furin (paired basic amino acid cleaving enzyme),INTERPRO[450000180$IPR000209:Peptidase S8 and S53, subtilisin, kexin, sedolisin, 450002550$IPR002884:Proprotein convertase, P, 450005638$IPR006212:Furin-like repeat, 450013941$IPR015500:Peptidase S8, subtilisin-related]
furin (paired basic amino acid cleaving enzyme),PIR_SUPERFAMILY[630001322$PIRSF001179:proprotein convertase, subtilisin/kexin types, 630030565$PIRSF500329:furin]
furin (paired basic amino acid cleaving enzyme),SMART[760000233$SM00261:FU]
furin (paired basic amino acid cleaving enzyme),SP_PIR_KEYWORDS[790000144$autocatalytic cleavage, 790000211$calcium, 790000264$cell membrane, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001652$zymogen]
furin (paired basic amino acid cleaving enzyme),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850020185$chain:Furin, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105910$metal ion-binding site:Calcium 1, 850105918$metal ion-binding site:Calcium 2, 850106258$modified residue, 850109663$propeptide:Inhibition peptide, 850111222$region of interest:Cell surface signal, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117748$short sequence motif:Trans Golgi network signal, 850117814$signal peptide, 850117976$site:Cleavage, first; by autolysis, 850117977$site:Cleavage, second; by autolysis, 850118623$transmembrane region]
galactosamine (N-acetyl)-6-sulfate sulfatase,COG_ONTOLOGY[90000075$Inorganic ion transport and metabolism]
galactosamine (N-acetyl)-6-sulfate sulfatase,INTERPRO[450000800$IPR000917:Sulfatase, 450016171$IPR017849:Alkaline phosphatase-like, alpha/beta/alpha]
galactosamine (N-acetyl)-6-sulfate sulfatase,KEGG_PATHWAY[470038771$hsa00531:Glycosaminoglycan degradation, 470038840$hsa04142:Lysosome]
galactosamine (N-acetyl)-6-sulfate sulfatase,OMIM_DISEASE[520003386$Mucopolysaccharidosis IVA]
galactosamine (N-acetyl)-6-sulfate sulfatase,PIR_SUPERFAMILY[630001123$PIRSF000971:animal sulfatase]
galactosamine (N-acetyl)-6-sulfate sulfatase,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000474$dwarfism, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790000937$metal-binding, 790000992$Mucopolysaccharidosis, 790001212$polymorphism, 790001405$signal, 790001465$sulfuric ester hydrolase]
galactosamine (N-acetyl)-6-sulfate sulfatase,UP_SEQ_FEATURE[850033176$chain:N-acetylgalactosamine-6-sulfatase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105909$metal ion-binding site:Calcium, 850105944$metal ion-binding site:Calcium; via 3-oxoalanine, 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide]
galactose-1-phosphate uridylyltransferase,BIOCARTA[30000120$h_g1pPathway:Leloir pathway of galactose metabolism]
galactose-1-phosphate uridylyltransferase,INTERPRO[450001715$IPR001937:Galactose-1-phosphate uridyl transferase, class I, 450005294$IPR005849:Galactose-1-phosphate uridyl transferase, N-terminal, 450005295$IPR005850:Galactose-1-phosphate uridyl transferase, C-terminal, 450010083$IPR011151:Histidine triad motif, 450018014$IPR019779:Galactose-1-phosphate uridyl transferase, class I His-active site]
galactose-1-phosphate uridylyltransferase,KEGG_PATHWAY[470038730$hsa00052:Galactose metabolism, 470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
galactose-1-phosphate uridylyltransferase,OMIM_DISEASE[520001958$Galactosemia]
galactose-1-phosphate uridylyltransferase,PIR_SUPERFAMILY[630000932$PIRSF000808:galactose-1-phosphate uridylyltransferase, 630000933$PIRSF000808:GalT]
galactose-1-phosphate uridylyltransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000232$carbohydrate metabolism, 790000252$cataract, 790000356$complete proteome, 790000446$disease mutation, 790000577$Galactose metabolism, 790000802$iron, 790000937$metal-binding, 790001064$nucleotidyltransferase, 790001212$polymorphism, 790001547$transferase, 790001648$zinc]
galactose-1-phosphate uridylyltransferase,UP_SEQ_FEATURE[850000164$active site:Tele-UMP-histidine intermediate, 850020392$chain:Galactose-1-phosphate uridylyltransferase, 850106003$metal ion-binding site:Iron, 850106218$metal ion-binding site:Zinc, 850117294$sequence conflict, 850117295$sequence variant]
gamma-aminobutyric acid (GABA) receptor, rho 2,INTERPRO[450005468$IPR006028:Gamma-aminobutyric acid A receptor, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450007394$IPR008057:Gamma-aminobutyric-acid A receptor, Rho, 450007396$IPR008059:Gamma-aminobutyric-acid A receptor, Rho2, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
gamma-aminobutyric acid (GABA) receptor, rho 2,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
gamma-aminobutyric acid (GABA) receptor, rho 2,PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
gamma-aminobutyric acid (GABA) receptor, rho 2,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001026$neurotransmitter receptor, 790001223$postsynaptic cell membrane, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001558$transport]
gamma-aminobutyric acid (GABA) receptor, rho 2,UP_SEQ_FEATURE[850020499$chain:Gamma-aminobutyric acid receptor subunit rho-2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
gamma-glutamyl carboxylase,INTERPRO[450007133$IPR007782:Vitamin K-dependent gamma-carboxylase, 450010004$IPR011020:HTTM]
gamma-glutamyl carboxylase,OMIM_DISEASE[520004168$Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 520005039$Vitamin K-dependent coagulation defect]
gamma-glutamyl carboxylase,SMART[760000658$SM00752:HTTM]
gamma-glutamyl carboxylase,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000859$ligase, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
gamma-glutamyl carboxylase,UP_SEQ_FEATURE[850100463$chain:Vitamin K-dependent gamma-carboxylase, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
gamma-glutamyl cyclotransferase,INTERPRO[450008399$IPR009288:AIG2-like, 450016251$IPR017939:Gamma-glutamylcyclotransferase]
gamma-glutamyl cyclotransferase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
gamma-glutamyl cyclotransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790001547$transferase]
gamma-glutamyl cyclotransferase,UP_SEQ_FEATURE[850020541$chain:Gamma-glutamylcyclotransferase, 850105852$helix, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase),INTERPRO[450010525$IPR011697:Peptidase C26, 450013967$IPR015527:Peptidase C26, gamma-glutamyl hydrolase]
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase),KEGG_PATHWAY[470038800$hsa00790:Folate biosynthesis]
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase),PIR_SUPERFAMILY[630015126$PIRSF018513:Gamma-glutamyl hydrolase]
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790001073$omega peptidase, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850020533$chain:Gamma-glutamyl hydrolase, 850104041$domain:Gamma-glutamyl hydrolase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105806$glycosylation site:N-linked (GlcNAc...); partial, 850105852$helix, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
gap junction protein, alpha 10, 62kDa,INTERPRO[450000426$IPR000500:Connexins, 450011736$IPR013092:Connexin, N-terminal, 450016298$IPR017990:Connexin, conserved site, 450016299$IPR017991:Connexin region, 450017807$IPR019570:Gap junction protein, cysteine-rich domain]
gap junction protein, alpha 10, 62kDa,SMART[760000029$SM00037:CNX]
gap junction protein, alpha 10, 62kDa,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000581$gap junction, 790000919$membrane, 790001555$transmembrane]
gap junction protein, alpha 10, 62kDa,UP_SEQ_FEATURE[850020607$chain:Gap junction alpha-10 protein, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
gap junction protein, beta 1, 32kDa,INTERPRO[450000426$IPR000500:Connexins, 450002013$IPR002267:Gap junction beta-1 protein (Cx32), 450011736$IPR013092:Connexin, N-terminal, 450016298$IPR017990:Connexin, conserved site, 450016299$IPR017991:Connexin region, 450017807$IPR019570:Gap junction protein, cysteine-rich domain]
gap junction protein, beta 1, 32kDa,OMIM_DISEASE[520000974$Charcot-Marie-Tooth neuropathy, X-linked dominant, 1]
gap junction protein, beta 1, 32kDa,PIR_SUPERFAMILY[630002418$PIRSF002292:gap junction protein]
gap junction protein, beta 1, 32kDa,SMART[760000029$SM00037:CNX]
gap junction protein, beta 1, 32kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000263$cell junction, 790000264$cell membrane, 790000289$charcot-marie-tooth disease, 790000356$complete proteome, 790000446$disease mutation, 790000581$gap junction, 790000885$liver, 790000919$membrane, 790001020$neuropathy, 790001162$phosphoprotein, 790001555$transmembrane, 790001556$transmembrane protein]
gap junction protein, beta 1, 32kDa,UP_SEQ_FEATURE[850020615$chain:Gap junction beta-1 protein, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
gap junction protein, delta 3, 31.9kDa,INTERPRO[450000426$IPR000500:Connexins, 450011736$IPR013092:Connexin, N-terminal, 450016298$IPR017990:Connexin, conserved site, 450016299$IPR017991:Connexin region, 450017807$IPR019570:Gap junction protein, cysteine-rich domain]
gap junction protein, delta 3, 31.9kDa,SMART[760000029$SM00037:CNX]
gap junction protein, delta 3, 31.9kDa,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000581$gap junction, 790000919$membrane, 790001555$transmembrane]
gap junction protein, delta 3, 31.9kDa,UP_SEQ_FEATURE[850020625$chain:Gap junction delta-3 protein, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
gasdermin A,INTERPRO[450007034$IPR007677:DFNA5 protein]
gasdermin A,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
gasdermin A,UP_SEQ_FEATURE[850020648$chain:Gasdermin-A, 850117294$sequence conflict, 850117295$sequence variant]
gasdermin C,INTERPRO[450007034$IPR007677:DFNA5 protein]
gasdermin C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
gasdermin C,UP_SEQ_FEATURE[850020653$chain:Gasdermin-C, 850117295$sequence variant]
gem (nuclear organelle) associated protein 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001433$Spliceosome]
gem (nuclear organelle) associated protein 4,UP_SEQ_FEATURE[850012409$chain:Component of gems 4, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
gem (nuclear organelle) associated protein 5,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
gem (nuclear organelle) associated protein 5,SMART[760000289$SM00320:WD40]
gem (nuclear organelle) associated protein 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001433$Spliceosome, 790001638$wd repeat]
gem (nuclear organelle) associated protein 5,UP_SEQ_FEATURE[850020864$chain:Gem-associated protein 5, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117174$repeat:WD 12, 850117175$repeat:WD 13, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant]
gem (nuclear organelle) associated protein 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001433$Spliceosome]
gem (nuclear organelle) associated protein 7,UP_SEQ_FEATURE[850020866$chain:Gem-associated protein 7, 850105852$helix, 850118575$strand]
geminin, DNA replication inhibitor,INTERPRO[450009069$IPR009984:Geminin]
geminin, DNA replication inhibitor,PIR_SUPERFAMILY[630030014$PIRSF038488:Geminin]
geminin, DNA replication inhibitor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000461$dna replication inhibitor, 790001162$phosphoprotein, 790001212$polymorphism]
geminin, DNA replication inhibitor,UP_SEQ_FEATURE[850020875$chain:Geminin, 850105852$helix, 850106258$modified residue, 850117295$sequence variant]
general transcription factor II, i; general transcription factor II, i, pseudogene,BBID[10000082$61.Myc_network]
general transcription factor II, i; general transcription factor II, i, pseudogene,INTERPRO[450003720$IPR004212:GTF2I-like repeat, 450014980$IPR016659:Transcription factor II-I]
general transcription factor II, i; general transcription factor II, i, pseudogene,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
general transcription factor II, i; general transcription factor II, i, pseudogene,OMIM_DISEASE[520005093$Williams-Beuren syndrome]
general transcription factor II, i; general transcription factor II, i, pseudogene,PIR_SUPERFAMILY[630013215$PIRSF016441:TF_II-I]
general transcription factor II, i; general transcription factor II, i, pseudogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001640$williams-beuren syndrome]
general transcription factor II, i; general transcription factor II, i, pseudogene,UP_SEQ_FEATURE[850021042$chain:General transcription factor II-I, 850102567$compositionally biased region:Poly-Asn, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850116107$repeat:GTF2I-like 1, 850116108$repeat:GTF2I-like 2, 850116109$repeat:GTF2I-like 3, 850116110$repeat:GTF2I-like 4, 850116111$repeat:GTF2I-like 5, 850116112$repeat:GTF2I-like 6, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
germinal center expressed transcript 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
germinal center expressed transcript 2,UP_SEQ_FEATURE[850021154$chain:Germinal center B-cell-expressed transcript 2 protein, 850106258$modified residue]
glial fibrillary acidic protein,BIOCARTA[30000239$h_prionPathway:Prion Pathway]
glial fibrillary acidic protein,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450006225$IPR006821:Intermediate filament, DNA-binding region, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
glial fibrillary acidic protein,OMIM_DISEASE[520000214$Alexander disease]
glial fibrillary acidic protein,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
glial fibrillary acidic protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000788$Intermediate filament, 790001162$phosphoprotein, 790001212$polymorphism]
glial fibrillary acidic protein,UP_SEQ_FEATURE[850021232$chain:Glial fibrillary acidic protein, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111277$region of interest:Coil 2A, 850111278$region of interest:Coil 2B, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
glioblastoma amplified sequence,INTERPRO[450011257$IPR012577:NIPSNAP]
glioblastoma amplified sequence,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome]
glioblastoma amplified sequence,UP_SEQ_FEATURE[850047036$chain:Protein NipSnap homolog 2, 850106258$modified residue, 850117294$sequence conflict]
glucocorticoid receptor DNA binding factor 1,INTERPRO[450000169$IPR000198:RhoGAP, 450002406$IPR002713:FF domain, 450012373$IPR013753:Ras]
glucocorticoid receptor DNA binding factor 1,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038873$hsa04670:Leukocyte transendothelial migration, 470038881$hsa04810:Regulation of actin cytoskeleton]
glucocorticoid receptor DNA binding factor 1,SMART[760000293$SM00324:RhoGAP, 760000387$SM00441:FF]
glucocorticoid receptor DNA binding factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000640$GTPase activation, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001580$tumor suppressor]
glucocorticoid receptor DNA binding factor 1,UP_SEQ_FEATURE[850021371$chain:Glucocorticoid receptor DNA-binding factor 1, 850102586$compositionally biased region:Pro-rich, 850103766$domain:FF 1, 850103767$domain:FF 2, 850103768$domain:FF 3, 850103769$domain:FF 4, 850105183$domain:Rho-GAP, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,INTERPRO[450000512$IPR000600:ROK, 450001155$IPR001312:Hexokinase, 450002906$IPR003331:UDP-N-acetylglucosamine 2-epimerase, 450018231$IPR020004:UDP-N-acetylglucosamine 2-epimerase,UDP-hydrolysing]
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,OMIM_DISEASE[520002625$Inclusion body myopathy, autosomal recessive, 520003671$Nonaka myopathy, 520004478$Sialuria]
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000045$allosteric enzyme, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000810$Isomerase, 790000825$kinase, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001547$transferase]
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,UP_SEQ_FEATURE[850008056$chain:Bifunctional UDP-N-acetylglucosamine 2- epimerase/N-acetylmannosamine kinase, 850105852$helix, 850106263$nucleotide phosphate-binding region:ATP, 850113510$region of interest:N-acetylmannosamine kinase, 850115006$region of interest:UDP-N-acetylglucosamine 2-epimerase, 850117295$sequence variant, 850118575$strand, 850118624$turn]
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group),INTERPRO[450002975$IPR003406:Glycosyl transferase, family 14]
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group),KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group),OMIM_DISEASE[520000159$Adult i phenotype with congenital cataract, 520000160$Adult i phenotype without cataract, 520000600$Blood group, Ii, 520002703$Juvenile congenital cataract]
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group),SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group),UP_SEQ_FEATURE[850033199$chain:N-acetyllactosaminide beta-1,6-N- acetylglucosaminyl-transferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),INTERPRO[450005639$IPR006213:Bax inhibitor 1, conserved site, 450005640$IPR006214:Uncharacterised protein family UPF0005]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),UP_SEQ_FEATURE[850021596$chain:Glutamate [NMDA] receptor-associated protein 1, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
glutamate receptor, ionotropic, kainate 5,INTERPRO[450001163$IPR001320:Ionotropic glutamate receptor, 450001341$IPR001508:NMDA receptor, 450001618$IPR001828:Extracellular ligand-binding receptor, 450014119$IPR015683:Glutamate receptor-related, 450017831$IPR019594:Glutamate receptor, L-glutamate/glycine-binding]
glutamate receptor, ionotropic, kainate 5,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
glutamate receptor, ionotropic, kainate 5,PIR_SUPERFAMILY[630002556$PIRSF002437:ionotropic glutamate receptor, AMPA/kainate types, 630030751$PIRSF500552:ionotropic glutamate receptor, kainate type, subunit 5]
glutamate receptor, ionotropic, kainate 5,SMART[760000069$SM00079:PBPe]
glutamate receptor, ionotropic, kainate 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001026$neurotransmitter receptor, 790001212$polymorphism, 790001223$postsynaptic cell membrane, 790001301$receptor, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001558$transport]
glutamate receptor, ionotropic, kainate 5,UP_SEQ_FEATURE[850021575$chain:Glutamate receptor, ionotropic kainate 5, 850102566$compositionally biased region:Poly-Arg, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glutamate receptor, metabotropic 2,INTERPRO[450000138$IPR000162:GPCR, family 3, metabotropic glutamate receptor, 450000290$IPR000337:GPCR, family 3, 450001299$IPR001458:GPCR, family 3, metabotropic glutamate receptor 2, 450001618$IPR001828:Extracellular ligand-binding receptor, 450010362$IPR011500:GPCR, family 3, nine cysteines region, 450016286$IPR017978:GPCR, family 3, C-terminal, 450016287$IPR017979:GPCR, family 3, conserved site]
glutamate receptor, metabotropic 2,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
glutamate receptor, metabotropic 2,PIR_SUPERFAMILY[630005529$PIRSF005608:metabotropic glutamate receptors and related]
glutamate receptor, metabotropic 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
glutamate receptor, metabotropic 2,UP_SEQ_FEATURE[850031237$chain:Metabotropic glutamate receptor 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glutathione S-transferase alpha 3,INTERPRO[450002706$IPR003080:Glutathione S-transferase, alpha class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase alpha 3,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase alpha 3,PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase alpha 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase alpha 3,UP_SEQ_FEATURE[850021776$chain:Glutathione S-transferase A3, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
glutathione S-transferase alpha 4,INTERPRO[450002706$IPR003080:Glutathione S-transferase, alpha class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase alpha 4,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase alpha 4,PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase alpha 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase alpha 4,UP_SEQ_FEATURE[850021777$chain:Glutathione S-transferase A4, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850117295$sequence variant, 850118575$strand, 850118624$turn]
glutathione S-transferase mu 1,INTERPRO[450002707$IPR003081:Glutathione S-transferase, Mu class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase mu 1,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase mu 1,PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase mu 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000436$dimer, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase mu 1,UP_SEQ_FEATURE[850021800$chain:Glutathione S-transferase Mu 1, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
glutathione S-transferase omega 2,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
glutathione S-transferase omega 2,INTERPRO[450003562$IPR004045:Glutathione S-transferase, N-terminal, 450004901$IPR005442:Glutathione S-transferase, omega-class, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase omega 2,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase omega 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase omega 2,UP_SEQ_FEATURE[850021808$chain:Glutathione S-transferase omega-2, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850117294$sequence conflict, 850117295$sequence variant]
glutathione S-transferase pi 1,BIOCARTA[30000192$h_mrpPathway:Multi-Drug Resistance Factors]
glutathione S-transferase pi 1,INTERPRO[450002708$IPR003082:Glutathione S-transferase, Pi class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase pi 1,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism, 470038899$hsa05200:Pathways in cancer, 470038905$hsa05215:Prostate cancer]
glutathione S-transferase pi 1,PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase pi 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000241$carboxylic ester hydrolase, 790000356$complete proteome, 790000426$Detoxification, 790000436$dimer, 790000445$direct protein sequencing, 790000602$glutathione, 790000679$heterodimer, 790000701$homodimer, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
glutathione S-transferase pi 1,UP_SEQ_FEATURE[850021812$chain:Glutathione S-transferase P, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
glutathione peroxidase 4 (phospholipid hydroperoxidase),INTERPRO[450000776$IPR000889:Glutathione peroxidase, 450011036$IPR012335:Thioredoxin fold]
glutathione peroxidase 4 (phospholipid hydroperoxidase),KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038780$hsa00590:Arachidonic acid metabolism]
glutathione peroxidase 4 (phospholipid hydroperoxidase),PIR_SUPERFAMILY[630000354$PIRSF000303:glutathione peroxidase, 630000355$PIRSF000303:Glutathion_perox]
glutathione peroxidase 4 (phospholipid hydroperoxidase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000050$alternative initiation, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000969$mitochondrion, 790001092$oxidoreductase, 790001127$peroxidase, 790001212$polymorphism, 790001368$selenium, 790001370$selenocysteine, 790001550$transit peptide]
glutathione peroxidase 4 (phospholipid hydroperoxidase),UP_SEQ_FEATURE[850038858$chain:Phospholipid hydroperoxide glutathione peroxidase, mitochondrial, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
glutathione reductase,BIOCARTA[30000117$h_freePathway:Free Radical Induced Apoptosis]
glutathione reductase,INTERPRO[450000708$IPR000815:Mercuric reductase, 450001169$IPR001327:Pyridine nucleotide-disulphide oxidoreductase, NAD-binding region, 450003614$IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation, 450005747$IPR006322:Glutathione reductase, animal and bacterial, 450011674$IPR012999:Pyridine nucleotide-disulphide oxidoreductase, class I, active site, 450011694$IPR013027:FAD-dependent pyridine nucleotide-disulphide oxidoreductase]
glutathione reductase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
glutathione reductase,OMIM_DISEASE[520002265$Hemolytic anemia due to glutathione reductase deficiency]
glutathione reductase,PIR_SUPERFAMILY[630000254$PIRSF000210:dihydrolipoamide dehydrogenase]
glutathione reductase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000050$alternative initiation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000537$FAD, 790000559$Flavoprotein, 790000701$homodimer, 790000969$mitochondrion, 790001008$nadp, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001302$Redox-active center, 790001303$redox-active disulfide, 790001550$transit peptide]
glutathione reductase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850021757$chain:Glutathione reductase, mitochondrial, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic,INTERPRO[450000146$IPR000173:Glyceraldehyde 3-phosphate dehydrogenase, 450005846$IPR006424:Glyceraldehyde-3-phosphate dehydrogenase, type I]
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic,PIR_SUPERFAMILY[630000175$PIRSF000149:GAP_DH, 630000176$PIRSF000149:glyceraldehyde-3-phosphate dehydrogenase]
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000615$glycolysis, 790001006$nad, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism]
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000378$binding site:Glyceraldehyde 3-phosphate, 850000454$binding site:NAD, 850000460$binding site:NAD; via carbonyl oxygen, 850021883$chain:Glyceraldehyde-3-phosphate dehydrogenase, testis-specific, 850105852$helix, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850111783$region of interest:Glyceraldehyde 3-phosphate binding, 850117294$sequence conflict, 850117295$sequence variant, 850117815$site:Activates thiol group during catalysis, 850118575$strand, 850118624$turn]
glycerol kinase 3 pseudogene; glycerol kinase,INTERPRO[450000491$IPR000577:Carbohydrate kinase, FGGY, 450005443$IPR005999:Glycerol kinase, 450016757$IPR018483:Carbohydrate kinase, FGGY, conserved site, 450016758$IPR018484:Carbohydrate kinase, FGGY, N-terminal, 450016759$IPR018485:Carbohydrate kinase, FGGY, C-terminal]
glycerol kinase 3 pseudogene; glycerol kinase,KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism, 470038821$hsa03320:PPAR signaling pathway]
glycerol kinase 3 pseudogene; glycerol kinase,OMIM_DISEASE[520002138$Glycerol kinase deficiency]
glycerol kinase 3 pseudogene; glycerol kinase,PIR_SUPERFAMILY[630000639$PIRSF000538:xylulokinase]
glycerol kinase 3 pseudogene; glycerol kinase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000606$glycerol metabolism, 790000825$kinase, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001063$nucleotide-binding, 790001168$phosphotransferase, 790001212$polymorphism, 790001547$transferase]
glycerol kinase 3 pseudogene; glycerol kinase,UP_SEQ_FEATURE[850000242$binding site:ATP, 850000249$binding site:ATP; via carbonyl oxygen, 850000555$binding site:Substrate, 850021892$chain:Glycerol kinase, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
glycerol-3-phosphate dehydrogenase 1-like,INTERPRO[450005542$IPR006109:NAD-dependent glycerol-3-phosphate dehydrogenase, C-terminal, 450005600$IPR006168:NAD-dependent glycerol-3-phosphate dehydrogenase, 450010068$IPR011128:NAD-dependent glycerol-3-phosphate dehydrogenase, N-terminal, 450011961$IPR013328:Dehydrogenase, multihelical, 450014426$IPR016040:NAD(P)-binding domain, 450016074$IPR017751:NAD-dependent glycerol-3-phosphate dehydrogenase, eukaryotic]
glycerol-3-phosphate dehydrogenase 1-like,KEGG_PATHWAY[470038778$hsa00564:Glycerophospholipid metabolism]
glycerol-3-phosphate dehydrogenase 1-like,OMIM_DISEASE[520000703$Brugada syndrome 2]
glycerol-3-phosphate dehydrogenase 1-like,PIR_SUPERFAMILY[630000135$PIRSF000114:glycerol-3-phosphate dehydrogenase (NAD), 630000136$PIRSF000114:Glycerol-3-P_dh]
glycerol-3-phosphate dehydrogenase 1-like,SP_PIR_KEYWORDS[790000002$3d-structure, 790000207$Brugada syndrome, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
glycerol-3-phosphate dehydrogenase 1-like,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850000458$binding site:NAD; via amide nitrogen, 850000555$binding site:Substrate, 850021923$chain:Glycerol-3-phosphate dehydrogenase 1-like protein, 850105852$helix, 850106301$nucleotide phosphate-binding region:NAD, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),INTERPRO[450001698$IPR001917:Aminotransferase, class-II, pyridoxal-phosphate binding site, 450004318$IPR004839:Aminotransferase, class I and II, 450010184$IPR011282:2-amino-3-ketobutyrate coenzyme A ligase, 450013864$IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),KEGG_PATHWAY[470038746$hsa00260:Glycine, serine and threonine metabolism]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),PIR_SUPERFAMILY[630029671$PIRSF038087:8-amino-7-oxononanoate synthase / 2-amino-3-ketobutyrate:CoA ligase, 630031205$PIRSF800003:alpha-oxoamine synthase]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000859$ligase, 790000969$mitochondrion, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase, 790001550$transit peptide]
glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase),UP_SEQ_FEATURE[850001077$chain:2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
glycine N-methyltransferase,COG_ONTOLOGY[90000073$General function prediction only]
glycine N-methyltransferase,INTERPRO[450011854$IPR013217:Methyltransferase type 12, 450012952$IPR014369:Glycine N-methyltransferase]
glycine N-methyltransferase,KEGG_PATHWAY[470038746$hsa00260:Glycine, serine and threonine metabolism]
glycine N-methyltransferase,OMIM_DISEASE[520002141$Glycine N-methyltransferase deficiency]
glycine N-methyltransferase,PIR_SUPERFAMILY[630000454$PIRSF000385:glycine N-methyltransferase, 630000455$PIRSF000385:Gly_N-mtase]
glycine N-methyltransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000563$folate, 790000565$folate-binding, 790000954$methyltransferase, 790001162$phosphoprotein, 790001348$s-adenosyl-l-methionine, 790001349$S-adenosylmethionine, 790001547$transferase]
glycine N-methyltransferase,UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850000543$binding site:S-adenosyl-L-methionine; via carbonyl oxygen, 850000555$binding site:Substrate, 850021990$chain:Glycine N-methyltransferase, 850105852$helix, 850106258$modified residue, 850114570$region of interest:S-adenosyl-L-methionine binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
glycine receptor, alpha 1,INTERPRO[450005468$IPR006028:Gamma-aminobutyric acid A receptor, 450005469$IPR006029:Neurotransmitter-gated ion-channel transmembrane region, 450005627$IPR006201:Neurotransmitter-gated ion-channel, 450005628$IPR006202:Neurotransmitter-gated ion-channel ligand-binding, 450007462$IPR008127:Glycine receptor alpha, 450007463$IPR008128:Glycine receptor alpha1, 450016308$IPR018000:Neurotransmitter-gated ion-channel, conserved site]
glycine receptor, alpha 1,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
glycine receptor, alpha 1,OMIM_DISEASE[520002425$Hyperekplexia and spastic paraparesis, 520004673$Startle disease, autosomal recessive, 520004674$Startle disease/hyperekplexia, autosomal dominant, 520004699$Stiff person syndrome]
glycine receptor, alpha 1,PIR_SUPERFAMILY[630002560$PIRSF002443:acetylcholine receptor]
glycine receptor, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001223$postsynaptic cell membrane, 790001301$receptor, 790001405$signal, 790001475$synapse, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
glycine receptor, alpha 1,UP_SEQ_FEATURE[850021993$chain:Glycine receptor subunit alpha-1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850114708$region of interest:Strychnine-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glycoprotein M6B,INTERPRO[450001432$IPR001614:Myelin proteolipid protein PLP, 450016522$IPR018237:Myelin proteolipid protein PLP, conserved site]
glycoprotein M6B,PIR_SUPERFAMILY[630002504$PIRSF002387:myelin proteolipid protein]
glycoprotein M6B,SMART[760000001$SM00002:PLP]
glycoprotein M6B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000616$glycoprotein, 790000919$membrane, 790001016$neurogenesis, 790001555$transmembrane]
glycoprotein M6B,UP_SEQ_FEATURE[850034040$chain:Neuronal membrane glycoprotein M6-b, 850105770$glycosylation site:N-linked (GlcNAc...), 850118574$splice variant, 850118623$transmembrane region]
glycoprotein V (platelet),COG_ONTOLOGY[90000070$Function unknown]
glycoprotein V (platelet),INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
glycoprotein V (platelet),KEGG_PATHWAY[470038854$hsa04512:ECM-receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage]
glycoprotein V (platelet),SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP]
glycoprotein V (platelet),SP_PIR_KEYWORDS[790000189$blocked amino end, 790000192$blood coagulation, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790000919$membrane, 790001205$platelet, 790001304$repeat, 790001405$signal, 790001484$tandem repeat, 790001555$transmembrane, 790001556$transmembrane protein]
glycoprotein V (platelet),UP_SEQ_FEATURE[850039525$chain:Platelet glycoprotein V, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast),INTERPRO[450006615$IPR007246:Gaa1-like, GPI transamidase component, 450015383$IPR017063:Glycosylphosphatidylinositol:protein transamidase complex, GAA1 component]
glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast),KEGG_PATHWAY[470038777$hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis]
glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast),PIR_SUPERFAMILY[630028246$PIRSF036762:GAA1, 630028247$PIRSF036762:glycosylphosphatidylinositol:protein transamidase, GAA1 component]
glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000629$gpi-anchor biosynthesis, 790000919$membrane, 790001555$transmembrane]
glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast),UP_SEQ_FEATURE[850022143$chain:Glycosylphosphatidylinositol anchor attachment 1 protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
golgi SNAP receptor complex member 1,INTERPRO[450007060$IPR007705:Vesicle transport v-SNARE]
golgi SNAP receptor complex member 1,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
golgi SNAP receptor complex member 1,PIR_SUPERFAMILY[630020684$PIRSF027109:Golgi SNARE protein 1]
golgi SNAP receptor complex member 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000919$membrane, 790001266$protein transport, 790001555$transmembrane, 790001558$transport]
golgi SNAP receptor complex member 1,UP_SEQ_FEATURE[850022221$chain:Golgi SNAP receptor complex member 1, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
golgi associated PDZ and coiled-coil motif containing,COG_ONTOLOGY[90000073$General function prediction only]
golgi associated PDZ and coiled-coil motif containing,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
golgi associated PDZ and coiled-coil motif containing,SMART[760000200$SM00228:PDZ]
golgi associated PDZ and coiled-coil motif containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000267$cell projection, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001266$protein transport, 790001475$synapse, 790001558$transport]
golgi associated PDZ and coiled-coil motif containing,UP_SEQ_FEATURE[850022227$chain:Golgi-associated PDZ and coiled-coil motif-containing protein, 850104918$domain:PDZ, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117884$site:Breakpoint for translocation to form GOPC-ROS1 fusion protein, 850118574$splice variant, 850118575$strand]
golgi associated, gamma adaptin ear containing, ARF binding protein 3,INTERPRO[450001785$IPR002014:VHS, 450003663$IPR004152:GAT, 450007483$IPR008152:Clathrin adaptor, alpha/beta/gamma-adaptin, appendage, Ig-like subdomain, 450007484$IPR008153:Clathrin adaptor, gamma-adaptin, appendage, 450008166$IPR008942:ENTH/VHS, 450016492$IPR018205:VHS subgroup]
golgi associated, gamma adaptin ear containing, ARF binding protein 3,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
golgi associated, gamma adaptin ear containing, ARF binding protein 3,PIR_SUPERFAMILY[630012714$PIRSF015944:Golgi-localized, gamma ear-containing, ARF-binding protein]
golgi associated, gamma adaptin ear containing, ARF binding protein 3,SMART[760000259$SM00288:VHS, 760000711$SM00809:Alpha_adaptinC2]
golgi associated, gamma adaptin ear containing, ARF binding protein 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000501$endosome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport, 790001592$ubl conjugation]
golgi associated, gamma adaptin ear containing, ARF binding protein 3,UP_SEQ_FEATURE[850004028$chain:ADP-ribosylation factor-binding protein GGA3, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102585$compositionally biased region:Poly-Val, 850104033$domain:GAE, 850104042$domain:GAT, 850105619$domain:VHS, 850105852$helix, 850106259$mutagenesis site, 850111086$region of interest:Binds to ARF1 (in long isoform), 850115017$region of interest:Unstructured hinge, 850117294$sequence conflict, 850117295$sequence variant, 850117306$short sequence motif:Autoinhibitory, 850118574$splice variant, 850118575$strand, 850118624$turn]
golgi autoantigen, golgin subfamily a, 1,INTERPRO[450000205$IPR000237:GRIP]
golgi autoantigen, golgin subfamily a, 1,SMART[760000661$SM00755:Grip]
golgi autoantigen, golgin subfamily a, 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
golgi autoantigen, golgin subfamily a, 1,UP_SEQ_FEATURE[850022237$chain:Golgin subfamily A member 1, 850102485$compositionally biased region:Gln-rich, 850104082$domain:GRIP, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant]
golgi autoantigen, golgin subfamily a, 7,INTERPRO[450017621$IPR019383:Golgin subfamily A member 7/ERF4]
golgi autoantigen, golgin subfamily a, 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate]
golgi autoantigen, golgin subfamily a, 7,UP_SEQ_FEATURE[850022252$chain:Golgin subfamily A member 7, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106259$mutagenesis site, 850117294$sequence conflict]
golgi phosphoprotein 3 (coat-protein),INTERPRO[450007886$IPR008628:Golgi phosphoprotein 3]
golgi phosphoprotein 3 (coat-protein),SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000501$endosome, 790000624$golgi apparatus, 790000919$membrane, 790000969$mitochondrion, 790001162$phosphoprotein]
golgi phosphoprotein 3 (coat-protein),UP_SEQ_FEATURE[850022214$chain:Golgi phosphoprotein 3, 850102568$compositionally biased region:Poly-Asp]
golgi transport 1 homolog B (S. cerevisiae),INTERPRO[450006670$IPR007305:Got1-like protein]
golgi transport 1 homolog B (S. cerevisiae),PIR_SUPERFAMILY[630008828$PIRSF009824:Golgi transport protein Got1]
golgi transport 1 homolog B (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001266$protein transport, 790001555$transmembrane, 790001558$transport]
golgi transport 1 homolog B (S. cerevisiae),UP_SEQ_FEATURE[850100219$chain:Vesicle transport protein GOT1B, 850102564$compositionally biased region:Phe-rich, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
gonadotropin-releasing hormone receptor,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450001469$IPR001658:Gonadotrophin releasing hormone receptor, 450014128$IPR015693:Gonadotropin-releasing hormone receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
gonadotropin-releasing hormone receptor,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038883$hsa04912:GnRH signaling pathway]
gonadotropin-releasing hormone receptor,OMIM_DISEASE[520001891$Fertile eunuch syndrome, 520002517$Hypogonadotropic hypogonadism]
gonadotropin-releasing hormone receptor,PIR_SUPERFAMILY[630030080$PIRSF038576:gonadotropin-releasing hormone receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
gonadotropin-releasing hormone receptor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000709$hormone receptor, 790000751$hypogonadotropic hypogonadism, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
gonadotropin-releasing hormone receptor,UP_SEQ_FEATURE[850022273$chain:Gonadotropin-releasing hormone receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
grainyhead-like 1 (Drosophila),INTERPRO[450006955$IPR007604:CP2 transcription factor]
grainyhead-like 1 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
grainyhead-like 1 (Drosophila),UP_SEQ_FEATURE[850022337$chain:Grainyhead-like protein 1 homolog, 850106258$modified residue, 850114907$region of interest:Transcription activation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
granzyme M (lymphocyte met-ase 1),INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
granzyme M (lymphocyte met-ase 1),PIR_SUPERFAMILY[630001286$PIRSF001135:trypsin]
granzyme M (lymphocyte met-ase 1),SMART[760000013$SM00020:Tryp_SPc]
granzyme M (lymphocyte met-ase 1),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000406$cytolysis, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001652$zymogen]
granzyme M (lymphocyte met-ase 1),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850022382$chain:Granzyme M, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850109636$propeptide:Activation peptide, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
growth arrest and DNA-damage-inducible, beta,INTERPRO[450003556$IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45]
growth arrest and DNA-damage-inducible, beta,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038834$hsa04110:Cell cycle, 470038836$hsa04115:p53 signaling pathway]
growth arrest and DNA-damage-inducible, beta,PIR_SUPERFAMILY[630009191$PIRSF010369:growth arrest and DNA-damage-inducible protein GADD45]
growth arrest and DNA-damage-inducible, beta,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation]
growth arrest and DNA-damage-inducible, beta,UP_SEQ_FEATURE[850022448$chain:Growth arrest and DNA-damage-inducible protein GADD45 beta, 850117294$sequence conflict]
growth arrest and DNA-damage-inducible, gamma interacting protein 1,INTERPRO[450016745$IPR018472:Growth arrest and DNA-damage-inducible proteins-interacting protein 1, 450016746$IPR018472:Growth arrest/ DNA-damage-inducible protein-interacting protein 1]
growth arrest and DNA-damage-inducible, gamma interacting protein 1,SP_PIR_KEYWORDS[790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein]
growth arrest and DNA-damage-inducible, gamma interacting protein 1,UP_SEQ_FEATURE[850022450$chain:Growth arrest and DNA-damage-inducible proteins-interacting protein 1, 850102570$compositionally biased region:Poly-Gln, 850106258$modified residue, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal]
growth arrest-specific 8,SP_PIR_KEYWORDS[790000267$cell projection, 790000321$cilium, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000557$flagellum, 790000624$golgi apparatus, 790000960$microtubule, 790001212$polymorphism]
growth arrest-specific 8,UP_SEQ_FEATURE[850022456$chain:Growth arrest-specific protein 8, 850113445$region of interest:Microtubule-binding, 850114197$region of interest:Regulates microtubule-binding, 850117295$sequence variant]
growth differentiation factor 9,INTERPRO[450001626$IPR001839:Transforming growth factor beta, 450014053$IPR015615:Transforming growth factor-beta-related, 450014055$IPR015617:Growth differentiation factor-9, 450016259$IPR017948:Transforming growth factor beta, conserved site]
growth differentiation factor 9,PIR_SUPERFAMILY[630028961$PIRSF037401:growth/differentiation factor, GDF9/GDF9B type, 630031210$PIRSF800009:TGF-beta-like cysteine-knot cytokine]
growth differentiation factor 9,SMART[760000177$SM00204:TGFB]
growth differentiation factor 9,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000632$growth factor, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
growth differentiation factor 9,UP_SEQ_FEATURE[850022498$chain:Growth/differentiation factor 9, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
growth factor independent 1 transcription repressor,COG_ONTOLOGY[90000073$General function prediction only]
growth factor independent 1 transcription repressor,INTERPRO[450001661$IPR001878:Zinc finger, CCHC-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
growth factor independent 1 transcription repressor,OMIM_DISEASE[520003625$Neutropenia, nonimmune chronic idiopathic, of adults, 520003626$Neutropenia, severe congenital]
growth factor independent 1 transcription repressor,SMART[760000311$SM00343:ZnF_C2HC, 760000323$SM00355:ZnF_C2H2]
growth factor independent 1 transcription repressor,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
growth factor independent 1 transcription repressor,UP_SEQ_FEATURE[850102016$chain:Zinc finger protein Gfi-1, 850102390$compositionally biased region:Ala/Gly-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),INTERPRO[450000561$IPR000654:G-protein alpha subunit, group Q, 450000892$IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit, 450002582$IPR002928:Myosin tail, 450014086$IPR015650:Heavy chain of Myosin]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038845$hsa04270:Vascular smooth muscle contraction, 470038858$hsa04540:Gap junction, 470038878$hsa04730:Long-term depression, 470038883$hsa04912:GnRH signaling pathway]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),PIR_SUPERFAMILY[630002519$PIRSF002400:GTP-binding regulatory protein Gs alpha chain]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),SP_PIR_KEYWORDS[790000028$ADP-ribosylation, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000637$GTP binding, 790000639$gtp-binding, 790000687$heterotrimer, 790000986$motor protein, 790000997$muscle protein, 790001002$myosin, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001407$signal transduction, 790001504$thick filament, 790001546$transducer]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),UP_SEQ_FEATURE[850022748$chain:Guanine nucleotide-binding protein subunit alpha-11, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict]
guanine nucleotide binding protein (G protein), alpha 14,INTERPRO[450000561$IPR000654:G-protein alpha subunit, group Q, 450000892$IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit]
guanine nucleotide binding protein (G protein), alpha 14,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
guanine nucleotide binding protein (G protein), alpha 14,PIR_SUPERFAMILY[630002519$PIRSF002400:GTP-binding regulatory protein Gs alpha chain]
guanine nucleotide binding protein (G protein), alpha 14,SP_PIR_KEYWORDS[790000028$ADP-ribosylation, 790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001546$transducer]
guanine nucleotide binding protein (G protein), alpha 14,UP_SEQ_FEATURE[850022751$chain:Guanine nucleotide-binding protein subunit alpha-14, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP]
guanine nucleotide binding protein (G protein), alpha z polypeptide,INTERPRO[450000892$IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit, 450001254$IPR001408:G-protein alpha subunit, group I]
guanine nucleotide binding protein (G protein), alpha z polypeptide,KEGG_PATHWAY[470038878$hsa04730:Long-term depression]
guanine nucleotide binding protein (G protein), alpha z polypeptide,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
guanine nucleotide binding protein (G protein), alpha z polypeptide,PIR_SUPERFAMILY[630002519$PIRSF002400:GTP-binding regulatory protein Gs alpha chain]
guanine nucleotide binding protein (G protein), alpha z polypeptide,SP_PIR_KEYWORDS[790000028$ADP-ribosylation, 790000189$blocked amino end, 790000356$complete proteome, 790000637$GTP binding, 790000639$gtp-binding, 790000687$heterotrimer, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001100$palmitate, 790001407$signal transduction, 790001511$thiolester bond, 790001546$transducer]
guanine nucleotide binding protein (G protein), alpha z polypeptide,UP_SEQ_FEATURE[850022744$chain:Guanine nucleotide-binding protein G(z) subunit alpha, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict]
guanine nucleotide binding protein (G protein), beta 5,INTERPRO[450001445$IPR001632:G-protein, beta subunit, 450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450014669$IPR016346:Guanine nucleotide-binding protein, beta subunit, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
guanine nucleotide binding protein (G protein), beta 5,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway]
guanine nucleotide binding protein (G protein), beta 5,PIR_SUPERFAMILY[630002511$PIRSF002394:GN-bd_beta, 630002512$PIRSF002394:guanine nucleotide-binding protein, beta subunit]
guanine nucleotide binding protein (G protein), beta 5,SMART[760000289$SM00320:WD40]
guanine nucleotide binding protein (G protein), beta 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001546$transducer, 790001638$wd repeat]
guanine nucleotide binding protein (G protein), beta 5,UP_SEQ_FEATURE[850022760$chain:Guanine nucleotide-binding protein subunit beta-5, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117295$sequence variant, 850118574$splice variant]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,INTERPRO[450001568$IPR001770:G-protein, gamma subunit, 450014319$IPR015898:G-protein, gamma-like subunit]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,PIR_SUPERFAMILY[630002518$PIRSF002398:GTP-binding regulatory protein gamma chain]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,SMART[760000196$SM00224:GGL]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790001212$polymorphism, 790001236$prenylation, 790001546$transducer]
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2,UP_SEQ_FEATURE[850022727$chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2, 850105890$lipid moiety-binding region:S-farnesyl cysteine, 850109701$propeptide:Removed in mature form, 850117295$sequence variant]
guanine nucleotide binding protein-like 3 (nucleolar)-like,INTERPRO[450002575$IPR002917:GTP-binding protein, HSR1-related, 450005508$IPR006073:GTP1/OBG]
guanine nucleotide binding protein-like 3 (nucleolar)-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001331$ribosome biogenesis]
guanine nucleotide binding protein-like 3 (nucleolar)-like,UP_SEQ_FEATURE[850022769$chain:Guanine nucleotide-binding protein-like 3-like protein, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850114444$region of interest:Required for nucleolar localization, 850117295$sequence variant]
guanylate cyclase 2C (heat stable enterotoxin receptor),INTERPRO[450000618$IPR000719:Protein kinase, core, 450000923$IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase, 450001096$IPR001245:Tyrosine protein kinase, 450001618$IPR001828:Extracellular ligand-binding receptor, 450016581$IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site]
guanylate cyclase 2C (heat stable enterotoxin receptor),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
guanylate cyclase 2C (heat stable enterotoxin receptor),PIR_SUPERFAMILY[630001613$PIRSF001451:membrane-bound guanylate cyclase]
guanylate cyclase 2C (heat stable enterotoxin receptor),SMART[760000036$SM00044:CYCc, 760000192$SM00219:TyrKc]
guanylate cyclase 2C (heat stable enterotoxin receptor),SP_PIR_KEYWORDS[790000134$ATP, 790000237$carbon-oxygen lyase, 790000285$cgmp biosynthesis, 790000356$complete proteome, 790000616$glycoprotein, 790000639$gtp-binding, 790000648$heat-stable protein, 790000709$hormone receptor, 790000891$lyase, 790000919$membrane, 790001063$nucleotide-binding, 790001167$phosphorus-oxygen lyase, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
guanylate cyclase 2C (heat stable enterotoxin receptor),UP_SEQ_FEATURE[850023203$chain:Heat-stable enterotoxin receptor, 850104090$domain:Guanylate cyclase, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
haloacid dehalogenase-like hydrolase domain containing 3,COG_ONTOLOGY[90000073$General function prediction only]
haloacid dehalogenase-like hydrolase domain containing 3,INTERPRO[450005280$IPR005833:Haloacid dehydrogenase/epoxide hydrolase, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005861$IPR006439:HAD-superfamily hydrolase, subfamily IA, variant 1, 450010774$IPR011949:HAD-superfamily hydrolase, subfamily IA, REG-2-like]
haloacid dehalogenase-like hydrolase domain containing 3,PIR_SUPERFAMILY[630001034$PIRSF000895:phosphoglycolate phosphatase]
haloacid dehalogenase-like hydrolase domain containing 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790001212$polymorphism]
haloacid dehalogenase-like hydrolase domain containing 3,UP_SEQ_FEATURE[850022919$chain:Haloacid dehalogenase-like hydrolase domain-containing protein 3, 850106258$modified residue, 850117295$sequence variant]
harbinger transposase derived 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790001049$nuclease, 790001065$nucleus]
harbinger transposase derived 1,UP_SEQ_FEATURE[850052941$chain:Putative nuclease HARBI1, 850105986$metal ion-binding site:Divalent metal cation]
heart and neural crest derivatives expressed 1,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart)]
heart and neural crest derivatives expressed 1,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
heart and neural crest derivatives expressed 1,SMART[760000321$SM00353:HLH]
heart and neural crest derivatives expressed 1,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
heart and neural crest derivatives expressed 1,UP_SEQ_FEATURE[850023020$chain:Heart- and neural crest derivatives- expressed protein 1, 850102565$compositionally biased region:Poly-Ala, 850102574$compositionally biased region:Poly-His, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850106258$modified residue]
heat shock 60kDa protein 1 (chaperonin) pseudogene 5; heat shock 60kDa protein 1 (chaperonin) pseudogene 6; heat shock 60kDa protein 1 (chaperonin) pseudogene 1; heat shock 60kDa protein 1 (chaperonin) pseudogene 4; heat shock 60kDa protein 1 (chaperonin),INTERPRO[450001630$IPR001844:Chaperonin Cpn60, 450002152$IPR002423:Chaperonin Cpn60/TCP-1, 450016306$IPR017998:Chaperone, tailless complex polypeptide 1, 450016653$IPR018370:Chaperonin Cpn60, conserved site]
heat shock 60kDa protein 1 (chaperonin) pseudogene 5; heat shock 60kDa protein 1 (chaperonin) pseudogene 6; heat shock 60kDa protein 1 (chaperonin) pseudogene 1; heat shock 60kDa protein 1 (chaperonin) pseudogene 4; heat shock 60kDa protein 1 (chaperonin),KEGG_PATHWAY[470038814$hsa03018:RNA degradation, 470038888$hsa04940:Type I diabetes mellitus]
heat shock 60kDa protein 1 (chaperonin) pseudogene 5; heat shock 60kDa protein 1 (chaperonin) pseudogene 6; heat shock 60kDa protein 1 (chaperonin) pseudogene 1; heat shock 60kDa protein 1 (chaperonin) pseudogene 4; heat shock 60kDa protein 1 (chaperonin),OMIM_DISEASE[520002881$Leukodystrophy, hypomyelinating, 4, 520002882$Leukodystrophy, hypomyelinating, autosomal recessive, 520004553$Spastic paraplegia-13]
heat shock 60kDa protein 1 (chaperonin) pseudogene 5; heat shock 60kDa protein 1 (chaperonin) pseudogene 6; heat shock 60kDa protein 1 (chaperonin) pseudogene 1; heat shock 60kDa protein 1 (chaperonin) pseudogene 4; heat shock 60kDa protein 1 (chaperonin),PIR_SUPERFAMILY[630003207$PIRSF003112:chaperonin GroEL]
heat shock 60kDa protein 1 (chaperonin) pseudogene 5; heat shock 60kDa protein 1 (chaperonin) pseudogene 6; heat shock 60kDa protein 1 (chaperonin) pseudogene 1; heat shock 60kDa protein 1 (chaperonin) pseudogene 4; heat shock 60kDa protein 1 (chaperonin),SP_PIR_KEYWORDS[790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000647$heat shock, 790000675$hereditary spastic paraplegia, 790000733$host-virus interaction, 790000856$leukodystrophy, 790000969$mitochondrion, 790000976$molecular chaperone, 790001015$neurodegeneration, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001450$stress response, 790001451$stress-induced protein, 790001550$transit peptide]
heat shock 60kDa protein 1 (chaperonin) pseudogene 5; heat shock 60kDa protein 1 (chaperonin) pseudogene 6; heat shock 60kDa protein 1 (chaperonin) pseudogene 1; heat shock 60kDa protein 1 (chaperonin) pseudogene 4; heat shock 60kDa protein 1 (chaperonin),UP_SEQ_FEATURE[850002543$chain:60 kDa heat shock protein, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
heat shock transcription factor 2,INTERPRO[450000200$IPR000232:Heat shock factor (HSF)-type, DNA-binding, 450009595$IPR010542:Vertebrate heat shock transcription factor, 450010816$IPR011991:Winged helix repressor DNA-binding]
heat shock transcription factor 2,PIR_SUPERFAMILY[630002705$PIRSF002591:heat shock transcription factor]
heat shock transcription factor 2,SMART[760000362$SM00415:HSF]
heat shock transcription factor 2,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001450$stress response, 790001539$Transcription, 790001543$transcription regulation]
heat shock transcription factor 2,UP_SEQ_FEATURE[850023071$chain:Heat shock factor protein 2, 850102570$compositionally biased region:Poly-Gln, 850106259$mutagenesis site, 850111929$region of interest:Hydrophobic repeat HR-A/B, 850111930$region of interest:Hydrophobic repeat HR-C, 850117610$short sequence motif:Nuclear localization signal]
heat shock transcription factor family member 5,INTERPRO[450000200$IPR000232:Heat shock factor (HSF)-type, DNA-binding, 450010816$IPR011991:Winged helix repressor DNA-binding]
heat shock transcription factor family member 5,SMART[760000362$SM00415:HSF]
heat shock transcription factor family member 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
heat shock transcription factor family member 5,UP_SEQ_FEATURE[850023074$chain:Heat shock factor protein 5, 850117295$sequence variant, 850118574$splice variant]
hect domain and RLD 5,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
hect domain and RLD 5,INTERPRO[450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450000485$IPR000569:HECT, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II]
hect domain and RLD 5,PIR_SUPERFAMILY[630029192$PIRSF037625:HERC protein]
hect domain and RLD 5,SMART[760000104$SM00119:HECTc]
hect domain and RLD 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
hect domain and RLD 5,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850041856$chain:Probable E3 ubiquitin-protein ligase HERC5, 850104105$domain:HECT, 850116898$repeat:RCC1 1, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850117295$sequence variant]
hect domain and RLD 6,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
hect domain and RLD 6,INTERPRO[450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450000485$IPR000569:HECT, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II]
hect domain and RLD 6,PIR_SUPERFAMILY[630029192$PIRSF037625:HERC protein]
hect domain and RLD 6,SMART[760000104$SM00119:HECTc]
hect domain and RLD 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
hect domain and RLD 6,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850041857$chain:Probable E3 ubiquitin-protein ligase HERC6, 850104105$domain:HECT, 850116898$repeat:RCC1 1, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
helicase-like transcription factor,INTERPRO[450000283$IPR000330:SNF2-related, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450001628$IPR001841:Zinc finger, RING-type, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450013354$IPR014905:HIP116, Rad5p N-terminal, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
helicase-like transcription factor,SMART[760000158$SM00184:RING, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
helicase-like transcription factor,SP_PIR_KEYWORDS[790000020$activator, 790000050$alternative initiation, 790000138$atp-binding, 790000311$chromatin regulator, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790000859$ligase, 790000937$metal-binding, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
helicase-like transcription factor,UP_SEQ_FEATURE[850023221$chain:Helicase-like transcription factor, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850112855$region of interest:Interaction with SP1 and SP3, 850117294$sequence conflict, 850117295$sequence variant, 850117399$short sequence motif:DEGH box, 850118574$splice variant, 850118911$zinc finger region:RING-type]
heme oxygenase (decycling) 2,INTERPRO[450001817$IPR002051:Haem oxygenase, 450014438$IPR016053:Haem oxygenase-like, 450014457$IPR016084:Haem oxygenase-like, multi-helical, 450016494$IPR018207:Haem oxygenase conserved site]
heme oxygenase (decycling) 2,KEGG_PATHWAY[470038802$hsa00860:Porphyrin and chlorophyll metabolism]
heme oxygenase (decycling) 2,PIR_SUPERFAMILY[630000402$PIRSF000343:Haem_Oase, 630000403$PIRSF000343:heme oxygenase (decyclizing)]
heme oxygenase (decycling) 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000937$metal-binding, 790000959$microsome, 790001092$oxidoreductase, 790001212$polymorphism, 790001304$repeat]
heme oxygenase (decycling) 2,UP_SEQ_FEATURE[850023270$chain:Heme oxygenase 2, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850116198$repeat:HRM 1, 850116199$repeat:HRM 2, 850117294$sequence conflict, 850117295$sequence variant, 850118624$turn]
hemoglobin, zeta,INTERPRO[450000843$IPR000971:Globin, subset, 450002081$IPR002338:Haemoglobin, alpha, 450002083$IPR002340:Haemoglobin, zeta, 450011002$IPR012292:Globin]
hemoglobin, zeta,PIR_SUPERFAMILY[630027980$PIRSF036518:globin, 630030321$PIRSF500045:hemoglobin, vertebrate type]
hemoglobin, zeta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000191$blood, 790000314$chromoprotein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000492$embryo, 790000512$erythrocyte, 790000652$heme, 790000686$heterotetramer, 790000802$iron, 790000937$metal-binding, 790000943$metalloprotein, 790001094$oxygen carrier, 790001095$oxygen transport, 790001558$transport]
hemoglobin, zeta,UP_SEQ_FEATURE[850023409$chain:Hemoglobin subunit zeta, 850105852$helix, 850106039$metal ion-binding site:Iron (heme distal ligand), 850106041$metal ion-binding site:Iron (heme proximal ligand), 850106258$modified residue, 850118624$turn]
hepatocellular carcinoma-associated gene TD26,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
hepatocellular carcinoma-associated gene TD26,UP_SEQ_FEATURE[850023494$chain:Hepatocellular carcinoma-associated protein TD26, 850117295$sequence variant, 850117814$signal peptide]
hepatoma-derived growth factor-related protein 2,INTERPRO[450000267$IPR000313:PWWP]
hepatoma-derived growth factor-related protein 2,SMART[760000264$SM00293:PWWP]
hepatoma-derived growth factor-related protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
hepatoma-derived growth factor-related protein 2,UP_SEQ_FEATURE[850023521$chain:Hepatoma-derived growth factor-related protein 2, 850102404$compositionally biased region:Arg-rich, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850105126$domain:PWWP, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand, 850118624$turn]
heterogeneous nuclear ribonucleoprotein M,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
heterogeneous nuclear ribonucleoprotein M,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
heterogeneous nuclear ribonucleoprotein M,SMART[760000328$SM00360:RRM]
heterogeneous nuclear ribonucleoprotein M,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001433$Spliceosome, 790001592$ubl conjugation, 790001613$viral nucleoprotein]
heterogeneous nuclear ribonucleoprotein M,UP_SEQ_FEATURE[850023594$chain:Heterogeneous nuclear ribonucleoprotein M, 850102573$compositionally biased region:Poly-Gly, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850110163$region of interest:27 X 6 AA repeats of [GEVSTPAN]-[ILMV]- [DE]-[RH]-[MLVI]-[GAV], 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
heterogeneous nuclear ribonucleoprotein U-like 1,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450002665$IPR003034:DNA-binding SAP, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
heterogeneous nuclear ribonucleoprotein U-like 1,SMART[760000394$SM00449:SPRY, 760000456$SM00513:SAP]
heterogeneous nuclear ribonucleoprotein U-like 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation, 790001613$viral nucleoprotein]
heterogeneous nuclear ribonucleoprotein U-like 1,UP_SEQ_FEATURE[850023598$chain:Heterogeneous nuclear ribonucleoprotein U-like protein 1, 850102448$compositionally biased region:Asn-rich, 850102485$compositionally biased region:Gln-rich, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102608$compositionally biased region:Tyr-rich, 850103078$domain:B30.2/SPRY, 850105257$domain:SAP, 850106258$modified residue, 850110480$region of interest:5 X 3 AA repeats of R-G-G, 850113596$region of interest:Necessary for interaction with BRD7 and transcriptional activation, 850113613$region of interest:Necessary for interaction with HRMT1L1, 850113654$region of interest:Necessary for interaction with TP53, 850113713$region of interest:Necessary for transcription repression, 850115075$repeat:1-1, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115116$repeat:1-5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hexosaminidase B (beta polypeptide),INTERPRO[450001369$IPR001540:Glycoside hydrolase, family 20, 450012395$IPR013781:Glycoside hydrolase, subgroup, catalytic core, 450014305$IPR015882:Beta-N-acetylhexosaminidase-like, 450014306$IPR015883:Glycoside hydrolase, family 20, catalytic core]
hexosaminidase B (beta polypeptide),KEGG_PATHWAY[470038767$hsa00511:Other glycan degradation, 470038770$hsa00520:Amino sugar and nucleotide sugar metabolism, 470038771$hsa00531:Glycosaminoglycan degradation, 470038785$hsa00603:Glycosphingolipid biosynthesis, 470038786$hsa00604:Glycosphingolipid biosynthesis, 470038840$hsa04142:Lysosome]
hexosaminidase B (beta polypeptide),OMIM_DISEASE[520004370$Sandhoff disease, infantile, juvenile, and adult forms, 520004597$Spinal muscular atrophy, juvenile]
hexosaminidase B (beta polypeptide),PIR_SUPERFAMILY[630001241$PIRSF001093:beta-hexosaminidase, eukaryotic type]
hexosaminidase B (beta polypeptide),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000580$gangliosidosis, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790000897$lysosome, 790001212$polymorphism, 790001405$signal, 790001652$zymogen]
hexosaminidase B (beta polypeptide),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850007799$chain:Beta-hexosaminidase subunit beta, 850007800$chain:Beta-hexosaminidase subunit beta chain A, 850007801$chain:Beta-hexosaminidase subunit beta chain B, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
high-mobility group 20A,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2, 450016275$IPR017967:HMG box A DNA-binding domain, conserved site]
high-mobility group 20A,SMART[760000349$SM00398:HMG]
high-mobility group 20A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
high-mobility group 20A,UP_SEQ_FEATURE[850023695$chain:High mobility group protein 20A, 850102920$DNA-binding region:HMG box, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
hippocalcin,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
hippocalcin,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
hippocalcin,PIR_SUPERFAMILY[630002469$PIRSF002350:calmodulin]
hippocalcin,SMART[760000046$SM00054:EFh]
hippocalcin,SP_PIR_KEYWORDS[790000189$blocked amino end, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000480$EF hand, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001212$polymorphism, 790001304$repeat]
hippocalcin,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850034017$chain:Neuron-specific calcium-binding protein hippocalcin, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117294$sequence conflict, 850117295$sequence variant]
hippocalcin like 4,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
hippocalcin like 4,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
hippocalcin like 4,SMART[760000046$SM00054:EFh]
hippocalcin like 4,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000881$lipoprotein, 790001004$myristate, 790001304$repeat]
hippocalcin like 4,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850023766$chain:Hippocalcin-like protein 4, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117294$sequence conflict]
hippocalcin-like 1,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
hippocalcin-like 1,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
hippocalcin-like 1,PIR_SUPERFAMILY[630002469$PIRSF002350:calmodulin]
hippocalcin-like 1,SMART[760000046$SM00054:EFh]
hippocalcin-like 1,SP_PIR_KEYWORDS[790000189$blocked amino end, 790000211$calcium, 790000356$complete proteome, 790000480$EF hand, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001304$repeat]
hippocalcin-like 1,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850023765$chain:Hippocalcin-like protein 1, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117294$sequence conflict]
hippocampus abundant transcript-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
hippocampus abundant transcript-like 1,UP_SEQ_FEATURE[850023768$chain:Hippocampus abundant transcript-like protein 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
histidine triad nucleotide binding protein 3,INTERPRO[450001154$IPR001310:Histidine triad (HIT) protein, 450010083$IPR011151:Histidine triad motif, 450018040$IPR019808:Histidine triad, conserved site]
histidine triad nucleotide binding protein 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001212$polymorphism]
histidine triad nucleotide binding protein 3,UP_SEQ_FEATURE[850023820$chain:Histidine triad nucleotide-binding protein 3, 850104135$domain:HIT, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117487$short sequence motif:Histidine triad motif]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),INTERPRO[450002058$IPR002314:Aminoacyl-tRNA synthetase, class II (G, H, P and S), conserved region, 450003274$IPR003732:D-tyrosyl-tRNA(Tyr) deacylase, 450003665$IPR004154:Anticodon-binding, 450004009$IPR004516:Histidyl-tRNA synthetase, class IIa, 450005622$IPR006195:Aminoacyl-tRNA synthetase, class II, conserved region, 450014238$IPR015807:Histidyl-tRNA synthetase, class IIa, subgroup]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),KEGG_PATHWAY[470038807$hsa00970:Aminoacyl-tRNA biosynthesis]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),PIR_SUPERFAMILY[630001717$PIRSF001549:His-tRNA_synth, 630001718$PIRSF001549:histidyl-tRNA synthetase]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000066$Aminoacyl-tRNA synthetase, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000859$ligase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001550$transit peptide]
histidyl-tRNA synthetase 2, mitochondrial (putative); D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850014256$chain:D-tyrosyl-tRNA(Tyr) deacylase 1, 850042305$chain:Probable histidyl-tRNA synthetase, mitochondrial, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118617$transit peptide:Mitochondrion]
histone acetyltransferase 1,INTERPRO[450014522$IPR016181:Acyl-CoA N-acyltransferase, 450015706$IPR017380:Histone acetyltransferase type B, catalytic subunit, 450017705$IPR019467:Histone acetyl transferase HAT1 N-terminal]
histone acetyltransferase 1,PIR_SUPERFAMILY[630029667$PIRSF038084:HAT-B_cat, 630029668$PIRSF038084:histone acetyltransferase type B, catalytic subunit]
histone acetyltransferase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000025$Acyltransferase, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
histone acetyltransferase 1,UP_SEQ_FEATURE[850023877$chain:Histone acetyltransferase type B catalytic subunit, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
histone cluster 1, H1c,INTERPRO[450005266$IPR005818:Histone H1/H5, 450005267$IPR005819:Histone H5, 450010816$IPR011991:Winged helix repressor DNA-binding]
histone cluster 1, H1c,PIR_SUPERFAMILY[630029831$PIRSF038219:histone H1]
histone cluster 1, H1c,SMART[760000466$SM00526:H15]
histone cluster 1, H1c,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000315$chromosomal protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000811$isopeptide bond, 790000953$methylation, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
histone cluster 1, H1c,UP_SEQ_FEATURE[850023953$chain:Histone H1.2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117295$sequence variant]
histone cluster 1, H1t,INTERPRO[450005266$IPR005818:Histone H1/H5, 450005267$IPR005819:Histone H5, 450010816$IPR011991:Winged helix repressor DNA-binding]
histone cluster 1, H1t,PIR_SUPERFAMILY[630029831$PIRSF038219:histone H1]
histone cluster 1, H1t,SMART[760000466$SM00526:H15]
histone cluster 1, H1t,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000315$chromosomal protein, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001426$spermatogenesis]
histone cluster 1, H1t,UP_SEQ_FEATURE[850023965$chain:Histone H1t, 850106258$modified residue, 850111754$region of interest:Globular, 850117295$sequence variant]
histone cluster 1, H2ag; histone cluster 1, H2ah; histone cluster 1, H2ai; histone cluster 1, H2ak; histone cluster 1, H2al; histone cluster 1, H2am,INTERPRO[450001877$IPR002119:Histone H2A, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
histone cluster 1, H2ag; histone cluster 1, H2ah; histone cluster 1, H2ai; histone cluster 1, H2ak; histone cluster 1, H2al; histone cluster 1, H2am,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone cluster 1, H2ag; histone cluster 1, H2ah; histone cluster 1, H2ai; histone cluster 1, H2ak; histone cluster 1, H2al; histone cluster 1, H2am,PIR_SUPERFAMILY[630002183$PIRSF002048:histone H2A]
histone cluster 1, H2ag; histone cluster 1, H2ah; histone cluster 1, H2ai; histone cluster 1, H2ak; histone cluster 1, H2al; histone cluster 1, H2am,SMART[760000361$SM00414:H2A]
histone cluster 1, H2ag; histone cluster 1, H2ah; histone cluster 1, H2ai; histone cluster 1, H2ak; histone cluster 1, H2al; histone cluster 1, H2am,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000315$chromosomal protein, 790000326$citrullination, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
histone cluster 1, H2ag; histone cluster 1, H2ah; histone cluster 1, H2ai; histone cluster 1, H2ak; histone cluster 1, H2al; histone cluster 1, H2am,UP_SEQ_FEATURE[850023969$chain:Histone H2A type 1, 850023976$chain:Histone H2A type 1-H, 850023977$chain:Histone H2A type 1-J, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850106259$mutagenesis site]
histone cluster 1, H2bk,INTERPRO[450000478$IPR000558:Histone H2B, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
histone cluster 1, H2bk,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone cluster 1, H2bk,PIR_SUPERFAMILY[630002184$PIRSF002050:histone H2B]
histone cluster 1, H2bk,SMART[760000373$SM00427:H2B]
histone cluster 1, H2bk,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000092$antibiotic, 790000100$Antimicrobial, 790000315$chromosomal protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
histone cluster 1, H2bk,UP_SEQ_FEATURE[850024027$chain:Histone H2B type 1-K, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105852$helix, 850106258$modified residue, 850118575$strand]
histone cluster 1, H4l; histone cluster 1, H4k; histone cluster 4, H4; histone cluster 1, H4h; histone cluster 1, H4j; histone cluster 1, H4i; histone cluster 1, H4d; histone cluster 1, H4c; histone cluster 1, H4f; histone cluster 1, H4e; histone cluster 1, H4b; histone cluster 1, H4a; histone cluster 2, H4a; histone cluster 2, H4b,INTERPRO[450001727$IPR001951:Histone H4, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold, 450018041$IPR019809:Histone H4, conserved site]
histone cluster 1, H4l; histone cluster 1, H4k; histone cluster 4, H4; histone cluster 1, H4h; histone cluster 1, H4j; histone cluster 1, H4i; histone cluster 1, H4d; histone cluster 1, H4c; histone cluster 1, H4f; histone cluster 1, H4e; histone cluster 1, H4b; histone cluster 1, H4a; histone cluster 2, H4a; histone cluster 2, H4b,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone cluster 1, H4l; histone cluster 1, H4k; histone cluster 4, H4; histone cluster 1, H4h; histone cluster 1, H4j; histone cluster 1, H4i; histone cluster 1, H4d; histone cluster 1, H4c; histone cluster 1, H4f; histone cluster 1, H4e; histone cluster 1, H4b; histone cluster 1, H4a; histone cluster 2, H4a; histone cluster 2, H4b,PIR_SUPERFAMILY[630002186$PIRSF002052:histone H4]
histone cluster 1, H4l; histone cluster 1, H4k; histone cluster 4, H4; histone cluster 1, H4h; histone cluster 1, H4j; histone cluster 1, H4i; histone cluster 1, H4d; histone cluster 1, H4c; histone cluster 1, H4f; histone cluster 1, H4e; histone cluster 1, H4b; histone cluster 1, H4a; histone cluster 2, H4a; histone cluster 2, H4b,SMART[760000363$SM00417:H4]
histone cluster 1, H4l; histone cluster 1, H4k; histone cluster 4, H4; histone cluster 1, H4h; histone cluster 1, H4j; histone cluster 1, H4i; histone cluster 1, H4d; histone cluster 1, H4c; histone cluster 1, H4f; histone cluster 1, H4e; histone cluster 1, H4b; histone cluster 1, H4a; histone cluster 2, H4a; histone cluster 2, H4b,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000015$acetyllysine, 790000315$chromosomal protein, 790000326$citrullination, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790000950$methylated amino acid, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
histone cluster 1, H4l; histone cluster 1, H4k; histone cluster 4, H4; histone cluster 1, H4h; histone cluster 1, H4j; histone cluster 1, H4i; histone cluster 1, H4d; histone cluster 1, H4c; histone cluster 1, H4f; histone cluster 1, H4e; histone cluster 1, H4b; histone cluster 1, H4a; histone cluster 2, H4a; histone cluster 2, H4b,UP_SEQ_FEATURE[850024099$chain:Histone H4, 850102721$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
histone deacetylase 11,INTERPRO[450000246$IPR000286:Histone deacetylase superfamily]
histone deacetylase 11,SP_PIR_KEYWORDS[790000311$chromatin regulator, 790000356$complete proteome, 790000743$hydrolase, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
histone deacetylase 11,UP_SEQ_FEATURE[850023890$chain:Histone deacetylase 11, 850111894$region of interest:Histone deacetylase, 850117294$sequence conflict]
histone deacetylase 3,BIOCARTA[30000254$h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells, 30000259$h_RELAPathway:Acetylation and Deacetylation of RelA in The Nucleus]
histone deacetylase 3,COG_ONTOLOGY[90000044$Chromatin structure and dynamics / Secondary metabolites biosynthesis, transport, and catabolism]
histone deacetylase 3,INTERPRO[450000246$IPR000286:Histone deacetylase superfamily, 450002710$IPR003084:Histone deacetylase]
histone deacetylase 3,PIR_SUPERFAMILY[630029485$PIRSF037913:histone deacetylase class I, eukaryotic type, 630029486$PIRSF037913:His_deacetylse_1]
histone deacetylase 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000743$hydrolase, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
histone deacetylase 3,UP_SEQ_FEATURE[850023897$chain:Histone deacetylase 3, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850111894$region of interest:Histone deacetylase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
histone deacetylase 8,COG_ONTOLOGY[90000044$Chromatin structure and dynamics / Secondary metabolites biosynthesis, transport, and catabolism]
histone deacetylase 8,INTERPRO[450000246$IPR000286:Histone deacetylase superfamily, 450002710$IPR003084:Histone deacetylase]
histone deacetylase 8,PIR_SUPERFAMILY[630029485$PIRSF037913:histone deacetylase class I, eukaryotic type, 630029486$PIRSF037913:His_deacetylse_1]
histone deacetylase 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
histone deacetylase 8,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850000576$binding site:Substrate; via carbonyl oxygen, 850023902$chain:Histone deacetylase 8, 850105852$helix, 850105986$metal ion-binding site:Divalent metal cation, 850106258$modified residue, 850106259$mutagenesis site, 850111894$region of interest:Histone deacetylase, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
histone deacetylase 9,BIOCARTA[30000189$h_MITRPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR, 30000249$h_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression]
histone deacetylase 9,COG_ONTOLOGY[90000044$Chromatin structure and dynamics / Secondary metabolites biosynthesis, transport, and catabolism]
histone deacetylase 9,INTERPRO[450000246$IPR000286:Histone deacetylase superfamily, 450015644$IPR017320:Histone deacetylase class II, eukaryotic]
histone deacetylase 9,PIR_SUPERFAMILY[630029483$PIRSF037911:HDAC_II_euk, 630029484$PIRSF037911:histone deacetylase class II, eukaryotic type]
histone deacetylase 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
histone deacetylase 9,UP_SEQ_FEATURE[850023903$chain:Histone deacetylase 9, 850106258$modified residue, 850111894$region of interest:Histone deacetylase, 850112225$region of interest:Interaction with CTBP1, 850112309$region of interest:Interaction with ETV6, 850112512$region of interest:Interaction with MAPK10, 850112530$region of interest:Interaction with mef2, 850117294$sequence conflict, 850118574$splice variant]
homeobox A13,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
homeobox A13,OMIM_DISEASE[520002203$Guttmacher syndrome, 520002212$Hand-foot-uterus syndrome]
homeobox A13,SMART[760000341$SM00389:HOX]
homeobox A13,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000446$disease mutation, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
homeobox A13,UP_SEQ_FEATURE[850024498$chain:Homeobox protein Hox-A13, 850102565$compositionally biased region:Poly-Ala, 850102927$DNA-binding region:Homeobox, 850117294$sequence conflict, 850117295$sequence variant]
homeobox A9,INTERPRO[450001200$IPR001356:Homeobox, 450006120$IPR006711:Hox9 activation region, 450010997$IPR012287:Homeodomain-related, 450015432$IPR017112:Homeobox, Hox9, 450016278$IPR017970:Homeobox, conserved site]
homeobox A9,PIR_SUPERFAMILY[630028615$PIRSF037109:homeobox protein, Hox9 type, 630028616$PIRSF037109:Homeobox_Hox9]
homeobox A9,SMART[760000341$SM00389:HOX]
homeobox A9,SP_PIR_KEYWORDS[790000316$chromosomal rearrangement, 790000356$complete proteome, 790000428$developmental protein, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001271$Proto-oncogene, 790001539$Transcription, 790001543$transcription regulation]
homeobox A9,UP_SEQ_FEATURE[850024512$chain:Homeobox protein Hox-A9, 850102927$DNA-binding region:Homeobox, 850117294$sequence conflict, 850117907$site:Breakpoint for translocation to form MSI2/HOXA9 fusion protein]
homeobox B13,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
homeobox B13,SMART[760000341$SM00389:HOX]
homeobox B13,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
homeobox B13,UP_SEQ_FEATURE[850024517$chain:Homeobox protein Hox-B13, 850102927$DNA-binding region:Homeobox, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118624$turn]
homeodomain interacting protein kinase 4,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
homeodomain interacting protein kinase 4,SMART[760000193$SM00220:S_TKc]
homeodomain interacting protein kinase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
homeodomain interacting protein kinase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850024781$chain:Homeodomain-interacting protein kinase 4, 850105086$domain:Protein kinase, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hook homolog 2 (Drosophila),INTERPRO[450007894$IPR008636:HOOK]
hook homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
hook homolog 2 (Drosophila),UP_SEQ_FEATURE[850046430$chain:Protein Hook homolog 2, 850106258$modified residue, 850114416$region of interest:Required for localization to the centrosome and induction of aggresome formation, 850114747$region of interest:Sufficient for interaction with CEP110, 850114780$region of interest:Sufficient for interaction with microtubules, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
huntingtin,BIOCARTA[30000143$h_HuntingtonPathway:Inhibition of Huntington's disease neurodegeneration by histone deacetylase inhibitors]
huntingtin,INTERPRO[450000076$IPR000091:Huntingtin, 450000307$IPR000357:HEAT]
huntingtin,KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
huntingtin,OMIM_DISEASE[520002385$Huntington disease]
huntingtin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001569$triplet repeat expansion, 790001592$ubl conjugation]
huntingtin,UP_SEQ_FEATURE[850025092$chain:Huntingtin, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850117294$sequence conflict, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal, 850117999$site:Cleavage; by apopain]
hyaluronan synthase 3,INTERPRO[450001029$IPR001173:Glycosyl transferase, family 2]
hyaluronan synthase 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
hyaluronan synthase 3,UP_SEQ_FEATURE[850025122$chain:Hyaluronan synthase 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
hydrocephalus inducing homolog 2 (mouse); hydrocephalus inducing homolog (mouse),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
hydrocephalus inducing homolog 2 (mouse); hydrocephalus inducing homolog (mouse),UP_SEQ_FEATURE[850025150$chain:Hydrocephalus-inducing protein homolog, 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),INTERPRO[450001972$IPR002225:3-beta hydroxysteroid dehydrogenase/isomerase, 450002724$IPR003100:Argonaute and Dicer protein, PAZ, 450002783$IPR003165:Stem cell self-renewal protein Piwi, 450014426$IPR016040:NAD(P)-binding domain]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038847$hsa04320:Dorso-ventral axis formation]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),OMIM_DISEASE[520000990$Cholestasis, progressive familial intrahepatic 4]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),PIR_SUPERFAMILY[630028161$PIRSF036679:bifunctional 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase, 630029992$PIRSF038460:piwi protein]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000790$intrahepatic cholestasis, 790000915$meiosis, 790000919$membrane, 790000953$methylation, 790001006$nad, 790001077$oogenesis, 790001092$oxidoreductase, 790001212$polymorphism, 790001339$rna-binding, 790001342$rna-mediated gene silencing, 790001426$spermatogenesis, 790001444$steroidogenesis, 790001551$translation regulation, 790001555$transmembrane]
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7; piwi-like 2 (Drosophila),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850001374$chain:3 beta-hydroxysteroid dehydrogenase type 7, 850039216$chain:Piwi-like protein 2, 850104911$domain:PAZ, 850105001$domain:Piwi, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
hydroxyacid oxidase 2 (long chain),INTERPRO[450000227$IPR000262:FMN-dependent dehydrogenase, 450007554$IPR008259:FMN-dependent alpha-hydroxy acid dehydrogenase, active site, 450010916$IPR012133:Alpha-hydroxy acid dehydrogenase, FMN-dependent, 450012397$IPR013785:Aldolase-type TIM barrel, 450016247$IPR017934:FMN-dependent alpha-hydroxy acid dehydrogenase]
hydroxyacid oxidase 2 (long chain),KEGG_PATHWAY[470038788$hsa00630:Glyoxylate and dicarboxylate metabolism]
hydroxyacid oxidase 2 (long chain),PIR_SUPERFAMILY[630000160$PIRSF000138:Al-hdrx_acd_dh, 630000161$PIRSF000138:alpha-hydroxy acid dehydrogenase, FMN-dependent]
hydroxyacid oxidase 2 (long chain),SP_PIR_KEYWORDS[790000356$complete proteome, 790000559$Flavoprotein, 790000562$fmn, 790001092$oxidoreductase, 790001128$peroxisome, 790001212$polymorphism]
hydroxyacid oxidase 2 (long chain),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000355$binding site:FMN, 850000555$binding site:Substrate, 850025230$chain:Hydroxyacid oxidase 2, 850104008$domain:FMN hydroxy acid dehydrogenase, 850106292$nucleotide phosphate-binding region:FMN, 850117294$sequence conflict, 850117295$sequence variant, 850117578$short sequence motif:Microbody targeting signal]
hydroxyacylglutathione hydrolase,INTERPRO[450001128$IPR001279:Beta-lactamase-like, 450016104$IPR017782:Hydroxyacylglutathione hydrolase]
hydroxyacylglutathione hydrolase,KEGG_PATHWAY[470038787$hsa00620:Pyruvate metabolism]
hydroxyacylglutathione hydrolase,OMIM_DISEASE[520002160$Glyoxalase II deficiency]
hydroxyacylglutathione hydrolase,PIR_SUPERFAMILY[630005381$PIRSF005457:glyoxalase]
hydroxyacylglutathione hydrolase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000050$alternative initiation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790000969$mitochondrion, 790001550$transit peptide, 790001648$zinc]
hydroxyacylglutathione hydrolase,UP_SEQ_FEATURE[850025242$chain:Hydroxyacylglutathione hydrolase, mitochondrial, 850105852$helix, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850114713$region of interest:Substrate, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
hydroxyacylglutathione hydrolase-like,INTERPRO[450001128$IPR001279:Beta-lactamase-like]
hydroxyacylglutathione hydrolase-like,KEGG_PATHWAY[470038787$hsa00620:Pyruvate metabolism]
hydroxyacylglutathione hydrolase-like,PIR_SUPERFAMILY[630005381$PIRSF005457:glyoxalase]
hydroxyacylglutathione hydrolase-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790001648$zinc]
hydroxyacylglutathione hydrolase-like,UP_SEQ_FEATURE[850025243$chain:Hydroxyacylglutathione hydrolase-like protein, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850118574$splice variant]
hydroxysteroid (11-beta) dehydrogenase 1,BIOCARTA[30000311$h_vobesityPathway:Visceral Fat Deposits and the Metabolic Syndrome]
hydroxysteroid (11-beta) dehydrogenase 1,COG_ONTOLOGY[90000032$Cell envelope biogenesis, outer membrane]
hydroxysteroid (11-beta) dehydrogenase 1,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
hydroxysteroid (11-beta) dehydrogenase 1,KEGG_PATHWAY[470038739$hsa00140:Steroid hormone biosynthesis, 470038740$hsa00150:Androgen and estrogen metabolism, 470038890$hsa04960:Aldosterone-regulated sodium reabsorption]
hydroxysteroid (11-beta) dehydrogenase 1,OMIM_DISEASE[520001245$Cortisone reductase deficiency]
hydroxysteroid (11-beta) dehydrogenase 1,PIR_SUPERFAMILY[630000148$PIRSF000126:11beta-hydroxysteroid dehydrogenase]
hydroxysteroid (11-beta) dehydrogenase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000873$lipid metabolism, 790000919$membrane, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001409$Signal-anchor, 790001442$steroid metabolism, 790001555$transmembrane, 790001556$transmembrane protein]
hydroxysteroid (11-beta) dehydrogenase 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850012641$chain:Corticosteroid 11-beta-dehydrogenase isozyme 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
hydroxysteroid (11-beta) dehydrogenase 1-like,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
hydroxysteroid (11-beta) dehydrogenase 1-like,PIR_SUPERFAMILY[630000148$PIRSF000126:11beta-hydroxysteroid dehydrogenase]
hydroxysteroid (11-beta) dehydrogenase 1-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001363$Secreted, 790001405$signal]
hydroxysteroid (11-beta) dehydrogenase 1-like,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850025270$chain:Hydroxysteroid 11-beta-dehydrogenase 1- like protein, 850106307$nucleotide phosphate-binding region:NADP, 850117814$signal peptide, 850118574$splice variant]
hydroxysteroid (17-beta) dehydrogenase 4,BIOCARTA[30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)]
hydroxysteroid (17-beta) dehydrogenase 4,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450002256$IPR002539:MaoC-like dehydratase, 450002664$IPR003033:Sterol-binding, 450014426$IPR016040:NAD(P)-binding domain]
hydroxysteroid (17-beta) dehydrogenase 4,KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis]
hydroxysteroid (17-beta) dehydrogenase 4,OMIM_DISEASE[520001309$D-bifunctional protein deficiency]
hydroxysteroid (17-beta) dehydrogenase 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000446$disease mutation, 790000543$fatty acid metabolism, 790000810$Isomerase, 790000873$lipid metabolism, 790000891$lyase, 790001006$nad, 790001092$oxidoreductase, 790001128$peroxisome, 790001162$phosphoprotein, 790001212$polymorphism]
hydroxysteroid (17-beta) dehydrogenase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850000458$binding site:NAD; via amide nitrogen, 850000460$binding site:NAD; via carbonyl oxygen, 850000555$binding site:Substrate, 850037979$chain:Peroxisomal multifunctional enzyme type 2, 850105274$domain:SCP2, 850105852$helix, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850110296$region of interest:3-alpha,7-alpha,12-alpha-trihydroxy-5- beta-cholest-24-enoyl-CoA hydratase, 850110302$region of interest:3-hydroxyacyl-CoA dehydrogenase, 850117295$sequence variant, 850118575$strand, 850118624$turn]
hypermethylated in cancer 2,COG_ONTOLOGY[90000073$General function prediction only]
hypermethylated in cancer 2,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
hypermethylated in cancer 2,SMART[760000197$SM00225:BTB, 760000323$SM00355:ZnF_C2H2]
hypermethylated in cancer 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
hypermethylated in cancer 2,UP_SEQ_FEATURE[850025283$chain:Hypermethylated in cancer 2 protein, 850103177$domain:BTB, 850111044$region of interest:Binding to CtBP, 850117294$sequence conflict, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5]
hypothetical LOC100128770,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
hypothetical LOC100128770,UP_SEQ_FEATURE[850055425$chain:Putative uncharacterized protein FLJ46214, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
hypothetical LOC100129478; chromosome 4 open reading frame 46,SP_PIR_KEYWORDS[790000356$complete proteome]
hypothetical LOC100129478; chromosome 4 open reading frame 46,UP_SEQ_FEATURE[850074199$chain:Uncharacterized protein C4orf46]
hypothetical LOC100129500; apolipoprotein E,INTERPRO[450000063$IPR000074:Apolipoprotein A1/A4/E, 450011960$IPR013326:Apolipoprotein/apolipophorin]
hypothetical LOC100129500; apolipoprotein E,KEGG_PATHWAY[470038891$hsa05010:Alzheimer's disease]
hypothetical LOC100129500; apolipoprotein E,OMIM_DISEASE[520000051$A genome-wide association study for late-onset Alzheimer's disease using DNA pooling, 520000074$A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease, 520000251$Alzheimer disease-2, 520000743$Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease, 520001127$Common SNPs in HMGCR in Micronesians and Whites Associated With LDL-Cholesterol Levels Affect Alternative Splicing of Exon13, 520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520002445$Hyperlipoproteinemia, type III, 520002917$Lipoprotein glomerulopathy, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520002932$Loci Related to Metabolic-Syndrome Pathways Including LEPR, HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study, 520003007$Macular degeneration, age-related, 520003475$Myocardial infarction susceptibility, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004049$Polymorphisms of the HNF1A Gene Encoding Hepatocyte Nuclear Factor-1 Alpha are Associated with C-Reactive Protein, 520004415$Sea-blue histiocyte disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans, 520004528$Sorl1 as an Alzheimer's disease predisposition gene?]
hypothetical LOC100129500; apolipoprotein E,PIR_SUPERFAMILY[630002484$PIRSF002367:apolipoprotein A-I]
hypothetical LOC100129500; apolipoprotein E,SP_PIR_KEYWORDS[790000002$3d-structure, 790000056$alzheimer disease, 790000133$atherosclerosis, 790000320$chylomicron, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000473$duplication, 790000605$glycation, 790000616$glycoprotein, 790000643$hdl, 790000669$heparin-binding, 790000748$hyperlipidemia, 790000867$lipid binding, 790000875$lipid transport, 790000881$lipoprotein, 790001162$phosphoprotein, 790001191$plasma, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001403$sialoglycoprotein, 790001405$signal, 790001484$tandem repeat, 790001558$transport, 790001630$vldl]
hypothetical LOC100129500; apolipoprotein E,UP_SEQ_FEATURE[850005819$chain:Apolipoprotein E, 850105762$glycosylation site:N-linked (Glc) (glycation), 850105822$glycosylation site:O-linked (GalNAc...), 850105852$helix, 850106258$modified residue, 850110703$region of interest:8 X 22 AA approximate tandem repeats, 850111863$region of interest:Heparin-binding, 850113257$region of interest:LDL receptor binding, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
hypothetical LOC100129773; ralA binding protein 1,BIOCARTA[30000246$h_rac1Pathway:Rac 1 cell motility signaling pathway, 30000255$h_rasPathway:Ras Signaling Pathway]
hypothetical LOC100129773; ralA binding protein 1,INTERPRO[450000169$IPR000198:RhoGAP]
hypothetical LOC100129773; ralA binding protein 1,KEGG_PATHWAY[470038899$hsa05200:Pathways in cancer, 470038902$hsa05212:Pancreatic cancer]
hypothetical LOC100129773; ralA binding protein 1,SMART[760000293$SM00324:RhoGAP]
hypothetical LOC100129773; ralA binding protein 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000640$GTPase activation, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001558$transport]
hypothetical LOC100129773; ralA binding protein 1,UP_SEQ_FEATURE[850056607$chain:RalA-binding protein 1, 850102577$compositionally biased region:Poly-Lys, 850105183$domain:Rho-GAP, 850106258$modified residue, 850113114$region of interest:Interacts with RalA, 850117295$sequence variant]
hypothetical LOC100130009; high mobility group AT-hook 1,INTERPRO[450000098$IPR000116:High mobility group, HMG-I and HMG-Y, 450000544$IPR000637:HMG-I and HMG-Y, DNA-binding, conserved site, 450016267$IPR017956:AT hook, DNA-binding, conserved site]
hypothetical LOC100130009; high mobility group AT-hook 1,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
hypothetical LOC100130009; high mobility group AT-hook 1,PIR_SUPERFAMILY[630002193$PIRSF002062:nonhistone chromosomal protein HMG-I]
hypothetical LOC100130009; high mobility group AT-hook 1,SMART[760000336$SM00384:AT_hook]
hypothetical LOC100130009; high mobility group AT-hook 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000189$blocked amino end, 790000315$chromosomal protein, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000733$host-virus interaction, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
hypothetical LOC100130009; high mobility group AT-hook 1,UP_SEQ_FEATURE[850023703$chain:High mobility group protein HMG-I/HMG-Y, 850102508$compositionally biased region:Glu-rich (acidic), 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850102889$DNA-binding region:A.T hook 3, 850106258$modified residue, 850106259$mutagenesis site, 850112396$region of interest:Interaction with HIPK2, 850117294$sequence conflict, 850118574$splice variant, 850118624$turn]
hypothetical LOC100132581; similar to speedy homolog A; WBSCR19-like protein 5-like; speedy homolog E8 (Xenopus laevis), pseudogene,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
hypothetical LOC100132581; similar to speedy homolog A; WBSCR19-like protein 5-like; speedy homolog E8 (Xenopus laevis), pseudogene,UP_SEQ_FEATURE[850056139$chain:Putative WBSCR19-like protein 4, 850117294$sequence conflict, 850118574$splice variant]
hypothetical LOC339674,SP_PIR_KEYWORDS[790000356$complete proteome]
hypothetical LOC339674,UP_SEQ_FEATURE[850055454$chain:Putative uncharacterized protein LOC100131404]
hypothetical LOC399717,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
hypothetical LOC399717,UP_SEQ_FEATURE[850055422$chain:Putative uncharacterized protein FLJ45983, 850117295$sequence variant]
hypothetical LOC400831,SP_PIR_KEYWORDS[790000356$complete proteome]
hypothetical LOC400831,UP_SEQ_FEATURE[850075912$chain:Uncharacterized protein LOC400831]
hypothetical LOC401388,SP_PIR_KEYWORDS[790000356$complete proteome]
hypothetical LOC401388,UP_SEQ_FEATURE[850055401$chain:Putative uncharacterized protein FLJ42280, 850117294$sequence conflict]
hypothetical LOC440944,SP_PIR_KEYWORDS[790000356$complete proteome]
hypothetical LOC440944,UP_SEQ_FEATURE[850055428$chain:Putative uncharacterized protein FLJ46541, 850102573$compositionally biased region:Poly-Gly]
hypothetical LOC652276,BIOCARTA[30000014$h_aktPathway:AKT Signaling Pathway, 30000095$h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000146$h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway, 30000195$h_mTORPathway:mTOR Signaling Pathway, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets., 30000243$h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis]
hypothetical LOC728772; transmembrane protein 106A,INTERPRO[450008878$IPR009790:Protein of unknown function DUF1356]
hypothetical LOC728772; transmembrane protein 106A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
hypothetical LOC728772; transmembrane protein 106A,UP_SEQ_FEATURE[850066003$chain:Transmembrane protein 106A, 850118623$transmembrane region]
hypothetical protein FLJ23834,INTERPRO[450001884$IPR002126:Cadherin]
hypothetical protein FLJ23834,SMART[760000099$SM00112:CA]
hypothetical protein FLJ23834,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
hypothetical protein FLJ23834,UP_SEQ_FEATURE[850008862$chain:Cadherin-like protein 28, 850103211$domain:Cadherin 1, 850103222$domain:Cadherin 2, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
hypothetical protein FLJ32682,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
hypothetical protein FLJ32682,UP_SEQ_FEATURE[850055376$chain:Putative uncharacterized protein FLJ32682, 850102507$compositionally biased region:Glu-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hypothetical protein FLJ35220,INTERPRO[450006932$IPR007581:Endonuclease V]
hypothetical protein FLJ35220,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000498$Endonuclease, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism]
hypothetical protein FLJ35220,UP_SEQ_FEATURE[850050651$chain:Putative endonuclease FLJ39025, 850102569$compositionally biased region:Poly-Cys, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hypothetical protein LOC389493,INTERPRO[450017064$IPR018792:Nuclear phosphoprotein p8, DNA binding]
hypothetical protein LOC389493,SP_PIR_KEYWORDS[790000356$complete proteome]
hypothetical protein LOC389493,UP_SEQ_FEATURE[850075911$chain:Uncharacterized protein LOC389493]
immunoglobulin lambda-like polypeptide 1,INTERPRO[450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450006486$IPR007110:Immunoglobulin-like, 450012396$IPR013783:Immunoglobulin-like fold]
immunoglobulin lambda-like polypeptide 1,KEGG_PATHWAY[470038919$hsa05340:Primary immunodeficiency]
immunoglobulin lambda-like polypeptide 1,OMIM_DISEASE[520000168$Agammaglobulinemia, autosomal recessive, 520003072$Many sequence variants affecting diversity of adult human height]
immunoglobulin lambda-like polypeptide 1,PIR_SUPERFAMILY[630002126$PIRSF001989:pre-B cell omega light chain]
immunoglobulin lambda-like polypeptide 1,SMART[760000355$SM00407:IGc1]
immunoglobulin lambda-like polypeptide 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000152$B-cell, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000768$Immunoglobulin domain, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
immunoglobulin lambda-like polypeptide 1,UP_SEQ_FEATURE[850025609$chain:Immunoglobulin lambda-like polypeptide 1, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850105852$helix, 850111120$region of interest:C region (By similarity to lambda light- chain), 850113228$region of interest:J region (By similarity to lambda light- chain), 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
immunoglobulin superfamily, member 3,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
immunoglobulin superfamily, member 3,SMART[760000357$SM00409:IG]
immunoglobulin superfamily, member 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
immunoglobulin superfamily, member 3,UP_SEQ_FEATURE[850025621$chain:Immunoglobulin superfamily member 3, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850104404$domain:Ig-like C2-type 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117454$short sequence motif:EWI motif, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
immunoglobulin-like domain containing receptor 1,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450007925$IPR008664:LISCH7]
immunoglobulin-like domain containing receptor 1,SMART[760000357$SM00409:IG]
immunoglobulin-like domain containing receptor 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000447$disulfide bond, 790000768$Immunoglobulin domain, 790000919$membrane, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
immunoglobulin-like domain containing receptor 1,UP_SEQ_FEATURE[850025629$chain:Immunoglobulin-like domain-containing receptor 1, 850102404$compositionally biased region:Arg-rich, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850104407$domain:Ig-like V-type, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
importin 11,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
importin 11,INTERPRO[450001329$IPR001494:Importin-beta, N-terminal, 450010814$IPR011989:Armadillo-like helical]
importin 11,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001558$transport]
importin 11,UP_SEQ_FEATURE[850025664$chain:Importin-11, 850104418$domain:Importin N-terminal, 850106258$modified residue, 850116140$repeat:HEAT 1, 850116141$repeat:HEAT 10, 850116142$repeat:HEAT 11, 850116143$repeat:HEAT 12, 850116144$repeat:HEAT 13, 850116145$repeat:HEAT 14, 850116146$repeat:HEAT 15, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850116167$repeat:HEAT 8, 850116168$repeat:HEAT 9, 850117294$sequence conflict, 850117295$sequence variant]
importin 13,INTERPRO[450001329$IPR001494:Importin-beta, N-terminal, 450010814$IPR011989:Armadillo-like helical, 450012222$IPR013598:Exportin-1/Importin-beta-like]
importin 13,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001266$protein transport, 790001304$repeat, 790001558$transport]
importin 13,UP_SEQ_FEATURE[850025665$chain:Importin-13, 850104418$domain:Importin N-terminal, 850116140$repeat:HEAT 1, 850116141$repeat:HEAT 10, 850116142$repeat:HEAT 11, 850116143$repeat:HEAT 12, 850116144$repeat:HEAT 13, 850116145$repeat:HEAT 14, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850116167$repeat:HEAT 8, 850116168$repeat:HEAT 9, 850117294$sequence conflict]
influenza virus NS1A binding protein,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006066$IPR006651:Kelch, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
influenza virus NS1A binding protein,PIR_SUPERFAMILY[630028538$PIRSF037037:kelch-like protein, gigaxonin type, 630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
influenza virus NS1A binding protein,SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
influenza virus NS1A binding protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000733$host-virus interaction, 790000819$kelch repeat, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
influenza virus NS1A binding protein,UP_SEQ_FEATURE[850025760$chain:Influenza virus NS1A-binding protein, 850103083$domain:BACK, 850103177$domain:BTB, 850106258$modified residue, 850106259$mutagenesis site, 850114735$region of interest:Sufficient for AHR interaction and signaling, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117294$sequence conflict]
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein,BBID[10000092$71.Id_proteins_G0-to-S_cell_cycle]
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH]
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein,SMART[760000321$SM00353:HLH]
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein,UP_SEQ_FEATURE[850015931$chain:DNA-binding protein inhibitor ID-3, 850104114$domain:Helix-loop-helix motif, 850117295$sequence variant]
inner membrane protein, mitochondrial (mitofilin),INTERPRO[450017379$IPR019133:Mitochondrial inner membrane protein Mitofilin]
inner membrane protein, mitochondrial (mitofilin),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001555$transmembrane]
inner membrane protein, mitochondrial (mitofilin),UP_SEQ_FEATURE[850031975$chain:Mitochondrial inner membrane protein, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118594$topological domain:Mitochondrial intermembrane, 850118596$topological domain:Mitochondrial matrix, 850118623$transmembrane region]
inositol 1,4,5-trisphosphate 3-kinase C,INTERPRO[450004977$IPR005522:Inositol polyphosphate kinase]
inositol 1,4,5-trisphosphate 3-kinase C,OMIM_DISEASE[520002719$Kawasaki disease, susceptibility to]
inositol 1,4,5-trisphosphate 3-kinase C,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001547$transferase]
inositol 1,4,5-trisphosphate 3-kinase C,UP_SEQ_FEATURE[850000242$binding site:ATP, 850000555$binding site:Substrate, 850026076$chain:Inositol-trisphosphate 3-kinase C, 850105852$helix, 850106263$nucleotide phosphate-binding region:ATP, 850111164$region of interest:Calmodulin-binding, 850113802$region of interest:Nuclear export signal, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
inositol hexakisphosphate kinase 1,INTERPRO[450004977$IPR005522:Inositol polyphosphate kinase]
inositol hexakisphosphate kinase 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001547$transferase]
inositol hexakisphosphate kinase 1,UP_SEQ_FEATURE[850026032$chain:Inositol hexakisphosphate kinase 1, 850106258$modified residue, 850114716$region of interest:Substrate binding]
inositol hexakisphosphate kinase 2,INTERPRO[450004977$IPR005522:Inositol polyphosphate kinase]
inositol hexakisphosphate kinase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001547$transferase]
inositol hexakisphosphate kinase 2,UP_SEQ_FEATURE[850026033$chain:Inositol hexakisphosphate kinase 2, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850118574$splice variant]
inositol(myo)-1(or 4)-monophosphatase 2,INTERPRO[450000655$IPR000760:Inositol monophosphatase]
inositol(myo)-1(or 4)-monophosphatase 2,KEGG_PATHWAY[470038776$hsa00562:Inositol phosphate metabolism, 470038832$hsa04070:Phosphatidylinositol signaling system]
inositol(myo)-1(or 4)-monophosphatase 2,OMIM_DISEASE[520000071$A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release]
inositol(myo)-1(or 4)-monophosphatase 2,PIR_SUPERFAMILY[630004897$PIRSF004949:metal-dependent/Li(+)-inhibited phosphomonoesterase]
inositol(myo)-1(or 4)-monophosphatase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001212$polymorphism]
inositol(myo)-1(or 4)-monophosphatase 2,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850026037$chain:Inositol monophosphatase 2, 850105852$helix, 850106134$metal ion-binding site:Magnesium 1, 850106136$metal ion-binding site:Magnesium 1; via carbonyl oxygen, 850106137$metal ion-binding site:Magnesium 2, 850106259$mutagenesis site, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
insulin receptor,BIOCARTA[30000125$h_ghPathway:Growth Hormone Signaling Pathway, 30000135$h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK), 30000163$h_insulinPathway:Insulin Signaling Pathway]
insulin receptor,INTERPRO[450000421$IPR000494:EGF receptor, L domain, 450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450001782$IPR002011:Receptor tyrosine kinase, class II, conserved site, 450003484$IPR003961:Fibronectin, type III, 450005637$IPR006211:Furin-like cysteine rich region, 450005638$IPR006212:Furin-like repeat, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008173$IPR008957:Fibronectin, type III-like fold, 450014570$IPR016246:Insulin receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
insulin receptor,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038882$hsa04910:Insulin signaling pathway, 470038887$hsa04930:Type II diabetes mellitus, 470038890$hsa04960:Aldosterone-regulated sodium reabsorption]
insulin receptor,OMIM_DISEASE[520001493$Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 520002436$Hyperinsulinemic hypoglycemia, familial, 5, 520002816$Leprechaunism, 520004209$Rabson-Mendenhall syndrome]
insulin receptor,PIR_SUPERFAMILY[630000730$PIRSF000620:insulin receptor, 630000731$PIRSF000620:Insulin_receptor]
insulin receptor,SMART[760000051$SM00060:FN3, 760000192$SM00219:TyrKc, 760000233$SM00261:FU]
insulin receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000149$autophosphorylation, 790000232$carbohydrate metabolism, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000430$diabetes mellitus, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000709$hormone receptor, 790000825$kinase, 790000826$kinase-related transforming protein, 790000906$manganese, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein, 790001586$tyrosine-protein kinase, 790001588$tyrosine-specific protein kinase]
insulin receptor,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850026139$chain:Insulin receptor subunit alpha, 850026140$chain:Insulin receptor subunit beta, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850113221$region of interest:IRS1- and SHC1-binding, 850114047$region of interest:PIK3R1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118206$site:Essential for IRS1-binding and important but not critical for SHC1-binding, 850118247$site:Important for biological activity, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
insulin-like growth factor 2 mRNA binding protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450016411$IPR018111:K Homology, type 1, subgroup]
insulin-like growth factor 2 mRNA binding protein 1,SMART[760000291$SM00322:KH, 760000328$SM00360:RRM]
insulin-like growth factor 2 mRNA binding protein 1,SP_PIR_KEYWORDS[790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding, 790001551$translation regulation]
insulin-like growth factor 2 mRNA binding protein 1,UP_SEQ_FEATURE[850026158$chain:Insulin-like growth factor 2 mRNA-binding protein 1, 850104521$domain:KH 1, 850104527$domain:KH 2, 850104528$domain:KH 3, 850104529$domain:KH 4, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850106258$modified residue, 850106259$mutagenesis site, 850113609$region of interest:Necessary for interaction with ELAVL4 and binding to TAU mRNA, 850114802$region of interest:Sufficient for nuclear export, 850117294$sequence conflict]
insulin-like growth factor binding protein, acid labile subunit,BIOCARTA[30000126$h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis]
insulin-like growth factor binding protein, acid labile subunit,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
insulin-like growth factor binding protein, acid labile subunit,OMIM_DISEASE[520000107$Acid-labile subunit, deficiency of]
insulin-like growth factor binding protein, acid labile subunit,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP]
insulin-like growth factor binding protein, acid labile subunit,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
insulin-like growth factor binding protein, acid labile subunit,UP_SEQ_FEATURE[850026183$chain:Insulin-like growth factor-binding protein complex acid labile subunit, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116317$repeat:LRR 18, 850116318$repeat:LRR 19, 850116319$repeat:LRR 2, 850116320$repeat:LRR 20, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117295$sequence variant, 850117814$signal peptide]
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor),INTERPRO[450000354$IPR000413:Integrin alpha chain, 450012142$IPR013517:FG-GAP, 450012144$IPR013519:Integrin alpha beta-propellor, 450012270$IPR013649:Integrin alpha-2, 450016472$IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site]
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor),KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038899$hsa05200:Pathways in cancer, 470038912$hsa05222:Small cell lung cancer, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor),PIR_SUPERFAMILY[630005593$PIRSF005666:integrin alpha, VLA protein type]
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor),SMART[760000165$SM00191:Int_alpha]
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000212$calcium binding, 790000256$cell adhesion, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000679$heterodimer, 790000783$integrin, 790000919$membrane, 790000936$metal binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor),UP_SEQ_FEATURE[850026258$chain:Integrin alpha-3, 850026259$chain:Integrin alpha-3 heavy chain, 850026260$chain:Integrin alpha-3 light chain, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850112417$region of interest:Interaction with HPS5, 850115919$repeat:FG-GAP 1, 850115921$repeat:FG-GAP 2, 850115923$repeat:FG-GAP 3, 850115925$repeat:FG-GAP 4, 850115927$repeat:FG-GAP 5, 850115928$repeat:FG-GAP 6, 850115929$repeat:FG-GAP 7, 850117295$sequence variant, 850117468$short sequence motif:GFFKR motif, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide),BIOCARTA[30000040$h_blymphocytePathway:B Lymphocyte Cell Surface Molecules, 30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000130$h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes, 30000169$h_LairPathway:Cells and Molecules involved in local acute inflammatory response, 30000175$h_lympathway:Adhesion and Diapedesis of Lymphocytes, 30000176$h_lymphocytePathway:Adhesion Molecules on Lymphocyte, 30000190$h_monocytePathway:Monocyte and its Surface Molecules, 30000198$h_neutrophilPathway:Neutrophil and Its Surface Molecules, 30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules]
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide),INTERPRO[450000354$IPR000413:Integrin alpha chain, 450001802$IPR002035:von Willebrand factor, type A, 450012138$IPR013513:Integrin alpha chain, C-terminal, cytoplasmic region, 450012142$IPR013517:FG-GAP, 450012144$IPR013519:Integrin alpha beta-propellor, 450012270$IPR013649:Integrin alpha-2, 450016472$IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site]
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide),KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038873$hsa04670:Leukocyte transendothelial migration, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038923$hsa05416:Viral myocarditis]
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide),PIR_SUPERFAMILY[630002616$PIRSF002497:integrin alpha with I domain, 630031136$PIRSF501009:integrin alpha-L]
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide),SMART[760000165$SM00191:Int_alpha, 760000296$SM00327:VWA]
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000679$heterodimer, 790000783$integrin, 790000899$magnesium, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide),UP_SEQ_FEATURE[850026284$chain:Integrin alpha-L, 850102883$disulfide bond, 850105627$domain:VWFA, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850115919$repeat:FG-GAP 1, 850115921$repeat:FG-GAP 2, 850115923$repeat:FG-GAP 3, 850115925$repeat:FG-GAP 4, 850115927$repeat:FG-GAP 5, 850115928$repeat:FG-GAP 6, 850115929$repeat:FG-GAP 7, 850117294$sequence conflict, 850117295$sequence variant, 850117468$short sequence motif:GFFKR motif, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
integrin, alpha M (complement component 3 receptor 3 subunit),BBID[10000061$37.Akt-PKB_Effector_of_P13K_in_Vivo, 10000101$8.MonocytesIFNF_IL4]
integrin, alpha M (complement component 3 receptor 3 subunit),BIOCARTA[30000130$h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes, 30000190$h_monocytePathway:Monocyte and its Surface Molecules, 30000198$h_neutrophilPathway:Neutrophil and Its Surface Molecules]
integrin, alpha M (complement component 3 receptor 3 subunit),INTERPRO[450000354$IPR000413:Integrin alpha chain, 450001802$IPR002035:von Willebrand factor, type A, 450012138$IPR013513:Integrin alpha chain, C-terminal, cytoplasmic region, 450012142$IPR013517:FG-GAP, 450012144$IPR013519:Integrin alpha beta-propellor, 450012270$IPR013649:Integrin alpha-2, 450016472$IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site]
integrin, alpha M (complement component 3 receptor 3 subunit),KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038867$hsa04640:Hematopoietic cell lineage, 470038873$hsa04670:Leukocyte transendothelial migration, 470038881$hsa04810:Regulation of actin cytoskeleton]
integrin, alpha M (complement component 3 receptor 3 subunit),OMIM_DISEASE[520000404$Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX, 520001985$Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus, 520002007$Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci, 520004786$Systemic lupus erythematous, association with susceptibility to, 6]
integrin, alpha M (complement component 3 receptor 3 subunit),PIR_SUPERFAMILY[630002616$PIRSF002497:integrin alpha with I domain, 630031134$PIRSF501007:integrin alpha-M]
integrin, alpha M (complement component 3 receptor 3 subunit),SMART[760000165$SM00191:Int_alpha, 760000296$SM00327:VWA]
integrin, alpha M (complement component 3 receptor 3 subunit),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000679$heterodimer, 790000783$integrin, 790000899$magnesium, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001478$systemic lupus erythematosus, 790001555$transmembrane, 790001556$transmembrane protein]
integrin, alpha M (complement component 3 receptor 3 subunit),UP_SEQ_FEATURE[850026285$chain:Integrin alpha-M, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850115919$repeat:FG-GAP 1, 850115921$repeat:FG-GAP 2, 850115923$repeat:FG-GAP 3, 850115925$repeat:FG-GAP 4, 850115927$repeat:FG-GAP 5, 850115928$repeat:FG-GAP 6, 850115929$repeat:FG-GAP 7, 850117294$sequence conflict, 850117295$sequence variant, 850117468$short sequence motif:GFFKR motif, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
integrin, beta 6,INTERPRO[450001025$IPR001169:Integrin beta subunit, C-terminal, 450001802$IPR002035:von Willebrand factor, type A, 450002108$IPR002369:Integrin beta subunit, N-terminal, 450003205$IPR003659:Plexin/semaphorin/integrin, 450010832$IPR012012:Integrin beta subunit, subgroup, 450011573$IPR012896:Integrin beta subunit, tail, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular, 450013285$IPR014836:Integrin beta subunit, cytoplasmic, 450013878$IPR015436:Integrin beta-6 subunit, C-terminal, 450014242$IPR015812:Integrin beta subunit]
integrin, beta 6,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
integrin, beta 6,PIR_SUPERFAMILY[630002630$PIRSF002512:integrin, beta subunit, 630002631$PIRSF002512:Integrin_B]
integrin, beta 6,SMART[760000161$SM00187:INB, 760000296$SM00327:VWA, 760000369$SM00423:PSI]
integrin, beta 6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000256$cell adhesion, 790000356$complete proteome, 790000410$cytoskeleton, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000783$integrin, 790000881$lipoprotein, 790000919$membrane, 790001005$myristylation, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001511$thiolester bond, 790001555$transmembrane, 790001556$transmembrane protein]
integrin, beta 6,UP_SEQ_FEATURE[850026314$chain:Integrin beta-6, 850102883$disulfide bond, 850105627$domain:VWFA, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850111383$region of interest:Cysteine-rich tandem repeats, 850112383$region of interest:Interaction with HAX1, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
integrin-binding sialoprotein,BIOCARTA[30000209$h_npp1Pathway:Regulators of Bone Mineralization]
integrin-binding sialoprotein,INTERPRO[450007689$IPR008412:Bone sialoprotein II]
integrin-binding sialoprotein,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
integrin-binding sialoprotein,PIR_SUPERFAMILY[630002693$PIRSF002579:bone sialoprotein]
integrin-binding sialoprotein,SP_PIR_KEYWORDS[790000183$biomineralization, 790000196$bone, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000744$hydroxyapatite binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001402$sialic acid, 790001403$sialoglycoprotein, 790001405$signal, 790001461$sulfation, 790001463$sulfoprotein]
integrin-binding sialoprotein,UP_SEQ_FEATURE[850008234$chain:Bone sialoprotein 2, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102572$compositionally biased region:Poly-Glu, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide]
intercellular adhesion molecule 1,BBID[10000022$125.T_Cells_CNS-APCs, 10000046$18.Cytokine_astocytes, 10000075$55.Allergen_recognition_by_Th2_or_Th0_cell, 10000078$58.(CD40L)_immnosurveillance, 10000081$60.IL-15_rheumatoid-arthritis_synovitis, 10000101$8.MonocytesIFNF_IL4, 10000103$81.Structure_of_Caps_and_SMACs, 10000117$96.Immune_injury_MS-lesions_genetic_environ]
intercellular adhesion molecule 1,BIOCARTA[30000040$h_blymphocytePathway:B Lymphocyte Cell Surface Molecules, 30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000130$h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes, 30000169$h_LairPathway:Cells and Molecules involved in local acute inflammatory response, 30000175$h_lympathway:Adhesion and Diapedesis of Lymphocytes, 30000176$h_lymphocytePathway:Adhesion Molecules on Lymphocyte, 30000190$h_monocytePathway:Monocyte and its Surface Molecules, 30000198$h_neutrophilPathway:Neutrophil and Its Surface Molecules, 30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules]
intercellular adhesion molecule 1,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450003510$IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal, 450003511$IPR003988:Intercellular adhesion molecule, 450012387$IPR013768:Intercellular adhesion molecule, N-terminal, 450012396$IPR013783:Immunoglobulin-like fold]
intercellular adhesion molecule 1,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038873$hsa04670:Leukocyte transendothelial migration, 470038923$hsa05416:Viral myocarditis]
intercellular adhesion molecule 1,OMIM_DISEASE[520003044$Malaria, cerebral, susceptibility to, 520003687$Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 Women]
intercellular adhesion molecule 1,PIR_SUPERFAMILY[630002628$PIRSF002510:intercellular adhesion molecule, ICAM-1 type]
intercellular adhesion molecule 1,SMART[760000357$SM00409:IG]
intercellular adhesion molecule 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001592$ubl conjugation]
intercellular adhesion molecule 1,UP_SEQ_FEATURE[850026351$chain:Intercellular adhesion molecule 1, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117336$short sequence motif:Cell attachment site; atypical, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
intercellular adhesion molecule 3,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450003510$IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal, 450003511$IPR003988:Intercellular adhesion molecule, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012387$IPR013768:Intercellular adhesion molecule, N-terminal, 450012396$IPR013783:Immunoglobulin-like fold]
intercellular adhesion molecule 3,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs)]
intercellular adhesion molecule 3,PIR_SUPERFAMILY[630002628$PIRSF002510:intercellular adhesion molecule, ICAM-1 type]
intercellular adhesion molecule 3,SMART[760000357$SM00409:IG]
intercellular adhesion molecule 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
intercellular adhesion molecule 3,UP_SEQ_FEATURE[850026353$chain:Intercellular adhesion molecule 3, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),INTERPRO[450003510$IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal, 450012387$IPR013768:Intercellular adhesion molecule, N-terminal, 450012396$IPR013783:Immunoglobulin-like fold]
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),OMIM_DISEASE[520000606$Blood group, Landsteiner-Wiener]
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000194$blood group antigen, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),UP_SEQ_FEATURE[850026354$chain:Intercellular adhesion molecule 4, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interferon induced transmembrane protein 5,INTERPRO[450006944$IPR007593:Interferon-induced transmembrane protein]
interferon induced transmembrane protein 5,PIR_SUPERFAMILY[630013367$PIRSF016581:interferon-induced transmembrane protein]
interferon induced transmembrane protein 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
interferon induced transmembrane protein 5,UP_SEQ_FEATURE[850026467$chain:Interferon-induced transmembrane protein 5, 850117295$sequence variant, 850118623$transmembrane region]
interferon regulatory factor 4,BBID[10000100$79.B_cell_Activation]
interferon regulatory factor 4,INTERPRO[450001188$IPR001346:Interferon regulatory factor, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016174$IPR017855:SMAD domain-like, 450017709$IPR019471:Interferon regulatory factor-3, 450018048$IPR019817:Interferon regulatory factor, conserved site]
interferon regulatory factor 4,OMIM_DISEASE[520000057$A Genome-Wide Association Study Identifies Novel Alleles Associated with Hair Color and Skin Pigmentation, 520000061$A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia, 520001984$Genetic determinants of hair, eye and skin pigmentation in Europeans, 520003405$Multiple myeloma]
interferon regulatory factor 4,PIR_SUPERFAMILY[630005637$PIRSF005710:interferon regulatory factor 3-9]
interferon regulatory factor 4,SMART[760000316$SM00348:IRF]
interferon regulatory factor 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
interferon regulatory factor 4,UP_SEQ_FEATURE[850026410$chain:Interferon regulatory factor 4, 850102968$DNA-binding region:Tryptophan pentad repeat, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
interferon regulatory factor 7,INTERPRO[450001188$IPR001346:Interferon regulatory factor, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016174$IPR017855:SMAD domain-like, 450017709$IPR019471:Interferon regulatory factor-3, 450018048$IPR019817:Interferon regulatory factor, conserved site]
interferon regulatory factor 7,KEGG_PATHWAY[470038862$hsa04620:Toll-like receptor signaling pathway, 470038864$hsa04622:RIG-I-like receptor signaling pathway, 470038865$hsa04623:Cytosolic DNA-sensing pathway]
interferon regulatory factor 7,SMART[760000316$SM00348:IRF]
interferon regulatory factor 7,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000104$Antiviral defense, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
interferon regulatory factor 7,UP_SEQ_FEATURE[850026413$chain:Interferon regulatory factor 7, 850102968$DNA-binding region:Tryptophan pentad repeat, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
interferon regulatory factor 8,INTERPRO[450001188$IPR001346:Interferon regulatory factor, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016174$IPR017855:SMAD domain-like, 450017709$IPR019471:Interferon regulatory factor-3, 450018048$IPR019817:Interferon regulatory factor, conserved site]
interferon regulatory factor 8,PIR_SUPERFAMILY[630005637$PIRSF005710:interferon regulatory factor 3-9]
interferon regulatory factor 8,SMART[760000316$SM00348:IRF]
interferon regulatory factor 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
interferon regulatory factor 8,UP_SEQ_FEATURE[850026414$chain:Interferon regulatory factor 8, 850102968$DNA-binding region:Tryptophan pentad repeat, 850117295$sequence variant]
interferon stimulated exonuclease gene 20kDa-like 2,INTERPRO[450005492$IPR006055:Exonuclease, 450012145$IPR013520:Exonuclease, RNase T and DNA polymerase III]
interferon stimulated exonuclease gene 20kDa-like 2,SMART[760000424$SM00479:EXOIII]
interferon stimulated exonuclease gene 20kDa-like 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism, 790001331$ribosome biogenesis]
interferon stimulated exonuclease gene 20kDa-like 2,UP_SEQ_FEATURE[850026480$chain:Interferon-stimulated 20 kDa exonuclease- like 2, 850103721$domain:Exonuclease, 850117295$sequence variant]
interferon, alpha-inducible protein 6,INTERPRO[450008421$IPR009311:Interferon-induced 6-16]
interferon, alpha-inducible protein 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
interferon, alpha-inducible protein 6,UP_SEQ_FEATURE[850026393$chain:Interferon alpha-inducible protein 6, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118623$transmembrane region]
interferon-induced protein 35,INTERPRO[450008994$IPR009909:Nmi/IFP 35, 450009023$IPR009938:Interferon induced 35 kDa, N-terminal]
interferon-induced protein 35,PIR_SUPERFAMILY[630010112$PIRSF011866:N-myc-interactor protein/interferon-induced protein IFP35, 630030865$PIRSF500704:interferon-induced protein IFP 35]
interferon-induced protein 35,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus]
interferon-induced protein 35,UP_SEQ_FEATURE[850026442$chain:Interferon-induced 35 kDa protein, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850118574$splice variant]
interferon-related developmental regulator 1,INTERPRO[450006320$IPR006921:Interferon-related developmental regulator, C-terminal, 450007056$IPR007701:Interferon-related developmental regulator, N-terminal]
interferon-related developmental regulator 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001162$phosphoprotein]
interferon-related developmental regulator 1,UP_SEQ_FEATURE[850026478$chain:Interferon-related developmental regulator 1, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue, 850117294$sequence conflict]
interferon-related developmental regulator 2,INTERPRO[450006320$IPR006921:Interferon-related developmental regulator, C-terminal, 450007056$IPR007701:Interferon-related developmental regulator, N-terminal]
interferon-related developmental regulator 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
interferon-related developmental regulator 2,UP_SEQ_FEATURE[850026479$chain:Interferon-related developmental regulator 2, 850117295$sequence variant]
interleukin 1 family, member 8 (eta),INTERPRO[450000847$IPR000975:Interleukin-1]
interleukin 1 family, member 8 (eta),SMART[760000107$SM00125:IL1]
interleukin 1 family, member 8 (eta),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000402$cytokine, 790001212$polymorphism, 790001363$Secreted]
interleukin 1 family, member 8 (eta),UP_SEQ_FEATURE[850026495$chain:Interleukin-1 family member 8, 850117295$sequence variant, 850118574$splice variant]
interleukin 1 receptor-like 1,INTERPRO[450000133$IPR000157:Toll-Interleukin receptor, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450003590$IPR004074:Interleukin-1 receptor, type I and type II, 450003591$IPR004075:Interleukin-1 receptor, type I/Toll precursor, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450014058$IPR015621:Interleukin-1 receptor]
interleukin 1 receptor-like 1,OMIM_DISEASE[520003637$Newly identified genetic risk variants for celiac disease related to the immune response]
interleukin 1 receptor-like 1,PIR_SUPERFAMILY[630005625$PIRSF005698:interleukin-1 receptor type I]
interleukin 1 receptor-like 1,SMART[760000227$SM00255:TIR, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
interleukin 1 receptor-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
interleukin 1 receptor-like 1,UP_SEQ_FEATURE[850026511$chain:Interleukin-1 receptor-like 1, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105529$domain:TIR, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 11 receptor, alpha,INTERPRO[450003097$IPR003530:Long hematopoietin receptor, soluble alpha chain, conserved site, 450003160$IPR003599:Immunoglobulin subtype, 450003484$IPR003961:Fibronectin, type III, 450006486$IPR007110:Immunoglobulin-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450011788$IPR013151:Immunoglobulin]
interleukin 11 receptor, alpha,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038867$hsa04640:Hematopoietic cell lineage]
interleukin 11 receptor, alpha,PIR_SUPERFAMILY[630002096$PIRSF001958:ciliary neurotrophic factor receptor]
interleukin 11 receptor, alpha,SMART[760000051$SM00060:FN3, 760000357$SM00409:IG]
interleukin 11 receptor, alpha,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
interleukin 11 receptor, alpha,UP_SEQ_FEATURE[850026520$chain:Interleukin-11 receptor subunit alpha, 850102883$disulfide bond, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 13 receptor, alpha 1,INTERPRO[450003099$IPR003532:Short hematopoietin receptor, family 2, conserved site, 450008173$IPR008957:Fibronectin, type III-like fold]
interleukin 13 receptor, alpha 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
interleukin 13 receptor, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
interleukin 13 receptor, alpha 1,UP_SEQ_FEATURE[850026529$chain:Interleukin-13 receptor subunit alpha-1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
interleukin 17 receptor C,INTERPRO[450012192$IPR013568:SEFIR]
interleukin 17 receptor C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
interleukin 17 receptor C,UP_SEQ_FEATURE[850026537$chain:Interleukin-17 receptor C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 18 receptor 1,BIOCARTA[30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000203$h_nktPathway:Selective expression of chemokine receptors during T-cell polarization, 30000294$h_th1th2Pathway:Th1/Th2 Differentiation]
interleukin 18 receptor 1,INTERPRO[450000133$IPR000157:Toll-Interleukin receptor, 450003160$IPR003599:Immunoglobulin subtype, 450003590$IPR004074:Interleukin-1 receptor, type I and type II, 450003591$IPR004075:Interleukin-1 receptor, type I/Toll precursor, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold, 450014058$IPR015621:Interleukin-1 receptor]
interleukin 18 receptor 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction]
interleukin 18 receptor 1,OMIM_DISEASE[520003637$Newly identified genetic risk variants for celiac disease related to the immune response]
interleukin 18 receptor 1,SMART[760000227$SM00255:TIR, 760000357$SM00409:IG]
interleukin 18 receptor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
interleukin 18 receptor 1,UP_SEQ_FEATURE[850026546$chain:Interleukin-18 receptor 1, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105529$domain:TIR, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 2 receptor, gamma (severe combined immunodeficiency),BIOCARTA[30000155$h_il2Pathway:IL 2 signaling pathway, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000158$h_il4Pathway:IL 4 signaling pathway, 30000161$h_il7Pathway:IL-7 Signal Transduction]
interleukin 2 receptor, gamma (severe combined immunodeficiency),INTERPRO[450003098$IPR003531:Short hematopoietin receptor, family 1, conserved site, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
interleukin 2 receptor, gamma (severe combined immunodeficiency),KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038841$hsa04144:Endocytosis, 470038866$hsa04630:Jak-STAT signaling pathway, 470038919$hsa05340:Primary immunodeficiency]
interleukin 2 receptor, gamma (severe combined immunodeficiency),OMIM_DISEASE[520001114$Combined immunodeficiency, X-linked, moderate, 520004459$Severe combined immunodeficiency, X-linked]
interleukin 2 receptor, gamma (severe combined immunodeficiency),PIR_SUPERFAMILY[630002092$PIRSF001955:interleukin-2 receptor gamma chain]
interleukin 2 receptor, gamma (severe combined immunodeficiency),SMART[760000051$SM00060:FN3]
interleukin 2 receptor, gamma (severe combined immunodeficiency),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000403$cytokine receptor, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000733$host-virus interaction, 790000765$immunodeficiency, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001360$scid, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
interleukin 2 receptor, gamma (severe combined immunodeficiency),UP_SEQ_FEATURE[850013992$chain:Cytokine receptor common subunit gamma, 850102883$disulfide bond, 850103799$domain:Fibronectin type-III, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
interleukin 21 receptor,INTERPRO[450003098$IPR003531:Short hematopoietin receptor, family 1, conserved site, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
interleukin 21 receptor,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
interleukin 21 receptor,OMIM_DISEASE[520002603$IgE, elevated level of, 520002986$Lymphoma, diffuse large B-cell]
interleukin 21 receptor,SMART[760000051$SM00060:FN3]
interleukin 21 receptor,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
interleukin 21 receptor,UP_SEQ_FEATURE[850026559$chain:Interleukin-21 receptor, 850102883$disulfide bond, 850103799$domain:Fibronectin type-III, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 22 receptor, alpha 2,BIOCARTA[30000154$h_il22bppathway:IL22 Soluble Receptor Signaling Pathway ]
interleukin 22 receptor, alpha 2,INTERPRO[450008173$IPR008957:Fibronectin, type III-like fold, 450017710$IPR019472:Interleukin-10-like receptor, alpha subunit]
interleukin 22 receptor, alpha 2,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
interleukin 22 receptor, alpha 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal]
interleukin 22 receptor, alpha 2,UP_SEQ_FEATURE[850026562$chain:Interleukin-22 receptor subunit alpha-2, 850102883$disulfide bond, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
interleukin 27 receptor, alpha,INTERPRO[450003096$IPR003529:Long hematopoietin receptor, gp130 family 2, conserved site, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
interleukin 27 receptor, alpha,SMART[760000051$SM00060:FN3]
interleukin 27 receptor, alpha,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
interleukin 27 receptor, alpha,UP_SEQ_FEATURE[850026569$chain:Interleukin-27 receptor subunit alpha, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 29 (interferon, lambda 1),KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
interleukin 29 (interferon, lambda 1),PIR_SUPERFAMILY[630030224$PIRSF038749:interferon lambda]
interleukin 29 (interferon, lambda 1),SP_PIR_KEYWORDS[790000104$Antiviral defense, 790000356$complete proteome, 790000402$cytokine, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
interleukin 29 (interferon, lambda 1),UP_SEQ_FEATURE[850026575$chain:Interleukin-29, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
intersectin 2,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
intersectin 2,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000090$IPR000108:Neutrophil cytosol factor 2, 450000189$IPR000219:Dbl homology (DH) domain, 450000226$IPR000261:EPS15 homology (EH), 450001294$IPR001452:Src homology-3 domain, 450001635$IPR001849:Pleckstrin homology, 450001814$IPR002048:Calcium-binding EF-hand, 450010373$IPR011511:Variant SH3, 450010817$IPR011992:EF-Hand type, 450010818$IPR011993:Pleckstrin homology-type, 450016334$IPR018029:C2 membrane targeting protein, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
intersectin 2,SMART[760000019$SM00027:EH, 760000046$SM00054:EFh, 760000205$SM00233:PH, 760000211$SM00239:C2, 760000294$SM00325:RhoGEF, 760000295$SM00326:SH3]
intersectin 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000496$Endocytosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain]
intersectin 2,UP_SEQ_FEATURE[850026637$chain:Intersectin-2, 850103199$domain:C2, 850103518$domain:DH, 850103572$domain:EF-hand 1, 850103707$domain:EH 1, 850103708$domain:EH 2, 850104979$domain:PH, 850105351$domain:SH3 1, 850105353$domain:SH3 2, 850105354$domain:SH3 3, 850105355$domain:SH3 4, 850105356$domain:SH3 5, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
intraflagellar transport 140 homolog (Chlamydomonas),INTERPRO[450001490$IPR001680:WD40 repeat, 450011736$IPR013092:Connexin, N-terminal, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450016298$IPR017990:Connexin, conserved site, 450016299$IPR017991:Connexin region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
intraflagellar transport 140 homolog (Chlamydomonas),SMART[760000029$SM00037:CNX, 760000289$SM00320:WD40]
intraflagellar transport 140 homolog (Chlamydomonas),SP_PIR_KEYWORDS[790000356$complete proteome, 790000581$gap junction, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001555$transmembrane, 790001638$wd repeat]
intraflagellar transport 140 homolog (Chlamydomonas),UP_SEQ_FEATURE[850026659$chain:Intraflagellar transport protein 140 homolog, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant]
intraflagellar transport 172 homolog (Chlamydomonas),INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450018010$IPR019775:WD40 repeat, conserved site]
intraflagellar transport 172 homolog (Chlamydomonas),SMART[760000289$SM00320:WD40]
intraflagellar transport 172 homolog (Chlamydomonas),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001638$wd repeat]
intraflagellar transport 172 homolog (Chlamydomonas),UP_SEQ_FEATURE[850026661$chain:Intraflagellar transport protein 172 homolog, 850106258$modified residue, 850117119$repeat:TPR 1, 850117120$repeat:TPR 10, 850117121$repeat:TPR 11, 850117122$repeat:TPR 12, 850117123$repeat:TPR 13, 850117125$repeat:TPR 14, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
intraflagellar transport 74 homolog (Chlamydomonas),COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
intraflagellar transport 74 homolog (Chlamydomonas),SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790001162$phosphoprotein, 790001212$polymorphism]
intraflagellar transport 74 homolog (Chlamydomonas),UP_SEQ_FEATURE[850026668$chain:Intraflagellar transport protein 74 homolog, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
intramembrane protease 5,INTERPRO[450006057$IPR006639:Peptidase A22, presenilin signal peptide, 450006731$IPR007369:Peptidase A22B, signal peptide peptidase]
intramembrane protease 5,SMART[760000636$SM00730:PSN]
intramembrane protease 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001252$Protease, 790001405$signal, 790001555$transmembrane]
intramembrane protease 5,UP_SEQ_FEATURE[850060768$chain:Signal peptide peptidase-like 2C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
inverted formin, FH2 and WH2 domain containing,INTERPRO[450002728$IPR003104:Actin-binding FH2 and DRF autoregulatory, 450002748$IPR003124:Actin-binding WH2, 450009531$IPR010472:Diaphanous FH3, 450009532$IPR010473:Diaphanous GTPase-binding, 450013218$IPR014768:GTPase-binding/formin homology 3, 450013867$IPR015425:Actin-binding FH2]
inverted formin, FH2 and WH2 domain containing,SMART[760000218$SM00246:WH2, 760000441$SM00498:FH2]
inverted formin, FH2 and WH2 domain containing,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
inverted formin, FH2 and WH2 domain containing,UP_SEQ_FEATURE[850026719$chain:Inverted formin-2, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850103774$domain:FH2, 850104044$domain:GBD/FH3, 850105698$domain:WH2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
iroquois homeobox 5,INTERPRO[450001200$IPR001356:Homeobox, 450003418$IPR003893:Iroquois-class homeodomain protein, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
iroquois homeobox 5,SMART[760000341$SM00389:HOX, 760000488$SM00548:IRO]
iroquois homeobox 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001377$sensory transduction, 790001622$vision, 790001628$vitamin d]
iroquois homeobox 5,UP_SEQ_FEATURE[850026829$chain:Iroquois-class homeodomain protein irx-5, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102935$DNA-binding region:Homeobox; TALE-type, 850117294$sequence conflict]
iroquois homeobox 6,INTERPRO[450001200$IPR001356:Homeobox, 450003418$IPR003893:Iroquois-class homeodomain protein, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
iroquois homeobox 6,SMART[760000341$SM00389:HOX, 760000488$SM00548:IRO]
iroquois homeobox 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus]
iroquois homeobox 6,UP_SEQ_FEATURE[850026830$chain:Iroquois-class homeodomain protein IRX-6, 850102935$DNA-binding region:Homeobox; TALE-type, 850117294$sequence conflict]
islet amyloid polypeptide,INTERPRO[450000378$IPR000443:Islet amyloid polypeptide, 450001499$IPR001693:Calcitonin-like, 450016645$IPR018360:Calcitonin, conserved site]
islet amyloid polypeptide,KEGG_PATHWAY[470038889$hsa04950:Maturity onset diabetes of the young]
islet amyloid polypeptide,PIR_SUPERFAMILY[630001969$PIRSF001830:calcitonin/calcitonin gene-related protein/amylin, 630030491$PIRSF500242:islet amyloid polypeptide]
islet amyloid polypeptide,SMART[760000100$SM00113:CALCITONIN]
islet amyloid polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000060$amidation, 790000077$amyloid, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000708$hormone, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
islet amyloid polypeptide,UP_SEQ_FEATURE[850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850107948$peptide:Islet amyloid polypeptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
isocitrate dehydrogenase 1 (NADP+), soluble,INTERPRO[450001597$IPR001804:Isocitrate/isopropylmalate dehydrogenase, 450004276$IPR004790:Isocitrate dehydrogenase NADP-dependent, eukaryotic, 450018049$IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site]
isocitrate dehydrogenase 1 (NADP+), soluble,KEGG_PATHWAY[470038726$hsa00020:Citrate cycle (TCA cycle), 470038764$hsa00480:Glutathione metabolism]
isocitrate dehydrogenase 1 (NADP+), soluble,PIR_SUPERFAMILY[630000125$PIRSF000108:IDH_NADP, 630000126$PIRSF000108:isocitrate dehydrogenase (NADP)]
isocitrate dehydrogenase 1 (NADP+), soluble,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000620$glyoxylate bypass, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding, 790001008$nadp, 790001092$oxidoreductase, 790001128$peroxisome, 790001212$polymorphism, 790001564$tricarboxylic acid cycle]
isocitrate dehydrogenase 1 (NADP+), soluble,UP_SEQ_FEATURE[850000461$binding site:NADP, 850000464$binding site:NADP; via amide nitrogen and carbonyl oxygen, 850000555$binding site:Substrate, 850026872$chain:Isocitrate dehydrogenase [NADP] cytoplasmic, 850105852$helix, 850106148$metal ion-binding site:Magnesium or manganese, 850106258$modified residue, 850106307$nucleotide phosphate-binding region:NADP, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850117295$sequence variant, 850118162$site:Critical for catalysis, 850118575$strand, 850118624$turn]
isopentenyl-diphosphate delta isomerase 2,INTERPRO[450000072$IPR000086:NUDIX hydrolase domain, 450010702$IPR011876:Isopentenyl-diphosphate delta-isomerase, type 1]
isopentenyl-diphosphate delta isomerase 2,KEGG_PATHWAY[470038803$hsa00900:Terpenoid backbone biosynthesis]
isopentenyl-diphosphate delta isomerase 2,PIR_SUPERFAMILY[630015043$PIRSF018427:Isopntndiph_ism]
isopentenyl-diphosphate delta isomerase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000248$carotenoid biosynthesis, 790000304$Cholesterol biosynthesis, 790000356$complete proteome, 790000810$Isomerase, 790000812$Isoprene biosynthesis, 790000874$lipid synthesis, 790000899$magnesium, 790000937$metal-binding, 790001128$peroxisome, 790001440$Steroid biosynthesis, 790001445$sterol biosynthesis]
isopentenyl-diphosphate delta isomerase 2,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850026914$chain:Isopentenyl-diphosphate Delta-isomerase 2, 850104864$domain:Nudix hydrolase, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850117578$short sequence motif:Microbody targeting signal, 850118575$strand, 850118624$turn]
isthmin 1 homolog (zebrafish),INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450004987$IPR005533:AMOP]
isthmin 1 homolog (zebrafish),SMART[760000182$SM00209:TSP1, 760000629$SM00723:AMOP]
isthmin 1 homolog (zebrafish),SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
isthmin 1 homolog (zebrafish),UP_SEQ_FEATURE[850026927$chain:Isthmin-1, 850102883$disulfide bond, 850103041$domain:AMOP, 850105554$domain:TSP type-1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
kallikrein 1,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
kallikrein 1,OMIM_DISEASE[520002707$Kallikrein, decreased urinary activity of]
kallikrein 1,PIR_SUPERFAMILY[630001286$PIRSF001135:trypsin]
kallikrein 1,SMART[760000013$SM00020:Tryp_SPc]
kallikrein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001102$pancreas, 790001212$polymorphism, 790001252$Protease, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001652$zymogen]
kallikrein 1,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850027027$chain:Kallikrein-1, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105806$glycosylation site:N-linked (GlcNAc...); partial, 850105822$glycosylation site:O-linked (GalNAc...), 850105852$helix, 850109636$propeptide:Activation peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
kallikrein-related peptidase 10,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
kallikrein-related peptidase 10,SMART[760000013$SM00020:Tryp_SPc]
kallikrein-related peptidase 10,SP_PIR_KEYWORDS[790000258$cell cycle, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001580$tumor suppressor]
kallikrein-related peptidase 10,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850027028$chain:Kallikrein-10, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
kallikrein-related peptidase 11,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
kallikrein-related peptidase 11,PIR_SUPERFAMILY[630001286$PIRSF001135:trypsin]
kallikrein-related peptidase 11,SMART[760000013$SM00020:Tryp_SPc]
kallikrein-related peptidase 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
kallikrein-related peptidase 11,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850027029$chain:Kallikrein-11, 850027030$chain:Kallikrein-11 inactive chain 1, 850027031$chain:Kallikrein-11 inactive chain 2, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850109636$propeptide:Activation peptide, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
kallikrein-related peptidase 4,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
kallikrein-related peptidase 4,OMIM_DISEASE[520000259$Amelogenesis imperfecta, pigmented hypomaturation type]
kallikrein-related peptidase 4,SMART[760000013$SM00020:Tryp_SPc]
kallikrein-related peptidase 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000058$amelogenesis imperfecta, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000937$metal-binding, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001648$zinc, 790001652$zymogen]
kallikrein-related peptidase 4,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850027038$chain:Kallikrein-4, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106218$metal ion-binding site:Zinc, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
kallikrein-related peptidase 5,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
kallikrein-related peptidase 5,SMART[760000013$SM00020:Tryp_SPc]
kallikrein-related peptidase 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001405$signal]
kallikrein-related peptidase 5,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850027039$chain:Kallikrein-5, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118399$site:Major binding site for inhibitory zinc, 850118575$strand, 850118624$turn]
kaptin (actin binding protein),SP_PIR_KEYWORDS[790000019$actin-binding, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm]
kaptin (actin binding protein),UP_SEQ_FEATURE[850027055$chain:Kaptin, 850117294$sequence conflict]
kelch domain containing 3,INTERPRO[450006067$IPR006652:Kelch repeat type 1, 450010360$IPR011498:Kelch repeat type 2, 450014332$IPR015915:Kelch-type beta propeller]
kelch domain containing 3,SMART[760000541$SM00612:Kelch]
kelch domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000819$kelch repeat, 790000915$meiosis, 790001304$repeat]
kelch domain containing 3,UP_SEQ_FEATURE[850027087$chain:Kelch domain-containing protein 3, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5]
kelch repeat and BTB (POZ) domain containing 4,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010360$IPR011498:Kelch repeat type 2, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller]
kelch repeat and BTB (POZ) domain containing 4,SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch repeat and BTB (POZ) domain containing 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000819$kelch repeat, 790001212$polymorphism, 790001304$repeat]
kelch repeat and BTB (POZ) domain containing 4,UP_SEQ_FEATURE[850027105$chain:Kelch repeat and BTB domain-containing protein 4, 850103083$domain:BACK, 850103177$domain:BTB, 850105852$helix, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
kelch repeat and BTB (POZ) domain containing 5,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch repeat and BTB (POZ) domain containing 5,PIR_SUPERFAMILY[630028538$PIRSF037037:kelch-like protein, gigaxonin type, 630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch repeat and BTB (POZ) domain containing 5,SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch repeat and BTB (POZ) domain containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000819$kelch repeat, 790001212$polymorphism, 790001304$repeat]
kelch repeat and BTB (POZ) domain containing 5,UP_SEQ_FEATURE[850027106$chain:Kelch repeat and BTB domain-containing protein 5, 850102577$compositionally biased region:Poly-Lys, 850103083$domain:BACK, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850117295$sequence variant, 850118574$splice variant]
kelch-like 11 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller]
kelch-like 11 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 11 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000819$kelch repeat, 790001304$repeat, 790001363$Secreted, 790001405$signal]
kelch-like 11 (Drosophila),UP_SEQ_FEATURE[850027127$chain:Kelch-like protein 11, 850103083$domain:BACK, 850103177$domain:BTB, 850105852$helix, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850117814$signal peptide, 850118575$strand, 850118624$turn]
kelch-like 18 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006066$IPR006651:Kelch, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch-like 18 (Drosophila),PIR_SUPERFAMILY[630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch-like 18 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 18 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000819$kelch repeat, 790001304$repeat]
kelch-like 18 (Drosophila),UP_SEQ_FEATURE[850027133$chain:Kelch-like protein 18, 850103083$domain:BACK, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850118574$splice variant]
kelch-like 31 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010360$IPR011498:Kelch repeat type 2, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch-like 31 (Drosophila),PIR_SUPERFAMILY[630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch-like 31 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 31 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000819$kelch repeat, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
kelch-like 31 (Drosophila),UP_SEQ_FEATURE[850027145$chain:Kelch-like protein 31, 850103083$domain:BACK, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117295$sequence variant]
kelch-like 5 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006066$IPR006651:Kelch, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch-like 5 (Drosophila),PIR_SUPERFAMILY[630028538$PIRSF037037:kelch-like protein, gigaxonin type, 630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch-like 5 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 5 (Drosophila),SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000819$kelch repeat, 790001212$polymorphism, 790001304$repeat]
kelch-like 5 (Drosophila),UP_SEQ_FEATURE[850027153$chain:Kelch-like protein 5, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
kelch-like ECH-associated protein 1,BIOCARTA[30000023$h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2]
kelch-like ECH-associated protein 1,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006066$IPR006651:Kelch, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch-like ECH-associated protein 1,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
kelch-like ECH-associated protein 1,PIR_SUPERFAMILY[630028538$PIRSF037037:kelch-like protein, gigaxonin type, 630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch-like ECH-associated protein 1,SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like ECH-associated protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000819$kelch repeat, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
kelch-like ECH-associated protein 1,UP_SEQ_FEATURE[850027124$chain:Kelch-like ECH-associated protein 1, 850103083$domain:BACK, 850103177$domain:BTB, 850106258$modified residue, 850106259$mutagenesis site, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal, 850118575$strand, 850118624$turn]
keratin 32,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002605$IPR002957:Keratin, type I, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 32,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 32,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000821$keratin, 790001212$polymorphism]
keratin 32,UP_SEQ_FEATURE[850027163$chain:Keratin, type I cuticular Ha2, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117295$sequence variant, 850118563$site:Stutter]
keratin 40,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002605$IPR002957:Keratin, type I, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 40,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 40,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000821$keratin, 790001212$polymorphism]
keratin 40,UP_SEQ_FEATURE[850027190$chain:Keratin, type I cytoskeletal 40, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118563$site:Stutter]
keratin 7,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 7,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 7,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000788$Intermediate filament, 790000821$keratin, 790000953$methylation, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 7,UP_SEQ_FEATURE[850027216$chain:Keratin, type II cytoskeletal 7, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850112418$region of interest:Interaction with HPV16 E7, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118563$site:Stutter]
keratin associated protein 13-1,INTERPRO[450007296$IPR007951:PMG]
keratin associated protein 13-1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001304$repeat]
keratin associated protein 13-1,UP_SEQ_FEATURE[850027251$chain:Keratin-associated protein 13-1, 850110454$region of interest:5 X 10 AA approximate repeats, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5]
keratin associated protein 13-2,INTERPRO[450007296$IPR007951:PMG]
keratin associated protein 13-2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001212$polymorphism, 790001304$repeat]
keratin associated protein 13-2,UP_SEQ_FEATURE[850027252$chain:Keratin-associated protein 13-2, 850110454$region of interest:5 X 10 AA approximate repeats, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850117295$sequence variant]
keratin associated protein 13-4,INTERPRO[450007296$IPR007951:PMG]
keratin associated protein 13-4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001212$polymorphism, 790001304$repeat]
keratin associated protein 13-4,UP_SEQ_FEATURE[850027254$chain:Keratin-associated protein 13-4, 850110337$region of interest:4 X 10 AA approximate repeats, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850117295$sequence variant]
keratin associated protein 15-1,INTERPRO[450007296$IPR007951:PMG]
keratin associated protein 15-1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001212$polymorphism]
keratin associated protein 15-1,UP_SEQ_FEATURE[850027256$chain:Keratin-associated protein 15-1, 850117295$sequence variant]
keratin associated protein 4-12,INTERPRO[450002214$IPR002494:Keratin, high sulphur B2 protein]
keratin associated protein 4-12,PIR_SUPERFAMILY[630005492$PIRSF005569:ultra-high-sulfur keratin]
keratin associated protein 4-12,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001304$repeat]
keratin associated protein 4-12,UP_SEQ_FEATURE[850027296$chain:Keratin-associated protein 4-12, 850110317$region of interest:31 X 5 AA repeats of C-C-[GRQVIL]-[SPTR]- [VSTQPC], 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115410$repeat:28, 850115412$repeat:29, 850115417$repeat:3, 850115444$repeat:30, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9]
keratin associated protein 4-5,INTERPRO[450002214$IPR002494:Keratin, high sulphur B2 protein]
keratin associated protein 4-5,PIR_SUPERFAMILY[630005492$PIRSF005569:ultra-high-sulfur keratin]
keratin associated protein 4-5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001212$polymorphism, 790001304$repeat]
keratin associated protein 4-5,UP_SEQ_FEATURE[850027300$chain:Keratin-associated protein 4-5, 850110156$region of interest:26 X 5 AA repeats of C-C-[GRQVCHIEK]- [SPTR]-[VSTQYC], 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117295$sequence variant]
keratin associated protein 4-6; keratin associated protein 4-7; keratin associated protein 4-8; keratin associated protein 4-11,INTERPRO[450002214$IPR002494:Keratin, high sulphur B2 protein]
keratin associated protein 4-6; keratin associated protein 4-7; keratin associated protein 4-8; keratin associated protein 4-11,PIR_SUPERFAMILY[630002379$PIRSF002248:keratin high-sulfur matrix protein IIIA, 630005492$PIRSF005569:ultra-high-sulfur keratin]
keratin associated protein 4-6; keratin associated protein 4-7; keratin associated protein 4-8; keratin associated protein 4-11,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001304$repeat]
keratin associated protein 4-6; keratin associated protein 4-7; keratin associated protein 4-8; keratin associated protein 4-11,UP_SEQ_FEATURE[850027295$chain:Keratin-associated protein 4-11, 850027301$chain:Keratin-associated protein 4-6, 850027302$chain:Keratin-associated protein 4-8, 850051696$chain:Putative keratin-associated protein 4-X, 850110110$region of interest:20 X 5 AA repeats of C-C-[GIKRQVHEML]- [SPTRV]-[STVQRCP], 850110148$region of interest:25 X 5 AA repeats of C-C-[IKRQVHEC]- [SPRT]-[STCVQPR], 850110162$region of interest:27 X 5 AA repeats of C-C-[GIKRQVHEL]- [SPTR]-[STVQRMC], 850110176$region of interest:29 X 5 AA repeats of C-C-[IRQVEL]-[SPTR]- [STVQRCP], 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115410$repeat:28, 850115412$repeat:29, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9]
keratin associated protein 5-5,PIR_SUPERFAMILY[630005492$PIRSF005569:ultra-high-sulfur keratin]
keratin associated protein 5-5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001304$repeat]
keratin associated protein 5-5,UP_SEQ_FEATURE[850027310$chain:Keratin-associated protein 5-5, 850110713$region of interest:8 X 4 AA repeats of C-C-X-P, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850117294$sequence conflict]
keratinocyte proline-rich protein,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
keratinocyte proline-rich protein,UP_SEQ_FEATURE[850027331$chain:Keratinocyte proline-rich protein, 850102485$compositionally biased region:Gln-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117295$sequence variant]
killer cell lectin-like receptor subfamily G, member 2,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
killer cell lectin-like receptor subfamily G, member 2,SMART[760000026$SM00034:CLECT]
killer cell lectin-like receptor subfamily G, member 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
killer cell lectin-like receptor subfamily G, member 2,UP_SEQ_FEATURE[850027414$chain:Killer cell lectin-like receptor subfamily G member 2, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
kinesin family member 13B,INTERPRO[450000219$IPR000253:Forkhead-associated, 450000819$IPR000938:Cytoskeleton-associated protein, CAP-Gly, 450001552$IPR001752:Kinesin, motor region, 450018052$IPR019821:Kinesin, motor region, conserved site]
kinesin family member 13B,PIR_SUPERFAMILY[630002444$PIRSF002321:kinesin protein, Kif1A/Kif1B types]
kinesin family member 13B,SMART[760000111$SM00129:KISc, 760000212$SM00240:FHA]
kinesin family member 13B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790000986$motor protein, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
kinesin family member 13B,UP_SEQ_FEATURE[850027467$chain:Kinesin-like protein KIF13B, 850103282$domain:CAP-Gly, 850103775$domain:FHA, 850104543$domain:Kinesin-motor, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
kinesin family member 1C,INTERPRO[450000219$IPR000253:Forkhead-associated, 450001552$IPR001752:Kinesin, motor region, 450018052$IPR019821:Kinesin, motor region, conserved site]
kinesin family member 1C,PIR_SUPERFAMILY[630002445$PIRSF002322:kinesin-related protein KIF1B]
kinesin family member 1C,SMART[760000111$SM00129:KISc, 760000212$SM00240:FHA]
kinesin family member 1C,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000960$microtubule, 790000986$motor protein, 790001063$nucleotide-binding, 790001162$phosphoprotein]
kinesin family member 1C,UP_SEQ_FEATURE[850027479$chain:Kinesin-like protein KIF1C, 850102586$compositionally biased region:Pro-rich, 850103775$domain:FHA, 850104543$domain:Kinesin-motor, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
kinesin family member 22,INTERPRO[450001552$IPR001752:Kinesin, motor region, 450003148$IPR003583:Helix-hairpin-helix DNA-binding, class 1, 450018052$IPR019821:Kinesin, motor region, conserved site]
kinesin family member 22,PIR_SUPERFAMILY[630002441$PIRSF002318:kinesin-like protein KIF22]
kinesin family member 22,SMART[760000111$SM00129:KISc, 760000249$SM00278:HhH1]
kinesin family member 22,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790000960$microtubule, 790000986$motor protein, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
kinesin family member 22,UP_SEQ_FEATURE[850027484$chain:Kinesin-like protein KIF22, 850104543$domain:Kinesin-motor, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
kinesin family member 2B,INTERPRO[450001552$IPR001752:Kinesin, motor region, 450018052$IPR019821:Kinesin, motor region, conserved site]
kinesin family member 2B,PIR_SUPERFAMILY[630002446$PIRSF002323:kinesin-related protein KIF2]
kinesin family member 2B,SMART[760000111$SM00129:KISc]
kinesin family member 2B,SP_PIR_KEYWORDS[790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000827$kinetochore, 790000960$microtubule, 790000973$mitosis, 790000986$motor protein, 790001063$nucleotide-binding, 790001212$polymorphism]
kinesin family member 2B,UP_SEQ_FEATURE[850027492$chain:Kinesin-like protein KIF2B, 850104543$domain:Kinesin-motor, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
kinesin heavy chain member 2A,BBID[10000054$28.KLFs_cytoplas_dynein_cargo_nerve_axons, 10000056$30.Kinesin_superfamily_proteins]
kinesin heavy chain member 2A,INTERPRO[450001552$IPR001752:Kinesin, motor region, 450018052$IPR019821:Kinesin, motor region, conserved site]
kinesin heavy chain member 2A,PIR_SUPERFAMILY[630002446$PIRSF002323:kinesin-related protein KIF2]
kinesin heavy chain member 2A,SMART[760000111$SM00129:KISc]
kinesin heavy chain member 2A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000434$differentiation, 790000960$microtubule, 790000986$motor protein, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001162$phosphoprotein]
kinesin heavy chain member 2A,UP_SEQ_FEATURE[850027491$chain:Kinesin-like protein KIF2A, 850104543$domain:Kinesin-motor, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111754$region of interest:Globular, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
kinesin light chain 4,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450001908$IPR002151:Kinesin light chain, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450013832$IPR015390:Rabaptin, GTPase-Rab5 binding, 450014226$IPR015792:Kinesin light chain repeat, 450017972$IPR019734:Tetratricopeptide repeat]
kinesin light chain 4,SMART[760000020$SM00028:TPR]
kinesin light chain 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000960$microtubule, 790000986$motor protein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
kinesin light chain 4,UP_SEQ_FEATURE[850027439$chain:Kinesin light chain 4, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
kininogen 1,BIOCARTA[30000165$h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway]
kininogen 1,INTERPRO[450000008$IPR000010:Proteinase inhibitor I25, cystatin, 450002128$IPR002395:HMW kininogen, 450016374$IPR018073:Proteinase inhibitor I25, cystatin, conserved site]
kininogen 1,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
kininogen 1,OMIM_DISEASE[520001913$Fitzgerald factor deficiency, 520002334$High molecular weight kininogen deficiency, 520002335$High-molecular-weight kininogen deficiency, 520002744$Kininogen deficiency]
kininogen 1,SMART[760000035$SM00043:CY]
kininogen 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000192$blood coagulation, 790000198$bradykinin, 790000356$complete proteome, 790000398$cysteine proteinase inhibitor, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000745$hydroxylation, 790000747$hydroxyproline, 790000775$inflammatory response, 790001162$phosphoprotein, 790001191$plasma, 790001212$polymorphism, 790001253$protease inhibitor, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat, 790001510$thiol protease inhibitor, 790001606$vasoactive, 790001608$vasodilator]
kininogen 1,UP_SEQ_FEATURE[850027560$chain:Kininogen-1, 850027561$chain:Kininogen-1 heavy chain, 850027562$chain:Kininogen-1 light chain, 850102540$compositionally biased region:His-rich, 850102883$disulfide bond, 850103469$domain:Cystatin 1, 850103470$domain:Cystatin 2, 850103471$domain:Cystatin 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106258$modified residue, 850106774$peptide:Bradykinin, 850108110$peptide:Low molecular weight growth-promoting factor, 850108134$peptide:Lysyl-bradykinin, 850109303$peptide:T-kinin, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118073$site:Cleavage; by kallikrein, 850118450$site:Not glycosylated, 850118574$splice variant]
lamin B1,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
lamin B1,INTERPRO[450001165$IPR001322:Intermediate filament, C-terminal, 450001474$IPR001664:Intermediate filament protein, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
lamin B1,OMIM_DISEASE[520002877$Leukodystrophy, adult-onset, autosomal dominant]
lamin B1,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
lamin B1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000788$Intermediate filament, 790000856$leukodystrophy, 790000881$lipoprotein, 790000919$membrane, 790000924$membrane protein, 790000952$methylated carboxyl end, 790001047$nuclear membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001235$prenylated cysteine, 790001236$prenylation, 790001452$structural protein]
lamin B1,UP_SEQ_FEATURE[850027917$chain:Lamin-B1, 850102510$compositionally biased region:Glu-rich (highly acidic; could be involved in chromatin binding), 850105890$lipid moiety-binding region:S-farnesyl cysteine, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand, 850118624$turn]
lamin B2,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
lamin B2,INTERPRO[450001165$IPR001322:Intermediate filament, C-terminal, 450001474$IPR001664:Intermediate filament protein, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
lamin B2,OMIM_DISEASE[520002910$Lipodystrophy, partial, acquired]
lamin B2,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
lamin B2,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000788$Intermediate filament, 790000881$lipoprotein, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001236$prenylation]
lamin B2,UP_SEQ_FEATURE[850027918$chain:Lamin-B2, 850102469$compositionally biased region:Asp/Glu-rich (highly acidic; could be involved in chromatin binding), 850105890$lipid moiety-binding region:S-farnesyl cysteine, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
late cornified envelope 2C,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 2C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization]
late cornified envelope 2C,UP_SEQ_FEATURE[850028028$chain:Late cornified envelope protein 2C, 850102480$compositionally biased region:Cys-rich]
late cornified envelope 4A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 4A,UP_SEQ_FEATURE[850028035$chain:Late cornified envelope protein 4A, 850102480$compositionally biased region:Cys-rich, 850117295$sequence variant]
latent transforming growth factor beta binding protein 4,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450001962$IPR002212:Matrix fibril-associated, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016196$IPR017878:TGF-beta binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
latent transforming growth factor beta binding protein 4,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
latent transforming growth factor beta binding protein 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000530$extracellular matrix, 790000616$glycoprotein, 790000633$Growth factor binding, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
latent transforming growth factor beta binding protein 4,UP_SEQ_FEATURE[850028086$chain:Latent-transforming growth factor beta- binding protein 4, 850102480$compositionally biased region:Cys-rich, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103600$domain:EGF-like 10; calcium-binding, 850103602$domain:EGF-like 11; calcium-binding, 850103604$domain:EGF-like 12; calcium-binding, 850103606$domain:EGF-like 13; calcium-binding, 850103608$domain:EGF-like 14; calcium-binding, 850103609$domain:EGF-like 15, 850103611$domain:EGF-like 16, 850103644$domain:EGF-like 2; calcium-binding, 850103646$domain:EGF-like 3, 850103687$domain:EGF-like 4; calcium-binding, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850103699$domain:EGF-like 7; calcium-binding, 850103701$domain:EGF-like 8; calcium-binding, 850103703$domain:EGF-like 9; calcium-binding, 850105465$domain:TB 1, 850105466$domain:TB 2, 850105467$domain:TB 3, 850105468$domain:TB 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
legumain,INTERPRO[450000961$IPR001096:Peptidase C13, legumain]
legumain,KEGG_PATHWAY[470038840$hsa04142:Lysosome, 470038860$hsa04612:Antigen processing and presentation]
legumain,PIR_SUPERFAMILY[630016242$PIRSF019663:transamidase/peptidase, legumain type, 630030403$PIRSF500139:asparaginyl endopeptidase]
legumain,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790001192$plasmid, 790001212$polymorphism, 790001252$Protease, 790001405$signal, 790001509$thiol protease, 790001652$zymogen]
legumain,UP_SEQ_FEATURE[850028212$chain:Legumain, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118006$site:Cleavage; by autolysis]
leptin,BIOCARTA[30000172$h_leptinPathway:Reversal of Insulin Resistance by Leptin]
leptin,INTERPRO[450000054$IPR000065:Obesity factor, 450011046$IPR012351:Four-helical cytokine, core]
leptin,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway]
leptin,OMIM_DISEASE[520003714$Obesity, morbid, with hypogonadism, 520003718$Obesity, severe, due to leptin deficiency]
leptin,PIR_SUPERFAMILY[630001976$PIRSF001837:Leptin]
leptin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000027$adipose tissue, 790000356$complete proteome, 790000430$diabetes mellitus, 790000446$disease mutation, 790000447$disulfide bond, 790001067$obesity, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
leptin,UP_SEQ_FEATURE[850028249$chain:Leptin, 850102883$disulfide bond, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
lethal giant larvae homolog 1 (Drosophila),INTERPRO[450000567$IPR000664:Lethal(2) giant larvae protein, 450001490$IPR001680:WD40 repeat, 450012201$IPR013577:Lethal giant larvae homologue 2, 450014355$IPR015943:WD40/YVTN repeat-like, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
lethal giant larvae homolog 1 (Drosophila),KEGG_PATHWAY[470038857$hsa04530:Tight junction]
lethal giant larvae homolog 1 (Drosophila),PIR_SUPERFAMILY[630008420$PIRSF009275:lethal(2) giant larvae protein homolog 1/2]
lethal giant larvae homolog 1 (Drosophila),SMART[760000289$SM00320:WD40]
lethal giant larvae homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000522$exocytosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
lethal giant larvae homolog 1 (Drosophila),UP_SEQ_FEATURE[850028257$chain:Lethal(2) giant larvae protein homolog 1, 850106258$modified residue, 850117171$repeat:WD 1, 850117172$repeat:WD 10, 850117173$repeat:WD 11, 850117174$repeat:WD 12, 850117175$repeat:WD 13, 850117176$repeat:WD 14, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117199$repeat:WD 8, 850117200$repeat:WD 9, 850117294$sequence conflict, 850117295$sequence variant]
leucine rich repeat (in FLII) interacting protein 2,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
leucine rich repeat (in FLII) interacting protein 2,INTERPRO[450017385$IPR019139:Leucine-rich repeat flightless-interacting protein]
leucine rich repeat (in FLII) interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001642$wnt signaling pathway]
leucine rich repeat (in FLII) interacting protein 2,UP_SEQ_FEATURE[850028334$chain:Leucine-rich repeat flightless- interacting protein 2, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850111545$region of interest:DVL3-binding, 850117295$sequence variant, 850118574$splice variant]
leucine rich repeat and Ig domain containing 3,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
leucine rich repeat and Ig domain containing 3,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2]
leucine rich repeat and Ig domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine rich repeat and Ig domain containing 3,UP_SEQ_FEATURE[850028324$chain:Leucine-rich repeat and immunoglobulin- like domain-containing nogo receptor- interacting protein 3, 850102565$compositionally biased region:Poly-Ala, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
leucine rich repeat containing 27,COG_ONTOLOGY[90000070$Function unknown]
leucine rich repeat containing 27,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
leucine rich repeat containing 27,SMART[760000333$SM00369:LRR_TYP]
leucine rich repeat containing 27,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat]
leucine rich repeat containing 27,UP_SEQ_FEATURE[850028381$chain:Leucine-rich repeat-containing protein 27, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
leucine rich repeat containing 4B,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
leucine rich repeat containing 4B,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2]
leucine rich repeat containing 4B,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001405$signal, 790001475$synapse, 790001555$transmembrane]
leucine rich repeat containing 4B,UP_SEQ_FEATURE[850028408$chain:Leucine-rich repeat-containing protein 4B, 850102517$compositionally biased region:Gly-rich, 850102565$compositionally biased region:Poly-Ala, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
leucine rich repeat containing 59,COG_ONTOLOGY[90000070$Function unknown]
leucine rich repeat containing 59,INTERPRO[450001429$IPR001611:Leucine-rich repeat]
leucine rich repeat containing 59,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000853$leucine-rich repeat, 790000919$membrane, 790000959$microsome, 790001162$phosphoprotein, 790001304$repeat, 790001409$Signal-anchor, 790001555$transmembrane]
leucine rich repeat containing 59,UP_SEQ_FEATURE[850028418$chain:Leucine-rich repeat-containing protein 59, 850102576$compositionally biased region:Poly-Leu, 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
leucine rich repeat containing 8 family, member A,COG_ONTOLOGY[90000070$Function unknown]
leucine rich repeat containing 8 family, member A,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
leucine rich repeat containing 8 family, member A,OMIM_DISEASE[520000169$Agammaglobulinemia, non-Bruton type]
leucine rich repeat containing 8 family, member A,SMART[760000333$SM00369:LRR_TYP]
leucine rich repeat containing 8 family, member A,SP_PIR_KEYWORDS[790000012$acetylation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000434$differentiation, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane]
leucine rich repeat containing 8 family, member A,UP_SEQ_FEATURE[850028429$chain:Leucine-rich repeat-containing protein 8A, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
leucine rich repeat containing 8 family, member D,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
leucine rich repeat containing 8 family, member D,SMART[760000333$SM00369:LRR_TYP]
leucine rich repeat containing 8 family, member D,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
leucine rich repeat containing 8 family, member D,UP_SEQ_FEATURE[850028432$chain:Leucine-rich repeat-containing protein 8D, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117295$sequence variant, 850118623$transmembrane region]
leucine zipper-EF-hand containing transmembrane protein 1,INTERPRO[450010513$IPR011685:LETM1-like, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
leucine zipper-EF-hand containing transmembrane protein 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000211$calcium, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001162$phosphoprotein, 790001550$transit peptide, 790001555$transmembrane]
leucine zipper-EF-hand containing transmembrane protein 1,UP_SEQ_FEATURE[850028264$chain:LETM1 and EF-hand domain-containing protein 1, mitochondrial, 850102580$compositionally biased region:Poly-Pro, 850103571$domain:EF-hand, 850104711$domain:LETM1, 850106258$modified residue, 850118574$splice variant, 850118594$topological domain:Mitochondrial intermembrane, 850118596$topological domain:Mitochondrial matrix, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
leucine-rich repeat kinase 1,COG_ONTOLOGY[90000070$Function unknown]
leucine-rich repeat kinase 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001429$IPR001611:Leucine-rich repeat, 450001870$IPR002110:Ankyrin, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012305$IPR013684:Miro-like, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
leucine-rich repeat kinase 1,SMART[760000220$SM00248:ANK, 760000333$SM00369:LRR_TYP]
leucine-rich repeat kinase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000639$gtp-binding, 790000825$kinase, 790000853$leucine-rich repeat, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001388$serine/threonine-protein kinase, 790001547$transferase]
leucine-rich repeat kinase 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850028348$chain:Leucine-rich repeat serine/threonine- protein kinase 1, 850105086$domain:Protein kinase, 850105206$domain:Roc, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
leucine-rich repeats and death domain containing,COG_ONTOLOGY[90000070$Function unknown]
leucine-rich repeats and death domain containing,INTERPRO[450000415$IPR000488:Death, 450000789$IPR000906:ZU5, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450010009$IPR011029:DEATH-like, 450017739$IPR019502:Peptidase S68, piddosome]
leucine-rich repeats and death domain containing,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
leucine-rich repeats and death domain containing,SMART[760000004$SM00005:DEATH, 760000191$SM00218:ZU5, 760000333$SM00369:LRR_TYP]
leucine-rich repeats and death domain containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000853$leucine-rich repeat, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
leucine-rich repeats and death domain containing,UP_SEQ_FEATURE[850028309$chain:Leucine-rich repeat and death domain- containing protein, 850103507$domain:Death, 850104972$domain:Peptidase S68, 850105754$domain:ZU5 1, 850105755$domain:ZU5 2, 850105852$helix, 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
leucine-rich repeats and immunoglobulin-like domains 1,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
leucine-rich repeats and immunoglobulin-like domains 1,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
leucine-rich repeats and immunoglobulin-like domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine-rich repeats and immunoglobulin-like domains 1,UP_SEQ_FEATURE[850028452$chain:Leucine-rich repeats and immunoglobulin- like domains protein 1, 850102581$compositionally biased region:Poly-Ser, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
leucyl-tRNA synthetase,INTERPRO[450001257$IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site, 450003988$IPR004493:Leucyl-tRNA synthetase, class Ia, archaeal/eukaryotic cytosolic, 450011792$IPR013155:Valyl/Leucyl/Isoleucyl-tRNA synthetase, class I, anticodon-binding, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold, 450013855$IPR015413:Aminoacyl-tRNA synthetase, class I (M)]
leucyl-tRNA synthetase,KEGG_PATHWAY[470038749$hsa00290:Valine, leucine and isoleucine biosynthesis, 470038807$hsa00970:Aminoacyl-tRNA biosynthesis]
leucyl-tRNA synthetase,PIR_SUPERFAMILY[630001688$PIRSF001521:cytosolic leucyl-tRNA synthetase]
leucyl-tRNA synthetase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000066$Aminoacyl-tRNA synthetase, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000859$ligase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis]
leucyl-tRNA synthetase,UP_SEQ_FEATURE[850000242$binding site:ATP, 850028468$chain:Leucyl-tRNA synthetase, cytoplasmic, 850105852$helix, 850106258$modified residue, 850111564$region of interest:Editing domain, 850117294$sequence conflict, 850117295$sequence variant, 850117296$short sequence motif:"HIGH" region, 850117297$short sequence motif:"KMSKS" region, 850118575$strand, 850118624$turn]
ligand dependent nuclear receptor corepressor-like,INTERPRO[450007237$IPR007889:Helix-turn-helix, Psq, 450010388$IPR011526:Helix-turn-helix, Psq-like]
ligand dependent nuclear receptor corepressor-like,OMIM_DISEASE[520001993$Genome-wide association analysis identifies 20 loci that influence adult height, 520003072$Many sequence variants affecting diversity of adult human height, 520004690$Stature, QTL 13]
ligand dependent nuclear receptor corepressor-like,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
ligand dependent nuclear receptor corepressor-like,UP_SEQ_FEATURE[850028554$chain:Ligand-dependent nuclear receptor corepressor-like protein, 850102378$compositionally biased region:Ala-rich, 850102916$DNA-binding region:H-T-H motif, 850104179$domain:HTH psq-type, 850117294$sequence conflict, 850118574$splice variant]
lin-7 homolog B (C. elegans),INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450003682$IPR004172:L27, 450013225$IPR014775:L27, C-terminal, 450015689$IPR017365:Lin-7 homologue]
lin-7 homolog B (C. elegans),PIR_SUPERFAMILY[630029624$PIRSF038039:Lin-7 homolog, 630029625$PIRSF038039:Lin-7_homologue]
lin-7 homolog B (C. elegans),SMART[760000200$SM00228:PDZ, 760000506$SM00569:L27]
lin-7 homolog B (C. elegans),SP_PIR_KEYWORDS[790000002$3d-structure, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000522$exocytosis, 790000919$membrane, 790001223$postsynaptic cell membrane, 790001266$protein transport, 790001475$synapse, 790001477$Synaptosome, 790001528$Tight junction, 790001558$transport]
lin-7 homolog B (C. elegans),UP_SEQ_FEATURE[850046712$chain:Protein lin-7 homolog B, 850104597$domain:L27, 850104918$domain:PDZ, 850105852$helix, 850117532$short sequence motif:Kinase interacting site, 850118575$strand]
lipase, hepatic,INTERPRO[450000631$IPR000734:Lipase, 450000897$IPR001024:Lipoxygenase, LH2, 450002076$IPR002333:Hepatic lipase, 450012422$IPR013818:Lipase, N-terminal, 450014596$IPR016272:Lipoprotein lipase, LIPH]
lipase, hepatic,KEGG_PATHWAY[470038775$hsa00561:Glycerolipid metabolism]
lipase, hepatic,OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520001498$Diabetes mellitus, noninsulin-dependent, 520001986$Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis, 520001989$Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum, 520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, 520002284$Hepatic lipase deficiency, 520002327$High density lipoprotein cholesterol level QTL 12, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
lipase, hepatic,PIR_SUPERFAMILY[630001000$PIRSF000865:lipoprotein lipase, LIPH type, 630001001$PIRSF000865:Lipoprotein_lipase_LIPH]
lipase, hepatic,SMART[760000278$SM00308:LH2]
lipase, hepatic,SP_PIR_KEYWORDS[790000241$carboxylic ester hydrolase, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000616$glycoprotein, 790000643$hdl, 790000669$heparin-binding, 790000743$hydrolase, 790000869$lipid degradation, 790000870$lipid digestion, 790000873$lipid metabolism, 790000885$liver, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
lipase, hepatic,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000090$active site:Nucleophile, 850023482$chain:Hepatic triacylglycerol lipase, 850105029$domain:PLAT, 850105770$glycosylation site:N-linked (GlcNAc...), 850111863$region of interest:Heparin-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
lipin 1,INTERPRO[450007008$IPR007651:Lipin, N-terminal conserved region, 450011846$IPR013209:LNS2, Lipin/Ned1/Smp2]
lipin 1,OMIM_DISEASE[520003481$Myoglobinuria, acute recurrent, autosomal recessive]
lipin 1,SMART[760000680$SM00775:LNS2]
lipin 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000543$fatty acid metabolism, 790000743$hydrolase, 790000811$isopeptide bond, 790000873$lipid metabolism, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
lipin 1,UP_SEQ_FEATURE[850038374$chain:Phosphatidate phosphatase LPIN1, 850102581$compositionally biased region:Poly-Ser, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850111125$region of interest:C-LIP, 850113515$region of interest:N-LIP, 850117295$sequence variant, 850117435$short sequence motif:DXDXT motif, 850117556$short sequence motif:LXXIL motif, 850117610$short sequence motif:Nuclear localization signal]
lipocalin 2,INTERPRO[450000483$IPR000566:Lipocalin-related protein and Bos/Can/Equ allergen, 450002086$IPR002345:Lipocalin, 450002713$IPR003087:Neutrophil gelatinase-associated lipocalin, 450011355$IPR012674:Calycin]
lipocalin 2,PIR_SUPERFAMILY[630002634$PIRSF002514:lipocalin, 630030509$PIRSF500262:neutrophil gelatinase-associated lipocalin]
lipocalin 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal]
lipocalin 2,UP_SEQ_FEATURE[850034169$chain:Neutrophil gelatinase-associated lipocalin, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand, 850118624$turn]
lipoic acid synthetase,INTERPRO[450003242$IPR003698:Lipoate synthase, 450006056$IPR006638:Elongator protein 3/MiaB/NifB, 450006568$IPR007197:Radical SAM, 450012397$IPR013785:Aldolase-type TIM barrel]
lipoic acid synthetase,KEGG_PATHWAY[470038799$hsa00785:Lipoic acid metabolism]
lipoic acid synthetase,PIR_SUPERFAMILY[630005901$PIRSF005963:Lipoyl_synth]
lipoic acid synthetase,SMART[760000635$SM00729:Elp3]
lipoic acid synthetase,SP_PIR_KEYWORDS[790000005$4fe-4s, 790000356$complete proteome, 790000802$iron, 790000806$iron-sulfur, 790000937$metal-binding, 790000969$mitochondrion, 790001348$s-adenosyl-l-methionine, 790001547$transferase, 790001550$transit peptide]
lipoic acid synthetase,UP_SEQ_FEATURE[850028882$chain:Lipoyl synthase, mitochondrial, 850106082$metal ion-binding site:Iron-sulfur 1 (4Fe-4S), 850106092$metal ion-binding site:Iron-sulfur 2 (4Fe-4S-S-AdoMet), 850117294$sequence conflict, 850118617$transit peptide:Mitochondrion]
lipoma HMGIC fusion partner-like 3,INTERPRO[450017610$IPR019372:Lipoma HMGIC fusion partner-like protein]
lipoma HMGIC fusion partner-like 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
lipoma HMGIC fusion partner-like 3,UP_SEQ_FEATURE[850028784$chain:Lipoma HMGIC fusion partner-like 3 protein, 850118623$transmembrane region]
low density lipoprotein receptor,BIOCARTA[30000118$h_fxrPathway:FXR and LXR Regulation of Cholesterol Metabolism, 30000170$h_LDLpathway:Low-density lipoprotein (LDL) pathway during atherogenesis, 30000264$h_s1pPathway:SREBP control of lipid synthesis]
low density lipoprotein receptor,INTERPRO[450000026$IPR000033:Low-density lipoprotein receptor, YWTD repeat, 450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
low density lipoprotein receptor,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
low density lipoprotein receptor,OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, 520002416$Hypercholesterolemia, familial, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
low density lipoprotein receptor,PIR_SUPERFAMILY[630002100$PIRSF001961:LDL receptor]
low density lipoprotein receptor,SMART[760000117$SM00135:LY, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000166$SM00192:LDLa]
low density lipoprotein receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000303$cholesterol, 790000305$cholesterol metabolism, 790000334$coated pit, 790000335$coated pits, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000473$duplication, 790000481$egf-like domain, 790000496$Endocytosis, 790000616$glycoprotein, 790000733$host-virus interaction, 790000842$LDL, 790000873$lipid metabolism, 790000875$lipid transport, 790000881$lipoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001442$steroid metabolism, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
low density lipoprotein receptor,UP_SEQ_FEATURE[850029114$chain:low-density lipoprotein receptor, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103646$domain:EGF-like 3, 850104665$domain:LDL-receptor class A 1, 850104678$domain:LDL-receptor class A 2, 850104691$domain:LDL-receptor class A 3, 850104700$domain:LDL-receptor class A 4, 850104701$domain:LDL-receptor class A 5, 850104703$domain:LDL-receptor class A 6, 850104705$domain:LDL-receptor class A 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111262$region of interest:Clustered O-linked oligosaccharides, 850116264$repeat:LDL-receptor class B 1, 850116275$repeat:LDL-receptor class B 2, 850116286$repeat:LDL-receptor class B 3, 850116295$repeat:LDL-receptor class B 4, 850116296$repeat:LDL-receptor class B 5, 850116297$repeat:LDL-receptor class B 6, 850117295$sequence variant, 850117444$short sequence motif:Endocytosis signal, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
low density lipoprotein receptor class A domain containing 1,INTERPRO[450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich]
low density lipoprotein receptor class A domain containing 1,SMART[760000166$SM00192:LDLa]
low density lipoprotein receptor class A domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000881$lipoprotein, 790000919$membrane, 790001301$receptor, 790001304$repeat, 790001555$transmembrane]
low density lipoprotein receptor class A domain containing 1,UP_SEQ_FEATURE[850029117$chain:Low-density lipoprotein receptor class A domain-containing protein 1, 850102883$disulfide bond, 850104665$domain:LDL-receptor class A 1, 850104689$domain:LDL-receptor class A 2; atypical, 850104699$domain:LDL-receptor class A 3; atypical, 850118574$splice variant, 850118623$transmembrane region]
low density lipoprotein receptor class A domain containing 3,INTERPRO[450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich]
low density lipoprotein receptor class A domain containing 3,SMART[760000166$SM00192:LDLa]
low density lipoprotein receptor class A domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000881$lipoprotein, 790000919$membrane, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
low density lipoprotein receptor class A domain containing 3,UP_SEQ_FEATURE[850029119$chain:Low-density lipoprotein receptor class A domain-containing protein 3, 850102580$compositionally biased region:Poly-Pro, 850102883$disulfide bond, 850104665$domain:LDL-receptor class A 1, 850104678$domain:LDL-receptor class A 2, 850104691$domain:LDL-receptor class A 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
low density lipoprotein receptor-related protein 5-like,INTERPRO[450000026$IPR000033:Low-density lipoprotein receptor, YWTD repeat]
low density lipoprotein receptor-related protein 5-like,SMART[760000117$SM00135:LY]
low density lipoprotein receptor-related protein 5-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
low density lipoprotein receptor-related protein 5-like,UP_SEQ_FEATURE[850029133$chain:Low-density lipoprotein receptor-related protein 5-like protein, 850116264$repeat:LDL-receptor class B 1, 850116275$repeat:LDL-receptor class B 2, 850116286$repeat:LDL-receptor class B 3, 850116295$repeat:LDL-receptor class B 4, 850116296$repeat:LDL-receptor class B 5, 850117295$sequence variant, 850118574$splice variant]
lymphocyte antigen 86,INTERPRO[450002789$IPR003172:MD-2-related lipid-recognition]
lymphocyte antigen 86,SMART[760000643$SM00737:ML]
lymphocyte antigen 86,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000763$immune response, 790000775$inflammatory response, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
lymphocyte antigen 86,UP_SEQ_FEATURE[850029239$chain:Lymphocyte antigen 86, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
lymphocyte-activation gene 3,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold, 450014058$IPR015621:Interleukin-1 receptor]
lymphocyte-activation gene 3,SMART[760000357$SM00409:IG]
lymphocyte-activation gene 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
lymphocyte-activation gene 3,UP_SEQ_FEATURE[850029221$chain:Lymphocyte activation gene 3 protein, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850109809$region of interest:12 X 2 AA tandem repeats of E-X, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
lysine (K)-specific demethylase 4B,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002638$IPR002999:Tudor domain, 450002921$IPR003347:Transcription factor jumonji/aspartyl beta-hydroxylase, 450002923$IPR003349:Transcription factor jumonji, JmjN, 450011770$IPR013129:Transcription factor jumonji, 450017293$IPR019023:Lamin-B receptor of TUDOR domain, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
lysine (K)-specific demethylase 4B,SMART[760000221$SM00249:PHD, 760000302$SM00333:TUDOR, 760000485$SM00545:JmjN, 760000497$SM00558:JmjC]
lysine (K)-specific demethylase 4B,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
lysine (K)-specific demethylase 4B,UP_SEQ_FEATURE[850000225$binding site:Alpha-ketoglutarate, 850029304$chain:Lysine-specific demethylase 4B, 850102586$compositionally biased region:Pro-rich, 850104488$domain:JmjC, 850104489$domain:JmjN, 850105584$domain:Tudor 1, 850105585$domain:Tudor 2, 850106100$metal ion-binding site:Iron; catalytic, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
lysine (K)-specific demethylase 4C,COG_ONTOLOGY[90000073$General function prediction only]
lysine (K)-specific demethylase 4C,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450002638$IPR002999:Tudor domain, 450002921$IPR003347:Transcription factor jumonji/aspartyl beta-hydroxylase, 450002923$IPR003349:Transcription factor jumonji, JmjN, 450011770$IPR013129:Transcription factor jumonji, 450018019$IPR019786:Zinc finger, PHD-type, conserved site]
lysine (K)-specific demethylase 4C,SMART[760000221$SM00249:PHD, 760000302$SM00333:TUDOR, 760000485$SM00545:JmjN, 760000497$SM00558:JmjC]
lysine (K)-specific demethylase 4C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
lysine (K)-specific demethylase 4C,UP_SEQ_FEATURE[850000225$binding site:Alpha-ketoglutarate, 850029305$chain:Lysine-specific demethylase 4C, 850104488$domain:JmjC, 850104489$domain:JmjN, 850105584$domain:Tudor 1, 850105585$domain:Tudor 2, 850106100$metal ion-binding site:Iron; catalytic, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
lysine (K)-specific demethylase 5C,INTERPRO[450001424$IPR001606:AT-rich interaction region, 450001740$IPR001965:Zinc finger, PHD-type, 450002921$IPR003347:Transcription factor jumonji/aspartyl beta-hydroxylase, 450002923$IPR003349:Transcription factor jumonji, JmjN, 450003707$IPR004198:Zinc finger, C5HC2-type, 450011770$IPR013129:Transcription factor jumonji, 450012259$IPR013637:PLU-1-like, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
lysine (K)-specific demethylase 5C,OMIM_DISEASE[520003221$Mental retardation, X-linked, syndromic, JARID1C-related]
lysine (K)-specific demethylase 5C,SMART[760000221$SM00249:PHD, 760000444$SM00501:BRIGHT, 760000485$SM00545:JmjN, 760000497$SM00558:JmjC]
lysine (K)-specific demethylase 5C,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000437$dioxygenase, 790000446$disease mutation, 790000802$iron, 790000930$mental retardation, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
lysine (K)-specific demethylase 5C,UP_SEQ_FEATURE[850029310$chain:Lysine-specific demethylase 5C, 850103060$domain:ARID, 850104488$domain:JmjC, 850104489$domain:JmjN, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
lysine (K)-specific demethylase 6A,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450002921$IPR003347:Transcription factor jumonji/aspartyl beta-hydroxylase, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011770$IPR013129:Transcription factor jumonji, 450017972$IPR019734:Tetratricopeptide repeat]
lysine (K)-specific demethylase 6A,SMART[760000020$SM00028:TPR, 760000497$SM00558:JmjC]
lysine (K)-specific demethylase 6A,SP_PIR_KEYWORDS[790000311$chromatin regulator, 790000356$complete proteome, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
lysine (K)-specific demethylase 6A,UP_SEQ_FEATURE[850029312$chain:Lysine-specific demethylase 6A, 850102565$compositionally biased region:Poly-Ala, 850104488$domain:JmjC, 850106258$modified residue, 850106259$mutagenesis site, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117294$sequence conflict, 850117295$sequence variant]
lysocardiolipin acyltransferase 1,INTERPRO[450001881$IPR002123:Phospholipid/glycerol acyltransferase]
lysocardiolipin acyltransferase 1,KEGG_PATHWAY[470038754$hsa00350:Tyrosine metabolism, 470038755$hsa00360:Phenylalanine metabolism, 470038775$hsa00561:Glycerolipid metabolism, 470038778$hsa00564:Glycerophospholipid metabolism, 470038779$hsa00565:Ether lipid metabolism, 470038804$hsa00903:Limonene and pinene degradation]
lysocardiolipin acyltransferase 1,SMART[760000502$SM00563:PlsC]
lysocardiolipin acyltransferase 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000499$endoplasmic reticulum, 790000919$membrane, 790001156$phospholipid biosynthesis, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
lysocardiolipin acyltransferase 1,UP_SEQ_FEATURE[850029335$chain:Lysocardiolipin acyltransferase 1, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117491$short sequence motif:HXXXXD motif, 850118574$splice variant, 850118623$transmembrane region]
lysophosphatidylcholine acyltransferase 1,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
lysophosphatidylcholine acyltransferase 1,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450001881$IPR002123:Phospholipid/glycerol acyltransferase, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
lysophosphatidylcholine acyltransferase 1,SMART[760000046$SM00054:EFh, 760000502$SM00563:PlsC]
lysophosphatidylcholine acyltransferase 1,SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000211$calcium, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000919$membrane, 790001156$phospholipid biosynthesis, 790001304$repeat, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
lysophosphatidylcholine acyltransferase 1,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850029346$chain:Lysophosphatidylcholine acyltransferase 1, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117418$short sequence motif:Di-lysine motif, 850117491$short sequence motif:HXXXXD motif, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
lysozyme G-like 2,INTERPRO[450001909$IPR002152:Glycoside hydrolase, family 23, 450007553$IPR008258:Lytic transglycosylase-like, catalytic]
lysozyme G-like 2,PIR_SUPERFAMILY[630001214$PIRSF001065:lysozyme g, 630001215$PIRSF001065:Lysozyme_g]
lysozyme G-like 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000617$glycosidase, 790000743$hydrolase, 790001363$Secreted, 790001405$signal]
lysozyme G-like 2,UP_SEQ_FEATURE[850029413$chain:Lysozyme g-like protein 2, 850102883$disulfide bond, 850117294$sequence conflict, 850117814$signal peptide]
macrophage stimulating, pseudogene 9,BIOCARTA[30000193$h_mspPathway:Msp/Ron Receptor Signaling Pathway]
macrophage stimulating, pseudogene 9,INTERPRO[450000001$IPR000001:Kringle, 450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450002648$IPR003014:PAN-1 domain, 450003169$IPR003609:Apple-like, 450016359$IPR018056:Kringle, conserved site, 450016361$IPR018059:Kringle, subgroup]
macrophage stimulating, pseudogene 9,PIR_SUPERFAMILY[630001301$PIRSF001152:hepatocyte growth factor/macrophage stimulating protein 1]
macrophage stimulating, pseudogene 9,SMART[760000013$SM00020:Tryp_SPc, 760000112$SM00130:KR, 760000418$SM00473:PAN_AP]
macrophage stimulating, pseudogene 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000743$hydrolase, 790000830$kringle, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001384$Serine protease homolog, 790001405$signal]
macrophage stimulating, pseudogene 9,UP_SEQ_FEATURE[850051864$chain:Putative macrophage-stimulating protein MSTP9, 850102883$disulfide bond, 850104557$domain:Kringle 1, 850104568$domain:Kringle 2, 850104579$domain:Kringle 3, 850104589$domain:Kringle 4, 850104890$domain:PAN, 850104964$domain:Peptidase S1, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
maestro,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
maestro,UP_SEQ_FEATURE[850046784$chain:Protein maestro, 850116139$repeat:HEAT, 850117295$sequence variant]
major facilitator superfamily domain containing 10,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
major facilitator superfamily domain containing 10,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane, 790001558$transport]
major facilitator superfamily domain containing 10,UP_SEQ_FEATURE[850030091$chain:Major facilitator superfamily domain- containing protein 10, 850117294$sequence conflict, 850118623$transmembrane region]
major facilitator superfamily domain containing 11,INTERPRO[450009360$IPR010291:Protein of unknown function DUF895, eukaryotic]
major facilitator superfamily domain containing 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
major facilitator superfamily domain containing 11,UP_SEQ_FEATURE[850068327$chain:UNC93-like protein MFSD11, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
major facilitator superfamily domain containing 6,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
major facilitator superfamily domain containing 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
major facilitator superfamily domain containing 6,UP_SEQ_FEATURE[850030098$chain:Major facilitator superfamily domain- containing protein 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
major histocompatibility complex, class I, A,BBID[10000091$70.Signal_peptides_(MHC)_class_I_molecules]
major histocompatibility complex, class I, A,BIOCARTA[30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000187$h_mhcPathway:Antigen Processing and Presentation, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity]
major histocompatibility complex, class I, A,INTERPRO[450000912$IPR001039:MHC class I, alpha chain, alpha1 and alpha2, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450006486$IPR007110:Immunoglobulin-like, 450009629$IPR010579:MHC class I, alpha chain, C-terminal, 450010088$IPR011161:MHC class I-like antigen recognition, 450012396$IPR013783:Immunoglobulin-like fold]
major histocompatibility complex, class I, A,KEGG_PATHWAY[470038841$hsa04144:Endocytosis, 470038855$hsa04514:Cell adhesion molecules (CAMs), 470038860$hsa04612:Antigen processing and presentation, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038888$hsa04940:Type I diabetes mellitus, 470038915$hsa05320:Autoimmune thyroid disease, 470038917$hsa05330:Allograft rejection, 470038918$hsa05332:Graft-versus-host disease, 470038923$hsa05416:Viral myocarditis]
major histocompatibility complex, class I, A,OMIM_DISEASE[520000086$Abacavir hypersensitivity, susceptibility to, 520000336$Ankylosing spondylitis, susceptibility to, 1, 520004694$Stevens-Johnson syndrome, susceptibility to]
major histocompatibility complex, class I, A,PIR_SUPERFAMILY[630002127$PIRSF001990:class I histocompatibility antigen]
major histocompatibility complex, class I, A,SMART[760000355$SM00407:IGc1]
major histocompatibility complex, class I, A,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000679$heterodimer, 790000733$host-virus interaction, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790000924$membrane protein, 790000955$mhc i, 790000956$mhc ii, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001461$sulfation, 790001555$transmembrane, 790001556$transmembrane protein, 790001557$transplantation antigen, 790001592$ubl conjugation]
major histocompatibility complex, class I, A,UP_SEQ_FEATURE[850024215$chain:HLA class I histocompatibility antigen, A-1 alpha chain, 850024216$chain:HLA class I histocompatibility antigen, A-11 alpha chain, 850024217$chain:HLA class I histocompatibility antigen, A-2 alpha chain, 850024218$chain:HLA class I histocompatibility antigen, A-23 alpha chain, 850024219$chain:HLA class I histocompatibility antigen, A-24 alpha chain, 850024220$chain:HLA class I histocompatibility antigen, A-25 alpha chain, 850024221$chain:HLA class I histocompatibility antigen, A-26 alpha chain, 850024222$chain:HLA class I histocompatibility antigen, A-29 alpha chain, 850024223$chain:HLA class I histocompatibility antigen, A-3 alpha chain, 850024224$chain:HLA class I histocompatibility antigen, A-31 alpha chain, 850024225$chain:HLA class I histocompatibility antigen, A-32 alpha chain, 850024226$chain:HLA class I histocompatibility antigen, A-34 alpha chain, 850024227$chain:HLA class I histocompatibility antigen, A-36 alpha chain, 850024228$chain:HLA class I histocompatibility antigen, A-43 alpha chain, 850024229$chain:HLA class I histocompatibility antigen, A-66 alpha chain, 850024230$chain:HLA class I histocompatibility antigen, A-68 alpha chain, 850024231$chain:HLA class I histocompatibility antigen, A-69 alpha chain, 850024232$chain:HLA class I histocompatibility antigen, A-80 alpha chain, 850031600$chain:MHC class I antigen, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850110907$region of interest:Alpha-1, 850110908$region of interest:Alpha-2, 850110909$region of interest:Alpha-3, 850111296$region of interest:Connecting peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
makorin ring finger protein 2,COG_ONTOLOGY[90000073$General function prediction only]
makorin ring finger protein 2,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type, 450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
makorin ring finger protein 2,SMART[760000158$SM00184:RING, 760000324$SM00356:ZnF_C3H1]
makorin ring finger protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000859$ligase, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
makorin ring finger protein 2,UP_SEQ_FEATURE[850041863$chain:Probable E3 ubiquitin-protein ligase makorin-2, 850106258$modified residue, 850113321$region of interest:Makorin-type Cys-His, 850117294$sequence conflict, 850117295$sequence variant, 850118752$zinc finger region:C3H1-type 1, 850118753$zinc finger region:C3H1-type 2, 850118754$zinc finger region:C3H1-type 3, 850118756$zinc finger region:C3H1-type 4, 850118911$zinc finger region:RING-type]
makorin ring finger protein pseudogene 6; makorin ring finger protein 1,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type, 450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
makorin ring finger protein pseudogene 6; makorin ring finger protein 1,SMART[760000158$SM00184:RING, 760000324$SM00356:ZnF_C3H1]
makorin ring finger protein pseudogene 6; makorin ring finger protein 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000859$ligase, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
makorin ring finger protein pseudogene 6; makorin ring finger protein 1,UP_SEQ_FEATURE[850016664$chain:E3 ubiquitin-protein ligase makorin-1, 850051870$chain:Putative makorin-5, 850106259$mutagenesis site, 850113321$region of interest:Makorin-type Cys-His, 850117294$sequence conflict, 850117295$sequence variant, 850118752$zinc finger region:C3H1-type 1, 850118753$zinc finger region:C3H1-type 2, 850118754$zinc finger region:C3H1-type 3, 850118756$zinc finger region:C3H1-type 4, 850118911$zinc finger region:RING-type]
mannosidase, alpha, class 1A, member 1,INTERPRO[450001227$IPR001382:Glycoside hydrolase, family 47]
mannosidase, alpha, class 1A, member 1,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
mannosidase, alpha, class 1A, member 1,PIR_SUPERFAMILY[630014256$PIRSF017531:mannosyl-oligosaccharide 1,2-alpha-mannosidase, 1A type]
mannosidase, alpha, class 1A, member 1,SP_PIR_KEYWORDS[790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000617$glycosidase, 790000624$golgi apparatus, 790000743$hydrolase, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane, 790001556$transmembrane protein]
mannosidase, alpha, class 1A, member 1,UP_SEQ_FEATURE[850030470$chain:Mannosyl-oligosaccharide 1,2-alpha- mannosidase IA, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
mannosidase, alpha, class 1B, member 1,INTERPRO[450000883$IPR001010:Thionin, 450001227$IPR001382:Glycoside hydrolase, family 47, 450011734$IPR013090:Phospholipase A2, active site]
mannosidase, alpha, class 1B, member 1,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
mannosidase, alpha, class 1B, member 1,PIR_SUPERFAMILY[630014256$PIRSF017531:mannosyl-oligosaccharide 1,2-alpha-mannosidase, 1A type]
mannosidase, alpha, class 1B, member 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000617$glycosidase, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
mannosidase, alpha, class 1B, member 1,UP_SEQ_FEATURE[850017377$chain:Endoplasmic reticulum mannosyl- oligosaccharide 1,2-alpha-mannosidase, 850102883$disulfide bond, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
mannosidase, alpha, class 1C, member 1,INTERPRO[450001227$IPR001382:Glycoside hydrolase, family 47]
mannosidase, alpha, class 1C, member 1,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
mannosidase, alpha, class 1C, member 1,PIR_SUPERFAMILY[630014256$PIRSF017531:mannosyl-oligosaccharide 1,2-alpha-mannosidase, 1A type]
mannosidase, alpha, class 1C, member 1,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000616$glycoprotein, 790000617$glycosidase, 790000624$golgi apparatus, 790000743$hydrolase, 790000919$membrane, 790001162$phosphoprotein, 790001409$Signal-anchor, 790001555$transmembrane]
mannosidase, alpha, class 1C, member 1,UP_SEQ_FEATURE[850030472$chain:Mannosyl-oligosaccharide 1,2-alpha- mannosidase IC, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
mannosidase, alpha, class 2A, member 1,INTERPRO[450000514$IPR000602:Glycoside hydrolase, family 38, core, 450010510$IPR011682:Glycosyl hydrolases 38, C-terminal, 450013783$IPR015341:Glycoside hydrolase, family 38, central region]
mannosidase, alpha, class 2A, member 1,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
mannosidase, alpha, class 2A, member 1,PIR_SUPERFAMILY[630012526$PIRSF015759:lysosomal alpha-mannosidase]
mannosidase, alpha, class 2A, member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000617$glycosidase, 790000624$golgi apparatus, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
mannosidase, alpha, class 2A, member 1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850004839$chain:Alpha-mannosidase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
mannosidase, alpha, class 2B, member 1,INTERPRO[450000514$IPR000602:Glycoside hydrolase, family 38, core, 450010510$IPR011682:Glycosyl hydrolases 38, C-terminal, 450012394$IPR013780:Glycosyl hydrolase, family 13, all-beta, 450013783$IPR015341:Glycoside hydrolase, family 38, central region]
mannosidase, alpha, class 2B, member 1,KEGG_PATHWAY[470038767$hsa00511:Other glycan degradation, 470038840$hsa04142:Lysosome]
mannosidase, alpha, class 2B, member 1,OMIM_DISEASE[520003070$Mannosidosis, alpha-, types I and II]
mannosidase, alpha, class 2B, member 1,PIR_SUPERFAMILY[630012526$PIRSF015759:lysosomal alpha-mannosidase]
mannosidase, alpha, class 2B, member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790000897$lysosome, 790000937$metal-binding, 790001212$polymorphism, 790001405$signal, 790001648$zinc, 790001652$zymogen]
mannosidase, alpha, class 2B, member 1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850029368$chain:Lysosomal alpha-mannosidase, 850029369$chain:Lysosomal alpha-mannosidase A peptide, 850029370$chain:Lysosomal alpha-mannosidase B peptide, 850029371$chain:Lysosomal alpha-mannosidase C peptide, 850029372$chain:Lysosomal alpha-mannosidase D peptide, 850029373$chain:Lysosomal alpha-mannosidase E peptide, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106218$metal ion-binding site:Zinc, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B,INTERPRO[450006166$IPR006759:Glycosyl transferase, family 54]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B,KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B,UP_SEQ_FEATURE[850004606$chain:Alpha-1,3-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase B, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
